Citrus Sinensis ID: 040202
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | 2.2.26 [Sep-21-2011] | |||||||
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | no | no | 0.670 | 0.433 | 0.479 | 1e-57 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | no | no | 0.670 | 0.459 | 0.438 | 3e-53 | |
| P43294 | 443 | Serine/threonine-protein | no | no | 0.636 | 0.426 | 0.443 | 2e-49 | |
| Q04859 | 622 | Serine/threonine-protein | yes | no | 0.639 | 0.305 | 0.376 | 8e-45 | |
| P20793 | 622 | Serine/threonine-protein | yes | no | 0.639 | 0.305 | 0.371 | 1e-44 | |
| P20794 | 623 | Serine/threonine-protein | yes | no | 0.639 | 0.304 | 0.367 | 1e-43 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | no | 0.649 | 0.305 | 0.383 | 5e-43 | |
| Q62726 | 629 | Serine/threonine-protein | no | no | 0.649 | 0.306 | 0.379 | 1e-42 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | no | 0.649 | 0.306 | 0.379 | 1e-42 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | no | 0.683 | 0.400 | 0.361 | 8e-41 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 223 bits (569), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 116/242 (47%), Positives = 148/242 (61%), Gaps = 43/242 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LR+MN HPNIVKL+ +++E++ ++ + +YME +L +LMK+ + FSE E RN CFQ+FQ
Sbjct: 54 LRRMN-HPNIVKLKEVIRENDILYFIMEYMECNLYQLMKDRV-KPFSEAEVRNWCFQIFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L YMH++GYFHRDLKP NLLVSK VIK+ D G+ +E+ S P T+YV+TRWYRAPEVLL
Sbjct: 112 ALAYMHQRGYFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------------- 163
S I VD WAMGAIM E+L+ LFPG + AD+I KI
Sbjct: 172 QSSIYDSAVDMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAE 231
Query: 164 ---------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
V LIS LCSW+P RP AAE L+H FF+ C FVP
Sbjct: 232 TMKFQFPQVSGNQLAEVMTSVSSEAVDLISSLCSWDPCKRPKAAEVLQHTFFQGCTFVPP 291
Query: 203 SV 204
+V
Sbjct: 292 TV 293
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 106/242 (43%), Positives = 143/242 (59%), Gaps = 43/242 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N HPNIVKL+ + E+ ++F +F+ ME +L +++E FSE+E RN Q+ Q
Sbjct: 54 LQKLN-HPNIVKLKEVTMENHELFFIFENMECNLYDVIRERQAA-FSEEEIRNFMVQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL YMH GYFHRDLKP NLLV+ G +KI D G+ +E+ SS P TDYV+TRWYRAPEVLL
Sbjct: 112 GLAYMHNNGYFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRW-------- 167
S P +D WA+GAI+ E+ + LFPG + DQ+YKI + W
Sbjct: 172 QSSAYTPAIDMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPR 231
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
+ LI LCSW+PR RPTA ++L+HPFF ++VPR
Sbjct: 232 SSSFNFFQIPPRNLWELIPNATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVGNWVPR 291
Query: 203 SV 204
+
Sbjct: 292 PL 293
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 103/232 (44%), Positives = 141/232 (60%), Gaps = 43/232 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LRK+N HP+I+KL+ +V+EH ++F +F+ M+ +L +MKE + FSE E R+ Q+ Q
Sbjct: 62 LRKLN-HPHIIKLKEIVREHNELFFIFECMDHNLYHIMKERE-RPFSEGEIRSFMSQMLQ 119
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL +MH+ GYFHRDLKP NLLV+ ++KI D G+ +E+ S P T+YV+TRWYRAPEVLL
Sbjct: 120 GLAHMHKNGYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLL 179
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---YGR--W----------- 167
S + P VD WA+GAI+ E+ + LFPG++ DQ+YKI G+ W
Sbjct: 180 QSSLYTPAVDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISR 239
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ LI+ LCSW+P RPTA EAL HPFF
Sbjct: 240 IMSISHTEFPQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFF 291
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 8e-45, Method: Compositional matrix adjust.
Identities = 88/234 (37%), Positives = 142/234 (60%), Gaps = 44/234 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ VF+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRW------- 167
L S + +D WA+G+IM E+ +FR LFPG + D+I+KI W
Sbjct: 172 LRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLA 231
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+ L++ + +W+P+ RPTA++AL+HP+F+
Sbjct: 232 SSMNFRFPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 87/234 (37%), Positives = 142/234 (60%), Gaps = 44/234 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ +F+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRW------- 167
L S + +D WA+G+IM E+ +FR LFPG + D+I+KI W
Sbjct: 172 LRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLA 231
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+ L++ + +W+P+ RPTA++AL+HP+F+
Sbjct: 232 SSMNFRFPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 86/234 (36%), Positives = 140/234 (59%), Gaps = 44/234 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ +F+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRW------- 167
L S + +D WA+G+IM E+ R LFPG + D+I+KI W
Sbjct: 172 LRSSVYSSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLA 231
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+ L++ + +W+P+ RPTA++AL+HP+F+
Sbjct: 232 SSMNFRFPQCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 5e-43, Method: Compositional matrix adjust.
Identities = 91/237 (38%), Positives = 137/237 (57%), Gaps = 44/237 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N+VKL+ +++E++ ++ +F+YM+ +L +L+KE + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVVKLKEVIRENDHLYFIFEYMKENLYQLIKER-NKLFPESAIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRDLKP NLL + ++KI D G+ +EI S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG----------------- 165
L S +D WA+G IM E+ + R LFPG + D I+KI
Sbjct: 172 LRSTNYSSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLS 231
Query: 166 -----RW-------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
RW V L+ + W+P+ RPTA++AL +P+F+ H
Sbjct: 232 SAMNFRWPQCVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQVGH 288
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 90/237 (37%), Positives = 135/237 (56%), Gaps = 44/237 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H NIVKL+ +++E++ ++ +F+YM+ +L +L+KE + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANIVKLKEVIRENDHLYFIFEYMKENLYQLIKER-NKLFPESAIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRDLKP NLL + ++KI D G+ +EI S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------------------- 163
L S +D WA+G IM E+ + R LFPG + D I+KI
Sbjct: 172 LRSTNYSSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLS 231
Query: 164 ----------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
+ L+ L W+P+ RPTA++AL +P+F+ H
Sbjct: 232 SAMNFIWPQCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIGH 288
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 90/237 (37%), Positives = 135/237 (56%), Gaps = 44/237 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H NIVKL+ +++E++ ++ +F+YM+ +L +L+KE + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANIVKLKEVIRENDHLYFIFEYMKENLYQLIKER-NKLFPESAIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRDLKP NLL + ++KI D G+ +EI S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------------------- 163
L S +D WA+G IM E+ + R LFPG + D I+KI
Sbjct: 172 LRSTNYSSPIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLS 231
Query: 164 ----------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
+ L+ L W+P+ RPTA++AL +P+F+ H
Sbjct: 232 SAMNFLWPQCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIGH 288
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (423), Expect = 8e-41, Method: Compositional matrix adjust.
Identities = 91/252 (36%), Positives = 138/252 (54%), Gaps = 49/252 (19%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+ HPNIVKL ++ E +++F VF+Y+E++L + +K+ + E RN+ +Q+ Q
Sbjct: 54 LKKLK-HPNIVKLLEIILERDELFFVFEYLENNLYESIKDRT-KLLPETTIRNIIYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
LH+MH G+FHRDLKP N+++ +KI D G+ +EI+S P TDY++TRWYRAPEVLL
Sbjct: 112 ALHFMHTNGFFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRW-------- 167
+D WA+GAIM E+ S + +FPG + DQ++KI W
Sbjct: 172 RCTYYNAPIDIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLAN 231
Query: 168 ----------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199
+ LI+ L ++P RPT +AL+H +F+
Sbjct: 232 SMGFTFPNVQPPSINPLSTLLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFKVS-- 289
Query: 200 VPRSVPLLCNNF 211
+P S+ LL NF
Sbjct: 290 IPSSI-LLKPNF 300
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| 9758733 | 530 | serine/threonine-protein kinase Mak (mal | 0.656 | 0.367 | 0.518 | 5e-62 | |
| 357110734 | 475 | PREDICTED: cyclin-dependent kinase F-4-l | 0.717 | 0.448 | 0.486 | 7e-62 | |
| 359474639 | 452 | PREDICTED: cyclin-dependent kinase F-4-l | 0.670 | 0.440 | 0.520 | 7e-62 | |
| 18422554 | 499 | conserved peptide upstream open reading | 0.656 | 0.390 | 0.518 | 7e-62 | |
| 334188209 | 497 | conserved peptide upstream open reading | 0.656 | 0.392 | 0.518 | 8e-62 | |
| 15450860 | 499 | serine/threonine-protein kinase Mak (mal | 0.656 | 0.390 | 0.518 | 8e-62 | |
| 115466036 | 484 | Os06g0116100 [Oryza sativa Japonica Grou | 0.717 | 0.440 | 0.480 | 1e-61 | |
| 218197453 | 419 | hypothetical protein OsI_21386 [Oryza sa | 0.717 | 0.508 | 0.480 | 2e-61 | |
| 357484657 | 449 | Serine/threonine protein kinase ICK [Med | 0.670 | 0.443 | 0.516 | 2e-61 | |
| 27948450 | 483 | GAMYB-binding protein [Hordeum vulgare s | 0.730 | 0.449 | 0.482 | 8e-61 |
| >gi|9758733|dbj|BAB09171.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 244 bits (622), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 123/237 (51%), Positives = 157/237 (66%), Gaps = 42/237 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHPNIVKL+ +++E++ ++ VF+YME +L +LMK+ ++F+E + RN CFQVFQGL YM
Sbjct: 66 NHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYM 124
Query: 69 HRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIC 128
H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +
Sbjct: 125 HQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVY 184
Query: 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW------------- 167
+VD WAMGAIM E+LS R LFPG + AD+IYKI W
Sbjct: 185 TSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQ 244
Query: 168 --------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSV 204
V LI LCSW+P RPT AEAL+HPFF+SC+++P S+
Sbjct: 245 FPQFPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSL 301
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357110734|ref|XP_003557171.1| PREDICTED: cyclin-dependent kinase F-4-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 243 bits (620), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 125/257 (48%), Positives = 160/257 (62%), Gaps = 44/257 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LRKMN HPNIVKL+ +++EH+ +F VF+YME +L +LMK + G+ FSE E RN CFQ+FQ
Sbjct: 54 LRKMN-HPNIVKLKEVIREHDMLFFVFEYMECNLYQLMK-NKGKPFSETEIRNWCFQIFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L +MH++GYFHRDLKP NLLV+K VIK+ D G+ +EI S P T+YV+TRWYRAPEVLL
Sbjct: 112 ALSHMHQRGYFHRDLKPENLLVTKEVIKVADFGLAREISSEPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW-------- 167
+ + VD WAMGAI+ E+ S R LFPG + AD+IYKI W
Sbjct: 172 QASVYSSAVDMWAMGAIIAELFSLRPLFPGSSEADEIYKICSILGTPNPRTWAEGLQLAA 231
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
V LISWLCSW+PR RPTA E L+HPFF+ C ++P
Sbjct: 232 SINFQFPQLESIHLSEVVPSASEDAVNLISWLCSWDPRRRPTAVEVLQHPFFQPCFYIPP 291
Query: 203 SVPLLCNNFEAVAFPTA 219
S+ + A P+A
Sbjct: 292 SLRFRSTGY-ATTPPSA 307
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474639|ref|XP_002265359.2| PREDICTED: cyclin-dependent kinase F-4-like [Vitis vinifera] gi|296088459|emb|CBI37450.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 243 bits (620), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 126/242 (52%), Positives = 157/242 (64%), Gaps = 43/242 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LRKMN HPNIVKLR + +E++ ++ VF+YME +L +LMK+ + FSE E RN CFQVFQ
Sbjct: 54 LRKMN-HPNIVKLREVFRENDILYFVFEYMECNLYQLMKDRL-KLFSETEVRNWCFQVFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL YMHR+GYFHRDLKP NLLV+K VIKI D G+ +EI+S P T+YV+TRWYRAPEVLL
Sbjct: 112 GLAYMHRRGYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRW-------- 167
S G VD WAMGAIM E+ + R LFPG + AD+IYKI + W
Sbjct: 172 QSSTYGSAVDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVMGSPTWNSWAEGLKLAN 231
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
++LI+ LCSW+P RPTA EAL+HPFF+SC +VP
Sbjct: 232 AINYQFPQFSSIHLSVLIPSASEDAISLITSLCSWDPCKRPTALEALQHPFFQSCFYVPP 291
Query: 203 SV 204
S+
Sbjct: 292 SL 293
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18422554|ref|NP_568646.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] gi|24899765|gb|AAN65097.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana] gi|332007866|gb|AED95249.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 243 bits (620), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 123/237 (51%), Positives = 157/237 (66%), Gaps = 42/237 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHPNIVKL+ +++E++ ++ VF+YME +L +LMK+ ++F+E + RN CFQVFQGL YM
Sbjct: 58 NHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYM 116
Query: 69 HRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIC 128
H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +
Sbjct: 117 HQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVY 176
Query: 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW------------- 167
+VD WAMGAIM E+LS R LFPG + AD+IYKI W
Sbjct: 177 TSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQ 236
Query: 168 --------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSV 204
V LI LCSW+P RPT AEAL+HPFF+SC+++P S+
Sbjct: 237 FPQFPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSL 293
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334188209|ref|NP_001190473.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] gi|332007867|gb|AED95250.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 243 bits (620), Expect = 8e-62, Method: Compositional matrix adjust.
Identities = 123/237 (51%), Positives = 157/237 (66%), Gaps = 42/237 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHPNIVKL+ +++E++ ++ VF+YME +L +LMK+ ++F+E + RN CFQVFQGL YM
Sbjct: 58 NHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYM 116
Query: 69 HRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIC 128
H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +
Sbjct: 117 HQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVY 176
Query: 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW------------- 167
+VD WAMGAIM E+LS R LFPG + AD+IYKI W
Sbjct: 177 TSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQ 236
Query: 168 --------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSV 204
V LI LCSW+P RPT AEAL+HPFF+SC+++P S+
Sbjct: 237 FPQFPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSL 293
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15450860|gb|AAK96701.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 243 bits (620), Expect = 8e-62, Method: Compositional matrix adjust.
Identities = 123/237 (51%), Positives = 157/237 (66%), Gaps = 42/237 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHPNIVKL+ +++E++ ++ VF+YME +L +LMK+ ++F+E + RN CFQVFQGL YM
Sbjct: 58 NHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYM 116
Query: 69 HRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIC 128
H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +
Sbjct: 117 HQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVY 176
Query: 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW------------- 167
+VD WAMGAIM E+LS R LFPG + AD+IYKI W
Sbjct: 177 TSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQ 236
Query: 168 --------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSV 204
V LI LCSW+P RPT AEAL+HPFF+SC+++P S+
Sbjct: 237 FPQFPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSL 293
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115466036|ref|NP_001056617.1| Os06g0116100 [Oryza sativa Japonica Group] gi|55296195|dbj|BAD67913.1| putative GAMYB-binding protein [Oryza sativa Japonica Group] gi|113594657|dbj|BAF18531.1| Os06g0116100 [Oryza sativa Japonica Group] gi|194396107|gb|ACF60471.1| myb-binding protein [Oryza sativa Japonica Group] gi|215697479|dbj|BAG91473.1| unnamed protein product [Oryza sativa Japonica Group] gi|222634854|gb|EEE64986.1| hypothetical protein OsJ_19906 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 242 bits (618), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 123/256 (48%), Positives = 160/256 (62%), Gaps = 43/256 (16%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LR+MN HPNIVKL+ +++E++ +F VF+YME +L +LMK S G+ FSE E RN CFQ+FQ
Sbjct: 54 LRRMN-HPNIVKLKEVIRENDMLFFVFEYMECNLYQLMK-SRGKPFSETEVRNWCFQIFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L +MH++GYFHRDLKP NLLV+K +IKI D G+ +EI S P T+YV+TRWYRAPEVLL
Sbjct: 112 ALSHMHQRGYFHRDLKPENLLVTKELIKIADFGLAREISSEPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW-------- 167
+ + VD WAMGAI+ E+ S R LFPG N AD+IYKI W
Sbjct: 172 QASVYNSAVDMWAMGAIIAELFSLRPLFPGSNEADEIYKICSILGTPNQRTWAEGLQLAA 231
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
++LISWLCSW+P+ RPTA E L+HPFF+ C ++P
Sbjct: 232 SIRFQFPQSGSIHLSEVVPSASEDAISLISWLCSWDPQRRPTAVEVLQHPFFQPCFYIPP 291
Query: 203 SVPLLCNNFEAVAFPT 218
S+ N A P+
Sbjct: 292 SLRFRSTNGYAATPPS 307
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218197453|gb|EEC79880.1| hypothetical protein OsI_21386 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 242 bits (617), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 123/256 (48%), Positives = 160/256 (62%), Gaps = 43/256 (16%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LR+MN HPNIVKL+ +++E++ +F VF+YME +L +LMK S G+ FSE E RN CFQ+FQ
Sbjct: 54 LRRMN-HPNIVKLKEVIRENDMLFFVFEYMECNLYQLMK-SRGKPFSETEVRNWCFQIFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L +MH++GYFHRDLKP NLLV+K +IKI D G+ +EI S P T+YV+TRWYRAPEVLL
Sbjct: 112 ALSHMHQRGYFHRDLKPENLLVTKELIKIADFGLAREISSEPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW-------- 167
+ + VD WAMGAI+ E+ S R LFPG N AD+IYKI W
Sbjct: 172 QASVYNSAVDMWAMGAIIAELFSLRPLFPGSNEADEIYKICSILGTPNQRTWAEGLQLAA 231
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
++LISWLCSW+P+ RPTA E L+HPFF+ C ++P
Sbjct: 232 SIRFQFPQSGSIHLSEVVPSASEDAISLISWLCSWDPQRRPTAVEVLQHPFFQPCFYIPP 291
Query: 203 SVPLLCNNFEAVAFPT 218
S+ N A P+
Sbjct: 292 SLRFRSTNGYAATPPS 307
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 241 bits (616), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 125/242 (51%), Positives = 158/242 (65%), Gaps = 43/242 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LRKMN HPNIVKL+ +++E + ++ VF+YME +L +LMK+ + FSE E RN CFQVFQ
Sbjct: 54 LRKMN-HPNIVKLKEVIRESDILYFVFEYMECNLYQLMKDRE-KLFSEGEIRNWCFQVFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL YMH++GYFHRDLKP NLLV+K VIKI D G+ +EI+S P T+YV+TRWYRAPEVLL
Sbjct: 112 GLAYMHQRGYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW-------- 167
S I +VD WAMGAIM E+ S R LFPG + AD+IYKI G W
Sbjct: 172 QSYIYSSKVDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTTDSWADGLKLAR 231
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
++LI LCSW+P RPTA+EAL+HPFF+SC ++P
Sbjct: 232 DINYQFPQLAGVNLSALIPSASDHAISLIQSLCSWDPCKRPTASEALQHPFFQSCFYIPP 291
Query: 203 SV 204
S+
Sbjct: 292 SL 293
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|27948450|gb|AAO25540.1| GAMYB-binding protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 239 bits (611), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 127/263 (48%), Positives = 160/263 (60%), Gaps = 46/263 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LR+MN HPNIVKL+ +++E++ +F VF+YME +L +LMK S G+ FSE E RN CFQVFQ
Sbjct: 54 LRRMN-HPNIVKLKEVIRENDMLFFVFEYMECNLYQLMK-SKGKPFSETEIRNWCFQVFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L +MH++GYFHRDLKP NLLV+K +IK+ D G+ +EI S P T+YV+TRWYRAPEVLL
Sbjct: 112 ALSHMHQRGYFHRDLKPENLLVTKELIKVADFGLAREIISEPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVA------ 169
S + VD WAMGAI+ E+ S R LFPG + AD+IYKI W
Sbjct: 172 QSSVYSSAVDMWAMGAIIAELFSHRPLFPGSSEADEIYKICNILGTPNQHTWAGGLQLAA 231
Query: 170 ---------------------------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
LISWLCSW+PR RPTA E L+HPFF+ C +VP
Sbjct: 232 SIHFQFPQSGSINLSEVVPTASEDALNLISWLCSWDPRKRPTAVEVLQHPFFQPCFYVP- 290
Query: 203 SVPLLCNNFEAVAFPTATVTMQG 225
P L A P +V +G
Sbjct: 291 --PSLRYRSTGYATPPPSVGAKG 311
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| TAIR|locus:2123221 | 444 | MHK [Arabidopsis thaliana (tax | 0.531 | 0.355 | 0.518 | 3.7e-52 | |
| TAIR|locus:2163583 | 499 | AT5G45430 [Arabidopsis thalian | 0.531 | 0.316 | 0.631 | 6.5e-51 | |
| TAIR|locus:2134746 | 464 | AT4G19110 [Arabidopsis thalian | 0.531 | 0.340 | 0.6 | 3.2e-49 | |
| ZFIN|ZDB-GENE-030131-7279 | 633 | mak "male germ cell-associated | 0.535 | 0.251 | 0.484 | 3.8e-46 | |
| DICTYBASE|DDB_G0268078 | 507 | DDB_G0268078 "RCK family prote | 0.531 | 0.311 | 0.456 | 2.5e-43 | |
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.531 | 0.253 | 0.453 | 5.1e-40 | |
| FB|FBgn0259712 | 706 | CG42366 [Drosophila melanogast | 0.531 | 0.223 | 0.509 | 7.4e-40 | |
| MGI|MGI:96913 | 622 | Mak "male germ cell-associated | 0.531 | 0.254 | 0.465 | 2.1e-39 | |
| RGD|3036 | 622 | Mak "male germ cell-associated | 0.531 | 0.254 | 0.459 | 2.8e-39 | |
| UNIPROTKB|P20793 | 622 | Mak "Serine/threonine-protein | 0.531 | 0.254 | 0.459 | 2.8e-39 |
| TAIR|locus:2123221 MHK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 3.7e-52, Sum P(2) = 3.7e-52
Identities = 83/160 (51%), Positives = 117/160 (73%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LRK+N HP+I+KL+ +V+EH ++F +F+ M+ +L +MKE + FSE E R+ Q+ Q
Sbjct: 62 LRKLN-HPHIIKLKEIVREHNELFFIFECMDHNLYHIMKERE-RPFSEGEIRSFMSQMLQ 119
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL +MH+ GYFHRDLKP NLLV+ ++KI D G+ +E+ S P T+YV+TRWYRAPEVLL
Sbjct: 120 GLAHMHKNGYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLL 179
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
S + P VD WA+GAI+ E+ + LFPG++ DQ+YKI
Sbjct: 180 QSSLYTPAVDMWAVGAILAELYALTPLFPGESEIDQLYKI 219
|
|
| TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 6.5e-51, P = 6.5e-51
Identities = 101/160 (63%), Positives = 129/160 (80%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L +MN HPNIVKL+ +++E++ ++ VF+YME +L +LMK+ ++F+E + RN CFQVFQ
Sbjct: 54 LSRMN-HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL YMH++GYFHRDLKP NLLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL
Sbjct: 112 GLSYMHQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
S + +VD WAMGAIM E+LS R LFPG + AD+IYKI
Sbjct: 172 QSYVYTSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKI 211
|
|
| TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 3.2e-49, P = 3.2e-49
Identities = 96/160 (60%), Positives = 128/160 (80%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LR+MN HPNIVKL+ +++E++ ++ VF+YME +L +LMK+ + F+E + +N CFQVFQ
Sbjct: 54 LRRMN-HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQ-KLFAEADIKNWCFQVFQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
GL YMH++GYFHRDLKP NLLVSK +IKI D G+ +E++SS P T+YV+TRWYRAPEVLL
Sbjct: 112 GLSYMHQRGYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
S + +VD WAMGAIM E+LS R +FPG + AD+IYKI
Sbjct: 172 QSYVYTSKVDMWAMGAIMAELLSLRPIFPGASEADEIYKI 211
|
|
| ZFIN|ZDB-GENE-030131-7279 mak "male germ cell-associated kinase" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 3.8e-46, Sum P(2) = 3.8e-46
Identities = 78/161 (48%), Positives = 117/161 (72%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N+VKL+ +++E++ ++ VF+YM+ +L +LMK+ + F+E+E RN+ FQV
Sbjct: 54 LKKLN-HANVVKLKEVIRENDHLYFVFEYMKENLYQLMKDRENKMFTENEIRNIMFQVLS 112
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +EI S P TDYV+TRWYRAPEVL
Sbjct: 113 GLAFVHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVL 172
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
L S + +D WA+G IM E+ + R LFPG + D+I+KI
Sbjct: 173 LRSPVYSSPIDIWAVGCIMAELYTLRPLFPGNSEVDEIFKI 213
|
|
| DICTYBASE|DDB_G0268078 DDB_G0268078 "RCK family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 405 (147.6 bits), Expect = 2.5e-43, Sum P(2) = 2.5e-43
Identities = 73/160 (45%), Positives = 110/160 (68%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+ HPNIVKL ++ E +++F VF+Y+E++L + +K+ + E RN+ +Q+ Q
Sbjct: 54 LKKLK-HPNIVKLLEIILERDELFFVFEYLENNLYESIKDRT-KLLPETTIRNIIYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
LH+MH G+FHRDLKP N+++ +KI D G+ +EI+S P TDY++TRWYRAPEVLL
Sbjct: 112 ALHFMHTNGFFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLL 171
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
+D WA+GAIM E+ S + +FPG + DQ++KI
Sbjct: 172 RCTYYNAPIDIWAVGAIMAELYSLKPMFPGSSEIDQLFKI 211
|
|
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 411 (149.7 bits), Expect = 5.1e-40, Sum P(2) = 5.1e-40
Identities = 73/161 (45%), Positives = 115/161 (71%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ +F+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
L S +D WA+G+IM E+ + R LFPG + D+I+KI
Sbjct: 172 LRSSAYSSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKI 212
|
|
| FB|FBgn0259712 CG42366 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 430 (156.4 bits), Expect = 7.4e-40, P = 7.4e-40
Identities = 82/161 (50%), Positives = 116/161 (72%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K++ HPNIVKL+ +++E++ ++ VF+YM+ +L +++K+ + E E +++ FQV
Sbjct: 54 LKKLS-HPNIVKLKEVIRENDTLYFVFEYMKENLYQMIKDR-DTHLPEPELKSILFQVLT 111
Query: 64 GLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL +MHR G+FHRDLKP NLL S +IKI D G+ +EI S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFMHRHGFFHRDLKPENLLCSGPDLIKIADFGLAREIRSRPPFTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
L S G +D WAMG IM E+ +FR LFPG + DQ++KI
Sbjct: 172 LHSTNYGSTIDLWAMGCIMAELYTFRPLFPGSSEVDQLFKI 212
|
|
| MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 422 (153.6 bits), Expect = 2.1e-39, P = 2.1e-39
Identities = 75/161 (46%), Positives = 117/161 (72%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ VF+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
L S + +D WA+G+IM E+ +FR LFPG + D+I+KI
Sbjct: 172 LRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKI 212
|
|
| RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 2.8e-39, P = 2.8e-39
Identities = 74/161 (45%), Positives = 117/161 (72%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ +F+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
L S + +D WA+G+IM E+ +FR LFPG + D+I+KI
Sbjct: 172 LRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKI 212
|
|
| UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 2.8e-39, P = 2.8e-39
Identities = 74/161 (45%), Positives = 117/161 (72%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+K+N H N++KL+ +++E++ ++ +F+YM+ +L +LMK+ + F E RN+ +Q+ Q
Sbjct: 54 LKKLN-HANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQ 111
Query: 64 GLHYMHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H+ G+FHRD+KP NLL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVL
Sbjct: 112 GLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVL 171
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
L S + +D WA+G+IM E+ +FR LFPG + D+I+KI
Sbjct: 172 LRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKI 212
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | LOC_Os06g02555.1 | expressed protein (462 aa) | |||||||||
(Oryza sativa Japonica) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 297 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-64 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-64 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-59 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-59 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-59 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-56 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-55 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-54 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-49 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-46 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-45 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-44 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-44 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-43 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-42 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-41 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-40 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-40 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-40 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-38 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-37 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-37 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-36 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-36 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-36 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-36 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-35 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-34 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-34 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-34 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-33 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-33 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-32 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-31 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-31 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-30 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-30 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-30 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-30 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-29 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-29 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-29 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-29 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-29 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-27 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-27 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-27 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-25 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-24 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-24 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-20 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-04 | |
| TIGR01982 | 437 | TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.003 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 2e-87
Identities = 100/234 (42%), Positives = 139/234 (59%), Gaps = 42/234 (17%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
LRK+N HPNIVKL+ + +E+++++ VF+YME +L +LMK+ G+ FSE R++ +Q+
Sbjct: 50 SLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
QGL ++H+ G+FHRDLKP NLLVS V+KI D G+ +EI S P TDYV+TRWYRAPE+
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------GRWVA---- 169
LL S VD WA+G IM E+ + R LFPG + DQ+YKI W
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229
Query: 170 -----------------------------LISWLCSWNPRMRPTAAEALEHPFF 194
LI + W+P+ RPTA++AL+HP+F
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 4e-64
Identities = 76/208 (36%), Positives = 117/208 (56%), Gaps = 21/208 (10%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K+ HPNIV+L ++ ++ + +++V +Y E DL L+K+ SEDEAR Q+
Sbjct: 51 LKKLK-HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQIL 107
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
L Y+H +G HRDLKP N+L+ G +K+ D G+ +++D T +V T Y APEV
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW-------------- 167
LL + G VD W++G I++E+L+ + FPG + +++K G+
Sbjct: 168 -LLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPE 226
Query: 168 -VALISWLCSWNPRMRPTAAEALEHPFF 194
LI L +P R TA EAL+HPFF
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 7e-64
Identities = 74/233 (31%), Positives = 119/233 (51%), Gaps = 44/233 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+++ HPNIVKL +++ +++VF+Y + DL K + S + +++ +Q+ +
Sbjct: 52 LKELK-HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLD-KRPGPLSPNLIKSIMYQLLR 109
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEV 121
GL Y H HRDLKP N+L+++ GV+K+ D G+ + L T V T WYRAPE+
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW------ 167
LL S+ VD W++G I EM++ + LFPG + DQ++KI+ W
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ L+S + +NP R +A EAL+HP+F
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 3e-59
Identities = 82/234 (35%), Positives = 126/234 (53%), Gaps = 45/234 (19%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+++N HPNI+KL ++ + D+++VF++M++DL KL+K+ + E ++ +Q+ Q
Sbjct: 52 LKELN-HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQ 109
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEV 121
GL + H G HRDLKP NLL++ GV+K+ D G+ + S P T YV TRWYRAPE+
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------------- 165
LL + VD W++G I E+LS R LFPGK+ DQ++KI+
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229
Query: 166 ---------RWV----------------ALISWLCSWNPRMRPTAAEALEHPFF 194
+ L+S + ++P R TA +AL HP+F
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-59
Identities = 73/238 (30%), Positives = 120/238 (50%), Gaps = 49/238 (20%)
Query: 4 LRKMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
L+K+ HPNIV+L+ +V +++VF+YM+ DL L+ +S F+E + + Q+
Sbjct: 52 LQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLL-DSPEVKFTESQIKCYMKQL 109
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS--SLPCTDYVTTRWYRA 118
+GL Y+H G HRD+K SN+L++ GV+K+ D G+ + S T+ V T WYR
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---G-----RW--- 167
PE+LL + GPEVD W++G I+ E+ + +F G +Q+ KI+ G W
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229
Query: 168 -------------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ L+ L + +P+ R +A +AL+H +F
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 4e-59
Identities = 76/247 (30%), Positives = 121/247 (48%), Gaps = 55/247 (22%)
Query: 4 LRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLC 58
LR + H NI+ L ++++ + DV+IV + ME+DL K++K + Q ++D +
Sbjct: 53 LRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK--SPQPLTDDHIQYFL 109
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC----TDYVTT 113
+Q+ +GL Y+H HRDLKPSN+LV+ +KI D G+ + +D T+YV T
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-------- 165
RWYRAPE+LL S +D W++G I E+L+ + LFPG++ DQ+ I
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 166 -----------RWVA-----------------------LISWLCSWNPRMRPTAAEALEH 191
++ L+ + ++P+ R TA EAL H
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 192 PFFRSCH 198
P+ H
Sbjct: 290 PYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-56
Identities = 82/212 (38%), Positives = 120/212 (56%), Gaps = 24/212 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
LR+++ HPNIV+L + ++ + +++V +Y E DL + G SEDEA+ + Q+
Sbjct: 52 LRRLS-HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQIL 108
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPE 120
+GL Y+H G HRDLKP N LL GV+KI D G+ K++ SS T +V T WY APE
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE 168
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-----------WVA 169
VLL GP+VD W++G I++E+L+ + F G+N DQ+ I W +
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 170 -------LISWLCSWNPRMRPTAAEALEHPFF 194
LI + +P RPTA E L+HP+F
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 7e-55
Identities = 78/233 (33%), Positives = 124/233 (53%), Gaps = 43/233 (18%)
Query: 4 LRKMNNHPNIVKLRNLV--KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
LR+++ HPNI++L ++ ++ + +VF+ M+ +L +L+K + E ++ +Q+
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQL 109
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
+ L +MHR G FHRD+KP N+L+ ++K+ D G + I S P T+Y++TRWYRAPE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY----------------- 164
LL GP++D WA+G + FE+LS LFPG N DQI KI+
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229
Query: 165 -----------GRWVA------------LISWLCSWNPRMRPTAAEALEHPFF 194
G + L+ L +++P R TA +AL HP+F
Sbjct: 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 5e-54
Identities = 78/243 (32%), Positives = 124/243 (51%), Gaps = 53/243 (21%)
Query: 4 LRKMN-----NHPNIVKLRNLV--KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
LR++N HPNIV ++ +V + +++V +Y+E DL LM+ Q F + E +
Sbjct: 52 LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKC 110
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTR 114
L Q+ G+ ++H HRDLK SNLL++ +G++KI D G+ +E S L P T V T
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------GR 166
WYRAPE+LL ++ +D W++G I E+L+ + LFPGK+ DQ+ KI+
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230
Query: 167 W-----------------------------------VALISWLCSWNPRMRPTAAEALEH 191
W L++ L +++P R +A +AL+H
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 192 PFF 194
P+F
Sbjct: 291 PYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-51
Identities = 74/231 (32%), Positives = 108/231 (46%), Gaps = 47/231 (20%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
H NIV L+ + +++VF+Y+E LL+L++ S G D R+ +Q+ Q + Y H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCH 117
Query: 70 RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE 126
HRD+KP N+LVS+ GV+K+ D G + + + P TDYV TRWYRAPE+L+
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---------------------- 164
G VD WA+G IM E+L LFPG + DQ+Y I
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 165 ---------------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194
+ + +P+ R T E L+HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-49
Identities = 65/194 (33%), Positives = 96/194 (49%), Gaps = 26/194 (13%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQV 61
L+K+N HPNIVKL + ++ +++V +Y E L L+KE+ SEDE + Q+
Sbjct: 44 ILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQI 101
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 118
+GL Y+H G HRDLKP N+L+ G +K+ D G+ K + S V T Y A
Sbjct: 102 LEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMA 161
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCSWN 178
PEVLL + D W++G I++E+ + LI + +
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYELPELK--------------------DLIRKMLQKD 201
Query: 179 PRMRPTAAEALEHP 192
P RP+A E LEH
Sbjct: 202 PEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 84/249 (33%), Positives = 126/249 (50%), Gaps = 56/249 (22%)
Query: 2 IFLRKMNNHPNIVKLRNLVK--EHEDVFIVFDYMESDLLKLMKESAGQNFSED-EARNLC 58
+FL+++ +HPNIVKL N++K +D+++VF+YME+DL +++ N ED R +
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR----ANILEDVHKRYIM 113
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC------TDYV 111
+Q+ + L Y+H HRDLKPSN+L+ S +K+ D G+ + + TDYV
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 112 TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------- 163
TRWYRAPE+LL S VD W++G I+ EML + LFPG ++ +Q+ KI
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233
Query: 164 ----------YGRWV------------------------ALISWLCSWNPRMRPTAAEAL 189
+ + L+ L +NP R TA EAL
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293
Query: 190 EHPFFRSCH 198
EHP+ H
Sbjct: 294 EHPYVAQFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 8e-46
Identities = 82/243 (33%), Positives = 118/243 (48%), Gaps = 56/243 (23%)
Query: 9 NHPNIVKLRNL----VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
H NI+ +R++ + +DV++V D MESDL ++ + Q +E+ R +Q+ +G
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH--SDQPLTEEHIRYFLYQLLRG 119
Query: 65 LHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP------CTDYVTTRWYR 117
L Y+H HRDLKPSNLLV++ ++IGD GM + + SS P T+YV TRWYR
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS-PTEHKYFMTEYVATRWYR 178
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------- 163
APE+LL +D W++G I EML R LFPGKN Q+ I
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 164 ------------YGR-----W-----------VALISWLCSWNPRMRPTAAEALEHPFFR 195
R W + L+S + ++P R T +AL+HPF
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 196 SCH 198
H
Sbjct: 299 QYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-45
Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 45/230 (19%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP +VKL ++ +V +YM SDL +++++ + E + ++ + +G+ YM
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYM 115
Query: 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS--SLPCTDYVTTRWYRAPEVLLLS 125
H G HRDLKP+NLL+S GV+KI D G+ + + V TRWYRAPE+L +
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------------------YG 165
P VD WA+G I E+L+ LFPG+N +Q+ + Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 166 ----------RW-----------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ L+ L ++P R +AAEAL HP+F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 71/238 (29%), Positives = 112/238 (47%), Gaps = 47/238 (19%)
Query: 3 FLRKMN--NHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKESAGQNFSEDEAR 55
L+++ HPNIV+L ++ + +VF++++ DL + + + +
Sbjct: 51 LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 114
+L Q+ +G+ ++H HRDLKP N+LV+ G +KI D G+ + + T V T
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL 170
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---GR----- 166
WYRAPEVLL S P VD W++G I E+ R LF G + ADQ+ KI+ G
Sbjct: 171 WYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 167 W--VALISW-----------------LC-----------SWNPRMRPTAAEALEHPFF 194
W + +C ++NP R +A EAL+HP+F
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-44
Identities = 74/242 (30%), Positives = 114/242 (47%), Gaps = 57/242 (23%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVF-------IVFDYMESDLLKLMKESAGQNFSEDEAR 55
L+++ HPNI+ L DVF +VF++ME+DL K++K+ + + + +
Sbjct: 55 LLQELK-HPNIIGLL-------DVFGHKSNINLVFEFMETDLEKVIKDKS-IVLTPADIK 105
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTT 113
+ +GL Y+H HRDLKP+NLL++ GV+K+ D G+ + + T V T
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT 165
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------G 165
RWYRAPE+L + G VD W++G I E+L PG + DQ+ KI+
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225
Query: 166 RW-------------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
W + L+ L + NP R TA +ALEHP+F
Sbjct: 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
Query: 195 RS 196
+
Sbjct: 286 SN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 7e-43
Identities = 78/242 (32%), Positives = 115/242 (47%), Gaps = 55/242 (22%)
Query: 9 NHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
H NI+ + ++++ DV+IV + ME+DL KL+K Q+ S D + +Q+ +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILR 117
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLP----CTDYVTTRWYRA 118
GL Y+H HRDLKPSNLL++ +KI D G+ + D T+YV TRWYRA
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------------- 165
PE++L S+ +D W++G I+ EMLS R LFPGK+ Q+ I G
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 166 ------------RWVALISW-----------------LCSWNPRMRPTAAEALEHPFFRS 196
+ + W + ++NP R T EAL HP+
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297
Query: 197 CH 198
H
Sbjct: 298 YH 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 78/265 (29%), Positives = 122/265 (46%), Gaps = 72/265 (27%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMK---ESAGQNFSEDEAR 55
+ LR++ H N+V L + EH D V+++FDY E DL +++K ++ + +
Sbjct: 53 IALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL-PCTD 109
+L +Q+ G+HY+H HRDLKP+N+LV +GV+KIGDLG+ + ++ L P D
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 110 ---YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS---------A 157
V T WYRAPE+LL + +D WA+G I E+L+ +F G+ +
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 158 DQIYKI-----------------------------------------YGRWVA------- 169
DQ+ +I +
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 170 LISWLCSWNPRMRPTAAEALEHPFF 194
L+ L ++P R TA EALEHP+F
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 73/255 (28%), Positives = 113/255 (44%), Gaps = 63/255 (24%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHED--------VFIVFDYMESDLLKLMKESAGQNFSEDE 53
I + K HPN+V L ++ E D V++V YM+ DL L+ E+ +E +
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQ 116
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC----- 107
+ Q+ +G++Y+H HRD+K +N+L+ +G++KI D G+ + D P
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 108 -------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160
T+ V TRWYR PE+LL VD W +G + EM + R + GK+ DQ+
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 161 YKI----------------------------------------YGRWVA-LISWLCSWNP 179
+ I G L+S L S +P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296
Query: 180 RMRPTAAEALEHPFF 194
R TA++ALEHP+F
Sbjct: 297 YKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 81/255 (31%), Positives = 120/255 (47%), Gaps = 57/255 (22%)
Query: 10 HPNIVKLRNLV--KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNIV+L+ +V K + +F+V +Y E DL L+ ++ FSE + + L Q+ +GL Y
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL-DNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 68 MHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLL 123
+H HRDLK SNLL++ KG +KI D G+ + LP V T WYRAPE+LL
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR--------W-------- 167
+D WA+G I+ E+L+ + L PGK+ +Q+ I W
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 168 -------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
+ L+++L ++P+ R TA EALE +F +
Sbjct: 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF-------K 294
Query: 203 SVPLLCNNFEAVAFP 217
PL C FP
Sbjct: 295 EKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-40
Identities = 75/237 (31%), Positives = 115/237 (48%), Gaps = 46/237 (19%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L K NHPNIV+L ++V +++VF++++ DL K M S ++ +Q+
Sbjct: 49 ISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
QG+ Y H HRDLKP NLL+ + G +K+ D G+ + +P Y V T WYR
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYR 166
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------- 163
APE+LL S VD W++G I EM++ R LFPG + DQ+++I
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226
Query: 164 ----------YGRWVA----------------LISWLCSWNPRMRPTAAEALEHPFF 194
+ +W L+S + ++P R +A AL+HP+F
Sbjct: 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-40
Identities = 77/237 (32%), Positives = 113/237 (47%), Gaps = 46/237 (19%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L K NHPNIVKL +++ +++VF+++ DL K M S ++ FQ+
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL 109
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
QGL + H HRDLKP NLL++ G IK+ D G+ + +P Y V T WYR
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 167
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------- 163
APE+LL + VD W++G I EM++ R LFPG + DQ+++I
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227
Query: 164 ----------YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ +W L+S + ++P R +A AL HPFF
Sbjct: 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 76/244 (31%), Positives = 118/244 (48%), Gaps = 55/244 (22%)
Query: 4 LRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L+ M+ H N++ L ++ +++ +DV++V M +DL ++K Q S+D + L
Sbjct: 68 LKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFL 123
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ +GL Y+H G HRDLKPSN+ V++ +KI D G+ + D + T YV TRWY
Sbjct: 124 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVATRWY 181
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---IYKIYG-------- 165
RAPE++L VD W++G IM E+L+ + LFPG + DQ I + G
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241
Query: 166 -------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFF 194
+ L+ + +P R TAAEAL HP+
Sbjct: 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
Query: 195 RSCH 198
H
Sbjct: 302 AEYH 305
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 52/244 (21%)
Query: 4 LRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLC 58
LR ++ H N++ +++++ DV+IV++ M++DL ++++ S Q S+D +
Sbjct: 58 LRHLD-HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFL 114
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLP-CTDYVTTRWY 116
+Q+ +GL Y+H HRDLKPSNLL+ + +KI D G+ + T+YV TRWY
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---IYKIYG-------- 165
RAPE+LL +D W++G I E+L + LFPGK+ Q I ++ G
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 166 --------RWVA-----------------------LISWLCSWNPRMRPTAAEALEHPFF 194
R++ L+ + ++P R T EAL HP+
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
Query: 195 RSCH 198
S H
Sbjct: 295 ASLH 298
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-37
Identities = 82/273 (30%), Positives = 136/273 (49%), Gaps = 70/273 (25%)
Query: 2 IFLRKMNNHPNIVKLRNLV-----KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
I L ++ HP+IV++++++ +E +D+++VF+ MESDL +++K A + + + +
Sbjct: 50 IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHHQF 107
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC----TDYV 111
+Q+ + L Y+H FHRDLKP N+L + +KI D G+ + + P TDYV
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 112 TTRWYRAPEVLLLSEICG-------PEVDRWAMGAIMFEMLSFRILFPGKN--------- 155
TRWYRAP E+CG P +D W++G I E+L+ + LFPGKN
Sbjct: 168 ATRWYRAP------ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221
Query: 156 ------SADQIYKIYG----RWVA-----------------------LISWLCSWNPRMR 182
S + I ++ R+++ L+ L +++P+ R
Sbjct: 222 DLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDR 281
Query: 183 PTAAEALEHPFFRSCHFV---PRSVPLLCNNFE 212
PTA EAL P+F+ V P + P+ FE
Sbjct: 282 PTAEEALADPYFKGLAKVEREPSAQPITKLEFE 314
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 77/239 (32%), Positives = 119/239 (49%), Gaps = 49/239 (20%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSED--EARNLCF 59
I L K H NIV+L +++ + +VF+YM+ DL K M ++ G + D ++ +
Sbjct: 49 ISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYM-DTHGVRGALDPNTVKSFTY 107
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRW 115
Q+ +G+ + H HRDLKP NLL++K G +K+ D G+ + +P + V T W
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLW 165
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---IYKIYG-----RW 167
YRAP+VLL S +D W++G IM EM++ R LFPG N+ DQ I++I G W
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225
Query: 168 --------------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ L+ L NP +R +A +AL+HP+F
Sbjct: 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 73/205 (35%), Positives = 116/205 (56%), Gaps = 27/205 (13%)
Query: 4 LRKMNNHPNIVKLRNLV----------KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDE 53
LR++N H NIV L+ +V K+ ++VF+YM+ DL+ L+ ES +FSED
Sbjct: 60 LRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDH 117
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK--EIDSSLPCTDY 110
++ Q+ +GL+Y H++ + HRD+K SN+L++ KG IK+ D G+ + + S P T+
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 111 VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVAL 170
V T WYR PE+LL E GP +D W+ G I+ E+ + + +F Q+ L
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--------EL 229
Query: 171 ISWLC-SWNPRMRPTAAEALEHPFF 194
IS LC S P + P + ++ P+F
Sbjct: 230 ISRLCGSPCPAVWP---DVIKLPYF 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-36
Identities = 83/244 (34%), Positives = 117/244 (47%), Gaps = 55/244 (22%)
Query: 4 LRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L K H N++ L ++ E +D ++V YM++DL K+M G SED+ + L
Sbjct: 67 LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM----GHPLSEDKVQYL 122
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ GL Y+H G HRDLKP NL V++ +KI D G+ + D+ + T YV TRWY
Sbjct: 123 VYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWY 180
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD---QIYKIYG-------- 165
RAPEV+L VD W++G IM EML+ + LF GK+ D QI K+ G
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 166 -------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFF 194
+ V L+ + + R TA EALEHP+F
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
Query: 195 RSCH 198
S
Sbjct: 301 DSFR 304
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 72/243 (29%), Positives = 113/243 (46%), Gaps = 54/243 (22%)
Query: 4 LRKMNNHPNIVKLRNLVKEHED-----VFIVFDYMESDLLKLM---KESAGQNFSEDEAR 55
L+ ++ IV+L ++ E +++VF+Y++SDL K M G+ +
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDY--- 110
+ +Q+ +G+ + H+ G HRDLKP NLLV KG++KI DLG+ + S+P Y
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHE 171
Query: 111 VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------- 163
+ T WYRAPEVLL S VD W++G I EM + LFPG + Q+ I
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231
Query: 164 ----------------YGRW----------------VALISWLCSWNPRMRPTAAEALEH 191
+ +W + L+ + ++P R +A AL H
Sbjct: 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
Query: 192 PFF 194
P+F
Sbjct: 292 PYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 60/166 (36%), Positives = 96/166 (57%), Gaps = 7/166 (4%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + K HPN+V L + + + +VF+Y + +L + E + E + + +Q
Sbjct: 51 IRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL-EKNPRGVPEHLIKKIIWQT 109
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYR 117
Q +++ H+ HRD+KP N+L++K G IK+ D G + + + P TDYV TRWYR
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYR 167
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
APE+L+ GP VD WA+G + E+L+ + L+PGK+ DQ+Y I
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (328), Expect = 2e-35
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 37/234 (15%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK--LMKESAGQNFSEDEARNLCFQ 60
L +N+ PNIVKL + ++ +++V +Y++ L+ L K SE EA + Q
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSS-------LPCTDYV 111
+ L Y+H +G HRD+KP N+L+ + V+K+ D G+ K + + V
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 112 TTRWYRAPEVLLLSEIC--GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW-- 167
T Y APEVLL + D W++G ++E+L+ F G+ ++ +
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
Query: 168 ----------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199
L+ L + +P+ R +++ L H
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283
|
Length = 384 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 73/233 (31%), Positives = 111/233 (47%), Gaps = 51/233 (21%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
H NIV L +++ + + +VF+Y+++DL + M + G S R FQ+ +GL Y H
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 70 RQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLS 125
++ HRDLKP NLL+S +G +K+ D G+ + S+P Y V T WYR P+VLL S
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKIY--------GRW--------- 167
+D W +G I +EM + R LFPG + DQ++KI+ W
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
L + P+ R +AAEA++HP+F
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 52/246 (21%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDE--ARNLCFQ 60
L++M H NIV+L+++V + +++VF+Y++ DL K M S +F+++ + +Q
Sbjct: 54 LLKEMQ-HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQ 110
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDY---VTTRW 115
+ +G+ Y H HRDLKP NLL+ +K+ D G+ + +P + V T W
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLW 168
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------- 165
YRAPE+LL S VD W++G I EM++ + LFPG + D+++KI+
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228
Query: 166 --------------RW----------------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+W V L+S + +P R TA ALEH +F+
Sbjct: 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 196 SCHFVP 201
P
Sbjct: 289 DLGDAP 294
|
Length = 294 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-34
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 3 FLRKMNNHPNIVKLR--NLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARN 56
L + HPNIV+ +E + I +Y+ S LLK E R
Sbjct: 52 ILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPEPVIRK 105
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLG---MVKEIDSSLPCTDYVT 112
Q+ +GL Y+H G HRD+K +N+LV S GV+K+ D G + +I++
Sbjct: 106 YTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKI-YGRWVAL 170
T ++ APEV+ E G D W++G + EM + + + N +YKI
Sbjct: 166 TPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE 224
Query: 171 ISWLCS------------WNPRMRPTAAEALEHPFF 194
I S +P+ RPTA E L+HPF
Sbjct: 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 72/238 (30%), Positives = 117/238 (49%), Gaps = 47/238 (19%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE-SAGQNFSEDEARNLCFQ 60
I L K HPNIV L++++ + ++++F+++ DL K + GQ + ++ +Q
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ 109
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY---VTTRWY 116
+ QG+ + H + HRDLKP NLL+ +KGVIK+ D G+ + +P Y V T WY
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWY 167
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------------- 163
RAPEVLL S VD W++G I EM + + LF G + DQ+++I
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227
Query: 164 -----------YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ +W + L+ + ++P R +A +AL HP+F
Sbjct: 228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 59/163 (36%), Positives = 95/163 (58%), Gaps = 4/163 (2%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L+++ H N+V L + + + +++VF++++ +L + E E R FQ+
Sbjct: 53 MLKQLR-HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL-EKYPNGLDESRVRKYLFQIL 110
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 120
+G+ + H HRD+KP N+LVS+ GV+K+ D G + + + TDYV TRWYRAPE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
+L+ G VD WA+G ++ EML+ LFPG + DQ+Y I
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
NHP IVKL + E +++V +Y +L + + FSE+ AR ++ L Y
Sbjct: 51 NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEY 108
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLS 125
+H G +RDLKP N+L+ + G IK+ D G+ KE+ S + T Y APEVLL
Sbjct: 109 LHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRWV-----ALISWL 174
G VD W++G +++EML+ + F ++ + KI + ++ LIS L
Sbjct: 169 GY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGL 227
Query: 175 CSWNPRMRPTAAEALE---HPFF 194
+P R + A E HPFF
Sbjct: 228 LQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 81/244 (33%), Positives = 115/244 (47%), Gaps = 54/244 (22%)
Query: 4 LRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L K H N++ L ++ + D ++V +M +DL KLMK + SED + L
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL 123
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ +GL Y+H G HRDLKP NL V++ +KI D G+ ++ DS + T YV TRWY
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTRWY 181
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---IYKIYG-------- 165
RAPEV+L VD W++G IM EML+ + LF G + DQ I K+ G
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 166 -------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFF 194
V ++ + + R TAAEAL HP+F
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
Query: 195 RSCH 198
H
Sbjct: 302 EEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 72/250 (28%), Positives = 115/250 (46%), Gaps = 59/250 (23%)
Query: 4 LRKMN--NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
L+ MN H NI+ L ++ E + + +V D M SDL K++ +E + + + Q+
Sbjct: 71 LKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQI 128
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV---------------KEIDSSL 105
GL+ +H+ + HRDL P+N+ + SKG+ KI D G+ + +
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 106 PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY- 164
T V T WYRAPE+L+ +E VD W++G I E+L+ + LFPG+N DQ+ +I+
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 165 -------GRW-------------------------------VALISWLCSWNPRMRPTAA 186
W + L+ L NP R +A
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308
Query: 187 EALEHPFFRS 196
EAL+H +F+S
Sbjct: 309 EALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 74/247 (29%), Positives = 117/247 (47%), Gaps = 52/247 (21%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
H NIV L ++V + + +VF+Y++ DL + M + G S + +Q+ +GL Y H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 70 RQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLS 125
R+ HRDLKP NLL++ +G +K+ D G+ + S+P Y V T WYR P+VLL S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------GRW---------- 167
++D W +G I FEM S R LFPG D+++ I+ W
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 168 -----------------------VALISWLCSWNPRMRPTAAEALEHPFFRS----CHFV 200
+ L++ + + R +A EA++H +FRS H +
Sbjct: 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSL 299
Query: 201 PRSVPLL 207
P S+ +
Sbjct: 300 PESISIF 306
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 29/213 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKE--SAGQNFSEDEARNLCFQ 60
L+K+N HPNI+K +E + IV +Y + DL + +K+ G+ F E++ + Q
Sbjct: 53 LKKLN-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 61 VFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRA 118
+ L Y+H + HRD+KP N L S G++K+GD G+ K + S++ V T +Y +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 119 PEVLLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------- 163
P E+C + D W++G +++E+ + + F G+N + KI
Sbjct: 172 P------ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS 225
Query: 164 -YGR-WVALISWLCSWNPRMRPTAAEALEHPFF 194
Y L+S L +P RP+ A+ L+ PF
Sbjct: 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-31
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 48/232 (20%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
H NIV L +++ + + +VF+Y++ DL + + + G + + + FQ+ +GL+Y H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 70 RQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLS 125
R+ HRDLKP NLL++ +G +K+ D G+ + S+P Y V T WYR P++LL S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---IYKIYG-----RW---------- 167
++D W +G I +EM + R LFPG +Q I++I G W
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239
Query: 168 -----------------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
L+S L + R R +A EA++HP+F
Sbjct: 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 72/255 (28%), Positives = 114/255 (44%), Gaps = 68/255 (26%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDY-----------MESDLLKLMKESAGQNFSE 51
LR H NI L D+ IVF ME+DL ++++ +GQ ++
Sbjct: 54 LLRHFRGHKNITCLY-------DMDIVFPGNFNELYLYEELMEADLHQIIR--SGQPLTD 104
Query: 52 DEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI-----DSSL 105
++ +Q+ GL Y+H HRDLKP NLLV + +KI D G+ + +++
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 106 PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-- 163
T+YV TRWYRAPE++L + +D W++G I+ E+L + +F GK+ DQ+ +I
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 164 --------------------YGR--------------------WVALISWLCSWNPRMRP 183
Y R + L+ L +++P R
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284
Query: 184 TAAEALEHPFFRSCH 198
+ EALEHP+ H
Sbjct: 285 SVEEALEHPYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 68/264 (25%)
Query: 4 LRKMNNHPNIVK---------------LRNLVKEHEDVFIVFDYMESDLLKLMKESAGQN 48
+R+++ H NIVK + +L E V+IV +YME+DL ++++
Sbjct: 56 IRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLT-ELNSVYIVQEYMETDLANVLEQ---GP 110
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLP 106
SE+ AR +Q+ +GL Y+H HRDLKP+N+ ++ V+KIGD G+ + +D
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 107 CTDY----VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
Y + T+WYR+P +LL +D WA G I EML+ + LF G + +Q+
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
Query: 163 I-------------------------YG----------------RWVALISWLCSWNPRM 181
I G + + + ++NP
Sbjct: 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290
Query: 182 RPTAAEALEHPFFRSCHFVPRSVP 205
R TA EAL HP+ SC+ P P
Sbjct: 291 RLTAEEALMHPYM-SCYSCPFDEP 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 63/171 (36%), Positives = 99/171 (57%), Gaps = 18/171 (10%)
Query: 4 LRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L K+ NH NI+ L N+ ++E +DV++V + M+++L ++++ + + L
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYL 123
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + +S T YV TR+Y
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 117 RAPEVLL---LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY 164
RAPEV+L E VD W++G IM EM+ +LFPG + DQ KI
Sbjct: 184 RAPEVILGMGYKE----NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARN 56
+ L+K HPNIVK + ++++IV ++ DLLK S Q +E +
Sbjct: 48 IQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK----STNQTLTESQIAY 102
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
+C ++ +GL Y+H G HRD+K +N+L+ S G +K+ D G+ ++ + V T +
Sbjct: 103 VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPY 162
Query: 116 YRAPEVLLLSEICGPEVDRWAMG--AI--------MFEMLSFRILFPGKNSADQIYKIYG 165
+ APEV+ + + D W++G AI E+ + LF K + + +
Sbjct: 163 WMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIATNGPPGLRN 219
Query: 166 RWVALIS-----WLC-SWNPRMRPTAAEALEHPF 193
C NP RPTA + L+HPF
Sbjct: 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 64/167 (38%), Positives = 96/167 (57%), Gaps = 12/167 (7%)
Query: 4 LRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L K H N++ L ++ ++E DV++V M +DL ++K Q ++D + L
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 125
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ +GL Y+H HRDLKPSNL V++ +KI D G+ + D + T YV TRWY
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWY 183
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
RAPE++L VD W++G IM E+L+ R LFPG + DQ+ I
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 63/166 (37%), Positives = 88/166 (53%), Gaps = 8/166 (4%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L K H NIV L +++ E + VF+YM +DL + M + G R FQ+ +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLR 114
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAP 119
GL Y+H Q HRDLKP NLL+S G +K+ D G+ + S+P Y V T WYR P
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPP 172
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA-DQIYKIY 164
+VLL + +D W G I EML + FPG + +Q+ KI+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-30
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNIVK ++ + ++I+ +Y E+ L +++K+ F E +QV QGL Y
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAY 114
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM-VKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
+H QG HRD+K +N+L +K GV+K+ D G+ K D S V T ++ APEV+ +S
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR---------WVALISWL-- 174
D W++G + E+L+ + N +++I L +L
Sbjct: 175 GAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233
Query: 175 C-SWNPRMRPTAAEALEHPFF 194
C +P +RPTA + L+HP+
Sbjct: 234 CFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 72/239 (30%), Positives = 115/239 (48%), Gaps = 49/239 (20%)
Query: 4 LRKMNNHPNIVKLRNL-VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L K H NI+ L ++ + ED++ V + + +DL +L+ + + + +Q+
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT---SRPLEKQFIQYFLYQIL 118
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
+GL Y+H G HRDLKPSN+L+++ +KI D G+ + D + T YV+TR+YRAPE+
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEI 176
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------------- 165
+L + EVD W+ G I EML + LFPGK+ +Q I
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236
Query: 166 ---RWV-----------------------ALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
R+V L+ + ++P+ R +AAEAL HP+ H
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-30
Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 44/236 (18%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L K H NIV+L +++ + + +VF+Y + DL K +S + + ++ FQ+
Sbjct: 50 ICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYF-DSCNGDIDPEIVKSFMFQL 108
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAP 119
+GL + H HRDLKP NLL++K G +K+ D G+ + + C + V T WYR P
Sbjct: 109 LKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQ---IYKIYGR--------- 166
+VL +++ +D W+ G I E+ + R LFPG + DQ I+++ G
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 167 -----------------WVALISWLCS-----------WNPRMRPTAAEALEHPFF 194
V ++ L S NP R +A EAL+HP+F
Sbjct: 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-29
Identities = 65/187 (34%), Positives = 107/187 (57%), Gaps = 8/187 (4%)
Query: 12 NIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
NIV+L+ + +++VF+Y+E ++L+L++E ++ R+ +Q+ + +H+ H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 72 GYFHRDLKPSNLLVSKG-VIKIGDLGMVKEID--SSLPCTDYVTTRWYRAPEVLLLSEIC 128
HRD+KP NLL+S V+K+ D G + + S+ T+YV TRWYR+PE LLL
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE-LLLGAPY 178
Query: 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY---KIYGRWVALISWLCSWNPRMRPTA 185
G VD W++G I+ E+ + LFPG++ DQ++ K+ G A L NPR
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238
Query: 186 AEALEHP 192
A+ HP
Sbjct: 239 FPAVNHP 245
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 59/165 (35%), Positives = 95/165 (57%), Gaps = 7/165 (4%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L K H NIV L +++ + +VF+Y++SDL + + ++ G S + FQ+ +
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLR 114
Query: 64 GLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAP 119
GL Y H++ HRDLKP NLL++ KG +K+ D G+ + S+P Y V T WYR P
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 172
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY 164
+VLL S +D W +G I++EM + R +FPG ++++ I+
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 71/230 (30%), Positives = 106/230 (46%), Gaps = 45/230 (19%)
Query: 9 NHPNIVKLRNL-----VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
+HPNIV+L ++ V +VF++++ DL + + + ++L Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 64 GLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL ++H HRDLKP N+LV S G +K+ D G+ + + T V T WYRAPEVL
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------RW------- 167
L S P VD W++G I EM + LF G + ADQ+ KI+ W
Sbjct: 180 LQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 168 -----------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
L+ + ++NP R +A AL+HPFF
Sbjct: 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 60/167 (35%), Positives = 98/167 (58%), Gaps = 12/167 (7%)
Query: 4 LRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L K H N++ L ++ ++ +V++V + M +DL ++K Q S++ + L
Sbjct: 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFL 123
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ +GL Y+H G HRDLKPSN+ V++ ++I D G+ ++ D + T YV TRWY
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWY 181
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
RAPE++L VD W++G IM E+L + LFPG + DQ+ +I
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 64/271 (23%)
Query: 9 NHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
H N++ ++++ E++++V + M+SDL K++ + Q S D + +Q+ +
Sbjct: 57 KHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKII--VSPQPLSSDHVKVFLYQILR 114
Query: 64 GLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSSLPCTDYVTTRWYRAPE 120
GL Y+H G HRD+KP NLLV S V+KI D G+ V+E D S T V T++YRAPE
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------------- 165
+L+ S VD W++G I E+L RILF ++ Q+ I
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234
Query: 166 ----------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFR-- 195
V L+ + ++P R +AA+AL HP+
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294
Query: 196 ---------SCHFVPRSVPLLCNNFEAVAFP 217
C + + ++FE A P
Sbjct: 295 RLRYHTCMCKCCYTTSGGRVYTSDFEPSANP 325
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 57/161 (35%), Positives = 87/161 (54%), Gaps = 7/161 (4%)
Query: 10 HPNIVKLRNL-----VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
HPN+V+L ++ + +VF++++ DL + + + +++ FQ+ +G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L ++H HRDLKP N+LV S G IK+ D G+ + + T V T WYRAPEVLL
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY 164
S P VD W++G I EM + LF G + DQ+ KI
Sbjct: 183 QSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
+ +HPNIVKL + E E + IV +YM DLL ++++ + S + + Q+ +G
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 65 LHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 116
+ Y+ + + HRDL N LV + V+KI D G+ +++ DY RW
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYKVKGGKLPIRWM 171
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI--YGR------- 166
APE L + D W+ G +++E+ + +PG ++A+ + + R
Sbjct: 172 -APESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229
Query: 167 ---WVALISWLCSWNPRMRPTAAEALE 190
L+ + +P RPT +E +E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 49/233 (21%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L ++N HP I+KL ++ E+++ V +Y + +LL+ +++ + E R ++
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEIL 112
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--------------- 106
L Y+H +G HRDLKP N+L+ K IKI D G K +D +
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 107 ------CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160
+V T Y +PE LL + G D WA+G I+++ML+ + F G N
Sbjct: 173 EKNRRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---- 227
Query: 161 YKIYGRWVA---------------LISWLCSWNPRMRPTAAEALE----HPFF 194
Y + + + LI L +P+ R E + HPFF
Sbjct: 228 YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 9 NHPNIVKL----RNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
H N+V L R + ++VF++ E DL L+ + F+ E + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMKM 127
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM-----VKEIDSSLPCTDYVTTR 114
+ GL+Y+HR HRD+K +N+L++K G++K+ D G+ + + T+ V T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWL 174
WYR PE+LL GP +D W G IM EM + + G Q+ LIS L
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL--------TLISQL 239
Query: 175 C-SWNPRMRP 183
C S P + P
Sbjct: 240 CGSITPEVWP 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 62/169 (36%), Positives = 99/169 (58%), Gaps = 12/169 (7%)
Query: 2 IFLRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEAR 55
+ L K NH NI+ L N+ ++E +DV++V + M+++L ++++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ----MELDHERMS 122
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
L +Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + +S T YV TR
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
+YRAPEV +L VD W++G IM EM+ +ILFPG++ DQ K+
Sbjct: 183 YYRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 62/169 (36%), Positives = 97/169 (57%), Gaps = 12/169 (7%)
Query: 2 IFLRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEAR 55
+ L K NH NI+ L N+ ++E +DV+IV + M+++L ++++ +
Sbjct: 74 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMS 129
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
L +Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + +S T YV TR
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
+YRAPEV +L VD W++G IM EM+ +LFPG + DQ K+
Sbjct: 190 YYRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 59/160 (36%), Positives = 90/160 (56%), Gaps = 8/160 (5%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
H NIV L +++ E + +VF+Y+ +DL + M + G + + FQ+ +GL Y+H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIH 120
Query: 70 RQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLS 125
++ HRDLKP NLL+S G +K+ D G+ + S+P Y V T WYR P+VLL S
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKIY 164
+D W +G I EM+ FPG K+ DQ+ +I+
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
+ +HPN+VKL + E E ++IV +YME DLL ++++ S + + Q+ +G
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARG 114
Query: 65 LHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 116
+ Y+ + + HRDL N LV + V+KI D G+ +++ DY RW
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIRWM 170
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI---YGRW----- 167
APE L + D W+ G +++E+ + +PG ++ + + + Y
Sbjct: 171 -APESLKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228
Query: 168 ----VALISWLCSWNPRMRPTAAEALE 190
L+ + +P RPT +E +E
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPNIV+ +E ++++I + + L KL+K+ +F E R Q+ GL Y+
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYL 118
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI 127
H + HRD+K +N+LV + GV+K+ D GM K++ + + ++ APEV+
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 128 CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVAL--------------ISW 173
G D W++G + EM + + + ++KI GR L I
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-GRSKELPPIPDHLSDEAKDFILK 237
Query: 174 LCSWNPRMRPTAAEALEHPF 193
+P +RPTAAE LEHPF
Sbjct: 238 CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 4 LRKMNNHPNIVKL--RNLVKEHEDVFIVFDYMES-DLLKLMKESAGQN--FSEDEARNLC 58
LR++ HPNIV+ R + + ++ ++IV +Y E DL +L+++ + E+ +
Sbjct: 53 LRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 59 FQVFQGLHYMHRQGY-----FHRDLKPSNL-LVSKGVIKIGDLGMVKEI-DSSLPCTDYV 111
Q+ L+ H + HRDLKP+N+ L + +K+GD G+ K + S YV
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 112 TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI----YGRW 167
T +Y +PE L + D W++G +++E+ + F +N KI + R
Sbjct: 172 GTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
Query: 168 VA--------LISWLCSWNPRMRPTAAEALEHPF 193
+I + + +P RP+ E L+ P
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 57/169 (33%), Positives = 95/169 (56%), Gaps = 12/169 (7%)
Query: 2 IFLRKMNNHPNIVKLRNL------VKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEAR 55
+ L K NH NI+ L N+ ++E +DV++V + M+++L +++ +
Sbjct: 71 LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH----MELDHERMS 126
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
L +Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + ++ T YV TR
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR 186
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
+YRAPEV+L VD W++G IM E++ ++F G + DQ K+
Sbjct: 187 YYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 19/167 (11%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMK-------ESAGQNFSEDE 53
LR++ HPN++ L+ + H D V+++FDY E DL ++K
Sbjct: 51 LLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSSL-PC 107
++L +Q+ G+HY+H HRDLKP+N+LV +G +KI D+G + +S L P
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 108 TDY---VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151
D V T WYRAPE+LL + +D WA+G I E+L+ +F
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 58/167 (34%), Positives = 91/167 (54%), Gaps = 19/167 (11%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEA------ 54
LR++ HPN++ L+ + H D V+++FDY E DL ++K ++
Sbjct: 51 LLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 55 -RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSSL-PC 107
++L +Q+ G+HY+H HRDLKP+N+LV +G +KI D+G + +S L P
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 108 TDY---VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151
D V T WYRAPE+LL + +D WA+G I E+L+ +F
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
P +VK + ++ IV +YM+ +DLLK + E + Q+ +G
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKG 111
Query: 65 LHYMHRQGY-FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEV 121
L Y+H + + HRD+KPSNLL+ SKG +KI D G+ K ++++L C +V T Y +PE
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE- 170
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLS--FRILFPGKNS-ADQIYKIYGRWVALISW---LC 175
+ E D W++G + E F L PG+ S + + I S
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD--GPPPSLPAEEF 228
Query: 176 SW------------NPRMRPTAAEALEHPFFRSCH 198
S +P+ RP+AAE L+HPF +
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
P +VKL + +++++V +Y+ DL L+ E+ G + ED AR ++ L Y
Sbjct: 51 QSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLL-ENVG-SLDEDVARIYIAEIVLALEY 108
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLG---------MVKEIDSSLPCTDYVTTRWYR 117
+H G HRDLKP N+L+ G +K+ D G + D V T Y
Sbjct: 109 LHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR---W------- 167
APEV +L + VD W++G I++E L F G+ + I W
Sbjct: 169 APEV-ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVS 227
Query: 168 ---VALISWLCSWNPRMRPTAAEALE---HPFF 194
+ LIS L +P R A E HPFF
Sbjct: 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-23
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 8 NNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
HP + +L + + + +F V +Y+ DL+ ++ S F E AR ++ GL
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQ 110
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAP 119
++H +G +RDLK N+L+ S+G IKI D GM KE VTT Y AP
Sbjct: 111 FLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE-----GILGGVTTSTFCGTPDYIAP 165
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-----V 168
E+L GP VD WA+G +++EML+ + F G + + I Y RW
Sbjct: 166 EILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAK 224
Query: 169 ALISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
+++ + NP R PT + + HPFFR
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-23
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQN--FSEDEARNLCFQVFQGL 65
NHPNI+ + + + IV +Y DL K + + + E E + Q+ +GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 66 HYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL- 123
+H Q HRDLK +N LLV+ ++KIGDLG+ K + ++ T + T Y APEV
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWKG 175
Query: 124 --LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRWVAL---------- 170
S D W++G +++EM +F F ++ D YK+ G++ +
Sbjct: 176 RPYSYKS----DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231
Query: 171 -ISWLCSWNPRMRPTAAEALEHP 192
I + P++RP + L P
Sbjct: 232 FIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-22
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L M HPNIV+ + +E+ +++IV DY E DL K + G F ED+ + Q+
Sbjct: 53 LSNMK-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY-VTTRWYRAPE 120
L ++H + HRD+K N+ ++K G IK+GD G+ + ++S++ + T +Y +P
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP- 170
Query: 121 VLLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRWV------ 168
EIC + D WA+G +++EM + + F N + + KI G +
Sbjct: 171 -----EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHY 225
Query: 169 -----ALISWLCSWNPRMRPTAAEALEHPF 193
L+S L NPR RP+ LE F
Sbjct: 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-22
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 54/222 (24%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEAR-------NLCFQ 60
HPN+V+L + E E +++V +YME DLL +++S S +++ + Q
Sbjct: 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT------ 113
+ +G+ Y+ + + HRDL N LV + V+KI D G+ +++ Y
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLP 170
Query: 114 -RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF---------------------RILF 151
RW APE L I + D W+ G +++E+ + R+
Sbjct: 171 IRWM-APES-LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK 228
Query: 152 PGKNSADQIYKIYGRWVALISWLCSW--NPRMRPTAAEALEH 191
P + D++Y++ L W +P RPT +E +E
Sbjct: 229 P-EYCPDELYELM---------LSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-22
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCF 59
+I L KM HPNIV +E+ +FIV +Y + DL+K + G FSED+ +
Sbjct: 50 VILLAKMK-HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLPCTDY-VTTRWY 116
Q+ GL ++H + HRD+K N+ +SK V K+GD G+ ++++ S+ V T +Y
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 117 RAPEVLLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVA-- 169
+P EIC + D W++G +++E+ + + F G N + KI + A
Sbjct: 169 LSP------EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI 222
Query: 170 ----------LISWLCSWNPRMRPTAAEALEHPFF 194
LIS L +PR RP+ L+ PF
Sbjct: 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-22
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
+ HPNI+ N + + I +Y L + GQ F E+ FQ+ +
Sbjct: 55 LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 66 HYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEVLL 123
Y+H+ G HRD+K N+ ++K G+IK+GD G+ K + S + V T +Y +P
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP---- 170
Query: 124 LSEIC-GPEV----DRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRW---------- 167
E+C G + D WA+G +++E+L+ + F N + + KI G +
Sbjct: 171 --ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE 228
Query: 168 -VALISWLCSWNPRMRPTAAEALEHPF 193
++L+ L +P RPTA E L+ P
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + K HPNIV + +++++V +YM+ L + +E + +C +V
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAP 119
QGL Y+H Q HRD+K N+L+SK G +K+ D G ++ V T ++ AP
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLS----------FRILF----------PGKNSADQ 159
EV+ + GP+VD W++G + EM R LF
Sbjct: 186 EVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244
Query: 160 IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFF-RSCH---FVP 201
+K + ++ +P RP+A E L+HPF ++C F P
Sbjct: 245 EFKDF------LNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-21
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 2 IFLRKMNNHPNIVKL--RNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59
I L K H NIV+ +L +H ++F+ +Y+ + + + G F E RN
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYGA-FEETLVRNFVR 113
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR---- 114
Q+ +GL+Y+H +G HRD+K +N+LV +KG IKI D G+ K+++++ T R
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 115 ---WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALI 171
++ APEV+ + + D W++G ++ EML+ + FP I+KI I
Sbjct: 174 GSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232
Query: 172 SWLCSWNPR------------MRPTAAEALEHPF 193
S RPTAAE L+HPF
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 8 NNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
NHP IVKL K+ + ++++ +Y +L ++++ F E AR V
Sbjct: 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFE 107
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
Y+H +G +RDLKP NLL+ S G +K+ D G K++ S + T Y APE+ +L+
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEI-ILN 166
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV----------------- 168
+ VD W++G +++E+L+ R F + +IY +
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGE--DDEDPMEIYNDILKGNGKLEFPNYIDKAAK 224
Query: 169 ALISWLCSWNPRMR-----PTAAEALEHPFF 194
LI L NP R + +H +F
Sbjct: 225 DLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEA--RNLCFQVFQGLH 66
HPN+VK + E V+I +Y L+ + E DE R Q+ +GL
Sbjct: 57 KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLA 113
Query: 67 YMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI-DSSLPC----TDYVTTRWYRAPE 120
Y+H G HRD+KP+N L GVIK+GD G ++ +++ T Y APE
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 121 VLLLSEICGPE--VDRWAMGAIMFEMLS---------------FRILFPGKNSADQIYKI 163
V+ + G D W++G ++ EM + F + K ++
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL 233
Query: 164 YGRWVALISWLCSWNPRMRPTAAEALEHPF 193
+ +P+ RPTA+E L+HPF
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 4e-21
Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNIV+L + + E ++IV +YM DLL +++ G+ + + + Q+ +G+ Y
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEY 117
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRA 118
+ + + HRDL N LV++ V+KI D G+ ++I DY +W A
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE----DDYYRKRGGGKLPIKWM-A 172
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIYGR----------- 166
PE L + D W+ G +++E+ + +PG ++ + + +
Sbjct: 173 PESLKDG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPD 231
Query: 167 -WVALISWLCSWNPRMRPTAAE 187
L+ +++P RPT +E
Sbjct: 232 ELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-21
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
HPNIV + ++IV +Y D+ ++ + SE + +C + +G
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP----LSELQIAYVCRETLKG 113
Query: 65 LHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVL 122
L Y+H G HRD+K +N LL G +K+ D G+ ++ +++ ++ T ++ APEV
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 123 LLSEICG--PEVDRWAMG--AI--------MFEMLSFRILFP-GKNSADQ-IYKIYGRWV 168
+ G + D WA+G AI MF++ R LF K++ K +W
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 169 AL----ISWLCSWNPRMRPTAAEALEHPF 193
+ I + +P+ RPTA + L+HPF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
I + K + P IVK ++ D++IV +Y SD++K+ ++ +E+E +
Sbjct: 49 ISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAI 104
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRW 115
+Q +GL Y+H HRD+K N+L++ +G K+ D G+ ++ ++ + + T +
Sbjct: 105 LYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164
Query: 116 YRAPEVLLLSEICGPEVDRWAMG--AI-MFE-------MLSFRILFPGKNSADQIYKIYG 165
+ APEV+ + D W++G AI M E + R +F N
Sbjct: 165 WMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223
Query: 166 RW----VALISWLCSWNPRMRPTAAEALEHPFF 194
+W + +P RP+A + L+HPF
Sbjct: 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+H NIV+ E + I +Y+ + + G+ F E R QV +GL Y+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGLAYL 124
Query: 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID---SSLPCTDYVTTRWYRAPEVLLL 124
H +G HRDLK NLLV G+ KI D G+ K+ D + + ++ APEV+
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 125 SEIC-GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR---------WVALISWL 174
+VD W++G ++ EM + R + + + ++K+ + +S +
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 175 --------CSWNPRMRPTAAEALEHPF 193
+ NP RPTA E L+HPF
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-20
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKE--SAGQNFSEDEARNLCFQVFQGL 65
+HP IVK E + I+ +Y E DL ++E G+ SE++ Q+ G+
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 66 HYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLL 124
HYMH++ HRDLK N+ + ++KIGD G+ + + S T + T +Y +PE L
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA-LK 178
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-----------YGRWV-ALIS 172
+ + D W++G I++EM F G+N + +I Y R + +++
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 173 WLCSWNPRMRPTAAEALEHPF 193
+ + +P +RP+AAE L +PF
Sbjct: 239 SMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 47/218 (21%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HP +V L ++ ++++V +Y+ +L +++S F E AR QV L Y
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEY 116
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR-W-------YRA 118
+H +RDLKP NLL+ S G IKI D G K V R + Y A
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYLA 166
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVA--------- 169
PE+ +LS+ G VD WA+G +++EML+ F D +IY + +
Sbjct: 167 PEI-ILSKGYGKAVDWWALGILIYEMLAGYPPF----FDDNPIQIYEKILEGKVRFPSFF 221
Query: 170 ------LISWLCSWNPRMR-----PTAAEALEHPFFRS 196
LI L + R + HP+F
Sbjct: 222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HP + L + + +F V +Y+ DL+ ++ S + F E +R +V L +
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMF 111
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLS 125
+HR G +RDLK N+L+ ++G K+ D GM KE I + + T + T Y APE+L
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-----VALISWL 174
E GP VD WA+G +M+EM++ + F N D I Y W V+++
Sbjct: 172 EY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230
Query: 175 CSWNP--RMRPTAAEALE-----HPFFR 195
+ NP R+ A++ E HPFF+
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-20
Identities = 81/270 (30%), Positives = 120/270 (44%), Gaps = 52/270 (19%)
Query: 8 NNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
+N P I +L+ ++ +++++V +Y DLL L+ Q F ED A+ ++ +H
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIH 116
Query: 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMV------KEIDSSLPCTDYVTTRWYRAP 119
+H+ GY HRD+KP N+L+ + G IK+ D G K ++S LP V T Y AP
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP----VGTPDYIAP 172
Query: 120 EVLLL-----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--YGR------ 166
EVL G E D W++G I +EM+ R F SA I + R
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE 232
Query: 167 -------WVALI-SWLCSWNPRMRPTAAEALE-HPFFRSCHF------VPRSVPLL---- 207
++ LI S LC R+ E L HPFF + +P VP L
Sbjct: 233 DPKVSSDFLDLIQSLLCGQKERL---GYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDD 289
Query: 208 -CNNFEAVAFPTATVTMQGRSLTYSQVPND 236
+NF+ P T + +S T PN
Sbjct: 290 DTSNFDE---PEKNSTRRSQSSTTQLKPNG 316
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-20
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARN 56
+ +++ HPNIV+ E++ ++IV D +E + +KE Q F+E+ N
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWN 117
Query: 57 LCFQVFQGLHYMHRQGYF-HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
+ Q+ L Y+H++ HRDL P+N +L + I D G+ K+ T V T
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS---ADQIY---------K 162
Y PE+ + +E G + D WA G I+++M + + F N A +I
Sbjct: 178 LYSCPEI-VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236
Query: 163 IYGRWVA-LISWLCSWNPRMRP 183
+Y V +I+ + + RP
Sbjct: 237 MYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N P IV + D+ I +YM+ L K++KE G+ E + V +GL Y
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTY 115
Query: 68 MHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
+H + HRD+KPSN+LV S+G IK+ D G+ ++ +SL T +V T Y APE
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE----- 169
Query: 126 EICGP----EVDRWAMGAIMFEMLSFRILFPGKNSA-----DQIYKIY---------GRW 167
I G + D W++G + E+ + R +P +N + + I G++
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229
Query: 168 ----VALISWLCSWNPRMRPTAAEALEHPFF 194
++ +PR RP+ E LEHPF
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+ I++ + + IV +Y E+ DL KL+K G+ ED+ Q+ GL +
Sbjct: 57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 68 MHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLS 125
+H + HRD+K NL + +KIGDLG+ K + D++ V T +Y +PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCED 175
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRW-----------VALISW 173
+ + D WA+G +++E + + F N I KI G + LI
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235
Query: 174 LCSWNPRMRPTAAEALEHP 192
+ + R RP + L +P
Sbjct: 236 CLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-19
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K+ +HPNI++ E + + IV +Y L + +++ ED + Q+
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113
Query: 65 LHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
LH++H + HRDLK N+L+ K V+KIGD G+ K + S V T Y +PE L
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-L 172
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVA------------L 170
+ + D WA+G +++E+ S + F N + KI A L
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQL 232
Query: 171 ISWLCSWNPRMRPTAAEALEHP 192
I + + +P RP ++ + P
Sbjct: 233 ILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
P + KL + + +++V +Y+ D L+K G ED A+ +V G+ +H
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLH 114
Query: 70 RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL---LS 125
++G HRD+KP NLL+ + G +K+ D G+ + + L +V T Y APE +L
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVGDD 171
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-KIYGR---W------------VA 169
++ D W++G ++FE L F + D ++ I R W V
Sbjct: 172 KMS----DWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226
Query: 170 LISWLCSWNPRMRPTA---AEALEHPFFRS 196
LI+ L +P R A E HPFF+S
Sbjct: 227 LINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 65/236 (27%), Positives = 99/236 (41%), Gaps = 54/236 (22%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+ P IVKL ++ E +++V +YM DL+ L+ F E+ AR ++ L
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDS 116
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS------------LPCTDYVTTR 114
+H+ G+ HRD+KP N+L+ + G IK+ D G+ K+++ + L D V R
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 115 W------------------YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156
Y APEV L G E D W++G I++EML F
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEV-LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 157 ADQIYKIYGRW----------------VALI-SWLCSWNPRMRPTAAEALEHPFFR 195
+ KI W + LI LC R+ + E HPFF+
Sbjct: 236 QETYNKII-NWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLG-SFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
HPNIV++ + +++++V +++E +D++ +E++ +C V + L
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLAVLKAL 128
Query: 66 HYMHRQGYFHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLL 123
++H QG HRD+K S LL S G +K+ D G ++ +P V T ++ APEV+
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 124 LSEICGPEVDRWAMGAIMFEMLS-----F---------RILFPGKNSADQIYKIYGRWVA 169
G EVD W++G ++ EM+ F RI ++K+ R +
Sbjct: 189 -RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
+ + +P R TAAE L HPF VPL+
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-19
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 5/155 (3%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHP +V L ++ E++++V D + L+ + FSE++ + ++ L Y+
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYL 116
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI 127
H +G HRD+KP N+L+ +G + I D + ++ T T Y APEV L +
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV-LCRQG 175
Query: 128 CGPEVDRWAMGAIMFEMLSFRILFPGKNS--ADQI 160
VD W++G +E L + + G + DQI
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 8 NNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQN-FSEDEARNLCFQVFQGL 65
NHPN+VK +++++V Y+ LL +MK S + E + +V +GL
Sbjct: 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 66 HYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVTTRWYRAP 119
Y+H G HRD+K N+L+ G +KI D G+ + T +V T + AP
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLS----FRILFPGK--------------NSADQIY 161
EV+ + D W+ G E+ + + P K AD Y
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD--Y 233
Query: 162 KIYGR-WVALISWLCSWNPRMRPTAAEALEHPFF 194
K Y + + +IS +P RPTA E L+H FF
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
NHP + +L + + +F V +++ DL+ +++S + F E AR ++ L +
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMF 111
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLS 125
+H +G +RDLK N+L+ G K+ D GM KE I + + + T Y APE+L
Sbjct: 112 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-E 170
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK-------IYGRW-----VALISW 173
+ GP VD WAMG +++EML F +N D +++ +Y W V ++
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 174 LCSWNPRMRPTAAE------ALEHPFFR 195
+ NP MR + L HPFF+
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 26/159 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNF-----SEDEARNLCFQVF 62
NHPNIVKL + +E +I+ + ME DLL ++++ + F + E ++C V
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKG------VIKIGDLGMVKEIDSSLPCTDY------ 110
+G Y+ + + HRDL N LVS+ V+KIGD G+ ++I S DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS----DYYRKEGE 172
Query: 111 --VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW APE LL + D W+ G +M+E+L+
Sbjct: 173 GLLPVRWM-APES-LLDGKFTTQSDVWSFGVLMWEILTL 209
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 50/167 (29%), Positives = 89/167 (53%), Gaps = 12/167 (7%)
Query: 9 NHPNIVKLRN------LVKEHEDVF--IVFDYMESDLLKLMKESAGQNFSEDE--ARNLC 58
NH NI+ L++ K +++F +V +++ + K MK A N + +
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV--IKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+Q+ + L Y+H + HRDLKP NLL+ +K+ D G K + + Y+ +R+Y
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFY 236
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
RAPE++L + +D W++G I+ EM+ +F G++S DQ+ +I
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-18
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 10 HPNIVKLRNLVKEHED--VFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
HPNIV R E ED ++IV + E DL +KE G+ E++ Q+ L
Sbjct: 58 HPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLL 124
Y+H + HRDLK N+ +++ +IK+GDLG+ + +++ + + T +Y +PE L
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFS 175
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-----------YGRWVA-LIS 172
++ + D WA+G ++EM + + F K+ +Y+I Y + LI+
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 173 WLCSWNPRMRPTAAEALEHPF 193
+ S P RP+ L P+
Sbjct: 236 TMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-18
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF---QVFQGLH 66
HP IV L + ++++ +Y+ L + E G F ED A CF ++ L
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTA---CFYLSEISLALE 114
Query: 67 YMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLL 123
++H+QG +RDLKP N LL ++G +K+ D G+ KE + ++ T + T Y APE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILM 173
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRWV----------ALIS 172
S G VD W++GA+M++ML+ F +N I KI G+ L+
Sbjct: 174 RSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK 232
Query: 173 WLCSWNPRMR----PTAAEALE-HPFFR 195
L NP R P A ++ HPFFR
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-18
Identities = 55/171 (32%), Positives = 91/171 (53%), Gaps = 14/171 (8%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
+ +NHP +V L + + +F V +Y+ DL+ M+ + E+ AR ++
Sbjct: 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEIS 106
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPE 120
L+Y+H +G +RDLK N+L+ S+G IK+ D GM KE + + + T Y APE
Sbjct: 107 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 166
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILF--------PGKNSADQIYKI 163
+L E G VD WA+G +MFEM++ R F P +N+ D ++++
Sbjct: 167 ILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL--KLMKESAGQNFSEDEARNLCFQVFQ 63
+ HP + L+ + H+ + V +Y L L +E FSED AR ++
Sbjct: 50 QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVS 106
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEV 121
L Y+H +RDLK NL++ K G IKI D G+ KE I + T Y APEV
Sbjct: 107 ALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS--------ADQI---YKIYGRWVAL 170
L ++ G VD W +G +M+EM+ R+ F ++ ++I + +L
Sbjct: 167 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
Query: 171 ISWLCSWNPRMR-----PTAAEALEHPFFRS 196
++ L +P+ R A E +EH FF S
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + K H NIV + ++I ++ L+ + G SE + + +
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP-LSESQIAYVSRET 115
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAP 119
QGL+Y+H +G HRD+K +N+L++ G +K+ D G+ +I +++ ++ T ++ AP
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 120 EVLLLSEICGPE--VDRWAMG--AI--------MFEMLSFRILFPGKNSADQIYKIYG-- 165
EV + G D WA+G AI MF++ R LF S Q K+
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 166 RWVA----LISWLCSWNPRMRPTAAEALEHPF 193
+W + + NP+ RPTA + L+HPF
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 53/167 (31%), Positives = 90/167 (53%), Gaps = 14/167 (8%)
Query: 8 NNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
+NHP +V L + + +F V +++ DL+ M+ + E+ AR ++ L+
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 110
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLL 124
++H +G +RDLK N+L+ ++G IK+ D GM KE I + + T Y APE+ L
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-LR 169
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILF--------PGKNSADQIYKI 163
E G VD WA+G +MFEM++ R F P +N+ D ++++
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-17
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 3 FLRKMNNHPNIVKLRN-LVKEHEDVFIVFDYM---ESDLLKLMKESAGQNFSEDEARNLC 58
FL+++ HPN ++ + ++EH ++V +Y SD+L++ K+ E E +C
Sbjct: 68 FLQQLR-HPNTIEYKGCYLREHT-AWLVMEYCLGSASDILEVHKKP----LQEVEIAAIC 121
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
QGL Y+H HRD+K N+L+++ G +K+ D G + P +V T ++
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWM 178
Query: 118 APEVLL-LSEICGP---EVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------- 164
APEV+L + E G +VD W++G E+ + N+ +Y I
Sbjct: 179 APEVILAMDE--GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236
Query: 165 GRW----VALISWLCSWNPRMRPTAAEALEHPFFR 195
W + P+ RP++ E L+H F
Sbjct: 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-17
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 9 NHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
NHP+I+++ E H ++F+ ++M + + G F E N Q+ +GL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLS 117
Query: 67 YMHRQGYFHRDLKPSNLLV-SKG-VIKIGDLGMVKEIDSSLPCTD-----YVTTRWYRAP 119
Y+H HRD+K +NLL+ S G ++I D G + + + T + AP
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---IYKIYG----------- 165
EV L E G D W++G ++ EM + + + + ++ I+KI
Sbjct: 178 EV-LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
Query: 166 ----RWVALISWLC-SWNPRMRPTAAEALEHPFFR 195
R V L C P RP + E L+HP FR
Sbjct: 237 SPGLRDVTL---RCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
+ L KM HPNIV + + ++IV +Y + DL++ +K G+ F ED Q
Sbjct: 50 VLLAKMK-HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ 108
Query: 61 VFQGLHYMHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDS--SLPCTDYVTTRWYR 117
+ G+ ++H + HRD+K N+ L G +K+GD G + + S + CT YV T +Y
Sbjct: 109 MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYV 167
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-----------YGR 166
PE+ + + D W++G I++E+ + + F + + I K+ Y
Sbjct: 168 PPEI-WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSY 226
Query: 167 WV-ALISWLCSWNPRMRPTAAEAL 189
+ +LI + NPR RP+A L
Sbjct: 227 ELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+H N+V + N +++++V +++E L + N E++ +C V + L Y+
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIATVCLSVLRALSYL 134
Query: 69 HRQGYFHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSE 126
H QG HRD+K S LL S G IK+ D G ++ +P V T ++ APEV +S
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV--ISR 192
Query: 127 I-CGPEVDRWAMGAIMFEMLS----------------FRILFPGKNSADQIYKIYGRWVA 169
+ G EVD W++G ++ EM+ R P + +K+
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR--VKDSHKVSSVLRG 250
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFR 195
+ + P R TA E L+HPF +
Sbjct: 251 FLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H N+V++ N +++++V +++E L + N E++ +C V + L +
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLKALSVL 132
Query: 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSE 126
H QG HRD+K ++L++ G +K+ D G ++ +P V T ++ APE L+S
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE--LISR 190
Query: 127 I-CGPEVDRWAMGAIMFEMLS----------------FRILFPGKNSADQIYKIYGRWVA 169
+ GPEVD W++G ++ EM+ R P K ++K+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK--LKNLHKVSPSLKG 248
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNN 210
+ L +P R TAAE L+HPF VPL+ N
Sbjct: 249 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLMRQN 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L K H IV+ +++ E + I +YM +K ++ G +E R Q+
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQI 113
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE---IDSSLPCTDYVT-TRWY 116
+G+ Y+H HRD+K +N+L S G +K+GD G K I SS VT T ++
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------------- 163
+PEV + E G + D W++G + EML+ + + + I+KI
Sbjct: 174 MSPEV-ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV 232
Query: 164 --YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194
R + N + RP+A E L H F
Sbjct: 233 SPDARN--FLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 44/215 (20%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHPN+VK ++ + ++ ++ ++M+ L E E ++ Q+ G+ Y+
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIA-DEQFLADVARQILSGIAYL 184
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEV----L 122
HR+ HRD+KPSNLL+ S +KI D G+ + + ++ PC V T Y +PE L
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFP-GKNSADQIYKIYGRWVALISWLC------ 175
G D W++G + E R F G+ G W +L+ +C
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---------GDWASLMCAICMSQPPE 295
Query: 176 -----------------SWNPRMRPTAAEALEHPF 193
P R +A + L+HPF
Sbjct: 296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQN--FSEDEARNLC 58
I L K +HPN++K E+ ++ IV + ++ DL +++K Q E
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 116
Q+ L +MH + HRD+KP+N+ ++ GV+K+GDLG+ + S + V T +Y
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 117 RAPEVL------LLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153
+PE + S+I W++G +++EM + + F G
Sbjct: 173 MSPERIHENGYNFKSDI-------WSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQN--FSEDEARNLCFQVFQGL 65
+H IVK + K + + ++ +Y DL K +K+ ++ F E E L +Q+ L
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 66 HYMHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEV 121
+H + HRDLK +N+ L+ G+IK+GD G K+ S+ + + T +Y APE+
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRW-----------VA 169
+ D W++G I++E+L+ F G + + + ++ YG++ A
Sbjct: 243 WERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFR 195
L+ L S NP +RPT + L F +
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
NHP IVKL + ++++ D++ DL +L KE F+E++ + ++ L
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALD 112
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLL 124
++H G +RDLKP N+L+ +G IK+ D G+ KE ID + T Y APEV +
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VN 171
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD---QIYK--------IYGRWVALISW 173
D W+ G +MFEML+ + F GK+ + I K + +L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA 231
Query: 174 LCSWNPRMR----PTAAEALE-HPFFRSCHFV 200
L NP R P E ++ HPFF + +
Sbjct: 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHP IVKL ++I+ ++ + + + +E + + +C Q+ + L Y+
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSE 126
H HRDLK N+L++ G IK+ D G+ + +L D ++ T ++ APEV++
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 127 ICGP----EVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCSW----- 177
+ + D W++G + EM N + KI +S W
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246
Query: 178 ---------NPRMRPTAAEALEHPFFRS 196
+P RP+AA+ LEHPF S
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
HP + L+ + H+ + V +Y L S + F+E+ AR ++ L Y+H
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLH 112
Query: 70 RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEI 127
+ +RD+K NL++ K G IKI D G+ KE I + T Y APEVL ++
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 128 CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-----------ALISWLCS 176
G VD W +G +M+EM+ R+ F ++ I + +L++ L
Sbjct: 173 -GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 231
Query: 177 WNPRMR-----PTAAEALEHPFFRS 196
+P+ R A E +EH FF S
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP + L + E +F V +Y+ DL+ ++ S F E AR ++ GL ++
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFL 112
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSE 126
H++G +RDLK N+L+ K G IKI D GM KE ++ + + T Y APE+ L +
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQ 171
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRWVA-----LISWLC 175
VD W+ G +++EML + F G++ + I + RW++ +S L
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF 231
Query: 176 SWNPRMR-PTAAEALEHPFFRSCHF 199
+P R + +HPFFR +
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRGIDW 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
HPNIV L ++I+ ++ + L + + +E + R +C Q+ + L+++H
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 70 RQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLL--- 124
HRDLK N LL G +K+ D G+ + S+L D ++ T ++ APEV+
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 125 -SEICGPEVDRWAMGAIMFEMLS----------FRILFPGKNSADQIYKIYGRWVA---- 169
+ D W++G + E+ R+L S +W +
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240
Query: 170 -LISWLCSWNPRMRPTAAEALEHPFF 194
L S L +P RPTAAE L+HPF
Sbjct: 241 FLKSCLVK-DPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 36/241 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+VKL ++ E +++ +Y+ D L+ + SED AR ++F+ +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA 116
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+H GY HRDLKP N L+ + G IK+ D G+ K I + V + Y APEV L +
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--ANSVVGSPDYMAPEV-LRGK 173
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCSWNPRMRPTAA 186
VD W++G +++E L F G ++ ++ ++ W + ++ +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQR-PVYDDPRFNLSD 231
Query: 187 EALE---------------------HPFFRSCHF------VPRSVPLLCNNFEAVAFPTA 219
EA + HPFF+ + P VP L + + F
Sbjct: 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDF 291
Query: 220 T 220
Sbjct: 292 E 292
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 3/145 (2%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQN-FSEDEARNLCFQVFQGLHY 67
+ IV L + +D+ +V M LK + G+ F E A Q+ GL +
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+H++ +RDLKP N+L+ G ++I DLG+ E+ T Y APEV L E
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV-LQGE 169
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILF 151
+ VD +A+G ++EM++ R F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPN+V+L + + +FIV +YM + LL ++E G+ + ++C V + + Y+
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYL 116
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI-DSSLPCTDYVTTRW---YRAPEVLL 123
G+ HRDL N LV V+K+ D G+ + + D + T++ + PEV
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS--QGTKFPVKWAPPEVFD 174
Query: 124 LSEICGPEVDRWAMGAIMFEMLS 146
S + D W+ G +M+E+ S
Sbjct: 175 YSRF-SSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 40/196 (20%)
Query: 28 IVFDYME----SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83
I+ +Y DLLK K E + +V GL Y+H +G HRD+K +N+
Sbjct: 76 IIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129
Query: 84 LVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIM 141
L+S+ G +K+ D G+ ++ + +V T ++ APEV+ S + D W++G
Sbjct: 130 LLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITA 188
Query: 142 FEML----------SFRILF--PGKNSADQIYKIYGRWVALISW-------LC-SWNPRM 181
E+ R+LF P KN+ + G S LC + +P+
Sbjct: 189 IELAKGEPPLSDLHPMRVLFLIP-KNNPPS---LEGN---KFSKPFKDFVSLCLNKDPKE 241
Query: 182 RPTAAEALEHPFFRSC 197
RP+A E L+H F +
Sbjct: 242 RPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 8/158 (5%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLL--KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HP +V L + + ++ V DY+ L L +E ++F E AR ++ L Y
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGY 111
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLS 125
+H +RDLKP N+L+ S+G + + D G+ KE I+ S + + T Y APEVL
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
VD W +GA+++EML F +++A+ I
Sbjct: 172 PY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 45/165 (27%), Positives = 88/165 (53%), Gaps = 16/165 (9%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L K H +V+L +V + E ++I+ +YM + LL +K G + + Q+
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVTTRW------ 115
+G+ Y+ R+ Y HRDL+ +N+LVS+ ++ KI D G+ + I+ + T R
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-----NEYTAREGAKFPI 168
Query: 116 -YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD 158
+ APE + + D W+ G +++E++++ +I +PG +++D
Sbjct: 169 KWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
H N+V++ E+++++ ++++ L + +E++ +C V Q L Y+H
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLH 134
Query: 70 RQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEI 127
QG HRD+K ++L++ G +K+ D G +I +P V T ++ APEV+ +
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 128 CGPEVDRWAMGAIMFEMLS--------------FRILFPGKNSADQIYKIYGRWVALISW 173
G EVD W++G ++ EM+ R+ +KI +
Sbjct: 195 -GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253
Query: 174 LCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
+ + P+ R TA E L+HPF VPL+
Sbjct: 254 MLTREPQERATAQELLDHPFLLQTGLPECLVPLI 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 12/169 (7%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
+ +++P +V L + + +F+V +Y+ DL+ M+ + E+ AR ++
Sbjct: 49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEIC 106
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPE 120
L+++H +G +RDLK N+L+ G IK+ D GM KE + + + T Y APE
Sbjct: 107 IALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILF------PGKNSADQIYKI 163
+L E G VD WA+G +MFEM++ R F P N+ D ++++
Sbjct: 167 ILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
HP +V L + + V V +Y LM FSE A V GL Y+H
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 70 RQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEI 127
+RDLK NLL+ +G +KI D G+ KE + + + T + APEVL +
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 128 CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK-------IYGRW-----VALISWLC 175
VD W +G +++EML FPG + ++++ Y R+ ++++ L
Sbjct: 179 -TRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDEVRYPRFLSREAISIMRRLL 236
Query: 176 SWNPRMR----PTAAEAL-EHPFFRSCHF 199
NP R AE + + PFFR ++
Sbjct: 237 RRNPERRLGSGEKDAEDVKKQPFFRDINW 265
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-15
Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 12/144 (8%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP +V+L + + + ++IV ++ME+ LL +++ G+ S+D ++C V +G+ Y+
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYL 116
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK-----EIDSSLPCTDYVTTRWYRAPEVL 122
R + HRDL N LVS GV+K+ D GM + E SS +W PEV
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS--SGAKFPVKW-SPPEVF 173
Query: 123 LLSEICGPEVDRWAMGAIMFEMLS 146
S+ + D W+ G +M+E+ +
Sbjct: 174 NFSKY-SSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-15
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 21/212 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
IF+ K H NIV E ++I +Y L+ + G SE + +C +
Sbjct: 57 IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP-LSELQIAYVCRET 115
Query: 62 FQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAP 119
QGL Y+H +G HRD+K +N LL G +K+ D G+ +I +++ ++ T ++ AP
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 120 EVLLLSEICGPE--VDRWAMGAI----------MFEMLSFRILFPGKNSADQIYKIYG-- 165
EV + + G D WA+G MF++ R LF S Q K+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT 235
Query: 166 RWVA----LISWLCSWNPRMRPTAAEALEHPF 193
+W + + + NP+ RPTA L H F
Sbjct: 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 48/145 (33%), Positives = 76/145 (52%), Gaps = 12/145 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N IV+L ++ + +++V +YM DL+ LM + + E AR +V L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDA 157
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLG--MVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
+H G+ HRD+KP N+L+ K G +K+ D G M + + + C V T Y +PEV L
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV-LK 216
Query: 125 SE----ICGPEVDRWAMGAIMFEML 145
S+ G E D W++G ++EML
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP + L + E++F V +Y+ L +S F A ++ GL ++
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFL 112
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLLLS 125
H +G +RDLK N+L+ G IKI D GM KE + + CT + T Y APE+ LL
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEI-LLG 170
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRWVA------LISW 173
+ VD W+ G +++EML + F G + + I Y RW+ L+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230
Query: 174 LCSWNPRMRPTAAEALEHPFFR 195
R + +HPFFR
Sbjct: 231 FVREPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL--KLMKESAGQNFSEDEARNLCFQVFQG 64
++ P IV L+ + D+++V DYM L L KE FSED A+ ++
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLA 108
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVL 122
L ++H+ +RDLKP N+L+ + G I + D G+ K + T+ + T Y APEVL
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--YGR-----------WVA 169
L + VD W++G ++FEM F +++ Q+Y+ +G+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRNIAFGKVRFPKNVLSDEGRQ 227
Query: 170 LISWLCSWNPRMR----PTAAEALEHPFFR 195
+ L + NP+ R A E EHPFF
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 66/241 (27%), Positives = 92/241 (38%), Gaps = 58/241 (24%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDY-MESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP + L + + +V DY +L +L++ G+ SE+ AR +V L Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 68 MHRQGYFHRDLKPSNLL------------------------VSKGVIKIGDLGMVKEI-- 101
+H G +RDLKP N+L VSK + K V I
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 102 -----DSSLPCTDYVTTRWYRAPEVLLLSEICG----PEVDRWAMGAIMFEMLSFRILFP 152
+ S +V T Y APEV I G VD W +G +++EML F
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV-----ISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233
Query: 153 GKNSADQIYKIYGRWVA-------------LISWLCSWNPRMR----PTAAEALEHPFFR 195
G N + I + V LI L +P R AAE +HPFFR
Sbjct: 234 GSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
Query: 196 S 196
Sbjct: 294 G 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+ HP + L+ + H+ + V +Y L S + FSED AR ++ L Y
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDY 110
Query: 68 MH-RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLL 124
+H + +RDLK NL++ K G IKI D G+ KE I + T Y APEVL
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------YGRWV-----ALIS 172
++ G VD W +G +M+EM+ R+ F ++ ++++++ + R + +L+S
Sbjct: 171 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIRFPRTLSPEAKSLLS 228
Query: 173 WLCSWNPRMR-----PTAAEALEHPFFRS 196
L +P+ R A E ++H FF
Sbjct: 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD--LLKLMKESAGQNFSEDEARNLCFQV 61
L K HP +V L + E ++ V DY+ L +E + F E AR +V
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEV 105
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAP 119
+ Y+H +RDLKP N+L+ S+G + + D G+ KE ++ + + T Y AP
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEML 145
EV L E VD W +GA+++EML
Sbjct: 166 EV-LRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 76/269 (28%), Positives = 112/269 (41%), Gaps = 46/269 (17%)
Query: 10 HPNIVKLRNLVKEHED-VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPNIV L + + +F VF+Y+ L+ + + G + + R L QV L
Sbjct: 37 HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGR-LMLQVLDALACA 95
Query: 69 HRQGYFHRDLKPSNLLVS-KGV---IKIGDLGM------VKEIDSS--LPCTDYVTTRWY 116
H QG HRDLKP N++VS GV K+ D G+ V++ D + T+ + T Y
Sbjct: 96 HNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTY 155
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-RWVALISWLC 175
APE L E P D +A G I E L+ + + G + A+ +Y+ V+L W+
Sbjct: 156 CAPE-QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIA 214
Query: 176 SW------------NPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNF--------EAVA 215
+PR R +A AL FR+ L EA+A
Sbjct: 215 GHPLGQVLRKALNKDPRQRAASAPALAER-FRALEL-----CALVGILRMGEGAGREAIA 268
Query: 216 FPTATV-TMQGRSLTYSQVPNDGQLCSCV 243
P T+ G + Q+ LC V
Sbjct: 269 APLVASGTLDGETGERRQLT---ALCCHV 294
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-14
Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 9/143 (6%)
Query: 7 MNNHPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
M ++PN +KL V + ++ DY+ + DL L+K+ SE E + + Q+ + L
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEAL 122
Query: 66 HYMHRQGYFHRDLKPSNLL--VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
+ +H+ H D+K N+L +K I + D G+ K I + P T ++ +PE +
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--PSCYDGTLDYF-SPEK-I 178
Query: 124 LSEICGPEVDRWAMGAIMFEMLS 146
D WA+G + +E+L+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYM---ESDLLKLMKESAGQNFSEDEARNLCF 59
FL+++ HPN ++ + + ++V +Y SDLL++ K+ E E +
Sbjct: 74 FLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITH 128
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
QGL Y+H HRD+K N+L+++ G +K+ D G + P +V T ++ A
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMA 185
Query: 119 PEVLLLSE--ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------YGRW 167
PEV+L + +VD W++G E+ + N+ +Y I W
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW 245
Query: 168 V----ALISWLCSWNPRMRPTAAEALEHPFFR 195
+ + P+ RP +AE L H F R
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 21/231 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
I + + N HPNIV + +++++V +Y+ L ++ E+ E + +C +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRE 123
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 118
Q L ++H HRD+K N+L+ G +K+ D G +I + V T ++ A
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY--------------KIY 164
PEV+ GP+VD W++G + EM+ + +N +Y K+
Sbjct: 184 PEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 165 GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEAVA 215
+ ++ + R +A E L+HPF + + PL+ EA
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAAKEATK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-14
Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 7 MN-NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
M +H +V+L + + ++IV +YM + L G+ F + +C V +G+
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113
Query: 66 HYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK-----EIDSSLPCTDYVTTRWYRAP 119
Y+ + + HRDL N LV +G +K+ D G+ + E SS+ V RW P
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV--RW-SPP 170
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSF 147
EVLL S+ + D WA G +M+E+ S
Sbjct: 171 EVLLYSKF-SSKSDVWAFGVLMWEVYSL 197
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 62/253 (24%), Positives = 96/253 (37%), Gaps = 77/253 (30%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLK-LMKESAGQNFSEDEARNLCFQVFQGLH 66
++P +VKL ++ ++++ +Y+ D++ LMK+ F+E+E R + +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAID 115
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY--------------- 110
+H+ GY HRD+KP NLL+ +KG IK+ D G+ + S Y
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 111 ------------------------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146
V T Y APEV L + E D W++G IM+EML
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLV 234
Query: 147 FRILFPGKNSADQIYKIYGRWVALISW-----------------------LCSWNPRM-R 182
F N + KI I+W C R+
Sbjct: 235 GYPPFCSDNPQETYRKI-------INWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGN 287
Query: 183 PTAAEALEHPFFR 195
E HPFF+
Sbjct: 288 NGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-14
Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 4/148 (2%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
K HP + L+ + + + V +Y+ L S + FSED R ++ L
Sbjct: 50 KNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYGAEIVSAL 108
Query: 66 HYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLL 123
Y+H +RDLK NL++ K G IKI D G+ KE I + + T Y APEVL
Sbjct: 109 DYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILF 151
++ G VD W +G +M+EM+ R+ F
Sbjct: 169 DNDY-GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR 70
P + +L + + + ++ V +Y+ L + G+ F E A ++ GL ++H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHS 119
Query: 71 QGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLLLSEI 127
+G +RDLK N+++ ++G IKI D GM KE T + T Y APE++
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAYQPY 178
Query: 128 CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGR-----WVALISWLCS 176
G VD WA G +++EML+ + F G++ + I Y + V++ L +
Sbjct: 179 -GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237
Query: 177 WNPRMR----PTAAEAL-EHPFFR 195
+P R PT + EH FFR
Sbjct: 238 KHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-14
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP I++L + ++++ +Y+ L ++G+ FS ++ L Y+
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYL 117
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLP-CTDYVTTRWYRAPEVLLLS 125
H + +RDLKP N+L+ K G IK+ D G K+ D + C T Y APEV + S
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEV-IQS 172
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
+ VD WA+G +++EML F N IY+
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYE 208
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQ-NFSEDEARNLCFQVF 62
L K+N+ +V L + + + +V M LK + G F E+ A ++
Sbjct: 54 LEKVNSQ-FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
GL +HR+ +RDLKP N+L+ G I+I DLG+ +I V T Y APEV
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV 172
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN-------------SADQIY--KIYGR 166
L ++ D W +G +++EM+ + F G+ +++Y K
Sbjct: 173 -LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE 231
Query: 167 WVALISWLCSWNPRMR-----PTAAEALEHPFFRSCHF 199
++ L + +P+ R A E HPFFR+ +F
Sbjct: 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H +V+L +V E E ++IV +YM + LL +K+ G+ ++ QV G+ Y+
Sbjct: 60 HDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 69 HRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPE 120
R Y HRDL+ +N+LV G++ KI D G+ + I+ + +Y +W APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN----EYTARQGAKFPIKW-TAPE 173
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
L + D W+ G ++ E+++ R+ +PG N+ + + ++
Sbjct: 174 AALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 17/167 (10%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
+ K H +VKL + V E ++I+ ++M LL +K G + + Q+
Sbjct: 54 VMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TR 114
+G+ ++ ++ Y HRDL+ +N+LVS ++ KI D G+ + I+ + +Y +
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIK 168
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQI 160
W APE + + D W+ G ++ E++++ RI +PG ++ + I
Sbjct: 169 W-TAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 53/223 (23%), Positives = 82/223 (36%), Gaps = 55/223 (24%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES---AGQNFS--EDEARNLCFQVF 62
NH NIV+L + E FI+ + M DL ++E+ + S + V
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDY-------- 110
+G Y+ + HRD+ N LL KG V KI D GM ++I + Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA----SYYRKGGRAM 182
Query: 111 VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGK--------------- 154
+ +W P L I + D W+ G +++E+ S + +PG+
Sbjct: 183 LPIKW--MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240
Query: 155 ----NSADQIYKIYGRWVALISWLCSWNPR--MRPTAAEALEH 191
+Y+I C W RP A LE
Sbjct: 241 DPPKGCPGPVYRIMTD--------C-WQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 13/142 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP IV + ++ V+ + +++ L AG+ F D A+ ++ Y+
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYL 134
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW----YRAPEVLL 123
H + +RDLKP NLL+ +KG +K+ D G K++ D T Y APEV +
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTPEYLAPEV-I 187
Query: 124 LSEICGPEVDRWAMGAIMFEML 145
S+ G VD W MG +++E +
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 46/167 (27%), Positives = 91/167 (54%), Gaps = 17/167 (10%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L K HP +V+L +V + E ++I+ +YME+ L+ +K G + ++ ++ Q+
Sbjct: 54 LMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVT-------TR 114
+G+ ++ R+ Y HRDL+ +N+LVS+ + KI D G+ + I+ + +Y +
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN----EYTAREGAKFPIK 168
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQI 160
W APE + + D W+ G ++ E++++ RI +PG + + I
Sbjct: 169 W-TAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNI+ L +V + + V IV +YME+ L +++ GQ F+ + + + G+ Y
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKY 121
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPE 120
+ GY HRDL N+LV S V K+ D G+ + ++ P Y T RW APE
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TAPE 179
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ + D W+ G +M+E++S+
Sbjct: 180 AIAYRKFTSAS-DVWSYGIVMWEVMSY 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP +V+L + E + +VF++ME L + FS++ +C V +G+ Y+
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 69 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLLL 124
HRDL N LV + V+K+ D GM + + + T +W +PEV
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW-SSPEVFSF 175
Query: 125 SEICGPEVDRWAMGAIMFEMLS 146
S+ + D W+ G +M+E+ S
Sbjct: 176 SKY-SSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNI++L +V + V I+ +YME+ L K ++E+ G+ F+ + + + G+ Y
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKY 121
Query: 68 MHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPE 120
+ Y HRDL N+LV+ V K+ D G+ + ++ S Y T RW APE
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIRW-TAPE 178
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ D W+ G +M+E++S+
Sbjct: 179 AIAY-RKFTSASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 27/202 (13%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYME-----SDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
PN+V L + + VF+V + E S + K + N E+ + ++ L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL------NIPEECVKRWAAEMVVAL 98
Query: 66 HYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
+HR+G RDL P+N+L+ +G I++ E++ S C Y APEV +
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI 156
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--RWV-----ALISWLCSW 177
SE D W++GAI+FE+L+ + L S + WV +L+ L +
Sbjct: 157 SEET-EACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQF 215
Query: 178 NPRMRPTAAEA-----LEHPFF 194
NP R A A HPFF
Sbjct: 216 NPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 38/210 (18%)
Query: 18 NLVKEHED--------------VFIVFDYMES-DLLKLMKESA--GQNFSEDEARNLCFQ 60
++VK HED + +V DY + DL + +K A + F E EA L Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 61 VFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYV-----TTR 114
V +H++H + HRD+K +N LL S G++K+GD G K +++ +D V T
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV--SDDVGRTFCGTP 209
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK-IYGRWVAL--- 170
+Y APE+ + D +++G +++E+L+ + F G+N + ++K + GR+ L
Sbjct: 210 YYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268
Query: 171 --------ISWLCSWNPRMRPTAAEALEHP 192
++ L S +P+ RP++++ L P
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYM---ESDLLKLMKESAGQNFSEDEARNLCF 59
FL+K+ HPN ++ R ++V +Y SDLL++ K+ E E +
Sbjct: 68 FLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTH 122
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
QGL Y+H HRD+K N+L+S+ G++K+GD G + P +V T ++ A
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMA 179
Query: 119 PEVLLLSE--ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALIS---W 173
PEV+L + +VD W++G E+ + N+ +Y I + W
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239
Query: 174 LCSWN----------PRMRPTAAEALEHPFFRSCHFVPRSV 204
+ P+ RPT+ L+H F P +V
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV--LRERPPTV 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 10 HPNIVKLRN-LVKEHE-DVFIVFDYMES----DLLKLMKESAGQNFSEDEARNLCFQVFQ 63
P IVK + E + I +Y E + K +K+ G+ E + V +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLK 116
Query: 64 GLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
GL Y+H + HRD+KPSN+L++ KG +K+ D G+ E+ +SL T + T +Y APE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE-- 173
Query: 123 LLSEICGPEV----DRWAMGAIMFEMLSFRILFP 152
I G D W++G + E+ R FP
Sbjct: 174 ---RIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 4 LRKMNNHPNIVK------LRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDE 53
LRK +NHPNI +N + +++V + +DL+K +++ G+ E+
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEW 114
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YV 111
+ + +GL Y+H HRD+K N LL +K+ D G+ ++DS+L + ++
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 112 TTRWYRAPEVLLLSEICGPEV------DRWAMG--AI--------MFEMLSFRILFPGKN 155
T ++ APEV+ E P+ D W++G AI + +M R LF
Sbjct: 175 GTPYWMAPEVIACDE--QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232
Query: 156 SADQIYKIYGRWVAL----ISWLCSWNPRMRPTAAEALEHPF 193
+ K W IS N RP E LEHPF
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 15/159 (9%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR 70
P + +L + + + ++ V +Y+ L + G+ F E +A ++ GL ++HR
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHR 119
Query: 71 QGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLL 123
+G +RDLK N+++ S+G IKI D GM KE D VTTR Y APE++
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-----HMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
G VD WA G +++EML+ + F G++ D++++
Sbjct: 175 YQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-13
Identities = 55/231 (23%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
I + + N +PNIV + +++++V +Y+ L ++ E+ E + +C +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRE 123
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYR 117
Q L ++H HRD+K N+L+ G +K+ D G +I + S T V T ++
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWM 182
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY--------------KI 163
APEV+ + GP+VD W++G + EM+ + +N +Y ++
Sbjct: 183 APEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 164 YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEAV 214
+ ++ + R +A E L+HPF + + PL+ EA+
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAI 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 10/144 (6%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N P +V+L ++ + +++V +YM DL+ LM + + E A+ +V L
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALDA 157
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLL 124
+H G HRD+KP N+L+ K G +K+ D G ++D + + C V T Y +PEVL
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 125 S---EICGPEVDRWAMGAIMFEML 145
G E D W++G +FEML
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 13 IVKLRNLVKEHEDVFIVFDY-MESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
I L ++ +++V DY + DLL L+ + + ED AR ++ +H +H+
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 72 GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE-- 126
Y HRD+KP N+L+ G I++ D G ++ D ++ + V T Y +PE+L E
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 127 --ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR 166
GPE D W++G M+EML F A+ + + YG+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGK 219
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 23/174 (13%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
FL++ H +V+L + E E ++IV +YM LL +K G+ + +
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD 107
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTR- 114
+ Q+ +G+ Y+ + Y HRDL N+LV + V KI D G+ + I+ D T R
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED-----DEYTARE 162
Query: 115 -------WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQI 160
W APE + D W+ G ++ E++++ R+ +PG + + +
Sbjct: 163 GAKFPIKW-TAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 23/231 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
I + K +PNIV + +++F+V +Y+ L ++ E+ E + +C +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRE 123
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYR 117
Q L ++H HRD+K N+L+ G +K+ D G +I + S T V T ++
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWM 182
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY--------------KI 163
APEV + + GP+VD W++G + EM+ + +N +Y K+
Sbjct: 183 APEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 164 YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEAV 214
+ ++ + R +A E L+HPF + + PL+ EA+
Sbjct: 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAM 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES----DLLKLMKESAGQ-NFSEDEARN 56
I L H NIV+ E+ I +ME L L++ G +E
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKI---FMEQVPGGSLSALLRSKWGPLKDNEQTIIF 112
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVT-T 113
Q+ +GL Y+H HRD+K N+LV+ GV+KI D G K + PCT+ T T
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGT 172
Query: 114 RWYRAPEVLLLSEI-CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ------IYKIYGR 166
Y APEV+ G D W++G + EM + + F ++KI+
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232
Query: 167 WVALISWLCSW--------NPRMRPTAAEALEHPF 193
+S +P R +A + L+ PF
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 8/159 (5%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL--KLMKESAGQNFSEDEARNLCFQV 61
L K HP +V L + + ++ V DY+ L L +E F E AR ++
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEI 105
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAP 119
L Y+H +RDLKP N+L+ S+G I + D G+ KE I+ + + + T Y AP
Sbjct: 106 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158
EV L + VD W +GA+++EML F +N+A+
Sbjct: 166 EV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 25/186 (13%)
Query: 26 VFIVFDYMES----DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81
++I+ +Y+ DLL+ AG F E + + ++ +GL Y+H + HRD+K +
Sbjct: 77 LWIIMEYLGGGSALDLLR-----AGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 82 NLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGA 139
N+L+S+ G +K+ D G+ ++ D+ + +V T ++ APEV+ S + D W++G
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGI 189
Query: 140 IMFE----------MLSFRILF--PGKNSADQIYKIYGRWVALISWLCSWNPRMRPTAAE 187
E M R+LF P N + + I + +P RPTA E
Sbjct: 190 TAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKE 249
Query: 188 ALEHPF 193
L+H F
Sbjct: 250 LLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 6/146 (4%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPN+V+L +V + ++IV +YM L+ ++ + + V +G+ Y+
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI 127
+ + HRDL N+LVS+ V K+ D G+ KE + + +W APE L +
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKW-TAPEALREKKF 176
Query: 128 CGPEVDRWAMGAIMFEMLSF-RILFP 152
+ D W+ G +++E+ SF R+ +P
Sbjct: 177 ST-KSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 8e-13
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
I + + N +PNIV + +++++V +Y+ L ++ E+ E + +C +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRE 124
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRA 118
Q L ++H HRD+K N+L+ G +K+ D G +I + V T ++ A
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY--------------KIY 164
PEV + + GP+VD W++G + EM+ + +N +Y K+
Sbjct: 185 PEV-VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 165 GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEA 213
+ ++ + R +A E L+H F + + PL+ EA
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 28/160 (17%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMK------------ESAGQNFSEDEARN 56
H NIVK + E + +VF+YME DL K ++ +S + +
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY----- 110
+ Q+ G+ Y+ Q + HRDL N LV V+KIGD GM +++ + TDY
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TDYYRVGG 182
Query: 111 ---VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW PE ++ + E D W+ G +++E+ ++
Sbjct: 183 HTMLPIRWM-PPESIMYRKFT-TESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 24/218 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQ-NFSEDEARNLCFQVF 62
L K+N+ +V L + + + +V M LK + G F E+ A ++
Sbjct: 54 LEKVNS-RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
GL +HR+ +RDLKP N+L+ G I+I DLG+ EI V T Y APEV
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV 172
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA-------------DQIY--KIYGR 166
+ +E D W +G +++EM+ + F + + Y K
Sbjct: 173 -VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA 231
Query: 167 WVALISWLCSWNPRMR-----PTAAEALEHPFFRSCHF 199
++ L + +P R A E HPFFR+ +F
Sbjct: 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL--KLMKESAGQNFSEDEARNLCFQV 61
L K HP +V L + E ++ V D++ L L +E ++F E AR ++
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEI 105
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAP 119
L Y+H +RDLKP N+L+ S+G + + D G+ KE I S T + T Y AP
Sbjct: 106 ASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR------WVALISW 173
EV + + VD W +GA+++EML F ++ A+ I + +L +W
Sbjct: 166 EV-IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
Query: 174 -----LCSWNPRMRPTAAEAL----EHPFFRS 196
L + + R A E EHPFF S
Sbjct: 225 SILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HPNIVKL + +++I+ ++ + + + +E + R +C Q + L+Y+
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSE 126
H HRDLK N+L + G IK+ D G+ + ++ D ++ T ++ APEV++
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM--- 176
Query: 127 ICGPEVDR--------WAMGAIMFEMLS----------FRILFPGKNSADQIYKIYGRWV 168
C DR W++G + EM R+L S RW
Sbjct: 177 -CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235
Query: 169 A----LISWLCSWNPRMRPTAAEALEHPF 193
+ + N R T + L+HPF
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 5/154 (3%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR 70
P + +L + + + ++ V +Y+ L + G+ F E A ++ GL ++H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHS 119
Query: 71 QGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIC 128
+G +RDLK N+++ S+G IKI D GM KE + + + T Y APE++
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178
Query: 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
G VD WA G +++EML+ + F G++ D++++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 12/146 (8%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H NI++L +V + + I+ +YME+ L K +++ G+ FS + + + G+ Y+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYL 123
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEV 121
Y HRDL N+LV S K+ D G+ + ++ P Y T+ RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD-PEGTYTTSGGKIPIRW-TAPEA 181
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF 147
+ + D W+ G +M+E++SF
Sbjct: 182 IAYRKFTSAS-DVWSFGIVMWEVMSF 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 16/149 (10%)
Query: 10 HPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
H NIVK + + E + ++ +++ S LK + + Q+ +G+ Y
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR--------WYRA 118
+ + Y HRDL N+LV S+ +KIGD G+ K I++ +Y T + WY A
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLDSPVFWY-A 180
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
PE L+ S+ D W+ G ++E+L++
Sbjct: 181 PECLIQSKFYIAS-DVWSFGVTLYELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 17/149 (11%)
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYR 117
++ +GL Y+H + HRD+K +N+L+S +G +K+ D G+ ++ D+ + +V T ++
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLS----------FRILF--PGKNSADQIYKIYG 165
APEV+ S + D W++G E+ R+LF P KNS + Y
Sbjct: 169 APEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYS 226
Query: 166 R-WVALISWLCSWNPRMRPTAAEALEHPF 193
+ + + + +PR RPTA E L+H F
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 57/248 (22%), Positives = 98/248 (39%), Gaps = 68/248 (27%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHP+++++++ + +V + SDL + + + D+A + Q+ +GL Y+
Sbjct: 115 NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYL 173
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLG-----MVKEIDSSLPCTDYVTTRWYRAPEVL 122
H Q HRD+K N+ + + IGDLG +V L T V T APEVL
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT--VETN---APEVL 228
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSF-RILF---------PGKNSADQIYKI--------- 163
+ + D W+ G ++FEML++ +F K+ + KI
Sbjct: 229 ARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 164 ------------------------YGRWVA------------LISWLCSWNPRMRPTAAE 187
Y R+ L+ + +++ MRP+A E
Sbjct: 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEE 347
Query: 188 ALEHPFFR 195
L +P F
Sbjct: 348 ILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H +++ L + E V+I+ + ME LL ++ GQ ++ QV +G+ Y+
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 69 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLS 125
Q HRDL N+LV + V K+ D G+ + I D L + +W APE
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPEAASHG 179
Query: 126 EICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
+ D W+ G +++EM ++ ++ +PG N+ + +I
Sbjct: 180 TF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQN--FSEDEARNLC 58
I L K NHPN++K E ++ IV + ++ DL +++K Q E
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 116
Q+ L +MH + HRD+KP+N+ ++ GV+K+GDLG+ + S + V T +Y
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153
+PE + + + D W++G +++EM + + F G
Sbjct: 173 MSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 9/141 (6%)
Query: 13 IVKLRNLVKEHEDVFIVFDY-MESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
I L ++ ++++V DY + DLL L+ + ED AR ++ + +H+
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 72 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE-- 126
GY HRD+KP N+L+ K G I++ D G + D ++ V T Y +PE+L E
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 127 --ICGPEVDRWAMGAIMFEML 145
GPE D W++G M+EML
Sbjct: 182 KGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59
I L K H IV+ +++ E+ + I +YM +K ++ G +E+ R
Sbjct: 55 IQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTR 113
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID----SSLPCTDYVTTR 114
Q+ QG+ Y+H HRD+K +N+L S G +K+GD G K I S T
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVA----- 169
++ +PEV + E G + D W++ + EML+ + + + I+KI +
Sbjct: 174 YWMSPEV-ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 170 --------LISWLCSWNPRMRPTAAEALEHPF 193
+ + R RPTA L HPF
Sbjct: 233 GVSDACRDFLKQIFVEEKR-RPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 47/144 (32%), Positives = 73/144 (50%), Gaps = 10/144 (6%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N P +V+L ++ +++V +YM DL+ LM + + E AR +V L
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDA 157
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLG--MVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
+H G+ HRD+KP N+L+ K G +K+ D G M + + C V T Y +PEVL
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 125 S---EICGPEVDRWAMGAIMFEML 145
G E D W++G ++EML
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 13 IVKLRNLVKEHEDVFIVFDY-MESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
I L ++ ++++V DY + DLL L+ + + ED AR ++ + +H+
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 72 GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE-- 126
Y HRD+KP N+L+ G I++ D G ++ D ++ + V T Y +PE+L E
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 127 --ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR 166
GPE D W++G M+EML F A+ + + YG+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGK 219
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 6/137 (4%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH 69
PNI K + ++I+ +Y E + LMK +E + +V L Y+H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYIH 118
Query: 70 RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEI 127
+ G HRD+K +N+LV+ G +K+ D G+ ++ S + +V T ++ APEV+ +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 128 CGPEVDRWAMGAIMFEM 144
+ D W++G ++EM
Sbjct: 179 YDTKADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 59/221 (26%)
Query: 25 DVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPS 81
DV+I + M++ L K K+ G ED + + + L Y+H + HRD+KPS
Sbjct: 74 DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133
Query: 82 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEV-------- 132
N+L+++ G +K+ D G+ + S+ T + Y APE + PE+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI------NPELNQKGYDVK 187
Query: 133 -DRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW------------------------ 167
D W++G M E+ + R FP Y W
Sbjct: 188 SDVWSLGITMIELATGR--FP-----------YDSWKTPFQQLKQVVEEPSPQLPAEKFS 234
Query: 168 ---VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVP 205
++ N + RP E L+HPFF V
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-11
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYM---ESDLLKLMKESAGQNFSEDEARNLCF 59
FL+++ HPN ++ + ++V +Y SDLL++ K+ E E +
Sbjct: 78 FLQRIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITH 132
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
QGL Y+H HRD+K N+L+++ G +K+ D G P +V T ++ A
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMA 189
Query: 119 PEVLLLSE--ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCS 176
PEV+L + +VD W++G E+ + N+ +Y I +
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-SNE 248
Query: 177 WN--------------PRMRPTAAEALEHPF 193
W+ P+ RPT+ E L+H F
Sbjct: 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK---ESAGQNFSEDEARNLCFQVF 62
+ ++ P IVK + D +I + M+ L K K E E+ +
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 63 QGLHYMHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
+ L+Y+ + HRD+KPSN+L+ G IK+ D G+ ++ S+ T R Y APE
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177
Query: 121 VLLLSEICGPEV--DRWAMGAIMFEMLSFRILFPGKNSA-DQIYK-IYG----------- 165
+ S G +V D W++G ++E+ + + +P NS DQ+ + + G
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237
Query: 166 ----RWVALISWLCSWNPRMRPTAAEALEHPFFR 195
+V I+ + RP E LEHPF +
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC 107
FSE E R ++ GL +MH + +RDLKP+N+L+ + G ++I DLG+ + P
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW 167
V T Y APEVL D +++G ++F++L F + D+
Sbjct: 154 AS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 168 VALISWLCSWNPRMRPT-------------------AAEALEHPFFRS 196
+ S++P +R A E EHPFFRS
Sbjct: 213 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 10 HPNIVKLRN-LVKEHEDVFIVFDYMESDLLKLMKESAGQN-FSEDEARNLCFQVFQGLHY 67
H N+V+L +V+E ++IV +YM L S G++ D V + + Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+ + HRDL N+LVS+ V K+ D G+ KE SS T + +W APE L +
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKW-TAPEA-LREK 174
Query: 127 ICGPEVDRWAMGAIMFEMLSF-RILFP 152
+ D W+ G +++E+ SF R+ +P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K +HPNIVKL + + + ++IV + + LL +++ + + + + G
Sbjct: 47 KQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAG 105
Query: 65 LHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE----IDSSLPCTDYVTTRWYRAP 119
+ Y+ + HRDL N LV V+KI D GM +E I + + +W AP
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAP 164
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSF 147
E L E D W+ G +++E S
Sbjct: 165 EALNYGRYTS-ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLM--------------KESAGQNFSEDE 53
HPNIV L + + + ++F+Y+ DL + + E+ + +
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSS----LPCT 108
++ Q+ G+ Y+ + HRDL N LV +G +KI D G+ ++I S+ +
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 109 DYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW PE +L + E D W+ G +++E+ S+
Sbjct: 186 SLLPVRWM-PPEAILYGKFT-TESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 22/152 (14%)
Query: 10 HPNIVKLRNLVKE--HEDVFIVFDYMESDLLK-LMKESAGQNFSEDEARNLCF--QVFQG 64
H NIVK + + ++ + ++ +Y+ S L+ ++ Q + R L F Q+ +G
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI---NLKRLLLFSSQICKG 121
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR--------W 115
+ Y+ Q Y HRDL N+LV S+ ++KI D G+ K + DY + W
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED---KDYYYVKEPGESPIFW 178
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
Y APE L S+ D W+ G ++E+ ++
Sbjct: 179 Y-APECLRTSKF-SSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 17/154 (11%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H +V L +V E E ++IV ++M + LL +KE G+ + ++ Q+ G+ Y+
Sbjct: 60 HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 69 HRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPE 120
R Y HRDL+ +N+LV ++ KI D G+ + I+ + +Y +W APE
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN----EYTARQGAKFPIKW-TAPE 173
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPG 153
L + D W+ G ++ E+++ R+ +PG
Sbjct: 174 AALYGRFT-IKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNI+ L +V + V I+ ++ME+ L ++++ GQ F+ + + + G+ Y
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKY 121
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK--EIDSSLPCTDY-----VTTRWYRAP 119
+ Y HRDL N+LV S V K+ D G+ + E D+S P + RW AP
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAP 180
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSF 147
E + + D W+ G +M+E++S+
Sbjct: 181 EAIAYRKFTSAS-DVWSYGIVMWEVMSY 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 56/170 (32%), Positives = 72/170 (42%), Gaps = 43/170 (25%)
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY------------- 110
L Y+H G HRDLKP NLL+ S G IK+ D G+ K SL Y
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 111 ---VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW 167
T Y APEV +L + G VD WAMG I++E L + F G D +++G+
Sbjct: 174 KQVCGTPEYIAPEV-ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG----DTPEELFGQV 228
Query: 168 VA------------------LISWLCSWNPRMR---PTAAEALEHPFFRS 196
++ LIS L NP R A E +H FF
Sbjct: 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59
I L K H IV+ +++ + + I +YM +K ++ G +E R
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTR 113
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID----SSLPCTDYVTTR 114
Q+ +G+ Y+H HRD+K +N+L S G +K+GD G K + S T
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI----------- 163
++ +PEV + E G + D W++G + EML+ + + + I+KI
Sbjct: 174 YWMSPEV-ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232
Query: 164 ----YGRWVALISWLCSWNPRMRPTAAEALEHPF 193
+ R ++ R RP+A E L HPF
Sbjct: 233 HISEHARDFLGCIFV---EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLP 106
E + + ++ +GL Y+H + HRD+K +N+L+S+ G +K+ D G+ ++ D+ +
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 107 CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM------------LSFRILFPGK 154
+V T ++ APEV+ S + D W++G E+ + L P K
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-K 215
Query: 155 NSADQIYKIYGRWVALISWLC-SWNPRMRPTAAEALEHPF 193
N+ + Y + + C + P RPTA E L+H F
Sbjct: 216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 21 KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80
KEH +F V +++ L + G+ F A ++ GL ++H +G +RDLK
Sbjct: 68 KEH--LFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKL 124
Query: 81 SNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMG 138
N+++ + G IKI D GM KE + + + T Y APE+L + VD W+ G
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF-SVDWWSFG 183
Query: 139 AIMFEMLSFRILFPGKNSADQIYKI------YGRWVA-----LISWLCSWNPRMRPTAAE 187
+++EML + F G + + I Y RW+ ++ L +P R
Sbjct: 184 VLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVG 243
Query: 188 ALE-HPFFRSCH------------FVPR-SVPLLCNNFE 212
+ HPFF++ + F P+ P +NF+
Sbjct: 244 NIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
Q+ G+ ++H +RD+KP N+L+ +G ++ DLG+ E+ T T Y A
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
PE+ L E VD +AMG ++EM++ R P K+ +++ K
Sbjct: 163 PEI-LKEEPYSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 64/256 (25%), Positives = 99/256 (38%), Gaps = 76/256 (29%)
Query: 13 IVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
+VKL ++ ++++ V DY+ D++ L+ F ED AR ++ + +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM 120
Query: 72 GYFHRDLKPSNLLVSK-GVIKIGDLGM-----------------------------VKEI 101
G+ HRD+KP N+L+ + G IK+ D G+ EI
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 102 DSSLP-------------CTDY--VTTRWYRAPEVLLLS---EICGPEVDRWAMGAIMFE 143
D C + V T Y APEVLL + ++C D W++G I++E
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC----DWWSVGVILYE 236
Query: 144 MLSFRILFPGKNSADQIYKIYGRW----------------VALISWLCSWNPRMR---PT 184
ML + F A+ K+ W LI LC R
Sbjct: 237 MLVGQPPFLADTPAETQLKVIN-WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNG 294
Query: 185 AAEALEHPFFRSCHFV 200
A E HPFF+ F
Sbjct: 295 ADEIKAHPFFKGIDFA 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 42/164 (25%), Positives = 82/164 (50%), Gaps = 16/164 (9%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP +++L + E ++IV + M+ LL+ ++ AG+ + ++ QV G+ Y+
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 69 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPE 120
Q Y HRDL N+LV + + K+ D G+ + I Y +W APE
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKW-TAPE 174
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
L + + D W+ G ++ E++++ R+ +PG +A+ + ++
Sbjct: 175 AALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQN--FSEDEARNLC 58
I L K NHPN++K + E ++ IV + ++ DL +++K Q E
Sbjct: 53 IDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF 112
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 116
Q+ + +MH + HRD+KP+N+ ++ GV+K+GDLG+ + S + V T +Y
Sbjct: 113 VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153
+PE + + + D W++G +++EM + + F G
Sbjct: 173 MSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-11
Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DS 103
NFSEDE R ++ L ++H+ G +RD+K N+L+ S+G + + D G+ KE +
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 104 SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146
+ T Y APE++ G VD W++G ++FE+L+
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
K ++ P IVK DVFI + M + L KL+K ED + + + L
Sbjct: 69 KSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI-QGPIPEDILGKMTVAIVKAL 127
Query: 66 HYM-HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV-KEIDS-----SLPCTDYVTTRWYR 117
HY+ + G HRD+KPSN+L+ + G +K+ D G+ + +DS S C Y+
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM------ 181
Query: 118 APEVLLLSEICGP---EVDRWAMGAIM----------------FEMLSFRIL---FPGKN 155
APE + + D W++G + FE+L+ +IL P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT-KILQEEPPSLP 240
Query: 156 SADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196
+ + +V L + + R RP E L+HPF R
Sbjct: 241 PNEGFSPDFCSFVDLC---LTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEAR--------- 55
+HPNIVKL + + + ++F+YM ++ L+ A + S +
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 56 ------NLCF--QVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLP 106
LC QV G+ Y+ + + HRDL N LV + V+KI D G+ + I S+
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 107 C----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149
D + RW PE + + E D WA G +++E+ S+ +
Sbjct: 186 YKASENDAIPIRWM-PPESIFYNRYT-TESDVWAYGVVLWEIFSYGM 230
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-10
Identities = 52/220 (23%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 3 FLRKMNNHPNIVKL------RNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEAR 55
L+K ++H NI +N + +++V ++ + + L+K + G E+
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTD-YVTT 113
+C ++ +GL ++H+ HRD+K N+L+++ +K+ D G+ ++D ++ + ++ T
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 114 RWYRAPEVLLLSEICGPEV------DRWAMGAIMFEMLS----------FRILF--PGKN 155
++ APEV+ E P+ D W++G EM R LF P +N
Sbjct: 175 PYWMAPEVIACDE--NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RN 231
Query: 156 SADQI--YKIYGRWVALISWLCSWNPRMRPTAAEALEHPF 193
A ++ K ++ + I N RPT + ++HPF
Sbjct: 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 35/162 (21%)
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
V +GL Y+ HRD+KPSN+LV ++G +K+ D G+ ++ +S+ T YV T Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAP 162
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-------------- 165
E + E G D W++G E+ R +P QI K G
Sbjct: 163 E-RISGEQYGIHSDVWSLGISFMELALGRFPYP------QIQKNQGSLMPLQLLQCIVDE 215
Query: 166 ------------RWVALISWLCSWNPRMRPTAAEALEHPFFR 195
++V I+ P+ RP ++HPF
Sbjct: 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 18/149 (12%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP IV+L + K E + +V + LLK +K+ + + + L QV G+ Y
Sbjct: 54 DHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAY 110
Query: 68 MHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRA 118
+ + + HRDL N LLV++ KI D GM + + +DY +WY A
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG---AGSDYYRATTAGRWPLKWY-A 166
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
PE + + D W+ G ++E S+
Sbjct: 167 PECINYG-KFSSKSDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 10/180 (5%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N P IV ++ I ++M+ L +++KE+ + E+ + V +GL Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAY 118
Query: 68 M-HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
+ + HRD+KPSN+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L +
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT 177
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV--ALISWLCSWNPRMRP 183
+ D W+MG + E+ R P + A ++ I+GR V S +PR RP
Sbjct: 178 HY-SVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRP 235
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 48/185 (25%)
Query: 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI--DS 103
++F+E E R ++ L ++H+ G +RD+K N LL S+G + + D G+ KE +
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 104 SLPCTDYVTTRWYRAPEVLLLSEICGPE------VDRWAMGAIMFEML------------ 145
+ T Y APEV I G VD W++G + FE+L
Sbjct: 160 EERAYSFCGTIEYMAPEV-----IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
Query: 146 ------SFRIL-----FPGKNSADQIYKIYGRWVALISWLCSWNPRMR---PTAAEALEH 191
S RIL FP SA+ I L +P+ R A E H
Sbjct: 215 NSQSEISRRILKSKPPFPKTMSAEAR--------DFIQKLLEKDPKKRLGANGADEIKNH 266
Query: 192 PFFRS 196
PFF+
Sbjct: 267 PFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 46/168 (27%), Positives = 85/168 (50%), Gaps = 20/168 (11%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H +V+L +V E E ++IV +YM + LL +K G+ + ++ Q+ G+ Y+
Sbjct: 60 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 69 HRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPE 120
R Y HRDL+ +N+LV + ++ K+ D G+ + I+ + +Y +W APE
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAPE 173
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPG---KNSADQIYKIY 164
L + D W+ G ++ E+ + R+ +PG + DQ+ + Y
Sbjct: 174 AALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
N P IV ++ I ++M+ L + + AG+ E + V +GL Y+
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYL 119
Query: 69 -HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+ HRD+KPSN+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L +
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH 178
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCSWNPRMRP 183
+ D W+MG + EM R P + A ++ ++G V +PR RP
Sbjct: 179 Y-SVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYM-ESDL---LKLMKESAGQN-----FSEDEARN 56
K N ++V+L +V + +V + M + DL L+ + A N + +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY----- 110
+ ++ G+ Y+ + + HRDL N +V++ +KIGD GM ++I TDY
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGG 179
Query: 111 ---VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPGKNSADQIYKIYG- 165
+ RW APE L + + D W+ G +++EM + + G S +++ K
Sbjct: 180 KGLLPVRWM-APES-LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-SNEEVLKFVID 236
Query: 166 ------------RWVALISWLCSWNPRMRPTAAE 187
+ + L+ +NP+MRPT E
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLE 270
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 38/206 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K +HPNIV+L + + + ++IV + ++ D L ++ + G E + G
Sbjct: 48 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAG 106
Query: 65 LHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE----IDSSLPCTDYVTTRWYRAP 119
+ Y+ + HRDL N LV+ K V+KI D GM +E + +S + +W AP
Sbjct: 107 MEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAP 165
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSF---------------------RILFPGKNSAD 158
E L E D W+ G +++E S R+ P + D
Sbjct: 166 EALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP-ELCPD 223
Query: 159 QIYKIYGRWVALISWLCSWNPRMRPT 184
+Y++ R W ++P RP+
Sbjct: 224 AVYRLMER-----CW--EYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 42/159 (26%), Positives = 79/159 (49%), Gaps = 27/159 (16%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKE-----------SAGQNFSEDEARNL 57
H +IVK + E + + +VF+YM+ DL K ++ + ++ + ++
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY------ 110
Q+ G+ Y+ Q + HRDL N LV + ++KIGD GM +++ S TDY
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS----TDYYRVGGH 181
Query: 111 --VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW PE ++ + E D W++G +++E+ ++
Sbjct: 182 TMLPIRWM-PPESIMYRKFT-TESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC 107
FSE E R ++ GL +MH + +RDLKP+N+L+ + G ++I DLG+ + P
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145
V T Y APEVL D +++G ++F++L
Sbjct: 154 AS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI-DSSLP 106
F E A Q+ GL ++H++ +RDLKP N LL + G ++I DLG+ E+ D
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 107 CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFR 148
Y T + APE LL E VD +A+G ++EM++ R
Sbjct: 154 TKGYAGTPGFMAPE-LLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 52/217 (23%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAG-------QNFSEDEARNLCFQ 60
+H N+V+L L +E E +++ +Y + DL + ++ + S + LC Q
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY-------VT 112
+ G+ ++ + HRDL N LV S+ +K+ L + K++ +S +Y +
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS----EYYKLRNALIP 181
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPG------------------ 153
RW APE + + + D W+ G +M+E+ + L F G
Sbjct: 182 LRWL-APEA-VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239
Query: 154 --KNSADQIYKIYGR-WVALISWLCSWNPRMRPTAAE 187
+ ++YK+ R W NP+ RP+ +E
Sbjct: 240 VPEGCPSRLYKLMTRCWAV--------NPKDRPSFSE 268
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 23/160 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLM-----KESAGQNFSED---------- 52
+HPNIV L +V + + V ++F+Y+ + DL + + G + ED
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 53 EARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSS----LPC 107
+ ++ Q+ G+ Y+ + H+DL N+L+ + + +KI DLG+ +EI S+ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW PE ++ + + D W+ G +++E+ SF
Sbjct: 185 KSLLPIRWM-PPEAIMYGKF-SSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 4 LRKMNNHPNIVKLRN-LVKE----HED-VFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
L+K ++H NI +K+ H+D +++V ++ + + L+K + G ED
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTD-YVTTR 114
+C ++ +GL ++H HRD+K N+L+++ +K+ D G+ ++D ++ + ++ T
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 185
Query: 115 WYRAPEVLLLSEICGPEV------DRWAMGAIMFEMLS----------FRILF------P 152
++ APEV+ E P+ D W++G EM R LF P
Sbjct: 186 YWMAPEVIACDE--NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243
Query: 153 GKNSADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPF 193
K + + K +++ I N RP+ + L+HPF
Sbjct: 244 PKLKSKKWSK---KFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 7e-10
Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 43/230 (18%)
Query: 10 HPNIVKL--RNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEAR---NLCFQVFQG 64
H NIV+ R L K ++ ++I+ ++ ++ L + + F + E ++ Q+
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 65 LHYMHR-------QGYFHRDLKPSNLLVSKG------------------VIKIGDLGMVK 99
L Y H + HRDLKP N+ +S G + KIGD G+ K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 100 EIDSSLPCTDYVTTRWYRAPEVLLL-SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158
I V T +Y +PE+LL ++ + D WA+G I++E+ S + F N+
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
Query: 159 QIYK---------IYGR---WVALISWLCSWNPRMRPTAAEALEHPFFRS 196
Q+ I G+ LI L + + + RP+A + L + ++
Sbjct: 251 QLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-10
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-----------KLMKESAGQ---NF 49
L + H +IV+ + E + +VF+YM L K++
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 50 SEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCT 108
+ + + Q+ G+ Y+ + HRDL N LV +G V+KIGD GM ++I S T
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----T 175
Query: 109 DY--------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
DY + RW PE +L + E D W+ G +++E+ ++
Sbjct: 176 DYYRVGGRTMLPIRWM-PPESILYRKFT-TESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSED---EARNLCFQVFQGL 65
NH NI+K+ +++ + +++ + DL M + A + R + Q+ +
Sbjct: 221 NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAV 280
Query: 66 HYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY--VTTRWYRAPEVL 122
Y+H + HRD+K N+ ++ G I +GD G + DY V T +PE+L
Sbjct: 281 EYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL 340
Query: 123 LLSEICGPEV-DRWAMGAIMFEMLSFRILFP----GKNSADQIYKI 163
C E+ D W+ G I+ +MLS P G Q+ KI
Sbjct: 341 AGDGYC--EITDIWSCGLILLDMLSHDFC-PIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 30/162 (18%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESA--------GQNFSED------EA 54
H +IVK + + + + +VF+YM+ DL K ++ GQ +
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--- 110
++ Q+ G+ Y+ Q + HRDL N LV ++KIGD GM +++ S TDY
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRV 181
Query: 111 -----VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW PE ++ + E D W+ G I++E+ ++
Sbjct: 182 GGHTMLPIRWM-PPESIMYRKF-TTESDVWSFGVILWEIFTY 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 6/160 (3%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
N P IV ++ I ++M+ L + + AG+ E+ + V +GL Y+
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYL 115
Query: 69 H-RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+ HRD+KPSN+LV S+G IK+ D G+ ++ S+ + +V TR Y +PE L +
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH 174
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR 166
+ D W++G + EM R P ++ ++ ++GR
Sbjct: 175 YT-VQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGR 212
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 49/214 (22%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQ-------NFSEDEARNL 57
K +HPNIVKL + + + ++IV + + D L +++ + F+ D A
Sbjct: 47 KQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAA--- 103
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTD---YVTT 113
G+ Y+ + HRDL N LV + V+KI D GM ++ D + + +
Sbjct: 104 -----AGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPG------------------- 153
+W APE L E D W+ G +++E S + +PG
Sbjct: 159 KW-TAPEALNYGRYSS-ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCP 216
Query: 154 KNSADQIYKIYGRWVALISWLCSWNPRMRPTAAE 187
+ D +YK+ R W + P RP +E
Sbjct: 217 QKCPDDVYKVMQR-----CW--DYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 10 HPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
H IV+ +++ + + I ++M +K +S G +E+ R Q+ +G+ Y
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSY 121
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID----SSLPCTDYVTTRWYRAPEVL 122
+H HRD+K +N+L S G +K+GD G K + S T ++ +PEV
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV- 180
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-----ALISWLCS- 176
+ E G + D W++G + EML+ + + + I+KI + +S C
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 177 ------WNPRMRPTAAEALEHPF 193
++RP+A E L H F
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L + P +V L + + ++ DY+ L S + F E E + ++
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL-FTHLSQRERFKEQEVQIYSGEIVL 116
Query: 64 GLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPE 120
L ++H+ G +RD+K N+L+ S G + + D G+ KE D + T Y AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 121 VLLLSEICGPE-VDRWAMGAIMFEMLSFRILFP---GKNSADQIYK-------IYGRWVA 169
++ + + VD W+MG +M+E+L+ F KNS +I + Y + ++
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236
Query: 170 -----LISWLCSWNPRMR----PTAAEAL-EHPFFR 195
+I L +P+ R P+ A+ + +HPFF+
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 56/227 (24%), Positives = 81/227 (35%), Gaps = 83/227 (36%)
Query: 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLG--------- 96
FSED R + + +H+ G+ HRD+KP N+L+ + G IK+ D G
Sbjct: 96 DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155
Query: 97 ------------------------MVKEIDSSLPCTDYVTTRW----------------Y 116
V I+ ++ D + T W Y
Sbjct: 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDY 214
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISW--- 173
APE+ L + G E D W++GAIMFE L F +NS + KI I+W
Sbjct: 215 IAPEI-FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI-------INWRET 266
Query: 174 --------------------LCSWNPRM-RPTAAEALEHPFFRSCHF 199
+ + R+ R A E HPFFR +
Sbjct: 267 LYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKES-AGQNFSEDEARNLCFQVFQGLH 66
P IV V++ +YM++ L KL A + ED R + + V +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 67 YMHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
++ + HRD+KP+N+LV G +K+ D G+ + +SL T+ + + Y APE +
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERI-- 173
Query: 125 SEICGP--------EVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISW--- 173
+ GP + D W++G + EM R +P + A+ I+ + A++
Sbjct: 174 -KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAIVDGDPP 228
Query: 174 ---------------LC-SWNPRMRPTAAEALEHPFFRS 196
C + P RPT A+ LEHP+
Sbjct: 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 22/204 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL--KLMKESAGQNFSEDEARNLCFQVFQGLH 66
N P IV L+ + E +++V ++ L L +E F AR ++ L
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALE 107
Query: 67 YMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLL 124
+H+ +RDLKP N+L+ +G I + D G+ K T+ + T Y APE LLL
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE-LLL 166
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-----------ALISW 173
VD W +G +++EML+ F +N + KI + L+
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIG 226
Query: 174 LCSWNPRMR---PTAAEALEHPFF 194
L S +P R A E HPFF
Sbjct: 227 LLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR 70
P IV L ++ +V++V +Y+ +K + G F E+ A +V L Y+HR
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHR 122
Query: 71 QGYFHRDLKPSNLLVS-KGVIKIGDLGMVK-EIDSSLPCTDYVTT 113
G HRDLKP N+L+S +G IK+ D G+ K ++ L D +TT
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 30/181 (16%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARN 56
FL++ +H N+++L +V H + +V + LL +++ A +F +
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTD--YVTT 113
Q+ G+ Y+ + + HRDL N+L+ S +KIGD G+++ +LP + YV
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR----ALPQNEDHYVME 157
Query: 114 RWYRAPEVLLLSEICGPEV----------DRWAMGAIMFEMLSF-RILFPGKNSADQIYK 162
+ P C PE D W G ++EM ++ + G + + + K
Sbjct: 158 EHLKVPFAW-----CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212
Query: 163 I 163
I
Sbjct: 213 I 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 37/149 (24%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 7 MNNHPNIVKLRNLVKEHEDVFIVFDY-MESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
+ NH NIV L + ++ +Y DLL ++ + ++ + +QV +G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 66 HYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVT-------TRWYR 117
++ + HRDL N+L++ G ++KI D G+ ++I + ++YV +W
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWM- 210
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLS 146
APE + + + E D W+ G +++E+ S
Sbjct: 211 APES-IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 24/218 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQ-NFSEDEARNLCFQVF 62
L K+N+ +V L + + + +V M LK G+ F E A ++
Sbjct: 54 LEKVNSR-FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEIC 112
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
GL +H++ +RDLKP N+L+ G I+I DLG+ + V T Y APEV
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 172
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS----------ADQIYKIYGRWV--- 168
+ +E D WA+G +++EM++ + F + ++ + Y
Sbjct: 173 -VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPD 231
Query: 169 --ALISWLCSWNPRMR-----PTAAEALEHPFFRSCHF 199
+L L +P+ R A E EHP F+ +F
Sbjct: 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLK--LMKESAGQNFSEDEAR----- 55
+R HPNIV L +V + + + ++F Y SDL + +M+ S D+ +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 56 -------NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS--- 104
++ Q+ G+ ++ H+DL N+LV K +KI DLG+ +E+ ++
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 105 -LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPGKNSADQIYK 162
L + RW +PE ++ + + D W+ G +++E+ S+ + + G ++ D I
Sbjct: 181 KLMGNSLLPIRWM-SPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238
Query: 163 IYGR-----------WVALISWLCSWN--PRMRP 183
I R WV + C WN P RP
Sbjct: 239 IRNRQVLPCPDDCPAWVYTLMLEC-WNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 33/176 (18%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLM------KESAGQNFSEDEARNLCFQVF- 62
HP IV + ++ + + V+ Y+E LK + KES + +E + +F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 63 ---QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK--------EIDSSLPCTDY 110
+ Y+H +G HRDLKP N+L+ G + I D G +D + +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 111 -----------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155
V T Y APE LL D +A+G I+++ML+ FP +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLS--FPYRR 233
|
Length = 932 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEAR------NLCF---Q 60
PNI++L + + + ++ +YME+ DL + + Q +E L F Q
Sbjct: 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ 138
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------V 111
+ G+ Y+ + HRDL N LV K IKI D GM + + S DY +
Sbjct: 139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG----DYYRIQGRAVL 194
Query: 112 TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
RW +LL +V WA G ++E+L+
Sbjct: 195 PIRWMSWESILLGKFTTASDV--WAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 2/98 (2%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC 107
F E A ++ GL + R+ +RDLKP N+L+ +G I+I DLG+ +I
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145
V T Y APEV + +E D W +G +++EM+
Sbjct: 159 RGRVGTVGYMAPEV-INNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 4 LRKMNNHPNIVKLRNLVKEHE-----DVFIVFDYME----SDLLK-LMKESAGQNFSEDE 53
L+ + NHPN+VK + + + +++V + ++L+K L+ GQ E
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAM 129
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSS-LPCTDYV 111
+ + GL ++H HRD+K +N LL ++G +K+ D G+ ++ S+ L V
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 112 TTRWYRAPEVLLLSE----ICGPEVDRWAMG--AI--------MFEMLSFRILFPGKNSA 157
T ++ APEV+ + D W++G AI +F+M + LF +
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249
Query: 158 DQIYKIYGRWVA----LISWLCSWNPRMRPTAAEALEHPFFR 195
+W IS + RP+ LEHPF +
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 7/139 (5%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDY-MESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
NHP V L K+ +++V ++ + + ++ + + F D Q+ Y
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEY 146
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+ +RDLKP NLL+ K G IK+ D G K +D+ T Y APE+ LL+
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEI-LLNV 203
Query: 127 ICGPEVDRWAMGAIMFEML 145
G D W +G ++E+L
Sbjct: 204 GHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK---LMKESAGQNFSEDEAR-- 55
M ++ + H NI+ L + ++++ +Y L+ + G +S D AR
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 56 ----------NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSS 104
+ +QV +G+ Y+ Q HRDL N+LV++ V+KI D G+ +++++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN- 189
Query: 105 LPCTDY--------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
DY + +W APE L + + D W+ G +M+E+ +
Sbjct: 190 ---IDYYKKTTNGRLPVKWM-APEA-LFDRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 34/167 (20%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDY---------------MESDLLKLMKESA 45
M ++ + H NI+ L + + +++V +Y
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 46 GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM---VKEI 101
+ ++ + + +QV +G+ ++ + HRDL N+LV++ V+KI D G+ + I
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
Query: 102 DSSLPCTD-YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
D T+ + +W APE L + + D W+ G +++E+ +
Sbjct: 186 DYYRKTTNGRLPVKWM-APEA-LFDRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 14/144 (9%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYM-ESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H N+V+L ++ H ++IV + M + +L+ ++ S + V +G+ Y+
Sbjct: 58 HKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK----EIDSSLPCTDYVTTRWYRAPEVLL 123
+ HRDL N+LVS+ GV K+ D G+ + +D+S + +W APE L
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK-----LPVKW-TAPEALK 170
Query: 124 LSEICGPEVDRWAMGAIMFEMLSF 147
+ + D W+ G +++E+ S+
Sbjct: 171 HKKF-SSKSDVWSYGVLLWEVFSY 193
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 43/225 (19%)
Query: 12 NIVKLRNLVKEHEDVFIVFDYM-ESDL---LKLMKESAGQNFSE-----DEARNLCFQVF 62
++V+L +V + + +V + M DL L+ ++ A N E + ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------VTT 113
G+ Y++ + + HRDL N +V+ +KIGD GM ++I TDY +
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPV 185
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------- 164
RW APE L + D W+ G +++E+ S S +Q+ K
Sbjct: 186 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243
Query: 165 ----GRWVALISWLCSWNPRMRPTAAEALE------HPFFRSCHF 199
R L+ +NP+MRPT E + HP F F
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPN+V+L + +I+ ++M +LL ++E Q + + Q+ + Y+
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 69 HRQGYFHRDLKPSNLLVSKG-VIKIGDLG---MVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
++ + HRDL N LV + ++K+ D G ++ + +W APE L
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW-TAPESLAY 179
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRIL-FPGKNSADQIY-----------------KIYGR 166
++ + D WA G +++E+ ++ + +PG + + Q+Y K+Y
Sbjct: 180 NKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKGYRMERPEGCPPKVY-- 235
Query: 167 WVALISWLCSWNPRMRPTAAE---ALEHPF 193
L+ WNP RP+ AE A E F
Sbjct: 236 --ELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 73/285 (25%), Positives = 112/285 (39%), Gaps = 90/285 (31%)
Query: 13 IVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
+VKL ++ ++++ V DY+ D++ L+ + F E AR ++ + +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 72 GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-----------------DSSLP------- 106
G+ HRD+KP N+L+ G IK+ D G+ DS P
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 107 ----CTD--------------------YVTTRWYRAPEVLL---LSEICGPEVDRWAMGA 139
C D V T Y APEVLL +++C D W++G
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC----DWWSVGV 236
Query: 140 IMFEMLSFRILFPGKNSADQIYKIYGRW----------------VALISWL-CSWNPRM- 181
I+FEML + F + K+ W V LI+ L CS R+
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVIN-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295
Query: 182 RPTAAEALEHPFFRSCHF-----------VPR-SVPLLCNNFEAV 214
R A + HPFF F VP+ S P+ +NF+ V
Sbjct: 296 RNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPV 340
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 16/98 (16%)
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-TDYVTTR--- 114
Q+ +G+ Y+ + Y HRDL N+LV S+ +KIGD G+ K LP +Y R
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK----VLPQDKEYYKVREPG 171
Query: 115 -----WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
WY APE L S+ D W+ G +++E+ ++
Sbjct: 172 ESPIFWY-APESLTESKF-SVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 4 LRKMNNHPNIVKLRNL-----VKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEA 54
L+ +++HPN+VK + VK + +++V + +DL+K + G+ E
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPII 126
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSS-LPCTDYVT 112
+ + GL ++H HRD+K +N LL ++G +K+ D G+ ++ S+ L V
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186
Query: 113 TRWYRAPEVLL----LSEICGPEVDRWAMGAIMFEM 144
T ++ APEV+ L D W++G E+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
P IV ++ + ++M+ L + + G + + V +GL Y+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP-IPVEILGKIAVAVVEGLTYL 119
Query: 69 ---HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
HR HRD+KPSN+LV S+G IK+ D G+ E+ +S+ T +V T Y +PE +
Sbjct: 120 YNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPE-RIQ 175
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158
+ D W++G + E+ + F N D
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 30/169 (17%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARN 56
FL+++ + PNI +L + + ++ +YME DL + +++ +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 57 ---------LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLP 106
+ Q+ G+ Y+ + HRDL N LV K IKI D GM +L
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM----SRNLY 181
Query: 107 CTDY--------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+DY + RW VLL +V WA G ++E+L+
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV--WAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 42/175 (24%), Positives = 83/175 (47%), Gaps = 49/175 (28%)
Query: 13 IVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
+VK+ ++ +++++ +++ D++ L+ + +E+E + + + +H+
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 72 GYFHRDLKPSNLLV-SKGVIKIGDLGMV------------KEIDSSLPCTDY-------- 110
G+ HRD+KP NLL+ SKG +K+ D G+ + ++ SLP +D+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP-SDFTFQNMNSK 179
Query: 111 -----------------VTTRWYRAPEVLL---LSEICGPEVDRWAMGAIMFEML 145
V T Y APEV + +++C D W++G IM+EML
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC----DWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 30/172 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKES-----------AGQNFSE 51
L K NHP+++KL + + ++ +Y + L ++ES +N S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 52 DEARN-----------LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM-- 97
+ + +Q+ +G+ Y+ HRDL N+LV++G +KI D G+
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 98 -VKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
V E DS + + +W A E L I + D W+ G +++E+++
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWM-AIES-LFDHIYTTQSDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 38/145 (26%), Positives = 70/145 (48%), Gaps = 18/145 (12%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHP+I++L+ ++ ++ ++DL + +A +N + + + V + + Y+
Sbjct: 141 NHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYL 198
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWY--------RAP 119
H HRD+K N+ ++ G + +GD G + P D ++Y AP
Sbjct: 199 HENRIIHRDIKAENIFINHPGDVCLGDFGA-----ACFP-VDINANKYYGWAGTIATNAP 252
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEM 144
E LL + GP VD W+ G ++FEM
Sbjct: 253 E-LLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 26/159 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKE-------SAGQNFSEDEARNLCF- 59
+PNI++L + + + ++ +YME+ DL + + + + N NL +
Sbjct: 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYM 134
Query: 60 --QVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY------ 110
Q+ G+ Y+ + HRDL N LV IKI D GM + + S DY
Sbjct: 135 AVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG----DYYRIQGR 190
Query: 111 --VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ RW A E +LL + D WA G ++EM +
Sbjct: 191 AVLPIRWM-AWESILLGKFTTAS-DVWAFGVTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 8/156 (5%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L+ ++ H I+ L + + V +V + DL + S ++A + ++
Sbjct: 139 ILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLL 195
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRA 118
+ L Y+H +G HRD+K N+ + + +GD G ++D+ C + T +
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154
PE+L L C + D W+ G ++FEM + GK
Sbjct: 256 PELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 10 HPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
H NIVK + E + ++ +Y+ L L + + Q+ +G+ Y
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 68 MHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTR--------WYRA 118
+H Q Y HRDL N+L+ ++KIGD G+ K + +Y R WY A
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 178
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLS 146
E L ++ D W+ G ++E+L+
Sbjct: 179 VECLKENKFSYAS-DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 59/258 (22%), Positives = 102/258 (39%), Gaps = 78/258 (30%)
Query: 13 IVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
+V+L ++ ++++ V DY+ D++ L+ F ED AR ++ + +H+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM 120
Query: 72 GYFHRDLKPSNLLVSK-GVIKIGDLGMVK----------------------------EID 102
G+ HRD+KP N+L+ + G IK+ D G+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 103 SSLPCTD--------------------YVTTRWYRAPEVLL---LSEICGPEVDRWAMGA 139
++ C D V T Y APEVLL +++C D W++G
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC----DWWSVGV 236
Query: 140 IMFEMLSFRILFPGKNSADQIYKIYGRWVA----------------LISWLCSW-NPRMR 182
I++EML + F + + K+ W LI LC R+
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVI-NWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLG 295
Query: 183 PTAAEALE-HPFFRSCHF 199
A+ ++ HPFF++ F
Sbjct: 296 KNGADEIKAHPFFKTIDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 60 QVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI--------DSSLPCTDY 110
Q+ G+ Y+H HRD+K +N +L+ G+IK+ D G + + S++ + +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 111 VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY------ 164
T W APEV+ S G + D W++G +FEM + + P S D++ ++
Sbjct: 170 GTPYWM-APEVINESGY-GRKSDIWSIGCTVFEMATGK---PPLASMDRLAAMFYIGAHR 224
Query: 165 -----------GRWVALISWLCSWNPRMRPTAAEALEHPF 193
+ ++ + + RP+A + L H F
Sbjct: 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 22/82 (26%), Positives = 36/82 (43%), Gaps = 7/82 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
HPNI+ ++++V M DLLK + E + V
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK---THFPEGLPELAIAFILKDVLNA 113
Query: 65 LHYMHRQGYFHRDLKPSNLLVS 86
L Y+H +G+ HR +K S++L+S
Sbjct: 114 LDYIHSKGFIHRSVKASHILLS 135
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 39/174 (22%), Positives = 79/174 (45%), Gaps = 47/174 (27%)
Query: 13 IVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71
+VK+ ++ +++++ +++ D++ L+ + SE+ + + + +H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 72 GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSL-----------PCTDY--------- 110
G+ HRD+KP NLL+ +KG +K+ D G+ + + P +D+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 111 ----------------VTTRWYRAPEVLL---LSEICGPEVDRWAMGAIMFEML 145
V T Y APEV + +++C D W++G IM+EML
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC----DWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 38/170 (22%), Positives = 77/170 (45%), Gaps = 30/170 (17%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK---LMKESAGQNFSEDEAR-- 55
M ++ + H NI+ L + ++++ +Y L+ + G ++S D +
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 56 ----------NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 104
+ +QV +G+ Y+ Q HRDL N+LV++ V+KI D G+ +++ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN- 186
Query: 105 LPCTDY--------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146
DY + +W APE L + + D W+ G +++E+ +
Sbjct: 187 ---IDYYKKTTNGRLPVKWM-APEA-LFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKES--------------AGQN 48
L K+ +HPNI+ L + ++I +Y +LL +++S
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVI-KIGDLGM-------VKE 100
+ + V G+ Y+ + + HRDL N+LV + + KI D G+ VK+
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 101 IDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
LP RW A E L S + + D W+ G +++E++S
Sbjct: 176 TMGRLP------VRWM-AIESLNYS-VYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 20/155 (12%)
Query: 43 ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR-DLKPSNLLVSKGVIKIGDLGMVKEI 101
E G+ +E+E +C Q L +HRQ L LL G +
Sbjct: 8 EVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAF--------- 58
Query: 102 DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161
P + APEV+ + D +++G ++E L + + + + I
Sbjct: 59 --KTPEQSRPDPYF-MAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAIL 114
Query: 162 KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196
+I L++ + + +PR R F
Sbjct: 115 EI------LLNGMPADDPRDRSNLEGVSAARSFED 143
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 26/140 (18%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYF-HRDLKPSNLLVSKG-----------------VI 90
FS + FQ L Y H + + H DLKP N+L+ +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 91 KIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL-LSEICGPEVDRWAMGAIMFEMLSFRI 149
+I DLG D T V+TR YR+PEV+L L + D W+MG I++E+ + ++
Sbjct: 288 RICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWMY--STDMWSMGCIIYELYTGKL 343
Query: 150 LFPGKNSADQIY---KIYGR 166
L+ ++ + ++ K GR
Sbjct: 344 LYDTHDNLEHLHLMEKTLGR 363
|
Length = 467 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 30/126 (23%), Positives = 67/126 (53%), Gaps = 8/126 (6%)
Query: 34 ESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKI 92
+S++ L+ + + + + + +QV +G+ ++ + HRDL N+L+++G ++KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 93 GDLGMVKEI--DSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF- 147
D G+ ++I DS+ + ++ +W APE + + D W+ G +++E+ S
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APES-IFDNLYTTLSDVWSYGILLWEIFSLG 336
Query: 148 RILFPG 153
+PG
Sbjct: 337 GTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL---CFQVFQGL 65
+HP+IVKL ++ E V+IV ME L ++ N + +L +Q+ L
Sbjct: 65 DHPHIVKLIGVITE-NPVWIV---MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 66 HYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
Y+ + + HRD+ N+LV S +K+GD G+ + ++ +Y+A + L
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE---------SYYKASKGKLP 171
Query: 125 SEICGPE----------VDRWAMGAIMFEMLSFRIL-FPGKNSADQIYKI 163
+ PE D W G M+E+L + F G + D I +I
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 51/167 (30%)
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSSLPC 107
FQV +G+ ++ + HRDL N+L+S V+KI D G+ ++I D+ LP
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 244
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPG------------- 153
+W APE + + + D W+ G +++E+ S +PG
Sbjct: 245 -----LKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297
Query: 154 -------KNSADQIYKIYGRWVALISWLCSWN--PRMRPTAAEALEH 191
+ ++Y+ + L W+ P RPT +E +EH
Sbjct: 298 GTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
++P IV++ + E E +V + E L K ++++ ++ +E L QV G+ Y
Sbjct: 54 DNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKY 110
Query: 68 MHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT-----RWYRAPEV 121
+ + HRDL N LLV++ KI D G+ K + + T +WY APE
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APEC 169
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF 147
+ + + D W+ G +M+E S+
Sbjct: 170 MNYYKF-SSKSDVWSFGVLMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 40/167 (23%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK---LMKESAGQNFSEDEAR-- 55
M ++ + H NI+ L + + ++++ +Y L+ + G +++ D +
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 56 --NLCF--------QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM---VKEI 101
L F QV +G+ Y+ + HRDL N+LV++ V+KI D G+ V +I
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 102 DSSLPCTD-YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
D ++ + +W APE L + + D W+ G +M+E+ +
Sbjct: 188 DYYKKTSNGRLPVKWM-APEA-LFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPNI+ + ++++ +M L+K + SE N+ F +GL+Y+
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117
Query: 69 HRQGYFHRDLKPSNLLVS 86
H+ GY HR++K S++L+S
Sbjct: 118 HQNGYIHRNIKASHILIS 135
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 12/146 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+H NIV+L ++ + IV +YM + L +++ GQ + + + G+ Y
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKY 122
Query: 68 MHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTR-----WYRAPEV 121
+ GY H+ L +LV+ V KI ++E S Y T + APE
Sbjct: 123 LSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE---AIYTTMSGKSPVLWAAPEA 179
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF 147
+ D W+ G +M+E++S+
Sbjct: 180 IQYHHF-SSASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 41/181 (22%), Positives = 83/181 (45%), Gaps = 27/181 (14%)
Query: 32 YMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VI 90
Y++ D+ + E ++ + +QV +G+ ++ + HRDL N+L++ G +
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 91 KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEICGPEVDRWAMGAIMFE 143
KI D G+ ++I + ++YV +W APE + + + E D W+ G +++E
Sbjct: 254 KICDFGLARDIRND---SNYVVKGNARLPVKWM-APES-IFNCVYTFESDVWSYGILLWE 308
Query: 144 MLSF-RILFPGKNSADQIYKIYGRWVALISWLCS-----------WN--PRMRPTAAEAL 189
+ S +PG + YK+ ++S C+ W+ P RPT + +
Sbjct: 309 IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
Query: 190 E 190
+
Sbjct: 369 Q 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 37/171 (21%), Positives = 74/171 (43%), Gaps = 30/171 (17%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES----DLLKLMKESA----------- 45
M ++ + H NI+ L + ++++ +Y + L+ +
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 46 GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 104
+ S + + +QV +G+ Y+ + HRDL N+LV++ V+KI D G+ ++I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH- 192
Query: 105 LPCTDY--------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
DY + +W APE L I + D W+ G +++E+ +
Sbjct: 193 ---IDYYKKTTNGRLPVKWM-APEA-LFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 41/161 (25%)
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT---- 113
FQV +G+ ++ + HRDL N+L+S+ V+KI D G+ ++I DYV
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGSAR 237
Query: 114 ---RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPG---------------- 153
+W APE + ++ + D W+ G +++E+ S +PG
Sbjct: 238 LPLKWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 154 ----KNSADQIYKIYGRWVALISWLCSWNPRMRPTAAEALE 190
+N+ +IY+I L W +P+ RPT + +E
Sbjct: 296 MRAPENATPEIYRI-----MLACW--QGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 16/154 (10%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
+ +++N P IV++ + E E + +V + L + L QV
Sbjct: 48 IMHQLDN-PYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVS 105
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTR------- 114
G+ Y+ + + HRDL N LLV++ KI D G+ K + + Y R
Sbjct: 106 MGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD---DSYYKARSAGKWPL 162
Query: 115 -WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
WY APE + + D W+ G M+E S+
Sbjct: 163 KWY-APECINFRKF-SSRSDVWSYGITMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL---PCTDYVTTRW 115
QV GL +HR G HRD+KP NLLV+ G +KI D G ++ + + P + R
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR- 375
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIM 141
Y PE L++ + C P AM A++
Sbjct: 376 YSPPEELVMPQSC-PRAPAPAMAALL 400
|
Length = 507 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 14/146 (9%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP++V+L + V ++ M LL ++ N N C Q+ +G+ Y+
Sbjct: 68 HPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYL 125
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY------VTTRWYRAPEV 121
+ HRDL N+LV + +KI D G+ K +D +Y V +W A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWM-ALES 182
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF 147
+L + D W+ G ++E+++F
Sbjct: 183 ILHRIYTH-KSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 31/167 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDY---------------MESDLLKLMKESAGQN 48
L K+ +HPNI+ L + +++ +Y +E+D + S
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM-------VKE 100
S + + V +G+ Y+ ++ + HRDL N+LV + V KI D G+ VK+
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 101 IDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
LP RW A E L S + D W+ G +++E++S
Sbjct: 181 TMGRLP------VRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 45/164 (27%)
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT---- 113
FQV +G+ ++ + HRDL N+L+S V+KI D G+ ++I DYV
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDAR 236
Query: 114 ---RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPGKN-------------- 155
+W APE + ++ + D W+ G +++E+ S +PG
Sbjct: 237 LPLKWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294
Query: 156 ------SADQIYKIYGRWVALISWLCSW--NPRMRPTAAEALEH 191
+ +IY I L W NP RPT +E +E
Sbjct: 295 MRAPEYATPEIYSIM---------LDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKES--------------AGQN 48
L K+ +HPNI+ L + +++ +Y +LL +++S
Sbjct: 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVI-KIGDLGM-------VKE 100
S + + V +G+ Y+ ++ + HRDL N+LV + + KI D G+ VK+
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 168
Query: 101 IDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
LP RW A E L S + D W+ G +++E++S
Sbjct: 169 TMGRLP------VRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 33/116 (28%), Positives = 58/116 (50%), Gaps = 18/116 (15%)
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVT----- 112
QV QG+ ++ + HRD+ N+L++ G V KI D G+ ++I + ++YV
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNYVVKGNAR 275
Query: 113 --TRWYRAPEVLLLSEICGPEV--DRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
+W APE + C V D W+ G +++E+ S + +PG + YK+
Sbjct: 276 LPVKWM-APESIF---DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 52/224 (23%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKL--------MKESAGQNF-SEDEA 54
+++ N H ++V+L +V + + ++ + M LK M+ + Q S +
Sbjct: 63 MKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--- 110
+ ++ G+ Y++ + HRDL N +V++ +KIGD GM ++I TDY
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRK 177
Query: 111 -----VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS--------------FRILF 151
+ RW +PE L + D W+ G +++E+ + R +
Sbjct: 178 GGKGLLPVRWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235
Query: 152 PG------KNSADQIYKIYGRWVALISWLCSWNPRMRPTAAEAL 189
G N D +++ L+ +NP+MRP+ E +
Sbjct: 236 EGGLLDKPDNCPDMLFE-------LMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 33/163 (20%)
Query: 11 PNIVKLRNLVKEHEDVFIVFDYMES-DLLKLM-------KESAGQNFSEDEAR------- 55
PNI++L + + + + ++ +YME+ DL + + KE G +
Sbjct: 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS 138
Query: 56 ---NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDY- 110
++ Q+ G+ Y+ + HRDL N LV + + IKI D GM + +L DY
Sbjct: 139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR----NLYAGDYY 194
Query: 111 -------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146
+ RW A E +L+ + D WA G ++E+L
Sbjct: 195 RIQGRAVLPIRWM-AWECILMGKFTTAS-DVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 23/71 (32%), Positives = 35/71 (49%), Gaps = 8/71 (11%)
Query: 27 FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86
IV +Y+E +LLK E A + + R + G +H+ G H DL SN+++S
Sbjct: 75 LIVMEYIEGELLKDALEEARPDLLREVGRLV------GK--LHKAGIVHGDLTTSNIILS 126
Query: 87 KGVIKIGDLGM 97
G I D G+
Sbjct: 127 GGRIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 27/156 (17%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEA----RNLCFQVFQGL 65
HPNI++ E +VF+Y E LK + + R C ++ G+
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC-EIAAGV 112
Query: 66 HYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWY 116
+MH+ + H DL N L S +K+GD G I S DY+ T RW
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWL 168
Query: 117 RAPEV-------LLLSEICGPEVDRWAMGAIMFEML 145
APE+ L+ +E P + WA+G ++E+
Sbjct: 169 -APELVGEFHGGLITAEQTKPS-NVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 37 LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDL 95
LL ++E+ + S+D N C Q+ +G+ Y+ HRDL N+LV S +KI D
Sbjct: 95 LLDYVRENKDRIGSQD-LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 96 GMVKEIDSSLPCTDY------VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
G+ + +D + T+Y V +W A E +L + D W+ G ++E+++F
Sbjct: 154 GLARLLD--IDETEYHADGGKVPIKWM-ALESILHRRFTH-QSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 32/143 (22%), Positives = 62/143 (43%), Gaps = 6/143 (4%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+H IV+L + + LL +++ + N C Q+ +G++Y+
Sbjct: 67 DHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYL 125
Query: 69 HRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLL 124
HR+L N LL S +++I D G+ + D +++ T + A E +L
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 125 SEICGPEVDRWAMGAIMFEMLSF 147
+ D W+ G ++EM+S+
Sbjct: 186 GRYTH-QSDVWSYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 16/102 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN--------LCFQ 60
+HPN++ L + E +V +L MK +NF E N Q
Sbjct: 54 SHPNVLSLLGICLPSEGSPLV-------VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ 106
Query: 61 VFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI 101
V +G+ Y+ + + HRDL N +L +K+ D G+ ++I
Sbjct: 107 VAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 16/106 (15%)
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMV----KEIDSSLPCTD 109
+ + ++ GL ++H+ + H DL N LL + +KIGD G+ KE P
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162
Query: 110 YVTTRWYRAPEVLLLSEICG--------PEVDRWAMGAIMFEMLSF 147
+V RW APE L+ E+ G E + W++G ++E+
Sbjct: 163 WVPLRWI-APE--LVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDL---LKLMKESAGQNFSEDEARNLCFQVFQG 64
NHPN+++ E +V ++ DL L+ + Q +D + + +V G
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 65 LHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RW 115
L ++H+ + H DL N L + +KIGD G+ E DY T RW
Sbjct: 113 LLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE----DYYITKDCHAVPLRW 168
Query: 116 YRAPEVL------LLSEICGPEVDRWAMGAIMFEM 144
APE++ LL + + + W++G M+E+
Sbjct: 169 L-APELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLG---MVKEIDSSLPCTDYVTTRW 115
Q+ + Y+H +G HRD+K N+LV+ I +GD G + S+ T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFE 143
APEV L + P VD W+ G ++FE
Sbjct: 328 TNAPEV-LAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 1/82 (1%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK-LMKESAGQNFSEDEARNLCFQVFQG 64
K+ NHPNIV R ++++V +M K L+ SE + V +
Sbjct: 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 65 LHYMHRQGYFHRDLKPSNLLVS 86
L Y+H GY HR +K S++L+S
Sbjct: 114 LDYIHHMGYVHRSVKASHILIS 135
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 13/72 (18%)
Query: 35 SDLLKLMKESAGQN---FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVI 90
SD+ L + AG + +E+ AR+ QV R G+FH DL P N+ V K G I
Sbjct: 246 SDIAAL--DEAGLDRKALAENLARSFLNQVL-------RDGFFHADLHPGNIFVLKDGKI 296
Query: 91 KIGDLGMVKEID 102
D G+V +
Sbjct: 297 IALDFGIVGRLS 308
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 26/104 (25%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSSL 105
S + +QV G+ ++ + HRDL N+L+ +G ++KI D G+ ++I DS+
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295
Query: 106 --PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
+ ++ +W APE + + + D W+ G +++E+ +
Sbjct: 296 ISKGSTFLPLKWM-APES-IFNNLYTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 11/99 (11%)
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY---- 110
N C Q+ +G++Y+ + HRDL N+LV + +KI D G+ K + + +Y
Sbjct: 113 NWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE--KEYHAEG 170
Query: 111 --VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
V +W + L I + D W+ G ++E+++F
Sbjct: 171 GKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 36/144 (25%), Positives = 63/144 (43%), Gaps = 8/144 (5%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP++V+L + + +V M L N N C Q+ +G+ Y+
Sbjct: 67 DHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK--EIDSSLPCTD--YVTTRWYRAPEVLL 123
+ HRDL N+LV S +KI D G+ + E D D + +W A E +
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM-ALECIH 184
Query: 124 LSEICGPEVDRWAMGAIMFEMLSF 147
+ + D W+ G ++E+++F
Sbjct: 185 YRKFTH-QSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.67 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.61 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.45 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.44 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.38 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.23 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.21 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.9 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.13 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.5 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.11 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.34 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.4 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.78 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.7 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.3 | |
| PLN02236 | 344 | choline kinase | 91.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.74 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.91 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.79 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.92 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 89.89 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 89.55 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 89.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.29 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 87.86 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 87.66 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 87.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 86.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 86.25 | |
| PTZ00296 | 442 | choline kinase; Provisional | 81.97 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=374.01 Aligned_cols=193 Identities=32% Similarity=0.584 Sum_probs=172.0
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+|+|+ +|||||+++++|+..+..|+||||++| ++++.+..+ +.+.|+..+.+++||+.|+.|||++||+||||||+
T Consensus 229 ILkkL-~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPe 305 (475)
T KOG0615|consen 229 ILKKL-SHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPE 305 (475)
T ss_pred HHHhc-CCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcc
Confidence 44555 999999999999999999999999986 788888876 56999999999999999999999999999999999
Q ss_pred cEEEeCC----eEEEEecCCceecCCCCCCccccccCCCCCCceecccc--cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 82 NLLVSKG----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE--ICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 82 Nill~~~----~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|||++.+ .+||+|||+|+..+....+.+.|||+.|.|||++..++ .+..++||||+||++|-+++|.+||.+..
T Consensus 306 NILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 306 NILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred eEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9999643 68999999999999988899999999999999998653 34568999999999999999999997654
Q ss_pred CH----------------HHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 156 SA----------------DQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 156 ~~----------------~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.. ..+.+|..+.++||.+||..||++|+|++|+|+||||+...
T Consensus 386 ~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 386 TDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred CCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 32 23456777899999999999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=363.36 Aligned_cols=197 Identities=49% Similarity=0.922 Sum_probs=186.0
Q ss_pred ccccccccccceeeeceeEEeCC-eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHE-DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~-~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.|+|+-.|||||++.+++.+++ .+|+|||||+.++++.+..+ ++.|+|..++.|++||++||+|+|++|+.|||+||
T Consensus 60 ksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKP 138 (538)
T KOG0661|consen 60 KSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKP 138 (538)
T ss_pred HHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCCh
Confidence 56788856999999999999988 99999999999999888877 77899999999999999999999999999999999
Q ss_pred CcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
||||+. ...+||+|||+||++....+.+.++.|+||+|||++.+..+|+.++|+|++|||++|+.+-++.|+|.++.++
T Consensus 139 ENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq 218 (538)
T KOG0661|consen 139 ENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ 218 (538)
T ss_pred hheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence 999999 6899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-----------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 160 IYKIYG-----------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 160 ~~~i~~-----------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
++||.. ++.++|.+||.+||++||||.++|+||||+...
T Consensus 219 i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 219 IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 999875 457899999999999999999999999997654
Q ss_pred C
Q 040202 199 F 199 (297)
Q Consensus 199 ~ 199 (297)
.
T Consensus 299 ~ 299 (538)
T KOG0661|consen 299 A 299 (538)
T ss_pred c
Confidence 4
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=376.01 Aligned_cols=198 Identities=28% Similarity=0.493 Sum_probs=185.2
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
|.|+|++.||||+++|++|+++..+|+|+||++| ++++++..+ ++++|.++++|++||+.|+.|+|..+|+|||+||
T Consensus 63 IviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKp 140 (786)
T KOG0588|consen 63 IVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKP 140 (786)
T ss_pred hHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCc
Confidence 5789999999999999999999999999999985 888888876 6699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+|+|+|. +++||+|||+|.....+....+.||+++|.|||++.+..|.+.++||||||||||+|++|++||++.+....
T Consensus 141 ENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 141 ENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred hhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 9999985 679999999999999999999999999999999999999999999999999999999999999999988888
Q ss_pred HHHHH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCCC
Q 040202 160 IYKIY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVP 201 (297)
Q Consensus 160 ~~~i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~~ 201 (297)
+.|+. .++++||++||..||.+|+|.+||++|||+.+....+
T Consensus 221 LlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 221 LLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 87765 3789999999999999999999999999998776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=365.59 Aligned_cols=193 Identities=34% Similarity=0.528 Sum_probs=176.2
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
|.|++.++|||||+++++|++.++.|||+|+|..+++..+.++ .+.++|.+|+.|++||+.||.|||+++|+|||||..
T Consensus 69 IeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLG 147 (592)
T KOG0575|consen 69 IEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLG 147 (592)
T ss_pred HHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchh
Confidence 4577888999999999999999999999999998888888775 467999999999999999999999999999999999
Q ss_pred cEEEeCC-eEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSKG-VIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~~-~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|+|++++ +|||+|||+|..+... ....+.||||.|+||||+... .++..+||||+||++|.|+.|++||+..+-.+.
T Consensus 148 NlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket 226 (592)
T KOG0575|consen 148 NLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET 226 (592)
T ss_pred heeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHH
Confidence 9999986 8999999999988643 566899999999999998854 459999999999999999999999999888888
Q ss_pred HHHHHH-----------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 IYKIYG-----------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ~~~i~~-----------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+.+|.. ++++||.+||+.||.+|||++++|.|+||+.
T Consensus 227 y~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 227 YNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 887753 6899999999999999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=339.26 Aligned_cols=194 Identities=34% Similarity=0.518 Sum_probs=173.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
|.+ .+||+||+++..|++++.+|+|+||+.||-|-+.+++. +.|+|+.++.|+.+|+.||.|||+.||+||||||+||
T Consensus 79 L~~-v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 79 LSK-IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI 156 (357)
T ss_pred HHh-CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence 444 59999999999999999999999999986555555553 5699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+|. |+++|+|||+++.. ..+....++|||+.|||||++.+. .|+..+|+|||||++|||++|..||.+.+......
T Consensus 157 LLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~ 235 (357)
T KOG0598|consen 157 LLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD 235 (357)
T ss_pred eecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH
Confidence 9985 99999999999854 455666789999999999998866 45999999999999999999999999999888888
Q ss_pred HHHH------------HHHHHHHHhhhcCCCCCC----CHHHHHcCCCCCCCCCC
Q 040202 162 KIYG------------RWVALISWLCSWNPRMRP----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 162 ~i~~------------~~~~li~~~l~~dP~~R~----t~~~ll~h~~f~~~~~~ 200 (297)
+|.. +.+++++++|..||++|. .+.++.+||||++++|.
T Consensus 236 ~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 236 KILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred HHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 7753 689999999999999996 57899999999999884
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=333.11 Aligned_cols=194 Identities=31% Similarity=0.643 Sum_probs=179.0
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
|.|+|.++|+|+|.++++|+....++||+|||+.+.++.+.... .+++++.++.|++|++.|+.|+|+++|+|||||||
T Consensus 52 IrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPE 130 (396)
T KOG0593|consen 52 IRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPE 130 (396)
T ss_pred HHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChh
Confidence 34667779999999999999999999999999999999888764 45999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|||++. |.+||||||+|+.+. .+...+.++.|+||.|||.+.+...|+..+|||++||++.||++|+..|++.++.++
T Consensus 131 NILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 131 NILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred heEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 999985 899999999999887 666678889999999999999988999999999999999999999999999999999
Q ss_pred HHHHHH------------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 IYKIYG------------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ~~~i~~------------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++.|.. -..+|+.+||..||++|++.+++|.|+||.+
T Consensus 211 Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 211 LYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 987753 2478999999999999999999999999943
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=335.99 Aligned_cols=191 Identities=28% Similarity=0.474 Sum_probs=170.8
Q ss_pred cccccccccceeeeceeEEeCCe-EEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHED-VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~-~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp 80 (297)
++++. +|||||++||+|..++. ++|+||||+||+|+.+.... +.++|.....++.++++||.|||+ .+|+||||||
T Consensus 130 il~~~-~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKP 207 (364)
T KOG0581|consen 130 ILRSC-QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKP 207 (364)
T ss_pred HHhhC-CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCH
Confidence 45555 99999999999999995 99999999999999888876 459999999999999999999995 8999999999
Q ss_pred CcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC-----
Q 040202 81 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK----- 154 (297)
Q Consensus 81 ~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~----- 154 (297)
.|||++ +|.|||+|||.++.+... .+.+++||..|||||.+.+. .|+.++||||||+.++|+..|+.||...
T Consensus 208 sNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~ 285 (364)
T KOG0581|consen 208 SNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL 285 (364)
T ss_pred HHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCC
Confidence 999997 599999999999998877 67899999999999998755 5699999999999999999999999875
Q ss_pred CCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 155 NSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 155 ~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...+.+..|. .++++||..||++||.+|+++.|+++|||++..
T Consensus 286 ~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 286 DIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 3344454443 368999999999999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=322.72 Aligned_cols=194 Identities=29% Similarity=0.438 Sum_probs=173.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++...||+++++++.|.+.+++|+||||++||-+-.++.+. ++|+|..++.|+.|++.||+|||+++|++||+|||||
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi 175 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL 175 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence 344558999999999999999999999999985554445443 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
|+|+ |.+||+|||+|+.+... +.+.||||.|+|||++..+ .|+.++|+|+|||++|||+.|.+||.+.+......+
T Consensus 176 LlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K 252 (355)
T KOG0616|consen 176 LLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK 252 (355)
T ss_pred eeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH
Confidence 9995 99999999999998876 4789999999999998754 569999999999999999999999999999998988
Q ss_pred HHH-----------HHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCCC
Q 040202 163 IYG-----------RWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFVP 201 (297)
Q Consensus 163 i~~-----------~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~~ 201 (297)
|.. ++++|++++|+.|-.+|. ...++.+||||++++|..
T Consensus 253 I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 253 ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 865 689999999999999993 467999999999998853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=343.83 Aligned_cols=195 Identities=36% Similarity=0.571 Sum_probs=175.1
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.|.++.+||.|+++|..|+++..+|+|+||+++ ++++++.+. +.|+|..++.|+.||+.||+|||++||||||||||
T Consensus 126 ~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPE 203 (604)
T KOG0592|consen 126 ALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPE 203 (604)
T ss_pred HHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChh
Confidence 356677999999999999999999999999985 777777665 56999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC--------------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL--------------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
|||+|+ +++||+|||.|+.+.... .+.+++||-.|++||++.++ ..+..+|||+|||++|.|+.
T Consensus 204 NILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmla 282 (604)
T KOG0592|consen 204 NILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLA 282 (604)
T ss_pred heeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhc
Confidence 999985 799999999998764321 12568999999999998754 45899999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHH-----------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCC
Q 040202 147 FRILFPGKNSADQIYKIYG-----------RWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 147 g~~pf~~~~~~~~~~~i~~-----------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~ 200 (297)
|.+||.+.++.-.+.+|.. ..++||+++|..||++|+|+.+|.+||||.+++|.
T Consensus 283 G~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 283 GQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred CCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 9999999999988888864 67999999999999999999999999999999885
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=344.05 Aligned_cols=191 Identities=32% Similarity=0.553 Sum_probs=173.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++++..||||+++++++.....+|+||||+.| ++++++..+ +++.|.+++.+|+||+.||+|||++||+||||||+|
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~EN 150 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPEN 150 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHH
Confidence 34443399999999999999999999999987 788888773 569999999999999999999999999999999999
Q ss_pred EEEeC--CeEEEEecCCceec-CCCCCCccccccCCCCCCceecccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVSK--GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSE-ICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~--~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
||+|+ +++||+|||++... .......+.|||+.|+|||++.+.. +.+.++|||||||+||.|++|+.||++.+...
T Consensus 151 illd~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~ 230 (370)
T KOG0583|consen 151 ILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN 230 (370)
T ss_pred EEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH
Confidence 99985 69999999999988 5667779999999999999999877 77899999999999999999999999988777
Q ss_pred HHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...+| ..+++.|+++||..||.+|+|+.++++||||+.
T Consensus 231 l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 231 LYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 77664 346789999999999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=311.10 Aligned_cols=191 Identities=31% Similarity=0.509 Sum_probs=172.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++++|||||++++.+.+.+..|||+|++.| ++...+.++ -.++|..+-.+++||+.||.|+|.+||+|||+||+|
T Consensus 63 IC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~n 140 (355)
T KOG0033|consen 63 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPEN 140 (355)
T ss_pred HHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 45677999999999999999999999999998 777777776 458999999999999999999999999999999999
Q ss_pred EEEe-C---CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVS-K---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~-~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+++. + .-+||+|||+|..+..+....++.|||+|||||++. +..|+..+|||++|||||-|+.|.+||.+.+...
T Consensus 141 llLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 141 LLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred eeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 9994 2 369999999999999887778899999999999976 4556999999999999999999999999977777
Q ss_pred HHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 159 QIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 159 ~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+.+|. .+.++|+++||..||++|+|+.|+|+|||+++.
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 666654 378999999999999999999999999999764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=334.52 Aligned_cols=193 Identities=37% Similarity=0.704 Sum_probs=173.8
Q ss_pred ccccccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
++|+++ +||||+++.++..+. ..+|||+|||+.+|...+.. .+-.|++.+++.|++||+.||+|||++||+|||||
T Consensus 168 ~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK 245 (560)
T KOG0600|consen 168 KILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIK 245 (560)
T ss_pred HHHHhc-CCCcccceeeEEEecCCceEEEEEecccchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeecccc
Confidence 455555 999999999999876 68999999999988766554 34569999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
..|||||+ |.+||+|||||++.... ..++..+-|.||.|||.+.+...|+..+|+||+||||.||+.|++.|++.++
T Consensus 246 ~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 246 GSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred ccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 99999985 89999999999976543 3567888899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHH----------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 157 ADQIYKIYG----------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 157 ~~~~~~i~~----------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+++.+|+. ...+|+.+||..||.+|.||.++|+|+||..
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 999988865 3478999999999999999999999999954
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.62 Aligned_cols=191 Identities=26% Similarity=0.487 Sum_probs=169.5
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++|-++|||||++++++++.+++|||||||+||.+..++.+. +.++|..++.|+.||+.||++||+++|+||||||+||
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNi 140 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNI 140 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceE
Confidence 344459999999999999999999999999987776666664 4699999999999999999999999999999999999
Q ss_pred EEeC-------CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 84 LVSK-------GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 84 ll~~-------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|++. -.+||+|||+|+.+..+....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|+.||+..+.
T Consensus 141 LLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 141 LLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9964 2589999999999999988899999999999999875 4568999999999999999999999998887
Q ss_pred HHHHHHHHH--------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 157 ADQIYKIYG--------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 157 ~~~~~~i~~--------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+....+.. ...+++...|..++..|.+..+-+.|++...
T Consensus 220 ~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 220 KELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred HHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 776654432 4568999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=330.45 Aligned_cols=210 Identities=30% Similarity=0.485 Sum_probs=181.6
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
...++|||+|-.|++.+++||||||++||.+..++.+. +.|+|+.++.|+.+++.||+.||+.|+|||||||+|+|||.
T Consensus 198 ~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~ 276 (550)
T KOG0605|consen 198 VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA 276 (550)
T ss_pred cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC
Confidence 58899999999999999999999999997777777664 56999999999999999999999999999999999999995
Q ss_pred -CeEEEEecCCceecCC-----------------------CC-------------------------CCccccccCCCCC
Q 040202 88 -GVIKIGDLGMVKEIDS-----------------------SL-------------------------PCTDYVTTRWYRA 118 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~-----------------------~~-------------------------~~~~~~gt~~y~a 118 (297)
|++||+||||+.-+.. .. .....+|||-|||
T Consensus 277 ~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiA 356 (550)
T KOG0605|consen 277 KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIA 356 (550)
T ss_pred CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccc
Confidence 9999999999843210 00 0113589999999
Q ss_pred CceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------HHHHHHHHhhhcCCCCCC
Q 040202 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------------RWVALISWLCSWNPRMRP 183 (297)
Q Consensus 119 PE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~---------------~~~~li~~~l~~dP~~R~ 183 (297)
|||+.+.+ |+..+|+||||||+||||.|.+||.+.+..+.+.+|.. +.++||.++|. ||++|.
T Consensus 357 PEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 357 PEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred hHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 99998766 69999999999999999999999999999999888764 68999999999 999997
Q ss_pred C---HHHHHcCCCCCCCCCC------CCCCCccCCCcccCCCCCcc
Q 040202 184 T---AAEALEHPFFRSCHFV------PRSVPLLCNNFEAVAFPTAT 220 (297)
Q Consensus 184 t---~~~ll~h~~f~~~~~~------~~~~~~~~~~~~~~~~~~~~ 220 (297)
. ++||.+||||++++|. ++.+|.+.+..+..+|....
T Consensus 435 G~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~ 480 (550)
T KOG0605|consen 435 GSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFP 480 (550)
T ss_pred CcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCc
Confidence 5 8899999999999984 56667777777777776543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=313.51 Aligned_cols=193 Identities=34% Similarity=0.540 Sum_probs=173.1
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.+|+++.+||||+++.++|+.+.++++|+|.|+ |++++++... -.++|+..+.+++||+.|++|||.++|+||||||
T Consensus 74 ~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKp 151 (411)
T KOG0599|consen 74 SILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKP 151 (411)
T ss_pred HHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccCh
Confidence 478999999999999999999999999999997 6888888887 4599999999999999999999999999999999
Q ss_pred CcEEEeCC-eEEEEecCCceecCCCCCCccccccCCCCCCceecc-----cccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 81 SNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL-----SEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 81 ~Nill~~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
+|||+|++ ++||+|||++..+..+......||||+|+|||.+.. ...|+..+|+|++|||+|.|+.|..||-..
T Consensus 152 ENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 152 ENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred hheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99999874 899999999999999999999999999999999864 345788999999999999999999999654
Q ss_pred CCHH---------------HHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 155 NSAD---------------QIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 155 ~~~~---------------~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...- ++..++...++||+++|+.||.+|+|++|+|+||||..
T Consensus 232 kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 3332 33445557799999999999999999999999999943
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=333.29 Aligned_cols=190 Identities=28% Similarity=0.538 Sum_probs=170.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++-.+|+|||+|++.|..++.+|.||||++|+.|..+... ..|+|.++..+.++++.||+|||.+||+|||||.+||
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnI 400 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNI 400 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeecccccee
Confidence 44556999999999999999999999999999888888776 3499999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++ +|.+||+|||++..+.... ...+.+||+.|||||++.. +.|++++||||||++++||+.|++||-..+....++
T Consensus 401 LL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 401 LLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred EeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 998 5899999999998776544 5678999999999999875 456999999999999999999999998877777666
Q ss_pred HHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.|. ..+++|+.+||+.|+.+|++|.|||+||||+.
T Consensus 480 LIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 480 LIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 553 47899999999999999999999999999964
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=338.51 Aligned_cols=208 Identities=32% Similarity=0.495 Sum_probs=181.7
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-C
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-K 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-~ 87 (297)
+||+++.++..|++++++|+||||+.||.+-.+.. .+.|+|..++.|++.++.||.|||++||||||||.+|||+| +
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e 504 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE 504 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc
Confidence 79999999999999999999999999977433333 25699999999999999999999999999999999999999 5
Q ss_pred CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Q 040202 88 GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG- 165 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~- 165 (297)
|++||+|||++++.- .+....++||||.|||||++.+. .|+..+|+|+|||++|||+.|+.||.+.+..+....|..
T Consensus 505 Gh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d 583 (694)
T KOG0694|consen 505 GHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND 583 (694)
T ss_pred CcEEecccccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 999999999998854 55677899999999999998765 459999999999999999999999999999998887754
Q ss_pred ----------HHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCCC--------CCCCCccCCCcccCCCCCc
Q 040202 166 ----------RWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHFV--------PRSVPLLCNNFEAVAFPTA 219 (297)
Q Consensus 166 ----------~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~~--------~~~~~~~~~~~~~~~~~~~ 219 (297)
+..++++++|..||++|.. ++++.+||||+.++|. |+..|......+..+|...
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~e 660 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEE 660 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchh
Confidence 7899999999999999986 4789999999999873 5566666666666665443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=315.87 Aligned_cols=196 Identities=32% Similarity=0.489 Sum_probs=171.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
|+++++||+++.+|..|+.+++.|++||||.||.+ ..+.++.++.|+|..++.|+.+++.||+|||-.|||+|||||||
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 56677999999999999999999999999998555 44455566789999999999999999999999999999999999
Q ss_pred EEEe-CCeEEEEecCCceecC----------------------------------C-----------------------C
Q 040202 83 LLVS-KGVIKIGDLGMVKEID----------------------------------S-----------------------S 104 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~~----------------------------------~-----------------------~ 104 (297)
|||- +|++.|+||.++.... . +
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9995 6999999999863210 0 0
Q ss_pred CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------HHHHHH
Q 040202 105 LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-------------RWVALI 171 (297)
Q Consensus 105 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~-------------~~~~li 171 (297)
.....++||-.|+|||++.+.+. +.++|+|+|||++|||+.|+.||.|.+..+.+.+|.. .+++||
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred ccccccccccccccceeeecCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 11234678999999999986654 9999999999999999999999999999999988753 689999
Q ss_pred HHhhhcCCCCCCC----HHHHHcCCCCCCCCCC
Q 040202 172 SWLCSWNPRMRPT----AAEALEHPFFRSCHFV 200 (297)
Q Consensus 172 ~~~l~~dP~~R~t----~~~ll~h~~f~~~~~~ 200 (297)
+++|.+||.+|.. |.||.+||||++++|.
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 9999999999998 9999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=301.37 Aligned_cols=193 Identities=38% Similarity=0.673 Sum_probs=174.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|+||+.++++|-..+.+.||+||++.++...+..+ ...++..+++.|+.++++||+|||++.|+||||||+|+
T Consensus 54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred HHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 34455999999999999999999999999999888766654 46799999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++ +|.+||+|||+|+....... ....+.|+||.|||.+.+.+.|+..+|+||.|||+.||+-|.+.|.|.++.+++.
T Consensus 133 Lis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 133 LISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred EEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 997 58999999999998865433 3334789999999999999999999999999999999999999999999999998
Q ss_pred HHHH---------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KIYG---------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i~~---------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+|.. +..+|+.+|+..||.+|+|+.|+|+|+||++.
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 8764 35889999999999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=317.58 Aligned_cols=194 Identities=31% Similarity=0.509 Sum_probs=162.0
Q ss_pred cccccccccceeeeceeEEeCC--eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~--~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+|.++ +|||||+++|...... .++++|||+.||.+..+..+.++.++|..++.+++|++.||+|||++||+||||||
T Consensus 67 iL~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~ 145 (313)
T KOG0198|consen 67 ILSRL-NHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKP 145 (313)
T ss_pred HHHhC-CCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCccc
Confidence 45555 6999999999854444 79999999998777777776555799999999999999999999999999999999
Q ss_pred CcEEEeC--CeEEEEecCCceecCC----CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 81 SNLLVSK--GVIKIGDLGMVKEIDS----SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 81 ~Nill~~--~~~kl~Dfgla~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
+|||++. +.+||+|||+++.... ........||+.|||||++..+...+.++||||+||++.||+||+.||...
T Consensus 146 ~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 146 ANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 9999986 6999999999987763 222346789999999999876333345899999999999999999999873
Q ss_pred -CCHHHHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 155 -NSADQIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 155 -~~~~~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...+...++ ..+.++|+++|+..||++||||+++|+|||.+..
T Consensus 226 ~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 226 FEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred cchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 333333332 2368999999999999999999999999999764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=314.90 Aligned_cols=191 Identities=27% Similarity=0.516 Sum_probs=177.8
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.++..++||||+.+|++|++.+.+.|||||..| +|++++.++ +.++|.+++.||+||++|+.|+|+++++|||||.+
T Consensus 105 eIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLE 182 (668)
T KOG0611|consen 105 EIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLE 182 (668)
T ss_pred HHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchh
Confidence 355567999999999999999999999999985 788888776 56999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|||+|. +++||+|||++..........++||++.|.+||++.+..|.++.+|.|||||+||.|+.|.+||+|.+....+
T Consensus 183 NILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv 262 (668)
T KOG0611|consen 183 NILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV 262 (668)
T ss_pred heeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH
Confidence 999985 7999999999999988888899999999999999998888899999999999999999999999999999999
Q ss_pred HHHHH----------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 161 YKIYG----------RWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 161 ~~i~~----------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
.+|.. +...||++||..||.+|.|++++-.|=|.+
T Consensus 263 rQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 263 RQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 88875 568899999999999999999999998873
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=305.86 Aligned_cols=193 Identities=41% Similarity=0.727 Sum_probs=172.5
Q ss_pred cccccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+|++. +|||||.+.++... -+.+|||||||+.++-..+... +.+|...+++.++.|++.|++|||.++|+|||||+
T Consensus 128 iLl~~-~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~ 205 (419)
T KOG0663|consen 128 ILLKA-RHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKT 205 (419)
T ss_pred HHHhc-CCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccch
Confidence 34455 79999999999864 4579999999998877665554 46799999999999999999999999999999999
Q ss_pred CcEEEe-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 81 SNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 81 ~Nill~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
.|+|++ +|.+||+|||+|+..+.. ...+..+.|.||.|||.+.+.+.|++.+|+||+|||+.||+.+++.|.|....+
T Consensus 206 SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d 285 (419)
T KOG0663|consen 206 SNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID 285 (419)
T ss_pred hheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence 999997 599999999999998765 345667789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHH-------------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 159 QIYKIYG-------------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 159 ~~~~i~~-------------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
++.+|.. ...+|+.++|..||.+|.||+|+|+|.||+
T Consensus 286 Ql~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~ 365 (419)
T KOG0663|consen 286 QLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR 365 (419)
T ss_pred HHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence 9998864 236799999999999999999999999998
Q ss_pred CC
Q 040202 196 SC 197 (297)
Q Consensus 196 ~~ 197 (297)
+.
T Consensus 366 e~ 367 (419)
T KOG0663|consen 366 ET 367 (419)
T ss_pred cC
Confidence 73
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=305.72 Aligned_cols=196 Identities=37% Similarity=0.688 Sum_probs=176.2
Q ss_pred cccccccccc-eeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 040202 3 FLRKMNNHPN-IVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQGY 73 (297)
Q Consensus 3 ~l~kl~~Hpn-Iv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~gi 73 (297)
.|.+.++|+| ||++++++.+.+ .+|+||||++.++-+++..... ..++...++.+++||+.||+|||++||
T Consensus 62 sllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~I 141 (323)
T KOG0594|consen 62 SLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGI 141 (323)
T ss_pred HHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4556679999 999999998877 8999999999998888876542 358889999999999999999999999
Q ss_pred cccCCCCCcEEEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 74 FHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 74 ~Hrdikp~Nill~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
+||||||+|||+++ |.+||+|||+|+... ........++|.||.|||++.+...|+..+||||+|||++||++++..|
T Consensus 142 lHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 142 LHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred ecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 99999999999985 899999999999766 3444678899999999999999988999999999999999999999999
Q ss_pred CCCCCHHHHHHHHH-----------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 152 PGKNSADQIYKIYG-----------------------------------------RWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 152 ~~~~~~~~~~~i~~-----------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+.++.+++.+|.. +..+++.+||+.+|++|.|+..+|.
T Consensus 222 pG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 222 PGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 99999999888764 3578999999999999999999999
Q ss_pred CCCCCCCC
Q 040202 191 HPFFRSCH 198 (297)
Q Consensus 191 h~~f~~~~ 198 (297)
||||....
T Consensus 302 h~yf~~~~ 309 (323)
T KOG0594|consen 302 HPYFSELP 309 (323)
T ss_pred Chhhcccc
Confidence 99998643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=309.50 Aligned_cols=194 Identities=39% Similarity=0.698 Sum_probs=169.8
Q ss_pred ccccccccceeeeceeEEe-----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 4 LRKMNNHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
|++.++|+||+.+.+++.. -+.+|+|+|+|+.++...+... ..++++.++.+++||+.||+|+|+.||+|||+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDL 151 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDL 151 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccccccccc
Confidence 3444589999999999964 3579999999977776655543 45999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCC---CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||.|+|++. ..+||+|||+|+.... ....+.++.|+||.|||++.....|+..+||||+|||+.||++|+..|.|.
T Consensus 152 KPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 152 KPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred chhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 999999985 5789999999998863 444577889999999999988888899999999999999999999999999
Q ss_pred CCHHHHHHHHH------------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 155 NSADQIYKIYG------------------------------------------RWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 155 ~~~~~~~~i~~------------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
+..+++..|.. ...+|+.+||..||.+|+|++|+|+||
T Consensus 232 d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 232 DYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred chHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 98888776542 458899999999999999999999999
Q ss_pred CCCCCCC
Q 040202 193 FFRSCHF 199 (297)
Q Consensus 193 ~f~~~~~ 199 (297)
|+...+.
T Consensus 312 Yl~~~hd 318 (359)
T KOG0660|consen 312 YLAPYHD 318 (359)
T ss_pred hhhhhcC
Confidence 9987654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=311.42 Aligned_cols=196 Identities=37% Similarity=0.639 Sum_probs=175.4
Q ss_pred cccccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+|+ .++|||||++.-+|... -++.+||||++.++.+.+... .+..++.-.++-|++||+.||.|||+.||+|
T Consensus 70 im~-~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcH 148 (364)
T KOG0658|consen 70 IMR-KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICH 148 (364)
T ss_pred HHH-hcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCccc
Confidence 344 55999999999988532 256799999999998877742 3456999999999999999999999999999
Q ss_pred cCCCCCcEEEeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 76 RDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 76 rdikp~Nill~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|||||+|+|+|. |.+||+|||.|+.+..+....++..|+.|+|||.+.+...|+.+.||||.|||+.||+-|++.|.|
T Consensus 149 RDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 149 RDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred CCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 999999999984 899999999999999988889999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHH----------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 154 KNSADQIYKIYG----------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 154 ~~~~~~~~~i~~----------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
.+..+++..|.+ ++.+|+.++|..+|.+|.++.|++.|||
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 999888776543 5689999999999999999999999999
Q ss_pred CCCCCC
Q 040202 194 FRSCHF 199 (297)
Q Consensus 194 f~~~~~ 199 (297)
|.....
T Consensus 309 Fdelr~ 314 (364)
T KOG0658|consen 309 FDELRD 314 (364)
T ss_pred hHHhhC
Confidence 976543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=311.43 Aligned_cols=195 Identities=26% Similarity=0.442 Sum_probs=166.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.+++++||||++++..|..+..+|+||.||.+ ++++.+......+|+|..+..+++++++||.|||++|.||||||+.|
T Consensus 77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgn 156 (516)
T KOG0582|consen 77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGN 156 (516)
T ss_pred HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccccccc
Confidence 45678999999999999999999999999986 55555555555679999999999999999999999999999999999
Q ss_pred EEEe-CCeEEEEecCCceecCCCC-----CCccccccCCCCCCce-ecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 83 LLVS-KGVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEV-LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~-~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|||+ +|.|||+|||.+..+..+. ...+++||++|||||+ ......|+.|+||||||++..||.+|..||....
T Consensus 157 ILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 157 ILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred EEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 9998 5999999999876653321 1156789999999999 4455678999999999999999999999997654
Q ss_pred C---------------------HHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 156 S---------------------ADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 156 ~---------------------~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
. .++..+....++.++..||+.||.+|||++++|+|+||+...
T Consensus 237 PmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 237 PMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3 344445556889999999999999999999999999997653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=315.08 Aligned_cols=195 Identities=25% Similarity=0.472 Sum_probs=180.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+|+.+|||||++|++..+...+|||+|+=+| ++++++.++ ..++.|+.+++||.||+.|+.|+|+..++||||||+|+
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENV 149 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENV 149 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCccee
Confidence 5778999999999999999999999999886 788888776 45699999999999999999999999999999999998
Q ss_pred EEe-C-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVS-K-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~-~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
.+- + |.|||.|||++.....+....+.||+..|-|||++.+..|..+++||||||||||.|++|+.||+..++.+.+-
T Consensus 150 VFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT 229 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT 229 (864)
T ss_pred EEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh
Confidence 764 4 99999999999999999999999999999999999999999999999999999999999999999999988877
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~ 200 (297)
.|. .++++||..||..||++|.+.++|..|+|++..+..
T Consensus 230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 664 489999999999999999999999999999887653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=299.38 Aligned_cols=181 Identities=28% Similarity=0.433 Sum_probs=156.2
Q ss_pred ccccccccceeeece-eEE-eCCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cc
Q 040202 4 LRKMNNHPNIVKLRN-LVK-EHEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHR--QG--YF 74 (297)
Q Consensus 4 l~kl~~HpnIv~~~~-~~~-~~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~--~g--i~ 74 (297)
|+|.++|||||+|++ .|. +++.++||||||++|.+..++++ .++.++|..+++++.||+.||..+|+ .. |+
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 556669999999999 554 44459999999998777776654 34579999999999999999999998 34 99
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
||||||.||+++. |.+||+|||+++.+.... ...+.+|||.||+||++...+ |+.++||||+||++|||+.-+.||.
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcc
Confidence 9999999999985 899999999999987653 346789999999999987655 5999999999999999999999999
Q ss_pred CCCCHHHHHHHHH-------------HHHHHHHHhhhcCCCCCCCH
Q 040202 153 GKNSADQIYKIYG-------------RWVALISWLCSWNPRMRPTA 185 (297)
Q Consensus 153 ~~~~~~~~~~i~~-------------~~~~li~~~l~~dP~~R~t~ 185 (297)
+.+-.+...+|.+ ++..+|..|+..||..||+.
T Consensus 230 g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 230 GDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 9987777777643 67889999999999999984
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.30 Aligned_cols=192 Identities=31% Similarity=0.479 Sum_probs=166.2
Q ss_pred cccccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQN-FSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~-l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
.++|.+.|||||+++++..+ .+.+|||+|||..|-+...-.. +. +.+.++++|+++++.||+|||.+||+|||||
T Consensus 160 ailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK 237 (576)
T KOG0585|consen 160 AILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK 237 (576)
T ss_pred HHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence 44555699999999999975 4689999999998766554433 44 8999999999999999999999999999999
Q ss_pred CCcEEEe-CCeEEEEecCCceec------CCCCCCccccccCCCCCCceecc---cccCCCccchhhHHHHHHHHHhCCC
Q 040202 80 PSNLLVS-KGVIKIGDLGMVKEI------DSSLPCTDYVTTRWYRAPEVLLL---SEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 80 p~Nill~-~~~~kl~Dfgla~~~------~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|.|+|++ +|++||+|||.+... +........+|||.|+|||.+.+ ..+.+.+.||||+||+||-|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 9999997 499999999998866 22233345789999999999876 3355788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH-------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 150 LFPGKNSADQIYKIYG-------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 150 pf~~~~~~~~~~~i~~-------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
||-+....+...||.. .+++||.+||++||++|+++.++..|||...
T Consensus 318 PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 318 PFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred CcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 9999999999888864 6799999999999999999999999999954
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=319.73 Aligned_cols=191 Identities=25% Similarity=0.524 Sum_probs=170.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
|.+.++|||||.++++|++..++|+|.||+.|++...+.+. +.++|+.++.++.|++.||.|||+++|+|||+||.||
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqni 131 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNI 131 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCccee
Confidence 33445999999999999999999999999999877777665 5699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+|++|||+|+.+..+.. .....|||.|||||++. ...|+..+|+||+|||+|||+.|++||......+...
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred eecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 9996 7999999999998876543 35678999999999876 5667999999999999999999999998887777777
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.|. ..+++|+..+|.+||.+|.|..+++.|||+++.
T Consensus 211 ~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 211 SILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 664 378999999999999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.94 Aligned_cols=193 Identities=33% Similarity=0.576 Sum_probs=162.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++..|+||||+.+++++.+... .+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil 135 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLL 135 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 3445999999999999999999999999999998887765 345999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH-HHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD-QIY 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~~ 161 (297)
+++ +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|..||.+..... ...
T Consensus 136 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 215 (303)
T cd07869 136 ISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215 (303)
T ss_pred ECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 975 88999999998765322 223456789999999998766667889999999999999999999998754322 111
Q ss_pred HH-------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 162 KI-------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 162 ~i-------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
++ ...+.+|+.+||+.||++|+|+.++++||||++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 11 12467899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.92 Aligned_cols=193 Identities=31% Similarity=0.455 Sum_probs=163.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||+.|+.+.....+ .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 50 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll 128 (323)
T cd05571 50 QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128 (323)
T ss_pred HhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence 345999999999999999999999999998655444443 2569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+. +.+||+|||+++... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+
T Consensus 129 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~ 207 (323)
T cd05571 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (323)
T ss_pred CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 75 789999999987642 22333556799999999998654 4589999999999999999999999877655544433
Q ss_pred -----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCC
Q 040202 164 -----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 164 -----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~ 200 (297)
..++.+||++||..||++|+ ++.++++||||++..+.
T Consensus 208 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 208 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred HcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 24789999999999999999 89999999999886553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=299.88 Aligned_cols=188 Identities=34% Similarity=0.641 Sum_probs=160.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||++|++.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 136 (288)
T cd07871 58 KNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136 (288)
T ss_pred HhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 445999999999999999999999999999877766544 4458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++...... ......+++.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 137 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 137 NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 75 789999999997654322 2245578999999999876566789999999999999999999999876654433221
Q ss_pred -----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 -----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 -----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..++++||++||+.||.+|+|++|+++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2356889999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=301.79 Aligned_cols=194 Identities=26% Similarity=0.415 Sum_probs=162.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+..+||||+++++++.+++.+|+||||+.|+.+...... +..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 49 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Ni 127 (316)
T cd05620 49 LALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNV 127 (316)
T ss_pred HHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 34456899999999999999999999999998555444443 24699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 128 MLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred EECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9985 7899999999875422 2233567799999999998754 45889999999999999999999998877655544
Q ss_pred HH-----------HHHHHHHHHHhhhcCCCCCCCH-HHHHcCCCCCCCCC
Q 040202 162 KI-----------YGRWVALISWLCSWNPRMRPTA-AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i-----------~~~~~~li~~~l~~dP~~R~t~-~~ll~h~~f~~~~~ 199 (297)
.+ ..++++++++||..||++|+++ +++++||||+..++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 207 SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 43 2367899999999999999998 58899999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=288.22 Aligned_cols=194 Identities=29% Similarity=0.457 Sum_probs=169.9
Q ss_pred ccccceeeeceeEEe----CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 8 NNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~----~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
..|||||.++++|++ ..++.+|||.++| +|+.++.++....|+|.++..|++||..|+.|||+.+|.||||||+|
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN 191 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN 191 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence 479999999999964 4689999999987 77788888766789999999999999999999999999999999999
Q ss_pred EEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC--
Q 040202 83 LLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS-- 156 (297)
Q Consensus 83 ill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-- 156 (297)
+|... ..+||+|||+|+.........+.|.|+.|.|||++.. ..|+...|+||+||++|-|++|.+||.....
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred eeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 99953 3689999999999988888889999999999999754 4579999999999999999999999965442
Q ss_pred -----------------HHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCCCC
Q 040202 157 -----------------ADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202 (297)
Q Consensus 157 -----------------~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~~~ 202 (297)
.+.+..+++..+++|+++|..+|.+|.|+.++++|||+.+...+|.
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 2344556778899999999999999999999999999987655543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=303.78 Aligned_cols=191 Identities=26% Similarity=0.416 Sum_probs=163.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+.....+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 73 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll 151 (329)
T PTZ00263 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL 151 (329)
T ss_pred HhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE
Confidence 3459999999999999999999999999875554444432 469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY 164 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~ 164 (297)
++ +.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++.
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 228 (329)
T PTZ00263 152 DNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228 (329)
T ss_pred CCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 75 799999999998765443 356799999999998754 45889999999999999999999998877665555543
Q ss_pred -----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCCC
Q 040202 165 -----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHFV 200 (297)
Q Consensus 165 -----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~~ 200 (297)
..+++||++||+.||.+|++ ++++++||||++..+.
T Consensus 229 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred cCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 36789999999999999997 7999999999876543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=303.61 Aligned_cols=186 Identities=26% Similarity=0.415 Sum_probs=161.9
Q ss_pred ccccccccceeeeceeEEeCC-eEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHE-DVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQG-YFHRDLKP 80 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~-~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~g-i~Hrdikp 80 (297)
|.+ ++|||||+++|++.+.. .+.|||||+++|++..+..+ .+..++...+..++.||+.|++|||+++ |||||||+
T Consensus 93 l~~-l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~ 171 (362)
T KOG0192|consen 93 LSR-LRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS 171 (362)
T ss_pred HHh-CCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence 444 59999999999999888 79999999998877777766 3567999999999999999999999999 99999999
Q ss_pred CcEEEeC-C-eEEEEecCCceecCCC-CCCccccccCCCCCCceecc-cccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 81 SNLLVSK-G-VIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL-SEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 81 ~Nill~~-~-~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
+|||++. + ++||+|||+++..... ...+...||..|||||++.+ ...|+.++||||||+++|||+||+.||.+...
T Consensus 172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 172 DNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred hhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 9999996 4 8999999999887764 34455789999999999885 35679999999999999999999999999887
Q ss_pred HHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 157 ADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 157 ~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+....+. ..+.+++..|+..||.+||+..+++.
T Consensus 252 ~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 252 VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 55444432 36899999999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=306.08 Aligned_cols=192 Identities=28% Similarity=0.393 Sum_probs=164.5
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++.+|+||||+.|+.+..+.... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 163 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL 163 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence 34459999999999999999999999999875555444442 46999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+++ +.+||+|||+++...... .+..||+.|+|||++.+. .++.++||||+||++|||++|..||.+.+......++
T Consensus 164 l~~~~~ikL~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 240 (340)
T PTZ00426 164 LDKDGFIKMTDFGFAKVVDTRT--YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240 (340)
T ss_pred ECCCCCEEEecCCCCeecCCCc--ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 975 789999999998765432 466899999999998654 4588999999999999999999999887766555544
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~ 200 (297)
. ..+.+++++||+.||.+|+ +++++++||||++.+|.
T Consensus 241 ~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 241 LEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred hcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 3 3678999999999999995 89999999999987653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=314.59 Aligned_cols=195 Identities=29% Similarity=0.479 Sum_probs=163.5
Q ss_pred cccccccceeeeceeEEeC--------CeEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 5 RKMNNHPNIVKLRNLVKEH--------EDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~--------~~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
++.++|+|||++++++... ..+++||||+++++.+.+.. ..+..+++..++.++.||+.||+|||++||+
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~Ii 192 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC 192 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 3445999999999887432 35789999999988776653 2345699999999999999999999999999
Q ss_pred ccCCCCCcEEEeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 75 HRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 75 Hrdikp~Nill~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
||||||+|||++. +.+||+|||+++............||+.|+|||++.+...++.++||||+||++|||++|..||.
T Consensus 193 HrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred cCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999974 46999999999877655555567889999999998766667899999999999999999999998
Q ss_pred CCCCHHHHHHH----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 153 GKNSADQIYKI----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 153 ~~~~~~~~~~i----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
+.+..+...++ ..++++||.+||+.||.+|+|+.|+|+||
T Consensus 273 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 273 GQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 87655443332 13578999999999999999999999999
Q ss_pred CCCCCCC
Q 040202 193 FFRSCHF 199 (297)
Q Consensus 193 ~f~~~~~ 199 (297)
||+....
T Consensus 353 ~f~~~~~ 359 (440)
T PTZ00036 353 FFDDLRD 359 (440)
T ss_pred hHHhhhc
Confidence 9986543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.48 Aligned_cols=191 Identities=28% Similarity=0.380 Sum_probs=161.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 48 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili 126 (312)
T cd05585 48 AQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126 (312)
T ss_pred HhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE
Confidence 3359999999999999999999999999985554444432 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...++
T Consensus 127 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~ 205 (312)
T cd05585 127 DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI 205 (312)
T ss_pred CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence 75 8899999999876432 2223456799999999998654 4588999999999999999999999887766555544
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCC---CHHHHHcCCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRP---TAAEALEHPFFRSCH 198 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~---t~~~ll~h~~f~~~~ 198 (297)
. ..+.+++.+||..||.+|+ ++.++++||||+...
T Consensus 206 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 206 LQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 3 3688999999999999997 578999999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.54 Aligned_cols=191 Identities=35% Similarity=0.581 Sum_probs=171.0
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+|+++..|||||.++++|++...+|+|||+|.| ++++.+... .++|..+..+++|++.|++|||+.||+||||||+
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE 164 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE 164 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence 455664599999999999999999999999986 777777766 3999999999999999999999999999999999
Q ss_pred cEEEeC-----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 82 NLLVSK-----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 82 Nill~~-----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|+|+.. +.+|++|||++..........+.+||+.|+|||++.. ..|+..+||||+||++|.|++|..||.+.+.
T Consensus 165 N~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 165 NLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred HeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 999942 3799999999999888777789999999999999764 4569999999999999999999999999887
Q ss_pred HHHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 ADQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 ~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.....+|. ..+++||++||..||.+|+|+.++|+|||+++.
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 66665553 478999999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=298.72 Aligned_cols=192 Identities=27% Similarity=0.362 Sum_probs=163.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++.+|+||||+.|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIl 133 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL 133 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 34459999999999999999999999999875544444432 46999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+++ +.+||+|||+++...... ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++
T Consensus 134 i~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 134 LDKEGHIKLTDFGFAKKLRDRT--WTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred ECCCCCEEEEecCcchhccCCc--ccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 975 799999999998765432 356789999999997654 4588999999999999999999999887766555544
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHFV 200 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~~ 200 (297)
. ..++++|++||+.||.+|++ ++++++||||+...+.
T Consensus 211 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 211 LAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 3 36789999999999999995 9999999999876653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=296.08 Aligned_cols=187 Identities=34% Similarity=0.697 Sum_probs=160.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.+++++.+... ...+++..++.++.|++.||+|||+.||+||||||+||++
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill 133 (287)
T cd07848 55 RTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI 133 (287)
T ss_pred HhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 445999999999999999999999999999988877654 3469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+. +.+||+|||+++..... .......|++.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 75 78999999999876432 2223467899999999987544 58899999999999999999999987655433221
Q ss_pred -------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 -------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 -------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+...+.+|+++||+.||++|+|++++|+||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 22347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.39 Aligned_cols=186 Identities=35% Similarity=0.629 Sum_probs=160.7
Q ss_pred ccccceeeeceeEE-----eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 8 NNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 8 ~~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++||||+++++++. ....+|+||||+++++.+.+.......+++..++.++.|++.||+|||++||+||||||+|
T Consensus 61 ~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~N 140 (290)
T cd07862 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 140 (290)
T ss_pred cCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 37999999999985 3457999999999988888776555569999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
||+++ +.+||+|||+++............||+.|+|||++... .++.++||||+||++|||++|+.||.+.+..+...
T Consensus 141 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 219 (290)
T cd07862 141 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 219 (290)
T ss_pred EEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 99975 78999999999877655545567789999999998654 45889999999999999999999998877655544
Q ss_pred HHH--------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 KIY--------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 ~i~--------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
++. ..+++++.+||+.||++|||+.++|+||||
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 220 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 432 234789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=302.85 Aligned_cols=194 Identities=27% Similarity=0.460 Sum_probs=160.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++.+|+||+++++++.+++.+|+||||+.|+ +.+.+..+ ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~N 135 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLEN 135 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence 445557999999999999999999999999874 44555443 459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS--- 156 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--- 156 (297)
||+++ +.+||+|||+++..... ......+||+.|+|||++.+...++.++|||||||++|||++|+.||.....
T Consensus 136 ili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred eEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 99975 79999999998765332 2223567999999999987655568899999999999999999999975432
Q ss_pred HHHH-HH-----------HHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 157 ADQI-YK-----------IYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 157 ~~~~-~~-----------i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
.... .+ +...+.+++.+||..||++|+ +++++++||||++..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 216 QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 2222 11 223678999999999999999 7889999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=300.54 Aligned_cols=194 Identities=30% Similarity=0.508 Sum_probs=165.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+.+.+|+||||+.|+.+.....+. +.+++..++.++.|++.||+|||++||+||||||+||
T Consensus 49 l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NI 127 (320)
T cd05590 49 LSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNV 127 (320)
T ss_pred HHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence 344558999999999999999999999999986665544442 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (320)
T cd05590 128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206 (320)
T ss_pred EECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9975 7899999999876432 233345679999999999764 446889999999999999999999999887766655
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCH------HHHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTA------AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~------~~ll~h~~f~~~~~ 199 (297)
.+. .++.+++++||+.||++|+++ +++++||||+...+
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 207 AILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 543 367899999999999999998 89999999987655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.28 Aligned_cols=193 Identities=30% Similarity=0.449 Sum_probs=163.5
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++.+|+||||+.|+.+...... .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl 127 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeE
Confidence 3445999999999999999999999999988655444443 246999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 128 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred ECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 985 7999999999876432 2233456799999999998654 458999999999999999999999987766555444
Q ss_pred H-----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 I-----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i-----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+ ..++.++|++||..||++|+ ++.++++|+||.+..+
T Consensus 207 ~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 207 ILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred hccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 3 24789999999999999997 8999999999987655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=298.65 Aligned_cols=193 Identities=30% Similarity=0.460 Sum_probs=163.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++..|+||||+.|+.+.....+. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 127 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 34459999999999999999999999999986655544442 46999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++.... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......
T Consensus 128 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 206 (323)
T cd05595 128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206 (323)
T ss_pred EcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 985 7899999999876422 2333456799999999998654 458899999999999999999999988776655544
Q ss_pred H-----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 I-----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i-----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+ ..++.++|.+||..||++|+ ++.++++|+||....+
T Consensus 207 ~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 207 ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 3 34788999999999999998 8999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.94 Aligned_cols=193 Identities=26% Similarity=0.374 Sum_probs=162.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK-ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~-~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.+++..|+||||+.|+.+.... ......+++..+..++.|++.||+|||+.||+||||||+|||
T Consensus 55 ~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05631 55 EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134 (285)
T ss_pred HhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence 3459999999999999999999999999986655444 333346999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
+++ +.+||+|||++.............||..|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 135 LDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred ECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 975 78999999999886555444567899999999998754 458899999999999999999999987654322111
Q ss_pred --------------HHHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 163 --------------IYGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 163 --------------i~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
+..++.+|+++||+.||.+|++ ++++++||||++..+
T Consensus 214 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 2336789999999999999997 899999999988655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=296.69 Aligned_cols=193 Identities=30% Similarity=0.482 Sum_probs=163.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
....+||||+++++++.+++..|+||||+.|+.+..+.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 50 ~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nil 128 (316)
T cd05592 50 ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL 128 (316)
T ss_pred HhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeE
Confidence 34568999999999999999999999999886665555443 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++. +.+||+|||+++.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 129 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~ 207 (316)
T cd05592 129 LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207 (316)
T ss_pred ECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 975 7899999999976532 2333456799999999998654 458899999999999999999999998776665554
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCHH-HHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTAA-EALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~~-~ll~h~~f~~~~~ 199 (297)
+. .++.+++.+||..||.+|+++. ++++|+||+...+
T Consensus 208 i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 208 ILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 42 3678999999999999999864 8899999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=298.32 Aligned_cols=195 Identities=30% Similarity=0.503 Sum_probs=166.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+++.+|+||||+.|+.+....... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 l~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Ni 127 (321)
T cd05591 49 LALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNI 127 (321)
T ss_pred HHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 334558999999999999999999999999986554444432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++... ........+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 206 (321)
T cd05591 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206 (321)
T ss_pred EECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9985 789999999987643 22333456789999999987644 45889999999999999999999999888776666
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCC-------CHHHHHcCCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRP-------TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~-------t~~~ll~h~~f~~~~~~ 200 (297)
++. .++.+++.+||+.||++|+ ++.++++||||+..++.
T Consensus 207 ~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 207 SILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 553 4788999999999999999 89999999999876653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=304.74 Aligned_cols=186 Identities=31% Similarity=0.570 Sum_probs=170.0
Q ss_pred cceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC---
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--- 87 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~--- 87 (297)
-|||+++++|...+++|||+|.++-+|++++..+.-.+|+...++.|+.||+.||.+||+.||||+|||||||||.+
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR 327 (586)
T ss_pred eeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence 47999999999999999999999999999999887778999999999999999999999999999999999999953
Q ss_pred CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Q 040202 88 GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-- 165 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~-- 165 (297)
..|||+|||.|........ +++-++.|+|||++.+.. |+.+.||||||||++||++|.+.|.|.+..+++..|.+
T Consensus 328 ~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred CceeEEecccccccCCcce--eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 5899999999988776653 788899999999999765 59999999999999999999999999999999887653
Q ss_pred ------------------------------------------------------------------------HHHHHHHH
Q 040202 166 ------------------------------------------------------------------------RWVALISW 173 (297)
Q Consensus 166 ------------------------------------------------------------------------~~~~li~~ 173 (297)
.+.+|+.+
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 24789999
Q ss_pred hhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 174 LCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 174 ~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
||++||.+|+|+.++|+||||.....
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HhccCchhcCCHHHHhcCcccccccc
Confidence 99999999999999999999986443
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=300.50 Aligned_cols=194 Identities=30% Similarity=0.450 Sum_probs=163.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+++.+|+||||+.|+.+.....+ .+.+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NI 127 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeE
Confidence 3445999999999999999999999999998665554444 2469999999999999999999997 7999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+......
T Consensus 128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred EECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 9975 7899999999876432 2333456799999999998654 45899999999999999999999998877655544
Q ss_pred HH-----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCC
Q 040202 162 KI-----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 162 ~i-----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~ 200 (297)
.+ ..++.+++.+||+.||++|+ ++.++++|+||++..+.
T Consensus 207 ~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 207 LILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 43 34689999999999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=298.13 Aligned_cols=194 Identities=29% Similarity=0.415 Sum_probs=164.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++.+.+++..|+||||+.|+.+..+..+ .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NI 127 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI 127 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence 34556999999999999999999999999998655544444 34699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 128 LLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred EECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 9975 7999999999876432 2233456799999999997654 46889999999999999999999998877665555
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCH----HHHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTA----AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~----~~ll~h~~f~~~~~ 199 (297)
++. ..+.++|.+||+.||.+|+++ .++++||||+...+
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 207 NILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 443 368999999999999999997 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=303.22 Aligned_cols=190 Identities=31% Similarity=0.521 Sum_probs=171.8
Q ss_pred ccccccccceeeeceeEEeCCe-EEEEEecCCCcHHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHED-VFIVFDYMESDLLKL-MKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~-~~lv~e~~~g~ll~~-~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
|.+ +.|||||.|.+.|.+++. ++|||+||+|+.+.. +.+..+..|+|+.+..|+.|++.|++|||+++|+|||||+.
T Consensus 57 is~-~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~ 135 (426)
T KOG0589|consen 57 LSK-LLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCA 135 (426)
T ss_pred HHh-ccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhh
Confidence 444 699999999999999888 999999999865554 45555578999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|||+++ +.|||+|||+|+.+.... ...+.+||+.||+||++.+ ..|+.++|||||||++|||++-+.+|.+.+....
T Consensus 136 Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 136 NIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred hhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 999985 778999999999998876 7788999999999998765 5569999999999999999999999999999999
Q ss_pred HHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 160 IYKIYG------------RWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 160 ~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
..+|.. +++.+|+.||..+|..||++.++|.+|...
T Consensus 215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 988865 678999999999999999999999998875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=296.09 Aligned_cols=193 Identities=33% Similarity=0.488 Sum_probs=163.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++..|+||||+.|+.+.....+. +.+.+..+..++.||+.||+|||++||+||||||+|||
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 132 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENIL 132 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 34459999999999999999999999999986555544442 45899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+......+
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~ 211 (323)
T cd05584 133 LDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211 (323)
T ss_pred ECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 974 8999999999875432 2233456799999999998654 458899999999999999999999988776665555
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+. .++.++|++||+.||++|+ +++++++||||+...+
T Consensus 212 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 212 ILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 42 3678999999999999999 8999999999987544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=301.14 Aligned_cols=194 Identities=28% Similarity=0.436 Sum_probs=165.4
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++++.+++.+|+||||+.|+.+..+... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (370)
T cd05596 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (370)
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 34456999999999999999999999999998666666554 3589999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceeccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLS---EICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|+++ +.+||+|||+++...... .....+||+.|+|||++... ..++.++|||||||++|||++|+.||.+.+..
T Consensus 174 Ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 253 (370)
T cd05596 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (370)
T ss_pred EEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH
Confidence 9985 899999999998764332 23456799999999997643 24688999999999999999999999987766
Q ss_pred HHHHHH---------------HHHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCC
Q 040202 158 DQIYKI---------------YGRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 158 ~~~~~i---------------~~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~ 199 (297)
....++ ..++++||.+||+.+|.+ |++++++++||||++..+
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 254 GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 555544 236789999999999988 999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=297.75 Aligned_cols=190 Identities=30% Similarity=0.477 Sum_probs=163.0
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++.+++..|+||||+.|+.+...... +.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 58 ~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred ccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 35899999999999999999999999998666555543 4699999999999999999999999999999999999997
Q ss_pred C-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY 164 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~ 164 (297)
+ +.+||+|||+++.... .......+|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++.
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5 7999999999875422 2333567899999999997654 45889999999999999999999999877666555442
Q ss_pred -----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 165 -----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 165 -----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
..+.++|.+||..||++|| ++.++++||||++..+
T Consensus 215 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 215 NDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 3678999999999999999 6899999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.06 Aligned_cols=190 Identities=30% Similarity=0.433 Sum_probs=162.7
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK- 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~- 87 (297)
+||||+++++.+.+++..|+||||+.|+.+.....+ .+.+++..++.++.||+.||+|||++||+||||||+|||+++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~ 132 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 799999999999999999999999987555444444 356999999999999999999999999999999999999975
Q ss_pred CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Q 040202 88 GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--- 163 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i--- 163 (297)
+.+||+|||+++.... .......+||..|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+...++
T Consensus 133 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 133 GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 7899999999876432 233356789999999999876666789999999999999999999999887766555443
Q ss_pred ---------HHHHHHHHHHhhhcCCCCCC----CHHHHHcCCCCCCCCC
Q 040202 164 ---------YGRWVALISWLCSWNPRMRP----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ---------~~~~~~li~~~l~~dP~~R~----t~~~ll~h~~f~~~~~ 199 (297)
..++.+++++||..||++|+ ++.++++||||+...+
T Consensus 213 ~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 213 KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 34678999999999999998 6899999999987654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=301.78 Aligned_cols=192 Identities=22% Similarity=0.408 Sum_probs=159.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++.+|+||||+.|+.+..++.+. +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 56 ~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi 134 (363)
T cd05628 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134 (363)
T ss_pred HhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE
Confidence 3459999999999999999999999999985555544442 569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC------------------------------------CCccccccCCCCCCceecccccC
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL------------------------------------PCTDYVTTRWYRAPEVLLLSEIC 128 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 128 (297)
++ +.+||+|||+++...... .....+||+.|+|||++.+. .+
T Consensus 135 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~ 213 (363)
T cd05628 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GY 213 (363)
T ss_pred CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CC
Confidence 75 899999999987543210 11345799999999998654 45
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------HHHHHHHHHhhhcCCC---CCCCHHHHHc
Q 040202 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---------------GRWVALISWLCSWNPR---MRPTAAEALE 190 (297)
Q Consensus 129 ~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~---------------~~~~~li~~~l~~dP~---~R~t~~~ll~ 190 (297)
+.++|||||||++|||++|+.||.+.+..+...++. .+++++|.+|+. +|. .||+++++++
T Consensus 214 ~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 889999999999999999999998877666555443 367889999875 444 4589999999
Q ss_pred CCCCCCCCCC
Q 040202 191 HPFFRSCHFV 200 (297)
Q Consensus 191 h~~f~~~~~~ 200 (297)
||||++.++.
T Consensus 293 hp~f~~~~~~ 302 (363)
T cd05628 293 NPFFEGVDWE 302 (363)
T ss_pred CCCCCCCCHH
Confidence 9999987663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=302.78 Aligned_cols=190 Identities=23% Similarity=0.388 Sum_probs=158.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||++++++..++..++|+|++.++++..+... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred HHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 3445999999999999999999999999998888877665 45899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS----- 156 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~----- 156 (297)
+++ +.+||+|||+++..... ......+||+.|+|||++.+. .++.++||||+||++|||++|..||.+...
T Consensus 215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~ 293 (391)
T PHA03212 215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293 (391)
T ss_pred EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC
Confidence 985 88999999998753221 223456899999999998654 468999999999999999999987643210
Q ss_pred --H----------------------------------------------HHHHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 157 --A----------------------------------------------DQIYKIYGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 157 --~----------------------------------------------~~~~~i~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
. .....+..++.+||.+||+.||.+|||+.|+
T Consensus 294 ~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el 373 (391)
T PHA03212 294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL 373 (391)
T ss_pred chhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH
Confidence 0 0001123367889999999999999999999
Q ss_pred HcCCCCCCC
Q 040202 189 LEHPFFRSC 197 (297)
Q Consensus 189 l~h~~f~~~ 197 (297)
|+||||+..
T Consensus 374 L~hp~f~~~ 382 (391)
T PHA03212 374 LDFAAFQDI 382 (391)
T ss_pred hcChhhccC
Confidence 999999864
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=298.43 Aligned_cols=194 Identities=30% Similarity=0.420 Sum_probs=163.5
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++.+++++.+|+||||+.|+.+.....+ .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NI 127 (325)
T cd05604 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENI 127 (325)
T ss_pred HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 44556999999999999999999999999998655444443 35699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+...
T Consensus 128 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (325)
T cd05604 128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206 (325)
T ss_pred EECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence 9975 7899999999875432 2223456799999999998654 45889999999999999999999998877666555
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCH----HHHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTA----AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~----~~ll~h~~f~~~~~ 199 (297)
++. ..+.+++++||..||.+|+++ .++++||||+...+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 207 NILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred HHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 443 357899999999999999986 58999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=298.00 Aligned_cols=196 Identities=29% Similarity=0.462 Sum_probs=165.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++|+||+++++++.+++..|+||||+.|+.+..+..+....+++..++.++.|++.||+|||++||+||||||+||
T Consensus 54 i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred HHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 34556999999999999999999999999988666555555445699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLL-----SEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|+++ +.+||+|||++........ .....||+.|+|||++.. ...++.++||||+||++|+|++|+.||...+
T Consensus 134 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred EECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 9985 8999999999987654322 123478999999999763 3446789999999999999999999998877
Q ss_pred CHHHHHHH---------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCC
Q 040202 156 SADQIYKI---------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 156 ~~~~~~~i---------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~ 200 (297)
......++ ...+.+|+.+||. ||++|+|++++++||||+...+.
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 66554443 3367899999998 99999999999999999876553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=308.01 Aligned_cols=196 Identities=26% Similarity=0.484 Sum_probs=174.1
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.|+..++||+||++++.|..++.++|+.|||+||-.+.+.-..+..++|.+++-+.+|++.||.|||+++|||||||..|
T Consensus 81 eILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN 160 (1187)
T KOG0579|consen 81 EILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN 160 (1187)
T ss_pred hhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence 35556799999999999999999999999999999988877778889999999999999999999999999999999999
Q ss_pred EEEe-CCeEEEEecCCceec-CCCCCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 83 LLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
||++ +|.++|+|||.+... .......+++|||+||||||... ...|+.++||||||++|.||..+++|-...+.
T Consensus 161 iL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 161 ILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred eEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 9998 799999999987543 33344478999999999999764 35678999999999999999999999988888
Q ss_pred HHHHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 157 ADQIYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 157 ~~~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
...+-+|- ..+.+|+.+||..||..||+++++|+||||.+..
T Consensus 241 MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 241 MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 77766653 3789999999999999999999999999998643
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=308.58 Aligned_cols=197 Identities=28% Similarity=0.387 Sum_probs=173.9
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNF--SEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l--~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
|.|++.+.|.|||+|.|.+.+++++-|+||-++||++..++...-+++ +|..+..|.+||+.||.|||++.|+|||||
T Consensus 623 IaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIK 702 (1226)
T KOG4279|consen 623 IALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIK 702 (1226)
T ss_pred HHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeecccc
Confidence 567888999999999999999999999999999988888887766778 899999999999999999999999999999
Q ss_pred CCcEEEe--CCeEEEEecCCceecCC-CCCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 80 PSNLLVS--KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 80 p~Nill~--~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
.+|+|++ .|.+||+|||-++.+.. +....++.||..|||||++..+ +.|+.++|||||||++.||.||++||....
T Consensus 703 GDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 703 GDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred CCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 9999997 49999999999988755 4455788999999999998754 568999999999999999999999997654
Q ss_pred CHHH-H-------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 156 SADQ-I-------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 156 ~~~~-~-------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.... . ..++.++++||.+|+..||.+||++.++|.+||++...
T Consensus 783 spqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 783 SPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred ChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 4332 1 23556889999999999999999999999999998653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=297.18 Aligned_cols=190 Identities=27% Similarity=0.438 Sum_probs=163.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 56 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 134 (333)
T cd05600 56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134 (333)
T ss_pred HhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 3448999999999999999999999999986665555442 469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI- 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i- 163 (297)
++ +.+||+|||+++.... ......||+.|+|||++.+. .++.++||||+||++|||++|..||.+.+..+....+
T Consensus 135 ~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 135 DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 75 7899999999976654 23567899999999998755 5689999999999999999999999887665544332
Q ss_pred ------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 ------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
..++.+++.+||..+|.+|+++.++++||||++..+
T Consensus 212 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 212 YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 346789999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=294.88 Aligned_cols=194 Identities=30% Similarity=0.531 Sum_probs=164.4
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+.+.+|+||||+.|+.+.....+. +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 49 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 127 (318)
T cd05570 49 LALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNV 127 (318)
T ss_pred HHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHe
Confidence 334448999999999999999999999999986655555443 4699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++++ +.+||+|||+++... ........+|+..|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~ 206 (318)
T cd05570 128 LLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206 (318)
T ss_pred EECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9975 799999999987632 22233456789999999998654 45889999999999999999999998877655554
Q ss_pred HH-----------HHHHHHHHHHhhhcCCCCCCCH-----HHHHcCCCCCCCCC
Q 040202 162 KI-----------YGRWVALISWLCSWNPRMRPTA-----AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i-----------~~~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f~~~~~ 199 (297)
.+ ...+.++|++||..||++|+++ .++++||||+...+
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 207 SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 43 2467899999999999999999 99999999988655
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=295.30 Aligned_cols=194 Identities=29% Similarity=0.400 Sum_probs=162.5
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++++.+.+..|+||||+.|+.+...... .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NI 127 (321)
T cd05603 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI 127 (321)
T ss_pred HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 34556999999999999999999999999998555444433 35699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++++ +.+||+|||+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+......
T Consensus 128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred EECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 9985 799999999987632 22233456789999999997654 46889999999999999999999998877655555
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCH----HHHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTA----AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~----~~ll~h~~f~~~~~ 199 (297)
.+. ..+.+++.+||+.||.+|+++ .++++|+||....+
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 207 NILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 443 257899999999999999876 49999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=296.92 Aligned_cols=194 Identities=28% Similarity=0.474 Sum_probs=158.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+++.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 l~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 127 (329)
T cd05588 49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127 (329)
T ss_pred HHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 345558999999999999999999999999985554444332 4699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC------
Q 040202 84 LVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN------ 155 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~------ 155 (297)
|+++ +.+||+|||+++.. .........+||+.|+|||++.+. .++.++|+||+||++|+|++|+.||....
T Consensus 128 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05588 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206 (329)
T ss_pred EECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCccccccccccc
Confidence 9975 78999999998753 223333567899999999998754 45889999999999999999999996321
Q ss_pred --CHHHHHH------------HHHHHHHHHHHhhhcCCCCCCC------HHHHHcCCCCCCCCC
Q 040202 156 --SADQIYK------------IYGRWVALISWLCSWNPRMRPT------AAEALEHPFFRSCHF 199 (297)
Q Consensus 156 --~~~~~~~------------i~~~~~~li~~~l~~dP~~R~t------~~~ll~h~~f~~~~~ 199 (297)
..+...+ +..++.+++++||+.||.+|+| ++++++||||+...+
T Consensus 207 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 207 QNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred ccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 1111111 1235789999999999999987 789999999987655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.00 Aligned_cols=191 Identities=31% Similarity=0.478 Sum_probs=157.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||+.|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 56 ~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll 134 (377)
T cd05629 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134 (377)
T ss_pred HhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 3459999999999999999999999999875554444432 569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC------------------------------------------------CCccccccCCC
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL------------------------------------------------PCTDYVTTRWY 116 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~------------------------------------------------~~~~~~gt~~y 116 (297)
+. +.+||+|||+++...... .....+||+.|
T Consensus 135 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 214 (377)
T cd05629 135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214 (377)
T ss_pred CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccc
Confidence 74 899999999986321100 00125799999
Q ss_pred CCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------HHHHHHHHHhhhcCCCC
Q 040202 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---------------GRWVALISWLCSWNPRM 181 (297)
Q Consensus 117 ~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~---------------~~~~~li~~~l~~dP~~ 181 (297)
+|||++.+. .++.++||||+||++|||++|..||.+.+..+...++. .++.+||.+||. +|.+
T Consensus 215 ~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 215 IAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred cCHHHHccC-CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 999998654 46899999999999999999999998877665554442 357899999997 7776
Q ss_pred C---CCHHHHHcCCCCCCCCC
Q 040202 182 R---PTAAEALEHPFFRSCHF 199 (297)
Q Consensus 182 R---~t~~~ll~h~~f~~~~~ 199 (297)
| +++.++++||||++.++
T Consensus 293 r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 293 RLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred cCCCCCHHHHhcCCCcCCCCH
Confidence 5 59999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=296.14 Aligned_cols=192 Identities=35% Similarity=0.664 Sum_probs=157.2
Q ss_pred ccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++||||+++++++... ..+|+||||+++++.+.+... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 54 ~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 131 (338)
T cd07859 54 RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKP 131 (338)
T ss_pred HhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 345999999999998543 358999999998887776544 4599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
+|||+++ +.+||+|||+++...... ......||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.+.
T Consensus 132 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 132 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred HHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999985 789999999997643221 12345789999999987542 45688999999999999999999999876
Q ss_pred CCHHHHHH------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 155 NSADQIYK------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 155 ~~~~~~~~------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
+....... ....+.+++.+||..||++|||++++++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 212 NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 54332211 112457899999999999999999999999
Q ss_pred CCCCCCC
Q 040202 193 FFRSCHF 199 (297)
Q Consensus 193 ~f~~~~~ 199 (297)
||++...
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9986443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.33 Aligned_cols=189 Identities=33% Similarity=0.638 Sum_probs=153.8
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESA-------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~-------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
+.++||||+++++++.+ +...|++|||+.+++...+.... ...+++..++.++.||+.||+|||++||+||
T Consensus 53 ~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHr 132 (317)
T cd07868 53 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 132 (317)
T ss_pred HhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcC
Confidence 34599999999999854 56789999999998877665321 1248999999999999999999999999999
Q ss_pred CCCCCcEEEe-----CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC
Q 040202 77 DLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147 (297)
Q Consensus 77 dikp~Nill~-----~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g 147 (297)
||||+|||++ .+.+||+|||+++...... ......||+.|+|||++.+...++.++||||+||++|+|++|
T Consensus 133 Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (317)
T cd07868 133 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred CCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 9999999993 2589999999998764322 224567899999999987766678999999999999999999
Q ss_pred CCCCCCCCCH---------HHHHHH-------------------------------------------------HHHHHH
Q 040202 148 RILFPGKNSA---------DQIYKI-------------------------------------------------YGRWVA 169 (297)
Q Consensus 148 ~~pf~~~~~~---------~~~~~i-------------------------------------------------~~~~~~ 169 (297)
+.||.+.... .+..++ ..++.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 292 (317)
T cd07868 213 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292 (317)
T ss_pred CCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHH
Confidence 9999654321 111100 013578
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 170 LISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 170 li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
||.+||+.||.+|+|++|+|+||||
T Consensus 293 li~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 293 LLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=291.32 Aligned_cols=192 Identities=35% Similarity=0.661 Sum_probs=162.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.+++.+.+... +..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 59 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill 137 (309)
T cd07872 59 KDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI 137 (309)
T ss_pred HhCCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 345999999999999999999999999999888776654 4458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.+||+|||+++...... ......++..|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 138 NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 75 789999999987654322 223456789999999987666678899999999999999999999987664433221
Q ss_pred ----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 ----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 ----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+..+++++|.+||..||.+|+|+.|+++||||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 123567899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.69 Aligned_cols=194 Identities=29% Similarity=0.470 Sum_probs=163.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+..+||||+++++++.+++.+|+||||+.|+.+....... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 49 l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Ni 127 (316)
T cd05619 49 LSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNI 127 (316)
T ss_pred HHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence 334569999999999999999999999999875555444432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... ........||..|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (316)
T cd05619 128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206 (316)
T ss_pred EECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9975 7899999999876422 2223456789999999998654 46899999999999999999999998877655544
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCHH-HHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTAA-EALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~~-~ll~h~~f~~~~~ 199 (297)
.+. .++.+++.+||..||++|+++. ++++||||+..++
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 207 SIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 432 3678999999999999999996 8999999988765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=288.24 Aligned_cols=185 Identities=37% Similarity=0.646 Sum_probs=158.5
Q ss_pred cccceeeeceeEEe-----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 9 NHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 9 ~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+||||+++++++.+ ....++||||+.+++.+.+.......+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Ni 139 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 139 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 79999999999864 3468999999999888777665445699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++++ +.+||+|||+++............||..|+|||++.+. .++.++||||+||++|+|++|+.||.+....+...+
T Consensus 140 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 140 LVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred EECCCCCEEECccCccccccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 9975 78999999999877655444556789999999998654 468899999999999999999999987765544433
Q ss_pred H--------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I--------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i--------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ...+.+++.+||+.||++|||+.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 2 2245789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.82 Aligned_cols=194 Identities=28% Similarity=0.440 Sum_probs=162.4
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++++.+++.+|+||||+.|+.+..+... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI 173 (370)
T cd05621 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM 173 (370)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 44556999999999999999999999999998666555554 3589999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceeccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLS---EICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|+++ +.+||+|||+++...... ...+.+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..
T Consensus 174 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~ 253 (370)
T cd05621 174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253 (370)
T ss_pred EECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence 9985 899999999998764332 23467899999999998653 23678999999999999999999999887765
Q ss_pred HHHHHHH---------------HHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCC
Q 040202 158 DQIYKIY---------------GRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 158 ~~~~~i~---------------~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~ 199 (297)
....++. ..+++++.+||..++.+ |+|+.++++||||+...+
T Consensus 254 ~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 254 GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 5554443 35789999999855544 899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=299.64 Aligned_cols=192 Identities=30% Similarity=0.498 Sum_probs=161.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|+||+++++++.+++.+|+||||+.|+.+..++... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl 133 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL 133 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence 34458999999999999999999999999886665555443 46999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC---------------------------------------CCccccccCCCCCCceecc
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL---------------------------------------PCTDYVTTRWYRAPEVLLL 124 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~ 124 (297)
+++ +.+||+|||+++.+.... .....+||+.|+|||++..
T Consensus 134 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (364)
T cd05599 134 LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213 (364)
T ss_pred ECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC
Confidence 985 889999999987543211 1123469999999999765
Q ss_pred cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHHHHHHHHHhhhcCCCCCCC---HH
Q 040202 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------YGRWVALISWLCSWNPRMRPT---AA 186 (297)
Q Consensus 125 ~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---------------~~~~~~li~~~l~~dP~~R~t---~~ 186 (297)
. .++.++|||||||++|||++|..||.+.+..+...++ ..++.+||.+||. +|.+|++ +.
T Consensus 214 ~-~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 214 T-GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred C-CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 4 4589999999999999999999999887765554433 2467899999996 9999998 99
Q ss_pred HHHcCCCCCCCCC
Q 040202 187 EALEHPFFRSCHF 199 (297)
Q Consensus 187 ~ll~h~~f~~~~~ 199 (297)
++++||||++.++
T Consensus 292 ~ll~h~~~~~~~~ 304 (364)
T cd05599 292 EIKSHPFFKGVDW 304 (364)
T ss_pred HHhcCCCcCCCCH
Confidence 9999999998765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.98 Aligned_cols=194 Identities=30% Similarity=0.493 Sum_probs=159.0
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+++.+|+||||+.|+.+....... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Ni 127 (329)
T cd05618 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 127 (329)
T ss_pred HHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 445668999999999999999999999999986555444432 4699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC------
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN------ 155 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~------ 155 (297)
+++. +.+||+|||+++... ........+||..|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus 128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05618 128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206 (329)
T ss_pred EECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcc
Confidence 9985 789999999987642 22233456799999999998654 45889999999999999999999995311
Q ss_pred --CHHHHHH-H-----------HHHHHHHHHHhhhcCCCCCCC------HHHHHcCCCCCCCCC
Q 040202 156 --SADQIYK-I-----------YGRWVALISWLCSWNPRMRPT------AAEALEHPFFRSCHF 199 (297)
Q Consensus 156 --~~~~~~~-i-----------~~~~~~li~~~l~~dP~~R~t------~~~ll~h~~f~~~~~ 199 (297)
......+ + ...+.+++++||..||++|++ +.++++||||+...|
T Consensus 207 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 207 QNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred cccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 1111111 1 235789999999999999998 579999999988765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.69 Aligned_cols=193 Identities=29% Similarity=0.402 Sum_probs=163.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++.+|+||||+.|+.+..+... .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil 128 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 4556999999999999999999999999998665555544 245899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++... ........+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...+
T Consensus 129 i~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 207 (325)
T cd05602 129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207 (325)
T ss_pred ECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 975 799999999987643 2233356679999999999865 4468899999999999999999999988776665554
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCHH----HHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTAA----EALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~~----~ll~h~~f~~~~~ 199 (297)
+. ..+.+++.+||+.||.+|+++. ++++|+||+..+|
T Consensus 208 i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 208 ILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred HHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 43 3678999999999999999876 8999999987655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.28 Aligned_cols=187 Identities=34% Similarity=0.582 Sum_probs=157.9
Q ss_pred cccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.+.++||||+++++++...+ .+|+||||+++++.+.+.. .+++..+..++.|++.||+|||++||+||||
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl 149 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 149 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 34459999999999986443 5799999999988776642 3899999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||++. +.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..
T Consensus 150 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 228 (359)
T cd07876 150 KPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228 (359)
T ss_pred CHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999985 79999999999876555555567889999999998654 4588999999999999999999999876643
Q ss_pred HHHHHH-----------------------------------------------------HHHHHHHHHHhhhcCCCCCCC
Q 040202 158 DQIYKI-----------------------------------------------------YGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 158 ~~~~~i-----------------------------------------------------~~~~~~li~~~l~~dP~~R~t 184 (297)
+...++ ...+++||.+||..||++|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 308 (359)
T cd07876 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308 (359)
T ss_pred HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC
Confidence 322111 124678999999999999999
Q ss_pred HHHHHcCCCCCC
Q 040202 185 AAEALEHPFFRS 196 (297)
Q Consensus 185 ~~~ll~h~~f~~ 196 (297)
+.|+|+||||..
T Consensus 309 ~~e~l~hp~~~~ 320 (359)
T cd07876 309 VDEALRHPYITV 320 (359)
T ss_pred HHHHhcCchhhh
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.70 Aligned_cols=188 Identities=36% Similarity=0.609 Sum_probs=159.6
Q ss_pred ccccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 4 LRKMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.+.++||||+++++++... ...|+||||+++++.+.+.. .+++..+..++.|++.||+|||++||+|||
T Consensus 76 ~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 151 (364)
T cd07875 76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151 (364)
T ss_pred HHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence 34456999999999988543 46899999999988876643 388999999999999999999999999999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|||+|||+++ +.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 152 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred CCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999999974 78999999999877665555667889999999998654 458899999999999999999999987765
Q ss_pred HHHHHHHH-----------------------------------------------------HHHHHHHHHhhhcCCCCCC
Q 040202 157 ADQIYKIY-----------------------------------------------------GRWVALISWLCSWNPRMRP 183 (297)
Q Consensus 157 ~~~~~~i~-----------------------------------------------------~~~~~li~~~l~~dP~~R~ 183 (297)
.+...++. ..+++||.+||+.||.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 231 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 44433321 1457899999999999999
Q ss_pred CHHHHHcCCCCCC
Q 040202 184 TAAEALEHPFFRS 196 (297)
Q Consensus 184 t~~~ll~h~~f~~ 196 (297)
|+.++|+||||..
T Consensus 311 t~~e~L~hp~~~~ 323 (364)
T cd07875 311 SVDEALQHPYINV 323 (364)
T ss_pred CHHHHhcCccccc
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=299.49 Aligned_cols=193 Identities=28% Similarity=0.456 Sum_probs=158.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++.+.+++.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL 133 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 34459999999999999999999999999875554444442 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC------------------------------------------------CCCCccccccCC
Q 040202 85 VSK-GVIKIGDLGMVKEIDS------------------------------------------------SLPCTDYVTTRW 115 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~------------------------------------------------~~~~~~~~gt~~ 115 (297)
++. +.+||+|||+++.... .....+.+||+.
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 975 8999999999753210 000123578999
Q ss_pred CCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHHHHHHHHHhhhcCCC
Q 040202 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------YGRWVALISWLCSWNPR 180 (297)
Q Consensus 116 y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---------------~~~~~~li~~~l~~dP~ 180 (297)
|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+...++ ..+..++|.+|+ .||.
T Consensus 214 Y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 214 YIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred cCCHHHhcCC-CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 9999998754 4589999999999999999999999887765554443 346788999986 5999
Q ss_pred CCCC---HHHHHcCCCCCCCCCC
Q 040202 181 MRPT---AAEALEHPFFRSCHFV 200 (297)
Q Consensus 181 ~R~t---~~~ll~h~~f~~~~~~ 200 (297)
+|++ ++++++||||++..+.
T Consensus 292 ~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 292 DRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HcCCCCCHHHHhcCCCcCCcChH
Confidence 9997 9999999999887653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=271.28 Aligned_cols=192 Identities=28% Similarity=0.430 Sum_probs=172.5
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.++.-++||||+++|++|-++...||++||.. |+++..+.....+.++|..+..|++|++.|+.|+|..+++||||||+
T Consensus 74 EIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe 153 (281)
T KOG0580|consen 74 EIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE 153 (281)
T ss_pred EeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH
Confidence 45566799999999999999999999999997 58888888766678999999999999999999999999999999999
Q ss_pred cEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 82 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 82 Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|+|++ +|.+||+|||-+.... .....+.|||..|.+||+..+ ..++..+|+|++|++.||++.|..||...+..+.+
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY 231 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY 231 (281)
T ss_pred HhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH
Confidence 99997 6999999999987765 344478999999999998764 45689999999999999999999999999977777
Q ss_pred HHHH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 161 YKIY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 161 ~~i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+|. .+..++|.+||..+|.+|.+..|++.|||+..
T Consensus 232 krI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 232 KRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 7664 37899999999999999999999999999854
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=296.85 Aligned_cols=193 Identities=28% Similarity=0.437 Sum_probs=157.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||+.||+||||||+|||
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil 133 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence 34459999999999999999999999999885554444442 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC------------------------------------------------CCCccccccCC
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS------------------------------------------------LPCTDYVTTRW 115 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~------------------------------------------------~~~~~~~gt~~ 115 (297)
++. +.+||+|||+++..... ....+.+||+.
T Consensus 134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred ECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence 985 89999999997532100 00124579999
Q ss_pred CCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHHHHHHHHHhhhc--C
Q 040202 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------YGRWVALISWLCSW--N 178 (297)
Q Consensus 116 y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---------------~~~~~~li~~~l~~--d 178 (297)
|+|||++.+. .++.++||||+||++|||++|+.||...+..+...++ ..++++||.+|+.. +
T Consensus 214 Y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 214 YIAPEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred ccCHHHHcCC-CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 9999998654 4588999999999999999999999887765544433 24688999997754 4
Q ss_pred CCCCCCHHHHHcCCCCCCCCC
Q 040202 179 PRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 179 P~~R~t~~~ll~h~~f~~~~~ 199 (297)
+.+|++++++++||||+...+
T Consensus 293 ~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 293 RLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred ccCCCCHHHHhcCcccCCCCh
Confidence 455999999999999987655
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=284.91 Aligned_cols=195 Identities=25% Similarity=0.355 Sum_probs=161.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+.++|+||+++.+++.+++..|+||||+.|+.+...... ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 126 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPE 126 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 3445999999999999999999999999998666544422 2345999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
||++++ +.+||+|||++....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||........
T Consensus 127 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 205 (280)
T cd05608 127 NVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205 (280)
T ss_pred HEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 999975 789999999997764432 22346789999999998754 457899999999999999999999976543211
Q ss_pred ----HH-----------HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCC
Q 040202 160 ----IY-----------KIYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 160 ----~~-----------~i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~ 200 (297)
.. ++...+.+++.+||+.||++|+ +++++++||||++..+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 206 NKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred HHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 11 1234688999999999999999 88999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=295.28 Aligned_cols=192 Identities=29% Similarity=0.450 Sum_probs=162.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||+.|+.+.....+ ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 53 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 131 (318)
T cd05582 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 131 (318)
T ss_pred HhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE
Confidence 344999999999999999999999999987544333333 2459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 132 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 132 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 75 78999999998765443 333456789999999997654 4588999999999999999999999887766555544
Q ss_pred -----------HHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 164 -----------YGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 164 -----------~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
...+.+++++||+.||.+|++ +.++++|+||+...+
T Consensus 211 ~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 211 LKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 246789999999999999999 778999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=291.34 Aligned_cols=193 Identities=27% Similarity=0.450 Sum_probs=161.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.++..|++|+++++++.+++.+|+||||+.|+.+....... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil 133 (324)
T cd05587 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133 (324)
T ss_pred HhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 34434567999999999999999999999986555544442 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++... ........+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 134 LDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred EcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 975 789999999987542 22223456789999999998754 458899999999999999999999988776665554
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCH-----HHHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTA-----AEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f~~~~~ 199 (297)
+. .++.+++++||..||.+|+++ +++++||||+..++
T Consensus 213 i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 213 IMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 43 367899999999999999986 79999999988665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.38 Aligned_cols=193 Identities=27% Similarity=0.458 Sum_probs=163.5
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.++..|++|+++++++.+.+.+|+||||+.|+.+....... +.+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil 133 (323)
T cd05616 55 ALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133 (323)
T ss_pred HhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeE
Confidence 34557999999999999999999999999875554444432 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....
T Consensus 134 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred ECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 985 7899999999976432 2333466799999999998754 458999999999999999999999998776665554
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCH-----HHHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTA-----AEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f~~~~~ 199 (297)
+. .++.+++.+||+.||.+|+++ .++++|+||+..+|
T Consensus 213 i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 213 IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 43 478899999999999999984 79999999987765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=303.39 Aligned_cols=192 Identities=27% Similarity=0.472 Sum_probs=173.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++|.++|||||+++.+.+....+|+||||+.| ++++++..+ +.+.|..++.++.|++.|++|||+++|+|||||.+|
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 45677999999999999999999999999986 566666655 458899999999999999999999999999999999
Q ss_pred EEEeCC-eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|||+.+ ++||+|||++.++.......++||++.|.|||++.+.++.++.+|+||+|+++|.|+.|.+||++.+-.+.-.
T Consensus 186 ilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 186 ILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred cccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 999976 4999999999999998889999999999999999998999999999999999999999999999887655433
Q ss_pred H-----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 K-----------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~-----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+ +..++.++|+++|..+|.+|++++++.+|+|....
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 3 23478999999999999999999999999999643
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=297.85 Aligned_cols=191 Identities=34% Similarity=0.606 Sum_probs=162.9
Q ss_pred ccccccceeeeceeEEeCC-----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|+||+++++++...+ ..|+||||+.+++.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 54 ~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp 131 (372)
T cd07853 54 CFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131 (372)
T ss_pred HhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 4459999999999998776 89999999998888776543 5699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+|||+++ +.+||+|||+++..... .......+++.|+|||++.+...++.++||||+||++|||++|+.||.+.+..
T Consensus 132 ~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 132 GNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred HHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 9999985 78999999999865432 22234567999999999877666788999999999999999999999887765
Q ss_pred HHHHHHH-------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 158 DQIYKIY-------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 158 ~~~~~i~-------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
++...+. .++.+||.+||+.||++|||+.++++||||
T Consensus 212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 5443321 245789999999999999999999999999
Q ss_pred CCCC
Q 040202 195 RSCH 198 (297)
Q Consensus 195 ~~~~ 198 (297)
++..
T Consensus 292 ~~~~ 295 (372)
T cd07853 292 DEGR 295 (372)
T ss_pred CCCc
Confidence 8754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=296.67 Aligned_cols=192 Identities=29% Similarity=0.457 Sum_probs=158.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|+||+++++.+.+++.+|+||||+.|+.+..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 133 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEE
Confidence 34459999999999999999999999999876555554443 45899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC--------------------------------------------CCCCccccccCCCCCC
Q 040202 85 VSK-GVIKIGDLGMVKEIDS--------------------------------------------SLPCTDYVTTRWYRAP 119 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~--------------------------------------------~~~~~~~~gt~~y~aP 119 (297)
++. +.+||+|||++..... .......+||+.|+||
T Consensus 134 l~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 213 (376)
T cd05598 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213 (376)
T ss_pred ECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence 985 7899999999742210 0001235799999999
Q ss_pred ceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHHHHHHHHHhhhcCCCCCC-
Q 040202 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------YGRWVALISWLCSWNPRMRP- 183 (297)
Q Consensus 120 E~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---------------~~~~~~li~~~l~~dP~~R~- 183 (297)
|++.+. .++.++||||+||++|+|++|+.||.+.+..+...++ .....++|.+|+ .+|.+|+
T Consensus 214 E~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 214 EVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred HHHcCC-CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 998654 4588999999999999999999999887765544333 236788999976 5999999
Q ss_pred --CHHHHHcCCCCCCCCC
Q 040202 184 --TAAEALEHPFFRSCHF 199 (297)
Q Consensus 184 --t~~~ll~h~~f~~~~~ 199 (297)
++.++++||||+..++
T Consensus 292 ~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 292 KNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCCHHHHhCCCCcCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=290.05 Aligned_cols=194 Identities=27% Similarity=0.460 Sum_probs=160.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+|+||+++++++.+.+.+|+||||+.|+.+..+.... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 127 (327)
T cd05617 49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNV 127 (327)
T ss_pred HHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 445668999999999999999999999999886655544432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC------
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN------ 155 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~------ 155 (297)
|+++ +.+||+|||+++... ........+||+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus 128 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~ 206 (327)
T cd05617 128 LLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206 (327)
T ss_pred EEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence 9975 789999999987632 23333567899999999998654 45889999999999999999999996422
Q ss_pred CHHHHHHH------------HHHHHHHHHHhhhcCCCCCCC------HHHHHcCCCCCCCCC
Q 040202 156 SADQIYKI------------YGRWVALISWLCSWNPRMRPT------AAEALEHPFFRSCHF 199 (297)
Q Consensus 156 ~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t------~~~ll~h~~f~~~~~ 199 (297)
..+...+. ...+.+++.+||..||++|++ ++++++||||+...|
T Consensus 207 ~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 207 TEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 12222221 235789999999999999998 469999999998765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=282.01 Aligned_cols=191 Identities=40% Similarity=0.773 Sum_probs=164.9
Q ss_pred cccccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.++++.+|+||+++++++.++ +.+|+||||+.|++++.+.... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 50 ~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p 128 (282)
T cd07831 50 ALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKP 128 (282)
T ss_pred HHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCH
Confidence 355666799999999999987 8999999999999888876643 4699999999999999999999999999999999
Q ss_pred CcEEEeCCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 81 SNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 81 ~Nill~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
+||+++++.+||+|||+++............++..|+|||++.....++.++||||+||++|||++|..||.+.+..+..
T Consensus 129 ~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 129 ENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred HHEEEcCCCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 99999889999999999987765554455678999999998766566688999999999999999999999876544322
Q ss_pred HH----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 161 YK----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 161 ~~----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.. +...+.++|.+||..||++|||++++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 21 23467899999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=283.79 Aligned_cols=193 Identities=23% Similarity=0.350 Sum_probs=160.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK-LMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~-~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||++++++++++...|+||||+.|+.+. .+.......+++..+..++.|++.||+|||+.||+||||||+||+
T Consensus 48 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nil 127 (277)
T cd05607 48 EKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127 (277)
T ss_pred HhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEE
Confidence 3459999999999999999999999999885554 444333346899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH----H
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD----Q 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~----~ 159 (297)
+++ +.+||+|||++.............|+..|+|||++.... ++.++|+||+||++|+|++|+.||.+..... .
T Consensus 128 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05607 128 LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206 (277)
T ss_pred EcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Confidence 975 789999999998776554445567899999999987555 6899999999999999999999997643321 1
Q ss_pred HHH------------HHHHHHHHHHHhhhcCCCCCCCH----HHHHcCCCCCCCCC
Q 040202 160 IYK------------IYGRWVALISWLCSWNPRMRPTA----AEALEHPFFRSCHF 199 (297)
Q Consensus 160 ~~~------------i~~~~~~li~~~l~~dP~~R~t~----~~ll~h~~f~~~~~ 199 (297)
... +..++++++++||+.||.+|+++ +++++|+||+...+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 207 KRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 111 23467999999999999999999 67889999988655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=296.16 Aligned_cols=193 Identities=31% Similarity=0.482 Sum_probs=163.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIl 133 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNIL 133 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 34458999999999999999999999999875554444443 56999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC------------------------------CCccccccCCCCCCceecccccCCCccc
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL------------------------------PCTDYVTTRWYRAPEVLLLSEICGPEVD 133 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 133 (297)
+++ +.+||+|||+++...... ......||+.|+|||++.+. .++.++|
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 212 (350)
T cd05573 134 IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECD 212 (350)
T ss_pred ECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCcee
Confidence 985 789999999987654432 23456789999999998755 5689999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------HHHHHHHHHhhhcCCCCCCC-HHHHHcCCCCCCC
Q 040202 134 RWAMGAIMFEMLSFRILFPGKNSADQIYKIY---------------GRWVALISWLCSWNPRMRPT-AAEALEHPFFRSC 197 (297)
Q Consensus 134 iwSlGv~l~ell~g~~pf~~~~~~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t-~~~ll~h~~f~~~ 197 (297)
||||||++|+|++|+.||.+.+..+...++. .++.++|.+||. ||.+|++ ++++++||||++.
T Consensus 213 iwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 213 WWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred eEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 9999999999999999998887665554443 367899999997 9999999 9999999999886
Q ss_pred CCC
Q 040202 198 HFV 200 (297)
Q Consensus 198 ~~~ 200 (297)
.+.
T Consensus 292 ~~~ 294 (350)
T cd05573 292 DWE 294 (350)
T ss_pred CHH
Confidence 653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=294.68 Aligned_cols=188 Identities=36% Similarity=0.626 Sum_probs=158.7
Q ss_pred cccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.+.++|+||+++++++... ...|+||||+++++.+.+.. .+++..+..++.|++.||+|||++||+||||
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDi 145 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 4456999999999998643 35799999999988776643 3899999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||+++ +.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..
T Consensus 146 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred ChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999975 78999999999877666555667899999999998654 4588999999999999999999999876643
Q ss_pred HHHHHH-----------------------------------------------------HHHHHHHHHHhhhcCCCCCCC
Q 040202 158 DQIYKI-----------------------------------------------------YGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 158 ~~~~~i-----------------------------------------------------~~~~~~li~~~l~~dP~~R~t 184 (297)
+...++ ...+++||.+||..||++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps 304 (355)
T cd07874 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_pred HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC
Confidence 332211 124578999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 040202 185 AAEALEHPFFRSC 197 (297)
Q Consensus 185 ~~~ll~h~~f~~~ 197 (297)
+.|+|+||||...
T Consensus 305 ~~ell~hp~~~~~ 317 (355)
T cd07874 305 VDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCcchhcc
Confidence 9999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.35 Aligned_cols=185 Identities=26% Similarity=0.403 Sum_probs=154.1
Q ss_pred cccceeeeceeEEeC-CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEe
Q 040202 9 NHPNIVKLRNLVKEH-EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVS 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~-~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~ 86 (297)
+|.+|+++++++..+ +.+|+|||++++++++.+... +.+++..++.++.||+.||+|||+ .||+||||||+|||++
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME 266 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence 566799999998764 579999999988888887765 469999999999999999999998 5999999999999997
Q ss_pred C-C----------------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 87 K-G----------------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 87 ~-~----------------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
. + .+||+|||.+...... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence 4 2 4999999987654332 2467899999999998754 46889999999999999999999
Q ss_pred CCCCCCCHHHHHHH-----------------------------------------------------HHHHHHHHHHhhh
Q 040202 150 LFPGKNSADQIYKI-----------------------------------------------------YGRWVALISWLCS 176 (297)
Q Consensus 150 pf~~~~~~~~~~~i-----------------------------------------------------~~~~~~li~~~l~ 176 (297)
||.+.+..+....+ ...+.+||.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 99876654432211 0134689999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCC
Q 040202 177 WNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 177 ~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.||++|+|++|+|+||||....
T Consensus 424 ~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred cChhhCCCHHHHhcCccccccC
Confidence 9999999999999999998643
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=294.60 Aligned_cols=194 Identities=27% Similarity=0.422 Sum_probs=161.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++.+.+++.+|+||||+.|+.+..+... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (371)
T cd05622 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (371)
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 44556999999999999999999999999998666666654 3489999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceeccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLS---EICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|+++ +.+||+|||+++...... .....+||+.|+|||++... ..++.++||||+||++|||++|+.||.+.+..
T Consensus 174 ll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 253 (371)
T cd05622 174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (371)
T ss_pred EECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence 9985 899999999998765332 23466799999999998643 23678999999999999999999999887765
Q ss_pred HHHHHHH---------------HHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCC
Q 040202 158 DQIYKIY---------------GRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 158 ~~~~~i~---------------~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~ 199 (297)
....++. ..++++|.+||..++.+ |++++++++|+||++..+
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 254 GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 5554442 35789999999844433 789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.20 Aligned_cols=193 Identities=27% Similarity=0.402 Sum_probs=162.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK-ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~-~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+.+++.+|+||||+.|+.+.... ......+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (285)
T cd05605 55 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134 (285)
T ss_pred HhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEE
Confidence 3449999999999999999999999999876555444 333346999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
+++ +.++|+|||+++............|+..|+|||++.+. .++.++||||+||++|+|++|+.||.+.........
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 135 LDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred ECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 985 78999999999877555444566889999999998654 458899999999999999999999987654332211
Q ss_pred --------------HHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 --------------IYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 --------------i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+...+.+++.+||..||++|+ +++++++|+||+..++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 234678999999999999999 8999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=294.38 Aligned_cols=190 Identities=26% Similarity=0.421 Sum_probs=155.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++..|+||||+.+++++++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil 189 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIF 189 (357)
T ss_pred HHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 3445999999999999999999999999999988887654 356999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC-CCCCCH-----
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF-PGKNSA----- 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf-~~~~~~----- 157 (297)
++. +.+||+|||+++............||..|+|||++.+. .++.++||||+||++|||+++..++ ......
T Consensus 190 l~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~ 268 (357)
T PHA03209 190 INDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268 (357)
T ss_pred ECCCCCEEEecCccccccccCcccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHH
Confidence 985 78999999999765444444566789999999998754 4689999999999999999855443 322111
Q ss_pred ----HHHHH---------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 158 ----DQIYK---------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 158 ----~~~~~---------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
..+.+ +..+..+||.+||+.||++|||+.|+
T Consensus 269 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~ 348 (357)
T PHA03209 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI 348 (357)
T ss_pred HHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHH
Confidence 00000 01134559999999999999999999
Q ss_pred HcCCCCCC
Q 040202 189 LEHPFFRS 196 (297)
Q Consensus 189 l~h~~f~~ 196 (297)
|+||||++
T Consensus 349 l~hp~f~~ 356 (357)
T PHA03209 349 LNYPMFAQ 356 (357)
T ss_pred hcCchhcc
Confidence 99999975
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.16 Aligned_cols=194 Identities=27% Similarity=0.409 Sum_probs=160.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++.+|+||||+.|+.+..+..+.+..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill 135 (331)
T cd05597 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135 (331)
T ss_pred HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE
Confidence 34599999999999999999999999998755555555445569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+. +.+||+|||++......... ....||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+..+
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~ 215 (331)
T cd05597 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH
Confidence 74 88999999998776443221 23468999999999863 2446789999999999999999999998876555
Q ss_pred HHHHH----------------HHHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCC
Q 040202 159 QIYKI----------------YGRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 159 ~~~~i----------------~~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~ 199 (297)
...++ ...+++++++||..++++ |+++.++++||||++.++
T Consensus 216 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 216 TYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 44433 346789999999764444 789999999999988655
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.39 Aligned_cols=192 Identities=23% Similarity=0.422 Sum_probs=159.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++.+|+||||+.|+.+..+..+. +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli 134 (360)
T cd05627 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134 (360)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE
Confidence 3459999999999999999999999999986555544432 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC------------------------------------CCccccccCCCCCCceecccccC
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL------------------------------------PCTDYVTTRWYRAPEVLLLSEIC 128 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 128 (297)
+. +.+||+|||+++...... .....+||+.|+|||++.+. .+
T Consensus 135 ~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~ 213 (360)
T cd05627 135 DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GY 213 (360)
T ss_pred CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CC
Confidence 74 899999999986542210 11245799999999998654 45
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHHHHHHHHHhhhcCCCCCC---CHHHHHc
Q 040202 129 GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------YGRWVALISWLCSWNPRMRP---TAAEALE 190 (297)
Q Consensus 129 ~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---------------~~~~~~li~~~l~~dP~~R~---t~~~ll~ 190 (297)
+.++||||+||++|||++|+.||.+.+..+...++ ..+++++|.+|+. ||.+|+ +++++++
T Consensus 214 ~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 88999999999999999999999887766554443 2367889999874 999998 4799999
Q ss_pred CCCCCCCCCC
Q 040202 191 HPFFRSCHFV 200 (297)
Q Consensus 191 h~~f~~~~~~ 200 (297)
||||++.+|.
T Consensus 293 hp~f~~~~~~ 302 (360)
T cd05627 293 HPFFEGVDWG 302 (360)
T ss_pred CCCCCCCCHH
Confidence 9999987764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=298.26 Aligned_cols=188 Identities=28% Similarity=0.496 Sum_probs=164.4
Q ss_pred CccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 1 i~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
|+-|+|+ +|+||+.|.|+|...-++|||||||..|-|..+++. +..+.......|..+|+.|+.|||.+.|||||||.
T Consensus 163 IKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKS 240 (904)
T KOG4721|consen 163 IKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKS 240 (904)
T ss_pred HHHHHhc-cCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCC
Confidence 4567787 999999999999999999999999986544444443 46799999999999999999999999999999999
Q ss_pred CcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
-||||+ ++.|||+|||-++..........++||..|||||++.. ...++|+||||||||||||+||+.||.+-+....
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred CceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 999998 58999999999999887777788999999999999874 5569999999999999999999999987666554
Q ss_pred HHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 IYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++-+ ...++-|++.|++..|..||++.++|.|
T Consensus 320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 4322 2367889999999999999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.69 Aligned_cols=189 Identities=25% Similarity=0.399 Sum_probs=158.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... ..+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil 136 (331)
T cd06649 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136 (331)
T ss_pred HHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence 3459999999999999999999999999986666665543 4599999999999999999999986 6999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH--
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-- 161 (297)
+++ +.+||+|||+++...... .....|++.|+|||++.+. .++.++||||+||++|+|++|+.||...+..+...
T Consensus 137 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 214 (331)
T cd06649 137 VNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214 (331)
T ss_pred EcCCCcEEEccCcccccccccc-cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 975 789999999987664432 3456789999999998654 46889999999999999999999997543322110
Q ss_pred ---------------------------------------------------------HHHHHHHHHHHHhhhcCCCCCCC
Q 040202 162 ---------------------------------------------------------KIYGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 162 ---------------------------------------------------------~i~~~~~~li~~~l~~dP~~R~t 184 (297)
....++++||.+||+.||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt 294 (331)
T cd06649 215 GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD 294 (331)
T ss_pred cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC
Confidence 12246789999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 040202 185 AAEALEHPFFRSC 197 (297)
Q Consensus 185 ~~~ll~h~~f~~~ 197 (297)
+.++++||||+..
T Consensus 295 ~~ell~h~~~~~~ 307 (331)
T cd06649 295 LKMLMNHTFIKRS 307 (331)
T ss_pred HHHHhcChHHhhc
Confidence 9999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.79 Aligned_cols=191 Identities=28% Similarity=0.498 Sum_probs=161.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+.++|||||++++++.+++.+||||||+.|+.+ +.+... ....+++..+..++.|++.||+|||++||+||||||+
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 198 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA 198 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHH
Confidence 3455999999999999999999999999987555 444322 2346899999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|||++. +.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..
T Consensus 199 NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred hEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999985 789999999998765432 2345679999999998765 44688999999999999999999999887766
Q ss_pred HHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 DQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+...++ ..++.++|.+||..||++||++++++.|+|++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 555543 236899999999999999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=313.13 Aligned_cols=207 Identities=30% Similarity=0.473 Sum_probs=179.4
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
.+.+-|+.++-+|++++++|+||||+.||.+-.+..+.+ .++|+.++.|+.+|+.||+-||+.|+|||||||+|||+|.
T Consensus 132 ~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 132 GNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred CCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 356779999999999999999999999865555555555 7999999999999999999999999999999999999995
Q ss_pred -CeEEEEecCCceecCCC--CCCccccccCCCCCCceecc---c-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 88 -GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLL---S-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~---~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|++||+|||.+-.+... ..+...+|||-|++||++.. + +.||..+|+||+||++|||+.|..||...+-.+.+
T Consensus 211 ~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY 290 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY 290 (1317)
T ss_pred cCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH
Confidence 99999999998776532 34567899999999999863 2 56899999999999999999999999998888888
Q ss_pred HHHHH---------------HHHHHHHHhhhcCCCCCCC---HHHHHcCCCCCCCCC------CCCCCCccCCCcccCCC
Q 040202 161 YKIYG---------------RWVALISWLCSWNPRMRPT---AAEALEHPFFRSCHF------VPRSVPLLCNNFEAVAF 216 (297)
Q Consensus 161 ~~i~~---------------~~~~li~~~l~~dP~~R~t---~~~ll~h~~f~~~~~------~~~~~~~~~~~~~~~~~ 216 (297)
.+|.. +.++||++++. +|..|.. ++++.+||||.+.+| .|+.+|-+....+..+|
T Consensus 291 ~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 291 GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 77754 67999999987 8888888 999999999999988 36667777777777777
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=282.60 Aligned_cols=192 Identities=33% Similarity=0.653 Sum_probs=161.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.+++...+... +..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 59 ~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~ 137 (301)
T cd07873 59 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI 137 (301)
T ss_pred HhcCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE
Confidence 344999999999999999999999999998887776654 4568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.+||+|||++....... ......+++.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 138 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 138 NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 789999999987654322 223456788999999987666678899999999999999999999987664333221
Q ss_pred ----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 ----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 ----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+...+.+||.+||..||.+|||++++++||||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 122457899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=297.54 Aligned_cols=192 Identities=23% Similarity=0.425 Sum_probs=165.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++..++++||.++|+.|..+..++++||||.||....+.+. +..+.|.++..++++++.|+.|||..+.+|||||+.||
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaani 142 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANI 142 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccce
Confidence 34446899999999999999999999999998776666654 34569999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+.. |.+|++|||++..+.... ...+++||+.||||||+. ...|+.+|||||||++.+||++|++|+........+.
T Consensus 143 l~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 143 LLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred eEeccCcEEEEecceeeeeechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 9975 899999999997765543 237899999999999998 4456999999999999999999999997765533222
Q ss_pred ------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 ------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.....+++|+..||+.||+.||+|.++|+|+|++..
T Consensus 222 lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 222 LIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred eccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 334468999999999999999999999999999764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=288.33 Aligned_cols=195 Identities=30% Similarity=0.453 Sum_probs=172.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG-QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~-~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
|.+. +.++||.+--+|++.+.+++||..|+||.+.+.+.+.+ ..|+|..++.|+.+|+.||++||+.+|++||+||+|
T Consensus 239 L~kV-~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 239 LEKV-SSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred HHHh-ccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 4444 88999999999999999999999999988887776655 469999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH--
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ-- 159 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~-- 159 (297)
||+|+ |+++|+|+|+|..+..+......+||.+|||||++.... |+..+|+||+||++|||+.|+.||........
T Consensus 318 ILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e 396 (591)
T KOG0986|consen 318 ILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE 396 (591)
T ss_pred eeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH
Confidence 99986 999999999999999998888889999999999988666 79999999999999999999999976543222
Q ss_pred -HH------------HHHHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCCC
Q 040202 160 -IY------------KIYGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHFV 200 (297)
Q Consensus 160 -~~------------~i~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~~ 200 (297)
+. +.+.+.+++.+.+|..||.+|.. ++++.+||||++++|.
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 11 23457899999999999999975 5699999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=294.91 Aligned_cols=192 Identities=24% Similarity=0.412 Sum_probs=159.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++..++..|++||++.+++++++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred HHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 344599999999999999999999999999999888743 356999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH---
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA--- 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~--- 157 (297)
+++ +.+||+|||+++...... ......||+.|+|||++... .++.++||||+||++|||++|+.||.+....
T Consensus 218 l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred EcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 985 799999999997664432 22356789999999998654 4588999999999999999999999764321
Q ss_pred HHHHHH---------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 158 DQIYKI---------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 158 ~~~~~i---------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
..+..+ ..++.++|++||..||++|||+.++|+||
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 111110 12456799999999999999999999999
Q ss_pred CCCCCCC
Q 040202 193 FFRSCHF 199 (297)
Q Consensus 193 ~f~~~~~ 199 (297)
||+..++
T Consensus 377 ~f~~~~~ 383 (392)
T PHA03207 377 LFTKEPI 383 (392)
T ss_pred hhhccch
Confidence 9976443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.98 Aligned_cols=196 Identities=25% Similarity=0.375 Sum_probs=161.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++.+.+++.+|+||||+.|+.+..+..+.+..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nil 134 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 34459999999999999999999999999875555555443456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+++ +.+||+|||++....... .....+||+.|+|||++.. ...++.++||||+||++|||++|+.||.+.+..
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 984 789999999987653322 1234579999999998752 345688999999999999999999999887765
Q ss_pred HHHHHH----------------HHHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCCC
Q 040202 158 DQIYKI----------------YGRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 158 ~~~~~i----------------~~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~~ 200 (297)
+...++ ..++++|+++||..++++ |++++++++||||++.++.
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 555443 346789999999765554 6899999999999886653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=279.62 Aligned_cols=189 Identities=35% Similarity=0.672 Sum_probs=158.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA-GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~-~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++.+|+||||+.+++.+.+.... +..+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil 133 (285)
T cd07861 54 KELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL 133 (285)
T ss_pred HhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE
Confidence 3448999999999999999999999999988877765432 256999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||++....... ......+++.|+|||++.+...++.++||||+||++|+|++|+.||.+....+....
T Consensus 134 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 134 IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred EcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 975 789999999987654322 223446788999999887655568899999999999999999999987654332221
Q ss_pred ----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 ----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 ----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..++.++|++||+.||++|||+.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 214 IFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 12356789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=282.74 Aligned_cols=189 Identities=33% Similarity=0.634 Sum_probs=152.8
Q ss_pred ccccccceeeeceeEE--eCCeEEEEEecCCCcHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 6 KMNNHPNIVKLRNLVK--EHEDVFIVFDYMESDLLKLMKESA-------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~--~~~~~~lv~e~~~g~ll~~~~~~~-------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
+.++||||+++++++. .+...|+||||+.+++++.+.... ...+++..++.++.||+.||+|||+.||+||
T Consensus 53 ~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~ 132 (317)
T cd07867 53 RELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHR 132 (317)
T ss_pred HhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcC
Confidence 3459999999999985 456889999999998887765321 1248899999999999999999999999999
Q ss_pred CCCCCcEEEe-----CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC
Q 040202 77 DLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147 (297)
Q Consensus 77 dikp~Nill~-----~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g 147 (297)
||||+|||+. .+.+||+|||+++...... ......||..|+|||++.+...++.++||||+||++|||++|
T Consensus 133 Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg 212 (317)
T cd07867 133 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred CCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence 9999999993 2589999999998764332 123457899999999987666678899999999999999999
Q ss_pred CCCCCCCCCH---------HHHHH-------------------------------------------------HHHHHHH
Q 040202 148 RILFPGKNSA---------DQIYK-------------------------------------------------IYGRWVA 169 (297)
Q Consensus 148 ~~pf~~~~~~---------~~~~~-------------------------------------------------i~~~~~~ 169 (297)
+.||...... .+..+ ....+.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (317)
T cd07867 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292 (317)
T ss_pred CCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHH
Confidence 9999653321 00000 0113567
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 170 LISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 170 li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
|+.+||+.||.+|||++|+|+||||
T Consensus 293 ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 293 LLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHhccCcccccCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.01 Aligned_cols=210 Identities=30% Similarity=0.433 Sum_probs=177.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+..+||++..+.-.|+.++.+|+||||+.||-+-+.+.+ .+.|+|+.++.|..+|+.||.|||+++|++||||.+|+|+
T Consensus 223 ~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL 301 (516)
T KOG0690|consen 223 QNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL 301 (516)
T ss_pred HhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee
Confidence 445999999999999999999999999998555444443 3569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
|+ |++||+|||++++- ..+....++||||.|+|||++.. ..|+..+|+|.+||++|||++|++||...+......-|
T Consensus 302 DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 302 DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred ccCCceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 95 89999999999874 45566789999999999999875 45699999999999999999999999988877666544
Q ss_pred -----------HHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCCC--------CCCCCccCCCcccCCCC
Q 040202 164 -----------YGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHFV--------PRSVPLLCNNFEAVAFP 217 (297)
Q Consensus 164 -----------~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~~--------~~~~~~~~~~~~~~~~~ 217 (297)
..+.+.|+..+|..||++|.. +.|+.+|+||++++|. |+..|+.....+...|.
T Consensus 381 l~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD 458 (516)
T KOG0690|consen 381 LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFD 458 (516)
T ss_pred HhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhh
Confidence 347899999999999999965 6799999999999873 55556555555544443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=289.17 Aligned_cols=187 Identities=27% Similarity=0.465 Sum_probs=154.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++.+|+||||+.|+.+.. .....+..+..++.||+.||+|||++||+||||||+|||+
T Consensus 127 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 201 (353)
T PLN00034 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201 (353)
T ss_pred HhCCCCCcceeeeEeccCCeEEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 44599999999999999999999999999876532 1336788899999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||+++..... .......||..|+|||++.. ..+.+.++|||||||++|||++|+.||......+.
T Consensus 202 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 281 (353)
T PLN00034 202 NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW 281 (353)
T ss_pred cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 85 78999999999876433 22345679999999998743 23445789999999999999999999974332211
Q ss_pred ---HHH------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 ---IYK------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ---~~~------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
... +..++++||.+||..||++|||+.|+++||||...
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 111 12478999999999999999999999999999763
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=285.57 Aligned_cols=193 Identities=27% Similarity=0.470 Sum_probs=161.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.++.+|++|+++++++.+.+.+|+||||+.|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nil 133 (323)
T cd05615 55 ALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM 133 (323)
T ss_pred HhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 34446788999999999999999999999986555555443 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......
T Consensus 134 l~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred ECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 985 78999999998764322 223456789999999997654 468899999999999999999999988776655554
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
+. .++.+++.+||..||.+|++ ..++++|+||+..++
T Consensus 213 i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 213 IMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 43 36789999999999999997 478999999998765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.54 Aligned_cols=187 Identities=36% Similarity=0.667 Sum_probs=156.1
Q ss_pred ccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++|+||+++++++... ...|+++|++++++...+ .. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik 145 (343)
T cd07878 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK 145 (343)
T ss_pred HhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHH-hc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 345999999999988643 457999999977665444 33 459999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+||++++ +.+||+|||+++...... ....||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+
T Consensus 146 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 223 (343)
T cd07878 146 PSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223 (343)
T ss_pred hhhEEECCCCCEEEcCCccceecCCCc--CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999985 789999999998765432 456789999999998765667899999999999999999999998765444
Q ss_pred HHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...++. ..+.+|+.+||..||++|||+.++++||||..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 224 QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 332221 12568999999999999999999999999976
Q ss_pred C
Q 040202 197 C 197 (297)
Q Consensus 197 ~ 197 (297)
.
T Consensus 304 ~ 304 (343)
T cd07878 304 Y 304 (343)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=279.73 Aligned_cols=188 Identities=31% Similarity=0.587 Sum_probs=157.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+.+..|+|+||+++++++.+... ++.+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~ 132 (284)
T cd07839 54 KELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI 132 (284)
T ss_pred HhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 345999999999999999999999999999888777654 3569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC-CCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~-~~~~~~~~~ 162 (297)
+. +.+||+|||+++...... ......++..|+|||++.+...++.++||||+||++|+|++|..||.. .+..+....
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 133 NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 74 789999999987654332 223456788999999987666678899999999999999999988543 332222211
Q ss_pred ----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 ----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 ----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..++.+++.+||..||.+|||++++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 22356789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=283.49 Aligned_cols=196 Identities=26% Similarity=0.378 Sum_probs=162.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++..|+||||+.|+.+..+..+.+..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nil 134 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEE
Confidence 34569999999999999999999999999886665555544456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceeccc----ccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLS----EICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
++. +.+||+|||+++........ ...+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..
T Consensus 135 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred EcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 975 78999999999876543221 235789999999987642 34578999999999999999999999877655
Q ss_pred HHHHHH----------------HHHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCCC
Q 040202 158 DQIYKI----------------YGRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 158 ~~~~~i----------------~~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~~ 200 (297)
+...++ ..++++++.+||..++++ |++++++++|+||++.+|.
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 544433 346889999999876554 5689999999999886653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.45 Aligned_cols=188 Identities=35% Similarity=0.693 Sum_probs=161.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+++++++.+.... ..+++..++.++.||+.||+|||+.|++||||||+||++
T Consensus 55 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~ 133 (286)
T cd07847 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI 133 (286)
T ss_pred HhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE
Confidence 3458999999999999999999999999999888876553 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||++....... ......++..|+|||++.+...++.++|+||+||++|+|++|+.||.+.+..+....+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 134 TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 85 789999999998765443 2234567889999999776566688999999999999999999999877654433221
Q ss_pred ------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 ------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 ------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...+.+|+.+||+.||++||++.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 214 RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 2356799999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=287.66 Aligned_cols=194 Identities=24% Similarity=0.388 Sum_probs=162.1
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
..|.|+-+|.+||+++|+-..++++|+||||=+-+|-..+.++ +..++...++.|..|+|.|+.++|+.||||.||||.
T Consensus 411 ~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~-~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPA 489 (677)
T KOG0596|consen 411 ALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKK-KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPA 489 (677)
T ss_pred HHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcc
Confidence 4578899999999999999999999999998666666555554 455666799999999999999999999999999999
Q ss_pred cEEEeCCeEEEEecCCceecCCCC---CCccccccCCCCCCceeccccc----------CCCccchhhHHHHHHHHHhCC
Q 040202 82 NLLVSKGVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEI----------CGPEVDRWAMGAIMFEMLSFR 148 (297)
Q Consensus 82 Nill~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----------~~~~~DiwSlGv~l~ell~g~ 148 (297)
|+|+-+|.+||+|||.|..+.... ...+.+||..||+||.+..... .++++||||||||||+|+.|+
T Consensus 490 NFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgk 569 (677)
T KOG0596|consen 490 NFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGK 569 (677)
T ss_pred cEEEEeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcC
Confidence 999999999999999998876653 3356799999999998764221 367899999999999999999
Q ss_pred CCCCCCCC-HHHHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 149 ILFPGKNS-ADQIYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 149 ~pf~~~~~-~~~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.||..... ...+..|. .+++++++.||..||++|+|+.++|+|||...
T Consensus 570 tPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 570 TPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99975432 22222221 14799999999999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=289.47 Aligned_cols=189 Identities=28% Similarity=0.482 Sum_probs=171.6
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
..++||++|..|+++.++|++||-|-| ++...+..+ +.|.+..++.|+.-++.|++|||++|||+|||||+|+++|.
T Consensus 478 ~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~ 555 (732)
T KOG0614|consen 478 RSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN 555 (732)
T ss_pred CchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc
Confidence 689999999999999999999999976 555555544 56999999999999999999999999999999999999985
Q ss_pred -CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Q 040202 88 -GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-- 164 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~-- 164 (297)
|.+||.|||+|+.+..+....++|||+.|+|||++..++. +.++|.|+||+++|||++|.+||.+.+....+..|.
T Consensus 556 ~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 556 RGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred CCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh
Confidence 8999999999999999999999999999999999986654 899999999999999999999999998877766554
Q ss_pred -----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCCC
Q 040202 165 -----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHFV 200 (297)
Q Consensus 165 -----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~~ 200 (297)
....+||++++..+|.+|.. +.+|.+|.||.+.+|.
T Consensus 635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 35688999999999999976 8899999999998884
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=280.75 Aligned_cols=191 Identities=29% Similarity=0.503 Sum_probs=171.6
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS- 86 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~- 86 (297)
.+-|++++++..|++-+.+|+||||+.||.|-+.+++.|+ |.|..+..|+.+|+.||-+||++||++||||.+|||+|
T Consensus 407 ~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~ 485 (683)
T KOG0696|consen 407 GKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 485 (683)
T ss_pred CCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc
Confidence 3568999999999999999999999999777777777654 99999999999999999999999999999999999998
Q ss_pred CCeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 040202 87 KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG 165 (297)
Q Consensus 87 ~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~ 165 (297)
+|++||+|||++++- -......++||||.|+|||++.... |+..+|+||+||+||||+.|+.||++.+..+....|..
T Consensus 486 eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 486 EGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred CCceEeeecccccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 599999999999874 3455567899999999999988654 59999999999999999999999999999888877654
Q ss_pred -----------HHHHHHHHhhhcCCCCCCCH-----HHHHcCCCCCCCCCC
Q 040202 166 -----------RWVALISWLCSWNPRMRPTA-----AEALEHPFFRSCHFV 200 (297)
Q Consensus 166 -----------~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f~~~~~~ 200 (297)
+..++...+|...|.+|..+ .++..||||+.++|.
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 78899999999999999765 489999999999884
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.65 Aligned_cols=189 Identities=38% Similarity=0.705 Sum_probs=159.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.+++.+.+....+..+++..++.++.|++.||+|||+.|++||||+|+||++
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill 133 (284)
T cd07860 54 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 133 (284)
T ss_pred HhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 33499999999999999999999999998887777766545679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.+||+|||++....... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+...+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 134 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 75 789999999987654332 223445688999999987666668889999999999999999999987654433222
Q ss_pred ---------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 ---------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 ---------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..+++++|.+||+.||.+|||++++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 12355789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=281.36 Aligned_cols=194 Identities=23% Similarity=0.332 Sum_probs=155.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE-SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~-~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.+.++||||+++++++.+++..|+||||+.++.+..+.. .....+++..++.++.|++.||+|||++||+||||||+|
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~N 131 (327)
T cd08227 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASH 131 (327)
T ss_pred HHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhh
Confidence 4455699999999999999999999999999766555443 333459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCC--------CCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
||++. +.++++|||.+....... ......++..|+|||++... ..++.++||||+||++|+|++|+.||.
T Consensus 132 il~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 132 ILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred EEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99985 789999998654332110 01223467789999998653 346889999999999999999999997
Q ss_pred CCCCHHHHH---------------------------------------------------------HHHHHHHHHHHHhh
Q 040202 153 GKNSADQIY---------------------------------------------------------KIYGRWVALISWLC 175 (297)
Q Consensus 153 ~~~~~~~~~---------------------------------------------------------~i~~~~~~li~~~l 175 (297)
......... .....+.+|+++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 291 (327)
T cd08227 212 DMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291 (327)
T ss_pred CcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHH
Confidence 543322111 11235778999999
Q ss_pred hcCCCCCCCHHHHHcCCCCCCC
Q 040202 176 SWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 176 ~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+.||++|||++++++||||+..
T Consensus 292 ~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 292 QRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhCchhcCCHHHHhcChhhhhc
Confidence 9999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=291.65 Aligned_cols=190 Identities=28% Similarity=0.429 Sum_probs=167.4
Q ss_pred cccccccccceeeeceeEEeCC--eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDL 78 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~--~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdi 78 (297)
.|+|.++|+|||++|+.|.+.. .+.+|+|.+.+|.|..+.++.+ .++.+.++.|++||+.||.|||++. |+||||
T Consensus 93 ~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDL 171 (632)
T KOG0584|consen 93 HLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDL 171 (632)
T ss_pred HHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCcccccc
Confidence 4678889999999999998655 4899999999877777666654 4999999999999999999999986 999999
Q ss_pred CCCcEEEeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 79 KPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 79 kp~Nill~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|-+||+|+. |.|||+|+|+|+....... ...+|||.|||||++. ..|.+.+||||||.+++||+|+++||..-..
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 999999985 8999999999998876654 3489999999999864 6789999999999999999999999998888
Q ss_pred HHHHHHHHH--------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 ADQIYKIYG--------------RWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 ~~~~~~i~~--------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+++|-.. +.++||.+||.. ...|+|+.|+|+|+||..-
T Consensus 249 ~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 888776432 678999999998 9999999999999999763
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.68 Aligned_cols=194 Identities=26% Similarity=0.397 Sum_probs=161.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK-ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~-~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++.+.+++..|+||||+.|+.+..+. ......+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 34459999999999999999999999999886555444 33334699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH---HH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA---DQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---~~ 159 (297)
++++ +.++|+|||++.............|+..|+|||++.+. .++.++||||+||++|+|++|+.||...... +.
T Consensus 134 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 134 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred EECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 9985 78999999999876554444556789999999998654 4688999999999999999999999865431 11
Q ss_pred HHH------------HHHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 160 IYK------------IYGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 160 ~~~------------i~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
... +..++.+|+.+||+.||.+|+| ++++++||||+...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 111 2236789999999999999999 899999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=290.47 Aligned_cols=189 Identities=26% Similarity=0.491 Sum_probs=167.2
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+|+++ +|||+|.|.|+|-.+...|||||||-|+--+.+.-. ++++.|.++..|..+.+.||.|||+.+-||||||..
T Consensus 78 rFL~~l-~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAG 155 (948)
T KOG0577|consen 78 RFLRQL-RHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAG 155 (948)
T ss_pred HHHHhc-cCCCcccccceeeccchHHHHHHHHhccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhcccc
Confidence 355666 999999999999999999999999999666555443 467999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceec--ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL--LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|||+++ |.|||+|||.|...... .+++|||.||||||+. +.+.|+-++||||||++..||...++|+-..+...
T Consensus 156 NILLse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS 232 (948)
T KOG0577|consen 156 NILLSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 232 (948)
T ss_pred ceEecCCCeeeeccccchhhcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH
Confidence 999986 89999999998766544 7899999999999986 34667899999999999999999999988887777
Q ss_pred HHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 159 QIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 159 ~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
.++.|- ..++.|+..||+.-|.+|||.+++|+|+|..
T Consensus 233 ALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 233 ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 777663 3678999999999999999999999999994
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.16 Aligned_cols=188 Identities=26% Similarity=0.393 Sum_probs=156.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.+++.+|+||||+.|+.+..+.... +.+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nil 136 (333)
T cd06650 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136 (333)
T ss_pred HHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEE
Confidence 3448999999999999999999999999886665555443 4589999999999999999999975 7999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH--
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-- 161 (297)
+++ +.+||+|||++...... ......|+..|+|||++.+. .++.++|+||+||++|+|++|+.||......+...
T Consensus 137 i~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (333)
T cd06650 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214 (333)
T ss_pred EcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh
Confidence 975 78999999998765432 22456789999999998654 45889999999999999999999997544322110
Q ss_pred -------------------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHH
Q 040202 162 -------------------------------------------------------KIYGRWVALISWLCSWNPRMRPTAA 186 (297)
Q Consensus 162 -------------------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~ 186 (297)
....++++|+.+||+.||++|||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ 294 (333)
T cd06650 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLK 294 (333)
T ss_pred cCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHH
Confidence 0123568999999999999999999
Q ss_pred HHHcCCCCCC
Q 040202 187 EALEHPFFRS 196 (297)
Q Consensus 187 ~ll~h~~f~~ 196 (297)
++++|+||+.
T Consensus 295 ell~h~~~~~ 304 (333)
T cd06650 295 QLMVHAFIKR 304 (333)
T ss_pred HHhhCHHHhc
Confidence 9999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=291.48 Aligned_cols=186 Identities=29% Similarity=0.535 Sum_probs=161.1
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
++.+..+|+||+++++++.++...|+|||++.| .+++.+..+ . ....++..|++||+.|++|||++|++|||+||+
T Consensus 368 ~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~--~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~ 444 (612)
T KOG0603|consen 368 ISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK--P-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPG 444 (612)
T ss_pred hhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc--c-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChh
Confidence 456667999999999999999999999999998 556666554 2 333888899999999999999999999999999
Q ss_pred cEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|||++ .++++|+|||.++..... +.+.+-|..|.|||++. ...|++++||||||++||+|++|+.||.......+
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 99994 489999999999887766 56777899999999987 44569999999999999999999999987665533
Q ss_pred HH----------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 160 IY----------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 160 ~~----------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+. .++..+++|+++||+.||.+|+++.+++.|+||
T Consensus 522 i~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 32 234578999999999999999999999999999
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=294.14 Aligned_cols=189 Identities=26% Similarity=0.344 Sum_probs=154.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+|||++++++..++..|+|||++.++++.++... ...+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 215 ~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl 293 (461)
T PHA03211 215 RRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293 (461)
T ss_pred HHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE
Confidence 345999999999999999999999999999888887654 3469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC-C----
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN-S---- 156 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~---- 156 (297)
+. +.+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|||++|..++-... .
T Consensus 294 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 294 NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 85 789999999998754322 12345789999999998654 45889999999999999998775532211 0
Q ss_pred --HHHHH----------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 157 --ADQIY----------------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 157 --~~~~~----------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
..++. ++..++.+||.+||+.||++|||+.|+
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 01111 111256789999999999999999999
Q ss_pred HcCCCCCC
Q 040202 189 LEHPFFRS 196 (297)
Q Consensus 189 l~h~~f~~ 196 (297)
|+||||++
T Consensus 453 L~hp~f~~ 460 (461)
T PHA03211 453 LRLPLFQS 460 (461)
T ss_pred hhCcccCC
Confidence 99999974
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=268.85 Aligned_cols=187 Identities=26% Similarity=0.433 Sum_probs=158.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+|+||+.|+.+....... +.+++..++.++.|++.||.|||+.||+||||+|+||++
T Consensus 59 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv 137 (263)
T cd06625 59 KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR 137 (263)
T ss_pred HhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 3459999999999999999999999999886555544442 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC----ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++ +.++|+|||+++........ ....|+..|+|||++.+.. ++.++||||+|+++|+|++|+.||...+.....
T Consensus 138 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 216 (263)
T cd06625 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI 216 (263)
T ss_pred cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHH
Confidence 85 78999999998765432111 2356788999999987654 688999999999999999999999876665544
Q ss_pred HHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 161 YKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 161 ~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.++ ...+.+++++||..+|++|||+.++++|+||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 332 2467899999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=269.73 Aligned_cols=194 Identities=28% Similarity=0.459 Sum_probs=162.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+..-..|+||+.++++|+++...|||||-|.| .++..+.++ +.|+|.++..++++|+.||+|||.+||.|||+||+|
T Consensus 129 f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPEN 206 (463)
T KOG0607|consen 129 FYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPEN 206 (463)
T ss_pred HHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccc
Confidence 34456899999999999999999999999987 667777776 569999999999999999999999999999999999
Q ss_pred EEEeC----CeEEEEecCCceecCCC--------CCCccccccCCCCCCceec----ccccCCCccchhhHHHHHHHHHh
Q 040202 83 LLVSK----GVIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLL----LSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 83 ill~~----~~~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
||-.+ .-+||+||.++.-+..+ ....+.+|+-.|||||+.. ...+|+.+.|.||||||+|-|++
T Consensus 207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 99964 35899999986443222 1234567888999999853 24578899999999999999999
Q ss_pred CCCCCCCCCCH------------------------------HHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 147 FRILFPGKNSA------------------------------DQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 147 g~~pf~~~~~~------------------------------~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
|..||.|.... ..+..|+.+.+++++.+|..|+..|.++.++++|||++.
T Consensus 287 GYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 287 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred CCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 99999775431 122345567899999999999999999999999999987
Q ss_pred CCC
Q 040202 197 CHF 199 (297)
Q Consensus 197 ~~~ 199 (297)
+..
T Consensus 367 ~~~ 369 (463)
T KOG0607|consen 367 CAP 369 (463)
T ss_pred cch
Confidence 543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=271.07 Aligned_cols=192 Identities=24% Similarity=0.427 Sum_probs=161.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++..|+|+||+.++.+..+..+....+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 57 ~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili 136 (282)
T cd06643 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF 136 (282)
T ss_pred HHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE
Confidence 34599999999999999999999999999877766554444569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||++...... .......++..|+|||++.. ...++.++|+||+||++|+|++|+.||...+..+.
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 137 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 75 78999999998765332 22244578999999998742 23456789999999999999999999987665544
Q ss_pred HHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..++ ..++.+++.+||..||.+||+++++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 3332 2368999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=268.81 Aligned_cols=196 Identities=35% Similarity=0.660 Sum_probs=165.6
Q ss_pred cccccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.|.|-++|+||+.+..+|.+ +..+++++||.+-+++..+..+ .++.++...++.++.||+.|+.|||++-|+||||
T Consensus 79 aL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDL 158 (438)
T KOG0666|consen 79 ALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDL 158 (438)
T ss_pred HHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccC
Confidence 45566799999999999977 7899999999999999877643 2246999999999999999999999999999999
Q ss_pred CCCcEEEe-C----CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 79 KPSNLLVS-K----GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 79 kp~Nill~-~----~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
||.|||+. + |.|||+|||+++..... ......+.|.||.|||.+.+.+.|+.+.|+|++|||+.||++-++
T Consensus 159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P 238 (438)
T KOG0666|consen 159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP 238 (438)
T ss_pred CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence 99999994 3 79999999999876543 123456779999999999999999999999999999999999999
Q ss_pred CCCCCCC---------HHHHHHHHH------------------------------------------------HHHHHHH
Q 040202 150 LFPGKNS---------ADQIYKIYG------------------------------------------------RWVALIS 172 (297)
Q Consensus 150 pf~~~~~---------~~~~~~i~~------------------------------------------------~~~~li~ 172 (297)
.|.+... .+++.+|.. ...+|+.
T Consensus 239 lF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~ 318 (438)
T KOG0666|consen 239 LFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQ 318 (438)
T ss_pred cccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHH
Confidence 8876431 233334332 2467999
Q ss_pred HhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 173 WLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 173 ~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+||+.||.+|+|++++|+|+||+...
T Consensus 319 klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 319 KLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred HHhccCchhhccHHHHhcccccccCC
Confidence 99999999999999999999998643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.13 Aligned_cols=188 Identities=35% Similarity=0.606 Sum_probs=169.7
Q ss_pred cccccccccceeeeceeEEe------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 3 FLRKMNNHPNIVKLRNLVKE------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
.+.+.++|+||++++.+|.- -...|+|||+|+.++-..+... +.-+.+..++.|++.|++|||+.||+||
T Consensus 67 ~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihR 142 (369)
T KOG0665|consen 67 KLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHR 142 (369)
T ss_pred hhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeec
Confidence 45667799999999999953 3468999999999988877743 7788999999999999999999999999
Q ss_pred CCCCCcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 77 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 77 dikp~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
||||+||++. +..+||.|||+|+..+.....+..+.|+.|.|||++.+.. |.+.+||||+||++.||+.|+..|.|.+
T Consensus 143 dLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 143 DLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred ccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCch
Confidence 9999999997 5789999999999888877778899999999999998776 7999999999999999999999999999
Q ss_pred CHHHHHHHHH-----------------------------------------------------HHHHHHHHhhhcCCCCC
Q 040202 156 SADQIYKIYG-----------------------------------------------------RWVALISWLCSWNPRMR 182 (297)
Q Consensus 156 ~~~~~~~i~~-----------------------------------------------------~~~~li~~~l~~dP~~R 182 (297)
..+++.++.. .+++++.+||..||++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 9998887753 24789999999999999
Q ss_pred CCHHHHHcCCCCC
Q 040202 183 PTAAEALEHPFFR 195 (297)
Q Consensus 183 ~t~~~ll~h~~f~ 195 (297)
.+++++|+|||++
T Consensus 302 isv~daL~HPY~~ 314 (369)
T KOG0665|consen 302 ISVDDALRHPYIK 314 (369)
T ss_pred ccHHHHhcCCeee
Confidence 9999999999998
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=249.91 Aligned_cols=194 Identities=32% Similarity=0.633 Sum_probs=175.0
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
|+|.|-++|.|||+++++...++.+-+|+|||+.++-++.-.-. +.+..+.++.++.|++.|+.|+|++++.|||+||+
T Consensus 52 icllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpq 130 (292)
T KOG0662|consen 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQ 130 (292)
T ss_pred HHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcc
Confidence 57788889999999999999999999999999998877766554 56999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
|+|++. |.+|++|||+++..+-.. .....+.|.||.+|.++.+.+.|+...|+||.|||+.|+.. |++.|++.+..+
T Consensus 131 nllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd 210 (292)
T KOG0662|consen 131 NLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_pred eEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence 999985 899999999999876654 33456779999999999999999999999999999999985 888899999999
Q ss_pred HHHHHHH----------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIYG----------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~~----------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++.+|.. ..+++++++|..+|.+|++++++++||||.+
T Consensus 211 qlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 211 QLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred HHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 9888864 2378999999999999999999999999975
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=271.71 Aligned_cols=196 Identities=26% Similarity=0.435 Sum_probs=162.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+..++..|+||||+.|+.+..+..+....+++..+..++.|++.|++|||+.|++||||||+||++
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred HhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 34599999999999999999999999999877766554444569999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||++...... .......++..|+|||++.. ...++.++|+||+||++|+|++|+.||...+....
T Consensus 144 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 223 (292)
T cd06644 144 TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223 (292)
T ss_pred cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH
Confidence 8 578999999998764332 22244567899999999753 23357789999999999999999999977664443
Q ss_pred HHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCCC
Q 040202 160 IYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVP 201 (297)
Q Consensus 160 ~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~~ 201 (297)
..++ ..++.+++.+||..||++||+++++++||||+.....+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 3322 23678999999999999999999999999998765543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=273.13 Aligned_cols=194 Identities=36% Similarity=0.631 Sum_probs=162.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+++++.+.+....+..+++..++.++.||+.||+|||++|++||||+|+||++
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill 135 (294)
T PLN00009 56 KEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI 135 (294)
T ss_pred HhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEE
Confidence 34499999999999999999999999999888887766544457899999999999999999999999999999999999
Q ss_pred eC--CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK--GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~--~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.+||+|||++....... ......++..|+|||++.+...++.++||||+||++|+|++|+.||......+...+
T Consensus 136 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 136 DRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred ECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 84 479999999997654322 223456788999999887656678899999999999999999999987655444332
Q ss_pred H----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 163 I----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
+ ..++.+++.+||..||++||++.++++||||++...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 2 234678999999999999999999999999987543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=272.59 Aligned_cols=190 Identities=27% Similarity=0.411 Sum_probs=158.8
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
.+|+||+++++.+.+++..|+||||+.|+.+..+.... +.+++..+..++.|++.||+|||+.||+||||||+||++++
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~ 132 (279)
T cd05633 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132 (279)
T ss_pred CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC
Confidence 47999999999999999999999999986665555443 45999999999999999999999999999999999999975
Q ss_pred -CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC--HHHHHH--
Q 040202 88 -GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS--ADQIYK-- 162 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--~~~~~~-- 162 (297)
+.+||+|||++........ ....|+..|+|||.+.....++.++||||+||++|+|++|..||.+... .....+
T Consensus 133 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 211 (279)
T cd05633 133 HGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (279)
T ss_pred CCCEEEccCCcceeccccCc-cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh
Confidence 7899999999876544322 3457899999999876555568899999999999999999999975432 122221
Q ss_pred ----------HHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 ----------IYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 ----------i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+..++.++|.+||..||++|+ ++.++++||||++..+
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 234678999999999999999 6999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=316.22 Aligned_cols=192 Identities=31% Similarity=0.515 Sum_probs=167.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
..++|||+|+|||+-.+.+..||+||||.||.+..+.++ ++..+|...+.|..|++.|+.|||+.||+||||||+||++
T Consensus 1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L 1367 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL 1367 (1509)
T ss_pred HhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee
Confidence 345999999999999999999999999999999998887 4568899999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccc--cCCCccchhhHHHHHHHHHhCCCCCCCCC-C
Q 040202 86 S-KGVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSE--ICGPEVDRWAMGAIMFEMLSFRILFPGKN-S 156 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~ 156 (297)
+ .|.+|++|||.|..+..+. ......||+.|||||++.+.. ..+.++||||||||+.||+||+.||...+ .
T Consensus 1368 d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1368 DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 8 5899999999998876653 224568999999999998643 45678999999999999999999997654 3
Q ss_pred HHHHHH------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 157 ADQIYK------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 157 ~~~~~~------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+...++ ++.+.++||..||+.||++|.++.|+++|.|-+.+.
T Consensus 1448 ~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1448 WAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred hHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 444443 456789999999999999999999999999987643
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=270.13 Aligned_cols=189 Identities=37% Similarity=0.670 Sum_probs=158.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+|+||+.+++.+.+... ...+++..++.++.|++.||+|||+.|++|+||||+||++
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~ 132 (286)
T cd07832 54 QACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI 132 (286)
T ss_pred HhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE
Confidence 344899999999999999999999999944555555443 4569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.++|+|||++....... ......|+..|+|||++.....++.++||||+||++++|++|..+|.+.+......+
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 133 SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 85 789999999988765432 234567899999999987666668899999999999999999888876654333221
Q ss_pred -----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 163 -----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 163 -----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
....+.+++.+||..||++|||++++++||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 124567899999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=268.93 Aligned_cols=191 Identities=21% Similarity=0.421 Sum_probs=156.4
Q ss_pred ccccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 4 LRKMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
++++.+|+||+++++++.+. ...|++|||+.++.+..+... .+..+++..+..++.|++.|+.|||++||+||
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~ 135 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 135 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 45555899999999999753 468999999997555444443 34568999999999999999999999999999
Q ss_pred CCCCCcEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCC
Q 040202 77 DLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRIL 150 (297)
Q Consensus 77 dikp~Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~p 150 (297)
||||+||++++ +.+||+|||+++..... .......|+..|+|||++.. ...++.++|+||+||++|+|++|+.|
T Consensus 136 dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p 215 (272)
T cd06637 136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215 (272)
T ss_pred CCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999985 78999999999865432 22345678999999998753 23467889999999999999999999
Q ss_pred CCCCCCHHHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 151 FPGKNSADQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 151 f~~~~~~~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
|........... +...+.+|+.+||..||.+|||+.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 216 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 976544333322 22478999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=270.75 Aligned_cols=192 Identities=26% Similarity=0.454 Sum_probs=161.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++..|+||||++|+.+..+....+..+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili 136 (280)
T cd06611 57 SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL 136 (280)
T ss_pred HhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 33489999999999999999999999999977777766655679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+. +.++|+|||++...... .......++..|+|||++.. ...++.++|+||+||++|+|++|+.||.+.+....
T Consensus 137 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~ 216 (280)
T cd06611 137 TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV 216 (280)
T ss_pred CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH
Confidence 74 89999999988665332 22234568999999998752 23356789999999999999999999987655443
Q ss_pred HHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..++ ..++.+++.+||..||.+||++.++++|+||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 217 LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 3222 2468899999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=272.09 Aligned_cols=187 Identities=39% Similarity=0.712 Sum_probs=158.6
Q ss_pred cccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 7 MNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.++||||+++++++... +..|+||||+.+++.+.+... ...+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus 60 ~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil 138 (293)
T cd07843 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138 (293)
T ss_pred hcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE
Confidence 34899999999999877 899999999998776665543 346999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||++...... .......++..|+|||.+.+....+.++|+||+|+++++|++|..||......+...+
T Consensus 139 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (293)
T cd07843 139 LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218 (293)
T ss_pred ECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 985 78999999999876554 3334556788999999887655568899999999999999999999987655443332
Q ss_pred H-------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I-------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i-------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ...+.++|++||+.||++|||+.|+++|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 219 IFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 2 2346789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=271.11 Aligned_cols=189 Identities=37% Similarity=0.676 Sum_probs=156.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++..|+||||+.+++.+.+... +..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil 135 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL 135 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE
Confidence 3445999999999999999999999999998777666544 346899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-HHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS-ADQIY 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-~~~~~ 161 (297)
+++ +.+||+|||+++...... ......++..|+|||++.+...++.++||||+||++|+|++|+.||.+... .+...
T Consensus 136 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~ 215 (291)
T cd07844 136 ISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH 215 (291)
T ss_pred EcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 985 789999999987643221 112345688899999877655568899999999999999999999976552 11111
Q ss_pred H-----------------------------------------HH--HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 K-----------------------------------------IY--GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 ~-----------------------------------------i~--~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
. +. .++.+++.+||+.||.+|||+.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 216 KIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1 11 355789999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=271.29 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=162.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK-ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~-~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++.+.+++..|+||||+.++.+.... ......+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 33459999999999999999999999999986554443 33334699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++++ +.+||+|||++.............|+..|+|||++.+. .++.++|+||+||++|+|++|..||.+.........
T Consensus 134 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 134 LLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred EECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9975 78999999999776544444556789999999998654 468899999999999999999999987655432222
Q ss_pred ---------------HHHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 163 ---------------IYGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 163 ---------------i~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
+...+.+|+.+||+.||++|++ +.++++|+||+...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 2235788999999999999999 889999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=292.64 Aligned_cols=191 Identities=25% Similarity=0.393 Sum_probs=153.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++|+|||++++++.+.+..|+|+|++.++++.++.... ........++.++.||+.||+|||++||+||||||+|
T Consensus 218 ~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N 297 (501)
T PHA03210 218 GRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297 (501)
T ss_pred HhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3349999999999999999999999999999888775431 1224467788999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC---C
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN---S 156 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~---~ 156 (297)
||+++ +.+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|||++|..++.+.. .
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99974 799999999998765432 22346799999999998754 45889999999999999999886543221 1
Q ss_pred HHHHHHH-------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 157 ADQIYKI-------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 157 ~~~~~~i-------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
..++.++ ..++.++|.+||..||++|||+.|+|+|||
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 1111110 113566799999999999999999999999
Q ss_pred CCCC
Q 040202 194 FRSC 197 (297)
Q Consensus 194 f~~~ 197 (297)
|...
T Consensus 457 f~~~ 460 (501)
T PHA03210 457 FSAE 460 (501)
T ss_pred hhcC
Confidence 9764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=274.53 Aligned_cols=191 Identities=38% Similarity=0.680 Sum_probs=159.8
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++.+. +.+|+||||+.+++.+.+... ...+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 139 (309)
T cd07845 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139 (309)
T ss_pred HhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 345999999999999755 578999999998877666543 35699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++++ +.+||+|||++...... .......++..|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 140 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~ 219 (309)
T cd07845 140 LLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219 (309)
T ss_pred EECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9985 79999999999876543 222334457889999998766667889999999999999999999998776554433
Q ss_pred HH-----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KI-----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i-----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+ ...+.++|.+||+.||++|||+.++++||||++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 22 2345789999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=269.83 Aligned_cols=191 Identities=27% Similarity=0.380 Sum_probs=161.2
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
..|+||+++++.+.+++..|+||||+.|+.+..+.... +.+++..++.++.|++.||+|||+.||+||||||+||++++
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~ 132 (278)
T cd05606 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 132 (278)
T ss_pred CCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC
Confidence 58999999999999999999999999987666555443 46999999999999999999999999999999999999975
Q ss_pred -CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH---HHHHH-
Q 040202 88 -GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA---DQIYK- 162 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---~~~~~- 162 (297)
+.+||+|||+++...... .....|+..|+|||++.....++.++||||+||++|+|++|+.||.+.... .....
T Consensus 133 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 211 (278)
T cd05606 133 HGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (278)
T ss_pred CCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh
Confidence 789999999987654332 235678999999999875555688999999999999999999999876321 11111
Q ss_pred ----------HHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCC
Q 040202 163 ----------IYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 163 ----------i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~ 200 (297)
...++.+++.+||..||.+|+ ++.++++||||++..+.
T Consensus 212 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 234788999999999999999 99999999999886653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=266.47 Aligned_cols=190 Identities=27% Similarity=0.442 Sum_probs=161.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+..+|+||+++++++.+++..|+|+||+.|+.+..+.... +.+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil 129 (260)
T cd05611 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129 (260)
T ss_pred hhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 44558999999999999999999999999986666666543 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+++ +.+||+|||+++..... ....++..|+|||.+.+.. ++.++||||+|+++|+|++|..||...+.......+
T Consensus 130 ~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 130 IDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred ECCCCcEEEeecccceecccc---ccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 985 78999999998765442 3456788999999977554 688999999999999999999999877665543332
Q ss_pred ---------------HHHHHHHHHHhhhcCCCCCCC---HHHHHcCCCCCCCCC
Q 040202 164 ---------------YGRWVALISWLCSWNPRMRPT---AAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ---------------~~~~~~li~~~l~~dP~~R~t---~~~ll~h~~f~~~~~ 199 (297)
...+.+++.+||..||++||+ ++|+++||||++.+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 346789999999999999995 579999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=270.99 Aligned_cols=192 Identities=35% Similarity=0.657 Sum_probs=158.9
Q ss_pred ccccccccceeeeceeEEeCCe-----EEEEEecCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHED-----VFIVFDYMESDLLKLMKESA---GQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~-----~~lv~e~~~g~ll~~~~~~~---~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++.+|+||+++++++...+. .|+||||+++++.+.+.... +..+++..++.++.||+.||+|||++||+|
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H 133 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMH 133 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 4455567999999999987665 89999999998877776542 235899999999999999999999999999
Q ss_pred cCCCCCcEEEeC--CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 76 RDLKPSNLLVSK--GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 76 rdikp~Nill~~--~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
|||||+||++++ +.+||+|||+++..... .......+++.|+|||++.+...++.++||||+||++|+|++|..||.
T Consensus 134 ~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 134 RDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999985 68999999998765332 122334568899999988765667889999999999999999999998
Q ss_pred CCCCHHHHHH---------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 153 GKNSADQIYK---------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 153 ~~~~~~~~~~---------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
+.+..+...+ +..++.++|.+||..||++||++.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 214 GDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 7654443322 2345788999999999999999999999999
Q ss_pred CC
Q 040202 194 FR 195 (297)
Q Consensus 194 f~ 195 (297)
|+
T Consensus 294 ~~ 295 (295)
T cd07837 294 FD 295 (295)
T ss_pred cC
Confidence 84
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=280.31 Aligned_cols=185 Identities=25% Similarity=0.445 Sum_probs=158.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+++.++|+|||++++++..++.+|||||||.. .|++++....+..+.......|+.||+.|++||+++++|||||...|
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARN 333 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARN 333 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhh
Confidence 34445999999999999998899999999984 67777776567789999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
|||++ ..+||+|||+|+...++... ....-..-|.|||.+..+++ +.++|||||||+||||+| |+.||.+.+..+
T Consensus 334 iLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~e 412 (468)
T KOG0197|consen 334 ILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEE 412 (468)
T ss_pred eeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence 99986 68999999999965544322 12222445999999887664 899999999999999998 999999999999
Q ss_pred HHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 159 QIYKIYG------------RWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 159 ~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
.+..+.. .+.+++..|+..+|++|||++.+.
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 8887754 678999999999999999998654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.03 Aligned_cols=192 Identities=36% Similarity=0.652 Sum_probs=159.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.|++.+.+. ..+..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill 135 (298)
T cd07841 57 QELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIK-DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI 135 (298)
T ss_pred hhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE
Confidence 3458999999999999999999999999555555544 333369999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+. +.+||+|||+++..... .......++..|+|||.+.+...++.++|+||+||++++|++|..+|.+.+..+...++
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 136 ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 85 78999999999876543 22234456888999998766566688999999999999999998888776655443332
Q ss_pred ---------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 164 ---------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 164 ---------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
...+.+++.+||..||++|||+.++++|+||++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred HHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 23567899999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=266.92 Aligned_cols=188 Identities=34% Similarity=0.644 Sum_probs=158.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++++ +|+||+++++++.+.+..|+||||+.+ ++.+.+... ..+++..+..++.|++.||++||++||+||||||+|
T Consensus 52 ~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~N 128 (260)
T PF00069_consen 52 LRRL-RHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPEN 128 (260)
T ss_dssp HHHH-TBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGG
T ss_pred cccc-ccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 3444 999999999999999999999999999 555555533 559999999999999999999999999999999999
Q ss_pred EEEe-CCeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 83 LLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|+++ ++.++|+|||.+... ..........++..|+|||++.....++.++||||+|+++++|++|..||......+..
T Consensus 129 Il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~ 208 (260)
T PF00069_consen 129 ILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL 208 (260)
T ss_dssp EEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 9998 589999999999863 33334456778999999999763556689999999999999999999999887322222
Q ss_pred H---HH---------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 161 Y---KI---------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 161 ~---~i---------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
. +. ...+.+++.+||+.||++|||+.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 209 EIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 2 11 1468899999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=264.84 Aligned_cols=188 Identities=26% Similarity=0.487 Sum_probs=159.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++.+.+++.+|++|||++|+.+..+.......+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 55 ~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i 134 (262)
T cd06613 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL 134 (262)
T ss_pred HhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE
Confidence 44599999999999999999999999999877776665544569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceeccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||++....... ......++..|+|||.+... ..++.++|+||+||++|+|++|+.||.+.+......
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~ 214 (262)
T cd06613 135 TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF 214 (262)
T ss_pred CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 85 789999999987654432 22445678899999987644 145788999999999999999999998765433322
Q ss_pred ----------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 162 ----------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 162 ----------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
++..++.+++++||..||.+|||+.++++|+|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 215 LISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 23356889999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=264.64 Aligned_cols=189 Identities=24% Similarity=0.473 Sum_probs=160.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++ +|+||+++++.+.+++.+|+++||+.++.+..+....+..+++..++.++.|++.|+.|||+.|++||||+|+||
T Consensus 52 ~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 130 (256)
T cd06612 52 LKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI 130 (256)
T ss_pred HHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 4444 999999999999999999999999998777666665556799999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++++ +.+||+|||++....... ......++..|+|||++.+. .++.++||||+||++|+|++|+.||..........
T Consensus 131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 131 LLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred EECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 9975 789999999988765443 22345578899999997654 45889999999999999999999997655433322
Q ss_pred --------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 --------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 --------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+...+.+++.+|++.||++|||+.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 223478899999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=267.52 Aligned_cols=188 Identities=36% Similarity=0.589 Sum_probs=156.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.+++++.+.... ..+++..++.++.|++.||.|||+.||+||||||+||++
T Consensus 58 ~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 58 KGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred HhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 3459999999999999999999999999988888776543 458899999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH-HHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD-QIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~~~ 162 (297)
+. +.+||+|||+++..... .......++..|+|||++.+...++.++||||+||++|+|++|..||.+..... ...+
T Consensus 137 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 216 (291)
T cd07870 137 SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216 (291)
T ss_pred cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Confidence 74 78999999998764322 122345678899999998755556788999999999999999999997654321 1111
Q ss_pred H-------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I-------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i-------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ...+.+++.+||..||++|||+.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 1256789999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=282.59 Aligned_cols=188 Identities=29% Similarity=0.538 Sum_probs=157.7
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS- 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~- 86 (297)
+.+-||++|-.|++++++|+||||+.| ++...+++. +.|+|+.++.|+.+|..|+++.|+.|+|||||||+|||||
T Consensus 687 Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr 764 (1034)
T KOG0608|consen 687 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 764 (1034)
T ss_pred CCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc
Confidence 678899999999999999999999987 566666665 6799999999999999999999999999999999999999
Q ss_pred CCeEEEEecCCceecC---------CC----------------------------------CCCccccccCCCCCCceec
Q 040202 87 KGVIKIGDLGMVKEID---------SS----------------------------------LPCTDYVTTRWYRAPEVLL 123 (297)
Q Consensus 87 ~~~~kl~Dfgla~~~~---------~~----------------------------------~~~~~~~gt~~y~aPE~~~ 123 (297)
+|++||+||||++-+. .+ ......+||+.|+|||++.
T Consensus 765 dGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~ 844 (1034)
T KOG0608|consen 765 DGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA 844 (1034)
T ss_pred CCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc
Confidence 5999999999984210 00 0012347999999999998
Q ss_pred ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHHHHHHHHHhhhcCCCCCCC---H
Q 040202 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------YGRWVALISWLCSWNPRMRPT---A 185 (297)
Q Consensus 124 ~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---------------~~~~~~li~~~l~~dP~~R~t---~ 185 (297)
..+ |...+|+||.|||||||+.|+.||......+...++ +.++.++|.+++. +++.|.. +
T Consensus 845 r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~ 922 (1034)
T KOG0608|consen 845 RTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGA 922 (1034)
T ss_pred ccC-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcccch
Confidence 655 488999999999999999999999887766654433 3478889998765 7888864 6
Q ss_pred HHHHcCCCCCCCCCC
Q 040202 186 AEALEHPFFRSCHFV 200 (297)
Q Consensus 186 ~~ll~h~~f~~~~~~ 200 (297)
+++..||||++++|.
T Consensus 923 d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 923 DQVKAHPFFKGIDFS 937 (1034)
T ss_pred hhhhcCccccccchH
Confidence 789999999999885
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.79 Aligned_cols=191 Identities=30% Similarity=0.440 Sum_probs=162.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... +.+++..+..++.|++.||+|||++||+||||+|.||++
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili 134 (290)
T cd05580 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134 (290)
T ss_pred HhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 3448999999999999999999999999765444444432 569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI- 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i- 163 (297)
++ +.+||+|||+++..... .....+++.|+|||.+... ..+.++|+||||+++|+|++|+.||...+......++
T Consensus 135 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 135 DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 75 78999999999876554 2455789999999987654 4578899999999999999999999877654444433
Q ss_pred ----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCCC
Q 040202 164 ----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHFV 200 (297)
Q Consensus 164 ----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~~ 200 (297)
...+++++.+||..||.+|+ +++++++||||+...|.
T Consensus 212 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 212 EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 24678999999999999999 89999999999887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=270.26 Aligned_cols=191 Identities=26% Similarity=0.478 Sum_probs=162.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++..|+|+||+.|+.+..+... ..+++.++..++.|++.||+|||++|++||||||+||++
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili 148 (296)
T cd06655 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148 (296)
T ss_pred HhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 445999999999999999999999999998777766654 358999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||++........ .....++..|+|||.+... .++.++|+||+||++|+|++|+.||.+.+.......+
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 74 7899999999876543322 2345688899999987654 4578999999999999999999999887665443332
Q ss_pred --------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 --------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 --------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
...+.++|.+||..||.+||++.++++||||+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 235789999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=265.28 Aligned_cols=192 Identities=29% Similarity=0.440 Sum_probs=162.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++..|+++||+.|+.+..+..+. ..+++..+..++.||+.||+|||++|++|+||+|+||++
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv 126 (262)
T cd05572 48 EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126 (262)
T ss_pred HhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE
Confidence 3459999999999999999999999999876555555442 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC--CHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN--SADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~--~~~~~~~ 162 (297)
++ +.+||+|||+++............++..|++||.+... .++.++|+||+|+++|+|++|..||.... ..+...+
T Consensus 127 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 205 (262)
T cd05572 127 DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205 (262)
T ss_pred cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH
Confidence 75 78999999999877654433456789999999987644 45789999999999999999999998766 3333333
Q ss_pred HH-------------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 163 IY-------------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-------------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
+. .++.+++.+||..||++|++ +.|+++||||++..|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 206 ILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 33 47899999999999999999 999999999987544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=267.42 Aligned_cols=188 Identities=38% Similarity=0.729 Sum_probs=161.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||++++++..+..+. ..+++..+..++.|++.|+.|||++|++||||+|+||++
T Consensus 55 ~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~ 133 (288)
T cd07833 55 RQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV 133 (288)
T ss_pred HhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 3448999999999999999999999999998887766553 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.+||+|||++....... ......++..|+|||++.....++.++|+||+|+++|+|++|+.||.+.+..+...+
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 134 SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 85 799999999988765543 334567889999999987664668999999999999999999999986554332221
Q ss_pred -------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 -------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 -------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..++++++++||..||++|||++++++|+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 13457899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=267.15 Aligned_cols=191 Identities=52% Similarity=0.972 Sum_probs=164.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++.+|+||+++++++.+++..|+||||+.|++++.+....+..+++..+..++.|++.+|.|||++|++|+||+|+||
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni 130 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENL 130 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 34443399999999999999999999999988888877766445689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++++ +.++|+|||+++............++..|+|||++.....++.++|+||+|+++++|++|+.||......+...+
T Consensus 131 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 131 LVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred EEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 9986 799999999998876655555667899999999986666668899999999999999999999987665444332
Q ss_pred H-----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I-----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i-----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ..++.+++++||+.||++|||+.|++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 2 1357899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=265.09 Aligned_cols=188 Identities=24% Similarity=0.439 Sum_probs=155.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++.+.+.+..|+||||++++.+..+.... +.+++..++.++.|++.|++|||++|++||||||+||+
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 138 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 34459999999999999999999999999986655555443 46999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceec--ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLL--LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++. +.+||+|||++....... ......|+..|+|||++. ....++.++|+||+||++|+|++|+.||.........
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~ 218 (267)
T cd06645 139 LTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred ECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence 985 789999999987654332 223457899999999864 2334578999999999999999999998655433322
Q ss_pred HH----------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 161 YK----------------IYGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 161 ~~----------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
.. +...+.+++.+||..||++|||++++++|||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 21 2235788999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.45 Aligned_cols=186 Identities=21% Similarity=0.377 Sum_probs=147.8
Q ss_pred ccccccccceeeeceeEEeC-CeEEEEEecCCCcHHHHHHHhc-------------------------------------
Q 040202 4 LRKMNNHPNIVKLRNLVKEH-EDVFIVFDYMESDLLKLMKESA------------------------------------- 45 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~-~~~~lv~e~~~g~ll~~~~~~~------------------------------------- 45 (297)
+.++.+||||+++++++.+. +.+|+||||++|+.+..++...
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 44555899999999988754 4689999999975554443321
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCcee
Q 040202 46 ------------------------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 100 (297)
Q Consensus 46 ------------------------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~ 100 (297)
...+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||+++.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~ 223 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 223 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccc
Confidence 124788899999999999999999999999999999999985 7899999999986
Q ss_pred cCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH-------------
Q 040202 101 IDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI------------- 163 (297)
Q Consensus 101 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i------------- 163 (297)
..... ......++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+...+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (338)
T cd05102 224 IYKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA 302 (338)
T ss_pred cccCcchhcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCC
Confidence 53321 12234456789999998654 46899999999999999997 99999876543332221
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 164 YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 164 ~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+.+++.+||..||++|||+.++++
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 236789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=278.22 Aligned_cols=187 Identities=36% Similarity=0.621 Sum_probs=157.2
Q ss_pred cccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.+.++|+||+++++++... ...|+||||+.+++.+.+... +++..+..++.|++.||+|||++||+||||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dl 144 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 144 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 3455999999999998643 357999999999887766432 899999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+||++++ +.+||+|||+++............++..|+|||++.+. .++.++||||+||++|+|++|+.||...+..
T Consensus 145 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 223 (353)
T cd07850 145 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223 (353)
T ss_pred CHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999985 78999999999887665544556789999999998654 4588999999999999999999999876543
Q ss_pred HHHHHH------------------------------------------------------HHHHHHHHHHhhhcCCCCCC
Q 040202 158 DQIYKI------------------------------------------------------YGRWVALISWLCSWNPRMRP 183 (297)
Q Consensus 158 ~~~~~i------------------------------------------------------~~~~~~li~~~l~~dP~~R~ 183 (297)
....++ ...++++|.+||+.||++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 303 (353)
T cd07850 224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303 (353)
T ss_pred HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence 322221 12357899999999999999
Q ss_pred CHHHHHcCCCCCC
Q 040202 184 TAAEALEHPFFRS 196 (297)
Q Consensus 184 t~~~ll~h~~f~~ 196 (297)
|+.++|+||||+.
T Consensus 304 t~~eiL~~~~~~~ 316 (353)
T cd07850 304 SVDDALQHPYINV 316 (353)
T ss_pred CHHHHhcChhHhh
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.93 Aligned_cols=182 Identities=16% Similarity=0.209 Sum_probs=153.1
Q ss_pred ccccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp 80 (297)
+.++||||+++++++.+ ...+++||||+.|+.+..+.... +.+++..+..++.|++.||.|||+ .+++||||||
T Consensus 73 ~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp 151 (283)
T PHA02988 73 RRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151 (283)
T ss_pred HhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh
Confidence 33499999999999977 45789999999987666665543 468999999999999999999998 4999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+||++++ +.+||+|||+++...... ....|+..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+
T Consensus 152 ~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 152 VSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred hhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999985 789999999988654432 345688999999997642 456899999999999999999999999877655
Q ss_pred HHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....+ ...+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 230 IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 54443 236889999999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=261.22 Aligned_cols=188 Identities=28% Similarity=0.540 Sum_probs=156.7
Q ss_pred ccccccceeeeceeEEe-CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE-HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++.+.. +..+|++|||+.+ ++.+.+....+..+++.+++.++.|++.|++|||++|++||||||+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~ni 133 (257)
T cd08223 54 SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNV 133 (257)
T ss_pred HhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhE
Confidence 34589999999998864 4578999999987 555555554455699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++++ +.++|+|||+++..... .......+++.|+|||++.+. .++.++|+||+||++++|++|+.||...+......
T Consensus 134 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 134 FLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred EEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9985 78999999999876432 222445688999999987654 45789999999999999999999998766554433
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+ ...+.+++.+|++.||++|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 32 2467899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=271.75 Aligned_cols=194 Identities=31% Similarity=0.471 Sum_probs=162.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+.+++..|+||||+.|+.+..+..+ .+..+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus 56 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 135 (316)
T cd05574 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENIL 135 (316)
T ss_pred HhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeE
Confidence 445899999999999999999999999988555444443 3456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC------------------------------CCccccccCCCCCCceecccccCCCccc
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL------------------------------PCTDYVTTRWYRAPEVLLLSEICGPEVD 133 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 133 (297)
++. +.++|+|||++....... ......|+..|+|||++.+. .++.++|
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~D 214 (316)
T cd05574 136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVD 214 (316)
T ss_pred EcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHH
Confidence 984 799999999986543211 11234678899999998654 4588999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------HHHHHHHHHHhhhcCCCCCCC----HHHHHcCCCCCC
Q 040202 134 RWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------YGRWVALISWLCSWNPRMRPT----AAEALEHPFFRS 196 (297)
Q Consensus 134 iwSlGv~l~ell~g~~pf~~~~~~~~~~~i-------------~~~~~~li~~~l~~dP~~R~t----~~~ll~h~~f~~ 196 (297)
|||||+++|+|++|+.||.+.+......++ ...+.+++.+||..||++||| ++++++||||++
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 999999999999999999887766555433 346899999999999999999 999999999998
Q ss_pred CCCC
Q 040202 197 CHFV 200 (297)
Q Consensus 197 ~~~~ 200 (297)
..|.
T Consensus 295 ~~~~ 298 (316)
T cd05574 295 VNWA 298 (316)
T ss_pred CChh
Confidence 7654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=267.47 Aligned_cols=193 Identities=28% Similarity=0.397 Sum_probs=160.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK-ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~-~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++.+...+..|+||||++|+.+.... ......+++..++.++.|++.||.|||++|++||||+|+||+
T Consensus 48 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil 127 (277)
T cd05577 48 EKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVL 127 (277)
T ss_pred HhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 4448999999999999999999999999985555444 433346999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH---HHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA---DQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---~~~ 160 (297)
+++ +.+||+|||++.............++..|+|||++.+.. ++.++|+||+||++|+|++|+.||...... +..
T Consensus 128 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05577 128 LDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206 (277)
T ss_pred ECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH
Confidence 985 789999999987765444445567788999999976544 688999999999999999999999776542 111
Q ss_pred H------------HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 161 Y------------KIYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 161 ~------------~i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
. .+...+.++|.+||+.||.+|| ++.++++||||+..++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 207 KRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 1 1234679999999999999999 8889999999987655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=267.92 Aligned_cols=192 Identities=21% Similarity=0.415 Sum_probs=156.2
Q ss_pred cccccccccceeeeceeEE------eCCeEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 3 FLRKMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~------~~~~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
.++++.+|+||+++++++. .++.+|++|||+.++.+..+... .+..+++..+..++.||+.|+.|||+.||+|
T Consensus 65 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH 144 (282)
T cd06636 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIH 144 (282)
T ss_pred HHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3456668999999999985 35689999999998555444443 3456899999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|||||+||++++ +.++|+|||++...... .......|+..|+|||++.. ...++.++|+|||||++|+|++|..
T Consensus 145 ~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224 (282)
T ss_pred CCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence 999999999985 78999999998765432 22245678999999998753 2345778999999999999999999
Q ss_pred CCCCCCCHHHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 150 LFPGKNSADQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 150 pf~~~~~~~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
||........... +...+.++|++||..||.+|||+.++++||||
T Consensus 225 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 225 PLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9976554333321 23478899999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=261.34 Aligned_cols=188 Identities=27% Similarity=0.427 Sum_probs=159.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++.+.+++..|+||||+.|+. .+.+....+..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nil 133 (256)
T cd08529 54 AKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133 (256)
T ss_pred HhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 34599999999999999999999999998744 44444443567999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++....... .....|+..|+|||++... .++.++|+|||||++++|++|+.||...+..+...+
T Consensus 134 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 134 LDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred EeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 985 7899999999887654322 2345688999999987654 457899999999999999999999987775544443
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ...+.+++.+|++.+|++||++.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 3 2368999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=263.54 Aligned_cols=183 Identities=23% Similarity=0.404 Sum_probs=153.9
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
.+|+||+++++.+..++..|+||||+.|+.+..+.... ..+++.+++.++.|++.||+|||+.|++||||||+||++++
T Consensus 66 ~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 66 KDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred hcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 37999999999999999999999999875544444442 36999999999999999999999999999999999999985
Q ss_pred -C-eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH----HH
Q 040202 88 -G-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ----IY 161 (297)
Q Consensus 88 -~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~----~~ 161 (297)
+ .++|+|||+++..... ....++..|+|||++.+.. ++.++|+||+||++|+|++|+.||........ ..
T Consensus 145 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred CCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 4 7999999998876543 3456899999999986544 58899999999999999999999975543221 11
Q ss_pred -----------HHHHHHHHHHHHhhhcCCCCCCC-HHHHHcCCCCC
Q 040202 162 -----------KIYGRWVALISWLCSWNPRMRPT-AAEALEHPFFR 195 (297)
Q Consensus 162 -----------~i~~~~~~li~~~l~~dP~~R~t-~~~ll~h~~f~ 195 (297)
.+...+.++|.+||+.||.+|++ ++++|+||||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 221 KRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 13346799999999999999996 69999999996
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=264.38 Aligned_cols=186 Identities=30% Similarity=0.522 Sum_probs=156.9
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++.+++..++||||+.|+.+..+.... +.+++..+..++.|++.||+|||++|++||||+|+||+++
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~ 140 (267)
T cd06628 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD 140 (267)
T ss_pred hcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc
Confidence 349999999999999999999999999886665555543 4589999999999999999999999999999999999997
Q ss_pred C-CeEEEEecCCceecCCCC-------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSL-------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+ +.+||+|||.++...... ......|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+...
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 141 NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 5 789999999987765221 11234578899999987654 45788999999999999999999998766554
Q ss_pred HHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 159 QIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 159 ~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...++ ...+.+++++||+.||++||++.++++|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 44332 2467899999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=271.11 Aligned_cols=189 Identities=26% Similarity=0.438 Sum_probs=157.0
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~N 82 (297)
++++ +||||+++++++.+++.+|+||||++|+.+..+..+. +.+++..+..++.|++.||.|||+ .+++||||||+|
T Consensus 53 l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 53 LHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred HHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 3444 9999999999999999999999999986665555543 569999999999999999999997 599999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++++ +.+||+|||++....... .....|+..|+|||++.+. .++.++|+||+||++|+|++|+.||...+......
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 208 (308)
T cd06615 131 ILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208 (308)
T ss_pred EEEecCCcEEEccCCCcccccccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence 99975 789999999987654332 2456789999999987644 45889999999999999999999986543222111
Q ss_pred -------------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 162 -------------------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 162 -------------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
....++.+++.+||..||++|||+.++++||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0123578999999999999999999999999
Q ss_pred CCCC
Q 040202 193 FFRS 196 (297)
Q Consensus 193 ~f~~ 196 (297)
||..
T Consensus 289 ~~~~ 292 (308)
T cd06615 289 FIKR 292 (308)
T ss_pred hhhh
Confidence 9975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.34 Aligned_cols=195 Identities=25% Similarity=0.405 Sum_probs=161.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKP 80 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp 80 (297)
+.+..+|+||+++++++.+++..|++|||++|++.+.+... .+..+++..++.++.|++.||+|||++ +++||||||
T Consensus 53 ~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp 132 (283)
T cd06617 53 SMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP 132 (283)
T ss_pred HHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence 35567999999999999999999999999998776665442 234699999999999999999999998 999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCC-
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS---EICGPEVDRWAMGAIMFEMLSFRILFPGKN- 155 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~ell~g~~pf~~~~- 155 (297)
+||++++ +.+||+|||+++............++..|+|||++... ..++.++|+||+||++|+|++|+.||....
T Consensus 133 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (283)
T cd06617 133 SNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212 (283)
T ss_pred HHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc
Confidence 9999975 78999999999876544333446788999999987542 335788999999999999999999996532
Q ss_pred CHHHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 156 SADQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 156 ~~~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
..+.... +..++.+++.+||..+|.+||++.++++|+||+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 213 PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 2222221 234688999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=299.27 Aligned_cols=194 Identities=26% Similarity=0.437 Sum_probs=159.2
Q ss_pred cccccccceeeeceeEEe--CCeEEEEEecCCCc-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-------C
Q 040202 5 RKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESD-LLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQ-------G 72 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~-ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~-------g 72 (297)
++.++|||||+++++|.+ .+.+||||||+.++ |.+.+... ....+++..++.|+.||+.||.|||+. +
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 344599999999999854 46799999999975 44444432 124699999999999999999999985 4
Q ss_pred ccccCCCCCcEEEeC------------------CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc-ccCCCccc
Q 040202 73 YFHRDLKPSNLLVSK------------------GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EICGPEVD 133 (297)
Q Consensus 73 i~Hrdikp~Nill~~------------------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 133 (297)
|+||||||+|||++. +.+||+|||+++............||+.|+|||++... ..++.++|
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD 225 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence 999999999999953 24899999999877655545567899999999997643 44688999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 134 RWAMGAIMFEMLSFRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 134 iwSlGv~l~ell~g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
|||||||+|+|++|..||...+....+... ..++.+||..||..+|.+||++.++|.|+|++...
T Consensus 226 VWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 226 MWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999999999999999999877665544332 23688999999999999999999999999997653
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.77 Aligned_cols=188 Identities=36% Similarity=0.707 Sum_probs=159.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.+++++.+.... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 55 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~ 133 (286)
T cd07846 55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV 133 (286)
T ss_pred HhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 3459999999999999999999999999998887766543 359999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.++|+|||++...... .......++..|+|||++.+...++.++||||+||++|+|++|+.||......+...++
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 134 SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 75 78999999998775433 22334567899999999876555678999999999999999999999766544332221
Q ss_pred ------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 ------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 ------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...+.+++.+||..||++||++.++++|+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 2347889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.27 Aligned_cols=189 Identities=26% Similarity=0.528 Sum_probs=159.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+..++..|+||||+.|+++..+... +.+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 74 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill 151 (292)
T cd06658 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151 (292)
T ss_pred HhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 345999999999999999999999999998777666654 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||++....... ......|+..|+|||.+... .++.++|+||+||++|||++|+.||.+.+.......+
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 789999999987653322 22345689999999987644 4578999999999999999999999876654443322
Q ss_pred --------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 164 --------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 164 --------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...+.+++.+|+..||++|||++++++|+||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 2357889999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=266.39 Aligned_cols=188 Identities=37% Similarity=0.705 Sum_probs=158.0
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++++.+++..|++|||+++++.+.+.......+++..+..++.|++.||+|||++|++||||+|+||+++
T Consensus 54 ~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~ 133 (283)
T cd07835 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID 133 (283)
T ss_pred hcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence 34899999999999999999999999988777766655334699999999999999999999999999999999999997
Q ss_pred C-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q 040202 87 K-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI- 163 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i- 163 (297)
+ +.++|+|||+++...... ......++..|+|||++.+...++.++|+||+||++|+|++|+.||.+.+......++
T Consensus 134 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 134 REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5 789999999987654321 1233456889999998876556688999999999999999999999876543332221
Q ss_pred ---------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 ---------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 ---------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...+.+++.+||+.||.+|||+.++++|+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1356789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=266.68 Aligned_cols=192 Identities=24% Similarity=0.436 Sum_probs=156.4
Q ss_pred ccccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 4 LRKMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
++++.+|+||+++++++.+. +..|+||||+.|+.+..+... .+..+++..++.++.|++.||+|||+.|++|
T Consensus 72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 151 (291)
T cd06639 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIH 151 (291)
T ss_pred HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45555899999999998753 468999999988665544431 2356899999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccc----cCCCccchhhHHHHHHHHHhCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSE----ICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|||||+||++++ +.+||+|||++....... ......|+..|+|||++.... .++.++||||+||++|+|++|+.
T Consensus 152 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 152 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred cCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 999999999975 789999999987654322 123456788999999875432 24789999999999999999999
Q ss_pred CCCCCCCHHHHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 150 LFPGKNSADQIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 150 pf~~~~~~~~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
||..........++ ...+.+++.+||..||++||++.++++||||+
T Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 232 PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 99876654444333 23578999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=272.05 Aligned_cols=189 Identities=38% Similarity=0.681 Sum_probs=156.2
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESA---GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~---~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++||||+++++++.+. +.+|+||||+++++++.+.... ...+++..++.++.|++.||+|||+.||+||||||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp 136 (316)
T cd07842 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136 (316)
T ss_pred HhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCH
Confidence 345999999999999988 8899999999998887665432 23689999999999999999999999999999999
Q ss_pred CcEEEeC-----CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 81 SNLLVSK-----GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 81 ~Nill~~-----~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
+||++++ +.+||+|||+++...... ......++..|+|||++.+...++.++|||||||++++|++|+.||
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999964 689999999988654332 1234567889999998776666788999999999999999999999
Q ss_pred CCCCCHH---------HHH------------------------------------------------HHHHHHHHHHHHh
Q 040202 152 PGKNSAD---------QIY------------------------------------------------KIYGRWVALISWL 174 (297)
Q Consensus 152 ~~~~~~~---------~~~------------------------------------------------~i~~~~~~li~~~ 174 (297)
.+..... ... ....++.+++.+|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 296 (316)
T cd07842 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296 (316)
T ss_pred cCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHH
Confidence 7654321 000 0112467899999
Q ss_pred hhcCCCCCCCHHHHHcCCCC
Q 040202 175 CSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 175 l~~dP~~R~t~~~ll~h~~f 194 (297)
|..||++|||+.++++||||
T Consensus 297 l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 297 LEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hcCCcccCcCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=259.78 Aligned_cols=188 Identities=28% Similarity=0.474 Sum_probs=160.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+..++..++||||+.|+ +.+.+....+..+++..+..++.|++.|++|||++|++||||||+||+
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 133 (256)
T cd08220 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133 (256)
T ss_pred hhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 4459999999999999999999999999874 455554444456899999999999999999999999999999999999
Q ss_pred EeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||++.............++..|+|||.+... .++.++|+||+|+++++|++|+.||.+.+......+
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 212 (256)
T cd08220 134 LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212 (256)
T ss_pred EcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 974 46899999999887665554566789999999998654 457899999999999999999999988766555444
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ..++.+++.+||..||++|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 213 IMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 3 2368899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=269.51 Aligned_cols=193 Identities=20% Similarity=0.327 Sum_probs=157.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE-SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~-~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.+++..|++|||+.++.+..+.. ..+..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nil 133 (314)
T cd08216 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133 (314)
T ss_pred HhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEE
Confidence 34589999999999999999999999999765555444 33456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--------CCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
++. +.+||+|||.+....... ......++..|+|||++... ..++.++|+||+||++++|++|+.||...
T Consensus 134 i~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred EecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 985 899999999886553211 11234567789999997643 34678999999999999999999999765
Q ss_pred CCHHHH-H--------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 155 NSADQI-Y--------------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 155 ~~~~~~-~--------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
...... . .+..++.+++.+||..||++|||+.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 214 PATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred CHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 432221 1 1123577899999999999999999999
Q ss_pred cCCCCCCCC
Q 040202 190 EHPFFRSCH 198 (297)
Q Consensus 190 ~h~~f~~~~ 198 (297)
+||||+.+.
T Consensus 294 ~~p~~~~~~ 302 (314)
T cd08216 294 NHSFFKQCK 302 (314)
T ss_pred cCchHhhhc
Confidence 999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=265.59 Aligned_cols=189 Identities=37% Similarity=0.712 Sum_probs=160.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA-GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~-~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+.+.+..|+||||+.|++.+.+.... ...+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 53 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~ 132 (284)
T cd07836 53 KELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLL 132 (284)
T ss_pred HhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 3459999999999999999999999999998877766542 245899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++...... ......++..|++||++.+...++.++|+||+||++|+|++|+.||.+.+..+...+
T Consensus 133 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 212 (284)
T cd07836 133 INKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212 (284)
T ss_pred ECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 975 789999999987654322 123456788999999876655668899999999999999999999987765544332
Q ss_pred H----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ...+++++.+||+.||.+||++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 2 2345789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=264.04 Aligned_cols=192 Identities=26% Similarity=0.464 Sum_probs=156.8
Q ss_pred cccccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHh-c--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKES-A--GQNFSEDEARNLCFQVFQGLHYMHRQGY 73 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~-~--~~~l~e~~~~~~~~qll~al~yLH~~gi 73 (297)
.++++.+|+||+++++++.+.. .+|+||||+.++.+..+... . +..+++..++.++.|++.||+|||+.|+
T Consensus 55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i 134 (275)
T cd06608 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKV 134 (275)
T ss_pred HHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 3455668999999999997644 58999999998665555433 2 3569999999999999999999999999
Q ss_pred cccCCCCCcEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceeccc----ccCCCccchhhHHHHHHHHHhC
Q 040202 74 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLS----EICGPEVDRWAMGAIMFEMLSF 147 (297)
Q Consensus 74 ~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g 147 (297)
+||||+|+||++++ +.+||+|||++....... ......|+..|+|||++... ..++.++||||+||++|+|++|
T Consensus 135 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g 214 (275)
T cd06608 135 IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214 (275)
T ss_pred ccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence 99999999999974 789999999987654322 22345688999999987532 3457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 148 RILFPGKNSADQIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 148 ~~pf~~~~~~~~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..||..........++ ...+++++.+||..||++|||+.++++|||+
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999765544433332 2367899999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=271.63 Aligned_cols=190 Identities=35% Similarity=0.586 Sum_probs=160.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++..++..|+||||+.|++.+.+... ..+++..+..++.|++.||+|||+.||+||||+|+||++
T Consensus 75 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred HhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 345999999999999999999999999999887776543 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCC---------------CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 86 SK-GVIKIGDLGMVKEIDS---------------SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
++ +.+||+|||+++.... ........++..|+|||++.+...++.++|+||+||++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 75 7899999999876541 1112234568889999998766666889999999999999999999
Q ss_pred CCCCCCCHHHHHHH---------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQIYKI---------------------------------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~~~~i---------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||.+.+..+....+ ..++.+++.+||+.||++|||+++++.
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 99877655443322 234678999999999999999999999
Q ss_pred CCCCCCC
Q 040202 191 HPFFRSC 197 (297)
Q Consensus 191 h~~f~~~ 197 (297)
|+||+..
T Consensus 313 ~~~~~~~ 319 (335)
T PTZ00024 313 HEYFKSD 319 (335)
T ss_pred CcccCCC
Confidence 9999864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=268.11 Aligned_cols=188 Identities=33% Similarity=0.610 Sum_probs=154.1
Q ss_pred ccccccceeeeceeEEeCC--------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 6 KMNNHPNIVKLRNLVKEHE--------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~--------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.++||||+++++++...+ ..|+||||+.+++.+.+... +..+++.+++.++.|++.||+|||++|++|||
T Consensus 66 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 144 (310)
T cd07865 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRD 144 (310)
T ss_pred HhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 4459999999999987543 46999999998877766544 34699999999999999999999999999999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
|||+||++++ +.+||+|||++....... ......++..|+|||++.+...++.++||||+|+++|+|++|..||
T Consensus 145 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 145 MKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred CCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999985 789999999987654321 1234567888999998766555688999999999999999999999
Q ss_pred CCCCCHHHHHHH-------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 152 PGKNSADQIYKI-------------------------------------------YGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 152 ~~~~~~~~~~~i-------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
.+.+.......+ ...+.++|.+||..||.+|||++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 776543221110 1235689999999999999999999
Q ss_pred HcCCCC
Q 040202 189 LEHPFF 194 (297)
Q Consensus 189 l~h~~f 194 (297)
++||||
T Consensus 305 l~h~~f 310 (310)
T cd07865 305 LNHDFF 310 (310)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=267.90 Aligned_cols=190 Identities=25% Similarity=0.486 Sum_probs=158.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++.+.++...|+||||+.|+.+..+... ..+++.++..++.|++.||+|||+.||+||||||+||+
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nil 148 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 3445999999999999999999999999998666555544 35899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH-
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~- 161 (297)
+++ +.+||+|||++....... ......|++.|+|||.+.. ..++.++||||+||++|+|++|+.||...+......
T Consensus 149 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred EcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 985 789999999987654322 1234568899999998764 445789999999999999999999997765433322
Q ss_pred -------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 -------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 -------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+...+.+++.+||..||++|||+.++++|+||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 223467899999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=266.98 Aligned_cols=185 Identities=25% Similarity=0.465 Sum_probs=155.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++.+...+..++||||++++.+... ..+++..+..++.|++.||+|||+.||+|+||||+||++
T Consensus 54 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill 128 (279)
T cd06619 54 YKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV 128 (279)
T ss_pred HhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE
Confidence 335999999999999999999999999999777543 247899999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-------
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA------- 157 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~------- 157 (297)
+. +.+||+|||++....... .....|+..|+|||++.+.. ++.++|+||+||++|+|++|+.||......
T Consensus 129 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 206 (279)
T cd06619 129 NTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206 (279)
T ss_pred CCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH
Confidence 85 799999999998765432 24567899999999987544 588999999999999999999999653221
Q ss_pred HHHH-------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 158 DQIY-------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 158 ~~~~-------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.... ....++.+++.+||..||++||+++++++||||+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 1111 122468899999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=262.08 Aligned_cols=189 Identities=26% Similarity=0.428 Sum_probs=159.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh-cC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES-AG-QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~-~~-~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++.+.+++..|+|||++.|+.+..+... .. ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni 133 (267)
T cd06610 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNI 133 (267)
T ss_pred HhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 445999999999999999999999999998665555443 22 4689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC-----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP-----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
++++ +.+||+|||++........ .....|+..|+|||++.....++.++|+||+||++++|++|+.||...+..
T Consensus 134 ~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 134 LLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred EEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 9985 7899999999876544321 134568899999999876546688999999999999999999999876554
Q ss_pred HHHHH-----------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 158 DQIYK-----------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 158 ~~~~~-----------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
....+ +...+.+++.+||..||++||++.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 214 KVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 33322 23467899999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=260.99 Aligned_cols=187 Identities=22% Similarity=0.376 Sum_probs=157.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+++||+.|+.+..+..+. ..+++..+..++.|++.||+|||+.||+|+||+|+||++
T Consensus 57 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 135 (265)
T cd06631 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML 135 (265)
T ss_pred HhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE
Confidence 3448999999999999999999999999986666665543 458999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCC-------CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 86 S-KGVIKIGDLGMVKEIDS-------SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+ ++.+||+|||++..... ........|+..|+|||++.+. .++.++|+||+||++|+|++|..||...+..
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 7 48999999999875421 1122345688999999997654 4578999999999999999999999876554
Q ss_pred HHHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 158 DQIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 158 ~~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.....+ ...+.+++++||..+|++||++.++++||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 215 AAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 433222 2367899999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=263.05 Aligned_cols=190 Identities=23% Similarity=0.419 Sum_probs=161.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.++...|+|+||+.++.+..+... ..+++..+..++.|++.|+.|||+.|++||||+|+||++
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i 131 (274)
T cd06609 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL 131 (274)
T ss_pred HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 334899999999999999999999999998655555544 269999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.++|+|||+++..... .......++..|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 132 SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred CCCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 85 78999999999887654 2234567888999999987555 68999999999999999999999987654443322
Q ss_pred ------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 ------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 ------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+...+.+++.+||..||++|||++++++|+||+...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 211 PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 234688999999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=268.14 Aligned_cols=191 Identities=25% Similarity=0.506 Sum_probs=161.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++.+..++..|+|+||++++.+..+... ..+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 73 ~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill 150 (297)
T cd06659 73 RDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150 (297)
T ss_pred HhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE
Confidence 335899999999999999999999999998777666654 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||++....... ......|+..|+|||++.+.. ++.++|+||+||++|||++|+.||......+....+
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 789999999987554322 223467899999999986544 588999999999999999999999876655544332
Q ss_pred --------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 --------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 --------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
...+.+++.+||+.||++||+++++++|+||.....
T Consensus 230 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred hccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 235789999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=266.81 Aligned_cols=194 Identities=27% Similarity=0.451 Sum_probs=159.8
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKL---MKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDL 78 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~---~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdi 78 (297)
.+.++.+|+||+++++++.+++..+++|||+.+++.+. +.......+++..+..++.|++.||+|||+. ||+||||
T Consensus 55 ~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dl 134 (288)
T cd06616 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDV 134 (288)
T ss_pred HHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCC
Confidence 45566579999999999999999999999998754432 2333335699999999999999999999975 9999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
||+||++++ +.+||+|||+++............|+..|+|||++... ..++.++||||+||++|+|++|+.||....
T Consensus 135 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 135 KPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 999999985 78999999999776554444555789999999998755 356889999999999999999999997654
Q ss_pred CH-HHHHH----------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 156 SA-DQIYK----------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 156 ~~-~~~~~----------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.. +...+ +..++.+|+.+||..||++|||++++++||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 215 SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 21 11111 2346789999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=262.05 Aligned_cols=185 Identities=36% Similarity=0.666 Sum_probs=159.1
Q ss_pred cccceeeeceeEEeCCe-----EEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 9 NHPNIVKLRNLVKEHED-----VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~-----~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+|+||+++++++.+.+. .|++|||+.+++.+.+.......+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ni 138 (287)
T cd07838 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNI 138 (287)
T ss_pred CCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhE
Confidence 69999999999988776 9999999998877766654344699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++++ +.+||+|||++.............++..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..+...+
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~ 217 (287)
T cd07838 139 LVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK 217 (287)
T ss_pred EEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH
Confidence 9985 789999999998876554445556788999999986544 58899999999999999999999987765544333
Q ss_pred H--------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I--------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i--------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ...+.+++.+||+.||.+||++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 218 IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 2 2456789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=264.91 Aligned_cols=190 Identities=25% Similarity=0.432 Sum_probs=157.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA--GQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNL 83 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~--~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Ni 83 (297)
.++|+||+++++.+..++..|+||||+.|+.+..+.... ...+++..+..++.||+.||+|||+ .||+||||||+||
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ni 134 (286)
T cd06622 55 KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNV 134 (286)
T ss_pred hcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHE
Confidence 359999999999999999999999999987766666542 2369999999999999999999997 5999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccc-----cCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE-----ICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
++++ +.+||+|||++....... .....++..|+|||.+.+.. .++.++|+||+||++|+|++|+.||......
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 135 LVNGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred EECCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 9985 789999999987654332 24456888999999875432 2477899999999999999999999765443
Q ss_pred HHHHH---------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 158 DQIYK---------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 158 ~~~~~---------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..... +..++.+++.+||..+|++||++++++.||||...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 214 NIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred hHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 32211 12467899999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.81 Aligned_cols=194 Identities=30% Similarity=0.412 Sum_probs=160.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++.+.+++..|+||||+.|+.+..+.... +.+++..+..++.|++.|++|||++|++||||||+||+
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIl 133 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEE
Confidence 34569999999999999999999999999986666666553 46999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC----------------CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS----------------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g 147 (297)
+++ +.+||+|||+++..... .......++..|+|||.+... .++.++|+|||||++|+|++|
T Consensus 134 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g 212 (305)
T cd05609 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVG 212 (305)
T ss_pred ECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhC
Confidence 985 78999999998642110 011234578889999987654 458999999999999999999
Q ss_pred CCCCCCCCCHHHHHHH--------------HHHHHHHHHHhhhcCCCCCCC---HHHHHcCCCCCCCCCC
Q 040202 148 RILFPGKNSADQIYKI--------------YGRWVALISWLCSWNPRMRPT---AAEALEHPFFRSCHFV 200 (297)
Q Consensus 148 ~~pf~~~~~~~~~~~i--------------~~~~~~li~~~l~~dP~~R~t---~~~ll~h~~f~~~~~~ 200 (297)
..||.+....+...++ ...+.+++.+||..||++||+ +.++++||||...++.
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 213 CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 9999877655544433 235789999999999999998 7899999999876553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=261.55 Aligned_cols=184 Identities=20% Similarity=0.301 Sum_probs=153.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.++...++||||++++.++.+..+....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 137 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNIL 137 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEE
Confidence 34459999999999999999999999999988777777655566999999999999999999999999999999999999
Q ss_pred EeC-C-------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH-hCCCCCCCCC
Q 040202 85 VSK-G-------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML-SFRILFPGKN 155 (297)
Q Consensus 85 l~~-~-------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell-~g~~pf~~~~ 155 (297)
+++ + .+|++|||++...... ....++..|+|||++.....++.++||||+||++|+|+ .|..||....
T Consensus 138 l~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 138 LAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred EecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 974 2 3899999998665432 34567889999998865566788999999999999997 5888887654
Q ss_pred CHHHHHH----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 156 SADQIYK----------IYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 156 ~~~~~~~----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..+...- ...++.+++.+||+.||.+||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 215 LAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 3332111 12467899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=256.83 Aligned_cols=188 Identities=30% Similarity=0.574 Sum_probs=159.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.+++.++++|||+.|+ +.+.+....+..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 54 ~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~ 133 (256)
T cd08221 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133 (256)
T ss_pred HhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEE
Confidence 3349999999999999999999999999874 444444433456899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||++....... ......++..|+|||++.+.. .+.++|+||+|+++++|++|+.||...+..+....
T Consensus 134 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 134 LTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred EeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 985 789999999988764433 234567899999999876544 57889999999999999999999988776665544
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ..++.+++.+||..||++||++.++++|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 3 2468999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=260.94 Aligned_cols=191 Identities=31% Similarity=0.498 Sum_probs=161.7
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++.+.+++..|+++||+.|+.+..+..+.+ .+++..+..++.|++.||.|||++|++||||+|+||+++
T Consensus 49 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~ 127 (265)
T cd05579 49 QAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID 127 (265)
T ss_pred hCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc
Confidence 3489999999999999999999999999866666555533 699999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCC---------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 87 K-GVIKIGDLGMVKEIDSSL---------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
+ +.+||+|||++....... ......++..|+|||.+.... .+.++|+||||+++|+|++|..||.....
T Consensus 128 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5 789999999987643321 223456788999999876544 57899999999999999999999987766
Q ss_pred HHHHHHH-------------HHHHHHHHHHhhhcCCCCCCCH---HHHHcCCCCCCCCC
Q 040202 157 ADQIYKI-------------YGRWVALISWLCSWNPRMRPTA---AEALEHPFFRSCHF 199 (297)
Q Consensus 157 ~~~~~~i-------------~~~~~~li~~~l~~dP~~R~t~---~~ll~h~~f~~~~~ 199 (297)
.+....+ ...+.+++.+||+.+|.+|||+ .++++||||++++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 207 EEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 5544433 3578999999999999999999 99999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=264.10 Aligned_cols=191 Identities=22% Similarity=0.410 Sum_probs=155.4
Q ss_pred ccccccccceeeeceeEE-----eCCeEEEEEecCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 4 LRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKE---SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~ll~~~~~---~~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
++++.+|+||+++++++. +++..|+||||++|+.+..+.. ..+..+++..++.++.|++.||.|||+.+|+|
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 147 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH 147 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 445557999999999883 4567999999999866554432 12346899999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|||||+||++++ +.+||+|||+++...... ......|+..|+|||++.. ...++.++||||+||++|+|++|+.
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred cCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 999999999975 789999999988764332 2234568999999998753 2335789999999999999999999
Q ss_pred CCCCCCCHHHHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 150 LFPGKNSADQIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 150 pf~~~~~~~~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
||..........++ ...+.+++.+||+.||++|||+.++++|+||
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 228 PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99876554443221 2358899999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=267.93 Aligned_cols=195 Identities=23% Similarity=0.373 Sum_probs=168.5
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.+++.++.+++|+|||.|-.+..+|||||||+.|+...+..-..+++.|+++..+++..++||+|||...-+|||||..|
T Consensus 80 SIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGN 159 (502)
T KOG0574|consen 80 SIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGN 159 (502)
T ss_pred HHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccccc
Confidence 34556799999999999999999999999999877777776667889999999999999999999999999999999999
Q ss_pred EEEe-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 83 LLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
||++ +|..||+|||.|..+... ....+.+||+.|||||++..-+ |..++||||||++..||..|++||.+-.....+
T Consensus 160 ILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI 238 (502)
T KOG0574|consen 160 ILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI 238 (502)
T ss_pred EEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence 9997 699999999998765432 3447889999999999987655 488999999999999999999999764432222
Q ss_pred --------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 161 --------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 161 --------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
...+.++-+|+++||..+|++|.|+.++++|+|.++..
T Consensus 239 FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 239 FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 23456789999999999999999999999999998653
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=267.36 Aligned_cols=192 Identities=24% Similarity=0.486 Sum_probs=160.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++.+..++..|+||||++|+.+..+..+ ..+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nil 147 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNIL 147 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 3445999999999999999999999999998666666554 45899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH-
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~- 161 (297)
+++ +.+||+|||++........ .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus 148 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred ECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 975 7899999999877644322 234568889999998765 445789999999999999999999997655432211
Q ss_pred -------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 162 -------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 162 -------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
.+...+.+++.+||..||++||++.++++||||+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 22345789999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=270.50 Aligned_cols=195 Identities=22% Similarity=0.373 Sum_probs=153.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.+.++||||++++++|..++..|+||||+.++. .+.+.......+++..+..++.|++.||+|||++||+||||||+|
T Consensus 52 ~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~N 131 (328)
T cd08226 52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131 (328)
T ss_pred HHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3455699999999999999999999999999744 444444333459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCC--------CccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLP--------CTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
|++++ +.+|++|||.+........ .....++..|+|||++.+. ..++.++||||+||++|+|++|..||.
T Consensus 132 ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred EEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99984 7899999986533211100 0112345679999998653 335789999999999999999999997
Q ss_pred CCCCHHHHH----------------------------------------------------------HHHHHHHHHHHHh
Q 040202 153 GKNSADQIY----------------------------------------------------------KIYGRWVALISWL 174 (297)
Q Consensus 153 ~~~~~~~~~----------------------------------------------------------~i~~~~~~li~~~ 174 (297)
+........ .....+.+|+++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 291 (328)
T cd08226 212 DMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291 (328)
T ss_pred CcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 654322221 1234578999999
Q ss_pred hhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 175 CSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 175 l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
|+.||++|||+.++++|+||+...
T Consensus 292 l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 292 LQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred ccCCcccCCCHHHHhhCHHHHHHH
Confidence 999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.84 Aligned_cols=189 Identities=41% Similarity=0.736 Sum_probs=157.2
Q ss_pred cccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 7 MNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.+|+||+++++++... ...|+||||+.+++...+... .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 63 l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nil 139 (337)
T cd07852 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL 139 (337)
T ss_pred hcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 33999999999998643 478999999998776665432 5899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+++ +.+||+|||+++...... ......|+..|+|||++.+...++.++|+||+||++|+|++|+.||.+....
T Consensus 140 l~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~ 219 (337)
T cd07852 140 LNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219 (337)
T ss_pred EcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH
Confidence 985 789999999987654321 2234568999999998876666688999999999999999999999876554
Q ss_pred HHHHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 158 DQIYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 158 ~~~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
+...++ ...+.+++.+||+.||++|||+.++++|+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~ 299 (337)
T cd07852 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299 (337)
T ss_pred HHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhh
Confidence 432221 23468899999999999999999999999998
Q ss_pred CCC
Q 040202 196 SCH 198 (297)
Q Consensus 196 ~~~ 198 (297)
...
T Consensus 300 ~~~ 302 (337)
T cd07852 300 QFH 302 (337)
T ss_pred hhc
Confidence 753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=264.33 Aligned_cols=187 Identities=24% Similarity=0.467 Sum_probs=159.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|++.+.+... ...+++..+..++.|++.||.|||+.||+||||+|+||++
T Consensus 70 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~ 148 (307)
T cd06607 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL 148 (307)
T ss_pred HhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE
Confidence 345999999999999999999999999999887776654 3469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.+||+|||++...... ....++..|+|||++.. ...++.++||||+|+++|+|++|+.||.+.+.......
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~ 225 (307)
T cd06607 149 TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (307)
T ss_pred CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH
Confidence 75 78999999998765433 34567889999998742 34467899999999999999999999977654443322
Q ss_pred -------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 163 -------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 163 -------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
....+.+++.+||..||++||++.+++.|+||..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 2346799999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=260.13 Aligned_cols=188 Identities=25% Similarity=0.424 Sum_probs=156.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..++|+||+.|+.+..+..+. +.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~ 136 (268)
T cd06630 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI 136 (268)
T ss_pred HHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 3459999999999999999999999999987666665543 469999999999999999999999999999999999999
Q ss_pred eC-C-eEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 86 SK-G-VIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 86 ~~-~-~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+. + .+||+|||++....... ......++..|+|||++.. ..++.++|+||+||++++|++|+.||.......
T Consensus 137 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred cCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 74 3 69999999987664321 1123567889999998764 445889999999999999999999997554322
Q ss_pred HHH----------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 159 QIY----------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 159 ~~~----------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
... .+..++.+++.+||..||.+||++.++++||||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 211 1234678999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.37 Aligned_cols=194 Identities=33% Similarity=0.612 Sum_probs=158.3
Q ss_pred ccccccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
++++.+|+||+++++.+.. ....|+++||+++++.+.+... ..+++..++.++.||+.||+|||+.||+|||||
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlk 132 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLK 132 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4455579999999997543 2468999999998887776543 569999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|+||++++ +.+||+|||+++...... ......|+..|+|||++.+...++.++||||+||++|+|++|+.||.+
T Consensus 133 p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 133 PGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred HHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 99999975 789999999997654321 123457899999999876555568899999999999999999999987
Q ss_pred CCCHHHHHH------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 154 KNSADQIYK------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 154 ~~~~~~~~~------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+......+ +...+.+++.+||+.||.+|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 553222111 12357789999999999999999999999
Q ss_pred CCCCCCCC
Q 040202 192 PFFRSCHF 199 (297)
Q Consensus 192 ~~f~~~~~ 199 (297)
||++.++.
T Consensus 293 ~~~~~~~~ 300 (332)
T cd07857 293 PYLAIWHD 300 (332)
T ss_pred hhhhhhcC
Confidence 99987644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=284.43 Aligned_cols=189 Identities=26% Similarity=0.472 Sum_probs=156.8
Q ss_pred cccccceeeeceeEEeCC--------eEEEEEecCCCc-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 7 MNNHPNIVKLRNLVKEHE--------DVFIVFDYMESD-LLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~--------~~~lv~e~~~g~-ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
.++|+||+++++.+...+ .+++||||+.++ +.+.+..+ ....+++..++.++.|++.||+|||+.||+|
T Consensus 87 ~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiH 166 (496)
T PTZ00283 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIH 166 (496)
T ss_pred cCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 358999999998875432 478999999874 54544432 2346999999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
|||||+|||+++ +.+||+|||+++..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 167 rDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred CCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999985 78999999999765432 223456799999999998654 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 152 PGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 152 ~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+.+..+...++. .++.+++.+||..||.+||++.++++|||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 8877655554432 36889999999999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=262.70 Aligned_cols=187 Identities=43% Similarity=0.819 Sum_probs=160.8
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++++.+++..|+|+||+.+++...+.... ..+++..+..++.|++.||+|||+.||+|+||||+||+++
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 132 (283)
T cd05118 54 ELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN 132 (283)
T ss_pred HhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC
Confidence 348999999999999999999999999998877776643 5699999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH--
Q 040202 87 K-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK-- 162 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~-- 162 (297)
+ +.+||+|||.+....... ......++..|+|||.+......+.++|+||+|+++|+|++|+.||.+.+..+...+
T Consensus 133 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5 789999999987765543 233456788999999987654668899999999999999999999987665444322
Q ss_pred ---------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 ---------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 ---------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..++.++|.+||..||.+||++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 23457899999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=260.13 Aligned_cols=187 Identities=26% Similarity=0.454 Sum_probs=154.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+..++.+|+||||++++.+..+..+. ..+++..+..++.|++.||+|||+.||+||||||+||++
T Consensus 61 ~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill 139 (267)
T cd06646 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred HhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 3459999999999999999999999999986665544432 468999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+++...... ......|+..|+|||.+.. ...++.++|+||+||++|||++|+.||......+...
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~ 219 (267)
T cd06646 140 TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219 (267)
T ss_pred CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe
Confidence 85 789999999998764332 2244568899999998742 2335678999999999999999999986543322211
Q ss_pred ----------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 162 ----------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 162 ----------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
.+...+.+++++||..||++|||++++++|+|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 220 LMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred eeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12357889999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.45 Aligned_cols=188 Identities=21% Similarity=0.401 Sum_probs=160.4
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK- 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~- 87 (297)
.|+||+++++++.++...|+||||+.|+.+..+... ..+++..+..++.|++.||.|||+.||+||||+|+||++++
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~ 137 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT 137 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC
Confidence 599999999999999999999999998666666554 36999999999999999999999999999999999999985
Q ss_pred CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH----
Q 040202 88 GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK---- 162 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~---- 162 (297)
+.++|+|||++....... ......|+..|+|||.+..+..++.++|+||+||++|+|++|..||.+.........
T Consensus 138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 217 (277)
T cd06917 138 GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS 217 (277)
T ss_pred CCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC
Confidence 899999999988765432 223456888999999887656668899999999999999999999977654433221
Q ss_pred ---------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 ---------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 ---------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+..++.+++.+||..||++||++.++++|+||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 234688999999999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=257.62 Aligned_cols=188 Identities=31% Similarity=0.569 Sum_probs=158.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++++++..|+|+||+.| ++.+.+....+..+++..+..++.|++.|+.|||++|++|+||+|+||+
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil 133 (256)
T cd08218 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133 (256)
T ss_pred HhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 334999999999999999999999999987 5555555544446899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++. +.++|+|||++........ .....|+..|+|||++.+. ..+.++|+||+||++++|++|..||...+..+...+
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred EcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 985 7899999999976644321 1234578899999997654 457899999999999999999999987666555443
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+ ..++.++|.+||+.+|++||++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 3 2367899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=261.49 Aligned_cols=190 Identities=26% Similarity=0.532 Sum_probs=160.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++..++..|+++||+.|+.+..+... ..+++..+..++.|++.||+|||++||+||||+|+||++
T Consensus 71 ~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~ 148 (285)
T cd06648 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148 (285)
T ss_pred HHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE
Confidence 345899999999999999999999999998666666655 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.++|+|||++....... ......|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+......++
T Consensus 149 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~ 227 (285)
T cd06648 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227 (285)
T ss_pred cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 85 799999999887654332 12345689999999997654 4588999999999999999999999776654443322
Q ss_pred --------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 164 --------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 164 --------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
...+.+++++||..||++|||+.++++|+||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 228 RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 23688999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=258.17 Aligned_cols=189 Identities=26% Similarity=0.370 Sum_probs=154.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNF--SEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l--~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++.+++..|+|+||+.|+.+..........+ ++..+..++.|++.||.|||++||+||||||+||
T Consensus 60 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~ni 139 (268)
T cd06624 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNV 139 (268)
T ss_pred HhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 44599999999999999999999999999865555544433345 8899999999999999999999999999999999
Q ss_pred EEeC--CeEEEEecCCceecCCCC-CCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVSK--GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~--~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+++. +.+||+|||++....... ......|+..|+|||++... ..++.++|+||+|+++|+|++|+.||........
T Consensus 140 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~ 219 (268)
T cd06624 140 LVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219 (268)
T ss_pred EEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence 9974 689999999987654322 22344678999999987543 3367899999999999999999999976443221
Q ss_pred -HHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 160 -IYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 160 -~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..+ +..++++++.+||..+|++|||+.+++.||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 220 AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 111 22367899999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.74 Aligned_cols=190 Identities=40% Similarity=0.706 Sum_probs=155.7
Q ss_pred ccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|+||+++++++... ...|+|+||+.+++.+.+.. +.+++..++.++.|++.||+|||+.||+||||||
T Consensus 58 ~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp 134 (336)
T cd07849 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKP 134 (336)
T ss_pred HhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 344899999999987654 35899999999887766543 4599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
+||++++ +.+||+|||+++...... ......|+..|+|||++.+...++.++||||+||++|+|++|+.||.+.+
T Consensus 135 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 135 SNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred HHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999985 789999999987654322 12345789999999987655556889999999999999999999997654
Q ss_pred CHHHHH------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 156 SADQIY------------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 156 ~~~~~~------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
...... .+..++.+++.+||+.||++|||+.++++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 215 YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred HHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 322111 11235678999999999999999999999999
Q ss_pred CCCCC
Q 040202 194 FRSCH 198 (297)
Q Consensus 194 f~~~~ 198 (297)
|+...
T Consensus 295 ~~~~~ 299 (336)
T cd07849 295 LEQYH 299 (336)
T ss_pred ccccC
Confidence 98654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=271.56 Aligned_cols=192 Identities=41% Similarity=0.738 Sum_probs=157.8
Q ss_pred cccccccceeeeceeEE----eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 5 RKMNNHPNIVKLRNLVK----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~----~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.+.++|+||+++++++. +...+|+||||+.|++.+.+... +.+++..++.++.|++.||.|||++||+||||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 135 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP 135 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 34458999999999886 34578999999988766665443 4599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
+||++++ +.+||+|||+++...... ......|+..|+|||++.....++.++||||+||++|+|++|+.||.+.
T Consensus 136 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 136 SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred HHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 9999985 789999999987654322 1234578999999999766555789999999999999999999999776
Q ss_pred CCHHHHH------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 155 NSADQIY------------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 155 ~~~~~~~------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
+...+.. ....++.++|.+||+.||.+|||+++++.||
T Consensus 216 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred ChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 5332211 1234678899999999999999999999999
Q ss_pred CCCCCC
Q 040202 193 FFRSCH 198 (297)
Q Consensus 193 ~f~~~~ 198 (297)
||+...
T Consensus 296 ~~~~~~ 301 (334)
T cd07855 296 FLAQYH 301 (334)
T ss_pred hhhhcc
Confidence 997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=257.76 Aligned_cols=184 Identities=16% Similarity=0.251 Sum_probs=151.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++||||+++++++..++..++||||+.++.+..+....+..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nil 132 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVL 132 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 44569999999999999999999999999987766666554456899999999999999999999999999999999999
Q ss_pred EeC-C--------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC-CCCCCCC
Q 040202 85 VSK-G--------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGK 154 (297)
Q Consensus 85 l~~-~--------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~ 154 (297)
++. + .++++|||++...... ....++..|+|||++.+...++.++||||+||++|+|++| ..||...
T Consensus 133 i~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 133 LIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred EecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 964 2 2799999998765432 3456788999999987656678899999999999999998 4666555
Q ss_pred CCHHHHHH----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 155 NSADQIYK----------IYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 155 ~~~~~~~~----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
........ ...++.+++.+||+.||++|||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 210 DSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 44333221 12367899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=265.15 Aligned_cols=188 Identities=37% Similarity=0.697 Sum_probs=155.7
Q ss_pred ccccccceeeeceeEEeC--------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 6 KMNNHPNIVKLRNLVKEH--------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.++|+||+++++++.+. ..+|+|+||+.+++...+... +..+++..++.++.|++.||+|||++||+|||
T Consensus 62 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~d 140 (311)
T cd07866 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRD 140 (311)
T ss_pred HhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 345999999999988543 357999999998887776653 34699999999999999999999999999999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCCCCC------------CccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLP------------CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|||+||++++ +.+||+|||+++....... .....+++.|+|||.+.+...++.++||||+||++|+|
T Consensus 141 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el 220 (311)
T cd07866 141 IKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220 (311)
T ss_pred CCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHH
Confidence 9999999985 7899999999876533211 12345688899999877655678899999999999999
Q ss_pred HhCCCCCCCCCCHHHHHHHH-----------------------------------------HHHHHHHHHhhhcCCCCCC
Q 040202 145 LSFRILFPGKNSADQIYKIY-----------------------------------------GRWVALISWLCSWNPRMRP 183 (297)
Q Consensus 145 l~g~~pf~~~~~~~~~~~i~-----------------------------------------~~~~~li~~~l~~dP~~R~ 183 (297)
++|+.||.+.+......++. ..+.+++.+||..||.+||
T Consensus 221 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 221 FTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence 99999998766554333221 2567999999999999999
Q ss_pred CHHHHHcCCCC
Q 040202 184 TAAEALEHPFF 194 (297)
Q Consensus 184 t~~~ll~h~~f 194 (297)
|+.+++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=258.62 Aligned_cols=184 Identities=17% Similarity=0.268 Sum_probs=153.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.++...|+||||++++.++.+.....+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nil 149 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL 149 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEE
Confidence 44569999999999999999999999999998777777654567999999999999999999999999999999999999
Q ss_pred EeC-C-------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH-hCCCCCCCCC
Q 040202 85 VSK-G-------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML-SFRILFPGKN 155 (297)
Q Consensus 85 l~~-~-------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell-~g~~pf~~~~ 155 (297)
+++ + .+|++|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|+.||.+..
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 964 1 4899999987654332 23456888999998876556689999999999999984 7999998765
Q ss_pred CHHHHHHH----------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 156 SADQIYKI----------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 156 ~~~~~~~i----------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..+..... ...+.+++.+||+.+|++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 44322211 1367899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=255.62 Aligned_cols=188 Identities=29% Similarity=0.499 Sum_probs=159.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++.+|+++||++|+.+..+..+. ..+++..+..++.|++.|+.|||+.||+|+||+|+||++
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~ 135 (258)
T cd06632 57 SKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135 (258)
T ss_pred HhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 3459999999999999999999999999986666555543 358999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI- 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i- 163 (297)
++ +.+||+|||++.............|+..|++||.+.....++.++|+||+||++|+|++|+.||......+...++
T Consensus 136 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 215 (258)
T cd06632 136 DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215 (258)
T ss_pred CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH
Confidence 74 7899999999887655443456678999999998765443688999999999999999999999776654443332
Q ss_pred ------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 ------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 ------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..++.+++++||..+|++||++.+++.|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 2367899999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.52 Aligned_cols=192 Identities=39% Similarity=0.690 Sum_probs=161.8
Q ss_pred ccccccceeeeceeEEeCC-----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|+||+++++++.+.+ .+|+||||+.+++.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp 131 (330)
T cd07834 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP 131 (330)
T ss_pred HhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 3448999999999998775 89999999998766665543 3699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
+||++++ +.++|+|||++....... ......++..|+|||++.+...++.++|+||+|+++|+|++|..||.+.+
T Consensus 132 ~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred HHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 9999985 799999999998765543 23456778999999998766467899999999999999999999998766
Q ss_pred CHHHHHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 156 SADQIYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 156 ~~~~~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
..+....+ ...+.+++.+||+.||.+|||++++++|||
T Consensus 212 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 54332221 234678999999999999999999999999
Q ss_pred CCCCCC
Q 040202 194 FRSCHF 199 (297)
Q Consensus 194 f~~~~~ 199 (297)
|++...
T Consensus 292 ~~~~~~ 297 (330)
T cd07834 292 LAQLHD 297 (330)
T ss_pred HHhhcc
Confidence 987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.70 Aligned_cols=190 Identities=35% Similarity=0.675 Sum_probs=157.3
Q ss_pred ccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|+||+++++++... ...|+|+||+.+++.+.+... +.+++..+..++.|++.||+|||++|++||||||
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp 136 (337)
T cd07858 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKP 136 (337)
T ss_pred HhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH
Confidence 345899999999988654 358999999998887776543 5699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+||+++. +.+||+|||+++..... .......++..|+|||++.....++.++||||+||++|+|++|+.||.+.+...
T Consensus 137 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 216 (337)
T cd07858 137 SNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216 (337)
T ss_pred HHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 9999984 78999999999866443 223455678899999987655557899999999999999999999997654221
Q ss_pred HHH------------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIY------------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~------------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
... .+..++.+++++||+.||++|||++++++||||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 110 12235679999999999999999999999999976
Q ss_pred C
Q 040202 197 C 197 (297)
Q Consensus 197 ~ 197 (297)
.
T Consensus 297 ~ 297 (337)
T cd07858 297 L 297 (337)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=262.26 Aligned_cols=188 Identities=25% Similarity=0.484 Sum_probs=160.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+.+..|+||||+.|++++.+... +..+++..+..++.|++.|+.|||++|++||||+|+||++
T Consensus 76 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili 154 (313)
T cd06633 76 QQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154 (313)
T ss_pred HhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE
Confidence 344899999999999999999999999999888776654 3569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.+||+|||++..... .....|+..|+|||++.. ...++.++||||+||++|+|++|..||...+......+
T Consensus 155 ~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~ 231 (313)
T cd06633 155 TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231 (313)
T ss_pred CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 75 7899999999865432 245678899999998742 34467889999999999999999999987665554443
Q ss_pred HH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 IY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+. ..+.+++.+||+.+|.+||++.++++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 32 357899999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=259.56 Aligned_cols=188 Identities=36% Similarity=0.692 Sum_probs=158.5
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++.+. +..|+|+||+++++.+.+... ...+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ni 131 (287)
T cd07840 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNI 131 (287)
T ss_pred HhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 344899999999999988 899999999998777666544 34699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++++ +.+||+|||++....... ......++..|+|||.+.+...++.++||||||+++++|++|+.||...+.....
T Consensus 132 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 132 LINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred EEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9985 789999999998765442 2234566888999998776555688999999999999999999999876654332
Q ss_pred HHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 161 YKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 161 ~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.++ ...+.+++++||..||.+||++.++++|+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 221 2356789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.19 Aligned_cols=186 Identities=26% Similarity=0.448 Sum_probs=159.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++.+++++..|+|+||+.|+.+....... ..+++..+..++.||+.||.|||++|++|+||+|+||+++
T Consensus 56 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 134 (258)
T cd05578 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134 (258)
T ss_pred hCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc
Confidence 349999999999999999999999999986666655543 4699999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---HHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS---ADQIYK 162 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~~~ 162 (297)
+ +.++|+|||++.............|+..|+|||++.... ++.++|+||+|+++|+|++|+.||...+. ......
T Consensus 135 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (258)
T cd05578 135 EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213 (258)
T ss_pred CCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH
Confidence 5 789999999988766554445567888999999876544 68899999999999999999999987764 222222
Q ss_pred -----------HHHHHHHHHHHhhhcCCCCCCCH--HHHHcCCCC
Q 040202 163 -----------IYGRWVALISWLCSWNPRMRPTA--AEALEHPFF 194 (297)
Q Consensus 163 -----------i~~~~~~li~~~l~~dP~~R~t~--~~ll~h~~f 194 (297)
....+.++|++||..||.+|+++ .|+++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 214 QETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 22478999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=258.96 Aligned_cols=188 Identities=22% Similarity=0.414 Sum_probs=158.2
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++++.+++..|+||||++|+.+..+... +.+++..+..++.|++.||+|||++|++|+||+|+||+++
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~ 135 (277)
T cd06640 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135 (277)
T ss_pred hCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc
Confidence 34999999999999999999999999998665555543 4589999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH---
Q 040202 87 K-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY--- 161 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~--- 161 (297)
+ +.++|+|||++....... ......++..|+|||++.+. ..+.++|+||+||++|+|++|..||.+........
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 214 (277)
T cd06640 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP 214 (277)
T ss_pred CCCCEEEcccccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh
Confidence 5 789999999997765432 22334678899999987654 45889999999999999999999997665443322
Q ss_pred ---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 ---------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ---------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+...+.+++.+||..+|++||++.++++|+||...
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 234568899999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=261.02 Aligned_cols=190 Identities=25% Similarity=0.505 Sum_probs=160.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+++..|+||||+.++.+..+... ..+++..++.++.|++.||+|||+.|++||||+|+||++
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv 149 (292)
T cd06657 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149 (292)
T ss_pred HhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 445899999999999999999999999998777666654 358999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.++|+|||++....... ......|+..|+|||.+... .++.++|+||+|+++|+|++|..||.+.........
T Consensus 150 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 150 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred CCCCCEEEcccccceecccccccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 789999999987654332 12345678999999987644 457899999999999999999999987655443222
Q ss_pred -------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 -------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 -------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+...+.+++.+||..||.+||++.++++|+||....
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 234678999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=256.32 Aligned_cols=181 Identities=28% Similarity=0.422 Sum_probs=150.1
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
.||||+++++++.+++..|+||||+.|+ +.+.+... ..+++..+..++.|++.||+|||+.||+||||||+||++++
T Consensus 43 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~ 120 (237)
T cd05576 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD 120 (237)
T ss_pred CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC
Confidence 6999999999999999999999999975 44555443 45999999999999999999999999999999999999985
Q ss_pred -CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH-------H
Q 040202 88 -GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD-------Q 159 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-------~ 159 (297)
+.++++|||.+....... ....++..|+|||.+... .++.++|+||+||++|+|++|+.++....... .
T Consensus 121 ~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 197 (237)
T cd05576 121 RGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI 197 (237)
T ss_pred CCCEEEecccchhcccccc--ccCCcCccccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCC
Confidence 789999999887665432 345567889999987544 34789999999999999999998875432211 1
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHcCCCC
Q 040202 160 IYKIYGRWVALISWLCSWNPRMRPTA-----AEALEHPFF 194 (297)
Q Consensus 160 ~~~i~~~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f 194 (297)
...+...+.+++.+||+.||++|+++ +++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 11234578899999999999999986 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=252.72 Aligned_cols=194 Identities=24% Similarity=0.391 Sum_probs=165.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~N 82 (297)
+.+.-..|+||+.+|+|..+...++-||.|.. .++.++.+..++++|..+-++...++.||.||-+ +||+|||+||.|
T Consensus 144 v~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 144 VLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred HhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 34444579999999999999999999998874 3334444445679999999999999999999996 589999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCC-CHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKN-SAD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~~~ 158 (297)
||+|+ |++|++|||.+-.+..+...+...|.+.|||||.+.- ...|+.++||||||+.++||.||+.||.+.+ +.+
T Consensus 223 ILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred eEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 99996 9999999999998888777788899999999998753 3457889999999999999999999998844 455
Q ss_pred HHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 159 QIYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 159 ~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.+.++. ..+++|+..||..|+.+||.-.++|+|||++...
T Consensus 303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 565554 3689999999999999999999999999997543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=255.68 Aligned_cols=208 Identities=28% Similarity=0.477 Sum_probs=169.3
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
-.+||++|-++.+|+++..+++|.||++|+.+-+..++. ..++|+.++.|..+|+.||.|||++||++||+|.+|+|+|
T Consensus 307 asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 307 ASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred ccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 458999999999999999999999999986554444432 4599999999999999999999999999999999999998
Q ss_pred -CCeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC-------CCCH
Q 040202 87 -KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG-------KNSA 157 (297)
Q Consensus 87 -~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~-------~~~~ 157 (297)
+|++||+|||++++- ..+....++||||.|+|||++.+ ..|+..+|+|+|||+++||+.|+.||+- .+..
T Consensus 386 aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte 464 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE 464 (593)
T ss_pred cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh
Confidence 599999999999874 45566689999999999999875 4569999999999999999999999952 2333
Q ss_pred HHHHHHHH------------HHHHHHHHhhhcCCCCCCC------HHHHHcCCCCCCCCCC--------CCCCCccCCCc
Q 040202 158 DQIYKIYG------------RWVALISWLCSWNPRMRPT------AAEALEHPFFRSCHFV--------PRSVPLLCNNF 211 (297)
Q Consensus 158 ~~~~~i~~------------~~~~li~~~l~~dP~~R~t------~~~ll~h~~f~~~~~~--------~~~~~~~~~~~ 211 (297)
+.+.++.- ....+++..|++||.+|.. ..++..|+||+.++|. |+..|....+.
T Consensus 465 dylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~ 544 (593)
T KOG0695|consen 465 DYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDY 544 (593)
T ss_pred HHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCcccccc
Confidence 33433321 3456889999999999965 5799999999988873 44445444444
Q ss_pred ccCCC
Q 040202 212 EAVAF 216 (297)
Q Consensus 212 ~~~~~ 216 (297)
...+|
T Consensus 545 ~l~~f 549 (593)
T KOG0695|consen 545 GLDNF 549 (593)
T ss_pred Ccccc
Confidence 44444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=271.33 Aligned_cols=186 Identities=24% Similarity=0.413 Sum_probs=149.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc-------------------------------------
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA------------------------------------- 45 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~------------------------------------- 45 (297)
++++.+|+|||++++++.+.+..|+||||+.+ ++.+.+....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 34445899999999999999999999999987 5555443321
Q ss_pred -------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEE
Q 040202 46 -------------------------------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIG 93 (297)
Q Consensus 46 -------------------------------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~ 93 (297)
...+++..++.++.|++.||+|||++||+||||||+|||+++ +.+||+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~ 254 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKIC 254 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEe
Confidence 124788999999999999999999999999999999999985 789999
Q ss_pred ecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH------
Q 040202 94 DLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI------ 163 (297)
Q Consensus 94 Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i------ 163 (297)
|||+++....... ..+..++..|+|||++.. ..++.++||||+||++|+|++ |+.||..........+.
T Consensus 255 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~ 333 (374)
T cd05106 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333 (374)
T ss_pred eceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence 9999987543321 122334567999999764 446899999999999999997 99999876544333222
Q ss_pred -------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 164 -------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 164 -------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..++.+++.+||+.||++|||+.++++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 246889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=257.81 Aligned_cols=182 Identities=21% Similarity=0.300 Sum_probs=151.7
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
++||||+++++++..++..|+||||+++++++.+....+..+++..++.++.|++.||+|||++|++||||||+||++++
T Consensus 63 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~ 142 (266)
T cd05064 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS 142 (266)
T ss_pred CCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC
Confidence 49999999999999999999999999998777766654456999999999999999999999999999999999999975
Q ss_pred -CeEEEEecCCceecCCCCCCc--cccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Q 040202 88 -GVIKIGDLGMVKEIDSSLPCT--DYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI 163 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i 163 (297)
+.+|++|||.+.......... ...++..|+|||++.+. .++.++||||+||++||+++ |+.||.+.+..+....+
T Consensus 143 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05064 143 DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221 (266)
T ss_pred CCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 789999999876543322111 22346789999987654 45889999999999999775 99999877766554443
Q ss_pred H------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 164 Y------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 164 ~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
. ..+.+++.+|++.+|.+||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 2 36789999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=280.14 Aligned_cols=189 Identities=26% Similarity=0.407 Sum_probs=153.1
Q ss_pred ccccccccccceeeecee-EE---e-C--CeEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 040202 2 IFLRKMNNHPNIVKLRNL-VK---E-H--EDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG- 72 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~-~~---~-~--~~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g- 72 (297)
.+|+++.+|+|||.|+|. .. . + -.++|+||||. |++++.+..+...+|+|.++.+|+.|++.||.+||...
T Consensus 86 ~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p 165 (738)
T KOG1989|consen 86 DIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP 165 (738)
T ss_pred HHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC
Confidence 456677779999999993 32 1 1 25789999999 59999999876667999999999999999999999998
Q ss_pred -ccccCCCCCcEEEe-CCeEEEEecCCceecCCCCCCc----------cccccCCCCCCceec--ccccCCCccchhhHH
Q 040202 73 -YFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCT----------DYVTTRWYRAPEVLL--LSEICGPEVDRWAMG 138 (297)
Q Consensus 73 -i~Hrdikp~Nill~-~~~~kl~Dfgla~~~~~~~~~~----------~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG 138 (297)
|||||||-|||||+ +|.+||||||.|...-...... ...-|+.|+|||++. .+...++|+|||+||
T Consensus 166 PiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG 245 (738)
T KOG1989|consen 166 PIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG 245 (738)
T ss_pred ccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence 99999999999997 4889999999986543222100 123489999999975 233458999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHH---------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 139 AIMFEMLSFRILFPGKNSADQI---------YKIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 139 v~l~ell~g~~pf~~~~~~~~~---------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|+||.|+.+..||.+.-....+ .+.+..+.+||+.||+.||++||+|.+++.
T Consensus 246 clLYkLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 246 CLLYKLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred HHHHHHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 9999999999999876333221 255678899999999999999999998874
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=256.11 Aligned_cols=187 Identities=26% Similarity=0.439 Sum_probs=150.7
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++.+ ++.+|+++||+.++.+....... +.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni 137 (266)
T cd06651 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI 137 (266)
T ss_pred HHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 34499999999999875 46789999999875554444432 4589999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++++ +.+||+|||+++..... .......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.......
T Consensus 138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 9985 68999999998765321 111234578899999987654 45789999999999999999999998765554
Q ss_pred HHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 159 QIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 159 ~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
...++ ...+.+++ +|+..+|++||+++++++||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 217 AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 44332 23467787 56668999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=250.15 Aligned_cols=192 Identities=33% Similarity=0.606 Sum_probs=165.0
Q ss_pred ccccccccceeeeceeEEe--------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 4 LRKMNNHPNIVKLRNLVKE--------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~--------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
++.+++|+|++.++++|.. ...+|+||++|..++...+... ...|+..++.+++.+++.||.|+|.+.|+|
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilH 147 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILH 147 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHh
Confidence 4455699999999999853 3358999999998777655443 346999999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCC-----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
||+|++|+||++ |.+||+|||+++.+... ...+..+.|.+|..||.+.+.+.|+.+.|||..|||+.||+++.+
T Consensus 148 RDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 148 RDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred hcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 999999999996 89999999999765322 223556779999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH----------------------------------------------HHHHHHHHhhhcCCCCCC
Q 040202 150 LFPGKNSADQIYKIYG----------------------------------------------RWVALISWLCSWNPRMRP 183 (297)
Q Consensus 150 pf~~~~~~~~~~~i~~----------------------------------------------~~~~li~~~l~~dP~~R~ 183 (297)
.+.+.+...++.-|+. +..+|+.+||..||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 9999888777665542 357899999999999999
Q ss_pred CHHHHHcCCCCCC
Q 040202 184 TAAEALEHPFFRS 196 (297)
Q Consensus 184 t~~~ll~h~~f~~ 196 (297)
.++++++|.||..
T Consensus 308 ~ad~alnh~~F~k 320 (376)
T KOG0669|consen 308 DADQALNHDFFWK 320 (376)
T ss_pred chHhhhchhhhhc
Confidence 9999999999964
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=260.17 Aligned_cols=188 Identities=36% Similarity=0.675 Sum_probs=156.5
Q ss_pred ccccccceeeeceeEEeCC----------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 6 KMNNHPNIVKLRNLVKEHE----------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~----------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++||||+++++++.+.. .+|+|+||+++++++.+... ...+++..++.++.|++.||.|||++||+|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H 139 (302)
T cd07864 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139 (302)
T ss_pred HhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3458999999999987654 89999999999888776654 346999999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
|||||+||++++ +.+||+|||++....... ......++..|+|||++.....++.++||||+||++++|++|+.||.
T Consensus 140 ~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred CCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999985 789999999987654332 22334567889999987655556889999999999999999999997
Q ss_pred CCCCHHHHHH-----------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 153 GKNSADQIYK-----------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 153 ~~~~~~~~~~-----------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..+..+.... +...+.+++.+||..||.+|||+.+++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 220 ANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 6554332211 23467899999999999999999999999
Q ss_pred CCC
Q 040202 192 PFF 194 (297)
Q Consensus 192 ~~f 194 (297)
|||
T Consensus 300 ~~~ 302 (302)
T cd07864 300 PWL 302 (302)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=258.35 Aligned_cols=188 Identities=29% Similarity=0.488 Sum_probs=157.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill 85 (297)
.++|+||+++++.+..++..|+++||+.|+.+..+.......+++..+..++.|++.|++|||+ .|++||||||+||++
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~ 134 (265)
T cd06605 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV 134 (265)
T ss_pred HCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE
Confidence 3479999999999999999999999999766666665543679999999999999999999999 999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC-----CHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN-----SADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-----~~~~ 159 (297)
++ +.+||+|||.+........ ....++..|+|||.+.+. .++.++|+||+|+++++|++|..||.... ..+.
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (265)
T cd06605 135 NSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL 212 (265)
T ss_pred CCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH
Confidence 85 7899999999876543222 226788899999987654 56889999999999999999999997542 1122
Q ss_pred HHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 IYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
... +...++++|.+||..||++|||+.+++.||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 213 LQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 211 2346899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=253.58 Aligned_cols=184 Identities=27% Similarity=0.443 Sum_probs=151.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+..|+||||+.|+.+..+.......+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i 133 (256)
T cd05114 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133 (256)
T ss_pred HHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE
Confidence 34599999999999999999999999998755544444333458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||.++........ ....++..|+|||++... .++.++|+||+|+++|+|++ |+.||...+..+...
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05114 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212 (256)
T ss_pred cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 75 78999999998765432211 122345679999997644 45889999999999999999 999998877666655
Q ss_pred HHHH------------HHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIYG------------RWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+.. .+.+++.+|+..||++||+++++++
T Consensus 213 ~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 213 MISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5432 5789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=256.73 Aligned_cols=188 Identities=39% Similarity=0.730 Sum_probs=159.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+.+..|+|+||+++++.+.+... ...+++..+..++.|++.||+|||++||+||||+|+||++
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~ 131 (282)
T cd07829 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131 (282)
T ss_pred HhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE
Confidence 344899999999999999999999999998776666554 2469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++...... ......++..|+|||.+.....++.++|+||+||++++|++|+.||.+.+..+...++
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 132 NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 85 789999999987764432 2234456788999999876656688999999999999999999999876654433222
Q ss_pred ----------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 ----------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 ----------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...+.+++++||..||.+||++++++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 2357889999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=260.74 Aligned_cols=189 Identities=22% Similarity=0.394 Sum_probs=158.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+..++..|+||||++|+.+..+... ..+++..++.++.|++.|+.|||++|++|+||+|+||++
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i 134 (277)
T cd06642 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL 134 (277)
T ss_pred HcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE
Confidence 335899999999999999999999999998666555543 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.+||+|||++........ .....|+..|+|||.+.+. .++.++|+||+||++++|++|+.||...........
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 75 7899999999877654321 2234678899999997654 457899999999999999999999976544433322
Q ss_pred -----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 -----------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 -----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+...+.+++.+|+..+|++||++.++++|+||+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 23467899999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=266.49 Aligned_cols=189 Identities=34% Similarity=0.644 Sum_probs=153.5
Q ss_pred ccccccceeeeceeEEeC--------------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 040202 6 KMNNHPNIVKLRNLVKEH--------------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--------------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~ 71 (297)
+.++||||+++++++... ...|+||||+++++.+.+.. ..+++..++.++.||+.||+|||+.
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~ 133 (342)
T cd07854 57 RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA 133 (342)
T ss_pred HhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 344999999999877654 36899999999876655532 4599999999999999999999999
Q ss_pred CccccCCCCCcEEEeC--CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH
Q 040202 72 GYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 72 gi~Hrdikp~Nill~~--~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 145 (297)
||+||||||+||+++. +.+||+|||+++...... ......++..|+|||++.....++.++||||+||++|+|+
T Consensus 134 givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 134 NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence 9999999999999973 578999999997653321 1123457889999998766566788999999999999999
Q ss_pred hCCCCCCCCCCHHHHHH-----------------------------------------HHHHHHHHHHHhhhcCCCCCCC
Q 040202 146 SFRILFPGKNSADQIYK-----------------------------------------IYGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 146 ~g~~pf~~~~~~~~~~~-----------------------------------------i~~~~~~li~~~l~~dP~~R~t 184 (297)
+|+.||.+.+..+.... +..++++|+.+||+.||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 99999976654333221 1235678999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 040202 185 AAEALEHPFFRSC 197 (297)
Q Consensus 185 ~~~ll~h~~f~~~ 197 (297)
+.++++||||+..
T Consensus 294 ~~ell~h~~~~~~ 306 (342)
T cd07854 294 AEEALMHPYMSCY 306 (342)
T ss_pred HHHHhCCCccccc
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=253.84 Aligned_cols=188 Identities=26% Similarity=0.475 Sum_probs=156.3
Q ss_pred ccccccceeeeceeEE--eCCeEEEEEecCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccc
Q 040202 6 KMNNHPNIVKLRNLVK--EHEDVFIVFDYMESDLLKLMKESA---GQNFSEDEARNLCFQVFQGLHYMH-----RQGYFH 75 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~--~~~~~~lv~e~~~g~ll~~~~~~~---~~~l~e~~~~~~~~qll~al~yLH-----~~gi~H 75 (297)
+.++|+||+++++.+. .+...|++|||+.++.+..+.... +..+++..++.++.||+.||+||| +.+++|
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h 133 (265)
T cd08217 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133 (265)
T ss_pred HhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCccee
Confidence 3459999999999875 345789999999875554444332 356999999999999999999999 899999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|||||+||++++ +.+||+|||++........ .....++..|+|||++.... ++.++|+||||+++++|++|..||..
T Consensus 134 ~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 134 RDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccC
Confidence 999999999985 8999999999987765443 34567899999999976544 57889999999999999999999988
Q ss_pred CCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 154 KNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 154 ~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+.......+ ...+.+++.+||..+|++||++.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 7644433332 2467899999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=260.64 Aligned_cols=183 Identities=23% Similarity=0.323 Sum_probs=146.9
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHH
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG------------------QNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~------------------~~l~e~~~~~~~~qll~al~yL 68 (297)
.++||||+++++++.+.+..|+||||+.++.+..+..... ..+++..+..++.||+.||.||
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred hcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 3499999999999999999999999998755544443211 2367888999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|+.||+||||||+|||+++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|+|
T Consensus 155 H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEI 233 (304)
T ss_pred HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHH
Confidence 9999999999999999985 789999999998654322 12334457789999987654 468899999999999999
Q ss_pred Hh--CCCCCCCCCCHHHHHHH-------------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 145 LS--FRILFPGKNSADQIYKI-------------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 145 l~--g~~pf~~~~~~~~~~~i-------------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
++ +..||.+.+..+....+ ...+.+++.+|++.||++|||+.++.+
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 86 66788776554443322 135789999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.66 Aligned_cols=188 Identities=30% Similarity=0.485 Sum_probs=156.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++...+..++||||+.|+.+..+.... +.+++..++.++.|++.||.|||++|++||||+|+||++
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~ 141 (272)
T cd06629 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV 141 (272)
T ss_pred HhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE
Confidence 3448999999999999999999999999886655555443 469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSE-ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++ +.++|+|||+++..... .......|+..|+|||++.... .++.++|+||+|+++++|++|..||......+..
T Consensus 142 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 221 (272)
T cd06629 142 DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221 (272)
T ss_pred cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence 74 78999999998765322 1123456788999999876543 3578999999999999999999999765544333
Q ss_pred HH-----------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 161 YK-----------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 161 ~~-----------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+ +...+.+++.+||..||++|||++++++|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 222 FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 22 13468899999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=260.26 Aligned_cols=187 Identities=24% Similarity=0.376 Sum_probs=150.5
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA--------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.++.+||||+++++++.+.+..|+||||+.+ ++.+.+.... ...+++..++.++.|++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45665899999999999999999999999987 4455544321 12488999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS- 146 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~- 146 (297)
|++||+||||||+|||+++ +.+||+|||++..............+..|+|||++... .++.++|||||||++|||++
T Consensus 136 H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~ 214 (297)
T cd05089 136 SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSL 214 (297)
T ss_pred HHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999999975 78999999998654322111222234579999987644 45889999999999999997
Q ss_pred CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|..||.+....+...++. ..+.+++.+||+.||.+|||++++++.
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 215 GGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999998876655444432 367899999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=266.01 Aligned_cols=187 Identities=41% Similarity=0.685 Sum_probs=154.3
Q ss_pred cccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 7 MNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.++|+||+++++++... ..+|+|+||+.+.+.... +..+++..+..++.|++.||+|||+.||+||||||
T Consensus 70 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp 145 (342)
T cd07879 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP 145 (342)
T ss_pred hcCCCCccchhheecccccCCCCceEEEEecccccCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 35999999999998754 356999999987554332 24599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+||++++ +.+||+|||+++..... .....++..|+|||++.+...++.++|+||+||++|||++|+.||.+.+....
T Consensus 146 ~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~ 223 (342)
T cd07879 146 GNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223 (342)
T ss_pred HHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999975 78999999998765432 23456788999999987655568899999999999999999999987654332
Q ss_pred HHH------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYK------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+ ...++.++|++||+.||.+||++++++.||||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 224 LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 221 11246799999999999999999999999999875
Q ss_pred CC
Q 040202 198 HF 199 (297)
Q Consensus 198 ~~ 199 (297)
..
T Consensus 304 ~~ 305 (342)
T cd07879 304 RD 305 (342)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=261.32 Aligned_cols=181 Identities=29% Similarity=0.519 Sum_probs=159.3
Q ss_pred eeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-----
Q 040202 13 IVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----- 87 (297)
Q Consensus 13 Iv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~----- 87 (297)
+|.+.++|+-.++.+||+|.++-++++.+..+...+++...++.+.+||+.+++|||+++++|-||||||||+.+
T Consensus 153 cv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 788899999999999999999989999998877778999999999999999999999999999999999999721
Q ss_pred -----C-----------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 88 -----G-----------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 88 -----~-----------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
. .+||+|||.|+.....- .+.+.|+.|.|||++.+-+. +.++||||+||||+|+.+|...|
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceec
Confidence 1 48999999998876554 67788999999999987665 89999999999999999999999
Q ss_pred CCCCCHHH---HHHHHH------------------------------------------------------HHHHHHHHh
Q 040202 152 PGKNSADQ---IYKIYG------------------------------------------------------RWVALISWL 174 (297)
Q Consensus 152 ~~~~~~~~---~~~i~~------------------------------------------------------~~~~li~~~ 174 (297)
++.++.+. ..+|.+ .+.+|+++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 98876663 222211 357899999
Q ss_pred hhcCCCCCCCHHHHHcCCCCCC
Q 040202 175 CSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 175 l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
|..||.+|+|+.|+|.||||+.
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HccCccccccHHHHhcCHHhhc
Confidence 9999999999999999999975
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=257.11 Aligned_cols=194 Identities=25% Similarity=0.395 Sum_probs=156.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG---------QNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~---------~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
.+.++|+||+++++++.+++..|+||||+.++.+..+..+.+ ..++...+..++.|++.||.|||++||+|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 344599999999999999999999999998755554443321 22466788999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRIL 150 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~p 150 (297)
|||||+||++++ +.+||+|||+++....... .....++..|+|||.+... .++.++|+||+||++|||++ |+.|
T Consensus 143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p 221 (288)
T cd05061 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQP 221 (288)
T ss_pred CCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999985 7899999999876533211 1223456779999987654 45889999999999999998 7889
Q ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc------CCCCCCCCC
Q 040202 151 FPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE------HPFFRSCHF 199 (297)
Q Consensus 151 f~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~------h~~f~~~~~ 199 (297)
|.+....+....+ ...+.+++.+||+.||++|||+.++++ ||||++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 222 YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 9876655544333 246889999999999999999999876 999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=260.92 Aligned_cols=192 Identities=26% Similarity=0.499 Sum_probs=160.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++.+..++..|+|+||+.|+.+..+..+ ..+++..+..++.|++.|+.|||++|++||||||+||++
T Consensus 71 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili 148 (293)
T cd06647 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148 (293)
T ss_pred hhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence 345899999999999999999999999998666666554 348999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH--
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-- 161 (297)
++ +.+||+|||++....... ......+++.|+|||.+... .++.++|+||+||++|++++|+.||...+..+...
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~ 227 (293)
T cd06647 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (293)
T ss_pred cCCCCEEEccCcceecccccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence 85 789999999887654332 22344678899999987654 45789999999999999999999998765443322
Q ss_pred ------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCC
Q 040202 162 ------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 162 ------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~ 200 (297)
.+...+.+++++||..+|++||++.+++.|+||+.....
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 223468899999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=262.58 Aligned_cols=187 Identities=24% Similarity=0.384 Sum_probs=150.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESA--------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.++.+|+||+++++++.+++..|+||||+.++. .+.+.... +..+++..++.++.|++.||+||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4556689999999999999999999999998754 44443321 12588999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS- 146 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~- 146 (297)
|++|++||||||+|||+++ +.+||+|||+++............++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 141 H~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 141 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred HhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhc
Confidence 9999999999999999975 7899999999864332211122234567999998754 446889999999999999998
Q ss_pred CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|..||.+.+..+....+ ...+.+++.+||+.+|++||++++++.+
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999876655544333 2367899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.82 Aligned_cols=185 Identities=23% Similarity=0.377 Sum_probs=152.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESAG--------------QNFSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~~--------------~~l~e~~~~~~~~qll~al~yLH~ 70 (297)
+.++||||+++++++.+.+..|++|||+.++. .+.+..... ..+++..+..++.|++.||.|||+
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~ 142 (283)
T cd05048 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred HhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34599999999999999999999999998754 444443211 348899999999999999999999
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
+|++||||||+||++++ +.+||+|||+++...... ......+++.|+|||.+.... ++.++|||||||++|||++
T Consensus 143 ~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~ 221 (283)
T cd05048 143 HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFS 221 (283)
T ss_pred CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHc
Confidence 99999999999999975 689999999997653321 223445678899999876544 5889999999999999998
Q ss_pred -CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 -FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|..||.+.+..+....+. .++.+++.+|++.||++||++.+++++
T Consensus 222 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 222 YGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999998877666555442 367899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=253.22 Aligned_cols=188 Identities=32% Similarity=0.583 Sum_probs=156.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+.+++..|+|+||+.+ .+.+.+....+..+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 54 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil 133 (257)
T cd08225 54 AKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133 (257)
T ss_pred HhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 445899999999999999999999999987 5555555444445899999999999999999999999999999999999
Q ss_pred EeCC--eEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VSKG--VIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~~--~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++++ .+||+|||.+........ .....|+..|+|||++... .++.++|+||+||++++|++|..||...+..+...
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 134 LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred EcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 9753 579999999876654322 1234578899999987644 45789999999999999999999998766555444
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+ ...+.+++.+|+..+|++|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 33 2368899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.60 Aligned_cols=185 Identities=24% Similarity=0.434 Sum_probs=153.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+..|+||||+.++.+..+....+..+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili 133 (256)
T cd05113 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133 (256)
T ss_pred hcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE
Confidence 44599999999999999999999999998865555555444469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||.++........ ....++..|+|||++.... ++.++|||||||++|+|++ |..||...+..+...
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05113 134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212 (256)
T ss_pred cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 85 78999999998765443211 1223456799999876544 5889999999999999998 999998776655444
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++. ..+++++.+||..||.+||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 213 KVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 443 267899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=259.21 Aligned_cols=186 Identities=25% Similarity=0.450 Sum_probs=159.0
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++++.+++..|+||||+.|++++.+... +..+++..+..++.|++.|+.|||++||+||||+|+||+++
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~ 159 (317)
T cd06635 81 RIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 159 (317)
T ss_pred hCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC
Confidence 34899999999999999999999999999877766544 45699999999999999999999999999999999999997
Q ss_pred C-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+ +.+||+|||++...... ....|+..|+|||++.. ...++.++|+||+||++|+|++|..||.+.+.......+
T Consensus 160 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 236 (317)
T cd06635 160 EPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236 (317)
T ss_pred CCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 5 78999999998765432 35568899999998742 344678999999999999999999999876655444433
Q ss_pred -------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 -------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 -------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...+.+++.+||+.+|.+||++.++++|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 235789999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=252.76 Aligned_cols=185 Identities=28% Similarity=0.526 Sum_probs=155.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+.+++.+|++|||+.+ ++.+.+....+..+++..++.++.|++.||.|||++||+|+||||+||+
T Consensus 53 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nil 132 (255)
T cd08219 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132 (255)
T ss_pred HhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 345999999999999999999999999987 5555555544556899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.++++|||+++...... ......|+..|+|||++.+. .++.++|+||+|+++|+|++|..||...+.......
T Consensus 133 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 133 LTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 975 789999999987664422 22345688999999987654 458899999999999999999999987765554443
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+ ...+.+++.+||+.||++|||+.+++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 212 VCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 3 2367899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.66 Aligned_cols=184 Identities=26% Similarity=0.439 Sum_probs=156.1
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA--------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~--------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.++|+||+++++++.+++..++||||+.|+.+..+.... +..+++..++.++.|++.||+|||++|++||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di 131 (262)
T cd00192 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDL 131 (262)
T ss_pred hcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCcc
Confidence 347999999999999999999999999775555555443 356999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPG 153 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~ 153 (297)
||+||++++ +.+||+|||.+...... .......++..|+|||.+... .++.++||||+||++|+|++ |..||..
T Consensus 132 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 132 AARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred CcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 999999986 89999999999876553 223445678899999987654 56889999999999999999 6999988
Q ss_pred CCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 154 KNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 154 ~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
....+...++. .++.+++.+||..||.+|||+.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 211 LSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 76655555443 468899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=258.87 Aligned_cols=188 Identities=26% Similarity=0.458 Sum_probs=159.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.|++.+.+... +..+++..+..++.|++.|+.|||+.|++||||||+||++
T Consensus 70 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~ 148 (308)
T cd06634 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148 (308)
T ss_pred HhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE
Confidence 345999999999999999999999999998777666544 3568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.+||+|||++...... ....++..|+|||.+.. ...++.++|||||||++|+|++|..||...+..+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 225 (308)
T cd06634 149 SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (308)
T ss_pred CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH
Confidence 75 78999999998766443 34567899999998742 23457899999999999999999999877654443332
Q ss_pred H-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 I-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+ ...+.++|++||..+|++||++.++++|+|+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 2 2367899999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.53 Aligned_cols=184 Identities=22% Similarity=0.419 Sum_probs=148.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc---------------------------------------
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA--------------------------------------- 45 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~--------------------------------------- 45 (297)
++.+||||+++++++.+++..|+||||++| ++++++....
T Consensus 94 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (375)
T cd05104 94 YLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKP 173 (375)
T ss_pred HhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCC
Confidence 344899999999999999999999999987 5555554321
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeE
Q 040202 46 ----------------------------------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVI 90 (297)
Q Consensus 46 ----------------------------------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~ 90 (297)
+..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 253 (375)
T cd05104 174 GVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253 (375)
T ss_pred CcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcE
Confidence 124788899999999999999999999999999999999986 679
Q ss_pred EEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH---
Q 040202 91 KIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI--- 163 (297)
Q Consensus 91 kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i--- 163 (297)
||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+........+.
T Consensus 254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 332 (375)
T cd05104 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE 332 (375)
T ss_pred EEecCccceeccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh
Confidence 9999999987644321 1223345679999998654 46889999999999999998 89999776544333322
Q ss_pred ----------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 164 ----------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 164 ----------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..++.+++.+||+.||++|||+.++++
T Consensus 333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 333 GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 236789999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=267.31 Aligned_cols=186 Identities=38% Similarity=0.667 Sum_probs=156.6
Q ss_pred cccccceeeeceeEEeCCe------EEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 7 MNNHPNIVKLRNLVKEHED------VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~------~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.++|+||+++++++...+. .|+|+||+++++.+.+.. ..+++..++.++.|++.||.|||+.||+||||||
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (343)
T cd07851 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP 146 (343)
T ss_pred hccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 3499999999998876554 999999997776655543 4599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+||++++ +.+||+|||++...... .....++..|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~ 224 (343)
T cd07851 147 SNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224 (343)
T ss_pred HHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9999985 78999999999876543 24557788999999876545668899999999999999999999987665443
Q ss_pred HHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...+ ...+.+++++||..||.+|||+.++++||||+..
T Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 3221 3356789999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=254.21 Aligned_cols=188 Identities=30% Similarity=0.562 Sum_probs=157.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE---SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~---~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++.+.+.+..++||||+.++.+..+.. ..+..+++..++.++.|++.|+.|||++|++|+||||+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n 136 (260)
T cd08222 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN 136 (260)
T ss_pred HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence 33489999999999999999999999999855554433 223569999999999999999999999999999999999
Q ss_pred EEEeCCeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVSKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++++.+||+|||+++...... ......|+..|+|||.+.. ..++.++|+||+|+++++|++|..||.+........
T Consensus 137 ili~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~ 215 (260)
T cd08222 137 IFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215 (260)
T ss_pred eEeecCCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 99999899999999987764332 2234567889999998754 345778999999999999999999998766554443
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
++ ..++.++|.+||..||++||++.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 33 3478899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=254.69 Aligned_cols=190 Identities=27% Similarity=0.474 Sum_probs=153.0
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKE---SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~---~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|+||+++++++.+ .+.+|+||||++|+.+..+.. .....+++..+..++.||+.||.|||+.|++|+||+|
T Consensus 54 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~ 133 (287)
T cd06621 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKP 133 (287)
T ss_pred HhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 34599999999999864 447999999998755544322 2235589999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS--- 156 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--- 156 (297)
+||++++ +.++|+|||++........ ....++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.....
T Consensus 134 ~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (287)
T cd06621 134 SNILLTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211 (287)
T ss_pred HHEEEecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC
Confidence 9999985 7899999999876543322 245678899999987644 457899999999999999999999986521
Q ss_pred --HHHHHH------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 --ADQIYK------------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 --~~~~~~------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+.... ....+.+++.+||..||.+|||+.|+++|+||+..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 212 GPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 111111 12357899999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=251.24 Aligned_cols=184 Identities=23% Similarity=0.401 Sum_probs=148.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~ 127 (252)
T cd05084 48 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV 127 (252)
T ss_pred HhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE
Confidence 44599999999999999999999999998866555554444568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++ +.+||+|||++......... ....++..|+|||.+.... ++.++||||+||++|+|++ |..||.........
T Consensus 128 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~ 206 (252)
T cd05084 128 TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR 206 (252)
T ss_pred cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH
Confidence 85 78999999998765432111 1112245699999876544 5889999999999999998 88998765544333
Q ss_pred HHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+ ...+.+++.+||+.||++|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 207 EAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 322 246789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=252.13 Aligned_cols=187 Identities=25% Similarity=0.430 Sum_probs=152.3
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.|+||+++++++.+ ...+|++|||+.|+.+..+..+. ..+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 137 (265)
T cd06652 59 KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI 137 (265)
T ss_pred HhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 34489999999999876 35789999999986555555443 4589999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++++ +.+||+|||+++..... .......|+..|+|||++.+. .++.++|+|||||++|+|++|+.||.......
T Consensus 138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 216 (265)
T cd06652 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216 (265)
T ss_pred EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence 9985 78999999998765321 112335688899999997654 45889999999999999999999998765444
Q ss_pred HHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 159 QIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 159 ~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
...+ +...+.+++++|+. +|++||+++++++|+|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 217 AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 3322 22357889999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=256.75 Aligned_cols=183 Identities=23% Similarity=0.384 Sum_probs=150.1
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG------------QNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~------------~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
.++|+||+++++++.+++..|+||||+.++.+..+....+ ..+++..+..++.|++.||+|||++|++
T Consensus 63 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~ 142 (288)
T cd05093 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV 142 (288)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3489999999999999999999999998755544443222 2489999999999999999999999999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
||||||+||++++ +.+||+|||+++...... ......++..|+|||++.. ..++.++|||||||++|+|++ |..
T Consensus 143 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~ 221 (288)
T cd05093 143 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQ 221 (288)
T ss_pred ecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999975 789999999997654321 1223345778999998764 455889999999999999998 999
Q ss_pred CCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||......+...++ ..++.+++.+||+.||.+|||+.++++
T Consensus 222 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 222 PWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99877655544433 236889999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=257.86 Aligned_cols=192 Identities=27% Similarity=0.445 Sum_probs=158.0
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~N 82 (297)
+.+..+|+||+++++++.++...|++|||+.+.+.+.+... ...+++..+..++.|++.||.|||+ .||+||||+|+|
T Consensus 67 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~n 145 (296)
T cd06618 67 VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145 (296)
T ss_pred HHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHH
Confidence 44555799999999999999999999999987655554443 3579999999999999999999997 599999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccc---cCCCccchhhHHHHHHHHHhCCCCCCCCCCH-
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE---ICGPEVDRWAMGAIMFEMLSFRILFPGKNSA- 157 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~- 157 (297)
|++++ +.+||+|||++.............++..|+|||.+.... .++.++||||||+++|+|++|+.||......
T Consensus 146 ill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 225 (296)
T cd06618 146 ILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225 (296)
T ss_pred EEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH
Confidence 99975 789999999987765444334456788999999976442 3578899999999999999999999764332
Q ss_pred HHHHH--------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 DQIYK--------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~~~~~--------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+...+ ...++.+|+.+||..||++||+++++++|+||..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 22222 1236789999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=254.74 Aligned_cols=187 Identities=24% Similarity=0.401 Sum_probs=149.6
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHH
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA--------------GQNFSEDEARNLCFQVFQGLHY 67 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~--------------~~~l~e~~~~~~~~qll~al~y 67 (297)
.+.++.+||||+++++++...+..|++|||+.+ ++.+.+.... ...+++..++.++.|++.||+|
T Consensus 48 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~ 127 (270)
T cd05047 48 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 127 (270)
T ss_pred HHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHH
Confidence 345666899999999999999999999999987 4445444321 1248899999999999999999
Q ss_pred HHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 68 LH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
||++|++||||||+||++++ +.+||+|||++..............+..|+|||++.. ..++.++|||||||++|||++
T Consensus 128 lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~ 206 (270)
T cd05047 128 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVS 206 (270)
T ss_pred HHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHc
Confidence 99999999999999999975 7899999999864332211122233567999998754 446889999999999999997
Q ss_pred -CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 147 -FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|..||.+.+..+...++ ..++.+++.+|+..||.+|||+.++++
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 207 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999776655444433 236789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=247.72 Aligned_cols=186 Identities=27% Similarity=0.521 Sum_probs=158.8
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++++..++..++++||++|+.+..+.......+++..+..++.|++.||.|||++|++||||+|+||+++
T Consensus 53 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~ 132 (253)
T cd05122 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT 132 (253)
T ss_pred hCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc
Confidence 34799999999999999999999999998666666555435699999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-- 163 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i-- 163 (297)
+ +.++|+|||.+.............++..|++||.+.... .+.++|+||+|+++++|++|+.||...+.......+
T Consensus 133 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 211 (253)
T cd05122 133 SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT 211 (253)
T ss_pred cCCeEEEeeccccccccccccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 5 789999999998776544335567889999999876544 578999999999999999999999876443333222
Q ss_pred ------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 164 ------------YGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 164 ------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
...+.+++.+||..||++|||+.++++|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 346789999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=254.87 Aligned_cols=187 Identities=22% Similarity=0.418 Sum_probs=158.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++.+.+++..|+||||++|+.+..+... ..+++..+..++.|++.|+.|||++|++|+||||+||+++
T Consensus 58 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~ 135 (277)
T cd06641 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 135 (277)
T ss_pred hcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC
Confidence 35999999999999999999999999998666666554 4589999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q 040202 87 K-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI- 163 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i- 163 (297)
+ +.++|+|||++....... ......++..|+|||.+... ..+.++|+||+||++|+|++|..||...........+
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 136 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred CCCCEEEeecccceecccchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 5 789999999987664432 12335678899999987644 4478899999999999999999999876654443332
Q ss_pred -----------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 -----------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 -----------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..++.+++.+||..+|.+||++.++++|+||..
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 236889999999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=249.72 Aligned_cols=188 Identities=29% Similarity=0.545 Sum_probs=156.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+.+.+..++|+||+.++.+..+.... ..+++..++.++.|++.||.|||+.||+|+||+|+||++
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~ 132 (264)
T cd06626 54 ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132 (264)
T ss_pred HhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 3349999999999999999999999999986666666543 458999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC-----ccccccCCCCCCceecccc--cCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC-----TDYVTTRWYRAPEVLLLSE--ICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
++ +.+||+|||++......... ....++..|+|||++.... ....++||||+|+++++|++|+.||.+....
T Consensus 133 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~ 212 (264)
T cd06626 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212 (264)
T ss_pred CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence 85 78999999998776543221 2346788999999986543 2578999999999999999999999765332
Q ss_pred HH-HHH--------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 158 DQ-IYK--------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 158 ~~-~~~--------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.. ... +...+.+++.+||+.||.+|||+.+++.|||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 213 FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 22 211 13467899999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.57 Aligned_cols=188 Identities=28% Similarity=0.474 Sum_probs=159.0
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEe
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVS 86 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~ 86 (297)
++|+||+++++++..++.+|+||||+.|+.+..+.... ..+++..+..++.|++.|++|||+ .|++||||+|+||+++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred cCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 37999999999999999999999999976665555543 569999999999999999999999 9999999999999997
Q ss_pred C-CeEEEEecCCceecCCCCCC-ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC--CH-HHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN--SA-DQIY 161 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~--~~-~~~~ 161 (297)
+ +.++|+|||++......... ....++..|+|||.+... .++.++|+||||+++|+|++|+.||.... .. +...
T Consensus 135 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (264)
T cd06623 135 SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213 (264)
T ss_pred CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH
Confidence 5 78999999999876554332 255678899999987654 56889999999999999999999997774 22 2222
Q ss_pred H-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 K-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
. +...+.+++.+||..+|++||++.++++|||++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 214 AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 2 23468999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=256.04 Aligned_cols=184 Identities=22% Similarity=0.348 Sum_probs=150.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~yLH~ 70 (297)
+.++|+||+++++++.+++..++||||+.++.+..+.... ...+++..++.++.||+.||+|||+
T Consensus 62 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 141 (291)
T cd05094 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 141 (291)
T ss_pred hcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3459999999999999999999999999875555444321 1348999999999999999999999
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
+||+||||||+||++++ +.+||+|||+++...... ......++..|+|||.+.+. .++.++||||+||++|+|++
T Consensus 142 ~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 142 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHh
Confidence 99999999999999985 789999999997654321 12334567889999987654 45889999999999999998
Q ss_pred -CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 147 -FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|..||...+..+....+ ...+.+++.+||+.||++|||+.++++
T Consensus 221 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 221 YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99999776655544332 236789999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=253.13 Aligned_cols=184 Identities=24% Similarity=0.392 Sum_probs=152.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG-------------QNFSEDEARNLCFQVFQGLHYMHRQG 72 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~-------------~~l~e~~~~~~~~qll~al~yLH~~g 72 (297)
+.++|+||+++++++.+++..|+||||+.|+.+..++...+ ..+++..+..++.|++.|+.|||++|
T Consensus 63 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 142 (280)
T cd05049 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142 (280)
T ss_pred HhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 33599999999999999999999999999866555544321 34889999999999999999999999
Q ss_pred ccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-C
Q 040202 73 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-F 147 (297)
Q Consensus 73 i~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g 147 (297)
++||||||+||++++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|+|++ |
T Consensus 143 i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g 221 (280)
T cd05049 143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYG 221 (280)
T ss_pred eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcC
Confidence 999999999999974 899999999997653321 11233457789999998654 45889999999999999998 9
Q ss_pred CCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 148 RILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 148 ~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..||.+.+..+....+. ..+.+++++||+.||++||++.|+++
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 222 KQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99998776655544432 36789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.53 Aligned_cols=187 Identities=21% Similarity=0.414 Sum_probs=151.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---------------AGQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---------------~~~~l~e~~~~~~~~qll~al~yL 68 (297)
++++.+|+||+++++++.+++..|++|||+.++.+..+... ....+++..+..++.|++.||+||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 34444899999999999999999999999987555544432 234589999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+||++++ +.+||+|||+++...... ......++..|+|||++.. ..++.++|||||||++|+|
T Consensus 149 H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el 227 (293)
T cd05053 149 ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred HHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHH
Confidence 9999999999999999975 789999999998654322 1122334567999998754 4558899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |..||.+....+....+ ..++.+|+.+|+..||++|||+.+++++
T Consensus 228 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 228 FTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred hcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 97 99999877655544432 2367899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=255.35 Aligned_cols=194 Identities=24% Similarity=0.435 Sum_probs=157.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
|.++.+|+||+++++.++.++..|+||||+.|+ +.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~n 135 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLEN 135 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 445557999999999999999999999999975 44544443 458999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
||+++ +.+||+|||+++...... ......|+..|+|||.+... ..++.++||||+|+++|+|++|+.||.......
T Consensus 136 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 215 (290)
T cd05613 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215 (290)
T ss_pred eEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc
Confidence 99975 789999999987754422 22345688999999997643 245788999999999999999999997533221
Q ss_pred H----HHH-----------HHHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 159 Q----IYK-----------IYGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 159 ~----~~~-----------i~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
. ... +...+.+++++||..||++|+ +++++++||||....|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 216 SQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred cHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 1 111 123568999999999999997 8899999999987554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=247.38 Aligned_cols=185 Identities=30% Similarity=0.568 Sum_probs=159.3
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
++|+||+++++++.+++..|++|||+.++.+..+.... ..+++..+..++.|++.|+.|||++||+||||||+||++++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 134 (254)
T cd06627 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134 (254)
T ss_pred CCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC
Confidence 48999999999999999999999999986666555543 46999999999999999999999999999999999999985
Q ss_pred -CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Q 040202 88 -GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY- 164 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~- 164 (297)
+.++|+|||++........ .....++..|+|||.+.... .+.++|+||+|+++++|++|..||..........+..
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (254)
T cd06627 135 DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213 (254)
T ss_pred CCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 7899999999987755432 23456788999999876544 6889999999999999999999998766555444432
Q ss_pred -----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 165 -----------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 165 -----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..+.+++.+||..+|++|||+.++++|+||
T Consensus 214 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 478999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=254.33 Aligned_cols=193 Identities=28% Similarity=0.498 Sum_probs=160.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++.+..++..|+|+||+.|+.+..+....+..+++..+..++.|++.||.|||+.||+|+||+|+||++
T Consensus 70 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred HHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 34599999999999999999999999999755555555433369999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
+. +.++|+|||++....... ......++..|++||++.+. .++.++|+||+||++|+|++|..||...+.......
T Consensus 150 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~ 228 (286)
T cd06614 150 SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228 (286)
T ss_pred cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 84 789999999876543321 11334578899999987654 458899999999999999999999987665443332
Q ss_pred -------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 163 -------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 -------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
+...+.+++.+||+.+|.+|||+.++++|+||+...+
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 2346889999999999999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=249.97 Aligned_cols=185 Identities=22% Similarity=0.392 Sum_probs=151.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+.+..|+||||++|+.+..+.......+++..+..++.|++.|+.|||++|++||||||+||++
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i 133 (256)
T cd05059 54 MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV 133 (256)
T ss_pred HhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE
Confidence 34599999999999999999999999998755444444334468999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+++........ ....++..|+|||.+... .++.++|+||+||++|+|++ |+.||...+..+...
T Consensus 134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05059 134 GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE 212 (256)
T ss_pred CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 75 78999999998876433211 112234579999987654 45889999999999999998 899998776655554
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+. ..+.+++.+||..+|++|||+.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 213 SVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 442 368999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=254.02 Aligned_cols=187 Identities=23% Similarity=0.374 Sum_probs=156.7
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill 85 (297)
.++|+||+++++.+.+.+.+|+||||++++.+..+.... +.+++..++.++.|++.||.|||+ .|++||||||+||++
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 137 (284)
T cd06620 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137 (284)
T ss_pred HcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence 349999999999999999999999999987776666553 469999999999999999999997 699999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-------
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA------- 157 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~------- 157 (297)
++ +.++|+|||++....... .....|+..|+|||++... .++.++|+||+||++|+|++|+.||......
T Consensus 138 ~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 215 (284)
T cd06620 138 NSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215 (284)
T ss_pred CCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh
Confidence 85 789999999987653322 2355789999999987654 4588999999999999999999999865542
Q ss_pred ----HHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 ----DQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ----~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+.... +..++.+|+.+|++.||++|||+.++++|+||..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 216 MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11111 2236789999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.37 Aligned_cols=189 Identities=40% Similarity=0.660 Sum_probs=155.0
Q ss_pred ccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++|+||+++++++..+. ..|+||||+++++.+. ... ..+++..++.++.|++.||+|||+.||+|||||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~-~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk 145 (343)
T cd07880 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKL-MKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK 145 (343)
T ss_pred HhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHH-Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 3459999999999997654 4699999996555544 433 459999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+||++++ +.+||+|||++....... ....+++.|+|||++.....++.++|+||+||++|+|++|+.||.+.+...
T Consensus 146 p~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 146 PGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred HHHEEEcCCCCEEEeecccccccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999974 789999999998664432 345678999999998654456889999999999999999999998765433
Q ss_pred HHHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...++ ...+.++|.+||..||++|||+.++++||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 32211 124678999999999999999999999999987
Q ss_pred CCC
Q 040202 197 CHF 199 (297)
Q Consensus 197 ~~~ 199 (297)
...
T Consensus 304 ~~~ 306 (343)
T cd07880 304 FHD 306 (343)
T ss_pred hcC
Confidence 543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=253.10 Aligned_cols=185 Identities=24% Similarity=0.382 Sum_probs=150.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG------QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~------~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++|+||+++++++.+.+..|+||||+.|+.+..+....+ ..+++..+..++.||+.||+|||++|++|||||
T Consensus 64 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 143 (277)
T cd05036 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIA 143 (277)
T ss_pred HhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 34599999999999999999999999998755554444322 248999999999999999999999999999999
Q ss_pred CCcEEEeC-C---eEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCC
Q 040202 80 PSNLLVSK-G---VIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILF 151 (297)
Q Consensus 80 p~Nill~~-~---~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf 151 (297)
|+||++++ + .+||+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999974 2 589999999987643221 11223356799999986544 6899999999999999997 99999
Q ss_pred CCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 152 PGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 152 ~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+.+..+....+. ..+.+++.+||+.||++||++.++++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 223 PGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8776655444332 367899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=270.67 Aligned_cols=193 Identities=30% Similarity=0.474 Sum_probs=173.9
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+|+++ .||.||.+...|++.+..+.|||-+.|+.++-++...+++++|...+.++.||+.||.|||-+||+|.||||+|
T Consensus 616 ILq~l-~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPEN 694 (888)
T KOG4236|consen 616 ILQNL-HHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPEN 694 (888)
T ss_pred HHHhc-CCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchh
Confidence 34455 99999999999999999999999999999999998888889999999999999999999999999999999999
Q ss_pred EEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-
Q 040202 83 LLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA- 157 (297)
Q Consensus 83 ill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~- 157 (297)
||+.. -.+||+|||+|+.+++.....+.+||+.|+|||++..++ |....|+||+|||+|--++|..||....+.
T Consensus 695 VLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 695 VLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred eeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchh
Confidence 99964 269999999999999988888999999999999988655 588999999999999999999999765443
Q ss_pred HHH------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 158 DQI------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 158 ~~~------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+++ ..|..+.++||.++|+..-.+|.|++..|.|||+++.
T Consensus 774 dQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 774 DQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 222 2456688999999999999999999999999999764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=247.06 Aligned_cols=187 Identities=29% Similarity=0.516 Sum_probs=158.8
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++.+.+. +..|+|+||+.++.+..+..... .+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni 132 (260)
T cd06606 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI 132 (260)
T ss_pred HHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 344899999999999988 89999999998766666555533 699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-H
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA-D 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~-~ 158 (297)
++++ +.++|+|||.+........ .....++..|++||.+.... .+.++|+||+|+++++|++|..||...... .
T Consensus 133 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (260)
T cd06606 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211 (260)
T ss_pred EEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 9985 7899999999988766543 34567889999999876544 588999999999999999999999876522 2
Q ss_pred HHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 159 QIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 159 ~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...++ ...+.+++.+|++.||++||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 212 ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 22222 2468999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=240.46 Aligned_cols=192 Identities=26% Similarity=0.534 Sum_probs=169.5
Q ss_pred CccccccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 1 MIFLRKMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 1 i~~l~kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
|++|+.+.+||||++++++..+. ....||+||+++..+..+.+. ++..+++.++.||+.||.|+|+.||+|||+
T Consensus 83 ikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDV 158 (338)
T KOG0668|consen 83 IKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDV 158 (338)
T ss_pred HHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccC
Confidence 35778888899999999999764 467899999999888777654 899999999999999999999999999999
Q ss_pred CCCcEEEeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC-CCCC
Q 040202 79 KPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF-PGKN 155 (297)
Q Consensus 79 kp~Nill~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf-~~~~ 155 (297)
||.|+++|. ..++|+|+|+|.+.-.+....-.+.++.|--||.+..-..|+...|+|||||++.+|+..+.|| .|.+
T Consensus 159 KPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 159 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred CcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 999999984 6899999999998877777777788999999999998888999999999999999999887775 6777
Q ss_pred CHHHHHHHHH------------------------------------------------HHHHHHHHhhhcCCCCCCCHHH
Q 040202 156 SADQIYKIYG------------------------------------------------RWVALISWLCSWNPRMRPTAAE 187 (297)
Q Consensus 156 ~~~~~~~i~~------------------------------------------------~~~~li~~~l~~dP~~R~t~~~ 187 (297)
+.+++-+|-. +..+|+.++|..|-.+|+|+.|
T Consensus 239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE 318 (338)
T ss_pred CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence 7777665532 4589999999999999999999
Q ss_pred HHcCCCCCC
Q 040202 188 ALEHPFFRS 196 (297)
Q Consensus 188 ll~h~~f~~ 196 (297)
++.||||..
T Consensus 319 am~HpyF~~ 327 (338)
T KOG0668|consen 319 AMAHPYFAP 327 (338)
T ss_pred HhcCchHHH
Confidence 999999975
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=250.92 Aligned_cols=183 Identities=23% Similarity=0.412 Sum_probs=150.2
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
.++|+||+++++++.+++..+++|||+.++ +.+.+.......+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~ 137 (263)
T cd05052 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137 (263)
T ss_pred hCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE
Confidence 359999999999999999999999999875 4445444434568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||++......... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 138 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~ 216 (263)
T cd05052 138 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216 (263)
T ss_pred cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 75 78999999998876543221 122335679999987644 45788999999999999998 999998766554444
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+. ..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 332 36789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=261.55 Aligned_cols=187 Identities=38% Similarity=0.653 Sum_probs=153.5
Q ss_pred cccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 7 MNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.++|+||+++++++... +..|++++++++++.+.+ .. ..+++..++.++.|++.||+|||++||+||||||
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~-~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 148 (345)
T cd07877 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 148 (345)
T ss_pred HcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHH-hc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence 34999999999998643 357899999866665443 33 3599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+||++++ +.+||+|||+++...... ....++..|+|||++.+...++.++||||+||++|+|++|+.||...+....
T Consensus 149 ~NIll~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 149 SNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred HHEEEcCCCCEEEecccccccccccc--cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999985 789999999988654432 4567889999999876545568899999999999999999999976654332
Q ss_pred HHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..++ ..++.++|.+||..||.+|+++.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 2211 1246789999999999999999999999999864
Q ss_pred C
Q 040202 198 H 198 (297)
Q Consensus 198 ~ 198 (297)
.
T Consensus 307 ~ 307 (345)
T cd07877 307 H 307 (345)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=255.18 Aligned_cols=186 Identities=21% Similarity=0.391 Sum_probs=151.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++.+|+||+++++.+..++..|++|||+.++.+ +.+....+..+++.++..++.|++.||+|||++||+|+||||+|
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 171 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccce
Confidence 44555899999999999999999999999987544 44444333448999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSA 157 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 157 (297)
|++++ +.+|++|||+++....... .....++..|+|||.+.... ++.++||||+||++|+|++ |..||.+....
T Consensus 172 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 172 VLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred EEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 99985 6899999999876543321 12334567899999876544 5889999999999999998 99999876655
Q ss_pred HHHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 DQIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 ~~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+...+. ...+.+++.+||..+|++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 443332 246789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=252.33 Aligned_cols=185 Identities=22% Similarity=0.360 Sum_probs=149.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG---------QNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~---------~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
+.++|+||+++++++.+++..++||||+.++.+..+..+.. ..+++..+..++.|++.||+|||+.|++||
T Consensus 64 ~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~ 143 (277)
T cd05062 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR 143 (277)
T ss_pred HhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 34599999999999999999999999999865555544321 235678899999999999999999999999
Q ss_pred CCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCC
Q 040202 77 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILF 151 (297)
Q Consensus 77 dikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf 151 (297)
||||+||++++ +.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||
T Consensus 144 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 144 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred CcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999985 7899999999876543221 1223456789999997654 45889999999999999998 78999
Q ss_pred CCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 152 PGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 152 ~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+.+..+....+ ...+.+++.+||+.||++|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 223 QGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 877655444332 2357899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=249.03 Aligned_cols=185 Identities=24% Similarity=0.440 Sum_probs=152.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++.+.+.+..|++|||+.| ++.+.+....+..+++..+..++.|++.||+|||++|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 3445999999999999999999999999986 555555554456689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++++ +.+||+|||+++....... .....++..|+|||.+... .++.++|||||||++|+|++ |..||.+....+.
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~ 213 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV 213 (261)
T ss_pred EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH
Confidence 9985 7899999999987654321 1223456679999987654 45789999999999999998 9999987766554
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. .++.+++.+|+..||++||+++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 214 MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44433 36789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=259.31 Aligned_cols=187 Identities=23% Similarity=0.387 Sum_probs=149.0
Q ss_pred ccccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhc-------------------------------------
Q 040202 4 LRKMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESA------------------------------------- 45 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~------------------------------------- 45 (297)
+.++.+|+||+++++++.. +..+|++|||+.|+.+..++...
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 4455589999999998864 56789999999985554443221
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceec
Q 040202 46 -----------------------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 101 (297)
Q Consensus 46 -----------------------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~ 101 (297)
...+++..+..++.|++.||+|||++||+||||||+|||+++ +.+||+|||+++.+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 125889999999999999999999999999999999999985 78999999999876
Q ss_pred CCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH-------------H
Q 040202 102 DSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI-------------Y 164 (297)
Q Consensus 102 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i-------------~ 164 (297)
.... ......++..|+|||++.+. .++.++||||+||++|||++ |..||.+....+...+. .
T Consensus 224 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (337)
T cd05054 224 YKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302 (337)
T ss_pred ccCcchhhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 4321 12334556789999987654 45889999999999999998 99999875543333222 2
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 165 GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 165 ~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.++.+++.+||+.+|++||++.++++|
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 367899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=247.14 Aligned_cols=188 Identities=30% Similarity=0.577 Sum_probs=158.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESA--GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~--~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++|+|++++++.+..++..++|+||++|+.+ +.+.... +..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n 133 (258)
T cd08215 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133 (258)
T ss_pred HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence 344899999999999999999999999998554 4444332 3669999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|++++ +.++|+|||++....... ......|++.|+|||.+... .++.++|+||+|+++++|++|..||...+..+..
T Consensus 134 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred eEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 99985 899999999987765543 33445788899999987644 4578999999999999999999999877654443
Q ss_pred HHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 161 YKI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 161 ~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
... ...+.+++.+||..+|++|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 332 2467899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=249.07 Aligned_cols=185 Identities=23% Similarity=0.386 Sum_probs=152.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|++|||+.++.+..+.....+.+++..+..++.|++.|++|||++||+||||||+||++
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili 139 (266)
T cd05033 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV 139 (266)
T ss_pred HhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 34499999999999999999999999999866655554444569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++ +.+||+|||+++..... .. .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+..
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~ 218 (266)
T cd05033 140 NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218 (266)
T ss_pred cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence 85 78999999999876421 11 1122345679999987654 45889999999999999998 99999776655544
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..+. ..+.+++.+|++.||++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 219 KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4432 367899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=247.52 Aligned_cols=183 Identities=22% Similarity=0.326 Sum_probs=148.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++. ++..++||||+.++.+..+.... ..+++..+..++.|++.||+|||++||+||||||.||+
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nil 127 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVL 127 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEE
Confidence 34459999999999886 45679999999976555544432 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+++....... .....++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+
T Consensus 128 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 128 LVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred EcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 985 6899999999987654321 122234578999998754 345789999999999999998 999998766555
Q ss_pred HHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....+. .++.++|.+|++.||++||+++++.+
T Consensus 207 ~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 207 VTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 444332 36789999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=255.31 Aligned_cols=186 Identities=22% Similarity=0.401 Sum_probs=149.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
++++.+||||+++++++.+++..|++|||+.++.+..+.... ...+++..+..++.|++.||+||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 444547999999999999999999999999875555444331 13488999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+||++++ +.+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++|+|
T Consensus 151 H~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 151 ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred HHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHH
Confidence 9999999999999999985 7899999999986643211 112233467999998765 4568899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 145 LS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
++ |..||.+.+..+....+. .++.+++.+||..||++|||+.++++
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 230 FTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99 899998766554443322 36789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=246.75 Aligned_cols=181 Identities=22% Similarity=0.319 Sum_probs=149.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.. +..|+||||+.++.++.+....+..+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 56 ~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill 134 (259)
T cd05037 56 SQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV 134 (259)
T ss_pred HcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE
Confidence 44599999999999988 77899999999877766665544469999999999999999999999999999999999999
Q ss_pred eC-C-------eEEEEecCCceecCCCCCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 040202 86 SK-G-------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLS-FRILFPGKN 155 (297)
Q Consensus 86 ~~-~-------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~ 155 (297)
+. + .+||+|||++...... ....++..|+|||++... ..++.++||||+||++|+|++ |..||...+
T Consensus 135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 135 ARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ecCccccCCceeEEeCCCCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 75 4 6999999999876542 345567889999997654 356889999999999999999 588886664
Q ss_pred CHHHHHHH----------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 156 SADQIYKI----------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 156 ~~~~~~~i----------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+..... ...+.+++.+||..||.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 212 SSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chhHHHHHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 33322211 136789999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=250.92 Aligned_cols=184 Identities=23% Similarity=0.370 Sum_probs=150.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG--------------QNFSEDEARNLCFQVFQGLHYMHRQ 71 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~--------------~~l~e~~~~~~~~qll~al~yLH~~ 71 (297)
+.++|+||+++++++.+++..|++|||+.++.+..+....+ ..+++..+..++.|++.|++|||+.
T Consensus 62 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 141 (280)
T cd05092 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141 (280)
T ss_pred hcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 34599999999999999999999999998755554443322 2488999999999999999999999
Q ss_pred CccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-
Q 040202 72 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS- 146 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~- 146 (297)
|++||||||+|||+++ +.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 142 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~ 220 (280)
T cd05092 142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTY 220 (280)
T ss_pred CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcC
Confidence 9999999999999975 789999999987654321 12233456789999987654 45889999999999999998
Q ss_pred CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 147 FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 147 g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|..||......+....+ ...+.+++.+||+.||++||++.++++
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 221 GKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999776655544333 246789999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=246.03 Aligned_cols=186 Identities=35% Similarity=0.562 Sum_probs=157.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+++++..|+||||+.+ ++.+.+... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~ 125 (250)
T cd05123 48 SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENIL 125 (250)
T ss_pred HHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEE
Confidence 445899999999999999999999999976 554444433 35899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.++|+|||++...... .......++..|++||.+.+.. .+.++|+||||+++|+|++|..||...+......+
T Consensus 126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~ 204 (250)
T cd05123 126 LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204 (250)
T ss_pred EcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 985 78999999998776543 2334567788999999876543 57889999999999999999999987765444443
Q ss_pred H-----------HHHHHHHHHHhhhcCCCCCCCH---HHHHcCCCC
Q 040202 163 I-----------YGRWVALISWLCSWNPRMRPTA---AEALEHPFF 194 (297)
Q Consensus 163 i-----------~~~~~~li~~~l~~dP~~R~t~---~~ll~h~~f 194 (297)
+ ...+.+++++||..||++||++ +++++||||
T Consensus 205 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 205 ILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 3 2368999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.82 Aligned_cols=189 Identities=37% Similarity=0.649 Sum_probs=155.0
Q ss_pred ccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.. ++..|+|+||+++++.+.+. . ..+++..+..++.|++.||.|||+.||+||||+|.||+
T Consensus 64 ~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil 140 (328)
T cd07856 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT-S--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140 (328)
T ss_pred HhcCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHh-c--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence 34489999999999875 56899999999776654443 2 45899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH--
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-- 161 (297)
+++ +.+||+|||+++...... ....++..|+|||++.+...++.++|+||+||++|+|++|+.||.+........
T Consensus 141 i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 141 INENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred ECCCCCEEeCccccccccCCCc--CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 975 789999999987654322 445678899999987665567899999999999999999999997654311100
Q ss_pred ----------------------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 162 ----------------------------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 162 ----------------------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
.+...+.++|++||+.+|++|||+++++.|+||+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 01246789999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=246.01 Aligned_cols=183 Identities=23% Similarity=0.372 Sum_probs=151.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++.+.+ ...++||||+.+ ++.+.+.......+++..++.++.|++.||+|||++|++||||||+||+
T Consensus 51 ~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 51 HSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred hhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 33499999999999988 899999999986 5555554443246899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+++...... ......++..|+|||.+... .++.++||||+||++|+|++ |+.||...+..+
T Consensus 130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred EecCCEEEeccccccccccccccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 985 889999999988764421 11234567789999987644 45889999999999999998 999998776665
Q ss_pred HHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....+. ..+.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 209 ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 554433 46789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=246.53 Aligned_cols=183 Identities=24% Similarity=0.420 Sum_probs=150.5
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
.++|+||+++++++..++..|++|||+.| ++.+.+....+..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 136 (261)
T cd05068 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV 136 (261)
T ss_pred HCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE
Confidence 34899999999999999999999999976 55555544434569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+++........ .....+..|+|||++.. ..++.++|+||||+++|+|++ |+.||.+.+......
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05068 137 GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ 215 (261)
T ss_pred cCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 75 78999999999876533211 11222457999998764 445889999999999999999 999998876655444
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+ ...+.+++.+|+..||++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 216 QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 43 246789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=250.76 Aligned_cols=187 Identities=21% Similarity=0.330 Sum_probs=151.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---------------AGQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---------------~~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.+.++||||+++++++.+.+..++++||+.++.+..+... ....+++..+..++.|++.||+||
T Consensus 61 ~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l 140 (283)
T cd05091 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL 140 (283)
T ss_pred HHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 33456999999999999999999999999987555444321 113488899999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+||++++ +.+||+|||+++....... .....+++.|+|||.+.... ++.++||||+||++|||
T Consensus 141 H~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el 219 (283)
T cd05091 141 SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEV 219 (283)
T ss_pred HHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHH
Confidence 9999999999999999975 6899999999876543221 23344577899999876544 58899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKIYG------------RWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |..||.+....+....+.. .+.+++.+|++.||++||++.+++..
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 220 FSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 98 8889987766655554432 57899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=250.16 Aligned_cols=185 Identities=22% Similarity=0.400 Sum_probs=150.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESA---------------GQNFSEDEARNLCFQVFQGLHYMH 69 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~yLH 69 (297)
+.++|+||+++++++..++..|+||||+.++ +.+++..+. ...+++..+..++.|++.||+|||
T Consensus 62 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 141 (283)
T cd05090 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred hhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 3459999999999999999999999999875 444443221 124789999999999999999999
Q ss_pred HCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH
Q 040202 70 RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 70 ~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 145 (297)
++||+||||||+|||+++ +.+||+|||+++...... ......++..|+|||++.+. .++.++|+|||||++|||+
T Consensus 142 ~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~ 220 (283)
T cd05090 142 SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIF 220 (283)
T ss_pred hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHH
Confidence 999999999999999985 689999999998764321 12334456779999987654 4588999999999999999
Q ss_pred h-CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 146 S-FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 146 ~-g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+ |..||.+....+....+ ...+.+++.+|++.||.+||++.+++++
T Consensus 221 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 221 SFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8 99999876654433332 2367899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=249.12 Aligned_cols=184 Identities=23% Similarity=0.381 Sum_probs=144.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG----QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~----~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++|+||+++++.+.+.+..|+||||+.++.+..+..... ...++..++.++.||+.||+|||++||+||||||+
T Consensus 50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 129 (269)
T cd05042 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129 (269)
T ss_pred HhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHh
Confidence 34599999999999999999999999999755555443322 23567889999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecc------cccCCCccchhhHHHHHHHHHh-CCCC
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLS-FRIL 150 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGv~l~ell~-g~~p 150 (297)
|||+++ +.+||+|||++....... ......++..|+|||++.. ...++.++||||+||++|||++ |..|
T Consensus 130 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred heEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 999985 789999999987543321 1123345677999998643 2345778999999999999999 8889
Q ss_pred CCCCCCHHHHHHHH-----------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 151 FPGKNSADQIYKIY-----------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 151 f~~~~~~~~~~~i~-----------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|......+...++. ..+.+++..|+ .||++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 210 YPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 98766554443321 24567888777 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=251.91 Aligned_cols=195 Identities=25% Similarity=0.408 Sum_probs=156.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+|+||+++++.+..++..|+||||+.|+.+...... ...+++..++.++.|++.||+|||+.|++||||||.||
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~ni 136 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENI 136 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 45555799999999999999999999999987544443333 24599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCHH-
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSE-ICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD- 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~- 158 (297)
++++ +.++|+|||+++....... .....|+..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.......
T Consensus 137 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 216 (288)
T cd05583 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216 (288)
T ss_pred EECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch
Confidence 9975 7899999999876543321 12346788999999876433 35788999999999999999999996433221
Q ss_pred --HH-HH-----------HHHHHHHHHHHhhhcCCCCCCC---HHHHHcCCCCCCCCC
Q 040202 159 --QI-YK-----------IYGRWVALISWLCSWNPRMRPT---AAEALEHPFFRSCHF 199 (297)
Q Consensus 159 --~~-~~-----------i~~~~~~li~~~l~~dP~~R~t---~~~ll~h~~f~~~~~ 199 (297)
.. .. +...+.+++.+||+.||++||| +.++|+||||+...|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 217 QSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 11 11 1236789999999999999998 567899999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.11 Aligned_cols=184 Identities=21% Similarity=0.297 Sum_probs=148.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||++++++++ .+..++||||+.|+.+..+.......+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 49 l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 127 (257)
T cd05115 49 MHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL 127 (257)
T ss_pred HHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEE
Confidence 34459999999999886 45789999999886665555443456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+++....... .....++..|+|||++... .++.++|||||||++|+|++ |..||.+....+
T Consensus 128 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 206 (257)
T cd05115 128 LVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206 (257)
T ss_pred EcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 985 6899999999876543211 1112235679999987644 45889999999999999996 999998776655
Q ss_pred HHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....+ ..++.+++.+|+..||++||++.++.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 207 VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 44433 246789999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=256.22 Aligned_cols=184 Identities=20% Similarity=0.306 Sum_probs=148.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++++... ..++++||+.++ +++.+.. ....+++..+..++.|++.||+|||++||+||||||+||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Ni 140 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNV 140 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 4455999999999999864 578999999875 5555544 345689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
|+++ +.+||+|||+++........ ....++..|+|||++... .++.++|||||||++|||++ |+.||.+....+
T Consensus 141 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 141 LVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred EecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9975 78999999999876543221 222345679999987654 45889999999999999997 999998765443
Q ss_pred HHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 159 QIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 159 ~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
....+ ..++.+++.+|+..||++||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 220 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211 1267899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.98 Aligned_cols=184 Identities=23% Similarity=0.389 Sum_probs=150.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
+.++|+||+++++++.+++..|+||||+.++.+..+.... ...+++..+..++.|++.||.|||++|++||
T Consensus 64 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 143 (277)
T cd05032 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143 (277)
T ss_pred HhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 3459999999999999999999999999875554444321 1237888999999999999999999999999
Q ss_pred CCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCC
Q 040202 77 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILF 151 (297)
Q Consensus 77 dikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf 151 (297)
||||+||++++ +.+||+|||+++...... ......++..|+|||.+... .++.++|||||||++||+++ |..||
T Consensus 144 di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred ccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCC
Confidence 99999999985 789999999987654332 12344567889999987644 45889999999999999998 99999
Q ss_pred CCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 152 PGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 152 ~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+.+..+....+. ..+.+++.+||+.+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 223 QGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8766554443332 36789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.61 Aligned_cols=183 Identities=23% Similarity=0.407 Sum_probs=149.3
Q ss_pred cccccccceeeeceeE-EeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 5 RKMNNHPNIVKLRNLV-KEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~-~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.+.++|+||+++++++ .+++..|+||||+++ .+.+.+.......+++..+..++.|++.||+|||++|++||||||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n 132 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARN 132 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchhe
Confidence 3445999999999976 456689999999987 55555544434458999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
|++++ +.+||+|||+++...... ....++..|+|||++... .++.++||||+||++|+|++ |+.||...+..+..
T Consensus 133 il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~ 209 (256)
T cd05082 133 VLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209 (256)
T ss_pred EEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99975 789999999988654432 233456789999987644 45789999999999999997 99999876655444
Q ss_pred HHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+ ...+.+++.+|+..||++|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 210 PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 433 246799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=248.66 Aligned_cols=183 Identities=19% Similarity=0.255 Sum_probs=147.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++. +...++++||+.++.+..+....++.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 64 ~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili 142 (279)
T cd05111 64 GSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL 142 (279)
T ss_pred hcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE
Confidence 3458999999999875 456789999998755544444444569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|||++ |..||.+.......
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~ 221 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP 221 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 85 689999999998654321 22344567789999987654 45889999999999999998 99999876544332
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+. .+..+++.+|+..||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2211 25678999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=243.72 Aligned_cols=183 Identities=22% Similarity=0.395 Sum_probs=150.1
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++|+||+++++++.+.+..++||||+.|+.+..+.......+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 48 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~ 127 (250)
T cd05085 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG 127 (250)
T ss_pred hCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc
Confidence 34999999999999999999999999987555555444345689999999999999999999999999999999999997
Q ss_pred C-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
+ +.+||+|||++......... ....++..|+|||++... .++.++||||+|+++|+|++ |..||.+.........
T Consensus 128 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~ 206 (250)
T cd05085 128 ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206 (250)
T ss_pred CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 5 78999999998765433211 122335679999987644 45789999999999999998 9999987665544333
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+ ...+.+++.+|+..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 207 VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 3 246889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.00 Aligned_cols=185 Identities=22% Similarity=0.395 Sum_probs=150.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~yLH~ 70 (297)
++.+|+||+++++++...+..|+||||+.++.+..++.+. ...+++..+..++.|++.||.|||+
T Consensus 76 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 155 (304)
T cd05101 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155 (304)
T ss_pred hhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence 3348999999999999999999999999875555544332 1247888999999999999999999
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
+||+||||||+||++++ +.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHc
Confidence 99999999999999975 7899999999987643221 1223456789999987654 45889999999999999998
Q ss_pred -CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 -FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|..||.+.+..+....+. ..+.+++.+||..+|++|||+.++++.
T Consensus 235 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 235 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 888888776555544432 367899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=245.97 Aligned_cols=184 Identities=25% Similarity=0.423 Sum_probs=152.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.+.+..|+||||+.+ ++.+.+....+..+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 57 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nil 136 (261)
T cd05148 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136 (261)
T ss_pred hcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEE
Confidence 344999999999999999999999999987 5555555444556899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
+++ +.+||+|||.+........ .....++..|+|||++... .++.++||||||+++|+|++ |+.||.+.+..+...
T Consensus 137 v~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~ 215 (261)
T cd05148 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215 (261)
T ss_pred EcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 975 7899999999876644322 1233346679999987654 45889999999999999998 899998777655544
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+. ..+.+++.+||+.||.+|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 216 QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 432 36789999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=244.97 Aligned_cols=187 Identities=28% Similarity=0.488 Sum_probs=156.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHH-HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK-LMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~-~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++|+||+++++++.++...|+||||++|+.+. .+... .+..+++..+..++.|++.||.|||+.|++||||+|+|
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n 133 (256)
T cd08530 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133 (256)
T ss_pred HhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 3448999999999999999999999999885444 44331 23458999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++++ +.+||+|||+++..... ......++..|++||.+.+. .++.++|+||+|+++++|++|+.||...+..+...
T Consensus 134 i~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~ 211 (256)
T cd08530 134 ILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211 (256)
T ss_pred EEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99985 78999999999876554 23345678899999997644 45789999999999999999999998776554433
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+ ..++++++.+||..+|++|||+.++++||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 32 2468999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=249.94 Aligned_cols=189 Identities=33% Similarity=0.527 Sum_probs=157.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++.+|+||+++++++.+++..|+||||+.++.+..+..+. ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni 133 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENI 133 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 344424999999999999999999999999765554444443 3699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC---------------------CCccccccCCCCCCceecccccCCCccchhhHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL---------------------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIM 141 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l 141 (297)
++++ +.++|+|||++....... ......++..|+|||++... ..+.++|+||+|+++
T Consensus 134 ~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l 212 (280)
T cd05581 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCII 212 (280)
T ss_pred EECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHH
Confidence 9985 889999999987654322 12334578899999987644 457899999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHH-----------HHHHHHHHHhhhcCCCCCCCH----HHHHcCCCC
Q 040202 142 FEMLSFRILFPGKNSADQIYKIY-----------GRWVALISWLCSWNPRMRPTA----AEALEHPFF 194 (297)
Q Consensus 142 ~ell~g~~pf~~~~~~~~~~~i~-----------~~~~~li~~~l~~dP~~R~t~----~~ll~h~~f 194 (297)
+++++|+.||..........++. ..+.+++.+||..||.+||++ +++++||||
T Consensus 213 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 213 YQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999998877554444332 367899999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=260.89 Aligned_cols=186 Identities=19% Similarity=0.384 Sum_probs=148.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhc-------------------------------------
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESA------------------------------------- 45 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~------------------------------------- 45 (297)
|.++..||||+++++++.+++..|||||||.|+ +.+.+....
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 444545999999999999999999999999874 444443321
Q ss_pred ---------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 46 ---------------------------------------------------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 46 ---------------------------------------------------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
...+++..+..++.|++.||+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 12478889999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+|||+++ +.+||+|||+++...... ......++..|+|||++.+. .++.++|||||||++|||
T Consensus 254 H~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~el 332 (400)
T cd05105 254 ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEI 332 (400)
T ss_pred HhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHH
Confidence 9999999999999999986 689999999998654322 12334567789999987654 458899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 145 LS-FRILFPGKNSADQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
++ |..||..........+ +...+.+++.+||+.||++||++.++.+
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 97 9999977544333221 2236789999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.59 Aligned_cols=187 Identities=22% Similarity=0.414 Sum_probs=149.0
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESA--------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
++++.+|+||+++++++.+++..|+||||+.++ +.+++..+. +..+++.++..++.|++.||+||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 344558999999999999999999999999874 444544321 12488999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++|++||||||+||++++ +.+||+|||+++........ ....++..|+|||++.+ ..++.++|+||+||++|+|
T Consensus 157 H~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 157 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred HHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999985 78999999998765432111 11223567999998765 4458899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |..||.+.+..+....+ ..++.+++.+||..+|++|||+.+++++
T Consensus 236 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 236 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 98 88998766544433322 2367899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=244.19 Aligned_cols=184 Identities=24% Similarity=0.442 Sum_probs=152.9
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++.+....|+||||+.|+.+..+....+..+++..++.++.|++.|++|||++|++||||||+||+++
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~ 134 (256)
T cd05112 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG 134 (256)
T ss_pred hCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc
Confidence 34999999999999999999999999998766666655445689999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
. +.+||+|||+++........ ....++..|+|||.+.+. .++.++|+||+||++|||++ |..||......+....
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 135 ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 5 78999999998766443211 122345689999987654 45789999999999999998 9999987665554444
Q ss_pred HH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 163 IY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 163 i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+. ..+.+++.+||..+|++|||+.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 214 INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 32 357899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=242.47 Aligned_cols=185 Identities=24% Similarity=0.409 Sum_probs=150.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+.+..|+||||+.|+.+..+....+..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nil 125 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCL 125 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEE
Confidence 34459999999999999999999999999886555555444456899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+++ +.+||+|||+++........ ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||........
T Consensus 126 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~ 204 (251)
T cd05041 126 VGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204 (251)
T ss_pred EcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH
Confidence 985 78999999998765432111 112235569999987654 46889999999999999998 8899977665444
Q ss_pred HHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+ ...+.+++.+||..+|++|||+.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 205 RERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3333 236789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=248.96 Aligned_cols=184 Identities=24% Similarity=0.291 Sum_probs=150.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG----------QNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~----------~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++|+||+++++++..++..+++|||+.++.+..+..... ..+++..++.++.|++.||+|||++||+|
T Consensus 74 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred HhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 33499999999999999999999999998755555444322 25899999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh--CCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS--FRI 149 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~~ 149 (297)
|||||+||++++ +.++|+|||+++...... ......++..|+|||++... .++.++|||||||++|+|++ +..
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred cccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCC
Confidence 999999999985 789999999987654332 12334557789999987654 45889999999999999998 778
Q ss_pred CCCCCCCHHHHHHHH-------------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQIYKIY-------------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~~~~i~-------------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||...+..+.+..+. .++.+++.+||+.||++|||+.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 887766554433321 46899999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=245.35 Aligned_cols=184 Identities=21% Similarity=0.337 Sum_probs=152.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+.+..|+||||+.++.+..+.....+.+++..+..++.|++.|++|||+.|++||||||+||++
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili 140 (268)
T cd05063 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV 140 (268)
T ss_pred hcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE
Confidence 44599999999999999999999999999876766665544569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC----ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||++......... .....+..|+|||++... .++.++||||+||++|||++ |..||...+..+.
T Consensus 141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~ 219 (268)
T cd05063 141 NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219 (268)
T ss_pred cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 75 78999999998766432211 111224569999987654 45889999999999999997 9999987766555
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+|+..||++||++.++++
T Consensus 220 ~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 220 MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55442 36789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=245.90 Aligned_cols=185 Identities=21% Similarity=0.306 Sum_probs=148.5
Q ss_pred ccccccceeeeceeEEeCCe------EEEEEecCCCcHHHHHH-Hh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 6 KMNNHPNIVKLRNLVKEHED------VFIVFDYMESDLLKLMK-ES----AGQNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~------~~lv~e~~~g~ll~~~~-~~----~~~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
+.++|+||+++++++.+.+. .+++|||+.++.+..+. .. ....+++..+..++.|++.||+|||++||+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~ 135 (273)
T cd05035 56 KDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFI 135 (273)
T ss_pred HhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 33599999999998865544 79999999975554443 22 123589999999999999999999999999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
||||||+||++++ +.+||+|||+++....... .....++..|+|||.+.. ..++.++||||+||++|||++ |..
T Consensus 136 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCC
Confidence 9999999999986 6899999999987644321 112234668999998754 456889999999999999999 999
Q ss_pred CCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 150 LFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 150 pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
||.+....+....+. ..+.+++.+||+.||++|||+.+++++
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998776655444332 367899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=249.49 Aligned_cols=186 Identities=30% Similarity=0.513 Sum_probs=147.4
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+.++ +||||++++|++.+.+..++|+||+.++ +.+.+.......+++..+..++.|++.||.|||+++++|+||++.
T Consensus 54 ~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~ 132 (259)
T PF07714_consen 54 ILRKL-RHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPS 132 (259)
T ss_dssp HHHTH-SBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred ccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34555 9999999999999888899999999865 555555543567999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNS 156 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~ 156 (297)
||++++ +.+||+|||+++....... .....+...|+|||.+.... ++.++||||||+++|||++ |+.||.+.+.
T Consensus 133 nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 133 NILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp GEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc
Confidence 999985 7999999999987732211 12334567899999976554 5889999999999999999 7899988876
Q ss_pred HHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 157 ADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 157 ~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+...++. ..+.+++..|+..||++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 212 EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 66555553 26889999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=248.97 Aligned_cols=184 Identities=21% Similarity=0.371 Sum_probs=149.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc-----------------------CCCCCHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA-----------------------GQNFSEDEARNLCFQVF 62 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~-----------------------~~~l~e~~~~~~~~qll 62 (297)
+.++||||+++++.+.+++..|+++||+.++.+..++... ...+++..+..++.|++
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~ 137 (290)
T cd05045 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137 (290)
T ss_pred hhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHH
Confidence 3459999999999999999999999999976555544321 12478999999999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHH
Q 040202 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMG 138 (297)
Q Consensus 63 ~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 138 (297)
.||+|||++||+||||||+||++++ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||
T Consensus 138 ~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG 216 (290)
T cd05045 138 RGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFG 216 (290)
T ss_pred HHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHH
Confidence 9999999999999999999999975 789999999987653321 1123345678999998754 4468899999999
Q ss_pred HHHHHHHh-CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 139 AIMFEMLS-FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 139 v~l~ell~-g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+++++|++ |..||.+....+....+ ..++.+++.+||+.||++||++.++++
T Consensus 217 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999998 99999876655443332 237889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=242.94 Aligned_cols=183 Identities=27% Similarity=0.450 Sum_probs=148.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++. .+..|++|||+.++ +.+.+.......+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nil 134 (260)
T cd05070 56 KKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134 (260)
T ss_pred HhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 3359999999999885 45689999999874 444444433445899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||++......... ....++..|+|||.+... .++.++|+||||+++|+|++ |..||.+.+..+..
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 213 (260)
T cd05070 135 VGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213 (260)
T ss_pred EeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 986 68999999999776443211 123345679999987644 45789999999999999999 99999887766555
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+. ..+.+++.+||..||++|||++++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 214 EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 5443 36789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=244.39 Aligned_cols=184 Identities=18% Similarity=0.274 Sum_probs=144.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh-c---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES-A---GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~-~---~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++||||+++++.+.+....|+||||++++.+..++.. . ....++..++.++.|++.|++|||++|++||||||+
T Consensus 50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~ 129 (269)
T cd05087 50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR 129 (269)
T ss_pred HhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 445999999999999999999999999997555444432 1 124667888999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccc------cCCCccchhhHHHHHHHHHh-CCCC
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSE------ICGPEVDRWAMGAIMFEMLS-FRIL 150 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGv~l~ell~-g~~p 150 (297)
||++++ +.+||+|||+++....... .....++..|+|||++.... .++.++||||+||++|||++ |+.|
T Consensus 130 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p 209 (269)
T cd05087 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209 (269)
T ss_pred eEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence 999985 6899999999875433211 12345678899999875321 24678999999999999996 9999
Q ss_pred CCCCCCHHHHHHH-----------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 151 FPGKNSADQIYKI-----------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 151 f~~~~~~~~~~~i-----------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|......+..... ...+.+++.+|+ .+|++|||+++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 210 YRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 9776554432221 125678999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=245.57 Aligned_cols=184 Identities=22% Similarity=0.361 Sum_probs=151.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..++||||+.++.+..+....++.+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 60 ~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili 139 (269)
T cd05065 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV 139 (269)
T ss_pred HhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE
Confidence 34599999999999999999999999999877766665545569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCcc---cc---ccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTD---YV---TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSA 157 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 157 (297)
++ +.+||+|||++........... .. .+..|+|||.+... .++.++||||+||++|||++ |..||...+..
T Consensus 140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 140 NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 85 6899999999876543221111 11 13469999987654 45889999999999999886 99999877665
Q ss_pred HHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 DQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 ~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+....+. ..+.+++.+|+..+|++||++.+++.
T Consensus 219 ~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 219 DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5444432 25788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=243.31 Aligned_cols=184 Identities=26% Similarity=0.436 Sum_probs=149.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++++. .+..|++|||+.+ ++.+.+....+..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni 133 (260)
T cd05069 55 MKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133 (260)
T ss_pred HHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 34459999999999885 4568999999987 566665554445589999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++++ +.+||+|||+++....... .....++..|+|||.+... ..+.++||||+||++|+|++ |..||.+....+.
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 212 (260)
T cd05069 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212 (260)
T ss_pred EEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9975 7899999999977643321 1223456789999987644 45889999999999999999 9999988766554
Q ss_pred HHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+ ...+.+++++||..||++||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 213 LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 4433 236889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=243.47 Aligned_cols=185 Identities=22% Similarity=0.343 Sum_probs=145.9
Q ss_pred cccccccceeeeceeEE-eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVK-EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~-~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++. .++..|++|||+.++.+..+..+.....++..+..++.|++.||.|||+.|++||||||+||
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~ni 129 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNC 129 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 34459999999999775 45678999999987555555544344578888999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNS 156 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~ 156 (297)
|+++ +.+||+|||+++...... ......++..|+|||.+... .++.++|||||||++|||++ |..||...+.
T Consensus 130 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 208 (262)
T cd05058 130 MLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208 (262)
T ss_pred EEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9985 789999999987654321 11233456789999987654 45889999999999999999 4666765554
Q ss_pred HHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 157 ADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 157 ~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+....+ ...+.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 209 FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4433222 246789999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=243.73 Aligned_cols=184 Identities=30% Similarity=0.510 Sum_probs=149.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA-----GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~-----~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++||||+++++++...+..|+||||+.| ++.+++.... ...+++..+..++.|++.||+|||+.|++|+|||
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 133 (269)
T cd05044 54 SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133 (269)
T ss_pred HhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 445999999999999999999999999987 4455554321 2347899999999999999999999999999999
Q ss_pred CCcEEEeC-C-----eEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCC
Q 040202 80 PSNLLVSK-G-----VIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 80 p~Nill~~-~-----~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
|+||++++ + .+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |+.
T Consensus 134 p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred hheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCC
Confidence 99999985 4 699999999876543211 12334567899999886544 5889999999999999998 999
Q ss_pred CCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||...+..+....+ ...+.+++.+||..+|.+||++.++++
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 213 PYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99876655443332 346889999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=244.90 Aligned_cols=184 Identities=24% Similarity=0.370 Sum_probs=151.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.......+++..+..++.|++.|+.|||++|++||||||+||++
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili 139 (267)
T cd05066 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139 (267)
T ss_pred HhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE
Confidence 33589999999999999999999999999866655555544568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC----ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||++......... ....++..|+|||.+... .++.++|+||+||++|++++ |..||.+....+.
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~ 218 (267)
T cd05066 140 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218 (267)
T ss_pred CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence 75 78999999999876443211 112235679999998654 45889999999999999886 9999987765544
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+|++.+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 219 IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 44332 36789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=243.30 Aligned_cols=187 Identities=26% Similarity=0.435 Sum_probs=152.7
Q ss_pred cccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 5 RKMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.+.++|+||+++++.+.+. +.+++++||+.|+.+....... +.+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~n 136 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 3445999999999998764 5689999999886555544442 358999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|++++ +.++|+|||+++..... .......++..|+|||.+.+.. .+.++|+||+||++++|++|+.||......
T Consensus 137 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred EEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 99985 78999999999765321 1123456889999999876544 578999999999999999999999876555
Q ss_pred HHHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 158 DQIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 158 ~~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
....++ ...+.+++.+||. +|.+||++.+++.|||.
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 444332 2367899999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=244.88 Aligned_cols=184 Identities=25% Similarity=0.418 Sum_probs=150.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++++.+.+..|+|+||+.++.+..+... ....+++..+..++.|++.||+|||++|++||||||+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~n 136 (267)
T cd08228 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN 136 (267)
T ss_pred HhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHH
Confidence 344999999999999999999999999998555444321 23458999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC--HH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS--AD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--~~ 158 (297)
|+++. +.++|+|||++........ .....|+..|+|||.+.+.. .+.++|+||+|+++|+|++|+.||..... .+
T Consensus 137 il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 215 (267)
T cd08228 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215 (267)
T ss_pred EEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence 99985 7899999999887654321 23456788999999876544 57899999999999999999999965432 12
Q ss_pred HHH-------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIY-------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~-------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... .....+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 111 12246899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=244.26 Aligned_cols=187 Identities=26% Similarity=0.440 Sum_probs=154.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHH-H--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK-E--SAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLK 79 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~-~--~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdik 79 (297)
+.+..+|+||+++++++.+++..|+||||+.|+.+..+. . ..+..+++..++.++.|++.||.|||+ .|++||||+
T Consensus 62 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~ 141 (269)
T cd08528 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLT 141 (269)
T ss_pred HhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCC
Confidence 445579999999999999999999999999975444333 2 234569999999999999999999996 789999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+||++++ +.+||+|||++.............|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+...
T Consensus 142 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 142 PNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred HHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 99999975 78999999999876655444566789999999998754 45889999999999999999999997765443
Q ss_pred HHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 159 QIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 159 ~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
....+ ...+.+++.+||+.||++||++.++..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 221 LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 33222 3468899999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=242.05 Aligned_cols=182 Identities=23% Similarity=0.334 Sum_probs=146.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++. .+..++||||+.++.+..++.+. ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 51 ~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili 128 (257)
T cd05060 51 AQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL 128 (257)
T ss_pred HhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE
Confidence 4459999999999876 45689999999875444444442 369999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC----ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||+++........ ....++..|+|||.+... .++.++|||||||++|+|++ |..||...+..+.
T Consensus 129 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~ 207 (257)
T cd05060 129 VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207 (257)
T ss_pred cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 75 78999999999866443221 111224579999987644 46889999999999999998 9999987765544
Q ss_pred HHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+ ...+.+++.+||..||++||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 208 IAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4333 136789999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=241.28 Aligned_cols=182 Identities=25% Similarity=0.424 Sum_probs=150.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.+++..|+||||+.+ ++.+.+.......+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 55 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nil 134 (256)
T cd05039 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL 134 (256)
T ss_pred HhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEE
Confidence 344899999999999999999999999997 5555544443346999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||.++....... ...++..|+|||.+... .++.++|+||+|+++++|++ |..||...+..+....
T Consensus 135 i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 135 VSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred EeCCCCEEEcccccccccccccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 985 7899999999987744322 33446679999987644 45789999999999999997 9999977655443332
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+ ...+.+++++||..+|++||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2 346889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=244.41 Aligned_cols=184 Identities=25% Similarity=0.428 Sum_probs=150.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++|+||+++++++.+++..|++|||+.|+.+..+... .+..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~n 136 (267)
T cd08229 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 136 (267)
T ss_pred HHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 445999999999999999999999999998555544432 23458999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH--H
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA--D 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~--~ 158 (297)
|+++. +.++|+|||++........ .....|+..|+|||.+.... ++.++|+||+|+++|+|++|..||.+.... +
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08229 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred EEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence 99975 7899999999876644322 23457889999999876544 578899999999999999999999754432 1
Q ss_pred HHH-------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIY-------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~-------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... .....+.+++.+|+..||++|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 216 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 111 12347899999999999999999997754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=253.21 Aligned_cols=187 Identities=21% Similarity=0.393 Sum_probs=150.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
++++.+|+||+++++++.+++..|+++||+.++.+..+.... ...+++..+..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 444558999999999999999999999999875554444321 12377888999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+||++++ +.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||
T Consensus 151 H~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el 229 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred HHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHH
Confidence 9999999999999999984 7899999999987644321 1222335679999997654 458899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |..||.+.+..+....+. ..+.+++.+|+..+|++|||+.+++++
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 230 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 98 889998776555544432 267899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=246.76 Aligned_cols=182 Identities=22% Similarity=0.341 Sum_probs=145.1
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+ ...+|+||||+.++.+..+... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred HhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 34499999999998865 3468999999998666665554 3499999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA- 157 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~- 157 (297)
++++ +.+||+|||+++....... .....++..|+|||.+... .++.++|||||||++|+|++|..||......
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 217 (283)
T cd05080 139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKF 217 (283)
T ss_pred EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9975 7899999999887644321 1223446679999987644 4588999999999999999999998643211
Q ss_pred -------------HHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 -------------DQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 -------------~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..... ....+.+++.+|++.||++|||+++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 218 EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 1246789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=244.54 Aligned_cols=185 Identities=19% Similarity=0.308 Sum_probs=146.3
Q ss_pred ccccccceeeeceeEEeC------CeEEEEEecCCCcHH-HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 6 KMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLL-KLMKES----AGQNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll-~~~~~~----~~~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
+.++|+||+++++++... ...+++|||+.++.+ +.+... ....+++..+..++.|++.||+|||++||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 134 (272)
T cd05075 55 KEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFI 134 (272)
T ss_pred HhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 345999999999987432 257999999987444 444322 123489999999999999999999999999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
||||||+|||+++ +.+||+|||+++....... .....++..|+|||.+.. ..++.++||||+||++|+|++ |+.
T Consensus 135 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 135 HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred ccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999985 7899999999987644321 122345678999998764 445889999999999999999 899
Q ss_pred CCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 150 LFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 150 pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
||.+....+....+. ..+.+++.+||..||++|||+.+++++
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 214 PYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 998766554433332 367899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=242.18 Aligned_cols=184 Identities=21% Similarity=0.350 Sum_probs=144.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHH-HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLK-LMKESA--GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~-~~~~~~--~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++.+.+....|+||||+.++.+. .+.... ...+++..++.++.|++.||+|||+.+++||||||+|
T Consensus 50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~n 129 (268)
T cd05086 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRN 129 (268)
T ss_pred hccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccce
Confidence 4459999999999999999999999999975554 444321 1346778889999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceeccc------ccCCCccchhhHHHHHHHHHh-CCCCC
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLS------EICGPEVDRWAMGAIMFEMLS-FRILF 151 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGv~l~ell~-g~~pf 151 (297)
||+++ +.+||+|||++...... .......++..|+|||++... ..++.++|||||||++|||++ |..||
T Consensus 130 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 209 (268)
T cd05086 130 CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209 (268)
T ss_pred EEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence 99975 78999999998643221 112345678899999987431 123678999999999999996 57788
Q ss_pred CCCCCHHHHHHHH-----------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 152 PGKNSADQIYKIY-----------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 152 ~~~~~~~~~~~i~-----------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+..+...++. ..+.+++..|+ .+|++||+++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 210 SHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 7766555444321 24677898888 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=242.02 Aligned_cols=182 Identities=26% Similarity=0.431 Sum_probs=147.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
.++|+||+++++.+.+ +..|+||||+.+ ++.+.+....+..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 57 ~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill 135 (262)
T cd05071 57 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135 (262)
T ss_pred hCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence 3489999999998754 568999999987 44555544344568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||.++........ ....++..|+|||++... .++.++||||+||++|+|++ |..||.+....+...
T Consensus 136 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~ 214 (262)
T cd05071 136 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214 (262)
T ss_pred cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Confidence 75 78999999999766443221 233456789999987644 45889999999999999999 898998776555444
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+ ...+.+++.+|++.||++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 215 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 33 246789999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=240.41 Aligned_cols=185 Identities=27% Similarity=0.451 Sum_probs=152.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQN-FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~-l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++ +|+||+++++++.+.+..|++|||+.|+.+..+....... +++..+..++.|++.||+|||+.|++||||||+|
T Consensus 55 l~~l-~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~n 133 (258)
T smart00219 55 MRKL-DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 133 (258)
T ss_pred HHhc-CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccce
Confidence 3444 9999999999999999999999999885554444432223 9999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCc--cccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCT--DYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
|++++ +.++|+|||+++......... ...++..|+|||.+. ...++.++|+||+|+++++|++ |..||...+...
T Consensus 134 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 134 CLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred EEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99986 689999999998765442211 123678899999874 4556889999999999999998 888988766555
Q ss_pred HHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....+. .++.+++.+||..||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 544432 46889999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=243.25 Aligned_cols=183 Identities=24% Similarity=0.381 Sum_probs=149.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+ +..|+||||+.++.+..+.......+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 62 ~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili 140 (270)
T cd05056 62 RQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140 (270)
T ss_pred HhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE
Confidence 33489999999999876 45789999998765555555444568999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC--ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
+. +.+||+|||+++........ ....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 141 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 141 SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred ecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 85 78999999998876443221 12234567999998754 445889999999999999996 999998877665554
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
++ ...+.+++.+|+..+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 43 247899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=244.64 Aligned_cols=182 Identities=20% Similarity=0.287 Sum_probs=145.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.. ...++++||+.+ ++++.+.. ..+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 64 ~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil 141 (279)
T cd05109 64 AGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141 (279)
T ss_pred HhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 34589999999999875 457899999986 55555443 3356999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+++ +.+||+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|||++ |..||........
T Consensus 142 ~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05109 142 VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220 (279)
T ss_pred EcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 975 78999999999876543221 122346679999997654 45889999999999999998 8999976554333
Q ss_pred HHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+ ..++.+++.+||..||++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2222 235678999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=241.94 Aligned_cols=184 Identities=25% Similarity=0.425 Sum_probs=152.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++.++...|+||||+.++ +.+.+....+..+++..+..++.|++.|+.|||++|++||||||+||+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil 135 (261)
T cd05034 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135 (261)
T ss_pred hhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE
Confidence 3458999999999999989999999999875 445554444456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+++....... .....++..|+|||.+.+. .++.++|+||+||++++|++ |+.||.+.+.....
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 136 VGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred EcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 975 7899999999877653211 1122345679999987644 45889999999999999998 99999887766655
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.++. ..+.+++.+||..||.+||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 215 EQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5543 36889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=243.29 Aligned_cols=186 Identities=25% Similarity=0.450 Sum_probs=151.5
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG--------QNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~--------~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++ +|+||+++++++.+.+..|+||||+.++.+..+..... ..+++..+..++.|++.||+|||++||+|
T Consensus 62 l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H 140 (275)
T cd05046 62 FRKL-SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH 140 (275)
T ss_pred HHhc-CCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 4444 99999999999999999999999999755555444322 15899999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILF 151 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf 151 (297)
|||||+||++++ +.++++|||+++...... ......++..|+|||.+.+.. .+.++||||||+++|+|++ |..||
T Consensus 141 ~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 141 RDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred CcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999999999985 789999999986543221 223345677899999876544 4788999999999999998 88899
Q ss_pred CCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 152 PGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 152 ~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+.........+. ..+.+++.+||+.||.+|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 7766555444433 367899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=260.50 Aligned_cols=185 Identities=24% Similarity=0.396 Sum_probs=157.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++||+.....-+|+|||+|.||.|+.++++.++.++..+...++.+.+.||+|||+++++||||-..|+|
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL 294 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCL 294 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhe
Confidence 44479999999999999999999999999987777666666667999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCc-cccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCT-DYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++. +.+||+|||+++......... ...-...|+|||.+... .|+.++||||+||++||+++ |..||.+....+...
T Consensus 295 ~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~ 373 (474)
T KOG0194|consen 295 YSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA 373 (474)
T ss_pred ecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence 997 667999999987764222212 11235679999998765 77999999999999999998 888999999888877
Q ss_pred HHHH-------------HHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIYG-------------RWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~~-------------~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+|.. ....++.+|+..||++|+|+.++.+
T Consensus 374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 7732 5678899999999999999988754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.20 Aligned_cols=184 Identities=23% Similarity=0.316 Sum_probs=147.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG-----------QNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~-----------~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
+.++|+||+++++++...+..|+||||+.|+.+..+..... ..+++..+..++.|++.||.|||++|++
T Consensus 72 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~ 151 (295)
T cd05097 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV 151 (295)
T ss_pred HhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCee
Confidence 34599999999999999999999999999855555443321 1368899999999999999999999999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh--CC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS--FR 148 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~ 148 (297)
||||||+||++++ +.+||+|||+++....... .....++..|+|||++.... ++.++|+|||||++|+|++ |.
T Consensus 152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999975 6899999999876543221 12334467899999876544 5889999999999999988 67
Q ss_pred CCCCCCCCHHHHHHH-------------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 149 ILFPGKNSADQIYKI-------------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 149 ~pf~~~~~~~~~~~i-------------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.||...+..+....+ ...+.+++.+|++.||++||+++++++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 788776654433322 135789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=240.16 Aligned_cols=184 Identities=26% Similarity=0.472 Sum_probs=150.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++++. .+..|++|||+.+ ++.+.+....+..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni 133 (260)
T cd05067 55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI 133 (260)
T ss_pred HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence 34459999999999875 4678999999986 555555554455799999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++++ +.++|+|||++........ .....++..|+|||++... .++.++||||+|+++|+|++ |+.||.+.+..+.
T Consensus 134 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 212 (260)
T cd05067 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212 (260)
T ss_pred EEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 9985 7899999999977653221 1233456789999987644 45789999999999999998 9999987776555
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. .++.+++.+||..||++||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 213 IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44332 36899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.75 Aligned_cols=184 Identities=27% Similarity=0.391 Sum_probs=148.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhc--------------------CCCCCHHHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESA--------------------GQNFSEDEARNLCFQVFQG 64 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~--------------------~~~l~e~~~~~~~~qll~a 64 (297)
+.++||||+++++++.+++..|++|||+.++.+ +.+.... ...+++..+..++.|++.|
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 142 (288)
T cd05050 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAG 142 (288)
T ss_pred HhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHH
Confidence 345999999999999999999999999997544 4444321 1237888999999999999
Q ss_pred HHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHH
Q 040202 65 LHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAI 140 (297)
Q Consensus 65 l~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~ 140 (297)
|+|||++|++||||||+||++++ +.+||+|||++........ ......+..|+|||++.+. .++.++|||||||+
T Consensus 143 L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i 221 (288)
T cd05050 143 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVV 221 (288)
T ss_pred HHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHH
Confidence 99999999999999999999974 7899999999876543321 1223446679999987654 45889999999999
Q ss_pred HHHHHh-CCCCCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 141 MFEMLS-FRILFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 141 l~ell~-g~~pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+|+|++ |..||.+.+..+....+ ..++.+++.+||+.||.+|||+.|+++
T Consensus 222 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 222 LWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999997 88898776655544433 246889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.29 Aligned_cols=183 Identities=23% Similarity=0.311 Sum_probs=146.3
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG----------QNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~----------~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
.++|+||+++++++.+++..|+||||+.++.+..+..... ..+++..+..++.|++.||+|||+.|++||
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 154 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 3499999999999999999999999998755444443321 236778999999999999999999999999
Q ss_pred CCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh--CCCC
Q 040202 77 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS--FRIL 150 (297)
Q Consensus 77 dikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~--g~~p 150 (297)
||||+||++++ +.++|+|||+++....... .....++..|+|||+.... .++.++|+|||||++|||++ |..|
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99999999975 7899999999886543321 1223346779999986654 46889999999999999998 7788
Q ss_pred CCCCCCHHHHHHH-------------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 151 FPGKNSADQIYKI-------------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 151 f~~~~~~~~~~~i-------------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|...+..+..... ...+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8766554433221 235789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=240.37 Aligned_cols=185 Identities=25% Similarity=0.433 Sum_probs=150.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+++ ++|+||+++++.+.+++..++||||+.|+.+..+..+ .+..+++..+..++.|++.||.|||+.||+||||||
T Consensus 56 l~~-~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p 134 (267)
T cd08224 56 LKQ-LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP 134 (267)
T ss_pred HHh-CCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcCh
Confidence 344 4999999999999999999999999997555444432 234589999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA- 157 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~- 157 (297)
+||++++ +.++|+|||+++...... ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||......
T Consensus 135 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08224 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred hhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccH
Confidence 9999974 789999999987664432 22345688899999987644 4588999999999999999999999654321
Q ss_pred -HHHH-------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 -DQIY-------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 -~~~~-------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+... .+...+.+++.+||..+|++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111 23347889999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=265.18 Aligned_cols=184 Identities=28% Similarity=0.491 Sum_probs=158.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhcC--------CC----CCHHHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAG--------QN----FSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~~--------~~----l~e~~~~~~~~qll~al~yLH~ 70 (297)
|...++|||||+++|+|.+++-+|+|+|||. |+|-+++..+.. .. ++..+...++.||+.|++||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4556799999999999999999999999998 566666654321 12 8889999999999999999999
Q ss_pred CCccccCCCCCcEEEeCC-eEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 71 QGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~-~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
+.++||||-..|+||.++ .|||+|||+++.+...... ....-...||+||.|.++++ ++++||||+||+|||+++
T Consensus 622 ~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFS 700 (774)
T ss_pred CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhc
Confidence 999999999999999986 7899999999987654322 12233567999999997765 899999999999999997
Q ss_pred -CCCCCCCCCCHHHHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHH
Q 040202 147 -FRILFPGKNSADQIYKIYG------------RWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~l 188 (297)
|+.||.+..+.+.++.|.. ++.+|+..|++.+|.+||++.||
T Consensus 701 yG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 701 YGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 9999999999998887754 68999999999999999999987
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=242.04 Aligned_cols=183 Identities=21% Similarity=0.295 Sum_probs=148.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.. ...++||||+.++.+..........+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 64 ~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~ 142 (279)
T cd05057 64 ASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142 (279)
T ss_pred HhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE
Confidence 34599999999999987 78999999998755544444444569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCc---cccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCT---DYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++ +.+||+|||+++......... ...++..|+|||.+.. ..++.++|+||+||++||+++ |+.||.+....+..
T Consensus 143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 221 (279)
T cd05057 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221 (279)
T ss_pred cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 75 789999999998765432211 1223567999998754 445789999999999999998 99999887655544
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+. .++.+++.+|+..||++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3332 25788999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.06 Aligned_cols=94 Identities=34% Similarity=0.580 Sum_probs=82.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+.+..|+||||+.|+.+..++... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NIL 136 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNML 136 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEE
Confidence 45569999999999999999999999999875555554442 45899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCce
Q 040202 85 VSK-GVIKIGDLGMVK 99 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~ 99 (297)
++. +.+||+|||+++
T Consensus 137 l~~~g~vkL~DFGls~ 152 (669)
T cd05610 137 ISNEGHIKLTDFGLSK 152 (669)
T ss_pred EcCCCCEEEEeCCCCc
Confidence 975 899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=237.71 Aligned_cols=181 Identities=23% Similarity=0.397 Sum_probs=147.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++..+ ..|++|||+.| ++.+.+....+..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 54 ~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil 132 (254)
T cd05083 54 TKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132 (254)
T ss_pred HhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence 345999999999998764 47999999987 5555554443445899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
++. +.+||+|||+++...... .....+..|+|||.+... .++.++|+||+||++|+|++ |..||...+..+....
T Consensus 133 i~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 209 (254)
T cd05083 133 VSEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209 (254)
T ss_pred EcCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 985 789999999987654322 233446679999987644 45889999999999999997 9999987765544333
Q ss_pred H------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 163 I------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 163 i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+ ...+.+++.+||..+|++||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 210 VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 236789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=252.49 Aligned_cols=186 Identities=23% Similarity=0.329 Sum_probs=146.6
Q ss_pred cccccccccceeeeceeEEeCC-eEEEEEecCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHE-DVFIVFDYMESDLLKLMKESAGQ-NFSEDEARNLCFQVFQGLHYMHRQG---YFHRD 77 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~-~~~lv~e~~~g~ll~~~~~~~~~-~l~e~~~~~~~~qll~al~yLH~~g---i~Hrd 77 (297)
.|-++ +|||+|+++|+|.+.+ ..+||+||+.+|.|...+..... .++|....+|+.+++.||+|||... |+|||
T Consensus 124 ~ls~l-~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrD 202 (361)
T KOG1187|consen 124 ILSRL-RHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRD 202 (361)
T ss_pred HHhcC-CCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCC
Confidence 34455 7999999999999998 59999999986555444433333 7999999999999999999999864 99999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCC-CCCCccc-cccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDY-VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||+.|||+|+ ...||+|||+|+.... .....+. .||.+|+|||.+.. +..+.++|||||||++.|+++|+.+.+..
T Consensus 203 iKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 203 IKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999999995 6899999999977665 4333333 89999999998765 45589999999999999999999887643
Q ss_pred CCH-----HHHH-------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 155 NSA-----DQIY-------------------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 155 ~~~-----~~~~-------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... ..+. +....+..+..+|++.+|.+||++.++++
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 210 0100 11123456778999999999999998644
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=246.39 Aligned_cols=185 Identities=23% Similarity=0.396 Sum_probs=145.8
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++.+. ...|+||||+.|+.+..+..+....+++..+..++.|++.||+|||++|++||||||+||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Ni 140 (284)
T cd05079 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140 (284)
T ss_pred HhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheE
Confidence 445999999999999875 678999999988666665554344689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC--
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS-- 156 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-- 156 (297)
++++ +.+||+|||+++....... .....++..|+|||++.+. .++.++||||+||++|+|+++..|+.....
T Consensus 141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred EEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchh
Confidence 9975 7899999999886643321 1234567789999987654 457899999999999999997765422110
Q ss_pred ------------HHHH-------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 157 ------------ADQI-------------YKIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 157 ------------~~~~-------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.... ..+...+.+|+.+||+.||++|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000 0112467899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=271.79 Aligned_cols=184 Identities=25% Similarity=0.351 Sum_probs=146.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA----------GQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~----------~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++||||+++++++.+++..|+||||++|+.+..+.... ...++...+..++.||+.||+|||++||+|
T Consensus 57 s~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIH 136 (932)
T PRK13184 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLH 136 (932)
T ss_pred HhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3458999999999999999999999999986665544321 123556778999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCC-------------------CCCccccccCCCCCCceecccccCCCccchh
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-------------------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRW 135 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 135 (297)
|||||+||+++. +.+||+|||+++..... ......+||+.|+|||++.+. .++.++|||
T Consensus 137 RDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIW 215 (932)
T PRK13184 137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIY 215 (932)
T ss_pred cCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHH
Confidence 999999999985 88999999999765210 011235789999999987654 458899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHH--------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 136 AMGAIMFEMLSFRILFPGKNSADQIY--------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 136 SlGv~l~ell~g~~pf~~~~~~~~~~--------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|+||++|||++|+.||.......... .+...+.+++.+||..||++|++..+.+.
T Consensus 216 SLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 216 ALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999997755433221 12345789999999999999987665443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=237.47 Aligned_cols=184 Identities=25% Similarity=0.443 Sum_probs=150.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+||+++++.+.+ ...|++|||+.+ ++.+.+....+..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 133 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 133 (260)
T ss_pred HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 344599999999999987 788999999986 555555544445688999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+++. +.+||+|||.+........ .....++..|+|||++... .++.++|+|||||++|++++ |..||.+.+..+.
T Consensus 134 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~ 212 (260)
T cd05073 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212 (260)
T ss_pred EEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9985 7899999999876543221 1223345679999987644 45889999999999999998 9999988766555
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. .++.+++.+|+..||++||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 54432 36789999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=252.75 Aligned_cols=142 Identities=19% Similarity=0.363 Sum_probs=117.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecc
Q 040202 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLL 124 (297)
Q Consensus 49 l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~ 124 (297)
+++..++.++.||+.||+|||+.||+||||||+|||+++ +.+||+|||+++...... ......++..|+|||.+..
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 677788999999999999999999999999999999986 789999999998653321 1234456788999998765
Q ss_pred cccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 125 SEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 125 ~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
. .++.++||||+||++|||++ |..||......+..... ..++.+++.+|+..||.+||++.++++
T Consensus 316 ~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 316 N-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred C-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4 45889999999999999998 89999876655543332 246789999999999999999999976
Q ss_pred C
Q 040202 191 H 191 (297)
Q Consensus 191 h 191 (297)
.
T Consensus 395 ~ 395 (401)
T cd05107 395 L 395 (401)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=232.87 Aligned_cols=188 Identities=24% Similarity=0.392 Sum_probs=148.1
Q ss_pred ccccccccceeeeceeEEeC-----CeEEEEEecCC-CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 040202 4 LRKMNNHPNIVKLRNLVKEH-----EDVFIVFDYME-SDLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQG--Y 73 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~-g~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~g--i 73 (297)
+.|..+||||++++++...+ ...||++.|.. |++++.+... .|..++|.++..|+.++++||++||+.. +
T Consensus 71 ~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~y 150 (302)
T KOG2345|consen 71 NHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPY 150 (302)
T ss_pred HHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcc
Confidence 45667999999999987433 35999999997 5677777653 3346999999999999999999999999 9
Q ss_pred cccCCCCCcEEEeC-CeEEEEecCCceecCCCCCC----------ccccccCCCCCCceeccc--ccCCCccchhhHHHH
Q 040202 74 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----------TDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAI 140 (297)
Q Consensus 74 ~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~----------~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~ 140 (297)
+||||||.|||+++ +..++.|||.++...-.... .....|..|.|||.+.-+ ...++++|||||||+
T Consensus 151 AH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 151 AHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCT 230 (302)
T ss_pred cccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHH
Confidence 99999999999986 89999999998654322111 123458899999987643 234689999999999
Q ss_pred HHHHHhCCCCCCCCCC---------------HHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 141 MFEMLSFRILFPGKNS---------------ADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 141 l~ell~g~~pf~~~~~---------------~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+|+|+.|..||+..-. .......+..+.++|++||+.||.+||++.+++.+
T Consensus 231 LYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 231 LYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999953111 00111245578999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=258.87 Aligned_cols=185 Identities=22% Similarity=0.356 Sum_probs=152.8
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.++|. +|.||+=|.|++..... .||+-+|+| +|+.+++.. ...|.....+.|++|++.|+.|||.++|||||||..
T Consensus 441 ~lkkT-RH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSn 517 (678)
T KOG0193|consen 441 VLKKT-RHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSN 517 (678)
T ss_pred HHhhc-chhhheeeehhhcCCce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcccc
Confidence 35666 99999999999998777 999999999 555555544 355999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceec---CCCCCCccccccCCCCCCceeccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 82 NLLVSK-GVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~---~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
||++.+ +.|||+|||++..- ..........|+..|||||++... -.|++.+||||||||+|||++|..||...+
T Consensus 518 NIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~ 597 (678)
T KOG0193|consen 518 NIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN 597 (678)
T ss_pred ceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC
Confidence 999986 89999999998543 333334566778899999998754 346889999999999999999999998444
Q ss_pred CHHHHH----------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 156 SADQIY----------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 156 ~~~~~~----------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....++ +...++++|+..|+..++++||.+.+||.
T Consensus 598 ~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 598 RDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 333222 12237899999999999999999998876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=242.03 Aligned_cols=194 Identities=25% Similarity=0.392 Sum_probs=164.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcH---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL---LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLK 79 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l---l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdik 79 (297)
.+|..+.||||+|||+.-.++..||-||+|+-++ ++++....+..++|..+-.+..-.+.||+||-.. .|||||+|
T Consensus 116 ~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK 195 (361)
T KOG1006|consen 116 VMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK 195 (361)
T ss_pred HHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence 4566689999999999999999999999998643 4444444456799999999999999999999964 89999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccccc-CCCccchhhHHHHHHHHHhCCCCCCCCCC-
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI-CGPEVDRWAMGAIMFEMLSFRILFPGKNS- 156 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGv~l~ell~g~~pf~~~~~- 156 (297)
|.|||++. |.+||+|||.+..+..+...+...|...|||||.+..... |+.++|+||||+++||+.||..|+.+.+.
T Consensus 196 PSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv 275 (361)
T KOG1006|consen 196 PSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV 275 (361)
T ss_pred hhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence 99999996 9999999999988887777778899999999999875433 78999999999999999999999977543
Q ss_pred HHHHHHHH-----------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 ADQIYKIY-----------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 ~~~~~~i~-----------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+++..+. ..++.+|.-||.+|-++||...+++++||++..
T Consensus 276 feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 276 FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 33333332 257899999999999999999999999999753
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=244.05 Aligned_cols=183 Identities=19% Similarity=0.298 Sum_probs=145.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|+||+++++++... ..++++||+.++ +.+.+. .....+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 64 ~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nil 141 (303)
T cd05110 64 ASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVL 141 (303)
T ss_pred HhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceee
Confidence 445999999999998754 567999999864 555444 33446899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+++ +.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+......
T Consensus 142 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~ 220 (303)
T cd05110 142 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220 (303)
T ss_pred ecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 975 7899999999987643321 123345678999998764 445889999999999999997 8999977553332
Q ss_pred HHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 IYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
...+ ...+.+++.+|+..||++||+++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 1357889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=260.80 Aligned_cols=181 Identities=28% Similarity=0.477 Sum_probs=149.9
Q ss_pred ccccccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESA--GQNFSEDEARNLCFQVFQGLHYMHRQGY 73 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~--~~~l~e~~~~~~~~qll~al~yLH~~gi 73 (297)
.+|+|+ +|+|||+++++-++.. .-.+|||||.||.+..+..+. ..+++|.+++.++..+..||.|||++||
T Consensus 63 eilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~I 141 (732)
T KOG4250|consen 63 EILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGI 141 (732)
T ss_pred HHHHHc-CchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 356666 8999999999887544 468999999987666665542 2469999999999999999999999999
Q ss_pred cccCCCCCcEEEeC---C--eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCC
Q 040202 74 FHRDLKPSNLLVSK---G--VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFR 148 (297)
Q Consensus 74 ~Hrdikp~Nill~~---~--~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~ 148 (297)
+||||||+||++-. | ..||+|||.|+.+..+..+.+.+||..|.+||++...++|+..+|.||+||++|+.+||.
T Consensus 142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred eeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 99999999999842 3 579999999999999999999999999999999876678899999999999999999999
Q ss_pred CCCCCCCCH----HHHHHHHH------------------------------------HHHHHHHHhhhcCCCCCC
Q 040202 149 ILFPGKNSA----DQIYKIYG------------------------------------RWVALISWLCSWNPRMRP 183 (297)
Q Consensus 149 ~pf~~~~~~----~~~~~i~~------------------------------------~~~~li~~~l~~dP~~R~ 183 (297)
.||-..... +..+.+.. .+-..+..+|..||++|.
T Consensus 222 lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 222 LPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 999654333 23333221 234577888999999998
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=240.01 Aligned_cols=180 Identities=16% Similarity=0.186 Sum_probs=143.8
Q ss_pred ccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 8 NNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+|+||+++++.+.... ..|+++|++..++.+.+... ..+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 80 ~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Ni 157 (294)
T PHA02882 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENI 157 (294)
T ss_pred CCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 48999999999776543 45888998877665544432 3478999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC--------CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
|++. +.+||+|||+|+..... .......||+.|+|||++.+ ..++.++||||+||+++||++|+.||.+.
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9985 78999999999765321 11123568999999998764 44689999999999999999999999877
Q ss_pred CCHHH---------HHHH----------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 155 NSADQ---------IYKI----------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 155 ~~~~~---------~~~i----------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..... ..++ ...+.++++.|+..+|.+||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 43221 1111 125788999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=261.89 Aligned_cols=194 Identities=22% Similarity=0.407 Sum_probs=166.4
Q ss_pred cccccccccceeeeceeEE-----eCCeEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 3 FLRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
+|+....|||++++||+|. .++.+|||||||.||+...+.+. .+..+.|..+..|++.++.|+.+||++.++||
T Consensus 68 il~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHR 147 (953)
T KOG0587|consen 68 MLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHR 147 (953)
T ss_pred HHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeee
Confidence 5677789999999999995 35689999999998777666554 45679999999999999999999999999999
Q ss_pred CCCCCcEEEe-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceecccc----cCCCccchhhHHHHHHHHHhCCCC
Q 040202 77 DLKPSNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSE----ICGPEVDRWAMGAIMFEMLSFRIL 150 (297)
Q Consensus 77 dikp~Nill~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGv~l~ell~g~~p 150 (297)
|||-.|||++ ++.|||+|||++..+... ....+.+||+.|||||++.... .|+..+|+||||++..||..|.+|
T Consensus 148 DikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP 227 (953)
T KOG0587|consen 148 DIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP 227 (953)
T ss_pred cccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence 9999999997 589999999998776543 3347889999999999987543 356789999999999999999999
Q ss_pred CCCCCCHHHH--------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 151 FPGKNSADQI--------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 151 f~~~~~~~~~--------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+.+......+ .+.+.++.+||..||..|-.+||+..++|+|||++.
T Consensus 228 l~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 228 LCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8776554443 345668899999999999999999999999999973
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=247.34 Aligned_cols=188 Identities=22% Similarity=0.375 Sum_probs=146.6
Q ss_pred cccccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhcC-----------------------------------
Q 040202 3 FLRKMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESAG----------------------------------- 46 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~~----------------------------------- 46 (297)
.+.++.+|+||+++++++.. +...|+||||++++.+..+.....
T Consensus 63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (343)
T cd05103 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSIT 142 (343)
T ss_pred HHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccc
Confidence 34555589999999998864 457899999999755544433211
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEe
Q 040202 47 -------------------------------QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGD 94 (297)
Q Consensus 47 -------------------------------~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~D 94 (297)
..+++..+..++.|++.||+|||++||+||||||+||++++ +.+||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~d 222 (343)
T cd05103 143 SSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICD 222 (343)
T ss_pred cccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEe
Confidence 23678889999999999999999999999999999999984 7899999
Q ss_pred cCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHH-------
Q 040202 95 LGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKI------- 163 (297)
Q Consensus 95 fgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i------- 163 (297)
||+++...... ......++..|+|||++... .++.++||||+||++|+|++ |..||.+..........
T Consensus 223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 301 (343)
T cd05103 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301 (343)
T ss_pred cccccccccCcchhhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC
Confidence 99987653321 11223456679999987644 45889999999999999997 99999775443322221
Q ss_pred ------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 164 ------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 164 ------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..++.+++.+|+..||++|||+.++++|
T Consensus 302 ~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2367889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=265.69 Aligned_cols=194 Identities=25% Similarity=0.417 Sum_probs=157.2
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh-cCCCCCH-HHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES-AGQNFSE-DEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~-~~~~l~e-~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.|+..=.|||||++|+.-.+.+++||..|.|..+|.+++... ....+.. ...+..+.|++.||++||+.+|+||||||
T Consensus 555 lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkP 634 (903)
T KOG1027|consen 555 LLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKP 634 (903)
T ss_pred HHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCC
Confidence 455566899999999999999999999999999998888764 1111222 45688999999999999999999999999
Q ss_pred CcEEEeC----C--eEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC-CC
Q 040202 81 SNLLVSK----G--VIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RI 149 (297)
Q Consensus 81 ~Nill~~----~--~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~ 149 (297)
+||||+. + .++|+|||+++.+..+.. ..+.-||-+|+|||++..... ..++||+|+|||+|+.++| ..
T Consensus 635 QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~H 713 (903)
T KOG1027|consen 635 QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSH 713 (903)
T ss_pred ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCcc
Confidence 9999964 3 689999999999865432 345678999999999876554 6689999999999998886 99
Q ss_pred CCCCCCCHHHHH--------HH--HH--HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 150 LFPGKNSADQIY--------KI--YG--RWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 150 pf~~~~~~~~~~--------~i--~~--~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
||.+....+.-- ++ .. +..+||.+|+..||..||+|.++|.||+|-+.
T Consensus 714 pFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 714 PFGDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred CCCchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 997654332110 00 01 67899999999999999999999999999553
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=238.57 Aligned_cols=182 Identities=19% Similarity=0.350 Sum_probs=146.9
Q ss_pred ccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 8 NNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESAG-------QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~~-------~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
++|+||+++++++.+ +...++++||+.++.+..+..... ..+++..+..++.|++.||+|||++|++|||||
T Consensus 65 l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred CCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 499999999998765 578899999998755554443321 358999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGK 154 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~ 154 (297)
|+||++++ +.+||+|||+++.+.... ......++..|+|||++... .++.++||||+||++||+++ |+.||...
T Consensus 145 p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 145 ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred HhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 99999975 789999999998653321 11223456779999987644 45889999999999999999 99999876
Q ss_pred CCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 155 NSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 155 ~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+..+....+ ..++.+++.+|+..||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 224 DPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 554433322 236889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=240.65 Aligned_cols=183 Identities=21% Similarity=0.351 Sum_probs=141.9
Q ss_pred cccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 7 MNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.++||||+++++++.. ...+|+||||+.++.+..+....+..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 61 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nil 140 (284)
T cd05081 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL 140 (284)
T ss_pred hCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEE
Confidence 3599999999998753 45789999999875555544443456899999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCC----ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH-
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD- 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~- 158 (297)
+++ +.+||+|||+++........ ....++..|+|||++.+. .++.++||||+||+++||++|..++.......
T Consensus 141 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 219 (284)
T cd05081 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM 219 (284)
T ss_pred ECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh
Confidence 975 78999999999876433211 112234469999987644 45889999999999999999877654322110
Q ss_pred --------------HHH-------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 --------------QIY-------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 --------------~~~-------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... .+...+.+++.+|+..+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 220 RMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 01236889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=276.81 Aligned_cols=188 Identities=16% Similarity=0.269 Sum_probs=144.6
Q ss_pred cccc-cceeeeceeE-------EeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 7 MNNH-PNIVKLRNLV-------KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 7 l~~H-pnIv~~~~~~-------~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.++| .||+++++.| .+.+..+++|||++++|.+.+... ...+++.+++.+++||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3477 7999999988 334578889999988888777543 356999999999999999999999999999999
Q ss_pred CCCcEEEeC--------------------CeEEEEecCCceecCCC-----------------CCCccccccCCCCCCce
Q 040202 79 KPSNLLVSK--------------------GVIKIGDLGMVKEIDSS-----------------LPCTDYVTTRWYRAPEV 121 (297)
Q Consensus 79 kp~Nill~~--------------------~~~kl~Dfgla~~~~~~-----------------~~~~~~~gt~~y~aPE~ 121 (297)
||+|||++. +.+|++|||+++..... .......||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999942 34667777776542110 00112467999999999
Q ss_pred ecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH-HH-HH--------HHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD-QI-YK--------IYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 122 ~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~-~~-~~--------i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+.+.. ++.++|||||||++|||++|..|+....... .. .. ......+++.+||..||.+||++.++++|
T Consensus 187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 187 DNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 87554 5899999999999999999988875432110 00 00 01245678899999999999999999999
Q ss_pred CCCCC
Q 040202 192 PFFRS 196 (297)
Q Consensus 192 ~~f~~ 196 (297)
|||..
T Consensus 266 ~~~~~ 270 (793)
T PLN00181 266 EFINE 270 (793)
T ss_pred hhhhh
Confidence 99965
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=229.92 Aligned_cols=185 Identities=38% Similarity=0.664 Sum_probs=157.3
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
++|+||+++++.+......++++||+.++.+..+..... .+++..+..++.+++.++.|||+.|++|+||+|.||++++
T Consensus 44 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~ 122 (244)
T smart00220 44 LKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE 122 (244)
T ss_pred CCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC
Confidence 499999999999999999999999999844444444322 3899999999999999999999999999999999999985
Q ss_pred -CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH----
Q 040202 88 -GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK---- 162 (297)
Q Consensus 88 -~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~---- 162 (297)
+.++|+|||.+.............++..|++||.+... ..+.++|+||+|+++++|++|..||..........+
T Consensus 123 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~ 201 (244)
T smart00220 123 DGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 201 (244)
T ss_pred CCcEEEccccceeeeccccccccccCCcCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 79999999999887765455667789999999987644 447799999999999999999999977433333222
Q ss_pred -----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 -----------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 -----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..++.+++.+|+..||++||++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 33467899999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=242.27 Aligned_cols=193 Identities=28% Similarity=0.461 Sum_probs=162.8
Q ss_pred cccccccccceeeeceeEE-eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVK-EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDLK 79 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~-~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdik 79 (297)
.++|-+.||-||++|++|. +.+..|-|+|||+|+.++++++.. +.++|++++.|+.||+.||.||.... |||-|||
T Consensus 519 rIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLK 597 (775)
T KOG1151|consen 519 RIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLK 597 (775)
T ss_pred hhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Confidence 4678899999999999996 667889999999998888888774 46999999999999999999999874 9999999
Q ss_pred CCcEEEeC----CeEEEEecCCceecCCCC--------CCccccccCCCCCCceeccc---ccCCCccchhhHHHHHHHH
Q 040202 80 PSNLLVSK----GVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLS---EICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 80 p~Nill~~----~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGv~l~el 144 (297)
|.|||+.+ |.+||.|||+++.+.... ......||-||++||.+.-+ ...+.++||||+|||+|..
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC 677 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC 677 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence 99999954 679999999999876542 23457899999999998644 2346789999999999999
Q ss_pred HhCCCCCCCCCCHHHH---HHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 145 LSFRILFPGKNSADQI---YKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 145 l~g~~pf~~~~~~~~~---~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+.|+-||........+ ..| ..+.++||++||.+--++|..+.++-.||||..
T Consensus 678 lYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 678 LYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 9999999765433221 111 236899999999999999999999999999964
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=238.32 Aligned_cols=184 Identities=21% Similarity=0.371 Sum_probs=146.2
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++.. +...|++|||+.++.+..+.......+++..+..++.|++.||+|||++|++||||||+||
T Consensus 61 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred HhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 34499999999999987 6689999999987555555544344599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++++ +.+||+|||++........ .....++..|+|||.+... .++.++|||||||+++||++|..|+.......
T Consensus 141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 219 (284)
T cd05038 141 LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEF 219 (284)
T ss_pred EEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchh
Confidence 9985 7899999999987653211 1122345669999987644 45789999999999999999999986543211
Q ss_pred --------------HHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 --------------QIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 --------------~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.... ...++.+++.+||..||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 220 LRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 1236789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=249.18 Aligned_cols=184 Identities=26% Similarity=0.512 Sum_probs=158.1
Q ss_pred cceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA-GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-- 87 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~-~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-- 87 (297)
-|+++|+..|...+++|||||-+.-+|-+.+.+.. ..+|....++.|+.||+.||..|-+.||+|.||||+|||+++
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 47899999999999999999999887776655431 124888999999999999999999999999999999999986
Q ss_pred CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Q 040202 88 GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---- 163 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i---- 163 (297)
+.+||||||.|-....+.. +-+..+..|.|||++.+.. |+...|+||+||+||||.||+..|+|.+..+++.-.
T Consensus 574 ~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred ceeeeccCccccccccccc-cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 6899999999987766543 4566788999999998654 589999999999999999999999998887765421
Q ss_pred -------------------------------------------------------------------HHHHHHHHHHhhh
Q 040202 164 -------------------------------------------------------------------YGRWVALISWLCS 176 (297)
Q Consensus 164 -------------------------------------------------------------------~~~~~~li~~~l~ 176 (297)
...+++|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 1146889999999
Q ss_pred cCCCCCCCHHHHHcCCCCCC
Q 040202 177 WNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 177 ~dP~~R~t~~~ll~h~~f~~ 196 (297)
.||++|.|+.++|+||||..
T Consensus 732 LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cChhhcCCHHHHhcCCcccC
Confidence 99999999999999999963
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=264.16 Aligned_cols=185 Identities=25% Similarity=0.466 Sum_probs=154.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA-----GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~-----~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
++-.+|||||+++|++-+....+|++|||.| +|+.++.+.. ...++..+...++.|++.|++||+++++|||||
T Consensus 749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 3445999999999999999999999999987 5555555431 345899999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCcc--c-cccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD--Y-VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPG 153 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~--~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~ 153 (297)
...|+||+. ..+||+|||+|+.+........ . .-...|||||.+.+ ..++.++|||||||++||+++ |..||.+
T Consensus 829 AaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 829 AARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred hhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999986 7899999999996544322111 1 12346999999876 556999999999999999998 9999999
Q ss_pred CCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 154 KNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 154 ~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+..+.+.... ..+.+++..|+..+|++||++..|++
T Consensus 908 ~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 908 RSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 98888776433 35789999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=237.34 Aligned_cols=191 Identities=31% Similarity=0.600 Sum_probs=164.3
Q ss_pred ccccccceeeeceeEEeCC-----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
-..+|.|++...++.+-.+ .+|.++|.+..++-+.+..- ..++.+.++-+++||+.||+|||+.||.||||||
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKP 184 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKP 184 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCC
Confidence 3458999999999886543 47889999888877766543 5699999999999999999999999999999999
Q ss_pred CcEEEeCC-eEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 81 SNLLVSKG-VIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 81 ~Nill~~~-~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
.|+|++.| .+||+|||+++..... ..++..+.|..|.|||++.+.+.|+..+||||+|||+.|++..+..|...+..
T Consensus 185 GNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 185 GNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred ccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 99999876 6799999999876543 34456677999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHH---------------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 158 DQIYKIYG---------------------------------------------RWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 158 ~~~~~i~~---------------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
+++.-|.+ +...++.++|..||++|++.++++.|+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 88776543 246789999999999999999999999
Q ss_pred CCCCCC
Q 040202 193 FFRSCH 198 (297)
Q Consensus 193 ~f~~~~ 198 (297)
+.....
T Consensus 345 ~~~e~R 350 (449)
T KOG0664|consen 345 YLEEGR 350 (449)
T ss_pred cccccc
Confidence 996543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=263.47 Aligned_cols=169 Identities=33% Similarity=0.523 Sum_probs=135.9
Q ss_pred CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceec
Q 040202 23 HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 101 (297)
Q Consensus 23 ~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~ 101 (297)
...+||-||||+..++++++.+....-.-..++++|+||+.||.|+|+.|||||||||.||++|+ +.|||+|||+|+..
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 35799999999999999998874321147889999999999999999999999999999999985 89999999999762
Q ss_pred C-------------------CCCCCccccccCCCCCCceecccc--cCCCccchhhHHHHHHHHHh--------------
Q 040202 102 D-------------------SSLPCTDYVTTRWYRAPEVLLLSE--ICGPEVDRWAMGAIMFEMLS-------------- 146 (297)
Q Consensus 102 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell~-------------- 146 (297)
. .....++.+||-.|+|||++.+.. .|+.|+|+||||||++||+.
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~ 827 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTN 827 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHh
Confidence 1 112346778999999999987665 58999999999999999984
Q ss_pred ---CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 147 ---FRILFPGKNSADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 147 ---g~~pf~~~~~~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
|..|++..- ...-...-..+|++||+.||++||||.|+|++.||-
T Consensus 828 LR~g~iP~~~~f----~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 828 LRKGSIPEPADF----FDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred cccCCCCCCccc----ccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 333333000 001112336799999999999999999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=253.49 Aligned_cols=177 Identities=24% Similarity=0.370 Sum_probs=131.2
Q ss_pred EeCCeEEEEEecCCCcHHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 21 KEHEDVFIVFDYMESDLLKLMKESAGQ-------------------NFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 21 ~~~~~~~lv~e~~~g~ll~~~~~~~~~-------------------~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.++..+++|+||+.++.+..+...... ...+..++.++.||+.||+|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 356689999999998655444432111 1124457789999999999999999999999999
Q ss_pred cEEEeC--CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccc---------------------cCCCccchhh
Q 040202 82 NLLVSK--GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSE---------------------ICGPEVDRWA 136 (297)
Q Consensus 82 Nill~~--~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwS 136 (297)
|||+++ +.+||+|||+|+.+... ......++++.|+|||.+.... .+..++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999984 68999999999865432 2335678899999999754321 1234569999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------------------------HHHHHHHHHhhhcCCCCCC
Q 040202 137 MGAIMFEMLSFRILFPGKNSADQIYKIY---------------------------------GRWVALISWLCSWNPRMRP 183 (297)
Q Consensus 137 lGv~l~ell~g~~pf~~~~~~~~~~~i~---------------------------------~~~~~li~~~l~~dP~~R~ 183 (297)
+||++|||+++..+++.. .....++. ....+||.+||+.||++||
T Consensus 365 lGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 999999999977664321 11111100 0234799999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q 040202 184 TAAEALEHPFFRSCHF 199 (297)
Q Consensus 184 t~~~ll~h~~f~~~~~ 199 (297)
|+.++|+||||++...
T Consensus 443 ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 443 SAKAALAHPYFDREGL 458 (566)
T ss_pred CHHHHhCCcCcCCCCc
Confidence 9999999999987554
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=229.57 Aligned_cols=184 Identities=20% Similarity=0.311 Sum_probs=144.2
Q ss_pred ccccccceeeeceeEEeCC------eEEEEEecCCCcHHHH-HHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 6 KMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKL-MKESA----GQNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~-~~~~~----~~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
+.++||||+++++++...+ ..++++||+.++.+.. +.... ...+++..+..++.|++.||+|||++||+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 135 (273)
T cd05074 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFI 135 (273)
T ss_pred hcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 3449999999999886432 3478999998755543 33221 12478999999999999999999999999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
||||||+||++++ +.+||+|||+++....... .....++..|++||.+... .++.++|||||||++|+|++ |+.
T Consensus 136 H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 136 HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred ecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCC
Confidence 9999999999985 7899999999886643221 1233446789999987644 45789999999999999999 899
Q ss_pred CCCCCCCHHHHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQIYKI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||.+.+..+....+ ...+.+++.+||..+|++||++.++++
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99776654433332 246789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=230.52 Aligned_cols=76 Identities=37% Similarity=0.642 Sum_probs=70.0
Q ss_pred ccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEE
Q 040202 10 HPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLL 84 (297)
Q Consensus 10 HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nil 84 (297)
-.+||++++.|.. +.++++|+|+++..||..|.....++++...++.|++|+|.||.|||. .||||-||||+|||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 3579999999974 568999999999999999999888889999999999999999999996 49999999999999
Q ss_pred E
Q 040202 85 V 85 (297)
Q Consensus 85 l 85 (297)
+
T Consensus 221 l 221 (590)
T KOG1290|consen 221 L 221 (590)
T ss_pred e
Confidence 5
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=239.85 Aligned_cols=273 Identities=18% Similarity=0.225 Sum_probs=191.6
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.|+++ +|+|+|++||+..+ ...-+|||++.+ +|++.+.+.....|.....-.|+.||+.|+.||.++++|||||...
T Consensus 164 ~M~~L-~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 164 HMLKL-QHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred HHHhc-cCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 35566 99999999999988 788999999985 7778877745567999999999999999999999999999999999
Q ss_pred cEEEe-CCeEEEEecCCceecCCCCCCcccc----ccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 040202 82 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYV----TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKN 155 (297)
Q Consensus 82 Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~ 155 (297)
|+|+- ...|||+|||+.+.+..+....... -...|.|||.+...+ ++.++|+|++||++|||++ |+.||.|..
T Consensus 242 NlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 242 NLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred hheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 99996 5899999999999887664332222 234599999987554 4889999999999999997 899999999
Q ss_pred CHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCCCCCCCccCCCcccCCCCCccc--
Q 040202 156 SADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEAVAFPTATV-- 221 (297)
Q Consensus 156 ~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (297)
....+.+|. +++.+++..|+..+|++|||+..|.+.-+................+.+...+...+.
T Consensus 321 g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~ep~aLh~~kgD~Iv 400 (1039)
T KOG0199|consen 321 GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIEPGALHLTKGDEIV 400 (1039)
T ss_pred HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccCCCceeeccCCeEE
Confidence 988888775 368999999999999999999988655444322111111111112222222222221
Q ss_pred cccCccccccCCCCCCCcccchhhhcccCCC-CCcccCCCCCCcccccccccccccccccC
Q 040202 222 TMQGRSLTYSQVPNDGQLCSCVKCEMQRTNH-DHMIINSAKPATSVICKTGYATRTEMLAS 281 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~q~~~~-~~~~~~s~~~~t~~~~~~~~~~~~~~~~~ 281 (297)
..+++. +.....+++.....-...|.+. ...-++++..++.+.-+.++.-.+..-|+
T Consensus 401 VIegs~---a~y~WfgQn~Rn~kvG~Fprsvvt~a~lga~pa~~~~t~~~vhtg~~~rg~~ 458 (1039)
T KOG0199|consen 401 VIEGSG---AGYDWFGQNKRNQKVGTFPRSVVTAATLGAVPAATAVTPQKVHTGPTIRGPP 458 (1039)
T ss_pred EEecCC---ccceeeccccccceecccCcceeeecccCCCCccccCccccccCCCCCCCCC
Confidence 222211 1222333333332222223222 23456666666666666666666665444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=238.73 Aligned_cols=185 Identities=22% Similarity=0.315 Sum_probs=135.8
Q ss_pred ceeeeceeEEe--------CCeEEEEEecCCCcHHHHHHHhcC-----------------------CCCCHHHHHHHHHH
Q 040202 12 NIVKLRNLVKE--------HEDVFIVFDYMESDLLKLMKESAG-----------------------QNFSEDEARNLCFQ 60 (297)
Q Consensus 12 nIv~~~~~~~~--------~~~~~lv~e~~~g~ll~~~~~~~~-----------------------~~l~e~~~~~~~~q 60 (297)
++++++++|.. .+..||||||+.++.+..+..... ..+++..++.++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 44777777753 356899999999755544433211 12456789999999
Q ss_pred HHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccc--cccCCCCCCceeccccc----------
Q 040202 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY--VTTRWYRAPEVLLLSEI---------- 127 (297)
Q Consensus 61 ll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~---------- 127 (297)
++.||.|||+.+|+||||||+|||++. +.+||+|||+++........... .+++.|+|||++.....
T Consensus 318 l~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~ 397 (507)
T PLN03224 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMA 397 (507)
T ss_pred HHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhh
Confidence 999999999999999999999999985 78999999999765443322222 34789999998753221
Q ss_pred ---------CC--CccchhhHHHHHHHHHhCCC-CCCCCCCHHH-----------H-------------HHHHHHHHHHH
Q 040202 128 ---------CG--PEVDRWAMGAIMFEMLSFRI-LFPGKNSADQ-----------I-------------YKIYGRWVALI 171 (297)
Q Consensus 128 ---------~~--~~~DiwSlGv~l~ell~g~~-pf~~~~~~~~-----------~-------------~~i~~~~~~li 171 (297)
++ .+.|+||+||++++|++|.. ||.+...... + ..+....++|+
T Consensus 398 ~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi 477 (507)
T PLN03224 398 ALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLA 477 (507)
T ss_pred hhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHH
Confidence 12 24799999999999999886 6643211110 0 11234578999
Q ss_pred HHhhhcCC---CCCCCHHHHHcCCCCCC
Q 040202 172 SWLCSWNP---RMRPTAAEALEHPFFRS 196 (297)
Q Consensus 172 ~~~l~~dP---~~R~t~~~ll~h~~f~~ 196 (297)
.+||..+| .+|+|++|+|+||||..
T Consensus 478 ~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 478 CKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 99999766 68999999999999953
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=228.42 Aligned_cols=193 Identities=31% Similarity=0.495 Sum_probs=156.3
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+|..+..+.||+++.+++..++...+||||++......+... ++-.+++.|++.++.||.++|.+||+||||||.|
T Consensus 87 ~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsN 162 (418)
T KOG1167|consen 87 MLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSN 162 (418)
T ss_pred HHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccc
Confidence 566788999999999999999999999999998766666643 7799999999999999999999999999999999
Q ss_pred EEEeC--CeEEEEecCCceecCC-----------------------------------CC----------CCccccccCC
Q 040202 83 LLVSK--GVIKIGDLGMVKEIDS-----------------------------------SL----------PCTDYVTTRW 115 (297)
Q Consensus 83 ill~~--~~~kl~Dfgla~~~~~-----------------------------------~~----------~~~~~~gt~~ 115 (297)
+|.+. +.-.|+|||+|...+. +. ..-...||++
T Consensus 163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G 242 (418)
T KOG1167|consen 163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG 242 (418)
T ss_pred cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence 99985 7889999999851100 00 0012468999
Q ss_pred CCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC-CHHHHHHH-------------------------------
Q 040202 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN-SADQIYKI------------------------------- 163 (297)
Q Consensus 116 y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~-~~~~~~~i------------------------------- 163 (297)
|.|||++..-...+.++||||.|||+..++++..||-... +.+.+..|
T Consensus 243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~ 322 (418)
T KOG1167|consen 243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP 322 (418)
T ss_pred CCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence 9999999877767889999999999999999999984321 11111000
Q ss_pred --------------H-----------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 --------------Y-----------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 --------------~-----------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
. ..+.+|+.+||+.||.+|+|++++|+||||...+.
T Consensus 323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0 03578999999999999999999999999986543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=259.15 Aligned_cols=178 Identities=20% Similarity=0.324 Sum_probs=140.4
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH---RQGYFHRDLKP 80 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH---~~gi~Hrdikp 80 (297)
+.++ +|||||+++|++.+++..|+||||++|+.+..+... +++..+..++.|++.|++||| +.+|+||||||
T Consensus 737 l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 737 MGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred HhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 3444 999999999999999999999999998766666542 889999999999999999999 67999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS--- 156 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~--- 156 (297)
+||+++. +..++. ||.+...... ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||+....
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred HhEEECCCCceEEE-eccccccccC---CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 9999986 444543 6655433222 23467899999999765 4468999999999999999999999854211
Q ss_pred -HHHH-------------------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 157 -ADQI-------------------------YKIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 157 -~~~~-------------------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
...+ .....++.+++.+|++.||++|||+.++++.
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 0112246788999999999999999999764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=235.78 Aligned_cols=184 Identities=24% Similarity=0.397 Sum_probs=153.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++|-.+|||||+++|++.+ .-.|||||.+.-|-+..+++..+..++......|..||..||.|||+..++||||...||
T Consensus 444 iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi 522 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI 522 (974)
T ss_pred HHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence 3445599999999999986 578999999996666666666667799999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccc--cCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVT--TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
|+.. ..+||+|||+++.+..........| ..-|||||.+.-. .++.++|||-|||++||++. |.-||.+-.+.+.
T Consensus 523 LVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 523 LVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred eecCcceeeecccchhhhccccchhhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 9976 7899999999999877654433333 4459999998644 45889999999999999886 9999998877766
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
+.++. ..+..|+.+|+..||.+||++.++.
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 55443 3678999999999999999987653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=207.66 Aligned_cols=161 Identities=25% Similarity=0.444 Sum_probs=135.9
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLK 79 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdik 79 (297)
+.++....|++|.|||.+.+....+|.||.|+-++-.++.+ +.++.++|..+-+++..++.||+|||++ .++|||+|
T Consensus 97 i~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvK 176 (282)
T KOG0984|consen 97 IIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVK 176 (282)
T ss_pred hhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCC
Confidence 34566689999999999999999999999999766555443 3467899999999999999999999975 89999999
Q ss_pred CCcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecc---cccCCCccchhhHHHHHHHHHhCCCCCCCC-
Q 040202 80 PSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL---SEICGPEVDRWAMGAIMFEMLSFRILFPGK- 154 (297)
Q Consensus 80 p~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGv~l~ell~g~~pf~~~- 154 (297)
|.|||++ +|.+|++|||.+-.+.++...+...|...|||||.+.. ...|+.++||||||+.+.||.+++.||+..
T Consensus 177 PsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 177 PSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 9999998 59999999999988877766556788999999998763 235789999999999999999999999753
Q ss_pred CCHHHHHHH
Q 040202 155 NSADQIYKI 163 (297)
Q Consensus 155 ~~~~~~~~i 163 (297)
+..+++.++
T Consensus 257 tpF~qLkqv 265 (282)
T KOG0984|consen 257 TPFQQLKQV 265 (282)
T ss_pred CHHHHHHHH
Confidence 444554443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=231.67 Aligned_cols=183 Identities=23% Similarity=0.428 Sum_probs=153.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++|-++|||+|++.|+|..+.-.|||+|||. |+||+++.+....-++.-....++.||..|++||..+++|||||...|
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARN 395 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 395 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 4566799999999999999999999999996 799999988766668888888999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccc---cCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSA 157 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 157 (297)
+|+.+ ..||++|||+++.+..... +-..| ..-|.|||-+..... +.++|||+|||+|||+.| |-.||.+-+..
T Consensus 396 CLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 396 CLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred ccccccceEEeeccchhhhhcCCce-ecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 99987 5689999999999876543 22223 456999999876554 889999999999999997 66788776644
Q ss_pred HHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 158 DQIYKIY------------GRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 158 ~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
..+.-.. ....+|++.|++++|.+||+++|+
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 3332221 256889999999999999999876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=202.55 Aligned_cols=147 Identities=22% Similarity=0.382 Sum_probs=119.4
Q ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCcccccc
Q 040202 35 SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 113 (297)
Q Consensus 35 g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt 113 (297)
|++.+.+.. .+..+++.+++.++.|++.||+|||+++ ||+|||+++ +.+|+ ||+++..... ...||
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 445555544 3456999999999999999999999998 999999985 67888 9998876543 23689
Q ss_pred CCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH-H------------------HHHH--HHHHHHH
Q 040202 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI-Y------------------KIYG--RWVALIS 172 (297)
Q Consensus 114 ~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~-~------------------~i~~--~~~~li~ 172 (297)
+.|||||++.+. .++.++||||+||++|||++|+.||......... . .+.. .+.+++.
T Consensus 68 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 68 PYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred ccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998754 4588999999999999999999999765432211 1 1122 4889999
Q ss_pred HhhhcCCCCCCCHHHHHcCCCCC
Q 040202 173 WLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 173 ~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
+||..||.+||++.++++|+|+.
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHH
Confidence 99999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=227.89 Aligned_cols=187 Identities=22% Similarity=0.342 Sum_probs=151.6
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG-QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~-~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
++|.++ +|||||+++|+|..++.+++|+||++.|.+..++.... ....-+....++.||++|++||.+.+++||||.+
T Consensus 587 kiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~ 665 (807)
T KOG1094|consen 587 KILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLAT 665 (807)
T ss_pred HHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccc
Confidence 456666 99999999999999999999999998655555544432 2234445567999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHH--hCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML--SFRILFPGK 154 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell--~g~~pf~~~ 154 (297)
.|+|+|+ .++||+|||+++.+..+.. .+..+-...|||+|.+..++. +.++|+|++|+++||++ +.+.||...
T Consensus 666 rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 666 RNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred cceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 9999995 7999999999997755432 233445678999999887665 89999999999999986 578899887
Q ss_pred CCHHHHHHHH-------------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 155 NSADQIYKIY-------------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 155 ~~~~~~~~i~-------------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+.+...... .++.+++..|+..|-.+||+++++-.
T Consensus 745 t~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 745 TDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 7766554332 25789999999999999999998743
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=234.87 Aligned_cols=188 Identities=24% Similarity=0.488 Sum_probs=153.0
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhc------C--------CCCCHHHHHHHHHHHHHHHH
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESA------G--------QNFSEDEARNLCFQVFQGLH 66 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~------~--------~~l~e~~~~~~~~qll~al~ 66 (297)
..+..+..|+||+.+.|++.+.+.+++|+||+. |++++++..+. . ..++..+...++.||+.|++
T Consensus 353 ~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe 432 (609)
T KOG0200|consen 353 NVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGME 432 (609)
T ss_pred HHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHH
Confidence 356778899999999999999999999999998 57777776653 0 13889999999999999999
Q ss_pred HHHHCCccccCCCCCcEEEeCC-eEEEEecCCceecCCCCCCc--cccc--cCCCCCCceecccccCCCccchhhHHHHH
Q 040202 67 YMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCT--DYVT--TRWYRAPEVLLLSEICGPEVDRWAMGAIM 141 (297)
Q Consensus 67 yLH~~gi~Hrdikp~Nill~~~-~~kl~Dfgla~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGv~l 141 (297)
||++..++||||-..|||+.++ .+||+|||+|+......... ...| ...|||||.+.. ..|+.++||||+||++
T Consensus 433 ~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 433 YLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILL 511 (609)
T ss_pred HHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHH
Confidence 9999999999999999999875 89999999999755433222 1222 234999999876 5679999999999999
Q ss_pred HHHHh-CCCCCCCCC-CHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 142 FEMLS-FRILFPGKN-SADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 142 ~ell~-g~~pf~~~~-~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||+++ |..||.+-. ..+....+. .++.++++.|+..+|++||+..++.+
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99998 889998854 333333222 26789999999999999999988754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-29 Score=234.06 Aligned_cols=185 Identities=24% Similarity=0.388 Sum_probs=160.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+-..+||||+++.|+....+-..||.|||+++.||..+...++.|+.-+...+++.|+.|++||-+.|++||||...|||
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL 763 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee
Confidence 33459999999999999999999999999998888877777777999999999999999999999999999999999999
Q ss_pred EeCC-eEEEEecCCceecCCCC--CCccccc--cCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 85 VSKG-VIKIGDLGMVKEIDSSL--PCTDYVT--TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 85 l~~~-~~kl~Dfgla~~~~~~~--~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
++.+ .+|++|||+++.+.+.. ..++.-| ...|.|||.+...+. +.++||||+||++||.++ |+.||-+.++.+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHH
Confidence 9987 67999999999886543 1122222 346999999986554 889999999999999775 999999999888
Q ss_pred HHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKIYG------------RWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+..|.. .+..|+..|+++|-++||.+.+|+.
T Consensus 843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 8887765 5789999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=231.47 Aligned_cols=194 Identities=26% Similarity=0.436 Sum_probs=160.3
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
|.+.|-.+|+|||.|+|.+-..+.+++.||||+||.++.+..-. ++++|.++....++.+.|++|||+.|-+|||||-.
T Consensus 63 i~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGa 141 (829)
T KOG0576|consen 63 IGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGA 141 (829)
T ss_pred eeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCccccccccc
Confidence 45667789999999999999999999999999998877766543 57999999999999999999999999999999999
Q ss_pred cEEEe-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceec--ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 82 NLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLL--LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 82 Nill~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|||++ .|.+|+.|||.+..+.-. .+...++||+.|||||+-. ....|...+|||++|+...|+-.-+.|.-.....
T Consensus 142 nilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 142 NILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 99996 599999999997654332 3336889999999999843 3456789999999999999987766664332222
Q ss_pred HHH----------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 DQI----------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~~~----------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
... .+.+..+.+|++.+|..+|++||+++.+|.|||...
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 222 133456789999999999999999999999999953
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=227.48 Aligned_cols=141 Identities=29% Similarity=0.488 Sum_probs=127.9
Q ss_pred cccceeeeceeEEeCCeEEEEEecCC-C-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYME-S-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~-g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.|+||+|++++|++++++||+||--+ | +|++++..+ ..|.|.++..+++|++.|+++||+.||+|||||-+|+.++
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd 704 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD 704 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEe
Confidence 49999999999999999999999865 4 778777765 5599999999999999999999999999999999999998
Q ss_pred -CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 87 -KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 87 -~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
+|.+||+|||.|.....+ +...++||..|.|||++.+.+|.+..-|||++|+++|.++..+.||.
T Consensus 705 ~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 589999999998766544 45789999999999999988898999999999999999999999885
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=236.32 Aligned_cols=193 Identities=28% Similarity=0.406 Sum_probs=161.3
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++...+.|+||+.....+.+....+-+||||+++++..+... +.+...++-.++.||+.||+|+|+.||.|||+|++|
T Consensus 373 ~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~en 450 (601)
T KOG0590|consen 373 CIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLEN 450 (601)
T ss_pred eecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCcccc
Confidence 344567999999999988887777777999999666665543 359999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCC-----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
+++.. |.+||+|||.+...... ......+|+..|+|||++....+....+||||+|+++..|.+|+.||.....
T Consensus 451 ll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 451 LLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred EEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 99986 69999999998654321 3346788999999999999888888889999999999999999999976554
Q ss_pred HHHH--------------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 ADQI--------------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 ~~~~--------------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+.. ..+....+.+|.+||+.||.+|.|+++|++.+||+.+
T Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 531 SDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred cccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 4321 1122356889999999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=190.66 Aligned_cols=167 Identities=37% Similarity=0.624 Sum_probs=142.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|++|+++++++......++++|++.|..+..+.......+++..++.++.+++.++++||+.|++|+||+|.||++
T Consensus 46 ~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~ 125 (215)
T cd00180 46 KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL 125 (215)
T ss_pred HhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE
Confidence 33489999999999999999999999999766656555532458999999999999999999999999999999999999
Q ss_pred eC--CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK--GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~--~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+. +.++|+|||.+....... ......+...|++||.+......+.+.|+|++|+++++|
T Consensus 126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------ 187 (215)
T cd00180 126 DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------ 187 (215)
T ss_pred eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------
Confidence 86 789999999998765432 123456788899999876543567899999999999999
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 163 IYGRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 163 i~~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
..+.+++.+|+..||++||++.++++|+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5678999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=198.48 Aligned_cols=178 Identities=24% Similarity=0.298 Sum_probs=135.4
Q ss_pred cccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------Cc
Q 040202 7 MNNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ---------GY 73 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~---------gi 73 (297)
.++|+||++|+++-+... .++||+||-+.|.|..++.. ..+++....+++..++.||+|||+. .|
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~I 337 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPI 337 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcc
Confidence 359999999999887655 89999999986544444444 3589999999999999999999963 59
Q ss_pred cccCCCCCcEEEe-CCeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCC-----CccchhhHHHHHHHH
Q 040202 74 FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICG-----PEVDRWAMGAIMFEM 144 (297)
Q Consensus 74 ~Hrdikp~Nill~-~~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlGv~l~el 144 (297)
+|||||..|||+. +....|+|||+|..+...... -..+||..|||||++.+.-... .+.||||+|.|+|||
T Consensus 338 aHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi 417 (534)
T KOG3653|consen 338 AHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEI 417 (534)
T ss_pred ccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999996 578999999999887654332 3468999999999987543322 247999999999999
Q ss_pred HhCCCC------------CCC----CCCHHHHHH-HH------------------HHHHHHHHHhhhcCCCCCCCHH
Q 040202 145 LSFRIL------------FPG----KNSADQIYK-IY------------------GRWVALISWLCSWNPRMRPTAA 186 (297)
Q Consensus 145 l~g~~p------------f~~----~~~~~~~~~-i~------------------~~~~~li~~~l~~dP~~R~t~~ 186 (297)
++.... |.. ....+.++. +. ..+++.+..|+..|++.|.|+.
T Consensus 418 ~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 418 ASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 974333 321 011111111 11 1357899999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=181.07 Aligned_cols=149 Identities=38% Similarity=0.645 Sum_probs=124.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++ +|+||+++++.+......++++||+.++.+..+.......+++..+..++.+++.++.+||+.|++|+||++.||
T Consensus 51 ~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni 129 (225)
T smart00221 51 LKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENI 129 (225)
T ss_pred HHhC-CCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 3344 899999999999999999999999998444444444222289999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
+++. +.++|+|||.+....... ......++..|++||.+.....++.++|+|++|+++++|++|+.||..
T Consensus 130 ~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 130 LLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9985 799999999988775542 334567788999999874344456799999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=187.56 Aligned_cols=185 Identities=19% Similarity=0.321 Sum_probs=139.6
Q ss_pred cccccceeeece-eEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRN-LVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~-~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.-|.||+.-|+ .|++.+.+++++||++-+.|..-... .++-|...+.++.|+++|++|+|+++++|||||.+||||
T Consensus 77 Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 77 LSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred eccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 457999998877 56888899999999986444333332 348999999999999999999999999999999999999
Q ss_pred eC---CeEEEEecCCceecCCCCCCccccccCCCCCCceecccc----cCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 86 SK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE----ICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 86 ~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
-+ -.+||+|||+++..+... ...-.+..|.+||+..... ...+..|+|.||++++.+++|..||+.....+
T Consensus 155 f~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 155 FDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred ecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 42 489999999987765432 1222366799999864321 23466899999999999999999998544333
Q ss_pred HHH-------------------HHHHHHHHHHHHhhhcCCCCC---CCHHHHHcCCCCC
Q 040202 159 QIY-------------------KIYGRWVALISWLCSWNPRMR---PTAAEALEHPFFR 195 (297)
Q Consensus 159 ~~~-------------------~i~~~~~~li~~~l~~dP~~R---~t~~~ll~h~~f~ 195 (297)
.-+ .....+..+.++-|..++++| -++....+..|..
T Consensus 233 ~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 233 KPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred chHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 221 112356778889999999999 5555656666653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=204.16 Aligned_cols=184 Identities=28% Similarity=0.436 Sum_probs=158.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
....+||.+|+++-.++.+..+|+++++..| .++...... ..+.+..++.+...++.+++++|+.||+|||+|++||
T Consensus 51 ~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~eni 128 (612)
T KOG0603|consen 51 AFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENV 128 (612)
T ss_pred hhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccce
Confidence 3444699999999999999999999999998 555555544 4589999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +|++++.|||+++....... .|||..|||||++. .+...+|.||+|++.++|++|..||.+ +....
T Consensus 129 lld~~Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~ 198 (612)
T KOG0603|consen 129 LLLLEGHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR 198 (612)
T ss_pred eecccCccccCCchhhhHhHhhhh---cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH
Confidence 998 59999999999988766542 29999999999976 346789999999999999999999988 44444
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCH-----HHHHcCCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTA-----AEALEHPFFRSCHFV 200 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f~~~~~~ 200 (297)
|. ..+++++..++..+|..|... .++++|+||..++|.
T Consensus 199 Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 199 ILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 43 367889999999999999754 699999999988875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=206.19 Aligned_cols=179 Identities=22% Similarity=0.330 Sum_probs=146.7
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
++|||++|+++++.... +-||++|+++ .|++++..+ +..+-.++...|..||++|+.|||+++++||||-..|+|+.
T Consensus 755 ldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk 832 (1177)
T KOG1025|consen 755 LDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK 832 (1177)
T ss_pred CCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec
Confidence 49999999999998765 8899999996 566666654 56799999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCCCC---ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
+ +.+||.|||+++.+.....- ......+-|||=|.+.. +.|+.++||||+||.+||++| |..|+++....+.-.
T Consensus 833 sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d 911 (1177)
T KOG1025|consen 833 SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD 911 (1177)
T ss_pred CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH
Confidence 6 89999999999887554221 22233556899898764 456899999999999999998 899998877655433
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
-+. .+..-++.+|+..|+..||+++++-
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 221 1567789999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=188.89 Aligned_cols=182 Identities=27% Similarity=0.408 Sum_probs=140.6
Q ss_pred ccccccceeeeceeEEeCC----eEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------C
Q 040202 6 KMNNHPNIVKLRNLVKEHE----DVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ--------G 72 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~----~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~--------g 72 (297)
.+++|+||+.|++.-..++ .+|||++|-+ |+|++++.. ..++-+...+++..++.||++||-. .
T Consensus 260 vmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 260 VMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred HHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 3679999999998775333 6899999998 566666655 4599999999999999999999953 4
Q ss_pred ccccCCCCCcEEEeC-CeEEEEecCCceecCCC-----CCCccccccCCCCCCceecccc----cCC-CccchhhHHHHH
Q 040202 73 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSE----ICG-PEVDRWAMGAIM 141 (297)
Q Consensus 73 i~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~-~~~DiwSlGv~l 141 (297)
|.|||||..|||+.+ +.+-|+|+|+|-..... ......+||..|||||++...- ..+ ..+||||||.|+
T Consensus 337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 999999999999975 79999999999665433 3346789999999999986431 112 348999999999
Q ss_pred HHHHh----------CCCCCCCC----CCHHHHHHH-------------------HHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 142 FEMLS----------FRILFPGK----NSADQIYKI-------------------YGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 142 ~ell~----------g~~pf~~~----~~~~~~~~i-------------------~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
||+.- .++||.+- ...++..++ ...+..+++.|+-.||.-|.|+-.+
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 99974 46677542 233333332 1245678999999999999998766
Q ss_pred Hc
Q 040202 189 LE 190 (297)
Q Consensus 189 l~ 190 (297)
.+
T Consensus 497 KK 498 (513)
T KOG2052|consen 497 KK 498 (513)
T ss_pred HH
Confidence 54
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=173.70 Aligned_cols=183 Identities=13% Similarity=0.251 Sum_probs=144.5
Q ss_pred cccccceeeeceeEEe-CCeEEEEEecCCC-cHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 7 MNNHPNIVKLRNLVKE-HEDVFIVFDYMES-DLLKLMKESA------GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~-~~~~~lv~e~~~g-~ll~~~~~~~------~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
-..|||+....++..+ ....+.++.+++- ++-.++.... ...++-.+...++.|+..|++|||+.|++|.||
T Consensus 343 ~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi 422 (563)
T KOG1024|consen 343 GASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI 422 (563)
T ss_pred cCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence 3579999999998854 5577888888874 4444444221 134677888999999999999999999999999
Q ss_pred CCCcEEEeCC-eEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCC
Q 040202 79 KPSNLLVSKG-VIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPG 153 (297)
Q Consensus 79 kp~Nill~~~-~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~ 153 (297)
...|++||+. .+||+|=.+++.+-.... ....-....||++|.+.. ..|+..+|+|||||++|||++ |+.|+..
T Consensus 423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred hhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 9999999984 799999999987633211 111222556999999875 456999999999999999997 9999988
Q ss_pred CCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 154 KNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 154 ~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
-+..+...-+. +++...+..|+..+|++||+.+++..
T Consensus 502 IDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 502 IDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 88777654432 37888999999999999999998753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-21 Score=169.30 Aligned_cols=189 Identities=31% Similarity=0.528 Sum_probs=154.7
Q ss_pred cccc-ceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 8 NNHP-NIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 8 ~~Hp-nIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.|+ +|+++++.+......+++++++.|+.+..+..... ..+.+..+..++.|++.+++|+|+.|++|||+||+||+
T Consensus 54 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil 133 (384)
T COG0515 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL 133 (384)
T ss_pred ccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 3555 89999999988888999999999866665555432 26999999999999999999999999999999999999
Q ss_pred EeC-C-eEEEEecCCceecCCCC-------CCccccccCCCCCCceeccc--ccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 85 VSK-G-VIKIGDLGMVKEIDSSL-------PCTDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 85 l~~-~-~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
++. + .++++|||.++...... ......||..|+|||.+... ..+....|+||+|++++++++|..||..
T Consensus 134 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred ecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 986 4 69999999998654432 34677899999999998763 4668899999999999999999999877
Q ss_pred CCC---HHHHHH-HH--------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 154 KNS---ADQIYK-IY--------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 154 ~~~---~~~~~~-i~--------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
... .....+ +. ....+++.+++..+|..|.+..+...+.|...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 214 EKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred CCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 764 222211 11 24678999999999999999999888866654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=169.42 Aligned_cols=186 Identities=22% Similarity=0.333 Sum_probs=137.9
Q ss_pred cccccceeeeceeEEe---------------------------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHH
Q 040202 7 MNNHPNIVKLRNLVKE---------------------------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~---------------------------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~ 59 (297)
+-+|||||++.++|.+ +..+|+||.-++.++..++..+ ..+-...+-++.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~---~~s~r~~~~~la 348 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR---HRSYRTGRVILA 348 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC---CCchHHHHHHHH
Confidence 4589999999998843 3579999999999888777654 367788899999
Q ss_pred HHHHHHHHHHHCCccccCCCCCcEEEe--C-C--eEEEEecCCceecCCC-------CCCccccccCCCCCCceecccc-
Q 040202 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS--K-G--VIKIGDLGMVKEIDSS-------LPCTDYVTTRWYRAPEVLLLSE- 126 (297)
Q Consensus 60 qll~al~yLH~~gi~Hrdikp~Nill~--~-~--~~kl~Dfgla~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~- 126 (297)
|+++|+.|||++||.|||+|.+|||+. + + .+.|+|||.+-.-... .......|.-.-||||+...-.
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999994 3 2 6899999975322211 1112334555679999865321
Q ss_pred ----cCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH---H----------HHHHHHHHHHHHhhhcCCCCCCCHH---
Q 040202 127 ----ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI---Y----------KIYGRWVALISWLCSWNPRMRPTAA--- 186 (297)
Q Consensus 127 ----~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~---~----------~i~~~~~~li~~~l~~dP~~R~t~~--- 186 (297)
..-.++|.|++|.+.||+++...||.+.-..... + .+....++++..+|+.||++|++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 1225899999999999999999999773221110 1 1223578999999999999998853
Q ss_pred HHHcCCCCC
Q 040202 187 EALEHPFFR 195 (297)
Q Consensus 187 ~ll~h~~f~ 195 (297)
.+++-..|.
T Consensus 509 Nvl~LsLw~ 517 (598)
T KOG4158|consen 509 NVLNLSLWR 517 (598)
T ss_pred hHHHHHHhc
Confidence 556544443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=197.05 Aligned_cols=184 Identities=20% Similarity=0.316 Sum_probs=146.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
++.+|||++.|..+-+.+...|||-+|+..+|++++.-+ ..+.+-+.+.|+.||+.||.-+|+.||+|+|||.||||+
T Consensus 76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred HhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 567999999999998899999999999999999998765 458888999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCC--CC------CCccccccCCCCCCceecccc----------cCCCccchhhHHHHHHHHHh
Q 040202 86 SK-GVIKIGDLGMVKEIDS--SL------PCTDYVTTRWYRAPEVLLLSE----------ICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~--~~------~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlGv~l~ell~ 146 (297)
+. |++.|+||...+...- .. ...+......|+|||.+.... ...++-||||+||+++|+++
T Consensus 154 TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 154 TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 97 8899999987655321 11 111222344699999876522 13456799999999999987
Q ss_pred -CCCCCCC----------CCCH-HHHHHHHH-HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 -FRILFPG----------KNSA-DQIYKIYG-RWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 -g~~pf~~----------~~~~-~~~~~i~~-~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|+++|.- .... ..+.+|.. .++++|..|++.||.+|.+|++.|+-
T Consensus 234 Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 234 EGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 6888741 1222 22334432 67899999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=189.16 Aligned_cols=140 Identities=34% Similarity=0.511 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCC----------------CCCCccccccCCCCCCcee
Q 040202 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS----------------SLPCTDYVTTRWYRAPEVL 122 (297)
Q Consensus 60 qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~----------------~~~~~~~~gt~~y~aPE~~ 122 (297)
+++.+++|||+-||+|||+||+|++|.. |++|+.|||+++.... ...-...|||+.|+||||+
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 3488999999999999999999999985 9999999999865321 1122456899999999998
Q ss_pred cccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------HHHHHHHHhhhcCCCCCC---CH
Q 040202 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------------RWVALISWLCSWNPRMRP---TA 185 (297)
Q Consensus 123 ~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~--------------~~~~li~~~l~~dP~~R~---t~ 185 (297)
...+ |+..+|+|++|+|+||.+-|..||.+....+.+.++.. +.++++..+|+.+|..|. .+
T Consensus 231 lrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 231 LRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred hhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 8655 59999999999999999999999999988887766543 678999999999999995 46
Q ss_pred HHHHcCCCCCCCCCC
Q 040202 186 AEALEHPFFRSCHFV 200 (297)
Q Consensus 186 ~~ll~h~~f~~~~~~ 200 (297)
-++.+|+||+..+|.
T Consensus 310 ~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 310 LEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhccceeecccc
Confidence 689999999988875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-19 Score=160.62 Aligned_cols=148 Identities=24% Similarity=0.331 Sum_probs=122.5
Q ss_pred cceeeeceeE-EeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--
Q 040202 11 PNIVKLRNLV-KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-- 87 (297)
Q Consensus 11 pnIv~~~~~~-~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-- 87 (297)
.++.++++.. ..+.+.|+||+.++.++.+.......+.|+...+..++.|++.+|++||+.|++||||||+|+++..
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~ 159 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS 159 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC
Confidence 5889999999 5888999999998888887665554467999999999999999999999999999999999999963
Q ss_pred ----CeEEEEecCCce--ecC-CC-------CC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 88 ----GVIKIGDLGMVK--EID-SS-------LP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 88 ----~~~kl~Dfgla~--~~~-~~-------~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
..+.|.|||+++ ... .. .. ...+.||..|+++.+..+... +.+.|+||++.++.+++.|.+||.
T Consensus 160 ~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 160 RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCc
Confidence 359999999998 321 11 11 234569999999998765544 899999999999999999999998
Q ss_pred CCCCHHH
Q 040202 153 GKNSADQ 159 (297)
Q Consensus 153 ~~~~~~~ 159 (297)
+......
T Consensus 239 ~~~~~~~ 245 (322)
T KOG1164|consen 239 ALEMTDL 245 (322)
T ss_pred cccccch
Confidence 7665433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-20 Score=169.96 Aligned_cols=167 Identities=30% Similarity=0.433 Sum_probs=125.3
Q ss_pred CeEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCcee
Q 040202 24 EDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 100 (297)
Q Consensus 24 ~~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~ 100 (297)
.++||.|++|..+.+...+. ..+..-+......++.|+..|++| +|.+|||+||.||+... +.+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999755544442 333456788899999999999999 99999999999999864 6799999999877
Q ss_pred cCCCC-------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCC---------HHHHHHH
Q 040202 101 IDSSL-------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNS---------ADQIYKI 163 (297)
Q Consensus 101 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~---------~~~~~~i 163 (297)
..... ..+..+||.+||+||.+.+ ..|+.++|||+||++++|++. -...|...-. ......-
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d 484 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQD 484 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhc
Confidence 65543 4567789999999999875 456999999999999999997 2222110000 0000011
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 164 YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 164 ~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
...-..|+.+||...|.+||++.+.--|.|.
T Consensus 485 ~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 485 YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1233679999999999999988777666664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.7e-21 Score=183.26 Aligned_cols=193 Identities=25% Similarity=0.374 Sum_probs=160.0
Q ss_pred cccccc-ccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCC
Q 040202 4 LRKMNN-HPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH-RQGYFHRDLKP 80 (297)
Q Consensus 4 l~kl~~-HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH-~~gi~Hrdikp 80 (297)
+++.++ |.|++++++...+.+..+++++|..|+ +++.+.......++...+..++.|+..++.|+| ..++.||||||
T Consensus 73 ~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP 152 (601)
T KOG0590|consen 73 IQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKP 152 (601)
T ss_pred ccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCC
Confidence 445555 999999999999999999999998874 444441222225888999999999999999999 99999999999
Q ss_pred CcEEEeC-C-eEEEEecCCceecCC----CCCCccccc-cCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 81 SNLLVSK-G-VIKIGDLGMVKEIDS----SLPCTDYVT-TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 81 ~Nill~~-~-~~kl~Dfgla~~~~~----~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
+|.+++. + .+|+.|||+|..... .......+| ++.|+|||...+..+.+...|+||+|+++..|++|..||..
T Consensus 153 ~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 153 SNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred ccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccc
Confidence 9999986 6 799999999976544 233455678 99999999988767778999999999999999999999976
Q ss_pred CCCHHHH----------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 154 KNSADQI----------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 154 ~~~~~~~----------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
....... .++.....+++.+++..+|..|.+++++..++|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 233 PSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 5443322 233446788999999999999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=148.00 Aligned_cols=177 Identities=16% Similarity=0.274 Sum_probs=142.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdikp~N 82 (297)
+...||||+.+++.|....++.+|..||+ |+++..+.+..+-..+..++.+++.+++.|+.|||+.. |.--.+....
T Consensus 242 rifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h 321 (448)
T KOG0195|consen 242 RIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH 321 (448)
T ss_pred eeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence 45699999999999999999999999998 57777777765556788999999999999999999875 5555788899
Q ss_pred EEEeCC---eEEEEecCCceecCCCCCCccccccCCCCCCceeccccc--CCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 83 LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI--CGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 83 ill~~~---~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+++|++ .+-.+|--++.. .......+.||+||.++.+.. .-..+|+|||++++||+.|.+.||.+....
T Consensus 322 vmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 322 VMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred EEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 999875 344445433321 234455889999999876543 236799999999999999999999988877
Q ss_pred HHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 158 DQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 158 ~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
+--.||- .....|+.-|+..||.+||.++.+
T Consensus 396 ecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 396 ECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred hhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 7655542 356789999999999999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=156.81 Aligned_cols=184 Identities=20% Similarity=0.279 Sum_probs=143.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGY-FHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi-~Hrdikp~Nil 84 (297)
+.+.|.|+.+++|.+.++...++|.+||..+++..++......+++--...++++|+.|++|||.-.| .|+.++..|++
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 44599999999999999999999999998766666665545568888899999999999999998766 99999999999
Q ss_pred EeC-CeEEEEecCCceecCC---CCCCccccccCCCCCCceeccccc------CCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 85 VSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLSEI------CGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
+|. -.+||+|||+...... ........-...|.|||.+..... -+.+.||||+|++++|+++.+.||+..
T Consensus 82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR 161 (484)
T ss_pred eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence 997 5789999999766532 011112223556999999875321 245699999999999999999999763
Q ss_pred CC----HHHHHHHH------------------HHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 155 NS----ADQIYKIY------------------GRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 155 ~~----~~~~~~i~------------------~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
.. .+...++. .+...++..|+..+|.+||+++++-
T Consensus 162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 162 NLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 22 12222221 2467899999999999999998763
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-18 Score=142.13 Aligned_cols=141 Identities=17% Similarity=0.168 Sum_probs=103.4
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL-KPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi-kp~ 81 (297)
+|.++.+|++|++++++ +..|++|||+.|..+..... +. ...++.|++.+|+++|++||+|||| ||+
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~ 121 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEA 121 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcc
Confidence 45666567889999886 45699999999976643221 11 2357889999999999999999999 799
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCCC--------------ccccccCCCCCCceecccccCC-CccchhhHHHHHHHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLPC--------------TDYVTTRWYRAPEVLLLSEICG-PEVDRWAMGAIMFEML 145 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~-~~~DiwSlGv~l~ell 145 (297)
|||+++ +.++|+|||++......... .-...++.|++|+........+ ...++++.|+-+|.++
T Consensus 122 NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 122 NWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred eEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHH
Confidence 999974 78999999999865443210 0112578888888533221112 4467888999999999
Q ss_pred hCCCCCCCCC
Q 040202 146 SFRILFPGKN 155 (297)
Q Consensus 146 ~g~~pf~~~~ 155 (297)
|+..+.-+.+
T Consensus 202 ~~~~~~~~~~ 211 (218)
T PRK12274 202 TRRVLHWEDN 211 (218)
T ss_pred hccCCccccC
Confidence 9999875544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=152.09 Aligned_cols=156 Identities=21% Similarity=0.321 Sum_probs=103.7
Q ss_pred eEEEEEecCCCcHHHHHH---HhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCc
Q 040202 25 DVFIVFDYMESDLLKLMK---ESAGQ--NFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMV 98 (297)
Q Consensus 25 ~~~lv~e~~~g~ll~~~~---~~~~~--~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla 98 (297)
+.+++|+-+.+++.+.+. ..... .+.......+..|++..+++||..|++|+||||+|+++++ |.++|+||+..
T Consensus 113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 347888888887765543 22111 1223334555689999999999999999999999999985 89999999987
Q ss_pred eecCCCCCCccccccCCCCCCceeccc-------ccCCCccchhhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Q 040202 99 KEIDSSLPCTDYVTTRWYRAPEVLLLS-------EICGPEVDRWAMGAIMFEMLSFRILFPGKNS-------ADQIYKIY 164 (297)
Q Consensus 99 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-------~~~~~~i~ 164 (297)
...+....+ ...+..|.+||..... -.++.+.|.|+||+++|.|.+++.||..... ......+.
T Consensus 193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~f~~C~~~P 270 (288)
T PF14531_consen 193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWDFSRCRDMP 270 (288)
T ss_dssp EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGGGTTSS---
T ss_pred eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccccchhcCCcC
Confidence 766554332 3345778999975432 2356788999999999999999999975432 22233677
Q ss_pred HHHHHHHHHhhhcCCCCC
Q 040202 165 GRWVALISWLCSWNPRMR 182 (297)
Q Consensus 165 ~~~~~li~~~l~~dP~~R 182 (297)
...+.||..+|+.||.+|
T Consensus 271 e~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 271 EPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCcccC
Confidence 788999999999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=145.78 Aligned_cols=155 Identities=24% Similarity=0.342 Sum_probs=127.0
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
+...++|...|-+..++.+-.||+|+++.+|.+.+.- .+..|+.+.+..++.|++.-++|+|++.+|+|||||+|+||.
T Consensus 80 L~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 80 LGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred HcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 4567899999988899999999999998877665544 467899999999999999999999999999999999999994
Q ss_pred ------CCeEEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 87 ------KGVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 87 ------~~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
.+.+.++|||+|+...... .....-||-.||+--...+.+. +.+.|+-|||-++.+.+-|.+||.
T Consensus 159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccc
Confidence 2679999999998764321 1245568999999777665554 788999999999999999999998
Q ss_pred CCC---CHHHHHHH
Q 040202 153 GKN---SADQIYKI 163 (297)
Q Consensus 153 ~~~---~~~~~~~i 163 (297)
+.. ..+...||
T Consensus 238 GLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 238 GLKADTNKEKYEKI 251 (449)
T ss_pred cccCcchHHHHHHh
Confidence 754 33344444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-18 Score=155.02 Aligned_cols=108 Identities=21% Similarity=0.235 Sum_probs=82.1
Q ss_pred cccccccceee-eceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCc
Q 040202 5 RKMNNHPNIVK-LRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL-KPSN 82 (297)
Q Consensus 5 ~kl~~HpnIv~-~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi-kp~N 82 (297)
++.++|+||+. +++ .+..|+||||+.|+.+.... . .. ...++.|++.||.|||++||+|||| ||+|
T Consensus 75 L~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~~-~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~N 142 (365)
T PRK09188 75 LKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLAR-P----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQN 142 (365)
T ss_pred HHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHhC-c----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcce
Confidence 34458999985 543 24689999999987665321 1 11 1568899999999999999999999 9999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCC---------CccccccCCCCCCceecc
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLP---------CTDYVTTRWYRAPEVLLL 124 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~---------~~~~~gt~~y~aPE~~~~ 124 (297)
||++. +.+||+|||+|+....... ..+..+++.|+|||.+.-
T Consensus 143 ILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 143 WLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99974 7899999999987644321 134567888999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6e-17 Score=135.64 Aligned_cols=147 Identities=20% Similarity=0.296 Sum_probs=117.3
Q ss_pred ccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--
Q 040202 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-- 87 (297)
Q Consensus 10 HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-- 87 (297)
-..|..+..+..+.++-.+|||.++.++.+.+.-. .+.|+.+.+..++-|++.-++|+|.++++||||||+|+|..-
T Consensus 70 g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 70 GVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR 148 (341)
T ss_pred CCCCchhhhhccccccceeeeeccCccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc
Confidence 34566777777888999999999988776655443 456999999999999999999999999999999999999953
Q ss_pred --CeEEEEecCCceecCCC--------CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 88 --GVIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 88 --~~~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+.+.++|||+|+..... ..-....||..|.+--...+... +...|+-|+|.++.+..-|.+||++....
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchh
Confidence 57999999999875332 12234568888887655443333 67889999999999999999999986543
Q ss_pred H
Q 040202 158 D 158 (297)
Q Consensus 158 ~ 158 (297)
.
T Consensus 228 t 228 (341)
T KOG1163|consen 228 T 228 (341)
T ss_pred h
Confidence 3
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.7e-17 Score=134.29 Aligned_cols=74 Identities=27% Similarity=0.345 Sum_probs=63.5
Q ss_pred EEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEeCCeEEEEecCCceec
Q 040202 27 FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM-HRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEI 101 (297)
Q Consensus 27 ~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yL-H~~gi~Hrdikp~Nill~~~~~kl~Dfgla~~~ 101 (297)
+|||||++|+.+...... ...+++..+..++.|++.+|.|+ |+.||+||||||+|||++++.++|+|||+|...
T Consensus 93 ~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEEEEccccccC
Confidence 899999998654332222 24699999999999999999999 799999999999999999899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-17 Score=138.15 Aligned_cols=120 Identities=18% Similarity=0.238 Sum_probs=88.1
Q ss_pred ccccccccceeeeceeEEeC--------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 4 LRKMNNHPNIVKLRNLVKEH--------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~--------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++ .|++|....+++... +..+|+|||++|..+..+. .+++. ...+++.++..+|+.|++|
T Consensus 89 l~rL-~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 89 TDRV-RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHGMVS 158 (232)
T ss_pred HHHH-HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcCCcc
Confidence 3444 899999999987643 3589999999996665542 13433 4569999999999999999
Q ss_pred cCCCCCcEEEeCCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH
Q 040202 76 RDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 76 rdikp~Nill~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 145 (297)
||+||.||+++++.++|+|||........... +.+.....++.++|+|+||+++....
T Consensus 159 ~Dikp~Nili~~~gi~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSKNGLRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeCCCEEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999998644999999987654332211 11222334568999999999876443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=8e-16 Score=128.79 Aligned_cols=91 Identities=21% Similarity=0.288 Sum_probs=71.6
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEe
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVS 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~ 86 (297)
.|++|.....+.... .||||||++|+ +....... ..+++..+..++.|++.++.++|. .||+||||||+||+++
T Consensus 77 ~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 77 YEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred HhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 566664444333332 48999999986 33333333 458899999999999999999999 9999999999999999
Q ss_pred CCeEEEEecCCceecCC
Q 040202 87 KGVIKIGDLGMVKEIDS 103 (297)
Q Consensus 87 ~~~~kl~Dfgla~~~~~ 103 (297)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-15 Score=127.65 Aligned_cols=84 Identities=21% Similarity=0.280 Sum_probs=66.6
Q ss_pred cccceeeeceeEEeCC---eEE-EEEecCC--CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCC
Q 040202 9 NHPNIVKLRNLVKEHE---DVF-IVFDYME--SDLLKLMKESAGQNFSEDEARNLCFQVFQGL-HYMHRQGYFHRDLKPS 81 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~---~~~-lv~e~~~--g~ll~~~~~~~~~~l~e~~~~~~~~qll~al-~yLH~~gi~Hrdikp~ 81 (297)
+||||++++|+++++. .++ +|+||.+ ++.+..+..+ ..+++. ..++.|++.++ +|||+++|+||||||+
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 6899999999999874 444 7899944 5566666654 237666 35678888777 9999999999999999
Q ss_pred cEEEeC-----CeEEEEecC
Q 040202 82 NLLVSK-----GVIKIGDLG 96 (297)
Q Consensus 82 Nill~~-----~~~kl~Dfg 96 (297)
|||++. ..++|+||+
T Consensus 135 NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNI 154 (210)
T ss_pred HEEEeccCCCCCcEEEEECC
Confidence 999963 279999955
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-15 Score=148.17 Aligned_cols=175 Identities=17% Similarity=0.218 Sum_probs=130.8
Q ss_pred cceeeeceeEEeCCeEEEEEecCC-CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-- 87 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~-g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-- 87 (297)
+-|..+..++.-.+..+||+||.+ |++++.+.. .+.|+|..+..+..|++..|+.||..||||+||||+|+||..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREI 831 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeeccc
Confidence 456666666677788899999998 577777663 367999999999999999999999999999999999999942
Q ss_pred ------CeEEEEecCCceec---CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC-CCCCCH
Q 040202 88 ------GVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF-PGKNSA 157 (297)
Q Consensus 88 ------~~~kl~Dfgla~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf-~~~~~~ 157 (297)
..++|+|||-+..+ ..+......++|-.+-++|+.. ++.++..+|.|.++.+++-|+.|+.-- .+...+
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~ 910 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSW 910 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcce
Confidence 25999999998654 4445566778899999999865 566689999999999999999987642 111111
Q ss_pred HH---HHH--HHHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 158 DQ---IYK--IYGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 158 ~~---~~~--i~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
.. +.+ -..-|-+++..+|+.|-..=|.+.++
T Consensus 911 ~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 911 MVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred eccccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 11 111 12346778888888544444444443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.6e-14 Score=131.34 Aligned_cols=192 Identities=20% Similarity=0.214 Sum_probs=153.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ----GLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~----al~yLH~~gi~Hrdikp 80 (297)
++.-.|+|.++.+..+++.+.+|+-+|+|+..+..+.... ...+++..++..+.+... ||.++|+.+++|-|+||
T Consensus 172 ~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp 250 (524)
T KOG0601|consen 172 HKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP 250 (524)
T ss_pred cccCccccccccCcccccCCcceeeeccccchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccch
Confidence 4556899999999999999999999999997777766654 345999999999999999 99999999999999999
Q ss_pred CcEEEeC--CeEEEEecCCceecCCCCCC------ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 81 SNLLVSK--GVIKIGDLGMVKEIDSSLPC------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 81 ~Nill~~--~~~kl~Dfgla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
+||++.+ ...+++|||+...+...... ....|...|++||.+. ..++...||+++|.++.+...+...+.
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhccccc
Confidence 9999964 57899999998877654321 1124677799999864 456889999999999999888766654
Q ss_pred CC--CCHHHHHH----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 153 GK--NSADQIYK----------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 153 ~~--~~~~~~~~----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
.. +.+.+..+ ...++...+..|++.+|..|++++.+++|++.+....
T Consensus 329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~ 387 (524)
T KOG0601|consen 329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF 387 (524)
T ss_pred CCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence 44 33333322 2234556889999999999999999999999975443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.1e-14 Score=139.06 Aligned_cols=192 Identities=27% Similarity=0.361 Sum_probs=151.9
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-C
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-K 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-~ 87 (297)
.||.+++..-.+.-...++|+++|++|+.+.......+ ..+++-++.++..+..+.+|||...+.|||++|.|++.. .
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhccc
Confidence 34666666555556778999999998755544444433 478888999999999999999999999999999999987 5
Q ss_pred CeEEEEecCCceecCC--------------------------------CCCCccccccCCCCCCceecccccCCCccchh
Q 040202 88 GVIKIGDLGMVKEIDS--------------------------------SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRW 135 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 135 (297)
+..++.|||.....+. ........||+.|.+||.+.+.. .+..+|+|
T Consensus 941 gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~ 1019 (1205)
T KOG0606|consen 941 GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWW 1019 (1205)
T ss_pred CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhh
Confidence 8999999984322110 01123356899999999987654 48899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------HHHHHHHHhhhcCCCCCCCHH---HHHcCCCCCCCC
Q 040202 136 AMGAIMFEMLSFRILFPGKNSADQIYKIYG--------------RWVALISWLCSWNPRMRPTAA---EALEHPFFRSCH 198 (297)
Q Consensus 136 SlGv~l~ell~g~~pf~~~~~~~~~~~i~~--------------~~~~li~~~l~~dP~~R~t~~---~ll~h~~f~~~~ 198 (297)
+.|++++|.++|..||...........|.+ +..+++.++|..+|.+|..+. +...|+||++.+
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 999999999999999988877766655532 578899999999999999887 899999999988
Q ss_pred CCCC
Q 040202 199 FVPR 202 (297)
Q Consensus 199 ~~~~ 202 (297)
|...
T Consensus 1100 ~~~l 1103 (1205)
T KOG0606|consen 1100 WENL 1103 (1205)
T ss_pred cccc
Confidence 7543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.4e-13 Score=131.19 Aligned_cols=87 Identities=23% Similarity=0.260 Sum_probs=74.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|++|+....++.+.+..++||||++|+.+..+.. ....++.|++.+|.+||+.|++||||||+|||+
T Consensus 391 ~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl 461 (535)
T PRK09605 391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV 461 (535)
T ss_pred HhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE
Confidence 34489999988877777778899999999866655443 356789999999999999999999999999999
Q ss_pred eCCeEEEEecCCceec
Q 040202 86 SKGVIKIGDLGMVKEI 101 (297)
Q Consensus 86 ~~~~~kl~Dfgla~~~ 101 (297)
+++.++|+|||+++..
T Consensus 462 ~~~~~~liDFGla~~~ 477 (535)
T PRK09605 462 RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ECCcEEEEeCcccccC
Confidence 8899999999998653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.9e-13 Score=114.75 Aligned_cols=88 Identities=25% Similarity=0.358 Sum_probs=75.0
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
+.|++|.....++.+.+..+++|||++|..+..+.... .. ....++.+++.+|.++|+.|++|||++|.|||+++
T Consensus 56 l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~ 130 (211)
T PRK14879 56 ARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130 (211)
T ss_pred HHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEEC
Confidence 47888887777777788899999999996666655431 22 78899999999999999999999999999999998
Q ss_pred CeEEEEecCCcee
Q 040202 88 GVIKIGDLGMVKE 100 (297)
Q Consensus 88 ~~~kl~Dfgla~~ 100 (297)
+.++|+|||.+..
T Consensus 131 ~~~~liDf~~a~~ 143 (211)
T PRK14879 131 GKIYLIDFGLAEF 143 (211)
T ss_pred CCEEEEECCcccC
Confidence 8999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-13 Score=119.33 Aligned_cols=189 Identities=21% Similarity=0.292 Sum_probs=134.2
Q ss_pred cccceeeeceeEEeCC-----eEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Q 040202 9 NHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDL 78 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdi 78 (297)
-|.|||+++.++.+.+ ...++.||+..+.+...+++ .++.+....-++|+.||+.||.|||+.. |+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 7999999999996543 57899999997666655543 3356889999999999999999999885 999999
Q ss_pred CCCcEEEeC-CeEEEEecCCcee-----cCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKE-----IDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
..+.|++.. |.+|++--..... ...........+-++|.|||.=. .......+|||++|....+|..++.--.
T Consensus 205 Tc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~t 283 (458)
T KOG1266|consen 205 TCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQST 283 (458)
T ss_pred chhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccC
Confidence 999999985 6667653221110 00111112234567899999522 2333567999999999999998876532
Q ss_pred CCC-CHHHHHHHHH--------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 153 GKN-SADQIYKIYG--------RWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 153 ~~~-~~~~~~~i~~--------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
... .......|.. .-++++.+||+-.|+.||++.+++.||..-.++
T Consensus 284 nseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 284 NSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred CCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 211 1111111211 225799999999999999999999999985544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.1e-13 Score=116.99 Aligned_cols=77 Identities=23% Similarity=0.363 Sum_probs=63.3
Q ss_pred eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEeCCeEEEEecCCceecC
Q 040202 25 DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG-YFHRDLKPSNLLVSKGVIKIGDLGMVKEID 102 (297)
Q Consensus 25 ~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g-i~Hrdikp~Nill~~~~~kl~Dfgla~~~~ 102 (297)
..|+||||++|+.+...... ...+.+..+..++.|++.++.+||+.| |+||||||+||+++++.++|+|||.+....
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKVVIIDVSQSVELD 199 (237)
T ss_pred CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCEEEEEChhhhccC
Confidence 35899999999655433222 234677778899999999999999999 999999999999998889999999876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=123.71 Aligned_cols=180 Identities=20% Similarity=0.311 Sum_probs=126.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH-RQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH-~~gi~Hrdikp~Nil 84 (297)
|.++||||++|++.+++++.+|||+|-+.. +..+.+. +....+..-++||+.||.||| +.+++|++|.-..|+
T Consensus 64 KtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVf 137 (690)
T KOG1243|consen 64 KTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVF 137 (690)
T ss_pred hhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEE
Confidence 455999999999999999999999999875 1111222 336677788899999999998 568999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++. |..||++|.++........ .....---.|..|+.+... .-..|.|-|||+++|++.| .+....+......
T Consensus 138 Vn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng--~~~~~~~~~~~~~ 212 (690)
T KOG1243|consen 138 VNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG--SLLTKTDLSNTGK 212 (690)
T ss_pred EcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc--ccCcchhhhccCc
Confidence 985 9999999998754432211 1111112235666643221 2357999999999999999 4444444445555
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHH----H-HcCCCCCC
Q 040202 163 IYGRWVALISWLCSWNPRMRPTAAE----A-LEHPFFRS 196 (297)
Q Consensus 163 i~~~~~~li~~~l~~dP~~R~t~~~----l-l~h~~f~~ 196 (297)
|......+..+-+...+.+|+.... + +-|.||++
T Consensus 213 ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n 251 (690)
T KOG1243|consen 213 IPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRN 251 (690)
T ss_pred cchhHHHHHHHHhccccccccchhhHHHHHHhccccccc
Confidence 5555566666667777788877432 2 34888865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.3e-13 Score=112.11 Aligned_cols=85 Identities=22% Similarity=0.289 Sum_probs=67.8
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
+.|+++.....++.+.+..++||||++|..+..+....+ . .++.|++.+|.+||+.|++|||++|+||++++
T Consensus 54 l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~ 125 (199)
T TIGR03724 54 ARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRD 125 (199)
T ss_pred HHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEEC
Confidence 366665555555556677899999999866655543311 1 78999999999999999999999999999998
Q ss_pred CeEEEEecCCcee
Q 040202 88 GVIKIGDLGMVKE 100 (297)
Q Consensus 88 ~~~kl~Dfgla~~ 100 (297)
+.++++|||+++.
T Consensus 126 ~~~~liDfg~a~~ 138 (199)
T TIGR03724 126 DKLYLIDFGLGKY 138 (199)
T ss_pred CcEEEEECCCCcC
Confidence 8999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=113.09 Aligned_cols=87 Identities=17% Similarity=0.167 Sum_probs=65.6
Q ss_pred ccccce--eeeceeEEeC-Ce---EEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 8 NNHPNI--VKLRNLVKEH-ED---VFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 8 ~~HpnI--v~~~~~~~~~-~~---~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.|++| ++.+++...+ .. .++|||+++| ..+..+... ..+++.. +.|++.+|.+||++||+||||||
T Consensus 97 L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp 170 (239)
T PRK01723 97 LYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNA 170 (239)
T ss_pred HHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCc
Confidence 367664 6777765432 22 2599999997 555555543 3466553 57899999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCcee
Q 040202 81 SNLLVSK-GVIKIGDLGMVKE 100 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~ 100 (297)
+|||++. +.++|+|||.+..
T Consensus 171 ~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 171 HNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred hhEEEcCCCCEEEEECCCccc
Confidence 9999985 6899999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.7e-11 Score=103.13 Aligned_cols=73 Identities=19% Similarity=0.280 Sum_probs=59.7
Q ss_pred CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecC
Q 040202 24 EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID 102 (297)
Q Consensus 24 ~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~ 102 (297)
...++||||+.|..+..+.. ......++.+++.++.++|+.||+||||||+||++++ +.++|+|||++....
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 45689999999976654432 1345678899999999999999999999999999984 789999999986543
Q ss_pred C
Q 040202 103 S 103 (297)
Q Consensus 103 ~ 103 (297)
.
T Consensus 177 ~ 177 (198)
T cd05144 177 H 177 (198)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.2e-11 Score=100.19 Aligned_cols=75 Identities=24% Similarity=0.369 Sum_probs=58.8
Q ss_pred eEEEEEecCCCcHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEeCCeEEEEecCCceecC
Q 040202 25 DVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKIGDLGMVKEID 102 (297)
Q Consensus 25 ~~~lv~e~~~g~ll-~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~~~~~kl~Dfgla~~~~ 102 (297)
..++||||++|+.+ ........ . ...++.++.+++.++.++|. .||+||||||+||+++++.++|+|||.+....
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~~~liDfg~a~~~~ 165 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDGKVYIIDVPQAVEID 165 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCcEEEEECccccccc
Confidence 45899999998321 11111111 1 16788999999999999999 99999999999999998899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.5e-11 Score=96.14 Aligned_cols=81 Identities=22% Similarity=0.334 Sum_probs=69.6
Q ss_pred cceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEeC
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ---GYFHRDLKPSNLLVSK 87 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~---gi~Hrdikp~Nill~~ 87 (297)
.++++++++....+..|++|||+.|..+..+ +......++.+++.++.++|.. +++|+|++|+||++++
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~ 124 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC
Confidence 6889999888888899999999998655332 5566677899999999999985 7999999999999987
Q ss_pred -CeEEEEecCCce
Q 040202 88 -GVIKIGDLGMVK 99 (297)
Q Consensus 88 -~~~kl~Dfgla~ 99 (297)
+.++++|||.++
T Consensus 125 ~~~~~l~Df~~~~ 137 (155)
T cd05120 125 GKILGIIDWEYAG 137 (155)
T ss_pred CcEEEEEeccccc
Confidence 899999999774
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.9e-12 Score=117.48 Aligned_cols=187 Identities=21% Similarity=0.238 Sum_probs=141.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
-.+..|.++++++..|......|+-.|||.|++..... .....+.+...+....|++.++.++|+..++|+|+||.||+
T Consensus 320 ~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~ 398 (524)
T KOG0601|consen 320 AILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNIL 398 (524)
T ss_pred hHhhcccccCCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhccccccccee
Confidence 34568999999999999999999999999875443333 22345899999999999999999999999999999999999
Q ss_pred EeC--CeEEEEecCCceecCCCCCCccccccCCCC-CCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR-APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
+.. +..+++|||....+... .....++-++. ..|++.....+..++|++|||.-+.+.+++...-........+.
T Consensus 399 i~~~~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~ 476 (524)
T KOG0601|consen 399 ISNDGFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR 476 (524)
T ss_pred eccchhhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee
Confidence 976 68899999987653221 12333444455 36666666777899999999999999998766533322211111
Q ss_pred --------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 162 --------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 162 --------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.....+..+.+.++..|+..|+.+.++..|.=|
T Consensus 477 ~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111355678888899999999999998887655
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.9e-10 Score=95.10 Aligned_cols=86 Identities=17% Similarity=0.261 Sum_probs=66.4
Q ss_pred cceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEeCC
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYM-HRQGYFHRDLKPSNLLVSKG 88 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yL-H~~gi~Hrdikp~Nill~~~ 88 (297)
-++.+.+++ ..-+|||||++|+ +....... ..+++..+..+..+++.+|..| |+.|++|+||++.||+++++
T Consensus 88 v~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~~ 161 (197)
T cd05146 88 IPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHDG 161 (197)
T ss_pred CCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEECC
Confidence 345555543 4568999999874 32222322 2366677888899999999999 89999999999999999999
Q ss_pred eEEEEecCCceecC
Q 040202 89 VIKIGDLGMVKEID 102 (297)
Q Consensus 89 ~~kl~Dfgla~~~~ 102 (297)
.+.|+|||.+....
T Consensus 162 ~v~iIDF~qav~~~ 175 (197)
T cd05146 162 KVWFIDVSQSVEPT 175 (197)
T ss_pred cEEEEECCCceeCC
Confidence 99999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.1e-09 Score=87.74 Aligned_cols=72 Identities=32% Similarity=0.451 Sum_probs=59.2
Q ss_pred EeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 21 KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 21 ~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
.+.+...|+|||++|.+++..+... . ..++..+=..+.-||.+||+|+||++.||+++++.+.++|||++..
T Consensus 69 vD~~~~~I~me~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 69 VDPDNGLIVMEYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EcCCCCEEEEEEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 4567778999999999988666552 2 3455566666777999999999999999999998899999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.1e-09 Score=96.16 Aligned_cols=166 Identities=19% Similarity=0.230 Sum_probs=120.5
Q ss_pred ccccceeeeceeEE----eCCeEEEEEecCCC--cHHHHHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHH
Q 040202 8 NNHPNIVKLRNLVK----EHEDVFIVFDYMES--DLLKLMKES-------------AGQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 8 ~~HpnIv~~~~~~~----~~~~~~lv~e~~~g--~ll~~~~~~-------------~~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.|.|||++.++|. .+..+++|++|.++ +|++.+... .+...+|..+|.|+.||..||.++
T Consensus 330 l~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI 409 (655)
T KOG3741|consen 330 LCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI 409 (655)
T ss_pred hccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH
Confidence 48999999999997 34579999999986 666655432 122378999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeCC-eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC
Q 040202 69 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g 147 (297)
|+.|...+-+.+.+|+++.+ .++|+.-|....+.... + |-+.. -.+-|.--||.+++.|.+|
T Consensus 410 HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------~-------~~le~----~Qq~D~~~lG~ll~aLAt~ 472 (655)
T KOG3741|consen 410 HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------T-------EPLES----QQQNDLRDLGLLLLALATG 472 (655)
T ss_pred HhcCceeecccHhHeEeeCcceEEEecccceeeecCCC------C-------cchhH----HhhhhHHHHHHHHHHHhhc
Confidence 99999999999999999976 89998888766555442 0 11221 2356888899999999998
Q ss_pred CCC-CCCCCCHHH-HH----HHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 148 RIL-FPGKNSADQ-IY----KIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 148 ~~p-f~~~~~~~~-~~----~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..- +........ .. ..+.++++++.-+...++++ -++.+++.+
T Consensus 473 ~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 473 TENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 542 111111111 11 23457888888888888886 577776654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.3e-10 Score=108.00 Aligned_cols=139 Identities=19% Similarity=0.304 Sum_probs=104.7
Q ss_pred HHHHHHHHHHHHHC-CccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCc----------cccccCCCCCCceeccc
Q 040202 58 CFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT----------DYVTTRWYRAPEVLLLS 125 (297)
Q Consensus 58 ~~qll~al~yLH~~-gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~----------~~~gt~~y~aPE~~~~~ 125 (297)
+.+...|+.|+|.. +++|+.|.|++|.++. +.+||+.|+++.......... -......|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence 34556889999965 8999999999999986 789999999876554421110 0122446999999875
Q ss_pred ccCCCccchhhHHHHHHHHH-hCCCCCCCCCCHHHH---------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 126 EICGPEVDRWAMGAIMFEML-SFRILFPGKNSADQI---------------YKIYGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 126 ~~~~~~~DiwSlGv~l~ell-~g~~pf~~~~~~~~~---------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
...+.++|++|+||++|.+. .|+..+......... .++..++++-+.+++..+...||++..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 45578999999999999988 555555444322211 12345788999999999999999999999
Q ss_pred cCCCCCCC
Q 040202 190 EHPFFRSC 197 (297)
Q Consensus 190 ~h~~f~~~ 197 (297)
..+||.+.
T Consensus 264 ~~~ff~D~ 271 (700)
T KOG2137|consen 264 SIPFFSDP 271 (700)
T ss_pred cccccCCc
Confidence 99999764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-09 Score=88.09 Aligned_cols=76 Identities=20% Similarity=0.206 Sum_probs=57.2
Q ss_pred eeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEEeC
Q 040202 13 IVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGY-----FHRDLKPSNLLVSK 87 (297)
Q Consensus 13 Iv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi-----~Hrdikp~Nill~~ 87 (297)
+.+++.... ...++||||++|..+... ......++.+++.+|..||+.++ +|+|++|.||++++
T Consensus 55 ~P~~~~~~~--~~~~lv~e~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~ 123 (170)
T cd05151 55 GPKLYYFDP--ETGVLITEFIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD 123 (170)
T ss_pred CCceEEEeC--CCCeEEEEecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC
Confidence 445555433 345899999999654321 11123457899999999999985 99999999999998
Q ss_pred CeEEEEecCCce
Q 040202 88 GVIKIGDLGMVK 99 (297)
Q Consensus 88 ~~~kl~Dfgla~ 99 (297)
+.++++|||.+.
T Consensus 124 ~~~~liDf~~a~ 135 (170)
T cd05151 124 GRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEeccccc
Confidence 899999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.2e-09 Score=96.79 Aligned_cols=78 Identities=22% Similarity=0.412 Sum_probs=56.7
Q ss_pred CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCCccccCCCCCcEEEe-CCeEEEEecCCcee
Q 040202 23 HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ-GLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE 100 (297)
Q Consensus 23 ~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~-al~yLH~~gi~Hrdikp~Nill~-~~~~kl~Dfgla~~ 100 (297)
....+|||||++|..+..+......... ...++.+++. .+..+|..|++|+|+||.||+++ ++.++++|||++..
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 3457999999999665544432111222 3345555555 47889999999999999999997 47899999999876
Q ss_pred cCC
Q 040202 101 IDS 103 (297)
Q Consensus 101 ~~~ 103 (297)
+..
T Consensus 307 l~~ 309 (437)
T TIGR01982 307 LSE 309 (437)
T ss_pred CCH
Confidence 643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.6e-08 Score=86.70 Aligned_cols=77 Identities=21% Similarity=0.148 Sum_probs=62.3
Q ss_pred CeEEEEEecCCCc-HHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--------CeEEEE
Q 040202 24 EDVFIVFDYMESD-LLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------GVIKIG 93 (297)
Q Consensus 24 ~~~~lv~e~~~g~-ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~--------~~~kl~ 93 (297)
...+||+|+++|. .+..+... .....++.....++.++...+.-||+.||+|+|+++.|||+++ ..+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999983 45555432 1234667888899999999999999999999999999999973 478999
Q ss_pred ecCCcee
Q 040202 94 DLGMVKE 100 (297)
Q Consensus 94 Dfgla~~ 100 (297)
||+.++.
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.3e-08 Score=78.69 Aligned_cols=81 Identities=14% Similarity=0.260 Sum_probs=61.6
Q ss_pred eEEeCCeEEEEEecCCC--cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--C--eEEE
Q 040202 19 LVKEHEDVFIVFDYMES--DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--G--VIKI 92 (297)
Q Consensus 19 ~~~~~~~~~lv~e~~~g--~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~--~--~~kl 92 (297)
++.+...-.|+|||++| .+-+++.......-.+.....+++++=..+.-||.++|+|+||...||++.. + .+.+
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence 34566677899999999 4555555543333333444788999999999999999999999999999953 2 4589
Q ss_pred EecCCce
Q 040202 93 GDLGMVK 99 (297)
Q Consensus 93 ~Dfgla~ 99 (297)
+|||++.
T Consensus 158 Idfgls~ 164 (229)
T KOG3087|consen 158 IDFGLSS 164 (229)
T ss_pred Eeecchh
Confidence 9999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.8e-08 Score=81.47 Aligned_cols=75 Identities=21% Similarity=0.340 Sum_probs=62.4
Q ss_pred eEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeCC----eEEEEecCCce
Q 040202 25 DVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVK 99 (297)
Q Consensus 25 ~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~~----~~kl~Dfgla~ 99 (297)
..|||+|+++| ..+..+...... .+......++.++...+.-||++||+|+|+++.|||++.+ .+.++||+.++
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 46899999998 456555554222 6778889999999999999999999999999999999864 59999999765
Q ss_pred e
Q 040202 100 E 100 (297)
Q Consensus 100 ~ 100 (297)
.
T Consensus 170 ~ 170 (206)
T PF06293_consen 170 F 170 (206)
T ss_pred e
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-08 Score=97.63 Aligned_cols=73 Identities=27% Similarity=0.456 Sum_probs=53.2
Q ss_pred CeEEEEEecCCCcHHHHHH--HhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-C----eEEEE
Q 040202 24 EDVFIVFDYMESDLLKLMK--ESAGQ---NFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G----VIKIG 93 (297)
Q Consensus 24 ~~~~lv~e~~~g~ll~~~~--~~~~~---~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~----~~kl~ 93 (297)
...+|||||+.|.-+..+. ...+. .+.+..+..++.|++ ..|++|+|+||.||+++. | .++++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~ll 306 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIAL 306 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence 3456999999996554432 22221 255666667777765 589999999999999974 5 89999
Q ss_pred ecCCceecCC
Q 040202 94 DLGMVKEIDS 103 (297)
Q Consensus 94 Dfgla~~~~~ 103 (297)
|||++..+..
T Consensus 307 DFGivg~l~~ 316 (537)
T PRK04750 307 DFGIVGSLNK 316 (537)
T ss_pred ecceEEECCH
Confidence 9999876643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-08 Score=83.10 Aligned_cols=84 Identities=25% Similarity=0.416 Sum_probs=56.4
Q ss_pred ceeeeceeEEeCCeEEEEEecCC--CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEeCC
Q 040202 12 NIVKLRNLVKEHEDVFIVFDYME--SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY-MHRQGYFHRDLKPSNLLVSKG 88 (297)
Q Consensus 12 nIv~~~~~~~~~~~~~lv~e~~~--g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~y-LH~~gi~Hrdikp~Nill~~~ 88 (297)
++.+.+++- .-+|||||++ |..+..+... .++......++.+++..+.. +|+.||+|+|+.+.||+++++
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG 143 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc
Confidence 455665442 2379999999 7555554442 13355667788888885555 579999999999999999999
Q ss_pred eEEEEecCCceecC
Q 040202 89 VIKIGDLGMVKEID 102 (297)
Q Consensus 89 ~~kl~Dfgla~~~~ 102 (297)
.+.|+|||.+....
T Consensus 144 ~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 KVYIIDFGQAVDSS 157 (188)
T ss_dssp CEEE--GTTEEETT
T ss_pred eEEEEecCcceecC
Confidence 99999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=9e-07 Score=80.73 Aligned_cols=129 Identities=13% Similarity=0.147 Sum_probs=97.9
Q ss_pred eEEEEEecCCC--cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCC
Q 040202 25 DVFIVFDYMES--DLLKLMKESAG----QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM 97 (297)
Q Consensus 25 ~~~lv~e~~~g--~ll~~~~~~~~----~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgl 97 (297)
..-+.|..+.| .....+..... ..+.++-+....+.|+.+...||..|..-+|+.++|+|+++ +.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 47788888887 33333322211 23678889999999999999999999999999999999975 7888888665
Q ss_pred ceecCCCCCCccccccCCCCCCceeccc----ccCCCccchhhHHHHHHHHHhC-CCCCCC
Q 040202 98 VKEIDSSLPCTDYVTTRWYRAPEVLLLS----EICGPEVDRWAMGAIMFEMLSF-RILFPG 153 (297)
Q Consensus 98 a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~ell~g-~~pf~~ 153 (297)
......+...-..+|...|.+||.-.-. .......|.|.|||++++++.| +.||.+
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 5444555555667889999999964312 1224568999999999999876 999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.4e-08 Score=96.29 Aligned_cols=189 Identities=16% Similarity=0.084 Sum_probs=138.0
Q ss_pred cccccccc-eeeeceeEEeCCeEEEEEecCCCc--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 5 RKMNNHPN-IVKLRNLVKEHEDVFIVFDYMESD--LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 5 ~kl~~Hpn-Iv~~~~~~~~~~~~~lv~e~~~g~--ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.-.+||| .+.+++-++.+...++.+++++++ ....... ....+.+-+.....+.-+.+++++|+.--+|||
T Consensus 287 LdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d---- 361 (829)
T KOG0576|consen 287 LDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD---- 361 (829)
T ss_pred HHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----
Confidence 33349999 888888888899999999999875 2211111 011244555666677778899999998878999
Q ss_pred cEEEeCCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC--------
Q 040202 82 NLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG-------- 153 (297)
Q Consensus 82 Nill~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~-------- 153 (297)
||+..++..|..||+....+.......+..+++.++|||+.....+ ....|.|++|+-..+|.-|..|-..
T Consensus 362 ~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~ 440 (829)
T KOG0576|consen 362 NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMI 440 (829)
T ss_pred cccccccccccccccCCcccCcccccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCCccccCCC
Confidence 9999999999999999887776655678889999999998775544 7789999999876677666555321
Q ss_pred ---CCCHHHHHHH--HHHH-HHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 154 ---KNSADQIYKI--YGRW-VALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 154 ---~~~~~~~~~i--~~~~-~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
.+......+. .... .++...|+...|..|+....++.|.+|.+|..
T Consensus 441 g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 441 GNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 1111111111 0011 24778899999999999999999999988753
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-06 Score=73.92 Aligned_cols=67 Identities=27% Similarity=0.539 Sum_probs=51.8
Q ss_pred CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 24 EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 24 ~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
...+++|||++|..+..+.. +++. +...+..++.-||+.|+.|+|.+|.|++++++.++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcccc
Confidence 34578999999954433221 3332 3456777899999999999999999999999999999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-06 Score=88.23 Aligned_cols=189 Identities=18% Similarity=0.162 Sum_probs=129.1
Q ss_pred ccccceeeeceeEEeCCeE----EEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 8 NNHPNIVKLRNLVKEHEDV----FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~----~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
..|+|++.++.+-.+.... .+..|+|.+..+..+.+.. +..+...++.+..+++.|+.|+|+....|.-+.....
T Consensus 239 ~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~ 317 (1351)
T KOG1035|consen 239 IAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSS 317 (1351)
T ss_pred hccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccc
Confidence 4899999999988655443 3456778775555555554 4589999999999999999999998555544433322
Q ss_pred E---Ee-CCeEEEE--ecCCceecCCCCCCccccccCCCCCCceeccccc-CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 84 L---VS-KGVIKIG--DLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI-CGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 84 l---l~-~~~~kl~--Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
. .+ ++.+.++ ||+..+............-+..+.++|....... .+...|+|.+|.....+..|..+-.-...
T Consensus 318 ~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~ 397 (1351)
T KOG1035|consen 318 KESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV 397 (1351)
T ss_pred cccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc
Confidence 1 12 2456666 8888877765544445555677888887543321 12336999999999999887655322111
Q ss_pred HHHHH-H-HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 ADQIY-K-IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 ~~~~~-~-i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...+. . ......+++.+|+..++++|+++.+++.|+|.+.-
T Consensus 398 ~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 398 PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 11111 1 11146788899999999999999999999999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.6e-06 Score=71.27 Aligned_cols=87 Identities=21% Similarity=0.308 Sum_probs=61.3
Q ss_pred cceeeeceeEEeC---CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q 040202 11 PNIVKLRNLVKEH---EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR----------------- 70 (297)
Q Consensus 11 pnIv~~~~~~~~~---~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~----------------- 70 (297)
.++.+++.+..++ +..|+||||++|..+...... ..+++.....++.+++.+|..||+
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~ 134 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGY 134 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCch
Confidence 3456666666553 367899999998655432211 236666667777777777777773
Q ss_pred ---------------------------------------CCccccCCCCCcEEEeC---CeEEEEecCCce
Q 040202 71 ---------------------------------------QGYFHRDLKPSNLLVSK---GVIKIGDLGMVK 99 (297)
Q Consensus 71 ---------------------------------------~gi~Hrdikp~Nill~~---~~~kl~Dfgla~ 99 (297)
..++|+|+++.||+++. +.+.|+||+.+.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 135 LERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 24699999999999976 357899999663
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-05 Score=67.74 Aligned_cols=76 Identities=16% Similarity=0.115 Sum_probs=61.1
Q ss_pred eEEEEEecCCC-cHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-CCe--EEEEecCCce
Q 040202 25 DVFIVFDYMES-DLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGV--IKIGDLGMVK 99 (297)
Q Consensus 25 ~~~lv~e~~~g-~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-~~~--~kl~Dfgla~ 99 (297)
.-+||+|-++| ..+..+... .-...++.....++.++..++.-||+.|+.|+|+.+.||+++ +|. ++++||.-++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 46899999987 444444433 223467888899999999999999999999999999999997 455 9999998765
Q ss_pred e
Q 040202 100 E 100 (297)
Q Consensus 100 ~ 100 (297)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0001 Score=63.32 Aligned_cols=76 Identities=25% Similarity=0.340 Sum_probs=58.7
Q ss_pred eEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEeCCeEEEEecCCceecC
Q 040202 25 DVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKIGDLGMVKEID 102 (297)
Q Consensus 25 ~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~~~~~kl~Dfgla~~~~ 102 (297)
.-.|||||++.. .-.=.+.. -.+...++..+..+++..+.-|-. .|++|+||+.-|||+.+|.+.|+|||-|....
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~iID~~QaV~~~ 217 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYIIDVSQAVTID 217 (268)
T ss_pred CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEEEEECccccccC
Confidence 347999999864 11111111 224455788999999999999888 89999999999999999999999999876544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00019 Score=62.52 Aligned_cols=71 Identities=21% Similarity=0.322 Sum_probs=54.7
Q ss_pred CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCce
Q 040202 23 HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 99 (297)
Q Consensus 23 ~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~ 99 (297)
.+.-.+||||++|-.+..+ ++..+.+..++..|+.-+.-+-..||+|+|+++-||++++ |.+.++||--+.
T Consensus 179 ~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 4566899999999544221 1235556677777887777777999999999999999986 699999997553
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0007 Score=63.86 Aligned_cols=142 Identities=21% Similarity=0.379 Sum_probs=91.7
Q ss_pred ccccccccceeeeceeEEeC-CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEH-EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~-~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++|.+.|+|...++++-+.. ....+|+|++..++.+....+. +... +++ .+|+.|-
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~---l~~~-------s~~-------~~~~~~~------ 91 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN---LKDE-------SLL-------AHGVLHL------ 91 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc---cchh-------hhc-------cccccee------
Confidence 35667999999999988643 4588999999988887765542 1111 111 1222221
Q ss_pred EEEeCCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 83 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 83 ill~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+.++++| -++ |. | |-. .++++||||+|.++.++.-|...|......++...
T Consensus 92 -----~~~~~td-~~~--------------t~-~--~~~------~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~ 142 (725)
T KOG1093|consen 92 -----NIIYITD-HFL--------------TK-Y--PSP------IGPKSDVWSLGFIILELYLGISLEAELTESEYLEI 142 (725)
T ss_pred -----hhhhccc-ccc--------------cc-C--CCC------CCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence 2233344 000 00 0 111 12599999999999999988777765555444433
Q ss_pred HH-----------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 IY-----------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i~-----------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+. .....+..+|+-..|..||...++.+++-|..+
T Consensus 143 i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 143 LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 22 134668889999999999999999999999654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.002 Score=55.39 Aligned_cols=27 Identities=30% Similarity=0.274 Sum_probs=23.6
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCc
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMV 98 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla 98 (297)
.++|+|+.|.||+++++.+.|+||+.+
T Consensus 154 ~~~HgD~~~~Nii~~~~~~~iIDwe~a 180 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKGTYWIDLGDF 180 (226)
T ss_pred ceEecCCCCCcEEEcCCCcEEEechhc
Confidence 478999999999998755999999965
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00073 Score=56.34 Aligned_cols=85 Identities=20% Similarity=0.286 Sum_probs=66.1
Q ss_pred cceeeeceeEEeCCeEEEEEecCCC-cHHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCcE
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYMES-DLLKL---MKESAGQNFSEDEARNLCFQVFQGLHYMHR---QGYFHRDLKPSNL 83 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~---~~~~~~~~l~e~~~~~~~~qll~al~yLH~---~gi~Hrdikp~Ni 83 (297)
+++++++|+|-+ ++|.||.+. .++.. +.+- ..-++..+.+++.+++..+++|+. ..+.-.|++++|+
T Consensus 20 ~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nf 93 (188)
T PF12260_consen 20 EPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNF 93 (188)
T ss_pred CCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHe
Confidence 699999999943 678899985 33211 1111 226899999999999999999997 4588889999999
Q ss_pred EEeC-CeEEEEecCCceec
Q 040202 84 LVSK-GVIKIGDLGMVKEI 101 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~ 101 (297)
-+++ +.+|++|...+...
T Consensus 94 gv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 94 GVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeCCCcEEEEechhcchh
Confidence 9975 69999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0017 Score=56.11 Aligned_cols=27 Identities=30% Similarity=0.318 Sum_probs=23.5
Q ss_pred CccccCCCCCcEEEeCC-eEEEEecCCc
Q 040202 72 GYFHRDLKPSNLLVSKG-VIKIGDLGMV 98 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~-~~kl~Dfgla 98 (297)
.++|+|+.|.|||++++ .+.|+||+.+
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 48999999999999975 5689999965
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0021 Score=61.64 Aligned_cols=80 Identities=24% Similarity=0.464 Sum_probs=50.5
Q ss_pred eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCcee
Q 040202 22 EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 100 (297)
Q Consensus 22 ~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~ 100 (297)
-.+.-.|+|||++|--++.+......+++.+.+...+.++. +.-+-..|++|.|.+|.||+++. |.+-+.|||+...
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceec
Confidence 34667899999999333333211112355333222222211 22233489999999999999985 7999999999866
Q ss_pred cCC
Q 040202 101 IDS 103 (297)
Q Consensus 101 ~~~ 103 (297)
+..
T Consensus 315 l~~ 317 (517)
T COG0661 315 LDP 317 (517)
T ss_pred CCH
Confidence 544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0077 Score=50.61 Aligned_cols=84 Identities=20% Similarity=0.296 Sum_probs=61.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCC---C---cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYME---S---DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~---g---~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.+...+.+|.+++|+.+++...-+|+|.+. | -++..+... +.+++ . +...+-.-.+||-+++|+.+|+
T Consensus 71 ~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl 144 (199)
T PF10707_consen 71 RRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDL 144 (199)
T ss_pred ccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCC
Confidence 344578999999999999999999999884 3 245555544 34665 3 3334445567889999999999
Q ss_pred CCCcEEEeC---C--eEEEEe
Q 040202 79 KPSNLLVSK---G--VIKIGD 94 (297)
Q Consensus 79 kp~Nill~~---~--~~kl~D 94 (297)
+|.||++.. + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 999999953 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0022 Score=61.45 Aligned_cols=76 Identities=21% Similarity=0.426 Sum_probs=52.4
Q ss_pred CeEEEEEecCCC---cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-----CCeEEEEec
Q 040202 24 EDVFIVFDYMES---DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDL 95 (297)
Q Consensus 24 ~~~~lv~e~~~g---~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-----~~~~kl~Df 95 (297)
....|+||||+| +.++.+.+. +++...+..-+.+... +-|=..|++|.|=+|.||++. +..+.+.||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 467999999998 444455443 3666654444333322 223346899999999999998 247999999
Q ss_pred CCceecCCC
Q 040202 96 GMVKEIDSS 104 (297)
Q Consensus 96 gla~~~~~~ 104 (297)
|+...+...
T Consensus 350 Gl~~~is~~ 358 (538)
T KOG1235|consen 350 GLYAVISHK 358 (538)
T ss_pred cccccccHH
Confidence 998766543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.003 Score=57.39 Aligned_cols=75 Identities=15% Similarity=0.304 Sum_probs=58.4
Q ss_pred eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 22 EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 22 ~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
+..++|++|++=.+.+. .+ +.-..+++..|+.+.+..+.-+.++ ..-|||+.-.||||++|+|.|+||-+++.
T Consensus 297 e~~y~yl~~kdhgt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeec
Confidence 44577888887544332 22 2245788899999988888877765 68999999999999999999999999985
Q ss_pred cC
Q 040202 101 ID 102 (297)
Q Consensus 101 ~~ 102 (297)
..
T Consensus 371 ~~ 372 (488)
T COG5072 371 SY 372 (488)
T ss_pred cc
Confidence 43
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0084 Score=61.23 Aligned_cols=29 Identities=31% Similarity=0.409 Sum_probs=24.0
Q ss_pred CccccCCCCCcEEEeC--C-eEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSK--G-VIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~--~-~~kl~Dfgla~~ 100 (297)
.++|+|+++.||+++. + ..-|.||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 4999999999999973 3 467999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.00024 Score=74.34 Aligned_cols=143 Identities=11% Similarity=0.018 Sum_probs=103.1
Q ss_pred ccccceeeeceeEE--eCCeEEEEEecCCC-cHHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---C--ccccC
Q 040202 8 NNHPNIVKLRNLVK--EHEDVFIVFDYMES-DLLKLMKESAGQ--NFSEDEARNLCFQVFQGLHYMHRQ---G--YFHRD 77 (297)
Q Consensus 8 ~~HpnIv~~~~~~~--~~~~~~lv~e~~~g-~ll~~~~~~~~~--~l~e~~~~~~~~qll~al~yLH~~---g--i~Hrd 77 (297)
..|+++...+.-.. ++...|..++|+.+ .++..+.+...+ .+.+.-+.....+.+.+..-+|+. | -+|++
T Consensus 1286 ~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1286 AKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred hhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence 37888888776553 45578999999986 555555543222 244455555555657777777753 2 78999
Q ss_pred CCCCcEEEeC-CeEEEEecCCce-ecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVK-EIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
+|+-|.+|.. -.+|++++|+.+ ........+...+++.|+++++...-++ +.+.|+|..|+.+|+...|..+|
T Consensus 1366 Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999875 579999999998 3333344467788999999997654443 66699999999999998877665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.037 Score=49.45 Aligned_cols=28 Identities=21% Similarity=0.460 Sum_probs=25.2
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla 98 (297)
.+++|+|+.+.||+++++.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECccc
Confidence 5789999999999999888899999954
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.023 Score=48.83 Aligned_cols=28 Identities=43% Similarity=0.769 Sum_probs=24.0
Q ss_pred CCccccCCCCCcEEEeCCeE-EEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSKGVI-KIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~-kl~Dfgla 98 (297)
.+++|+|+.+.||+++++.+ -|+||+.+
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a 192 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCL 192 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence 35899999999999998654 69999965
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.086 Score=47.41 Aligned_cols=29 Identities=24% Similarity=0.290 Sum_probs=25.0
Q ss_pred CCccccCCCCCcEEEeCCeE-EEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKGVI-KIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~-kl~Dfgla~ 99 (297)
.|++|+|+.+.||+++++.+ -|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 48999999999999987665 799999763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.037 Score=47.35 Aligned_cols=28 Identities=21% Similarity=0.349 Sum_probs=24.7
Q ss_pred CCccccCCCCCcEEEeC--CeEEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSK--GVIKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~--~~~kl~Dfgla 98 (297)
.+++|+|+.+.|||+++ +.+.++||..|
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 36999999999999986 67999999865
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.081 Score=47.40 Aligned_cols=28 Identities=29% Similarity=0.417 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEEeCCe-EEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSKGV-IKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~-~kl~Dfgla 98 (297)
.+++|+|+++.||+++++. +.|+||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccc
Confidence 6899999999999998754 589999975
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.07 Score=47.58 Aligned_cols=28 Identities=21% Similarity=0.370 Sum_probs=24.7
Q ss_pred CccccCCCCCcEEEeC-----CeEEEEecCCce
Q 040202 72 GYFHRDLKPSNLLVSK-----GVIKIGDLGMVK 99 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-----~~~kl~Dfgla~ 99 (297)
+++|+|+.+.||++++ +.++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 5899999999999975 789999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.045 Score=45.43 Aligned_cols=29 Identities=21% Similarity=0.306 Sum_probs=25.3
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
-.+|+|+.|.||+++++.++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASGLRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCCEEEEeCCcccC
Confidence 36999999999999887799999998743
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.092 Score=44.21 Aligned_cols=28 Identities=39% Similarity=0.534 Sum_probs=19.8
Q ss_pred CCccccCCCCCcEEEe--CCeEEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVS--KGVIKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~--~~~~kl~Dfgla 98 (297)
.+++|+|+.+.||+++ ++.+.|+||+.+
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred cEEEEeccccccceeeeccceeEEEecccc
Confidence 4599999999999999 567789999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.062 Score=48.49 Aligned_cols=69 Identities=16% Similarity=0.306 Sum_probs=51.3
Q ss_pred CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-CCeEEEEecCCc
Q 040202 23 HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV 98 (297)
Q Consensus 23 ~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-~~~~kl~Dfgla 98 (297)
.+.-++|||++.|--+..+.. ...+..+...++.-+.-|..+|+||+|..-=||+++ ++.++++||--.
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHh
Confidence 455688999998844433222 122445666777778889999999999999999997 578999999743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.15 Score=46.91 Aligned_cols=76 Identities=22% Similarity=0.279 Sum_probs=60.5
Q ss_pred eEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEeCCeEEEEecCCceecC
Q 040202 25 DVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKIGDLGMVKEID 102 (297)
Q Consensus 25 ~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~~~~~kl~Dfgla~~~~ 102 (297)
.-.|||+|+++ |.-.-.++. ..++...++.+-.|++.-+.-|.+ .+.+|.||.--|+|+-+|.+.|+|-+-+....
T Consensus 238 ~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 238 NHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKLYIIDVSQSVEHD 315 (520)
T ss_pred cceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEEEEEEccccccCC
Confidence 34799999986 443333333 348888899999999988888875 58999999999999999999999999775543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.12 Score=45.92 Aligned_cols=28 Identities=25% Similarity=0.309 Sum_probs=24.4
Q ss_pred CCccccCCCCCcEEEeCCe-EEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSKGV-IKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~-~kl~Dfgla 98 (297)
.+++|+|+.|.||+++++. +.|+||+.+
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 4799999999999999755 589999965
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.11 Score=45.86 Aligned_cols=49 Identities=22% Similarity=0.244 Sum_probs=36.7
Q ss_pred HHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEeC-CeEEEEecCCcee
Q 040202 52 DEARNLCFQVFQGLHYMHRQ--GYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 100 (297)
Q Consensus 52 ~~~~~~~~qll~al~yLH~~--gi~Hrdikp~Nill~~-~~~kl~Dfgla~~ 100 (297)
..++..+..+-.++.-.+.. -++|+|+.|+|++.++ |.++|+||.-|..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444555555566555555 5899999999999998 9999999987643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.07 E-value=0.068 Score=46.49 Aligned_cols=28 Identities=25% Similarity=0.315 Sum_probs=24.8
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
.++|+|+.+.||+++++.+.|+||+.+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQGLKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCCCEEEeccccC
Confidence 5899999999999987668999999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.23 Score=41.78 Aligned_cols=55 Identities=27% Similarity=0.320 Sum_probs=40.9
Q ss_pred EEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeCCeEEEEecCCc
Q 040202 26 VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMV 98 (297)
Q Consensus 26 ~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~~~~kl~Dfgla 98 (297)
.-||.||+.... .+... -+.+|++-+..+|+.||+-+|+++.|.. .-||+|||.+
T Consensus 152 ~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 152 RAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHKLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred EEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHHCCeeeccCcccccc----CCEEEecccC
Confidence 467888877643 13333 3456777888899999999999999986 4589999854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.30 E-value=0.17 Score=45.95 Aligned_cols=26 Identities=31% Similarity=0.442 Sum_probs=23.3
Q ss_pred ccccCCCCCcEEEeCC--eEEEEecCCc
Q 040202 73 YFHRDLKPSNLLVSKG--VIKIGDLGMV 98 (297)
Q Consensus 73 i~Hrdikp~Nill~~~--~~kl~Dfgla 98 (297)
+||+|+.|.||+++.+ .+.++||+-+
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccc
Confidence 9999999999999975 3899999965
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.88 E-value=0.19 Score=45.98 Aligned_cols=29 Identities=28% Similarity=0.493 Sum_probs=25.0
Q ss_pred CccccCCCCCcEEEeC--CeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSK--GVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~--~~~kl~Dfgla~~ 100 (297)
.++|+|+++.||++++ +.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999975 5799999997743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.74 E-value=0.21 Score=42.01 Aligned_cols=30 Identities=30% Similarity=0.543 Sum_probs=20.3
Q ss_pred CCccccCCCCCcEEE--eCCeEEEEecCCcee
Q 040202 71 QGYFHRDLKPSNLLV--SKGVIKIGDLGMVKE 100 (297)
Q Consensus 71 ~gi~Hrdikp~Nill--~~~~~kl~Dfgla~~ 100 (297)
..++|+|+.+.||++ .++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 568999999997743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.91 E-value=0.18 Score=43.11 Aligned_cols=36 Identities=31% Similarity=0.483 Sum_probs=30.3
Q ss_pred HHHHHHHHH--CCccccCCCCCcEEEeC-CeEEEEecCC
Q 040202 62 FQGLHYMHR--QGYFHRDLKPSNLLVSK-GVIKIGDLGM 97 (297)
Q Consensus 62 l~al~yLH~--~gi~Hrdikp~Nill~~-~~~kl~Dfgl 97 (297)
+.+|.-.|+ .+.+|+|..|+||+-|+ |.+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 566777884 36999999999999996 8999999763
|
The function of this family is unknown. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.79 E-value=0.45 Score=39.70 Aligned_cols=29 Identities=17% Similarity=0.182 Sum_probs=23.9
Q ss_pred HCCccccCCCCCcEEEeC-C-----eEEEEecCCc
Q 040202 70 RQGYFHRDLKPSNLLVSK-G-----VIKIGDLGMV 98 (297)
Q Consensus 70 ~~gi~Hrdikp~Nill~~-~-----~~kl~Dfgla 98 (297)
...++|||+.+.||++.. + .+.++||..+
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~ 153 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS 153 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence 346999999999999963 2 5899999865
|
subfamily of choline kinases |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.55 E-value=0.23 Score=45.15 Aligned_cols=74 Identities=18% Similarity=0.248 Sum_probs=41.1
Q ss_pred EEEEecCCCcHHH---HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCCCcEEE-eCC----------
Q 040202 27 FIVFDYMESDLLK---LMKESAGQNFSEDEARNLCFQVFQGLHYMHR----QGYFHRDLKPSNLLV-SKG---------- 88 (297)
Q Consensus 27 ~lv~e~~~g~ll~---~~~~~~~~~l~e~~~~~~~~qll~al~yLH~----~gi~Hrdikp~Nill-~~~---------- 88 (297)
.+|+....++.-+ ......|-.--.+-++.++.|++.-.--+-+ .+.+|-||||+|||+ |..
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 4788887653221 1111212111123355666666544322322 468999999999998 221
Q ss_pred --------eEEEEecCCcee
Q 040202 89 --------VIKIGDLGMVKE 100 (297)
Q Consensus 89 --------~~kl~Dfgla~~ 100 (297)
.++|.||.+++.
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred EEEecccceeeecccCHHHh
Confidence 256778887654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.15 E-value=0.37 Score=43.68 Aligned_cols=27 Identities=26% Similarity=0.219 Sum_probs=23.3
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla 98 (297)
.+++|+|+.+.|||+++ .+.|+||+-+
T Consensus 196 ~~liHgD~h~~NvL~~d-~~~iIDFDd~ 222 (325)
T PRK11768 196 LLRLHGDCHPGNILWRD-GPHFVDLDDA 222 (325)
T ss_pred ccceecCCCchhccccC-CcEEEeCCCC
Confidence 46899999999999964 6789999965
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.92 E-value=0.22 Score=44.06 Aligned_cols=28 Identities=25% Similarity=0.373 Sum_probs=23.7
Q ss_pred CccccCCCCCcEEEeC-Ce-EEEEecCCce
Q 040202 72 GYFHRDLKPSNLLVSK-GV-IKIGDLGMVK 99 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-~~-~kl~Dfgla~ 99 (297)
.++|+|+++.||++++ +. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999987 54 5799999763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.89 E-value=0.63 Score=42.21 Aligned_cols=60 Identities=20% Similarity=0.262 Sum_probs=35.7
Q ss_pred eEEEEEecCCCcHH----HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----CCccccCCCCCcEEE
Q 040202 25 DVFIVFDYMESDLL----KLMKESAGQNFSEDEARNLCFQVFQGLHYMHR----QGYFHRDLKPSNLLV 85 (297)
Q Consensus 25 ~~~lv~e~~~g~ll----~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~----~gi~Hrdikp~Nill 85 (297)
.-.||+....++.- ....+. |-.--.+-++.++.|++.-.-.+-. .+.+|-||||+|||+
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~-GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi 316 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAEL-GFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILI 316 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHc-CCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEE
Confidence 34677887765321 122222 2111134467777787766544533 368999999999998
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=89.55 E-value=0.52 Score=42.28 Aligned_cols=28 Identities=14% Similarity=0.025 Sum_probs=24.6
Q ss_pred CccccCCCCCcEEEeC-CeEEEEecCCce
Q 040202 72 GYFHRDLKPSNLLVSK-GVIKIGDLGMVK 99 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-~~~kl~Dfgla~ 99 (297)
+++|+|+.+.|+++++ +.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 7999999999999975 688999998653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.02 E-value=0.3 Score=45.61 Aligned_cols=28 Identities=21% Similarity=0.389 Sum_probs=25.3
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCc
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMV 98 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla 98 (297)
..++|+|+.+.||++.++.++++||.++
T Consensus 223 ~~l~HgDl~~gni~~~~~~~~viD~E~a 250 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEEETKVIDPEFA 250 (401)
T ss_pred CceeeccCCcccEEeeCCCcEEEecccc
Confidence 4689999999999999888999999865
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.29 E-value=0.63 Score=48.80 Aligned_cols=29 Identities=28% Similarity=0.332 Sum_probs=24.2
Q ss_pred CCccccCCCCCcEEEeCC---eE-EEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKG---VI-KIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~---~~-kl~Dfgla~ 99 (297)
.++||+|+.+.|||++.+ .+ -|+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 579999999999999854 45 499999764
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.86 E-value=0.65 Score=48.52 Aligned_cols=30 Identities=20% Similarity=0.189 Sum_probs=24.1
Q ss_pred HCCccccCCCCCcEEEeCC---e---EEEEecCCce
Q 040202 70 RQGYFHRDLKPSNLLVSKG---V---IKIGDLGMVK 99 (297)
Q Consensus 70 ~~gi~Hrdikp~Nill~~~---~---~kl~Dfgla~ 99 (297)
..|+||+|+.+.||+++.+ . .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 3589999999999999742 2 4799999753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=87.66 E-value=0.77 Score=41.68 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=24.3
Q ss_pred ccccCCCCCcEEEeC--CeEEEEecCCcee
Q 040202 73 YFHRDLKPSNLLVSK--GVIKIGDLGMVKE 100 (297)
Q Consensus 73 i~Hrdikp~Nill~~--~~~kl~Dfgla~~ 100 (297)
.+|+|+.+.||++++ +.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999963 6799999997743
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.17 E-value=0.74 Score=42.88 Aligned_cols=29 Identities=24% Similarity=0.327 Sum_probs=26.0
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
...+|+|+.|.|||++++.+|++|..+|.
T Consensus 227 ~aLlHGDlHtGSI~v~~~~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKNDSTKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCCceEEEcccccc
Confidence 46999999999999999999999988763
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=86.82 E-value=0.35 Score=44.43 Aligned_cols=29 Identities=24% Similarity=0.324 Sum_probs=25.5
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
..++|+|+.+.||+++++.++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCCCEEEcCcccc
Confidence 46899999999999998889999998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.25 E-value=2.4 Score=39.45 Aligned_cols=29 Identities=24% Similarity=0.174 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
...+|.|+.+.||+.+++.++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEecccc
Confidence 46899999999999988889999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=81.97 E-value=2.4 Score=40.19 Aligned_cols=28 Identities=18% Similarity=0.402 Sum_probs=24.9
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
.++|.|+.+.|||.+++.++++||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKCLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCCEEEEeecccc
Confidence 5899999999999888789999998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 297 | ||||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-31 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-31 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-31 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-31 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-31 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-31 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-31 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-31 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-31 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-31 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-31 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-31 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-31 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-31 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-31 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-31 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-31 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-31 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-31 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-31 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-31 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-31 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-31 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-31 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-31 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-31 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-31 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-31 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-31 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-31 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-30 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-30 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-30 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-30 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-30 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-29 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-28 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-28 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-28 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-28 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-28 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-28 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-28 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-28 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-28 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-28 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-28 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-28 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-28 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-28 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-28 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-28 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-28 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-28 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-28 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-28 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-28 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-27 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-27 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-27 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-27 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-27 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-26 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-26 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-26 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-25 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-25 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-25 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-25 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-25 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-25 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-25 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-25 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-25 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-25 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-25 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-25 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-25 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-25 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-25 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-25 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-25 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-25 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-25 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-25 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-25 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-25 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-25 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-25 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-25 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-25 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-25 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-25 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-25 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-25 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-25 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-25 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-25 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-25 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-25 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-25 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-25 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-25 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-25 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-25 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-25 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-25 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-25 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-25 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-25 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-25 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-25 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-25 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-25 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-25 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-25 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-25 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-25 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-25 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-24 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-24 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-24 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-24 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-24 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-24 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-24 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-24 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-24 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-24 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-24 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-24 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-24 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-24 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-24 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-24 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-24 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-24 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-24 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-24 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-24 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-24 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-24 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-24 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-24 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-24 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-24 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-24 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-24 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-24 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-24 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-24 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-24 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-24 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-23 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-23 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-23 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-23 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-23 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-23 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-23 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-23 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-23 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-23 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-23 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-22 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-22 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-22 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-21 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-21 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-21 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-21 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-20 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-20 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-20 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-12 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-12 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-12 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-04 |
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-71
Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 46/248 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+++ HPN+V L + + + +VF+Y + +L + + + E +++ +Q Q
Sbjct: 56 LKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL-DRYQRGVPEHLVKSITWQTLQ 113
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEV 121
+++ H+ HRD+KP N+L++K VIK+ D G + + D V TRWYR+PE+
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY----------------- 164
L+ GP VD WA+G + E+LS L+PGK+ DQ+Y I
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 165 -------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199
+ L+ +P R T + L HP+F +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 200 VPRSVPLL 207
+
Sbjct: 294 IEDLAKEH 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 7e-69
Identities = 68/248 (27%), Positives = 105/248 (42%), Gaps = 46/248 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L+++ H N+V L + K+ + ++VF++++ +L + E + FQ+
Sbjct: 78 LKQLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDL-ELFPNGLDYQVVQKYLFQIIN 135
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEV 121
G+ + H HRD+KP N+LVS+ GV+K+ D G + + + D V TRWYRAPE+
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------GRW------ 167
L+ G VD WA+G ++ EM LFPG + DQ+Y I
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 168 ----------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199
+ L +P RP AE L H FF+ F
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315
Query: 200 VPRSVPLL 207
R L
Sbjct: 316 AERFSQEL 323
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-62
Identities = 68/241 (28%), Positives = 116/241 (48%), Gaps = 48/241 (19%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L K +HPNIV L +++ + +VF++ME DL K++ + + + + +Q+
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVL-DENKTGLQDSQIKIYLYQL 128
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
+G+ + H+ HRDLKP NLL++ G +K+ D G+ + +P Y V T WYR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYR 186
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------- 163
AP+VL+ S+ VD W++G I EM++ + LFPG DQ+ KI
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246
Query: 164 -----------YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
+ + + L+S + ++P R +A +A+ HP+F+
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 197 C 197
Sbjct: 307 L 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 1e-62
Identities = 69/238 (28%), Positives = 115/238 (48%), Gaps = 47/238 (19%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + K H NIVKL +++ + + +VF++++ DL KL+ + A++ Q+
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLLQL 109
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
G+ Y H + HRDLKP NLL++ +G +KI D G+ + +P Y + T WYR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYR 167
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------- 163
AP+VL+ S+ +D W++G I EM++ LFPG + ADQ+ +I
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 164 ----------YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+ + + L+S + +P R TA +ALEH +F+
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-62
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 48/240 (20%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L K H NIV+L +++ + + +VF++ + DL K +S + + ++ FQ+
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQL 110
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
+GL + H + HRDLKP NLL++ G +K+ + G+ + +P Y V T WYR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYR 168
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRI-LFPGKNSADQIYKI------------- 163
P+VL +++ +D W+ G I E+ + LFPG + DQ+ +I
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 164 ----------YGRWVA-----------------LISWLCSWNPRMRPTAAEALEHPFFRS 196
Y + A L+ L NP R +A EAL+HP+F
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-62
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 6 KMNNHPNIVKLRNLV-----KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
+ HPN+V+L ++ V +VF++++ DL + ++ + ++L Q
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
+GL ++H HRDLKP N+LV+ G +K+ D G+ + + T V T WYRAP
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------GRW---- 167
EVLL S VD W++G I EM + LF G + ADQ+ KI+ W
Sbjct: 189 EVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVP 201
L+ + ++NP R +A AL+H + P
Sbjct: 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-62
Identities = 72/251 (28%), Positives = 118/251 (47%), Gaps = 51/251 (20%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+ L K H NIV L +++ + + +VF+Y++ DL + + + G + + FQ+
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQL 109
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
+GL Y HRQ HRDLKP NLL++ +G +K+ D G+ + S+P Y V T WYR
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK--SIPTKTYDNEVVTLWYR 167
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-------------- 163
P++LL S ++D W +G I +EM + R LFPG +Q++ I
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 164 -----------YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
Y ++ L++ L + R R +A +A++HPFF S
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
Query: 197 CHFVPRSVPLL 207
+ + L
Sbjct: 288 ---LGERIHKL 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-62
Identities = 72/238 (30%), Positives = 110/238 (46%), Gaps = 46/238 (19%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I L + +HPNI+ L + ++ +VFD+ME+DL ++ + + +
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII-KDNSLVLTPSHIKAYMLMT 121
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYR 117
QGL Y+H+ HRDLKP+NLL+ GV+K+ D G+ K P Y V TRWYR
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYR 179
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------GRW-- 167
APE+L + + G VD WA+G I+ E+L PG + DQ+ +I+ +W
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 168 -----------------------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
+ LI L +NP R TA +AL+ +F +
Sbjct: 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-61
Identities = 67/250 (26%), Positives = 109/250 (43%), Gaps = 48/250 (19%)
Query: 6 KMNNHPNIVKLRNLV-----KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
+ HPN+V+L ++ + +VF++++ DL + + + +++ FQ
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
+ +GL ++H HRDLKP N+LV+ G IK+ D G+ + + T V T WYRAP
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------------- 163
EVLL S VD W++G I EM + LF G + DQ+ KI
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 164 ------YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVP 201
+ L+ ++NP R +A AL HP+F+ +
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD---LE 304
Query: 202 RSVPLLCNNF 211
R L ++
Sbjct: 305 RCKENLDSHL 314
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 5e-61
Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 54/250 (21%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+ L K H NI++L++++ + + ++F+Y E+DL K M ++ + S ++ +Q+
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQL 141
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLVS------KGVIKIGDLGMVKEIDSSLPCTDY---VT 112
G+++ H + HRDLKP NLL+S V+KIGD G+ + +P + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEII 199
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-------- 164
T WYR PE+LL S VD W++ I EML LFPG + DQ++KI+
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259
Query: 165 GRW---------------------------------VALISWLCSWNPRMRPTAAEALEH 191
W + L++ + +P R +A ALEH
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 192 PFFRSCHFVP 201
P+F F P
Sbjct: 320 PYFSHNDFDP 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 8e-61
Identities = 64/257 (24%), Positives = 106/257 (41%), Gaps = 55/257 (21%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVF------IVFDYMESDLLKLMKE--SAGQNFSEDEAR 55
+RK++ H NIV+LR + +V DY+ + ++ + A Q +
Sbjct: 101 MRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
+Q+F+ L Y+H G HRD+KP NLL+ V+K+ D G K++ P Y+ +
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------- 163
R+YRAPE++ + +D W+ G ++ E+L + +FPG + DQ+ +I
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 164 -------------YGRWVA-----------------LISWLCSWNPRMRPTAAEALEHPF 193
+ + A L S L + P R T EA H F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 194 FRSCH----FVPRSVPL 206
F +P
Sbjct: 340 FDELRDPNVKLPNGRDT 356
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-61
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 55/248 (22%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMK----ESAGQNFSEDEARNL 57
I L K H NIV+L +++ + +VF++M++DL K M + + + +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTT 113
+Q+ QGL + H HRDLKP NLL++ +G +K+GD G+ + +P + V T
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVT 171
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------- 163
WYRAP+VL+ S +D W+ G I+ EM++ + LFPG N +Q+ I
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 164 --------------YGRW---------------------VALISWLCSWNPRMRPTAAEA 188
+ + + L NP MR +A +A
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 189 LEHPFFRS 196
L HP+F
Sbjct: 292 LHHPWFAE 299
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 51/245 (20%)
Query: 4 LRKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMK--ESAGQNFSEDEAR 55
+R + HPN+V L+ + + +V +Y+ + + + Q +
Sbjct: 86 MRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK 144
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
+Q+ + L Y+H G HRD+KP NLL+ GV+K+ D G K + + P Y+ +
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI---------- 163
R+YRAPE++ + +D W+ G +M E++ + LFPG++ DQ+ +I
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 164 -------------YGRWVA-----------------LISWLCSWNPRMRPTAAEALEHPF 193
+ + LIS L + P R TA EAL HPF
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324
Query: 194 FRSCH 198
F
Sbjct: 325 FDELR 329
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-59
Identities = 64/252 (25%), Positives = 102/252 (40%), Gaps = 58/252 (23%)
Query: 2 IFLRKMNNHPNIVKLRNLV--------KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDE 53
I + ++ H N+V L + + +++VFD+ E DL L+ + F+ E
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSE 125
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC----- 107
+ + + GL+Y+HR HRD+K +N+L++ GV+K+ D G+ + +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--- 164
T+ V T WYR PE+LL GP +D W G IM EM + + G Q+ I
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 165 -----GRW-----------------------------------VALISWLCSWNPRMRPT 184
W + LI L +P R
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 185 AAEALEHPFFRS 196
+ +AL H FF S
Sbjct: 306 SDDALNHDFFWS 317
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 7e-59
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 51/245 (20%)
Query: 3 FLRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L + HPNI+ LR++ +++V + M +DL +++ S +
Sbjct: 82 LLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQHIQYF 139
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+ + GLH +H G HRDL P N+L+ I I D + +E + T YVT RWY
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG----------- 165
RAPE+++ + VD W+ G +M EM + + LF G +Q+ KI
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259
Query: 166 --------RWVA------------------------LISWLCSWNPRMRPTAAEALEHPF 193
++ LI+ + +NP+ R + +AL HP+
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319
Query: 194 FRSCH 198
F S
Sbjct: 320 FESLF 324
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-58
Identities = 76/245 (31%), Positives = 113/245 (46%), Gaps = 56/245 (22%)
Query: 3 FLRKMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
L+ M H N++ L ++ D ++V +M++DL K+M FSE++ +
Sbjct: 76 LLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQY 130
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L +Q+ +GL Y+H G HRDLKP NL V +KI D G+ + D+ + T YV TRW
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRW 188
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------- 165
YRAPEV+L VD W++G IM EML+ + LF GK+ DQ+ +I
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 166 ---------RWVA-----------------------LISWLCSWNPRMRPTAAEALEHPF 193
++ L+ + + R TAA+AL HPF
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 194 FRSCH 198
F
Sbjct: 309 FEPFR 313
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-58
Identities = 77/248 (31%), Positives = 119/248 (47%), Gaps = 56/248 (22%)
Query: 3 FLRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L + H NI+ + ++++ + +DV+IV D ME+DL KL+K Q+ S D
Sbjct: 78 ILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYF 133
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC----TDYVT 112
+Q+ +GL Y+H HRDLKPSNLL+ + +KI D G+ + D T+YV
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------- 165
TRWYRAPE++L S+ +D W++G I+ EMLS R +FPGK+ DQ+ I G
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 166 ------------RWVA-----------------------LISWLCSWNPRMRPTAAEALE 190
++ L+ + ++NP R +AL
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 191 HPFFRSCH 198
HP+ +
Sbjct: 314 HPYLEQYY 321
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-58
Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 64/256 (25%)
Query: 3 FLRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L+ H NI+ + N+ + +V+I+ + M++DL +++ Q S+D +
Sbjct: 62 ILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS---TQMLSDDHIQYF 117
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC--------- 107
+Q + + +H HRDLKPSNLL+ S +K+ D G+ + ID S
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 108 --TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG 165
++V TRWYRAPEV+L S +D W+ G I+ E+ R +FPG++ Q+ I+G
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 166 --------------------RWVA-----------------------LISWLCSWNPRMR 182
++ L+ + ++P R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 183 PTAAEALEHPFFRSCH 198
TA EALEHP+ ++ H
Sbjct: 298 ITAKEALEHPYLQTYH 313
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-58
Identities = 77/245 (31%), Positives = 113/245 (46%), Gaps = 55/245 (22%)
Query: 3 FLRKMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
L+ M H N++ L ++ + D ++V +M +DL KLMK + ED +
Sbjct: 77 LLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQF 132
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L +Q+ +GL Y+H G HRDLKP NL V +KI D G+ ++ DS + T YV TRW
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRW 190
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------- 165
YRAPEV+L VD W++G IM EM++ + LF G + DQ+ +I
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 166 ---------RWVA-----------------------LISWLCSWNPRMRPTAAEALEHPF 193
++ L+ + + R TA EAL HP+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 194 FRSCH 198
F S H
Sbjct: 311 FESLH 315
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-57
Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 77/272 (28%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMK-------ESAGQNFSE 51
+ LR++ HPN++ L+ + H D V+++FDY E DL ++K
Sbjct: 69 IALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 52 DEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL- 105
++L +Q+ G+HY+H HRDLKP+N+LV +G +KI D+G + +S L
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 106 PCTDY---VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN------- 155
P D V T WYRAPE+LL + +D WA+G I E+L+ +F +
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 156 --SADQIYKIY--------GRW-------------------------------------- 167
DQ+ +I+ W
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 168 ---VALISWLCSWNPRMRPTAAEALEHPFFRS 196
L+ L + +P R T+ +A++ P+F
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-57
Identities = 67/257 (26%), Positives = 112/257 (43%), Gaps = 65/257 (25%)
Query: 3 FLRKMNNHPNIVKLRNLVK--------------EHEDVFIVFDYMESDLLKLMKESAGQN 48
+R+++ H NIVK+ ++ E V+IV +YME+DL +++
Sbjct: 61 IIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE---QGP 116
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLP 106
E+ AR +Q+ +GL Y+H HRDLKP+NL ++ V+KIGD G+ + +D
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 107 C----TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
++ + T+WYR+P +LL +D WA G I EML+ + LF G + +Q+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 163 I------------------YGRWVA-----------------------LISWLCSWNPRM 181
I ++ + + +++P
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 182 RPTAAEALEHPFFRSCH 198
R TA EAL HP+
Sbjct: 297 RLTAEEALSHPYMSIYS 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-57
Identities = 73/245 (29%), Positives = 109/245 (44%), Gaps = 55/245 (22%)
Query: 3 FLRKMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
L+ M H N++ L ++ E DV++V M +DL ++K Q ++D +
Sbjct: 81 LLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQF 136
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L +Q+ +GL Y+H HRDLKPSNL V +KI D G+ + + T YV TRW
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRW 194
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG---------- 165
YRAPE++L VD W++G IM E+L+ R LFPG + DQ+ I
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 166 ---------RWVA-----------------------LISWLCSWNPRMRPTAAEALEHPF 193
++ L+ + + R TAA+AL H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 194 FRSCH 198
F H
Sbjct: 315 FAQYH 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-54
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 60/267 (22%)
Query: 6 KMNNHPNIVKLRNLV-----KEHEDVF--IVFDYMESDLLKLMK--ESAGQNFSEDEARN 56
+ +HPNIV+L++ ++ D++ +V +Y+ L + + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 57 LCFQVFQGLHYMHRQ--GYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVT 112
FQ+ + + +H HRD+KP N+LV + G +K+ D G K++ S P Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------- 163
+R+YRAPE++ ++ VD W++G I EM+ +F G NSA Q+++I
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 164 ---------YGR----------W---------------VALISWLCSWNPRMRPTAAEAL 189
+ W L+S L + P R EAL
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313
Query: 190 EHPFFRSCH----FVPRSVPLLCNNFE 212
HP+F H +P + L + F
Sbjct: 314 CHPYFDELHDPATKLPNNKDLPEDLFR 340
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-53
Identities = 58/186 (31%), Positives = 100/186 (53%), Gaps = 28/186 (15%)
Query: 3 FLRKMNNHPNIVKLRNLVK--EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
L +++ H NIV L N+++ DV++VFDYME+DL +++ + + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR---ANILEPVHKQYVVYQ 117
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC------------ 107
+ + + Y+H G HRD+KPSN+L+ ++ +K+ D G+ + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 108 ----------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157
TDYV TRWYRAPE+LL S +D W++G I+ E+L + +FPG ++
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 158 DQIYKI 163
+Q+ +I
Sbjct: 238 NQLERI 243
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 12/29 (41%), Positives = 17/29 (58%)
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFRSCH 198
L+ L +NP R +A +AL+HPF H
Sbjct: 308 LLDKLLQFNPNKRISANDALKHPFVSIFH 336
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-51
Identities = 60/168 (35%), Positives = 95/168 (56%), Gaps = 13/168 (7%)
Query: 3 FLRKMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
++ +N H NI+ L N+ E +DV+IV + M+++L ++++ +
Sbjct: 77 LMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSY 131
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L +Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + +S T YV TR+
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
YRAPEV+L VD W++G IM EM+ +LFPG + DQ K+
Sbjct: 192 YRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 60/168 (35%), Positives = 97/168 (57%), Gaps = 13/168 (7%)
Query: 3 FLRKMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARN 56
++ +N H NI+ L N+ E +DV++V + M+++L ++++ +
Sbjct: 114 LMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSY 168
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L +Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + +S T YV TR+
Sbjct: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
YRAPEV+L VD W++G IM EM+ +ILFPG++ DQ K+
Sbjct: 229 YRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-50
Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 102/295 (34%)
Query: 3 FLRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L ++ I++L +L+ + ++++IV + +SDL KL K +E+ + +
Sbjct: 78 ILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK--TPIFLTEEHIKTI 134
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC--------- 107
+ + G +++H G HRDLKP+N L+ +K+ D G+ + I+S
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 108 --------------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS------- 146
T +V TRWYRAPE++LL E +D W+ G I E+L+
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 147 ----FRILFPG-----------------KNSADQIYKIYG-------------------R 166
LFPG K++ DQ+ I+ +
Sbjct: 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314
Query: 167 WVA-----------------------LISWLCSWNPRMRPTAAEALEHPFFRSCH 198
++ L+ + +NP R T +AL+HP+ +
Sbjct: 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-50
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 82/277 (29%)
Query: 4 LRKMNNHPNIVKLRNLVKEHE--------------------------------------D 25
+ K+ +H NI+KL +
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 26 VFIVFDYMESDLLKLMK--ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83
+ ++ +Y+ L K++K +G++ + +Q+F+ + ++H G HRD+KP NL
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 84 LV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIM 141
LV +K+ D G K++ S P Y+ +R+YRAPE++L + P +D W++G +
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 142 FEMLSFRILFPGKNSADQIYKI------------------YGR----------W------ 167
E++ + LF G+ S DQ+ +I Y W
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 168 ------VALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
+ L+ + + P +R EA+ HPFF
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-48
Identities = 49/249 (19%), Positives = 99/249 (39%), Gaps = 59/249 (23%)
Query: 4 LRKMNNHPNIVKLRNLVK---EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
L + PNI+ L ++VK + +D +L Q ++ + R ++
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE 138
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ + L Y H G HRD+KP N+++ +++ D G+ + V +R+++
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRI-LFPGKNSADQIYKIY------------- 164
PE+L+ ++ +D W++G ++ M+ + F G ++ DQ+ +I
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258
Query: 165 --------------GRW---------------------VALISWLCSWNPRMRPTAAEAL 189
GR + + L ++ + R TA EA+
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
Query: 190 EHPFFRSCH 198
EHP+F +
Sbjct: 319 EHPYFYTVV 327
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-48
Identities = 44/206 (21%), Positives = 83/206 (40%), Gaps = 14/206 (6%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
+ K+ HP V+L +E +++ + L + + G + E +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAW-GASLPEAQVWGYLRD 165
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
L ++H QG H D+KP+N+ + G K+GD G++ E+ ++ Y AP
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV----------A 169
E+ L G D +++G + E+ L G Q+ + Y +
Sbjct: 226 EL--LQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRS 283
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFR 195
++ + +P++R TA L P R
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 67/303 (22%), Positives = 108/303 (35%), Gaps = 110/303 (36%)
Query: 3 FLRKMNNHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL 57
L ++N H ++VK+ ++V + +++++V + +SD KL + +E + L
Sbjct: 105 ILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR--TPVYLTELHIKTL 161
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC--------- 107
+ + G+ Y+H G HRDLKP+N LV +K+ D G+ + +D
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 108 -------------------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF- 147
T +V TRWYRAPE++LL E +D W++G I E+L+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 148 ----------RILFPGKN--------------------SADQIYKIY------------- 164
LFPG + + DQ+ I+
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 165 ---GRWVALISWLCSWNP-------------------RM-------RPTAAEALEHPFFR 195
I RM R T E L HPFF+
Sbjct: 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401
Query: 196 SCH 198
Sbjct: 402 EVR 404
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-45
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 49/243 (20%)
Query: 1 MIFLRKMNNHPNIVKL-------------RNLVKEHEDVFIVFDYME-SDLLKLMKESAG 46
++ L +N H +V+ VK+ +FI +Y E L L+
Sbjct: 53 VMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-EN 110
Query: 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSL 105
N DE L Q+ + L Y+H QG HRDLKP N + +KIGD G+ K + SL
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 106 PCTDYVT---------------TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL 150
+ T Y A EVL + ++D +++G I FEM+
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PF 228
Query: 151 FPGKNSADQIYKIYGR--------WVA-------LISWLCSWNPRMRPTAAEALEHPFFR 195
G + + K+ +I L +P RP A L +
Sbjct: 229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
Query: 196 SCH 198
H
Sbjct: 289 VKH 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-45
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 4 LRKMNNHPNIVKLRNLVKEHED----------------VFIVFDYMES-DLLKLMKESAG 46
L K++ H NIV + +FI ++ + L + +++ G
Sbjct: 58 LAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL 105
+ + A L Q+ +G+ Y+H + +RDLKPSN+ + +KIGD G+V + +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 106 PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY- 164
T T Y +PE + + G EVD +A+G I+ E+L + ++ +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLH--VCDTAFETSKFFTDLRD 233
Query: 165 --------GRWVALISWLCSWNPRMRPTAAEALEHPFFR 195
+ L+ L S P RP +E L
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 28/220 (12%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
LR+ + HPN+++ K+ + +I + + L + +++ E L Q
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQK-DFAHLGLEPITLLQQTTS 129
Query: 64 GLHYMHRQGYFHRDLKPSNLLV------SKGVIKIGDLGMVKEID----SSLPCTDYVTT 113
GL ++H HRDLKP N+L+ K I D G+ K++ S + T
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 114 RWYRAPEVLL--LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR----- 166
+ APE+L E VD ++ G + + ++S GK+ Q + G
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 167 ---WVA-------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI + + +P+ RP+A L+HPFF S
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-43
Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L M HPNIV+ R +E+ ++IV DY E DL K + G F ED+ + Q+
Sbjct: 77 LANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPE 120
L ++H + HRD+K N+ ++K G +++GD G+ + ++S++ + T +Y +PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI----YGRW--------V 168
+ ++ + D WA+G +++E+ + + F + + + KI +
Sbjct: 196 I-CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254
Query: 169 ALISWLCSWNPRMRPTAAEALEHPFFRS 196
+L+S L NPR RP+ LE F
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-43
Identities = 44/220 (20%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 4 LRKMN-NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L K+ + I++L + + +++V + DL +K+ ++ E ++ +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNML 137
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAP 119
+ +H +H+ G H DLKP+N L+ G++K+ D G+ ++ S+ V T Y P
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 120 EVLLLS----------EICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKI----- 163
E + P+ D W++G I++ M + F N +++ I
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257
Query: 164 ---YGRWV-----ALISWLCSWNPRMRPTAAEALEHPFFR 195
+ ++ +P+ R + E L HP+ +
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-41
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLL-KLMKESAGQNFSEDEARNLCFQV 61
LRK++ HPNI++L++ + + F+VFD M+ +L L ++ SE E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 133
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
+ + +H+ HRDLKP N+L+ IK+ D G ++D + T Y APE
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 121 VLLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSA---DQIYKIYGR------ 166
++ S G EVD W+ G IM+ +L+ F + I G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGSP 251
Query: 167 -WVA-------LISWLCSWNPRMRPTAAEALEHPFFR 195
W L+S P+ R TA EAL HPFF+
Sbjct: 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 33/227 (14%), Positives = 77/227 (33%), Gaps = 29/227 (12%)
Query: 6 KMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKE-----SAGQNFSEDEARNLC 58
K ++++R ++ F ++ M+S+L + S ++ L
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
QV + L +H G H L+P ++++ + G + + + + +R +
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGFE 269
Query: 118 APEVLLLSEIC----------GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW 167
PE+ D WA+G +++ + + + I+
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 168 V-------ALISWLCSWNPRMRPTAAEALEHPFFRSCH-FVPRSVPL 206
AL+ + R +A+E P + + ++PL
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 376
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 44/220 (20%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 4 LRKMN-NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L K+ + I++L + + +++V + DL +K+ ++ E ++ +
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNML 118
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAP 119
+ +H +H+ G H DLKP+N L+ G++K+ D G+ ++ S+ V T Y P
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 120 EVLLLS----------EICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKI----- 163
E + P+ D W++G I++ M + F N +++ I
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238
Query: 164 ---YGRWV-----ALISWLCSWNPRMRPTAAEALEHPFFR 195
+ ++ +P+ R + E L HP+ +
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-41
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K+N HP I+K++N + ED +IV + ME +L + + + E + +Q+
Sbjct: 194 LKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQML 249
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ Y+H G HRDLKP N+L+S +IKI D G K + + T Y A
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 119 PEVLLLSEIC--GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK--IYGR-------W 167
PEVL+ VD W++G I+F LS F + + G+ W
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369
Query: 168 VA-------LISWLCSWNPRMRPTAAEALEHPFFRS 196
L+ L +P+ R T EAL HP+ +
Sbjct: 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 43/220 (19%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 4 LRKMN-NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L K+ + I++L + + +++V + DL +K+ ++ E ++ +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNML 165
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAP 119
+ +H +H+ G H DLKP+N L+ G++K+ D G+ ++ S+ V Y P
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 120 EVLLLS----------EICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKI----- 163
E + P+ D W++G I++ M + F N +++ I
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 164 ---YGRWV-----ALISWLCSWNPRMRPTAAEALEHPFFR 195
+ ++ +P+ R + E L HP+ +
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-40
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLL-KLMKESAGQNFSEDEARNLCFQV 61
LR++ HP+I+ L + + +F+VFD M +L L ++ SE E R++ +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSL 209
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
+ + ++H HRDLKP N+L+ I++ D G ++ + T Y APE
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 121 VLLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSA---DQIYKIYGR------ 166
+L S G EVD WA G I+F +L+ F + I + G+
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME--GQYQFSSP 327
Query: 167 -WVA-------LISWLCSWNPRMRPTAAEALEHPFF 194
W LIS L +P R TA +AL+HPFF
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 6e-40
Identities = 34/219 (15%), Positives = 66/219 (30%), Gaps = 31/219 (14%)
Query: 6 KMNNHPNIVKLRNL--VKEHEDVFIVFDYMESDLLKLMKE-----SAGQNFSEDEARNLC 58
+ + P +L + ++ DL L + L
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
Q+ + + +G H P NL + G + +GD+ + ++ + P + Y
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS--SVPVTYA 258
Query: 118 APEVLLLSEIC-GPEVDRWAMGAIMFEMLSFRILFPGKNSA-DQIYKIYGRWV------- 168
E L S ++ W +G ++ + + F +K V
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318
Query: 169 ------------ALISWLCSWNPRMRPTAAEALEHPFFR 195
LI +++ R R EA+E P F
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-40
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 4 LRKMNNHPNIVKLRNLVKEHED--VFIVFDYMES-DLLKLMKES--AGQNFSEDEARNLC 58
LR++ HPNIV+ + + + + ++IV +Y E DL ++ + Q E+ +
Sbjct: 59 LRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 59 FQVFQGLHYMHRQGYF-----HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YV 111
Q+ L HR+ HRDLKP+N L K +K+GD G+ + ++ +V
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 112 TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI----YGRW 167
T +Y +PE + + D W++G +++E+ + F + + KI + R
Sbjct: 178 GTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 168 --------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+I+ + + RP+ E LE+P
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 54/244 (22%), Positives = 90/244 (36%), Gaps = 47/244 (19%)
Query: 4 LRKMNNHPNIVKLRN------------LVKEHEDVFIVFDYMES-DLLKLMKESAGQNFS 50
L K+ HP IV+ N ++I +L M
Sbjct: 57 LAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 51 E-DEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC- 107
E ++ Q+ + + ++H +G HRDLKPSN+ + V+K+GD G+V +D
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 108 ------------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155
T V T+ Y +PE + +VD +++G I+FE+L F +
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFELL---YPFSTQM 231
Query: 156 SADQIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
+ Y ++ + S +P RP A +E+ F F P
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF-PG 290
Query: 203 SVPL 206
L
Sbjct: 291 KTVL 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 49/241 (20%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE-----SAGQNFSEDEARNLC 58
L + ++HPN+++ ++I + +L L++ + E +L
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------------GVIKIGDLGMVKEIDS- 103
Q+ G+ ++H HRDLKP N+LVS I I D G+ K++DS
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 104 ----SLPCTDYVTTRWYRAPEVLLLSEI------CGPEVDRWAMGAIMFEMLS------- 146
+ T +RAPE+L S +D ++MG + + +LS
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 147 ------FRILFPGKNSADQIYKIYGRWVA-----LISWLCSWNPRMRPTAAEALEHPFFR 195
I+ G S D++ ++ R + LIS + +P RPTA + L HP F
Sbjct: 242 DKYSRESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
Query: 196 S 196
Sbjct: 301 P 301
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+ ++ HPNI+KL + ++ + ++V + + +L + F+E +A + QV
Sbjct: 90 LKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVL 146
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
G+ Y+H+ HRDLKP NLL+ +IKI D G+ ++ + + T +Y A
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVA- 169
PEV L + + D W++G I+F +L+ F G+ + + K+ W
Sbjct: 207 PEV--LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI + ++ + R +A +ALEHP+ +
Sbjct: 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L++++ HPNI+KL ++ ++V + +L + + FSE +A + QV
Sbjct: 80 LKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVL 136
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
G+ YMH+ HRDLKP N LL SK I+I D G+ ++S D + T +Y A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVA- 169
PEV L + D W+ G I++ +LS F G N D + K+ +W
Sbjct: 197 PEV--LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI + ++ P MR +A +AL+H + ++
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K++ HPNI+KL ++++ +IV + +L + + + FSE +A + QVF
Sbjct: 75 LKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
G+ YMH+ HRDLKP N LL SK IKI D G+ + D + T +Y A
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGR-------WVA- 169
PEV L + D W+ G I++ +LS F GKN D + ++ G+ W
Sbjct: 192 PEV--LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFR 195
LI + +++P +R TA + LEHP+ +
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 30/231 (12%)
Query: 4 LRKMNNHPNIVKLR----NLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLC 58
+ + P+IV++ NL + + IV + ++ +L +++ Q F+E EA +
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTR 114
+ + + Y+H HRD+KP NLL SK ++K+ D G KE S T T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------- 166
+Y APEV L E D W++G IM+ +L F + + R
Sbjct: 228 YYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286
Query: 167 ----WVA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
W LI L P R T E + HP+ VP PL
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP-QTPL 336
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 68/248 (27%), Positives = 104/248 (41%), Gaps = 27/248 (10%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K+N HP I+K++N + ED +IV + ME +L + + + E + +Q+
Sbjct: 69 LKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQML 124
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ Y+H G HRDLKP N+L+S +IKI D G K + + T Y A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 119 PEVLLLSEIC--GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK--IYGR-------W 167
PEVL+ VD W++G I+F LS F + + G+ W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 168 VA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEAVAFPTAT 220
L+ L +P+ R T EAL HP+ + + LL E+ A P
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304
Query: 221 VTMQGRSL 228
Sbjct: 305 AQPSTSRK 312
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
++ ++ HPNI++L +++ D+++V + +L + + + F E +A + V
Sbjct: 60 MKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVL 116
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ Y H+ HRDLKP N L +K+ D G+ V T +Y +
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGR-------WVA- 169
P+VL GPE D W+ G +M+ +L F ++ + KI G W+
Sbjct: 177 PQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV 234
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
LI L + +P+ R T+ +ALEH +F LL
Sbjct: 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK-QLSSSPRNLL 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-38
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
+ H ++V ++++ VF+V + LL+L K + +E EAR Q+ G
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSSLPCT-----DYVTTRWY 116
Y+HR HRDLK NL + +KIGD G+ E D +Y+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI----- 182
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWVA- 169
APEV L + EVD W++G IM+ +L + F + +I + +
Sbjct: 183 -APEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
Query: 170 ----LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLC 208
LI + +P RPT E L FF S ++P +P+ C
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPITC 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-38
Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 33/220 (15%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSE-DEARNLCFQVFQ 63
+ N V ++I +L M E ++ Q+ +
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175
Query: 64 GLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-------------TD 109
+ ++H +G HRDLKPSN V+K+GD G+V +D T
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 110 YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------ 163
V T+ Y +PE + +VD +++G I+FE+L F + +I
Sbjct: 236 QVGTKLYMSPEQ-IHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKF 291
Query: 164 -------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196
Y + ++ + S +P RP A + +E+ F +
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-38
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLK--LMKESAGQNFSEDEARNLCFQ 60
L+ ++ HPNI+K+ + +++ +++IV + E +LL+ + ++ G+ SE L Q
Sbjct: 74 LKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+ L Y H Q H+DLKP N+L IKI D G+ + S T+ T Y
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRWV------- 168
APEV + D W+ G +M+ +L+ + F G + + K Y
Sbjct: 193 MAPEV--FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250
Query: 169 ----A--LISWLCSWNPRMRPTAAEALEHPFFR 195
A L+ + + +P RP+AA+ L H +F+
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
+ H ++V ++++ VF+V + LL+L K + +E EAR Q+ G
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 153
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSSLPCT-----DYVTTRWY 116
Y+HR HRDLK NL + +KIGD G+ E D +Y+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI----- 208
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWVA- 169
APEV L + EVD W++G IM+ +L + F + +I + +
Sbjct: 209 -APEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266
Query: 170 ----LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLC 208
LI + +P RPT E L FF S ++P +P+ C
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPITC 308
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLK--LMKESAGQNFSEDEARNLCFQ 60
+ HP+IV+L +++VF++M+ +DL + + AG +SE A + Q
Sbjct: 80 CHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 61 VFQGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEI-DSSLPCTDYVTTRW 115
+ + L Y H HRD+KP LL SK +K+G G+ ++ +S L V T
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK--IYGR------- 166
+ APEV + E G VD W G I+F +LS + F G +++++ I G+
Sbjct: 199 FMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQ 255
Query: 167 WVA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
W L+ + +P R T EAL HP+ + + L
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHL 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HP+I++L N ++ V++V + + ++ + +K FSE+EAR+ Q+ G+ Y
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLY 127
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSSLPCT-----DYVTTRWYRAP 119
+H G HRDL SNLL+ IKI D G+ ++ T +Y+ +P
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI------SP 181
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWVA---- 169
E+ G E D W++G + + +L R F + + K+ +++
Sbjct: 182 EI-ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 170 -LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRS 203
LI L NP R + + L+HPF + +S
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSR-NSSTKS 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
RK+ HPNIV+L + ++E ++VFD + +L + + + +SE +A + Q+
Sbjct: 59 CRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQIL 115
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ + Y H G HR+LKP N LL SK +K+ D G+ E++ S + T Y +
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGR-------WVA- 169
PEV L + VD WA G I++ +L F ++ +I G W
Sbjct: 176 PEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
LI + + NP+ R TA +AL+ P+ + V ++
Sbjct: 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K++ HPNI+KL ++++ +IV + +L + + + FSE +A + QVF
Sbjct: 75 LKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
G+ YMH+ HRDLKP N LL SK IKI D G+ + D + T +Y A
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVA- 169
PEV L + D W+ G I++ +LS F GKN D + ++ +W
Sbjct: 192 PEV--LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI + +++P +R TA + LEHP+ +
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKE--SAGQNFSEDEARNLCFQ 60
L+++N HPN++K E ++ IV + ++ DL +++K + E Q
Sbjct: 86 LKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS--SLPCTDYVTTRWYR 117
+ L +MH + HRD+KP+N+ ++ GV+K+GDLG+ + S + + V T +Y
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYM 203
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK--NSADQIYKI-YGRW------- 167
+PE + + + D W++G +++EM + + F G N KI +
Sbjct: 204 SPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 168 -----VALISWLCSWNPRMRPTAAEALEHPF 193
L++ + +P RP +
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 60/231 (25%), Positives = 91/231 (39%), Gaps = 31/231 (13%)
Query: 4 LRKMNNHPNIVKLR----NLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLC 58
+ + P+IV + N+ + I+ + ME +L ++E Q F+E EA +
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTR 114
+ + ++H HRD+KP NLL SK V+K+ D G KE + T
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTP 193
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------- 166
+Y APEV L E D W++G IM+ +L F + R
Sbjct: 194 YYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 167 ----WVA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
W LI L +P R T + + HP+ VP PL
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP-QTPL 302
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-37
Identities = 44/225 (19%), Positives = 85/225 (37%), Gaps = 35/225 (15%)
Query: 4 LRKMNNHPNIVKLR----NLVKEHEDVFIVFDYMES-DLLKLMKE--SAGQNFSEDEARN 56
R N HPNI++L + +++ + + L ++ G +ED+
Sbjct: 80 HRLFN-HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD------ 109
L + +GL +H +GY HRDLKP+N+L+ G + DLG + + + +
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 110 ----YVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161
T YRAPE+ + + D W++G +++ M+ +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 162 KIYGRW------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ + L++ + + +P RP L
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+ ++ HPNI+KL ++ ++ + ++V ++ E +L + + F E +A N+ Q+
Sbjct: 100 LKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQIL 156
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
G+ Y+H+ HRD+KP N LL +K IKI D G+ D + T +Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVA- 169
PEV L + + D W+ G IM+ +L F G+N D I K+ + W
Sbjct: 217 PEV--LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI + +++ R TA EAL + +
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-37
Identities = 34/219 (15%), Positives = 72/219 (32%), Gaps = 24/219 (10%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHED-----VFIVFDYMESDLLKLMKE-----SAGQNFS 50
IF + P K+ + + D F ++ M+S+L + S ++
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 51 EDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PC 107
L QV + L +H G H L+P ++++ + G + + + +S P
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 108 TDYVTTRWYRAPEVLLLSE----ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
A +L + + D W +G ++ + + + I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
Query: 164 YGRWV-------ALISWLCSWNPRMRPTAAEALEHPFFR 195
+ AL+ + R +A+E P +
Sbjct: 330 FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-37
Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 35/228 (15%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQN--FSEDEARNL 57
+ + H ++V+ + E + + I +Y L + E+ F E E ++L
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------------------GVIKIGDLGM 97
QV +GL Y+H H D+KPSN+ +S+ + KIGDLG
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 98 VKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157
V I S + A EVL + P+ D +A+ + L +
Sbjct: 181 VTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 158 DQIYK-----IYGRW----VALISWLCSWNPRMRPTAAEALEHPFFRS 196
+I + I L+ + +P RP+A ++H S
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 21/223 (9%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
L + P ++ L + + ++ ++ +Y ++ L + SE++ L Q+
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+G++Y+H+ H DLKP N LL S G IKI D GM ++I + + + T Y A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRW---------- 167
PE+L I D W +G I + +L+ F G+++ + I
Sbjct: 202 PEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 168 ----VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
I L NP RPTA L H + + F P
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 33/234 (14%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L + HPNI+ L+++ + + V++V + M+ +LL + + FSE EA + F +
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTIT 126
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 116
+ + Y+H QG HRDLKPSN+L I+I D G K++ + + T +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKIYGR------ 166
APEV L + D W++G +++ ML+ F ++ ++I G
Sbjct: 187 VAPEV-LERQGYDAACDIWSLGVLLYTMLTGYTPFAN--GPDDTPEEILARIGSGKFSLS 243
Query: 167 ---WVA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNN 210
W + L+S + +P R TAA L HP+ +P L +
Sbjct: 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP-QYQLNRQD 296
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNI++L + V+++ +Y + + +++ F E ++ L Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 124
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVTTRWYRAPEV 121
H + HRD+KP NLL+ S G +KI D G SS DY+ PE+
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEM 178
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWVA-----L 170
+ + +VD W++G + +E L + F + +I +V L
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237
Query: 171 ISWLCSWNPRMRPTAAEALEHPFFR 195
IS L NP RP E LEHP+
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
RK+ HPNIV+L + ++E ++VFD + +L + + + +SE +A + Q+
Sbjct: 82 CRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQIL 138
Query: 63 QGLHYMHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ + Y H G HR+LKP N LL SK +K+ D G+ E++ S + T Y +
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 198
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGR-------WVA- 169
PEV L + VD WA G I++ +L F ++ +I G W
Sbjct: 199 PEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI + + NP+ R TA +AL+ P+ +
Sbjct: 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 32/231 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
L+ HPNIVKL + + F+V + + +L + +K+ ++FSE EA + ++
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLV 116
Query: 63 QGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEI-DSSLPCTDYVTTRWYR 117
+ +MH G HRDLKP NLL + IKI D G + + P T Y
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN---SADQIYKIYGR-------- 166
APE+ L D W++G I++ MLS ++ F + + +I +
Sbjct: 177 APEL-LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 167 ----WVA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
W LI L + +P R + + + + + S PL
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS-SNPL 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
+HP ++ L + ++ ++ ++ +++ +L ++ E SE E N Q +GL
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLK 163
Query: 67 YMHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
+MH H D+KP N++ +KI D G+ +++ T + APE++
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRWV------------A- 169
+ G D WA+G + + +LS F G++ + + + W A
Sbjct: 224 REPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282
Query: 170 -LISWLCSWNPRMRPTAAEALEHPFFR 195
I L PR R T +ALEHP+ +
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLK 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 41/247 (16%), Positives = 84/247 (34%), Gaps = 57/247 (23%)
Query: 4 LRKMNNHPNIVKLRNLVKEHED--VFIVFDYMES-DLL-KLMKESAGQNFSEDEARNLCF 59
L+K+N H NIVKL + +E ++ ++ L L + S E E +
Sbjct: 61 LKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
V G++++ G HR++KP N++ + V K+ D G +E++ T
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 115 WYRAPEVLLLSEIC-------GPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKI 163
Y P++ + + G VD W++G + + FR + + + +YKI
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 164 ----YGRWVA--------------------------------LISWLCSWNPRMRPTAAE 187
++ +++ + + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 188 ALEHPFF 194
Sbjct: 300 FFAETSD 306
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
+H N+++L + + D+ +V +Y++ +L +++ E N +E + Q+ +G+
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIR 201
Query: 67 YMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
+MH+ H DLKP N+L IKI D G+ + T + APEV+
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRW--------------V 168
+ D W++G I + +LS F G N A+ + I RW
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 169 ALISWLCSWNPRMRPTAAEALEHPFFR 195
IS L R +A+EAL+HP+
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLS 347
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K+ NHPNIVKL +++ + ++++ +Y ++ + E EAR+ Q+
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSA 126
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRA 118
+ Y H++ HRDLK NLL+ + IKI D G S+ + Y A
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVGGKLDAFCGAPPYAA 181
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWV---- 168
PE+ + GPEVD W++G I++ ++S + F G+N + ++ ++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 169 -ALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
L+ NP R T + ++ + + H P +
Sbjct: 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 63/255 (24%), Positives = 100/255 (39%), Gaps = 64/255 (25%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----------------------------- 34
++K++ HPNI +L + ++ + + +V +
Sbjct: 82 MKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 35 ----------SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84
+ + +ES E N+ Q+F LHY+H QG HRD+KP N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 85 VSK---GVIKIGDLGMVKEIDSSLP-----CTDYVTTRWYRAPEVLLLSEIC-GPEVDRW 135
S IK+ D G+ KE T T ++ APEVL + GP+ D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 136 AMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVA-------LISWLCSWNPR 180
+ G ++ +L + FPG N AD I ++ + L+S L + N
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 181 MRPTAAEALEHPFFR 195
R A AL+HP+
Sbjct: 321 ERFDAMRALQHPWIS 335
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES--DLLKLMKESAGQNFSEDEARNLC 58
+ + HP +++L + + E +V + DL + E E +R
Sbjct: 88 LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFF 145
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 116
QV + + H +G HRD+K N+L+ +G K+ D G + P TD+ TR Y
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVY 204
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWV-- 168
PE + + W++G ++++M+ I F ++ +I V
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELHFPAHVSP 258
Query: 169 ---ALISWLCSWNPRMRPTAAEALEHPFFRS 196
ALI + P RP+ E L P+ ++
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 51/242 (21%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQV 61
L + H N+++L +E + ++VF+ M +L + K ++F+E EA + V
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDV 120
Query: 62 FQGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRW-- 115
L ++H +G HRDLKP N+L +KI D + I + C+ T
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 116 ------YRAPEVLLLSEIC----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG 165
Y APEV+ D W++G I++ +LS F G+ +D +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 166 RWVA------------------------------LISWLCSWNPRMRPTAAEALEHPFFR 195
A LIS L + + R +AA+ L+HP+ +
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
Query: 196 SC 197
C
Sbjct: 301 GC 302
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 38/236 (16%), Positives = 85/236 (36%), Gaps = 52/236 (22%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES----DLL---KLMKESAGQNFSEDEARNLC 58
+ + ++ +++V+I+++YME+ ++ ++ + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 59 FQVFQGLHYMHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYV 111
V Y+H + HRD+KPSN+L+ G +K+ D G + + +++
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM 217
Query: 112 TTRWYRAPEVLLLSEIC-GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK-------- 162
PE G +VD W++G ++ M + F K S +++
Sbjct: 218 ------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 163 ------------------IYGRWVA-----LISWLCSWNPRMRPTAAEALEHPFFR 195
+++ + NP R T+ +AL+H +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L +++ HPNI+KL+ + + ++ +V + + +L + E +SE +A + Q+
Sbjct: 102 LLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQIL 158
Query: 63 QGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ + Y+H G HRDLKP NLL + +KI D G+ K ++ + T Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK--IYGR-------WVA 169
PE+L GPEVD W++G I + +L F + +++ + W
Sbjct: 219 PEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277
Query: 170 -------LISWLCSWNPRMRPTAAEALEHPFFRS 196
L+ L +P+ R T +AL+HP+
Sbjct: 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 40/180 (22%), Positives = 74/180 (41%), Gaps = 21/180 (11%)
Query: 4 LRKMNNHPNIVKLRNLV--KEHEDVFIVFDYMES-DLL-KLMKESAGQNFSEDEARNLCF 59
L+K+N H NIVKL + ++ ++ L L + S E E +
Sbjct: 61 LKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
V G++++ G HR++KP N++ + V K+ D G +E++ T
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 115 WYRAPEVLLLSEIC-------GPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKI 163
Y P++ + + G VD W++G + + FR + + + +YKI
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
HP +V L + ++ ++ +++++M +L K+ E SEDEA QV +GL
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLC 269
Query: 67 YMHRQGYFHRDLKPSNLL-VSKGV--IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
+MH Y H DLKP N++ +K +K+ D G+ +D T + APEV
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRWV------------A- 169
+ G D W++G + + +LS F G+N + + + W
Sbjct: 330 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 170 -LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
I L +P R T +ALEHP+ + R +
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNI+ L ++ + DV ++ + + +L + E ++ +EDEA Q+ G+HY
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHY 123
Query: 68 MHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
+H + H DLKP N +L+ K V IK+ D G+ +I++ + T + APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 123 LLSEICGPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKI-YGRW---------- 167
+ G E D W++G I + +LS F G+ + + I +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFL----GETKQETLTNISAVNYDFDEEYFSNT 238
Query: 168 --VA--LISWLCSWNPRMRPTAAEALEHPFFRS 196
+A I L +P+ R T A++LEH + ++
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNI+++ N + + ++++ ++ +L K +++ F E + ++ LHY
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHY 129
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVTTRWYRAPEV 121
H + HRD+KP NLL+ KG +KI D G S T DY+ PE+
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEM 183
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWVA-----L 170
+ + +VD W G + +E L F + + +I +++ L
Sbjct: 184 -IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 171 ISWLCSWNPRMRPTAAEALEHPFFR 195
IS L ++P R +EHP+ +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
H N++ L ++ + DV ++ + + +L + + ++ SE+EA + Q+ G++Y
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNY 130
Query: 68 MHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
+H + H DLKP N+++ IK+ D G+ EI+ + + T + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 123 LLSEICGPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKIY-GRW---------- 167
+ G E D W++G I + +LS F G + + I +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFL----GDTKQETLANITSVSYDFDEEFFSHT 245
Query: 168 ----VALISWLCSWNPRMRPTAAEALEHPFFRS 196
I L R R T EAL HP+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 45/208 (21%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
H NI+ L + E++ ++F+++ D+ ++ +E E + QV + L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQ 116
Query: 67 YMHRQGYFHRDLKPSNLL-VSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
++H H D++P N++ ++ IKI + G +++ T Y APEV
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGRWV------------A- 169
+ D W++G +++ +LS F + + I I + A
Sbjct: 177 HDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 170 -LISWLCSWNPRMRPTAAEALEHPFFRS 196
+ L + R TA+EAL+HP+ +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNI+ L ++ + DV ++ + + +L + + ++ SE+EA + Q+ G++Y
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNY 130
Query: 68 MHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
+H + H DLKP N+++ IK+ D G+ EI+ + + T + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 123 LLSEICGPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKI-YGRW---------- 167
+ G E D W++G I + +LS F G + + I +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFL----GDTKQETLANITAVSYDFDEEFFSQT 245
Query: 168 ----VALISWLCSWNPRMRPTAAEALEHPFFRS 196
I L R R T EAL HP+
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 38/228 (16%)
Query: 3 FLRKMNNHPNIVKL--------RNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDE 53
F++K++ HPNIV+ + ++ + + L+ L K + S D
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 54 ARNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GVIKIGDLG----MVKEIDSSLP 106
+ +Q + + +MHRQ HRDLK NLL+S G IK+ D G + D S
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 107 CTD---------YVTTRWYRAPEVLLLSEIC--GPEVDRWAMGAIMFEMLSFRILFPGKN 155
TT YR PE++ L G + D WA+G I++ + + F
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED-G 256
Query: 156 SADQI----YKI------YGRWVALISWLCSWNPRMRPTAAEALEHPF 193
+ +I Y I Y + +LI + NP R + AE +
Sbjct: 257 AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPN++ L + + DV ++ + + +L + E ++ +E+EA Q+ G++Y
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 129
Query: 68 MHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122
+H H DLKP N+++ K IKI D G+ +ID + T + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRW-------------- 167
+ G E D W++G I + +LS F G + + + +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 248
Query: 168 VALISWLCSWNPRMRPTAAEALEHPFFRS 196
I L +P+ R T ++L+HP+ +
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 53/231 (22%), Positives = 85/231 (36%), Gaps = 51/231 (22%)
Query: 4 LRKMNNHPNIVKLR----NLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLC 58
+ + P+IV++ NL + + IV + ++ +L +++ Q F+E EA +
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTR 114
+ + + Y+H HRD+KP NLL SK ++K+ D G
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------- 166
A E E D W++G IM+ +L F + + R
Sbjct: 167 ---AKET--TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 167 ----WVA-------LISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
W LI L P R T E + HP+ VP PL
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP-QTPL 271
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K+ H NIV L ++ + ++V + +L + E ++E +A + QV
Sbjct: 60 LKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVL 116
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
+ Y+H G HRDLKP NLL + I I D G+ K + + T Y A
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVA 175
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGR-------WVA- 169
PEV L + VD W++G I + +L F + + KI G W
Sbjct: 176 PEV-LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI 234
Query: 170 ------LISWLCSWNPRMRPTAAEALEHPFFRS 196
I L +P R T +AL HP+
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
R + HPNIV+L + + E +++FD + +L + + + +SE +A + Q+
Sbjct: 64 CRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQIL 120
Query: 63 QGLHYMHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDS-SLPCTDYVTTRWYR 117
+ + + H+ G HR+LKP NLL SK +K+ D G+ E++ + T Y
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-YGR-------WVA 169
+PEV L + G VD WA G I++ +L F ++ +I G W
Sbjct: 181 SPEV-LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 170 -------LISWLCSWNPRMRPTAAEALEHPFFRS 196
LI+ + + NP R TAAEAL+HP+
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 6 KMNNHPNIVKLRNLVKEHED--VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
K +HPN+VKL ++ + + +++VF+ + +M+ + SED+AR + +
Sbjct: 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTLKPLSEDQARFYFQDLIK 148
Query: 64 GLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM---VKEIDSSL------PCTDYVTT 113
G+ Y+H Q HRD+KPSNLLV G IKI D G+ K D+ L P
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA------ 202
Query: 114 RWYRAPEVL--LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------ 165
+ APE L G +D WAMG ++ + + F + KI
Sbjct: 203 --FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP 260
Query: 166 RWVA-------LISWLCSWNPRMRPTAAEALEHPFFR 195
LI+ + NP R E HP+
Sbjct: 261 DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-33
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 28/217 (12%)
Query: 2 IFLRKMNNHPNIVKL----RNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
+ K HPNIV+ + VK + + +V + M S L +K + R+
Sbjct: 76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRS 133
Query: 57 LCFQVFQGLHYMHRQGYF--HRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVT 112
C Q+ +GL ++H + HRDLK N+ ++ G +KIGDLG+ +S T
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT 193
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR------ 166
+ APE+ E VD +A G M EM + + +A QIY+
Sbjct: 194 PEFM-APEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250
Query: 167 --------WVALISWLCSWNPRMRPTAAEALEHPFFR 195
+I N R + + L H FF+
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-33
Identities = 50/221 (22%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 2 IFLRKMNNH--PNIVKLRNLVKEHEDVFIVFDYMES--DLLKLMKESAGQNFSEDEARNL 57
+ L K + +++L + + + ++ + E DL + E E+ AR+
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSF 154
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
+QV + + + H G HRD+K N+L+ ++G +K+ D G + ++ TD+ TR
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRV 213
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWV- 168
Y PE + G W++G ++++M+ I F + +I + V
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVS 267
Query: 169 ----ALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVP 205
LI W + P RPT E HP+ + +P+
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD-VLLPQETA 307
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-33
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 41/216 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIV---------FDYMESDLLKLMKESAGQNFSEDEARN 56
K+ HP+I+KL ++ D F+V FDY+ E EAR
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEMEARR 115
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L Q+ + Y HR HRDLKP N+L+ + KI D G+ S++
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTS 170
Query: 116 -----YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG----- 165
Y APEV+ GPEVD W+ G I++ +L + F ++ KI G
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI 230
Query: 166 -RWVA-----LISWLCSWNPRMRPTAAEALEHPFFR 195
++ L+ + +P R T + EH +F+
Sbjct: 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 46/211 (21%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 6 KMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
+ H N+++L +++ E +++V +Y + +++ + F +A Q+
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 64 GLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAP 119
GL Y+H QG H+D+KP NLL+ + G +KI LG+ + + T + ++ P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 120 EVLLLSEI-CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWV---- 168
E+ + G +VD W+ G ++ + + F G N I
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 169 -ALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
L+ + + P R + + +H +FR H
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQG 64
K+ HP+I+KL +++ D+ +V +Y +L ++++ + +EDE R Q+
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---KRMTEDEGRRFFQQIICA 120
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRA 118
+ Y HR HRDLKP NLL+ +KI D G+ S++ Y A
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL-----SNIMTDGNFLKTSCGSPNYAA 175
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWVA--- 169
PEV+ GPEVD W+ G +++ ML R+ F + + K+ +++
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGA 235
Query: 170 --LISWLCSWNPRMRPTAAEALEHPFFR 195
LI + +P R T E P+F
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 40/219 (18%), Positives = 81/219 (36%), Gaps = 38/219 (17%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIV----------FDYMESDLLKLMKESAGQNFSEDEAR 55
H NI+K+ ++ + +V F +++ E A
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID----------RHPRLDEPLAS 133
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
+ Q+ + Y+ + HRD+K N+++ IK+ D G ++ + T
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------RWV 168
Y APEVL+ + GPE++ W++G ++ ++ F ++ + V
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIHPPYLV 247
Query: 169 -----ALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
+L+S L P R T + + P+ +
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 57/237 (24%), Positives = 88/237 (37%), Gaps = 48/237 (20%)
Query: 6 KMNNHPNIVKLRNLVKEHEDV------FIVFDYMES-DLLK-LMKESAGQNFSEDEARNL 57
K NHPN+V R + + + + +Y E DL K L + E R L
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPCTDYVTT 113
+ L Y+H HRDLKP N+++ G + KI DLG KE+D CT++V T
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--------- 164
Y APE+ L + VD W+ G + FE ++ F Q +
Sbjct: 187 LQYLAPEL-LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 165 --------GRWVA------------------LISWLCSWNPRMRPTAAEALEHPFFR 195
++ + + + W+ R R T + F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 24/228 (10%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQ-NFSEDEARNLCF 59
I L K H NIV+ E+ + I + + L L++ G +E
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVT-TRWY 116
Q+ +GL Y+H HRD+K N+L++ GV+KI D G K + PCT+ T T Y
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQY 189
Query: 117 RAPEVLLLSEI-CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ-IYKIY---------- 164
APE++ G D W++G + EM + + F ++K+
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249
Query: 165 -----GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
+ A I +P R A + L F + ++ P L
Sbjct: 250 SMSAEAK--AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 53/217 (24%), Positives = 85/217 (39%), Gaps = 37/217 (17%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIV---------FDYMESDLLKLMKESAGQNFSEDEARN 56
KM NH N+VK +E ++ FD +E D E +A+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQR 109
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT--- 112
Q+ G+ Y+H G HRD+KP NLL+ + +KI D G+ +
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-KIYGR----- 166
T Y APE+L E VD W+ G ++ ML+ + + + + Q Y +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 167 -WV-------ALISWLCSWNPRMRPTAAEALEHPFFR 195
W AL+ + NP R T + + ++
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 3 FLRKMNNHPNIVKLR-NLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+ K ++ P IV+ + DVFI + M + KL K G E + +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNT-DVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAI 133
Query: 62 FQGLHYMHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
+ L+Y+ + G HRD+KPSN+L+ +G IK+ D G+ + Y AP
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 120 EVLLLSEICGPE----VDRWAMGAIMFEMLSFRILFPGKNSA-DQIYKI----------Y 164
E + + P+ D W++G + E+ + + + + + + K+ +
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253
Query: 165 GRW----VALISWLCSWNPRMRPTAAEALEHPFFRS 196
+ + + + + R RP + LEH F +
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 41/216 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIV---------FDYMESDLLKLMKESAGQNFSEDEARN 56
K+ HP+I+KL ++ D+F+V FDY+ E E+R
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKESRR 120
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
L Q+ G+ Y HR HRDLKP N+L+ + KI D G+ S++
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTS 175
Query: 116 -----YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG----- 165
Y APEV+ GPEVD W+ G I++ +L + F + KI
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235
Query: 166 -RWVA-----LISWLCSWNPRMRPTAAEALEHPFFR 195
+++ L+ + +P R T + EH +F+
Sbjct: 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 49/241 (20%), Positives = 74/241 (30%), Gaps = 40/241 (16%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
+ + P IV L V+E V I + +E L+K ED A
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYY 155
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVT--- 112
Q +GL Y+H + H D+K N+L+S + D G + +T
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 113 ---TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS--------------FRILFPGKN 155
T + APEV++ C +VD W+ +M ML+ +I
Sbjct: 216 IPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---ASE 271
Query: 156 SADQIYKIYGRW----VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNF 211
+I I P R +A E P
Sbjct: 272 PPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330
Query: 212 E 212
E
Sbjct: 331 E 331
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 53/217 (24%), Positives = 85/217 (39%), Gaps = 37/217 (17%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIV---------FDYMESDLLKLMKESAGQNFSEDEARN 56
KM NH N+VK +E ++ FD +E D E +A+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQR 109
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT--- 112
Q+ G+ Y+H G HRD+KP NLL+ + +KI D G+ +
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-KIYGR----- 166
T Y APE+L E VD W+ G ++ ML+ + + + + Q Y +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 167 -WV-------ALISWLCSWNPRMRPTAAEALEHPFFR 195
W AL+ + NP R T + + ++
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 58/220 (26%), Positives = 82/220 (37%), Gaps = 41/220 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIV---------FDYMESDLLKLMKESAGQNFSEDEARN 56
+ HPNIV+ + ++ + I+ ++ + FSEDEAR
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI----------CNAGRFSEDEARF 120
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV---SKGVIKIGDLGMVKEI-DSSLPCTDYVT 112
Q+ G+ Y H HRDLK N L+ +KI D G K S P + V
Sbjct: 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVG 179
Query: 113 TRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR------ 166
T Y APEVLL E G D W+ G ++ ML F K R
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 167 ------WVA-----LISWLCSWNPRMRPTAAEALEHPFFR 195
++ LIS + +P R + E H +F
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 11/168 (6%)
Query: 4 LRKMNNHP-----NIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLC 58
L + N++ + + + F+ + +L +L+K++ Q FS R
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLV---SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 115
+ Q L +H+ H DLKP N+L+ + IK+ D G + Y+ +R+
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRF 264
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
YRAPEV+L + G +D W++G I+ E+L+ L PG++ DQ+ +
Sbjct: 265 YRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 10/29 (34%), Positives = 15/29 (51%)
Query: 177 WNPRMRPTAAEALEHPFFRSCHFVPRSVP 205
W+P +R T +AL HP+ R P +
Sbjct: 395 WDPAVRMTPGQALRHPWLRRRLPKPPTGE 423
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 25/217 (11%), Positives = 68/217 (31%), Gaps = 29/217 (13%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES----DLLKLMKESAGQNFSEDEARNLCFQV 61
K + +K + +V + + + L K + + + + ++
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV------------SKGVIKIGDLGMVKEIDSSLPCTD 109
+ +H H D+KP N ++ + + DLG ++ P
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-KLFPKGT 240
Query: 110 YVTTRW----YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK-NSADQIYKIY 164
T + ++ E+ L ++ ++D + + A ++ ML + + ++
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 165 GR------WVALISWLCSWNPRMRPTAAEALEHPFFR 195
R W + + + + L +
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+ I +L ++ +++V +Y DLL L+ + G+ + AR ++ +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDS 177
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLL 124
+HR GY HRD+KP N+L+ G I++ D G ++ D ++ V T Y +PE+L
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 125 SEIC------GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI-----------YGRW 167
GPE D WA+G +EM + F ++A+ KI
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 168 V-----ALISWLCSWNPRMR---PTAAEALEHPFFRS 196
V I L P R A + HPFF
Sbjct: 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N +V L + + + +V M DL + F E A ++ GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+HR+ +RDLKP N+L+ G I+I DLG+ + V T Y APEV + +E
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV-VKNE 360
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV---------------ALI 171
D WA+G +++EM++ + F + + ++ +L
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 172 SWLCSWNPRMR-----PTAAEALEHPFFRS 196
S L +P R +A E EHP F+
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 8 NNHPNIVKL------RNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+I+KL + H V +VF+ + +LL L+K+ + + + Q+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVH--VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 62 FQGLHYMHRQ-GYFHRDLKPSNLLVS-------KGVIKIGDLGMVKEIDSSLPCTDYVTT 113
GL YMHR+ G H D+KP N+L+ IKI DLG T+ + T
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQT 198
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK------NSADQIYKI 163
R YR+PEVLL + G D W+ ++FE+++ LF D I +I
Sbjct: 199 REYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+ I L ++ ++++V DY DLL L+ + + E+ AR ++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDS 190
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLL 124
+H+ Y HRD+KP N+L+ G I++ D G ++ D ++ + V T Y +PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 125 SEIC----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI--------YGRWVALIS 172
E GPE D W++G M+EML F ++ + KI + V +S
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310
Query: 173 ---------WLCSWNPRMRPTAAEAL-EHPFFRS 196
+CS R+ E +HPFF
Sbjct: 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 3 FLRKMNNHPNIVKLR-NLVKEHEDVFIVFDYME---SDLLKLMKESAGQNFSEDEARNLC 58
+ + ++ P IV+ L +E D +I + M K + E+ +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 59 FQVFQGLHYMHRQGY-FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 116
+ L+++ HRD+KPSN+L+ G IK+ D G+ ++ S+ T R Y
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPY 191
Query: 117 RAPEVLLLSEICGP---EVDRWAMGAIMFEMLSFRILFPGKNS-ADQIYKI--------- 163
APE + S D W++G ++E+ + R +P NS DQ+ ++
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 164 ---YGRW----VALISWLCSWNPRMRPTAAEALEHPFFR 195
+ + ++ + + RP E L+HPF
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP VKL ++ E ++ Y ++ +LLK +++ +F E R ++ L Y
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEY 145
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLL 123
+H +G HRDLKP N+L+ I+I D G K + + T Y +PE+ L
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-L 204
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-KI------YGRWVA-----LI 171
+ D WA+G I++++++ F N I+ KI + L+
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKLEYDFPEKFFPKARDLV 263
Query: 172 SWLCSWNPRMRPT------AAEALEHPFFRS 196
L + R HPFF S
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
LRK H NI+ + IV + E S L + S + F + ++ Q
Sbjct: 74 LRKTR-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTA 130
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYV----TTRWYR 117
+G+ Y+H + HRDLK +N+ + + +KIGD G+ E + + W
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW-M 189
Query: 118 APEVLLLSEI--CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR--------- 166
APEV+ + + + D +A G +++E+++ ++ + N+ DQI ++ GR
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 167 --------WVALISWLCSWNPRMRPTAAEALEH 191
L++ RP+ L
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 37/216 (17%), Positives = 83/216 (38%), Gaps = 30/216 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
R+ H N+V + I+ + L +++ A ++ R + ++
Sbjct: 83 YRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIV 140
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGM--VKEIDSSLPCTDYVTTR--WYR- 117
+G+ Y+H +G H+DLK N+ G + I D G+ + + + D + + W
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 118 -APEVLLLSEICGPE--------VDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---- 164
APE++ E D +A+G I +E+ + F + + I+++
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 165 ---------GRWVALISWLCSWNPRMRPTAAEALEH 191
++ + ++ RPT + ++
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 4 LRKMNNHP-----NIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLC 58
L MN H IV L+ + +VF+ + +L L++ + + S + R
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 59 FQVFQGLHYMHRQ--GYFHRDLKPSNLLV---SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
Q+ L ++ H DLKP N+L+ + IKI D G ++ + Y+ +
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQS 221
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
R+YR+PEVLL +D W++G I+ EM + LF G N DQ+ KI
Sbjct: 222 RFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 46/209 (22%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNI+ LR + + ++ +V ++ L +++ G+ D N Q+ +G++Y
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNY 120
Query: 68 MHRQGYF---HRDLKPSNLLVSKG---------VIKIGDLGMVKEIDSSLPCTDYVTTRW 115
+H + HRDLK SN+L+ + ++KI D G+ +E + + W
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW 180
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR--------- 166
APEV + + + D W+ G +++E+L+ + F G + Y +
Sbjct: 181 -MAPEV-IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 167 ----WVALISWLCSWNPRMRPTAAEALEH 191
+ L+ + +P RP+ L+
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 3 FLRKMNNHPNIVKLR-NLVKEHEDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCF 59
+ + P V L +E DV+I + M++ L K K+ GQ ED +
Sbjct: 58 ISMRTVDCPFTVTFYGALFREG-DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 60 QVFQGLHYMHRQGYF-HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
+ + L ++H + HRD+KPSN+L++ G +K+ D G+ + + + Y
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 118 APEVLLLSEICGP---EVDRWAMGAIMFEMLSFRILFPGKNSA---DQIYKI-------- 163
APE + + D W++G M E+ R FP + Q+ ++
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQL 234
Query: 164 -YGRW----VALISWLCSWNPRMRPTAAEALEHPFFR 195
++ V S N + RPT E ++HPFF
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N P +V+L ++ +++V +YM DL+ LM + E AR +V L
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDA 183
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLL- 123
+H G+ HRD+KP N+L+ G +K+ D G ++ + + C V T Y +PEVL
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 124 --LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI----------YGRWV--- 168
G E D W++G ++EML F + KI +
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 169 --ALISWLCSWNPRMR---PTAAEALEHPFFRS 196
LI + + +R E H FF++
Sbjct: 304 AKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 335
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HP +V L ++ ED+F+V D + DL ++++ +F E+ + ++ L Y
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDY 130
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 126
+ Q HRD+KP N+L+ G + I D + + T T+ Y APE+ +
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 127 ICG--PEVDRWAMGAIMFEMLSFRILFPGKNSAD--QIYK-------IYGRWV-----AL 170
G VD W++G +E+L R + ++S +I Y +L
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
Query: 171 ISWLCSWNPRMRPTAAEAL-EHPFFRS 196
+ L NP R + + P+
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
+ P IV + + + + D M DL + + FSE + R ++ G
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILG 304
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
L +MH + +RDLKP+N+L+ G ++I DLG+ + P V T Y APEVL
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ 363
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD--QIYK-------IYGRWV-----A 169
D +++G ++F++L F + D +I + +
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 170 LISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
L+ L + R A+ + E PFFRS
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 9 NHPNIVKLRNLVKEHEDV------FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
HP+IV++ N V EH D +IV +Y+ LK S GQ EA ++
Sbjct: 137 VHPSIVQIFNFV-EHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYLLEIL 192
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEV 121
L Y+H G + DLKP N+++++ +K+ DLG V I+S Y+ T ++APE+
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS----FGYLYGTPGFQAPEI 248
Query: 122 LLLSEICGPEVDR---WAMGAIMFEMLSFRILFPGKNSA-----DQIYKIYGRWVALISW 173
+ + +G + + G+ D + K Y + L+
Sbjct: 249 VR-----TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 174 LCSWNPRMRPTAAEAL 189
+PR R T AE +
Sbjct: 304 AIDPDPRQRFTTAEEM 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLK-LMKESAGQNFSEDEARNLCFQV 61
++++ HPNIV V + ++ IV +Y+ L + L K A + E ++ + V
Sbjct: 88 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 62 FQGLHYMHRQGYF--HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYV--TTRWY 116
+G++Y+H + HR+LK NLLV K +K+ D G+ + S+ + T W
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW- 205
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR---------- 166
APEV L E + D ++ G I++E+ + + + N A + + +
Sbjct: 206 MAPEV-LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264
Query: 167 ---WVALISWLCSWNPRMRPTAAEALEH 191
A+I + P RP+ A ++
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L HP + + + E++F V +Y+ DL+ ++ F A ++
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEII 128
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------ 115
GL ++H +G +RDLK N+L+ G IKI D GM KE T
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-----NMLGDAKTNTFCGTPD 183
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-- 167
Y APE+LL + VD W+ G +++EML + F G++ + + I Y RW
Sbjct: 184 YIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242
Query: 168 ---VALISWLCSWNPRMRPTAAEAL-EHPFFRS 196
L+ L P R + +HP FR
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DL---LKLMKESAGQNFSEDEARNLCFQVFQG 64
+ IV L + D+ +V M D+ + + E F E A Q+ G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSG 301
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVL 122
L ++H++ +RDLKP N+L+ G ++I DLG+ E Y T + APE+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL- 360
Query: 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN---SADQIYK-------IYGRW----- 167
LL E VD +A+G ++EM++ R F + ++ + Y
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 168 VALISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
L +P R + + L HP FR
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L NHP + +L + + +F V +++ DL+ +++S + F E AR ++
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEII 134
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------ 115
L ++H +G +RDLK N+L+ +G K+ D GM KE + VTT
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-----GICNGVTTATFCGTPD 189
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-- 167
Y APE+L + GP VD WAMG +++EML F +N D I Y W
Sbjct: 190 YIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248
Query: 168 ---VALISWLCSWNPRMR----PTAAEA--LEHPFFRS 196
++ + NP MR E L HPFF+
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMK---ESAGQNFSEDEA 54
I +HPNIV +++++V + D++K + E E
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD---- 109
+ +V +GL Y+H+ G HRD+K N+L+ G ++I D G+ + + T
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 110 --YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS----------FRILF------ 151
+V T + APEV+ + D W+ G E+ + ++L
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 152 -PGKNSADQIYKIYGRWVA----LISWLCSWNPRMRPTAAEALEHPFFRSC 197
P + Q ++ ++ +IS +P RPTAAE L H FF+
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-24
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DL-LKLMKESAGQNFSEDEARNLCFQVFQGLH 66
HP IV L + ++++ +Y+ +L ++L +E F ED A ++ L
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALG 135
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLL 124
++H++G +RDLKP N+++ +G +K+ D G+ KE I + T Y APE+L+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-----VALISW 173
S VD W++GA+M++ML+ F G+N I KI + L+
Sbjct: 196 SG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKK 254
Query: 174 LCSWNPRMR----PTAAEAL-EHPFFRS 196
L N R P A + HPFFR
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-24
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DL-LKLMKESAGQNFSEDEARNLCFQV 61
L P + +L + + + ++ V +Y+ DL + + F E A ++
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEI 130
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW----- 115
GL ++ +G +RDLK N+++ S+G IKI D GM KE D VTT+
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTP 185
Query: 116 -YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW- 167
Y APE+ + + G VD WA G +++EML+ + F G++ + I Y +
Sbjct: 186 DYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244
Query: 168 ----VALISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
VA+ L + +P R P + EH FFR
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-24
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
N P +VKL K++ ++++V +Y+ ++ ++ FSE AR Q+ Y
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEY 156
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT-----TRWYRAPEV 121
+H +RDLKP NLL+ +G I++ D G K + T T APE+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------RTWTLCGTPEALAPEI 209
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-KI------YGRWV-----A 169
+LS+ VD WA+G +++EM + F QIY KI +
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKVRFPSHFSSDLKD 267
Query: 170 LISWLCSWNPRMR-----PTAAEALEHPFFRS 196
L+ L + R + H +F +
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
HP + L+ + H+ + V +Y +L L +E + F+E+ AR ++ L
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALE 119
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAP 119
Y+H + +RD+K NL++ G IKI D G+ KE +D T + Y AP
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-----GISDGATMKTFCGTPEYLAP 174
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-----V 168
EV L G VD W +G +M+EM+ R+ F ++ I + R
Sbjct: 175 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 169 ALISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
+L++ L +P+ R P+ A+ + EH FF S
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 38/237 (16%)
Query: 3 FLRKMNNHPNIVKL------RNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSED 52
L+K ++H NI +N + +++V ++ +DL+K K G E+
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEE 129
Query: 53 EARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDY 110
+C ++ +GL ++H+ HRD+K N+L+++ +K+ D G+ ++D ++ +
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 189
Query: 111 VTTRWYRAPEVLLLSEIC----GPEVDRWAMG--AI--------MFEMLSFRILF--PGK 154
+ T ++ APEV+ E + D W++G AI + +M R LF P +
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-R 248
Query: 155 NSADQIYKIYGRWVAL----ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
N A ++ +W I N RP + ++HPF R + L
Sbjct: 249 NPAPRLKS--KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 40/194 (20%), Positives = 75/194 (38%), Gaps = 41/194 (21%)
Query: 4 LRKMNNHP----NIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59
L+K+ N NIVK ++ + ++F+ + L +++ + F ++ + C
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCI 144
Query: 60 QVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGM-----------------VKEI 101
++ + L+Y+ + H DLKP N LL K +K I
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 102 D--SSLPCTD------YVTTRWYRAPEVLLLSEICG----PEVDRWAMGAIMFEMLSFRI 149
D + + TR YRAPEV+L D W+ G ++ E+ + +
Sbjct: 205 DFGCA--TFKSDYHGSIINTRQYRAPEVIL-----NLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 150 LFPGKNSADQIYKI 163
LF + + +
Sbjct: 258 LFRTHEHMEHLAMM 271
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 55/272 (20%), Positives = 88/272 (32%), Gaps = 83/272 (30%)
Query: 4 LRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLC 58
L+K+ N V + + H + I F+ + + + +KE+ Q + R++
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGM-----------VKEID--SS 104
+Q+ L ++H H DLKP N L V+ + + ++ D S+
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 105 LPCTD------YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158
D V TR YR PEV+L P D W++G I+FE LF + +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 159 QIYKI------------------------YGRWVALISWLCSWNPRMRP----------- 183
+ + W S +P
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 184 --------------------TAAEALEHPFFR 195
T AEAL HPFF
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DL-LKLMKESAGQNFSEDEARNLCFQVFQGLH 66
NHP IVKL + ++++ D++ DL +L KE F+E++ + ++ L
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALD 140
Query: 67 YMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLL 124
++H G +RDLKP N+L+ +G IK+ D G+ KE ID + T Y APEV+
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-----VALISW 173
D W+ G +MFEML+ + F GK+ + + I ++ +L+
Sbjct: 201 RG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259
Query: 174 LCSWNPRMR----PTAAEAL-EHPFFRS 196
L NP R P E + H FF +
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 3e-23
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HP I+++ ++ + +F++ DY+E +L L+++S Q F A+ +V L Y
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEY 121
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID---SSLPC--TDYVTTRWYRAPEV 121
+H + +RDLKP N+L+ G IKI D G K + +L C DY+ APEV
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-CGTPDYI------APEV 174
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-KI------YGRWV-----A 169
+ ++ +D W+ G +++EML+ F N+ + Y KI + +
Sbjct: 175 -VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAELRFPPFFNEDVKD 232
Query: 170 LISWLCSWNPRMR-----PTAAEALEHPFFRS 196
L+S L + + R + HP+F+
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 27/226 (11%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
+ + + H N+V++ E+++++ ++++ +D++ ++ +E++ +
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR------LNEEQIATV 146
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRW 115
C V Q L Y+H QG HRD+K + LL G +K+ D G +I +P V T +
Sbjct: 147 CEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 206
Query: 116 YRAPEVLLLSEICGPEVDRWAMG--AI--------MFEMLSFRILFPGKNSADQIYKIYG 165
+ APEV+ S EVD W++G I F + + ++S K
Sbjct: 207 WMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSH 265
Query: 166 RWVAL----ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
+ + + + +P+ R TA E L+HPF VPL+
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L K HP +V L + + ++ V DY+ +L ++ + F E AR ++
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIA 149
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------ 115
L Y+H +RDLKP N+L+ S+G I + D G+ KE TT
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-----NIEHNSTTSTFCGTPE 204
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-- 167
Y APEV L + VD W +GA+++EML F +N+A+ I
Sbjct: 205 YLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 168 ---VALISWLCSWNPRMR----PTAAEALEHPFFRS 196
L+ L + R E H FF
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-23
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLL-KLMKESAGQNFSEDEARNLCFQVFQGLH 66
HP + L+ + H+ + V +Y +L L +E + FSED AR ++ L
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALD 262
Query: 67 YMH-RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLL 123
Y+H + +RDLK NL++ G IKI D G+ KE I + T Y APEVL
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-----VALIS 172
G VD W +G +M+EM+ R+ F ++ I + R +L+S
Sbjct: 323 -DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381
Query: 173 WLCSWNPRMR----PT-AAEALEHPFFRS 196
L +P+ R A E ++H FF
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
I + + + P++VK ++ D++IV +Y SD+++L ++ +EDE +
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATI 130
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSL-PCTDYVTTRW 115
+GL Y+H HRD+K N LL ++G K+ D G+ ++ ++ + T +
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 116 YRAPEVLLLSEICGPEVDRWAMG--AI--------MFEMLSFRILF--PGKNSADQIYKI 163
+ APEV+ D W++G AI ++ R +F P N +
Sbjct: 191 WMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPPTF-RK 247
Query: 164 YGRWVAL----ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
W + +P R TA + L+HPF RS V L+
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 6e-23
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
L P + +L + + + ++ V +Y+ DL+ +++ F E A ++
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIA 452
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------ 115
GL ++ +G +RDLK N+++ S+G IKI D GM KE D VTT+
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTPD 507
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRW-- 167
Y APE+ + + G VD WA G +++EML+ + F G++ + I Y +
Sbjct: 508 YIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 566
Query: 168 ---VALISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
VA+ L + +P R P + EH FFR
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-23
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DL-LKLMKESAGQNFSEDEARNLCFQV 61
L + P +V L + + ++ DY+ +L L + + F+E E + ++
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEI 168
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRA 118
L ++H+ G +RD+K N+L+ S G + + D G+ KE D + D+ T Y A
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 119 PEVLLLSEI-CGPEVDRWAMGAIMFEMLS----FRILFPGKNSADQIYKI------YGRW 167
P+++ + VD W++G +M+E+L+ F + + A+ +I Y +
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 168 -----VALISWLCSWNPRMR----PTAAEAL-EHPFFRS 196
LI L +P+ R P A+ + EH FF+
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 26/225 (11%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+ + HPN ++ R ++V +Y L++ E E +
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGA 163
Query: 62 FQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
QGL Y+H HRD+K N LL G++K+GD G + + +V T ++ APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPE 220
Query: 121 VLLLSEICG--PEVDRWAMG--AI--------MFEMLSFRILF--PGKNSADQIYKIYGR 166
V+L + +VD W++G I +F M + L+ +N + + G
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQS--GH 277
Query: 167 WVAL----ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
W + P+ RPT+ L+H F + L+
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 29/227 (12%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
I + + N +PNIV + +++++V +Y+ +D++ E + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAV 121
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRW 115
C + Q L ++H HRD+K N LL G +K+ D G +I + V T +
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 116 YRAPEVLLLSEICGPEVDRWAMG--AI--------MFEMLSFRILFP-GKNSADQIYKIY 164
+ APEV+ GP+VD W++G AI R L+ N ++ +
Sbjct: 182 WMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNP 239
Query: 165 GRWVAL----ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
+ A+ ++ + R +A E L+H F + + PL+
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 28/185 (15%)
Query: 4 LRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLC 58
L +N + V++ + H + IVF+ + +KE+ F D R +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGM-----------VKEID--SS 104
+Q+ + ++++H H DLKP N L V + + + +K +D S+
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 105 LPCTD------YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158
D V+TR YRAPEV+L P D W++G I+ E +FP +S +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 159 QIYKI 163
+ +
Sbjct: 242 HLAMM 246
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 43/210 (20%), Positives = 78/210 (37%), Gaps = 34/210 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
NHPNIVKL L+ +V +++ DL + L + G+ Y
Sbjct: 81 NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEY 137
Query: 68 MHRQGYF--HRDLKPSNLLVSKG------VIKIGDLGMVKEIDSSLPCTDYV-TTRWYRA 118
M Q HRDL+ N+ + K+ D G+ ++ S+ + + +W A
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQW-MA 194
Query: 119 PEVLLL-SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------------ 165
PE + E + D ++ I++ +L+ F + +I I
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREEGLRPTIPE 253
Query: 166 ----RWVALISWLCSWNPRMRPTAAEALEH 191
R +I S +P+ RP + ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 32/232 (13%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
I + +HP IVKL ++I+ ++ ++ + +E + + +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVV 122
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YVTTRW 115
C Q+ + L+++H + HRDLK N L+ +G I++ D G+ + +L D ++ T +
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 116 YRAPEVLLLSEIC----GPEVDRWAMG--AI--------MFEMLSFRILF--PGKNSADQ 159
+ APEV++ + + D W++G I E+ R+L K+
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPT 241
Query: 160 IYKIYGRWVAL----ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
+ +W + NP RP+AA+ LEHPF S L+
Sbjct: 242 L-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 28/205 (13%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLK--LMKESAGQNFSEDEARNLCFQVFQGLH 66
NHPNIVKL V +V +Y E L L ++ A + C Q QG+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 67 YMHR---QGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLPCTDYV-TTRWYRAPE 120
Y+H + HRDLKP NLL+ G V+KI D G +I + + T+ + W APE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAW-MAPE 173
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG-KNSADQIYKIYGR------------- 166
V + D ++ G I++E+++ R F A +I
Sbjct: 174 V-FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 167 WVALISWLCSWNPRMRPTAAEALEH 191
+L++ S +P RP+ E ++
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-22
Identities = 34/207 (16%), Positives = 76/207 (36%), Gaps = 35/207 (16%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPN++K ++ + + + + +Y++ L ++K Q + + + + G+ Y+
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYL 124
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYV---------------- 111
H HRDL N LV + + + D G+ + + + +
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 112 TTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR----- 166
W APE+ + +VD ++ G ++ E++ P + + R
Sbjct: 185 NPYWM-APEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 167 ---------WVALISWLCSWNPRMRPT 184
+ + C +P RP+
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKRPS 269
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
+ +NHP +V L + + +F V +Y+ DL+ M+ + E+ AR ++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEIS 120
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------ 115
L+Y+H +G +RDLK N+L+ S+G IK+ D GM KE TT
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPN 175
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY---------KI--- 163
Y APE+ L E G VD WA+G +MFEM++ R F S+D I
Sbjct: 176 YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234
Query: 164 ---YGRW-----VALISWLCSWNPRMR------PTAAEALEHPFFRS 196
R +++ + +P+ R A+ HPFFR+
Sbjct: 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVF 62
+ +NHP +V L + + +F V +Y+ DL+ M+ + E+ AR ++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEIS 163
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------ 115
L+Y+H +G +RDLK N+L+ S+G IK+ D GM KE TT
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPN 218
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY---------KI--- 163
Y APE+ L E G VD WA+G +MFEM++ R F S+D I
Sbjct: 219 YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 164 ---YGRW-----VALISWLCSWNPRMR------PTAAEALEHPFFRS 196
R +++ + +P+ R A+ HPFFR+
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-21
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLK-LMKESAGQNFSEDEARNLCFQVFQGLHY 67
+H NIV + ++ +E + ++V +Y+E L ++ S D A N Q+ G+ +
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKH 126
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVT-TRWYRAPEVLLL 124
H HRD+KP N+L+ +KI D G+ K + ++SL T++V T Y +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAK 185
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPG 153
E D +++G +++EML F G
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-21
Identities = 28/209 (13%), Positives = 69/209 (33%), Gaps = 26/209 (12%)
Query: 4 LRKMNNHPNIVKLRNLVKE--HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
LR + HPN++ + + ++ +M L ++ E + +A
Sbjct: 61 LRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 61 VFQGLHYMHRQGYF--HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
+ +G+ ++H L ++++ + +I + S W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAPAWV- 175
Query: 118 APEVLL--LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR--------- 166
APE L + D W+ +++E+++ + F ++ + K+
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235
Query: 167 ----WVALISWLCSWNPRMRPTAAEALEH 191
L+ + +P RP +
Sbjct: 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL 57
I + + P + K + ++I+ +Y+ DLL+ E + +
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATI 124
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRW 115
++ +GL Y+H + HRD+K +N+L+S+ G +K+ D G+ ++ + +V T +
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 184
Query: 116 YRAPEVLLLSEICGPEVDRWAMG--AI--------MFEMLSFRILF--PGKNSADQIYKI 163
+ APEV+ S + D W++G AI E+ ++LF P KN+ +
Sbjct: 185 WMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPP---TL 239
Query: 164 YGRWVAL----ISWLCSWNPRMRPTAAEALEHPFFRSC 197
G + + + P RPTA E L+H F
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-20
Identities = 44/265 (16%), Positives = 85/265 (32%), Gaps = 70/265 (26%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME--SDLLKLMKESAGQNFSEDEARNLCF 59
+ + K+ NHPNIV R ++++V +M S L+ +E +
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS-AKDLICTHFMDGMNELAIAYILQ 135
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLG--------MVKEIDSSLPCTDY 110
V + L Y+H GY HR +K S++L+S G + + L ++
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 111 VTTRWYRAPEVLLLSEIC-GPEVDRWAMG--AI--------MFEMLSFRILF-------- 151
V + +PEVL + + D +++G A +M + ++L
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 152 -------------------------PGKNSADQIYKIYGRWVALISWLCSWNPRMR---- 182
+ + + +++P
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 183 ----------PTAAEALEHPFFRSC 197
P+A+ L H FF+
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQI 340
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 9/140 (6%)
Query: 9 NHPNIVK-LRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
N P IV + ++ I ++M+ L +++K+ E + V +GL
Sbjct: 89 NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 145
Query: 67 YMHRQGY-FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
Y+ + HRD+KPSN+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPER-LQ 203
Query: 125 SEICGPEVDRWAMGAIMFEM 144
+ D W+MG + EM
Sbjct: 204 GTHYSVQSDIWSMGLSLVEM 223
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 8/158 (5%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
P++V + + + +++ + DL +++ + A + Q+ L
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDA 149
Query: 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVT-TRWYRAPEVLLL 124
H G HRD+KP N+LVS + D G+ D L T +Y APE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE-RFS 208
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162
D +A+ +++E L+ + G + +
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGA 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 45/209 (21%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
FL++ HPN+V+L + +I+ ++M +LL ++E Q S
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 322
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
+ Q+ + Y+ ++ + HR+L N LV ++K+ D G+ + + Y
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAG 378
Query: 114 -----RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIYG-- 165
+W APE L + + D WA G +++E+ ++ +PG + + +
Sbjct: 379 AKFPIKWT-APESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436
Query: 166 ---------RWVALISWLC-SWNPRMRPT 184
V + C WNP RP+
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRPS 465
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 51/249 (20%), Positives = 80/249 (32%), Gaps = 66/249 (26%)
Query: 2 IFLRKMNNHPNIVKL----RNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDE 53
I+ + H NI+ ++++ DY E D LK
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKS 135
Query: 54 ARNLCFQVFQGLHYMHRQGYF--------HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 104
L + GL ++H + + HRDLK N+LV K G I DLG+ + S
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 105 LPCTDYVT-----TRWYRAPEVLLLSEICGPE-----VDRWAMGAIMFEMLS-------- 146
D T+ Y PEVL S D ++ G I++E+
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
Query: 147 ------FRILFPGKNSADQIYKIYGR-------------------WVALISWLCSWNPRM 181
+ L P S + + +I L++ + NP
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 182 RPTAAEALE 190
R TA +
Sbjct: 316 RLTALRVKK 324
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 25/170 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNI++L +V + + V IV +YME+ L +++ Q F+ + + + G+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKY 162
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPE 120
+ GY HRDL N+L+ S V K+ D G+ + ++ P Y T RW +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRWT-SPE 220
Query: 121 VLL------LSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
+ S D W+ G +++E++S+ + ++ D I +
Sbjct: 221 AIAYRKFTSAS-------DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-19
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 43/208 (20%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K H +V+L +V E E ++IV +YM LL +K G+ + ++ Q+ G
Sbjct: 234 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 65 LHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 116
+ Y+ R Y HRDL+ +N+LV V K+ D G+ + I+ + +Y +W
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWT 348
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD----------------- 158
APE L + D W+ G ++ E+ + R+ +PG + +
Sbjct: 349 -APEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406
Query: 159 --QIYKIYGRWVALISWLCSWNPRMRPT 184
++ + W P RPT
Sbjct: 407 PESLHDL-----MCQCW--RKEPEERPT 427
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 53/249 (21%), Positives = 80/249 (32%), Gaps = 66/249 (26%)
Query: 2 IFLRKMNNHPNIVKL----RNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDE 53
++ M H NI+ ++++ Y E D L+
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVS 106
Query: 54 ARNLCFQVFQGLHYMHRQGYF--------HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 104
+ + GL ++H + + HRDLK N+LV K G I DLG+ S
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 105 LPCTDYVT-----TRWYRAPEVL-----LLSEICGPEVDRWAMGAIMFEMLS-------- 146
D T+ Y APEVL + VD WA G +++E+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 147 ------FRILFPGKNSADQIYK----------IYGRW---------VALISWLCSWNPRM 181
F + P S + + K I RW L+ NP
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSA 286
Query: 182 RPTAAEALE 190
R TA +
Sbjct: 287 RLTALRIKK 295
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 43/208 (20%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K H +V+L +V E E ++IV +YM LL +K G+ + ++ Q+ G
Sbjct: 317 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 65 LHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 116
+ Y+ R Y HRDL+ +N+LV V K+ D G+ + I+ + +Y +W
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWT 431
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD----------------- 158
APE L + D W+ G ++ E+ + R+ +PG + +
Sbjct: 432 -APEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489
Query: 159 --QIYKIYGRWVALISWLCSWNPRMRPT 184
++ + W P RPT
Sbjct: 490 PESLHDL-----MCQCW--RKEPEERPT 510
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNIV+L + + + ++IV + ++ D L ++ + G + G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEY 228
Query: 68 MHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRA 118
+ + HRDL N LV+ K V+KI D GM +E Y + +W A
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWT-A 283
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI---Y---------G 165
PE L E D W+ G +++E S +P ++ +
Sbjct: 284 PEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 166 RWVALISWLCSWNPRMRPTAAE 187
L+ ++ P RP+ +
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFST 364
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 56/249 (22%), Positives = 81/249 (32%), Gaps = 66/249 (26%)
Query: 2 IFLRKMNNHPNIVKL----RNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDE 53
I+ M H NI+ +++V DY E D L + +
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEG 140
Query: 54 ARNLCFQVFQGLHYMHRQGYF--------HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 104
L GL ++H + HRDLK N+LV K G I DLG+ DS+
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 105 LPCTDYVT-----TRWYRAPEVLLLSEICGPE-----VDRWAMGAIMFEMLS-------- 146
D T+ Y APEVL S D +AMG + +E+
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 147 ------FRILFPGKNSADQIYK----------IYGRW---------VALISWLCSWNPRM 181
+ L P S +++ K I RW ++ N
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320
Query: 182 RPTAAEALE 190
R TA +
Sbjct: 321 RLTALRIKK 329
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP +V+L + E + +V ++ME L ++ G F+ + +C V +G+ Y
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAY 119
Query: 68 MHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ HRDL N LV VIK+ D GM + + Y ++ +W +P
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWA-SP 174
Query: 120 EVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
EV S D W+ G +M+E+ S +I + +++++ + I
Sbjct: 175 EVFSFSRYSSKS-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 42/171 (24%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+H +V+L + + +FI+ +YM + LL ++E + F + +C V + + Y
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEY 135
Query: 68 MHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ + + HRDL N LV+ +GV+K+ D G+ + + +Y ++ RW P
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PP 190
Query: 120 EVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
EVL+ S D WA G +M+E+ S ++ + +++ I
Sbjct: 191 EVLMYSKFSSKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 30/199 (15%), Positives = 73/199 (36%), Gaps = 29/199 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+H ++V + ++ +V ++++ L +K++ + + Q+ +H+
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHF 128
Query: 68 MHRQGYFHRDLKPSNLLVSK---------GVIKIGDLGMVKEIDSSLPCTDYVTT--RWY 116
+ H ++ N+L+ + IK+ D G+ + D + W
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWV 184
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIYGRW-------- 167
PE + + D+W+ G ++E+ S +S ++ R
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA 243
Query: 168 -VALISWLC-SWNPRMRPT 184
+A + C + P RP+
Sbjct: 244 ELANLINNCMDYEPDHRPS 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 34/209 (16%)
Query: 9 NHPNIVKL----RNLVKEHEDVFIVFDYMESDLLK-LMKESAGQNFSEDEARNLCFQVFQ 63
NHP IV + +IV +Y++ L+ ++ + A + Q
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQ 127
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-------TRW 115
L++ H+ G HRD+KP+N+++S +K+ D G+ + I S + VT T
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAVIGTAQ 184
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK----------IYG 165
Y +PE + D +++G +++E+L+ F G + Y+
Sbjct: 185 YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 166 RWV-----ALISWLCSWNPRMRPTAAEAL 189
+ A++ + NP R A +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPNI++L +V IV +YME+ L ++ GQ F+ + + V G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRY 166
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPE 120
+ GY HRDL N+LV S V K+ D G+ + ++ P Y TT RW APE
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWT-APE 224
Query: 121 VLL------LSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
+ S D W+ G +M+E+L++ + + D I +
Sbjct: 225 AIAFRTFSSAS-------DVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 25/170 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+H NI++L ++ +++ + I+ +YME+ L K ++E G+ FS + + + G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKY 162
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPE 120
+ Y HRDL N+LV S V K+ D G+ + ++ P Y T+ RW APE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWT-APE 220
Query: 121 VLL------LSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
+ S D W+ G +M+E++++ + ++ + + I
Sbjct: 221 AISYRKFTSAS-------DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-18
Identities = 40/171 (23%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP +VK + + ++IV +Y+ + LL ++ G+ + +C+ V +G+ +
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAF 119
Query: 68 MHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ + HRDL N LV +K+ D GM + + YV++ +W AP
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-AP 174
Query: 120 EVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
EV S D WA G +M+E+ S ++ + +++ + K+
Sbjct: 175 EVFHYFKYSSKS-------DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 26/199 (13%), Positives = 54/199 (27%), Gaps = 49/199 (24%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+ P + ++ ++V +V +++ L+ E A + S A +
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ---EVADTSPSPVGAIRAMQSLAAAADAA 145
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI 127
HR G PS + VS G + +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA------- 179
Query: 128 CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-------------GRWV-----A 169
P+ D +GA ++ +L R P + R + A
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 170 LISWLCSWNPRMRPTAAEA 188
+ + + +R +
Sbjct: 239 VAARSVQGDGGIRSASTLL 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 40/171 (23%), Positives = 71/171 (41%), Gaps = 30/171 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP+IVKL +++E E +I+ + +L ++ + Q+ + + Y
Sbjct: 71 DHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAY 128
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ HRD+ N+LV S +K+GD G+ + I+ DY +W +P
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWM-SP 183
Query: 120 EVLL------LSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
E + S D W M+E+LSF + F + D I +
Sbjct: 184 ESINFRRFTTAS-------DVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 33/182 (18%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
FL++ HPN+V+L + +I+ ++M +LL ++E Q S
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
+ Q+ + Y+ ++ + HRDL N LV ++K+ D G+ + + Y
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAG 171
Query: 114 -----RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIY 161
+W APE L S D WA G +++E+ ++ +PG + +
Sbjct: 172 AKFPIKWT-APESLAYNKFSIKS-------DVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223
Query: 162 KI 163
+
Sbjct: 224 LL 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 55/214 (25%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K H +VKL +V + E ++I+ ++M LL +K G + + Q+ +G
Sbjct: 238 KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 65 LHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 116
+ ++ ++ Y HRDL+ +N+LVS V KI D G+ + I+ + +Y +W
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKWT 352
Query: 117 RAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD----------- 158
APE + S D W+ G ++ E++++ RI +PG ++ +
Sbjct: 353 -APEAINFGSFTIKS-------DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 404
Query: 159 --------QIYKIYGRWVALISWLCSWNPRMRPT 184
++Y I + W P RPT
Sbjct: 405 PRPENCPEELYNI-----MMRCW--KNRPEERPT 431
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 30/171 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HP+IVKL ++ E V+I+ + +L ++ +Q+ L Y
Sbjct: 74 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 131
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ + + HRD+ N+LV S +K+GD G+ + ++ S Y +W AP
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWM-AP 186
Query: 120 EVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
E + S D W G M+E+L F G + D I +I
Sbjct: 187 ESINFRRFTSAS-------DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 42/185 (22%), Positives = 70/185 (37%), Gaps = 32/185 (17%)
Query: 2 IFLRKMNNHPNIVKL----RNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDE 53
++ H NI++ + D++++ + E SD LK S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNE 122
Query: 54 ARNLCFQVFQGLHYMH----------RQGYFHRDLKPSNLLVSK-GVIKIGDLGM--VKE 100
++ + +GL Y+H + HRD+K N+L+ I D G+ E
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 101 IDSSLPCTDYVT-TRWYRAPEVL----LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155
S T TR Y APEVL +D +AMG +++E+ S G
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 156 SADQI 160
+
Sbjct: 243 DEYML 247
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 60/222 (27%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
FL + N H +V+L +V + E ++I+ +YME+ L+ +K +G + ++ +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
+ Q+ +G+ ++ + Y HRDL+ +N+LVS KI D G+ + I+ +Y
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED----NEYTAREG 169
Query: 114 -----RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD--- 158
+W APE + S D W+ G ++ E+++ RI +PG + +
Sbjct: 170 AKFPIKWT-APEAINYGTFTIKS-------DVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221
Query: 159 ----------------QIYKIYGRWVALISWLCSWNPRMRPT 184
++Y++ + W P RPT
Sbjct: 222 NLERGYRMVRPDNCPEELYQL-----MRLCW--KERPEDRPT 256
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 36/182 (19%), Positives = 72/182 (39%), Gaps = 34/182 (18%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
L + ++P++ +L + V ++ M LL ++E N
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 121
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
C Q+ +G++Y+ + HRDL N+LV + +KI D G+ K + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEG 178
Query: 114 -----RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIY 161
+W A E +L S D W+ G ++E+++F + G +++
Sbjct: 179 GKVPIKWM-ALESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASEISS 230
Query: 162 KI 163
+
Sbjct: 231 IL 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+H N+++L +V + +V + LL +++ G F QV +G+ Y
Sbjct: 79 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 136
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ + + HRDL NLL+ ++ ++KIGD G+++ + + YV W AP
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC-AP 193
Query: 120 EVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
E L S D W G ++EM ++ + + G N + ++KI
Sbjct: 194 ESLKTRTFSHAS-------DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-17
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 3 FLRKMN-----NHPNIVKLRNLV-KEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEAR 55
FL + + H N+V+L ++ +E ++IV +YM L+ ++ D
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-----LPCTD 109
V + + Y+ + HRDL N+LVS V K+ D G+ KE S+ LP
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--- 177
Query: 110 YVTTRWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYK 162
+W APE L S D W+ G +++E+ SF R+ +P D + +
Sbjct: 178 ---VKWT-APEALREKKFSTKS-------DVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
Query: 163 I 163
+
Sbjct: 227 V 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-17
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 34/181 (18%)
Query: 3 FLRKMN-----NHPNIVKLRNLV-KEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEAR 55
FL + + H N+V+L ++ +E ++IV +YM L+ ++ D
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-----LPCTD 109
V + + Y+ + HRDL N+LVS V K+ D G+ KE S+ LP
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--- 349
Query: 110 YVTTRWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYK 162
+W APE L S D W+ G +++E+ SF R+ +P D + +
Sbjct: 350 ---VKWT-APEALREKKFSTKS-------DVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398
Query: 163 I 163
+
Sbjct: 399 V 399
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-17
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 28/171 (16%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
++P IV+L + + E + +V + L K + + L QV G+ Y
Sbjct: 68 DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKY 125
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAP 119
+ + + HRDL N+L+ ++ KI D G+ K + + Y +WY AP
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWY-AP 182
Query: 120 EVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
E + S D W+ G M+E LS+ + + + + I
Sbjct: 183 ECINFRKFSSRS-------DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 38/172 (22%), Positives = 74/172 (43%), Gaps = 31/172 (18%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
++P IV++ + + E +V + E L K +++ ++ + L QV G+ Y
Sbjct: 76 DNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKY 132
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRA 118
+ + HRDL N+L+ ++ KI D G+ K + + +Y +WY A
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWY-A 188
Query: 119 PEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
PE + S D W+ G +M+E S+ + + G ++ +
Sbjct: 189 PECINYYKFSSKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 23/176 (13%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
FL++ +HP+IVKL ++ E V+I+ + +L ++
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLIL 495
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
+Q+ L Y+ + + HRD+ N+LV S +K+GD G+ + ++ S Y
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASK 551
Query: 114 -----RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
+W APE + D W G M+E+L F G + D I +I
Sbjct: 552 GKLPIKWM-APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 43/177 (24%), Positives = 64/177 (36%), Gaps = 36/177 (20%)
Query: 2 IFLRKMNNHPNIVKL-----RNLVKEHEDVFIVFDYME--SDLLKLMKESAGQNFSEDEA 54
I+ + H NI + R + +V +Y S L K + +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS----LXKYLSLHTSDWVSS 113
Query: 55 RNLCFQVFQGLHYMHRQGYF---------HRDLKPSNLLV-SKGVIKIGDLGM------- 97
L V +GL Y+H + HRDL N+LV + G I D G+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 98 --VKEIDSSLPCTDYVTTRWYRAPEVL------LLSEICGPEVDRWAMGAIMFEMLS 146
V+ + V T Y APEVL E +VD +A+G I +E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKE--HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEA 54
F R++ H NIVK + + ++ ++ +Y+ L +++ + +
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKL 116
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
Q+ +G+ Y+ + Y HRDL N+LV ++ +KIGD G+ K + ++
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKV 173
Query: 114 --------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
WY APE L S D W+ G +++E+ ++
Sbjct: 174 KEPGESPIFWY-APESLTES-KFSVASDVWSFGVVLYELFTY 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 38/162 (23%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKE--HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEA 54
F R++ H NIVK + + ++ ++ +Y+ L +++ + +
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKL 147
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
Q+ +G+ Y+ + Y HRDL N+LV ++ +KIGD G+ K + +Y
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKV 204
Query: 114 --------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
WY APE L S D W+ G +++E+ ++
Sbjct: 205 KEPGESPIFWY-APESLTES-KFSVASDVWSFGVVLYELFTY 244
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 42/225 (18%)
Query: 3 FLR-----KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES-----AGQNFSE 51
FL NH NIV+ + + FI+ + M DL ++E+ + +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 52 DEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPC 107
+ ++ + G Y+ + HRD+ N L++ V KIGD GM ++I
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---- 195
Query: 108 TDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD 158
Y +W PE + I + D W+ G +++E+ S + +P K++ +
Sbjct: 196 ASYYRKGGCAMLPVKWM-PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 159 QIYKIYGRW-----------VALISWLC-SWNPRMRPTAAEALEH 191
+ + V I C P RP A LE
Sbjct: 254 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 30/172 (17%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
++P IV+L + + E + +V + L K + + L QV G+ Y
Sbjct: 394 DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKY 451
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRA 118
+ + + HR+L N+L+ ++ KI D G+ K + + Y T +WY A
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWY-A 507
Query: 119 PEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKI 163
PE + S D W+ G M+E LS+ + + + + I
Sbjct: 508 PECINFRKFSSRS-------DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 23/162 (14%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHED--VFIVFDYMES-DLLKLMKESAGQNFSEDEA 54
+++ H NIVK + + E + ++ +++ S L + + ++ + + +
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQ 128
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
Q+ +G+ Y+ + Y HRDL N+LV S+ +KIGD G+ K I++ +Y T
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTV 185
Query: 114 --------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
WY APE L+ S D W+ G + E+L++
Sbjct: 186 KDDRDSPVFWY-APECLMQS-KFYIASDVWSFGVTLHELLTY 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-16
Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 48/227 (21%)
Query: 3 FLR-----KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLL--------------KLMK 42
F R H +IVK + + + + +VF+YM+ DL
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 43 ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI 101
A + ++ Q+ G+ Y+ Q + HRDL N LV ++KIGD GM +++
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 102 DSSLPCTDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFP 152
S TDY RW PE ++ E D W+ G I++E+ ++ + +
Sbjct: 184 YS----TDYYRVGGHTMLPIRWM-PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 153 GKNSADQIYKIYGR-----------WVALISWLC-SWNPRMRPTAAE 187
++ + I I V + C P+ R E
Sbjct: 238 QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKE 284
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 8e-16
Identities = 41/182 (22%), Positives = 65/182 (35%), Gaps = 54/182 (29%)
Query: 28 IVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLV- 85
+VF+ + LLK + +S Q + + QV QGL Y+H + H D+KP N+L+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
Query: 86 -------------------------------------------------SKGVIKIGDLG 96
K +KI DLG
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241
Query: 97 MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156
+ T+ + TR YR+ EVL+ S D W+ + FE+ + LF +
Sbjct: 242 NACWVHK--HFTEDIQTRQYRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSG 298
Query: 157 AD 158
+
Sbjct: 299 EE 300
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 37/242 (15%), Positives = 62/242 (25%), Gaps = 76/242 (31%)
Query: 14 VKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGY 73
+K N++ + +I E+ + +
Sbjct: 173 IKPENILLSVNEQYIRRLAAEATEWQRSGA--------------PPPSGSAVSTAPATAG 218
Query: 74 FHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVD 133
K +KI DLG + T+ + TR YR+ EVL+ S D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGY-NTPAD 275
Query: 134 RWAMGAIMFEMLS----FRILFPGKNSAD-----QIYKIYG--------RW--------- 167
W+ + FE+ + F + + D I ++ G
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 168 ---------------------------------VALISWLCSWNPRMRPTAAEALEHPFF 194
+ + P R TAAE L HP+
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
Query: 195 RS 196
S
Sbjct: 396 NS 397
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-16
Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 35/168 (20%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKE--HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEA 54
F R++ + IVK R + + + +V +Y+ S L ++ +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRL 129
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT 113
Q+ +G+ Y+ + HRDL N+LV S+ +KI D G+ K + DY
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD---KDYYVV 186
Query: 114 --------RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF 147
WY APE L S D W+ G +++E+ ++
Sbjct: 187 REPGQSPIFWY-APESLSDNIFSRQS-------DVWSFGVVLYELFTY 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 42/225 (18%)
Query: 3 FLR-----KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES-----AGQNFSE 51
FL NH NIV+ + + FI+ + M DL ++E+ + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 52 DEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPC 107
+ ++ + G Y+ + HRD+ N L++ V KIGD GM ++I
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---- 236
Query: 108 TDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD 158
Y +W PE + I + D W+ G +++E+ S + +P K++ +
Sbjct: 237 AGYYRKGGCAMLPVKWM-PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 159 QIYKIYGRW-----------VALISWLC-SWNPRMRPTAAEALEH 191
+ + V I C P RP A LE
Sbjct: 295 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 45/229 (19%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
FL + + N ++V+L +V + + ++ + M DL ++ +
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 57 L--------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC 107
++ G+ Y++ + HRDL N +V++ +KIGD GM ++I
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE---- 190
Query: 108 TDYVTTRWYR------------APEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGK 154
TDY YR +PE L + D W+ G +++E+ + + G
Sbjct: 191 TDY-----YRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 155 NSADQIYKIY--GRW---------VALISWLC-SWNPRMRPTAAEALEH 191
++ + + G + + +C +NP+MRP+ E +
Sbjct: 245 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 35/182 (19%), Positives = 69/182 (37%), Gaps = 34/182 (18%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
M +H +IV+L L + +V Y+ LL +++ G N
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLN 119
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
Q+ +G++Y+ G HR+L N+L+ S +++ D G+ + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSE 176
Query: 114 -----RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIY 161
+W A E + S D W+ G ++E+++F + G A+
Sbjct: 177 AKTPIKWM-ALESIHFGKYTHQS-------DVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
Query: 162 KI 163
+
Sbjct: 229 LL 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 55/230 (23%), Positives = 89/230 (38%), Gaps = 47/230 (20%)
Query: 3 FLR-----KMNNHPNIVKLRNLVKEHEDVFIVFDYME--------------SDLLKLMKE 43
F R M H +IV+ + E + +VF+YM + LL ++
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 44 SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEID 102
A + + QV G+ Y+ + HRDL N LV +G V+KIGD GM ++I
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 103 SSLPCTDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPG 153
S TDY RW PE +L E D W+ G +++E+ ++ + +
Sbjct: 210 S----TDYYRVGGRTMLPIRWM-PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 154 KNSADQIYKIYGR-----------WVALISWLC-SWNPRMRPTAAEALEH 191
++ + I I V I C P+ R + +
Sbjct: 264 LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 36/182 (19%), Positives = 72/182 (39%), Gaps = 34/182 (18%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
L + ++P++ +L + V ++ M LL ++E N
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 121
Query: 57 LCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-- 113
C Q+ +G++Y+ + HRDL N+LV + +KI D G+ K + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEG 178
Query: 114 -----RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIY 161
+W A E +L S D W+ G ++E+++F + G +++
Sbjct: 179 GKVPIKWM-ALESILHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASEISS 230
Query: 162 KI 163
+
Sbjct: 231 IL 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 25/162 (15%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEH--EDVFIVFDYMES-DLLKLMKESAGQNFSEDEA 54
+ ++++ H +I+K + ++ + +V +Y+ L + + +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQL 136
Query: 55 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT 113
Q+ +G+ Y+H Q Y HRDL N+L+ ++KIGD G+ K + +Y
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRV 193
Query: 114 --------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
WY APE L D W+ G ++E+L+
Sbjct: 194 REDGDSPVFWY-APECLKEY-KFYYASDVWSFGVTLYELLTH 233
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 49/230 (21%), Positives = 86/230 (37%), Gaps = 60/230 (26%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
F + HPN+V L +V + + + ++F Y DL + + + + +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 57 L--------------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI 101
Q+ G+ Y+ H+DL N+LV +KI DLG+ +E+
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 102 DSSLPCTDYVTT--------RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF 147
+ DY RW APE ++ S D W+ G +++E+ S+
Sbjct: 179 YA----ADYYKLLGNSLLPIRWM-APEAIMYGKFSIDS-------DIWSYGVVLWEVFSY 226
Query: 148 -RILFPGKNSADQIYKIYGR-----------WVALISWLC-SWNPRMRPT 184
+ G ++ D + I R WV + C + P RP
Sbjct: 227 GLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPR 276
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 35/184 (19%), Positives = 74/184 (40%), Gaps = 34/184 (18%)
Query: 3 FLR-----KMNNHPNIVKLRNLVKEHED-VFIVFDYMES-DLLKLMKESAGQNFSEDEAR 55
FL K +HPN++ L + E +V YM+ DL ++ + +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 195
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT- 113
QV +G+ ++ + + HRDL N ++ + +K+ D G+ +++ + + T
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 114 -----RWYRAPEVLLLSEICGPEVDR--------WAMGAIMFEMLSF-RILFPGKNSADQ 159
+W A E L + W+ G +++E+++ +P N+ D
Sbjct: 256 AKLPVKWM-ALESLQ---------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305
Query: 160 IYKI 163
+
Sbjct: 306 TVYL 309
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 45/223 (20%), Positives = 87/223 (39%), Gaps = 58/223 (26%)
Query: 3 FLRKMN-----NHPNIVKLRNLV-KEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEAR 55
FLR+ NHPN++ L ++ ++ YM DLL+ ++ +N + +
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLI 127
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT- 113
+ QV +G+ Y+ Q + HRDL N ++ + +K+ D G+ ++I +
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 114 -----RWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD--- 158
+W A E L S D W+ G +++E+L+ + + D
Sbjct: 188 ARLPVKWT-ALESLQTYRFTTKS-------DVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 159 ----------------QIYKIYGR-WVALISWLCSWNPRMRPT 184
+Y++ + W +P +RPT
Sbjct: 240 FLAQGRRLPQPEYCPDSLYQVMQQCW--------EADPAVRPT 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 51/232 (21%), Positives = 84/232 (36%), Gaps = 56/232 (24%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLL--------KLMKESAGQNFSE 51
+ L + NH NIV L ++ +Y DLL + E
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 52 DEARNL--------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEID 102
D+ L +QV +G+ ++ + HRDL N+L++ G + KI D G+ ++I
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 103 SSLPCTDY--VTT------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPG 153
+ V +W APE + + E D W+ G ++E+ S +PG
Sbjct: 197 N----DSNYVVKGNARLPVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 154 KNSADQIYK-----------------IYGRWVALISWLC-SWNPRMRPTAAE 187
+ YK +Y I C +P RPT +
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----IMKTCWDADPLKRPTFKQ 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 37/184 (20%), Positives = 75/184 (40%), Gaps = 34/184 (18%)
Query: 3 FLR-----KMNNHPNIVKLRNLVKEHED-VFIVFDYMES-DLLKLMKESAGQNFSEDEAR 55
FL K +HPN++ L + E +V YM+ DL ++ N + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLI 131
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT- 113
QV +G+ Y+ + + HRDL N ++ + +K+ D G+ +++ + + T
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 114 -----RWYRAPEVLLLSEICGPEVDR--------WAMGAIMFEMLSF-RILFPGKNSADQ 159
+W A E L + W+ G +++E+++ +P N+ D
Sbjct: 192 AKLPVKWM-ALESLQ---------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241
Query: 160 IYKI 163
+
Sbjct: 242 TVYL 245
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 45/231 (19%), Positives = 88/231 (38%), Gaps = 60/231 (25%)
Query: 3 FLRKMN-----NHPNIVKL------RNLVKEHEDVFIVFDYMES-DLLK-LMKESAGQNF 49
FLR+ +HP++ KL ++ +M+ DL L+ G+N
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 50 SEDEARNL---CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSL 105
+ L + G+ Y+ + + HRDL N ++++ + + D G+ ++I S
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG- 190
Query: 106 PCTDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNS 156
DY +W A E L + + D WA G M+E+++ + + G +
Sbjct: 191 ---DYYRQGCASKLPVKWL-ALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 157 A-------------------DQIYKIYGR-WVALISWLCSWNPRMRPTAAE 187
A +++Y + + W S +P+ RP+
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEEVYDLMYQCW--------SADPKQRPSFTC 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-13
Identities = 44/234 (18%), Positives = 82/234 (35%), Gaps = 59/234 (25%)
Query: 3 FLRKMN-----NHPNIVKL-----RNLVKEHEDVFIVFDYME-----SDLLKLMKESAGQ 47
FL + +HPN+++L + ++ +M+ + LL E+ +
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142
Query: 48 NFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLP 106
+ + G+ Y+ + + HRDL N ++ + + D G+ K+I S
Sbjct: 143 HIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS--- 199
Query: 107 CTDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSA 157
DY +W A E L + + D WA G M+E+ + +PG +
Sbjct: 200 -GDYYRQGRIAKMPVKWI-AIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256
Query: 158 -------------------DQIYKIYGR-WVALISWLCSWNPRMRPTAAEALEH 191
D++Y+I W +P RPT +
Sbjct: 257 EMYDYLLHGHRLKQPEDCLDELYEIMYSCW--------RTDPLDRPTFSVLRLQ 302
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 50/228 (21%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNL----- 57
+ + H NIV L V ++ +Y DLL ++ + ++
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 58 -------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTD 109
QV QG+ ++ + HRD+ N+L++ G V KIGD G+ ++I + ++
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SN 219
Query: 110 YVTT-------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIY 161
Y+ +W APE + + + D W+ G +++E+ S +PG + Y
Sbjct: 220 YIVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 162 K-----------------IYGRWVALISWLC-SWNPRMRPTAAEALEH 191
K IY I C + P RPT +
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYS-----IMQACWALEPTHRPTFQQICSF 320
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 46/228 (20%), Positives = 88/228 (38%), Gaps = 57/228 (25%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNL----- 57
++ + H NI+ L + ++++ +Y +L + ++ N
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 58 ---------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC 107
+Q+ +G+ Y+ Q HRDL N+LV++ V+KI D G+ ++I++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN---- 255
Query: 108 TDY--VTT------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSA- 157
DY TT +W APE L + + D W+ G +M+E+ + +PG
Sbjct: 256 IDYYKKTTNGRLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 158 ------------------DQIYKIYGRWVALISWLCSWNPRMRPTAAE 187
+++Y + W P RPT +
Sbjct: 314 LFKLLKEGHRMDKPANCTNELYMM-----MRDCW--HAVPSQRPTFKQ 354
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 47/227 (20%), Positives = 91/227 (40%), Gaps = 55/227 (24%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNL----- 57
++ + H NI+ L + ++++ +Y +L + ++ N
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 58 ---------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC 107
+Q+ +G+ Y+ Q HRDL N+LV++ V+KI D G+ ++I++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN---- 209
Query: 108 TDY--VTT------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSAD 158
DY TT +W APE L + + D W+ G +M+E+ + +PG +
Sbjct: 210 IDYYKKTTNGRLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 266
Query: 159 QIYK-----------------IYGRWVALISWLC-SWNPRMRPTAAE 187
+++K +Y + C P RPT +
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYM-----MMRDCWHAVPSQRPTFKQ 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 46/229 (20%), Positives = 87/229 (37%), Gaps = 59/229 (25%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES------AGQNFSEDEARN 56
++ + H NI+ L + ++++ +Y +L + ++ N S +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 57 L--------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC 107
L +QV +G+ Y+ + HRDL N+LV++ V+KI D G+ ++I
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH---- 243
Query: 108 TDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSA- 157
DY +W APE L I + D W+ G +++E+ + +PG
Sbjct: 244 IDYYKKTTNGRLPVKWM-APEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 158 ------------------DQIYKIYGR-WVALISWLCSWNPRMRPTAAE 187
+++Y + W P RPT +
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCW--------HAVPSQRPTFKQ 342
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 53/229 (23%), Positives = 87/229 (37%), Gaps = 51/229 (22%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNL----- 57
L ++PNIVKL + + + ++F+YM DL + ++ + +L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 58 -----------------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVK 99
QV G+ Y+ + + HRDL N LV + V+KI D G+ +
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 100 EIDSSLPCTDY--VTT------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RIL 150
I S DY RW PE + + E D WA G +++E+ S+
Sbjct: 223 NIYS----ADYYKADGNDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 151 FPGKNSADQIYKIYGR-----------WVALISWLC-SWNPRMRPTAAE 187
+ G + IY + + + LC S P RP+
Sbjct: 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 43/228 (18%), Positives = 83/228 (36%), Gaps = 55/228 (24%)
Query: 4 LRKMNNHPNIVKLRNLV-KEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNL---- 57
L + +H N+V L K + ++ ++ + +L ++ + A
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 58 ----------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLP 106
FQV +G+ ++ + HRDL N+L+S+ V+KI D G+ ++I
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--- 200
Query: 107 CTDYVTT--------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSA 157
+W APE + + + D W+ G +++E+ S +PG
Sbjct: 201 -DPDYVRKGDARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 158 DQIYK-----------------IYGRWVALISWLC-SWNPRMRPTAAE 187
++ + +Y C P RPT +E
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQ-----TMLDCWHGEPSQRPTFSE 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 31/167 (18%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNL----- 57
L K+ +HPNI+ L + +++ +Y +LL +++S A
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 58 ---------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC 107
V +G+ Y+ ++ + HRDL N+LV + V KI D G+ + +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----- 193
Query: 108 TDYVTT-------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147
YV RW A E L S + D W+ G +++E++S
Sbjct: 194 -VYVKKTMGRLPVRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 237
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 61/234 (26%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLL-------------KLMKESAGQNF 49
+ ++ +H NIV L ++++F+Y DLL ++ E+ +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 50 SEDEARNL--------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKE 100
E++ L +QV +G+ ++ + HRDL N+LV+ G V+KI D G+ ++
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 101 IDSSLPCTDY--VTT------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILF 151
I S V +W APE L I + D W+ G +++E+ S +
Sbjct: 222 IMS----DSNYVVRGNARLPVKWM-APESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 152 PGKNSADQIYK-----------------IYGRWVALISWLC-SWNPRMRPTAAE 187
PG YK IY I C +++ R RP+
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYI-----IMQSCWAFDSRKRPSFPN 324
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 46/243 (18%), Positives = 89/243 (36%), Gaps = 72/243 (29%)
Query: 3 FLRKMN-----NHPNIVKLRNLVKEHEDVFIVFDYME---------------SDLLKLMK 42
L + N NHP+++KL + + ++ +Y + L
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 43 ESAGQNFSEDEARNL--------CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIG 93
+ + R L +Q+ QG+ Y+ HRDL N+LV++G +KI
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 94 DLGMVKEIDSSLPCTDY--VTT------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145
D G+ +++ D + +W A E L I + D W+ G +++E++
Sbjct: 193 DFGLSRDVYE----EDSYVKRSQGRIPVKWM-AIESLFDH-IYTTQSDVWSFGVLLWEIV 246
Query: 146 SF-RILFPG-------------------KNSADQIYKIYGR-WVALISWLCSWNPRMRPT 184
+ +PG N ++++Y++ + W P RP
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCW--------KQEPDKRPV 298
Query: 185 AAE 187
A+
Sbjct: 299 FAD 301
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 13/77 (16%), Positives = 26/77 (33%), Gaps = 3/77 (3%)
Query: 27 FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86
F+V + L + S SE + ++ L ++H Y H ++ N+ V
Sbjct: 134 FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193
Query: 87 KG---VIKIGDLGMVKE 100
+ + G
Sbjct: 194 PEDQSQVTLAGYGFAFR 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 4/77 (5%)
Query: 27 FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86
F++ D SDL K+ + + + FS L ++ L Y+H Y H D+K SNLL++
Sbjct: 128 FMIMDRFGSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186
Query: 87 KG---VIKIGDLGMVKE 100
+ + D G+
Sbjct: 187 YKNPDQVYLVDYGLAYR 203
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 57/228 (25%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLK--LMKESAGQNFSEDEAR-NLCFQVFQGLH 66
HP++V L E ++ +++ YME+ LK L E R +C +GLH
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 67 YMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD--YVTTRW-----YRA 118
Y+H + HRD+K N LL V KI D G+ K D +++T Y
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISK----KGTELDQTHLSTVVKGTLGYID 209
Query: 119 PE-----------------VLLLSEICG-PEVDR-----------WAMGAIMFEMLSFRI 149
PE V+L +C + + WA+ + L +I
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE-QI 268
Query: 150 LFP---GKNSADQIYKIYGRWVALISWLC-SWNPRMRPTAAE---ALE 190
+ P K + + K + C + + RP+ + LE
Sbjct: 269 VDPNLADKIRPESLRK-----FGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 5/77 (6%)
Query: 27 FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86
F+V + + DL K+ ++ F + L ++ L Y+H Y H D+K +NLL+
Sbjct: 128 FMVMERLGIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG 185
Query: 87 KG---VIKIGDLGMVKE 100
+ + D G+
Sbjct: 186 YKNPDQVYLADYGLSYR 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
R + I +R E + +V D + L L + S L Q+
Sbjct: 55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMI 113
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKE 100
+ ++H + + HRD+KP N L+ G + I D G+ K+
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 49/227 (21%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNL--- 57
+ P +K R ++E L ++E + L
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 58 ---CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT 113
FQV +G+ ++ + HRDL N+L+S+ V+KI D G+ ++I DYV
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRK 252
Query: 114 -------RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPG------------ 153
+W APE + + + D W+ G +++E+ S +PG
Sbjct: 253 GDARLPLKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310
Query: 154 --------KNSADQIYKIYGR-WVALISWLCSWNPRMRPTAAEALEH 191
+ ++Y+ W P RPT +E +EH
Sbjct: 311 EGTRMRAPDYTTPEMYQTMLDCW--------HGEPSQRPTFSELVEH 349
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 5/102 (4%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
+ M I +R E + +V + + L L + FS L Q+
Sbjct: 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMI 115
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKE 100
+ Y+H + + HRD+KP N L+ G ++ I D G+ K+
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 22/104 (21%), Positives = 43/104 (41%), Gaps = 7/104 (6%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
F +++ + I ++ + +V + + L L + FS + Q+
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLC-DRTFSLKTVLMIAIQLI 115
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKG------VIKIGDLGMVKE 100
+ Y+H + +RD+KP N L+ + VI I D + KE
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 5e-07
Identities = 46/329 (13%), Positives = 94/329 (28%), Gaps = 93/329 (28%)
Query: 4 LRKMNNHPNIV--------K-------LRNLVKEHEDVFIVFDYM-------ESDLLKLM 41
L ++ N++ K + + + F +F ++ +L+++
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEML 202
Query: 42 KESAGQNFSEDEARNLCFQVFQGLHYMHR--------QGYFHRDLKPSNLLV-----SKG 88
Q N + + R + + LLV +
Sbjct: 203 -----QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 89 VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFR 148
+L C +TTR+ + + L + +D +M E+ S
Sbjct: 258 AWNAFNLS----------CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 149 ILFPGKNSAD---QIYKIYGRWVALIS-----WLCSWNP----------RMRPTAAEALE 190
+ + D ++ R +++I+ L +W+ + ++ LE
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 191 HPFFRSCH-----FVPRSVP----LLC---NNFEAVAFPTATVTMQGRSL--------TY 230
+R F P S LL + + SL T
Sbjct: 368 PAEYRKMFDRLSVF-PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 231 SQVPNDGQLCSCVKCEMQRTNHDHMIINS 259
S +P L VK E + H I++
Sbjct: 427 S-IP-SIYLELKVKLENEYALHR-SIVDH 452
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 7/104 (6%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
+ + I + +E +V D + L L+ G+ FS Q+
Sbjct: 58 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQML 116
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSKG------VIKIGDLGMVKE 100
+ +H + +RD+KP N L+ + +I + D GMVK
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 1e-05
Identities = 14/63 (22%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 26 VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLL 84
+FIV ++ +++ + S A+++ Q+ L + HRDL N+L
Sbjct: 137 LFIVLEFE--FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 85 VSK 87
+ K
Sbjct: 195 LKK 197
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 44/232 (18%), Positives = 72/232 (31%), Gaps = 67/232 (28%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYME----SDLLKLMKESAGQNFSEDEARNL-------- 57
H N+V+L + +D+ +V+ YM D L D L
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL----------SCLDGTPPLSWHMRCKI 138
Query: 58 CFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRW- 115
G++++H + HRD+K +N LL KI D G+ + + +T+R
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF--AQTVMTSRIV 196
Query: 116 ----YRAPE----------------VLLLSEICG-PEVDR---------WAMGAIMFEML 145
Y APE V+LL I G P VD E
Sbjct: 197 GTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256
Query: 146 SFRILFP--GKNSADQIYKIYGRWVALISWLC-SWNPRMRPTAAE---ALEH 191
+ + + + ++ C RP + L+
Sbjct: 257 IEDYIDKKMNDADSTSVEA-----MYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 15/123 (12%)
Query: 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLK--LMKESAGQNFSEDEAR-NLCFQVFQGLH 66
H N+++LR + +V+ YM + + L + Q + R + +GL
Sbjct: 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 67 YMHRQGY---FHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVTTRW-----YR 117
Y+H HRD+K +N+L+ + +GD G+ K +D +VTT +
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK---DTHVTTAVRGTIGHI 202
Query: 118 APE 120
APE
Sbjct: 203 APE 205
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.68 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.47 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.57 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.44 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.85 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.31 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.88 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 91.04 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 87.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 86.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 84.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.27 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=384.80 Aligned_cols=190 Identities=29% Similarity=0.508 Sum_probs=160.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++++++.+|+|||||+|++++.+.++ +.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL 144 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL 144 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence 3445999999999999999999999999988998888765 56999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+++ +.+||+|||+|+.........+.+||+.|||||++.+..+++.++||||+||++|+|++|+.||.+.+..+...++
T Consensus 145 l~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i 224 (275)
T 3hyh_A 145 LDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 224 (275)
T ss_dssp ECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 985 7999999999998777666678899999999999987777788999999999999999999999988776666655
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. .++++||++||+.||++|||++|+++||||+.
T Consensus 225 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 225 SNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 4 36899999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=390.95 Aligned_cols=191 Identities=26% Similarity=0.503 Sum_probs=169.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||+++++|++++.+|||||||+|+.+..++.+ +.++|.+++.|+.||+.||+|||++||+||||||+||
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 201 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 201 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 34445999999999999999999999999998777666665 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ |.+||+|||+|+.+... ....+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 202 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 280 (346)
T 4fih_A 202 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 280 (346)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 9984 89999999999987543 445678999999999998654 56999999999999999999999999988777776
Q ss_pred HHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.|. .++++||.+||+.||++|||++|+|+||||+..
T Consensus 281 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 281 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 654 368999999999999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=386.83 Aligned_cols=193 Identities=28% Similarity=0.457 Sum_probs=170.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++.++|||||+++++|++++.+|||||||.| +|.+.+... +.++|.+++.|+.||+.||+|||++||+||||||+||
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNI 163 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 163 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 4455999999999999999999999999997 555555544 4699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC---CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|+++ +.+||+|||+|+.+.. .....+.+||+.|||||++.+. .|+.++||||+||++|+|++|+.||.+.+..+.
T Consensus 164 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 242 (311)
T 4aw0_A 164 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242 (311)
T ss_dssp EECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9985 8999999999998743 2345678999999999998754 569999999999999999999999999888777
Q ss_pred HHHHHH-----------HHHHHHHHhhhcCCCCCCCHHH------HHcCCCCCCCCCC
Q 040202 160 IYKIYG-----------RWVALISWLCSWNPRMRPTAAE------ALEHPFFRSCHFV 200 (297)
Q Consensus 160 ~~~i~~-----------~~~~li~~~l~~dP~~R~t~~~------ll~h~~f~~~~~~ 200 (297)
..+|.. ++++||.+||+.||++|+|++| +++||||++++|.
T Consensus 243 ~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 243 FAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 777653 6899999999999999999987 6899999998874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=379.91 Aligned_cols=193 Identities=29% Similarity=0.480 Sum_probs=168.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+++.++|||||++++++++++.+|||||||+| +|.+.+... +.++|.+++.++.||+.||+|||++||+||||||+|
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 34455999999999999999999999999997 555555544 469999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
||+++ |.+||+|||+|+.... .....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+..
T Consensus 157 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 235 (304)
T 3ubd_A 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235 (304)
T ss_dssp EEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH
Confidence 99985 8999999999987543 3445678999999999998754 5689999999999999999999999998888777
Q ss_pred HHHH-----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 161 YKIY-----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 161 ~~i~-----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
.+|. .++++||++||+.||++|+| ++|+++||||++++|
T Consensus 236 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 236 TMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 7764 37899999999999999998 579999999998776
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=392.99 Aligned_cols=191 Identities=26% Similarity=0.503 Sum_probs=170.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||+++++|.+++.+|||||||+||.|..++.. +.++|.+++.|+.||+.||+|||++||+||||||+||
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NI 278 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 278 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTE
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence 34455999999999999999999999999998777667665 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++. |.+||+|||+|+.+... ....+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 279 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 357 (423)
T 4fie_A 279 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 357 (423)
T ss_dssp EECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 9984 89999999999887543 445678999999999998654 56999999999999999999999999988877776
Q ss_pred HHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.|. .++++||.+||+.||++|+|++|+|+||||+..
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 664 368999999999999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=386.09 Aligned_cols=191 Identities=29% Similarity=0.556 Sum_probs=168.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++.++|||||++++++++++.+|||||||+| +|.+.+..+.+..++|..++.|+.||+.||+|||++||+||||||+||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 3445999999999999999999999999987 566666655555689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ |.+||+|||+|+...... ...+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 157 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 235 (350)
T 4b9d_A 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235 (350)
T ss_dssp EECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 9985 899999999998765432 23467899999999998754 56899999999999999999999999988888777
Q ss_pred HHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIYG------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++.. ++++||.+||+.||++|||++|+|+||||+.
T Consensus 236 ~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 236 KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 7653 6899999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=370.63 Aligned_cols=188 Identities=28% Similarity=0.401 Sum_probs=159.8
Q ss_pred cccccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdi 78 (297)
++.++|||||+++++|++ ++.+|||||||+|+.|..++.+. +.+++..++.|+.||+.||+|||++| |+||||
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDl 157 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEeccc
Confidence 444599999999999975 35789999999985555544442 46999999999999999999999999 999999
Q ss_pred CCCcEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 79 KPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 79 kp~Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
||+|||++ ++.+||+|||+|+.... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+.
T Consensus 158 Kp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 158 KCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred ChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 99999997 37999999999986543 34467899999999998753 379999999999999999999999988776
Q ss_pred HHHHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 157 ADQIYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 157 ~~~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...+.+.. .++++||.+||..||++|||++|+|+||||++
T Consensus 235 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 65544322 36899999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=369.65 Aligned_cols=192 Identities=25% Similarity=0.262 Sum_probs=161.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||++++++++++.+|||||||+|+.|..++.+. +.+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 181 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGE
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence 344559999999999999999999999999975554444443 4699999999999999999999999999999999999
Q ss_pred EEeC-C-eEEEEecCCceecCCCC------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 84 LVSK-G-VIKIGDLGMVKEIDSSL------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 84 ll~~-~-~~kl~Dfgla~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|++. | .+||+|||+|+...... .....+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+
T Consensus 182 Ll~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp EECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred EEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9985 5 69999999998765432 12346899999999998754 56899999999999999999999999877
Q ss_pred CHHHHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHH-------------HcCCCCCCC
Q 040202 156 SADQIYKIY--------------GRWVALISWLCSWNPRMRPTAAEA-------------LEHPFFRSC 197 (297)
Q Consensus 156 ~~~~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~l-------------l~h~~f~~~ 197 (297)
..+...+|. ..+.+||.+||+.||++|||+.|+ ++|||+...
T Consensus 261 ~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 665555543 368899999999999999999997 579998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=373.54 Aligned_cols=191 Identities=28% Similarity=0.440 Sum_probs=159.5
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+|+++.+|||||+++++|++++++|+|||||+|+.+..+.. .+++.+++.+++||+.||+|||++||+||||||+|
T Consensus 72 ~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeN 147 (361)
T 4f9c_A 72 CLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSN 147 (361)
T ss_dssp HHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHH
Confidence 45566689999999999999999999999999755444442 49999999999999999999999999999999999
Q ss_pred EEEeC--CeEEEEecCCceecCCC-----------------------------CCCccccccCCCCCCceecccccCCCc
Q 040202 83 LLVSK--GVIKIGDLGMVKEIDSS-----------------------------LPCTDYVTTRWYRAPEVLLLSEICGPE 131 (297)
Q Consensus 83 ill~~--~~~kl~Dfgla~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 131 (297)
||++. +.+||+|||+|+..... ....+.+||++|||||++.+...|+.+
T Consensus 148 iLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~ 227 (361)
T 4f9c_A 148 FLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227 (361)
T ss_dssp EEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTH
T ss_pred eEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCc
Confidence 99984 69999999999765332 123456899999999998877778999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCC-CHHHHHHH-----------------------------------------------
Q 040202 132 VDRWAMGAIMFEMLSFRILFPGKN-SADQIYKI----------------------------------------------- 163 (297)
Q Consensus 132 ~DiwSlGv~l~ell~g~~pf~~~~-~~~~~~~i----------------------------------------------- 163 (297)
+||||+||++|||++|+.||.+.+ ..+++.+|
T Consensus 228 ~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~ 307 (361)
T 4f9c_A 228 IDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPK 307 (361)
T ss_dssp HHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------
T ss_pred cchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccc
Confidence 999999999999999999995543 33333222
Q ss_pred ------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 164 ------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 164 ------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+.++++||++||+.||++|+|++|+|+||||+++
T Consensus 308 ~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 308 LTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp --------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1256789999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=379.08 Aligned_cols=192 Identities=40% Similarity=0.713 Sum_probs=168.2
Q ss_pred cccccccceeeeceeEEe------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKE------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
++.++|||||++++++.. .+.+|||||||+|++++.+... +.+++..++.|++||+.||+|||++||+||||
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDl 184 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDL 184 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCc
Confidence 444599999999999864 3689999999999988777654 56999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCC-----CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDS-----SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
||+|||++. +.+||+|||+|+.+.. .....+.+||+.|||||++.+..+|+.++||||+||++|||++|+.||.
T Consensus 185 KP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 185 KPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 999999985 8999999999987533 2344678999999999998877788999999999999999999999999
Q ss_pred CCCCHHHHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 153 GKNSADQIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 153 ~~~~~~~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+.+..+++.+|. .++++||.+||+.||++|+|++|+|+
T Consensus 265 g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 265 GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 998887776653 25688999999999999999999999
Q ss_pred CCCCCCCC
Q 040202 191 HPFFRSCH 198 (297)
Q Consensus 191 h~~f~~~~ 198 (297)
||||+..+
T Consensus 345 Hp~f~~~~ 352 (398)
T 4b99_A 345 HPFLAKYH 352 (398)
T ss_dssp SGGGTTTC
T ss_pred CHhhCcCC
Confidence 99998654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.15 Aligned_cols=193 Identities=26% Similarity=0.377 Sum_probs=166.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.+.++|||||+++++|++.+.+|||||||.|| |.+.+... +.|+|..++.|++||+.||+|||++||+||||||+|
T Consensus 245 ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeN 322 (689)
T 3v5w_A 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322 (689)
T ss_dssp HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred HHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHH
Confidence 334559999999999999999999999999974 55555444 469999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH---H
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA---D 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~---~ 158 (297)
||+++ |.+||+|||+|+...... ..+.+||+.|||||++..+..|+.++|||||||++|||++|+.||.+.+.. +
T Consensus 323 ILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 323 ILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp EEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred eEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99985 899999999999876544 367899999999999876667899999999999999999999999765432 2
Q ss_pred HHHHH-----------HHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 159 QIYKI-----------YGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 159 ~~~~i-----------~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
....+ +.++++||.+||+.||++|++ ++|+++||||++++|
T Consensus 402 i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 402 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 22222 237899999999999999998 799999999999887
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=346.58 Aligned_cols=191 Identities=26% Similarity=0.424 Sum_probs=144.7
Q ss_pred cccccccceeeeceeEEeCC------------eEEEEEecCCCcHHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH
Q 040202 5 RKMNNHPNIVKLRNLVKEHE------------DVFIVFDYMESDLLKLMKESAGQ--NFSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~------------~~~lv~e~~~g~ll~~~~~~~~~--~l~e~~~~~~~~qll~al~yLH~ 70 (297)
++.++|||||+++++|.+.+ .+|+|||||.|+.+..+....+. ..++..++.++.||+.||+|||+
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence 34459999999999997654 47999999998665555544221 24567799999999999999999
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC-------------CCccccccCCCCCCceecccccCCCccchhh
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWA 136 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 136 (297)
+||+||||||+|||++. +.+||+|||+|+...... ...+.+||+.|||||++.+. .|+.++||||
T Consensus 137 ~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwS 215 (299)
T 4g31_A 137 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFS 215 (299)
T ss_dssp TTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHH
T ss_pred CcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHH
Confidence 99999999999999985 899999999998765432 22456899999999998754 5699999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCH-HHHHH------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 137 MGAIMFEMLSFRILFPGKNSA-DQIYK------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 137 lGv~l~ell~g~~pf~~~~~~-~~~~~------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
|||++|||++ ||.+.... ..... ......+||++||+.||++|||+.|+++||||++.++
T Consensus 216 lGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 216 LGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 9999999996 77543221 11111 1234678999999999999999999999999998665
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=343.79 Aligned_cols=184 Identities=21% Similarity=0.328 Sum_probs=151.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||+++|++.+ +.+|||||||+|+.|..++...+..+++.++..|+.|++.||+|||++||+||||||+|||
T Consensus 86 l~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NIL 164 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIF 164 (307)
T ss_dssp HTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEE
T ss_pred HHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEE
Confidence 344599999999998865 5689999999986665555544567999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC---CCCCccccccCCCCCCceeccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+|+.... .....+.+||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+.+...
T Consensus 165 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~ 244 (307)
T 3omv_A 165 LHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244 (307)
T ss_dssp EETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred ECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence 986 6899999999987543 2234567899999999998643 347889999999999999999999999877766
Q ss_pred HHHHHH-----------------HHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 159 QIYKIY-----------------GRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 159 ~~~~i~-----------------~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
....+. ..+.+|+.+||+.||++|||+.+++
T Consensus 245 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 554332 3678999999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=375.80 Aligned_cols=195 Identities=27% Similarity=0.444 Sum_probs=172.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+++.++|||||+++++|++++.+|||||||.| +|++++..+ .+.|+|.+++.|++||+.||+|||++||+||||||+|
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N 285 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 34456999999999999999999999999987 555555443 3569999999999999999999999999999999999
Q ss_pred EEEeC---CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 83 LLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 83 ill~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
||++. +.+||+|||+|+.+.......+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+.
T Consensus 286 ill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~ 364 (573)
T 3uto_A 286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364 (573)
T ss_dssp EEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 99963 68999999999998877777788999999999998754 468999999999999999999999999888877
Q ss_pred HHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCC
Q 040202 160 IYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 160 ~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~ 200 (297)
+.+|. .++++||++||+.||++|||+.|+|+||||+...+.
T Consensus 365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 77664 368999999999999999999999999999876553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=340.61 Aligned_cols=186 Identities=24% Similarity=0.355 Sum_probs=152.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA--------------GQNFSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yLH~ 70 (297)
++.++|||||+++|++.+++.+|||||||+|+.|..++.+. ...+++.++..|+.|++.||+|||+
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 34459999999999999999999999999986555554332 2359999999999999999999999
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
++|+||||||+|||+++ +.+||+|||+|+..... ......+||+.|||||++.+. .|+.++|||||||++|||+|
T Consensus 177 ~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp TTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHT
T ss_pred CCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHc
Confidence 99999999999999986 79999999999876433 223456799999999998754 46899999999999999999
Q ss_pred -CCCCCCCCCCHHHHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 -FRILFPGKNSADQIYKIYG------------RWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|+.||.+.+..+....+.. ++.+|+.+||+.||++|||+.|++++
T Consensus 256 ~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 256 YGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8999999887777666543 68999999999999999999998763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=338.35 Aligned_cols=188 Identities=22% Similarity=0.363 Sum_probs=158.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA------------GQNFSEDEARNLCFQVFQGLHYMHRQG 72 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~------------~~~l~e~~~~~~~~qll~al~yLH~~g 72 (297)
++.++|||||+++|++.+++.+|||||||+||.|..++... ...+++.++..++.|++.||+|||+++
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34459999999999999999999999999975555444332 246999999999999999999999999
Q ss_pred ccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-C
Q 040202 73 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-F 147 (297)
Q Consensus 73 i~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g 147 (297)
|+||||||+|||+++ +.+||+|||+|+...... ......||+.|||||++.+. .|+.++|||||||++|||+| |
T Consensus 149 iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G 227 (299)
T 4asz_A 149 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYG 227 (299)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTT
T ss_pred cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999985 789999999998764432 22345689999999998755 46999999999999999998 8
Q ss_pred CCCCCCCCCHHHHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 148 RILFPGKNSADQIYKIYG------------RWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 148 ~~pf~~~~~~~~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
+.||.+.+..+....+.. ++.+|+.+||+.||++|||+.++. +|++
T Consensus 228 ~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 228 KQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 999999887777666543 689999999999999999999984 3554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=335.15 Aligned_cols=186 Identities=23% Similarity=0.349 Sum_probs=158.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESA--------------GQNFSEDEARNLCFQVFQGLHYMH 69 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yLH 69 (297)
++.++|||||+++|++.+++.+|||||||++|.| +++..+. ...+++.++..++.|++.||+|||
T Consensus 83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3445999999999999999999999999997555 4444321 235999999999999999999999
Q ss_pred HCCccccCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH
Q 040202 70 RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 70 ~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 145 (297)
+++|+||||||+|||+++ +.+||+|||+|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|||+
T Consensus 163 ~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 163 SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHH
Confidence 999999999999999986 79999999999876432 234567899999999998755 4699999999999999999
Q ss_pred h-CCCCCCCCCCHHHHHHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 146 S-FRILFPGKNSADQIYKIYG------------RWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 146 ~-g~~pf~~~~~~~~~~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
| |+.||.+.+..+....+.. .+.+|+.+||+.||++|||+.|++++
T Consensus 242 t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 242 SYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8 8999999887777666543 67899999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=327.50 Aligned_cols=192 Identities=28% Similarity=0.495 Sum_probs=170.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+++.+|+||||+.| ++.+.+... +.+++..++.++.|++.||+|||++||+||||||+||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI 145 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence 3445999999999999999999999999986 556666554 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
|++. +.+||+|||+++...........+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+..+...+
T Consensus 146 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 225 (328)
T 3fe3_A 146 LLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225 (328)
T ss_dssp EECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9985 799999999998877666667789999999999988777667899999999999999999999999887776666
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+. .++.+|+++||..||.+|||++++++||||+...
T Consensus 226 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 226 VLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 53 3689999999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=337.76 Aligned_cols=188 Identities=22% Similarity=0.374 Sum_probs=156.2
Q ss_pred cccccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHH
Q 040202 3 FLRKMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLH 66 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~ 66 (297)
+|.++..|||||+++|+|.+ ++.+|||||||+||.|..++... ...+++..+..|+.||+.||+
T Consensus 120 il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~ 199 (353)
T 4ase_A 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 199 (353)
T ss_dssp HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHH
Confidence 45566566999999999965 46799999999975554444321 234899999999999999999
Q ss_pred HHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHH
Q 040202 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMF 142 (297)
Q Consensus 67 yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ 142 (297)
|||+++|+||||||+|||+++ +.+||+|||+|+.+.... ...+.+||+.|||||++.+. .|+.++|||||||++|
T Consensus 200 yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~ 278 (353)
T 4ase_A 200 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLW 278 (353)
T ss_dssp HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred hHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHH
Confidence 999999999999999999985 799999999998765432 22456789999999998754 5699999999999999
Q ss_pred HHHh-CCCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 143 EMLS-FRILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 143 ell~-g~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
||+| |+.||.+.+..+.+.++. .++.+++.+||+.||++|||+.++++|
T Consensus 279 El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 279 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9998 999999877555444332 268999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=331.18 Aligned_cols=193 Identities=31% Similarity=0.527 Sum_probs=163.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
|.++.+||||+++++++.+.+.+|+||||+.|+.+ ..+... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred HHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 33445899999999999999999999999997544 444444 459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
||++. +.+||+|||+++... ......+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+..
T Consensus 155 ILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 233 (353)
T 3txo_A 155 VLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233 (353)
T ss_dssp EEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH
Confidence 99985 899999999998643 33344677899999999998654 4689999999999999999999999998887777
Q ss_pred HHHHH-----------HHHHHHHHhhhcCCCCCCCH------HHHHcCCCCCCCCC
Q 040202 161 YKIYG-----------RWVALISWLCSWNPRMRPTA------AEALEHPFFRSCHF 199 (297)
Q Consensus 161 ~~i~~-----------~~~~li~~~l~~dP~~R~t~------~~ll~h~~f~~~~~ 199 (297)
.++.. ++.++|++||..||.+|+++ +++++||||++.+|
T Consensus 234 ~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 234 EAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 77643 68999999999999999998 89999999998776
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=322.92 Aligned_cols=192 Identities=34% Similarity=0.665 Sum_probs=167.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||++|++.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp HHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 344999999999999999999999999999888877664 3569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+. +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+....+...++
T Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 153 NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 74 79999999999876533 33345678999999999876667799999999999999999999999987776665554
Q ss_pred H-----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 164 Y-----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 164 ~-----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
. .++.+||.+||+.||++|||++|+|+||||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 3 2567899999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=322.05 Aligned_cols=192 Identities=30% Similarity=0.467 Sum_probs=166.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 60 ~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138 (337)
T ss_dssp HSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred HhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE
Confidence 3458999999999999999999999999985544444332 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+. +.+||+|||+++... ......+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+
T Consensus 139 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 217 (337)
T 1o6l_A 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 85 899999999998643 33445678899999999998654 4689999999999999999999999988776666555
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
. .++.+||.+||..||++|+ +++++++||||++.+|
T Consensus 218 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 3 4789999999999999999 8999999999998765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=345.46 Aligned_cols=188 Identities=36% Similarity=0.626 Sum_probs=158.4
Q ss_pred cccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
++.++||||+++++++... +.+|+||||+++++++.+. ..+++..++.++.||+.||+|||++||+||||
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDl 190 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3445999999999999654 4689999999999887664 34999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||++. +.+||+|||+++...........+||++|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..
T Consensus 191 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp CGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999985 79999999999988776666778999999999998765 5689999999999999999999999998876
Q ss_pred HHHHHH-----------------------------------------------------HHHHHHHHHHhhhcCCCCCCC
Q 040202 158 DQIYKI-----------------------------------------------------YGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 158 ~~~~~i-----------------------------------------------------~~~~~~li~~~l~~dP~~R~t 184 (297)
+++.++ ..++++||.+||..||++|||
T Consensus 270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 349 (464)
T 3ttj_A 270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349 (464)
T ss_dssp HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence 665554 235789999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 040202 185 AAEALEHPFFRSC 197 (297)
Q Consensus 185 ~~~ll~h~~f~~~ 197 (297)
++|+|+||||+..
T Consensus 350 a~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 350 VDDALQHPYINVW 362 (464)
T ss_dssp HHHHHTSTTTGGG
T ss_pred HHHHhcChhhhhc
Confidence 9999999999854
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=330.16 Aligned_cols=194 Identities=30% Similarity=0.498 Sum_probs=162.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
|.++.+|||||++++++.+++.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 106 l~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI 184 (396)
T 4dc2_A 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184 (396)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 345568999999999999999999999999985544444432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCcee-cCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----
Q 040202 84 LVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS----- 156 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~----- 156 (297)
|++. +.+||+|||+++. ........+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 185 Ll~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~ 263 (396)
T 4dc2_A 185 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263 (396)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----
T ss_pred EECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccc
Confidence 9985 8999999999986 3344455778999999999998754 468999999999999999999999964322
Q ss_pred ---HHH-HHHH-----------HHHHHHHHHHhhhcCCCCCCCH------HHHHcCCCCCCCCC
Q 040202 157 ---ADQ-IYKI-----------YGRWVALISWLCSWNPRMRPTA------AEALEHPFFRSCHF 199 (297)
Q Consensus 157 ---~~~-~~~i-----------~~~~~~li~~~l~~dP~~R~t~------~~ll~h~~f~~~~~ 199 (297)
.+. ...+ ..++++||++||+.||++|+++ +++++||||++++|
T Consensus 264 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 264 QNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp -CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred hhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 121 2222 2368999999999999999985 79999999998876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=331.25 Aligned_cols=194 Identities=27% Similarity=0.417 Sum_probs=169.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|+||||+.|+.+..+... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL 200 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHee
Confidence 4456999999999999999999999999988665555555 35999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccc---cCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSE---ICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+++...... ...+.+||+.|+|||++.... .++.++|||||||++|||++|+.||.+.+..+
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 985 899999999998775543 234778999999999987543 26789999999999999999999999988777
Q ss_pred HHHHHH---------------HHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCCC
Q 040202 159 QIYKIY---------------GRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 159 ~~~~i~---------------~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~~ 200 (297)
...+|. .++++||.+||..+|.+ |++++|+++||||++.+|.
T Consensus 281 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 766653 35789999999999988 9999999999999988763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.99 Aligned_cols=191 Identities=28% Similarity=0.459 Sum_probs=166.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+.+|+||||+.|+.+..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 70 ~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll 148 (361)
T 2yab_A 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148 (361)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 345899999999999999999999999987544444443 3569999999999999999999999999999999999999
Q ss_pred eC-C----eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 86 SK-G----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~----~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++ + .+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+..
T Consensus 149 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~ 227 (361)
T 2yab_A 149 LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227 (361)
T ss_dssp SCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred eCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 64 4 699999999998877666677889999999999765 44689999999999999999999999988776665
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
..+. ..+++||.+||..||.+|||+.++++||||+...
T Consensus 228 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 228 ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 5543 3578999999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=324.08 Aligned_cols=194 Identities=29% Similarity=0.416 Sum_probs=168.4
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++||||+++++++.+.+.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 92 ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp CBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 456679999999999999999999999999985544444432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++. |.+||+|||+++.. .......+.+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+...
T Consensus 171 ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 249 (373)
T 2r5t_A 171 LLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249 (373)
T ss_dssp EECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH
T ss_pred EECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9984 89999999999864 333445678999999999998754 46899999999999999999999999888777776
Q ss_pred HHHH-----------HHHHHHHHhhhcCCCCCCCH----HHHHcCCCCCCCCC
Q 040202 162 KIYG-----------RWVALISWLCSWNPRMRPTA----AEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~~-----------~~~~li~~~l~~dP~~R~t~----~~ll~h~~f~~~~~ 199 (297)
++.. .+++||++||+.||.+|+++ .++++||||++.+|
T Consensus 250 ~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 250 NILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp HHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred HHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 6643 68999999999999999987 69999999998876
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=325.24 Aligned_cols=196 Identities=32% Similarity=0.565 Sum_probs=170.6
Q ss_pred cccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 5 RKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
.+.++||||+++++++...+ .+|+||||+.++++..+.. .....+++..++.++.||+.||+|||++||+||
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 165 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 44559999999999996543 3899999999988776553 234569999999999999999999999999999
Q ss_pred CCCCCcEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 77 DLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 77 dikp~Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||||+|||++ ++.+||+|||+++............||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.
T Consensus 166 Dlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998 47999999999998876666677889999999999877666799999999999999999999999998
Q ss_pred CCHHHHHHHH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 155 NSADQIYKIY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 155 ~~~~~~~~i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..++...+. .++.+||.+||+.||++|||+.++++||||
T Consensus 246 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 8776665543 257899999999999999999999999999
Q ss_pred CCCCCC
Q 040202 195 RSCHFV 200 (297)
Q Consensus 195 ~~~~~~ 200 (297)
++..+.
T Consensus 326 ~~~~~~ 331 (394)
T 4e7w_A 326 DELRTG 331 (394)
T ss_dssp STTTSS
T ss_pred hhhccc
Confidence 876553
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.18 Aligned_cols=195 Identities=25% Similarity=0.378 Sum_probs=168.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||+.|+.+..++.+.++.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 208 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208 (437)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE
Confidence 34599999999999999999999999998755555555444669999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+. +.+||+|||+++....... ....+||+.|+|||++.. ...++.++||||+||++|||++|+.||.+.+..+
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 288 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence 85 8999999999987654332 234689999999999862 3456899999999999999999999999988777
Q ss_pred HHHHHH----------------HHHHHHHHHhhhcCCCC--CCCHHHHHcCCCCCCCCCC
Q 040202 159 QIYKIY----------------GRWVALISWLCSWNPRM--RPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 159 ~~~~i~----------------~~~~~li~~~l~~dP~~--R~t~~~ll~h~~f~~~~~~ 200 (297)
...+|. .++++||++||+.+|++ |++++|+++||||++.+|.
T Consensus 289 ~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 289 TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred HHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 766653 36789999999988888 9999999999999998875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=328.13 Aligned_cols=193 Identities=36% Similarity=0.693 Sum_probs=163.4
Q ss_pred cccccccccceeeeceeEEeCC--eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~--~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.|+++.+||||+++++++..++ .+|+||||++|++...+.. ..+++..++.++.||+.||+|||+.||+||||||
T Consensus 61 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 137 (388)
T 3oz6_A 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP 137 (388)
T ss_dssp HHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH
Confidence 3455556999999999997544 7999999999887766654 3599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCC----------------------CCCCccccccCCCCCCceecccccCCCccchhhH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDS----------------------SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAM 137 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 137 (297)
+|||++. +.+||+|||+++.... .......+||++|+|||++.+...++.++||||+
T Consensus 138 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 217 (388)
T 3oz6_A 138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217 (388)
T ss_dssp GGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred HHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHH
Confidence 9999985 7899999999986532 1223456899999999998776677999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHH-----------------------------------------------------
Q 040202 138 GAIMFEMLSFRILFPGKNSADQIYKIY----------------------------------------------------- 164 (297)
Q Consensus 138 Gv~l~ell~g~~pf~~~~~~~~~~~i~----------------------------------------------------- 164 (297)
||++|||++|+.||.+.+..+++.++.
T Consensus 218 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (388)
T 3oz6_A 218 GCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297 (388)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccc
Confidence 999999999999999888776665542
Q ss_pred -----HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 165 -----GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 165 -----~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.++.+|+.+||+.||++|||++|+|+||||+..+
T Consensus 298 ~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp TCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred cccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 2567999999999999999999999999997654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=324.31 Aligned_cols=194 Identities=29% Similarity=0.470 Sum_probs=167.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+.+.+|+||||+.|+.+..++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 71 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 149 (345)
T 1xjd_A 71 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149 (345)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence 334459999999999999999999999999875444444432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++. +.+||+|||+++... ......+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...
T Consensus 150 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 228 (345)
T 1xjd_A 150 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228 (345)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9985 899999999998653 23344678899999999998754 46899999999999999999999999888777666
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCHH-HHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTAA-EALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~~-~ll~h~~f~~~~~ 199 (297)
++. .++.+||.+||..||++|+++. ++++||||++.+|
T Consensus 229 ~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 229 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 654 3689999999999999999998 9999999998875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.75 Aligned_cols=195 Identities=35% Similarity=0.654 Sum_probs=164.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++.+|+||||++|++.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl 164 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence 3445999999999999999999999999999888777654 45999999999999999999999999999999999999
Q ss_pred EeC------CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 85 VSK------GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 85 l~~------~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
++. +.+||+|||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..
T Consensus 165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 244 (329)
T 3gbz_A 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244 (329)
T ss_dssp EEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 952 35999999999876432 23345678999999999877666799999999999999999999999988877
Q ss_pred HHHHHHH-----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 DQIYKIY-----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~~~~~i~-----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+...++. .++.+||.+||+.||++|||++|+|+||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 245 DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 7665543 45679999999999999999999999999998
Q ss_pred CCCCC
Q 040202 197 CHFVP 201 (297)
Q Consensus 197 ~~~~~ 201 (297)
.++.|
T Consensus 325 ~~~~P 329 (329)
T 3gbz_A 325 NDFDP 329 (329)
T ss_dssp SCSCC
T ss_pred CCCCC
Confidence 77653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=326.51 Aligned_cols=194 Identities=26% Similarity=0.431 Sum_probs=166.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||+.|+.+..++.+.+..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 195 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195 (412)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence 34599999999999999999999999998755555544444579999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecc------cccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLL------SEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
++ +.+||+|||+++....... ....+||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 85 8999999999988755432 235689999999999863 24568999999999999999999999998887
Q ss_pred HHHHHHHH----------------HHHHHHHHHhhhcCCCCC---CCHHHHHcCCCCCCCCCC
Q 040202 157 ADQIYKIY----------------GRWVALISWLCSWNPRMR---PTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 157 ~~~~~~i~----------------~~~~~li~~~l~~dP~~R---~t~~~ll~h~~f~~~~~~ 200 (297)
.+...+|. .++++||++||. +|.+| ++++++++||||++.+|.
T Consensus 276 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 276 AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 76655543 357899999999 99998 589999999999998875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=317.40 Aligned_cols=191 Identities=28% Similarity=0.466 Sum_probs=167.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+.+.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 34459999999999999999999999999975554444442 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++. |.+||+|||+++..... ..+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...++
T Consensus 139 l~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 215 (318)
T 1fot_A 139 LDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215 (318)
T ss_dssp ECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 985 89999999999876543 2567899999999997654 4689999999999999999999999988877776666
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
. .++.++|++||..||++|+ +++++++||||++.+|
T Consensus 216 ~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 216 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 4 3689999999999999999 8999999999998766
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.57 Aligned_cols=191 Identities=30% Similarity=0.614 Sum_probs=164.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++.+|+||||++|++++.+... .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~ 134 (292)
T 3o0g_A 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134 (292)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 445999999999999999999999999999999887765 3569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC-CCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF-PGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf-~~~~~~~~~~~ 162 (297)
++ +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|..|| .+.+..+...+
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~ 214 (292)
T 3o0g_A 135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 85 79999999999876533 33356688999999999877666799999999999999999888774 44444444444
Q ss_pred HH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 IY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+. ..+++||++||+.||++|||++|+++||||++.
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 32 356799999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=316.15 Aligned_cols=194 Identities=35% Similarity=0.659 Sum_probs=168.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA----GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~----~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.+.++||||+++++++.+++.+|+||||++|++.+.+.... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp 136 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCh
Confidence 34459999999999999999999999999998888776642 13599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+|||+++ +.+||+|||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+
T Consensus 137 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 216 (317)
T 2pmi_A 137 QNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216 (317)
T ss_dssp GGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999985 79999999999876533 233556889999999998766667999999999999999999999999887766
Q ss_pred HHHHHH---------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 159 QIYKIY---------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 159 ~~~~i~---------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
....+. .++.+||.+||+.||++|||+.++|+|||
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 555442 25789999999999999999999999999
Q ss_pred CCCCC
Q 040202 194 FRSCH 198 (297)
Q Consensus 194 f~~~~ 198 (297)
|++..
T Consensus 297 f~~~~ 301 (317)
T 2pmi_A 297 FAEYY 301 (317)
T ss_dssp GGGGC
T ss_pred hhccc
Confidence 98643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.38 Aligned_cols=190 Identities=29% Similarity=0.481 Sum_probs=168.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+.+..|+||||++|++++.+... +.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 140 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence 4456999999999999999999999999988999988876 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH--
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-- 161 (297)
+++ +.+||+|||+++...........+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+........
T Consensus 141 l~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 220 (336)
T 3h4j_B 141 LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220 (336)
T ss_dssp ECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC
T ss_pred EcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 985 78999999999887776666788999999999998876666789999999999999999999998754433221
Q ss_pred ---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 ---------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ---------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+...+.+||++||..||.+|||++|+++||||+.
T Consensus 221 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 13457899999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=313.24 Aligned_cols=191 Identities=35% Similarity=0.643 Sum_probs=162.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++..|+||||+.+++.+.+... .+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 132 (288)
T 1ob3_A 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132 (288)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 3445999999999999999999999999999877766543 356999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+...+
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (288)
T 1ob3_A 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (288)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 985 89999999999776432 2234567899999999987666679999999999999999999999998877666554
Q ss_pred HH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 163 IY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 163 i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+. .++.+||.+||+.||++|||++++++||||++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 42 34578999999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=318.72 Aligned_cols=194 Identities=30% Similarity=0.478 Sum_probs=161.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+||||+++++++.+++.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 63 l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 141 (345)
T 3a8x_A 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141 (345)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 345568999999999999999999999999875444444332 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC------
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN------ 155 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~------ 155 (297)
|++. +.+||+|||+++... ......+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 142 ll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 142 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp EECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred EECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 9985 899999999998643 33445677899999999998754 45899999999999999999999997532
Q ss_pred --CHH-HHHHH-----------HHHHHHHHHHhhhcCCCCCCCH------HHHHcCCCCCCCCC
Q 040202 156 --SAD-QIYKI-----------YGRWVALISWLCSWNPRMRPTA------AEALEHPFFRSCHF 199 (297)
Q Consensus 156 --~~~-~~~~i-----------~~~~~~li~~~l~~dP~~R~t~------~~ll~h~~f~~~~~ 199 (297)
... ....+ ..++.+||.+||..||++|+++ +++++||||++.+|
T Consensus 221 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 221 QNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp --CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred cccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 111 22222 2367899999999999999995 79999999998776
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=320.13 Aligned_cols=194 Identities=27% Similarity=0.456 Sum_probs=167.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
|.++.+||||+++++++++.+.+|+||||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 152 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 344558999999999999999999999999875444444432 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++. +.+||+|||+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...
T Consensus 153 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 231 (353)
T 2i0e_A 153 MLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231 (353)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9985 899999999998643 33445678899999999998654 45899999999999999999999999888777766
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
++. .++.+||.+||..||.+|++ ++++++||||++.+|
T Consensus 232 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 232 SIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 654 37899999999999999995 689999999998776
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=311.16 Aligned_cols=188 Identities=34% Similarity=0.620 Sum_probs=165.7
Q ss_pred cccceeeeceeEEeCC-----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 9 NHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+||||+++++++.+.. .+|+||||+.|++.+.+.......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 151 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 5999999999998765 58999999999888887766545599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
|+++ +.+||+|||+++...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+...+
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 230 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred EEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9975 799999999998877666667788999999999987554 58999999999999999999999999887777666
Q ss_pred HH--------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 IY--------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i~--------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+. ..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 53 356789999999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=316.16 Aligned_cols=193 Identities=34% Similarity=0.645 Sum_probs=163.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||++|++.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 133 (324)
T 3mtl_A 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI 133 (324)
T ss_dssp SCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE
T ss_pred HhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE
Confidence 445999999999999999999999999999888877665 4569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+. +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 134 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 213 (324)
T 3mtl_A 134 NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213 (324)
T ss_dssp CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 79999999999765432 23345678999999999876667799999999999999999999999988776665544
Q ss_pred H-----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 Y-----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ~-----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
. .++.+||.+||+.||++|||++|+|+||||.+...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 214 FRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred HHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 2 24679999999999999999999999999987544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=317.77 Aligned_cols=189 Identities=26% Similarity=0.424 Sum_probs=166.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++.+|+||||+.| ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 96 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence 445999999999999999999999999987 555555544 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++. +.+||+|||+++...... .+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++
T Consensus 174 l~~~g~~kL~DFg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 250 (350)
T 1rdq_E 174 IDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSCB--CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEcccccceeccCCc--ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH
Confidence 985 899999999998775543 567899999999998754 4689999999999999999999999988877776665
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
. .++.++|.+||+.||.+|++ ++++++||||++.+|
T Consensus 251 ~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 4 37899999999999999998 999999999998776
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=310.07 Aligned_cols=189 Identities=25% Similarity=0.484 Sum_probs=164.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 149 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (297)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 445999999999999999999999999988666666655 359999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+ ++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 228 (297)
T 3fxz_A 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (297)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8 489999999999876543 334567899999999998754 4589999999999999999999999888776655544
Q ss_pred H--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 164 Y--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 164 ~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
. ..+.+|+.+||+.||++|||++++++||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 229 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 3 357899999999999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=325.83 Aligned_cols=195 Identities=31% Similarity=0.545 Sum_probs=167.1
Q ss_pred cccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 5 RKMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
.+.++|||||++++++... .++++||||+.+++++.+.. ..+..+++..++.++.||+.||+|||++||+||
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 180 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 3445999999999998532 24789999999987766543 234679999999999999999999999999999
Q ss_pred CCCCCcEEEeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 77 DLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 77 dikp~Nill~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||||+|||++. +.+||+|||+++...........+||+.|+|||++.+...++.++|||||||++|||++|+.||.+.
T Consensus 181 Dlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999984 5789999999998766655667889999999999876666799999999999999999999999998
Q ss_pred CCHHHHHHHH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 155 NSADQIYKIY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 155 ~~~~~~~~i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+..+++.++. .++++||++||..||.+|||+.|+++||||
T Consensus 261 ~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 261 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 8766655442 357899999999999999999999999999
Q ss_pred CCCCC
Q 040202 195 RSCHF 199 (297)
Q Consensus 195 ~~~~~ 199 (297)
+....
T Consensus 341 ~~~~~ 345 (420)
T 1j1b_A 341 DELRD 345 (420)
T ss_dssp GGGGC
T ss_pred ccccc
Confidence 87544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.43 Aligned_cols=193 Identities=24% Similarity=0.411 Sum_probs=166.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||++++++.+.+.+|+||||+.|+.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 70 ~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll 148 (384)
T 4fr4_A 70 QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL 148 (384)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 345999999999999999999999999998666666554 3469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH---H
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD---Q 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~---~ 159 (297)
++ +.+||+|||+++.........+.+||+.|+|||++.. ...++.++|||||||++|+|++|+.||....... .
T Consensus 149 ~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 228 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228 (384)
T ss_dssp CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH
T ss_pred CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 85 8999999999998877777778899999999999864 2346889999999999999999999997544322 2
Q ss_pred HHHH-----------HHHHHHHHHHhhhcCCCCCCC-HHHHHcCCCCCCCCC
Q 040202 160 IYKI-----------YGRWVALISWLCSWNPRMRPT-AAEALEHPFFRSCHF 199 (297)
Q Consensus 160 ~~~i-----------~~~~~~li~~~l~~dP~~R~t-~~~ll~h~~f~~~~~ 199 (297)
...+ ...+.+||.+||..||.+|++ ++++++||||++.+|
T Consensus 229 ~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 229 VHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 2222 236889999999999999998 899999999998876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.49 Aligned_cols=191 Identities=23% Similarity=0.381 Sum_probs=166.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+.+.+|+||||+.|+.+.......+..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl 134 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII 134 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 34459999999999999999999999999985444444443456999999999999999999999999999999999999
Q ss_pred Ee---CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~---~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++ ++.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+...
T Consensus 135 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 213 (321)
T 1tki_A 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213 (321)
T ss_dssp ESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence 97 468999999999988766555677899999999997654 45889999999999999999999999887766555
Q ss_pred HHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+. .++.+|+.+||..||.+|||+.|+|+||||+.
T Consensus 214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 443 36789999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=317.92 Aligned_cols=182 Identities=27% Similarity=0.279 Sum_probs=144.2
Q ss_pred cccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccc
Q 040202 7 MNNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ--------GYF 74 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~--------gi~ 74 (297)
.++|||||++++++.+++ .+|||||||+|+.|..++.+ ..++++.+..++.|++.||+|||++ +|+
T Consensus 53 ~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~Ii 130 (303)
T 3hmm_A 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130 (303)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEE
T ss_pred cCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEe
Confidence 459999999999998654 68999999997666565555 4599999999999999999999987 999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccc-----cCCCccchhhHHHHHHH
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSE-----ICGPEVDRWAMGAIMFE 143 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~e 143 (297)
||||||+|||+++ +.+||+|||+|+...... ...+.+||+.|||||++.+.. .++.++|||||||++||
T Consensus 131 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~E 210 (303)
T 3hmm_A 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHH
Confidence 9999999999985 799999999998765432 223568999999999986432 24678999999999999
Q ss_pred HHhCCCCCCCCC--------------CHHHHHH-------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 144 MLSFRILFPGKN--------------SADQIYK-------------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 144 ll~g~~pf~~~~--------------~~~~~~~-------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|++|..||.... ..+...+ ....+.+|+.+||..||++|||+.++++
T Consensus 211 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 999977653211 1122221 1235788999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=330.04 Aligned_cols=192 Identities=34% Similarity=0.656 Sum_probs=155.0
Q ss_pred ccccccceeeeceeEEe-----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|||||++++++.. .+.+|+||||++|++.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp 184 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP 184 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCCh
Confidence 34499999999999943 3579999999998888777543 5699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCC----------------------------CCCccccccCCCCCCceecccccCCCc
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSS----------------------------LPCTDYVTTRWYRAPEVLLLSEICGPE 131 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 131 (297)
+|||++. +.+||+|||+++..... ......+||++|+|||++.....++.+
T Consensus 185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 264 (458)
T 3rp9_A 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264 (458)
T ss_dssp GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence 9999985 79999999999876422 123456889999999987666678999
Q ss_pred cchhhHHHHHHHHHh-----------CCCCCCCCCC--------------------HHHHHHH-----------------
Q 040202 132 VDRWAMGAIMFEMLS-----------FRILFPGKNS--------------------ADQIYKI----------------- 163 (297)
Q Consensus 132 ~DiwSlGv~l~ell~-----------g~~pf~~~~~--------------------~~~~~~i----------------- 163 (297)
+|||||||++|||++ |+.+|.+.+. .+++..|
T Consensus 265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 344 (458)
T 3rp9_A 265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344 (458)
T ss_dssp HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence 999999999999998 7777876542 1222211
Q ss_pred -------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 -------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 -------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
..++.+||++||..||++|+|++|+|+||||++.++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 235789999999999999999999999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=324.27 Aligned_cols=193 Identities=31% Similarity=0.460 Sum_probs=164.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+++.+|+||||+.|+.+..+.... +.+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus 202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 34459999999999999999999999999985554444432 469999999999999999999998 9999999999999
Q ss_pred EEeC-CeEEEEecCCceecC-CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+......
T Consensus 281 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 359 (446)
T 4ejn_A 281 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359 (446)
T ss_dssp EECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9985 799999999998643 33344677899999999998654 46899999999999999999999999887776666
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
.+. .++.+||.+||..||++|| +++++++||||++..|
T Consensus 360 ~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 360 LILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 553 3689999999999999999 9999999999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=311.46 Aligned_cols=190 Identities=27% Similarity=0.451 Sum_probs=164.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 69 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll 147 (326)
T 2y0a_A 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147 (326)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE
Confidence 345899999999999999999999999987555444443 3569999999999999999999999999999999999999
Q ss_pred eC-C----eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 86 SK-G----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~----~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++ + .+||+|||+++............||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 148 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 226 (326)
T 2y0a_A 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226 (326)
T ss_dssp SCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred ecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 75 4 699999999998876555567789999999998764 44689999999999999999999999887766655
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+. ..+.+||.+||..||++|||+.++|+||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 227 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 4442 357899999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=312.33 Aligned_cols=190 Identities=23% Similarity=0.354 Sum_probs=160.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+|+||+++++++.+++.+|+||||+++++.+.+... +..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 110 ~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 188 (311)
T 3p1a_A 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188 (311)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 34556899999999999999999999999988888877765 45699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH--
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI-- 160 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~-- 160 (297)
|++. +.+||+|||+++............||+.|+|||++.+ .++.++||||+||++|||++|..+|.+.......
T Consensus 189 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 266 (311)
T 3p1a_A 189 FLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266 (311)
T ss_dssp EECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT
T ss_pred EECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc
Confidence 9974 7999999999988776665567789999999998764 4689999999999999999997776553332222
Q ss_pred --------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 161 --------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 161 --------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..+..++.+++.+||+.||++|||++++++||||++
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 123457899999999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.08 Aligned_cols=193 Identities=31% Similarity=0.595 Sum_probs=168.2
Q ss_pred cccccccceeeeceeEEe--------------------------------------CCeEEEEEecCCCcHHHHHHH--h
Q 040202 5 RKMNNHPNIVKLRNLVKE--------------------------------------HEDVFIVFDYMESDLLKLMKE--S 44 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~--------------------------------------~~~~~lv~e~~~g~ll~~~~~--~ 44 (297)
.+.++||||+++++++.. +..+|+||||++|++.+.+.. .
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~ 133 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR 133 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHh
Confidence 345599999999999943 345899999999987666543 2
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCcee
Q 040202 45 AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 122 (297)
Q Consensus 45 ~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 122 (297)
.+..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++............||+.|+|||++
T Consensus 134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 134 SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELM 213 (383)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHh
Confidence 346799999999999999999999999999999999999997 478999999999988776666778899999999998
Q ss_pred cccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------------------------------
Q 040202 123 LLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG------------------------------------- 165 (297)
Q Consensus 123 ~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~------------------------------------- 165 (297)
.+...++.++||||+||++|+|++|+.||.+.+..++..++..
T Consensus 214 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (383)
T 3eb0_A 214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG 293 (383)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTT
T ss_pred cCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCC
Confidence 7766679999999999999999999999999887777665532
Q ss_pred ---HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 166 ---RWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 166 ---~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
++.+||.+||..||.+|||+.|+++||||+..
T Consensus 294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 37899999999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=308.10 Aligned_cols=193 Identities=33% Similarity=0.620 Sum_probs=162.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||++|+++..+.... +.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~ 135 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135 (311)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE
Confidence 3458999999999999999999999999998888777653 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 136 TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 89999999999876533 33356688999999999876667799999999999999999999999988776665443
Q ss_pred HH------------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 164 YG------------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 164 ~~------------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
.. .+.+|+.+||..||++|||++++++||||++...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 216 RKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp HHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred HHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 22 3678999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=313.49 Aligned_cols=184 Identities=24% Similarity=0.468 Sum_probs=161.1
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe--
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-- 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-- 86 (297)
+||||+++++++.+.+..|+||||+++++.+.+.......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCT
T ss_pred CCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccc
Confidence 599999999999999999999999977888777766555699999999999999999999999999999999999996
Q ss_pred ------------------------CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHH
Q 040202 87 ------------------------KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMF 142 (297)
Q Consensus 87 ------------------------~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ 142 (297)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH--GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLA 250 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC--CSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC--cCccCcccccCcHHHcCC-CCCCccchHHHHHHHH
Confidence 4689999999998755433 567899999999998754 4689999999999999
Q ss_pred HHHhCCCCCCCCCCHHHHHHHH---------------------------------------------------------H
Q 040202 143 EMLSFRILFPGKNSADQIYKIY---------------------------------------------------------G 165 (297)
Q Consensus 143 ell~g~~pf~~~~~~~~~~~i~---------------------------------------------------------~ 165 (297)
+|++|+.||.+.+..+....+. .
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 9999999998877655544332 2
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 166 RWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 166 ~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
.+.+||.+||+.||++|||+.|+|+||||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 355999999999999999999999999995
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=321.61 Aligned_cols=189 Identities=30% Similarity=0.495 Sum_probs=164.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+++..|+||||+.| ++.+.+..+ +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI 141 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3445999999999999999999999999987 555666554 5699999999999999999999999999999999999
Q ss_pred EEe----CCeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVS----KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~----~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|++ ++.+||+|||+++...... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+
T Consensus 142 ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~ 220 (444)
T 3soa_A 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220 (444)
T ss_dssp EESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence 996 2679999999998765432 23567899999999997654 46899999999999999999999998887766
Q ss_pred HHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
....+. .++.+||.+||+.||++|||+.++|+||||+.
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 665543 36899999999999999999999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.17 Aligned_cols=194 Identities=32% Similarity=0.598 Sum_probs=154.4
Q ss_pred cccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 5 RKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESA-------GQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~-------~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
.+.++||||+++++++.+ +..+|+||||+.|++++.+.... ...+++..++.++.||+.||+|||++||+|
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH 151 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH 151 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeC
Confidence 344589999999999954 67899999999999888776431 124999999999999999999999999999
Q ss_pred cCCCCCcEEE----eC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 76 RDLKPSNLLV----SK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 76 rdikp~Nill----~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
|||||+|||+ ++ +.+||+|||+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++
T Consensus 152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 231 (405)
T 3rgf_A 152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231 (405)
T ss_dssp CCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh
Confidence 9999999999 33 68999999999876532 233557889999999998876667999999999999999999
Q ss_pred CCCCCCCCCCH---------HHHHHH-------------------------------------------------HHHHH
Q 040202 147 FRILFPGKNSA---------DQIYKI-------------------------------------------------YGRWV 168 (297)
Q Consensus 147 g~~pf~~~~~~---------~~~~~i-------------------------------------------------~~~~~ 168 (297)
|+.||.+.... +++.++ ...+.
T Consensus 232 g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (405)
T 3rgf_A 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311 (405)
T ss_dssp SSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHH
T ss_pred CCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHH
Confidence 99999765431 222222 23567
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 169 ALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 169 ~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+||.+||..||.+|||++|+|+||||++..
T Consensus 312 ~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred HHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 899999999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.38 Aligned_cols=192 Identities=29% Similarity=0.478 Sum_probs=170.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+.+.+|+||||+.|+.+..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl 148 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence 3456999999999999999999999999987554444433 356999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++. +.+||+|||+++.........+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+......++
T Consensus 149 l~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 228 (476)
T 2y94_A 149 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228 (476)
T ss_dssp ECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred EecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 985 7899999999998877666677899999999999887666678999999999999999999999998887777665
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
. .++.+||++||..||++|||+.++++||||+..
T Consensus 229 ~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 229 CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred hcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 4 368999999999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=310.73 Aligned_cols=191 Identities=30% Similarity=0.489 Sum_probs=161.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++.+|+||||+.| ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 76 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nil 153 (327)
T 3a62_A 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIM 153 (327)
T ss_dssp HHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred HhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeE
Confidence 345899999999999999999999999987 455555443 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++. +.+||+|||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...+
T Consensus 154 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 232 (327)
T 3a62_A 154 LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232 (327)
T ss_dssp ECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 975 8999999999976432 2334567899999999998654 458999999999999999999999998887776666
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+. .++.++|.+||..||++|| ++.++++||||++..|
T Consensus 233 i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 233 ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 54 3689999999999999999 8899999999998765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=313.52 Aligned_cols=191 Identities=32% Similarity=0.592 Sum_probs=164.7
Q ss_pred ccccccceeeeceeEEe--------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 6 KMNNHPNIVKLRNLVKE--------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.++||||+++++++.+ ++.+|+||||++|++++.+.... ..+++..++.++.||+.||+|||++||+|||
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D 149 (351)
T 3mi9_A 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149 (351)
T ss_dssp HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence 44589999999999987 45799999999998888877653 4599999999999999999999999999999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCC-----CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDS-----SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
|||+|||+++ +.+||+|||+++.... ........||+.|+|||++.+...++.++|||||||++|+|++|+.||
T Consensus 150 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 9999999984 8999999999987642 223355678999999999876666799999999999999999999999
Q ss_pred CCCCCHHHHHHHH-------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 152 PGKNSADQIYKIY-------------------------------------------GRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 152 ~~~~~~~~~~~i~-------------------------------------------~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
.+.+..+....+. ..+.+||.+||+.||++|||++|+
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 9887666555442 247799999999999999999999
Q ss_pred HcCCCCCCC
Q 040202 189 LEHPFFRSC 197 (297)
Q Consensus 189 l~h~~f~~~ 197 (297)
|+||||++.
T Consensus 310 l~hp~f~~~ 318 (351)
T 3mi9_A 310 LNHDFFWSD 318 (351)
T ss_dssp HTSGGGGSS
T ss_pred hCCCCcCCC
Confidence 999999763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=316.97 Aligned_cols=195 Identities=23% Similarity=0.342 Sum_probs=161.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|||||++++++.+++.+|+||||+.|+.+ +.+.......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 4455999999999999999999999999997554 444444345699999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCC--------CCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|++ ++.+||+|||.+...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+
T Consensus 160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 998 489999999987654211 122345789999999998753 4568999999999999999999999987
Q ss_pred CCCHHHHHH---------------------------------------------------------HHHHHHHHHHHhhh
Q 040202 154 KNSADQIYK---------------------------------------------------------IYGRWVALISWLCS 176 (297)
Q Consensus 154 ~~~~~~~~~---------------------------------------------------------i~~~~~~li~~~l~ 176 (297)
.+..+...+ +...+.+||++||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 665443322 12347889999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCCCC
Q 040202 177 WNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 177 ~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
.||++|||++|+|+||||+....
T Consensus 320 ~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 320 RNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp SCTTTSCCHHHHTTSGGGGGC--
T ss_pred cCcccCCCHHHHhcCHHHHHHhh
Confidence 99999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=318.11 Aligned_cols=193 Identities=25% Similarity=0.412 Sum_probs=167.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++.+|+||||+.|+.+..+....+..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIl 181 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeE
Confidence 34459999999999999999999999999875554444443456999999999999999999999999999999999999
Q ss_pred EeC---CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++. +.+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 182 l~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 260 (387)
T 1kob_A 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 260 (387)
T ss_dssp ESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred EecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 963 5799999999998876655566789999999999765 446889999999999999999999999887766655
Q ss_pred HHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 162 KIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 162 ~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
++. .++.+||.+||..||++|||+.++++||||++..
T Consensus 261 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 443 3689999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.95 Aligned_cols=188 Identities=30% Similarity=0.485 Sum_probs=164.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+..+ ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIl 160 (362)
T 2bdw_A 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 160 (362)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence 345999999999999999999999999997 555555443 46999999999999999999999999999999999999
Q ss_pred EeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++. +.+||+|||+++...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+..
T Consensus 161 l~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 239 (362)
T 2bdw_A 161 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239 (362)
T ss_dssp ESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 964 36999999999887766655678899999999997654 4689999999999999999999999887766655
Q ss_pred HHH---------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 161 YKI---------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 161 ~~i---------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..+ ..++.+||.+||..||++|||+.++|+||||+.
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 544 236889999999999999999999999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.70 Aligned_cols=192 Identities=28% Similarity=0.394 Sum_probs=162.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++..|+||||+.|+.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 137 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE
Confidence 4455999999999999999999999999988544444433 245999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC---CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+++.... .......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.......
T Consensus 138 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp ECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred EeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 985 8999999999976532 223356789999999999877666678899999999999999999999876654332
Q ss_pred H--------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 Y--------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~--------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
. .+...+.+|+.+||..||++|||+.|+++||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 2 123467899999999999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=337.48 Aligned_cols=195 Identities=27% Similarity=0.449 Sum_probs=170.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
|.++.+|+||+++++++++.+.+||||||+.|+.+..++... +.+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NI 473 (674)
T 3pfq_A 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473 (674)
T ss_dssp HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTE
T ss_pred HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhE
Confidence 445568999999999999999999999999875544444443 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceec-CCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.. .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 474 Ll~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 474 MLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp EECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9985 89999999999874 334445678999999999998654 56999999999999999999999999988877777
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCH-----HHHHcCCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTA-----AEALEHPFFRSCHFV 200 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~-----~~ll~h~~f~~~~~~ 200 (297)
+|. .++.+||++||+.||++|+++ +++++||||++++|.
T Consensus 553 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 553 SIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp HHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred HHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 765 378999999999999999997 899999999988763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.34 Aligned_cols=194 Identities=27% Similarity=0.441 Sum_probs=154.3
Q ss_pred ccccccccceeeeceeEEe----CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 4 LRKMNNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
+.+..+||||+++++++.. ++.+|+||||+.| ++.+.+.......+++..++.++.||+.||+|||++||+||||
T Consensus 108 ~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 187 (400)
T 1nxk_A 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187 (400)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 3466799999999999976 6789999999987 5555555433346999999999999999999999999999999
Q ss_pred CCCcEEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 79 KPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 79 kp~Nill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||+|||++. +.+||+|||+++.........+.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 188 kp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 999999973 6899999999998776655677889999999999764 45689999999999999999999999775
Q ss_pred CCHH----HHHH---------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 155 NSAD----QIYK---------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 155 ~~~~----~~~~---------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
+... ...+ +..++.+||++||..||++|||+.++++||||....
T Consensus 267 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 267 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 4321 1111 334689999999999999999999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.44 Aligned_cols=190 Identities=31% Similarity=0.433 Sum_probs=148.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+++.+|+||||+.| ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni 147 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 3445999999999999999999999999987 555555444 4599999999999999999999999999999999999
Q ss_pred EEeC-C--eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH-
Q 040202 84 LVSK-G--VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ- 159 (297)
Q Consensus 84 ll~~-~--~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~- 159 (297)
|++. + .+||+|||+++...........+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+......
T Consensus 148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (361)
T 3uc3_A 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227 (361)
T ss_dssp EECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence 9974 3 49999999998655554556778999999999987766655569999999999999999999987554222
Q ss_pred ---HHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 ---IYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ---~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...+ ...+.+||.+||..||++|||+.++++||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 228 RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 2222 246789999999999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=310.43 Aligned_cols=192 Identities=31% Similarity=0.517 Sum_probs=167.6
Q ss_pred ccccceeeeceeEEeCCe-------EEEEEecCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccc
Q 040202 8 NNHPNIVKLRNLVKEHED-------VFIVFDYMESDLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMH--RQGYFHR 76 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~-------~~lv~e~~~g~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH--~~gi~Hr 76 (297)
++||||+++++++.+.+. +|+||||+.|+++..+... ....+++..++.++.|++.||.||| ++||+||
T Consensus 76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~ 155 (360)
T 3e3p_A 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR 155 (360)
T ss_dssp HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred cCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 489999999999975433 8999999999887765542 3456999999999999999999999 9999999
Q ss_pred CCCCCcEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 77 DLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 77 dikp~Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||||+|||++ ++.+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.
T Consensus 156 Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 156 DIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 9999999997 47999999999998876666667789999999999876666799999999999999999999999988
Q ss_pred CCHHHHHHHH-------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 155 NSADQIYKIY-------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 155 ~~~~~~~~i~-------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+.......+. .++.+||.+||+.||.+|||+.|+|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 8766655543 367899999999999999999999999
Q ss_pred CCCCCCCC
Q 040202 192 PFFRSCHF 199 (297)
Q Consensus 192 ~~f~~~~~ 199 (297)
|||++...
T Consensus 316 p~f~~~~~ 323 (360)
T 3e3p_A 316 PYFDELHD 323 (360)
T ss_dssp GGGGGGGC
T ss_pred ccccccCC
Confidence 99987554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.33 Aligned_cols=190 Identities=27% Similarity=0.421 Sum_probs=166.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+.+.+|+||||++| ++.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 141 ~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 219 (373)
T 2x4f_A 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219 (373)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 344999999999999999999999999987 555555543 346999999999999999999999999999999999999
Q ss_pred Ee---CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~---~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++ ++.+||+|||+++...........+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 220 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 298 (373)
T 2x4f_A 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298 (373)
T ss_dssp EEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 94 36899999999998876665567789999999998764 456889999999999999999999999888777666
Q ss_pred HHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
++. .++.+||.+||+.||.+|||+.++++||||++.
T Consensus 299 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 299 NILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 543 368999999999999999999999999999763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=316.96 Aligned_cols=186 Identities=30% Similarity=0.557 Sum_probs=164.1
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK- 87 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~- 87 (297)
+|+||+++++++...+.+|+||||+.+++++.+.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ 236 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST
T ss_pred CCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC
Confidence 7899999999999999999999999999998888765556999999999999999999999999999999999999985
Q ss_pred Ce--EEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Q 040202 88 GV--IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY- 164 (297)
Q Consensus 88 ~~--~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~- 164 (297)
+. +||+|||+++...... .+.+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+.
T Consensus 237 ~~~~vkL~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQRV--YTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp TSCCEEECCCTTCEETTCCC--CSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcceEEeecccceecCCcc--cccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 44 9999999998765443 5678999999999987554 5899999999999999999999999888766655443
Q ss_pred ---------------------------------------------------------------------HHHHHHHHHhh
Q 040202 165 ---------------------------------------------------------------------GRWVALISWLC 175 (297)
Q Consensus 165 ---------------------------------------------------------------------~~~~~li~~~l 175 (297)
..+.+||++||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 23579999999
Q ss_pred hcCCCCCCCHHHHHcCCCCCCC
Q 040202 176 SWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 176 ~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+.||++|||++|+|+||||+..
T Consensus 394 ~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 394 EWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp CSSTTTSCCHHHHHTSTTTC--
T ss_pred CCChhhCCCHHHHhCChhhccC
Confidence 9999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=310.99 Aligned_cols=192 Identities=36% Similarity=0.655 Sum_probs=167.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+..|+||||+++++...+... +..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145 (346)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred hhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
Confidence 345899999999999999999999999999877666543 4569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+...++
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i 225 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 85 79999999999876432 33456788999999999876666789999999999999999999999988877666554
Q ss_pred H---------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 164 Y---------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 164 ~---------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
. .++.+||.+||..||++|||+.|+++||||++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 3 3578899999999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=313.58 Aligned_cols=189 Identities=40% Similarity=0.664 Sum_probs=162.0
Q ss_pred ccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++||||+++++++...+ .+|+||||+++++.+. ... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~-~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk 155 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 155 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH-HHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHH-Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence 4458999999999998653 4699999995555544 444 459999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+|||+++ +.+||+|||+++..... ....+||++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+
T Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 233 (367)
T 1cm8_A 156 PGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233 (367)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999985 78999999999886543 3567889999999998765667999999999999999999999999888776
Q ss_pred HHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++.++. ..+.+|+.+||..||++|||++++|+||||+.
T Consensus 234 ~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 234 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 665442 24688999999999999999999999999987
Q ss_pred CCC
Q 040202 197 CHF 199 (297)
Q Consensus 197 ~~~ 199 (297)
.+.
T Consensus 314 ~~~ 316 (367)
T 1cm8_A 314 LHD 316 (367)
T ss_dssp TC-
T ss_pred hcC
Confidence 543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=313.08 Aligned_cols=192 Identities=31% Similarity=0.505 Sum_probs=161.1
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+.++.+||||+++++++.+++.+|+||||+.| ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+
T Consensus 68 ~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~ 145 (342)
T 2qr7_A 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145 (342)
T ss_dssp HHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHH
Confidence 355666899999999999999999999999987 555555443 56999999999999999999999999999999999
Q ss_pred cEEEeC--C---eEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 82 NLLVSK--G---VIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 82 Nill~~--~---~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|||+.+ + .+||+|||+++..... ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 999843 2 4999999999876543 3345678999999999986543 5789999999999999999999998632
Q ss_pred ---CHHHHHHH---------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 156 ---SADQIYKI---------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 156 ---~~~~~~~i---------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+...++ ..++.+||++||..||++|||+.++++||||.+.
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 225 DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 22233332 3468999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=310.48 Aligned_cols=197 Identities=27% Similarity=0.483 Sum_probs=163.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++++.+||||+++++++.+.+..|+||||+.|+ +.+.+.......+++..++.++.||+.||+|||++||+||||||+|
T Consensus 82 l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~N 161 (327)
T 3lm5_A 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN 161 (327)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHH
Confidence 455557899999999999999999999999984 4444443334669999999999999999999999999999999999
Q ss_pred EEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
||++. +.+||+|||+++............||+.|+|||++... .++.++|||||||++|+|++|+.||.+.+..+
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 99975 68999999999988766555677899999999997654 45889999999999999999999999887766
Q ss_pred HHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCCC
Q 040202 159 QIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFVP 201 (297)
Q Consensus 159 ~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~~ 201 (297)
....+. ..+.++|.+||+.||++|||++++|+||||++..+..
T Consensus 241 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred HHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 655543 3588999999999999999999999999999876643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=319.77 Aligned_cols=193 Identities=33% Similarity=0.614 Sum_probs=156.7
Q ss_pred ccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++|+||+++++++... +.+|+||||++|++.+.+... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 157 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKP 157 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 344899999999999776 579999999999887776543 5699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC-----------------------CCccccccCCCCCCceecccccCCCccchhh
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL-----------------------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWA 136 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 136 (297)
+|||+++ +.+||+|||+++...... .....+||++|+|||++.....++.++||||
T Consensus 158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS 237 (432)
T 3n9x_A 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237 (432)
T ss_dssp GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence 9999985 789999999998765432 2367789999999998766677899999999
Q ss_pred HHHHHHHHHh-----------CCCCCCCCCC-----------------HHHHHH--------------------------
Q 040202 137 MGAIMFEMLS-----------FRILFPGKNS-----------------ADQIYK-------------------------- 162 (297)
Q Consensus 137 lGv~l~ell~-----------g~~pf~~~~~-----------------~~~~~~-------------------------- 162 (297)
+||++|||++ |..+|.+.+. .+++..
T Consensus 238 lG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 317 (432)
T 3n9x_A 238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317 (432)
T ss_dssp HHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred HHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 9999999998 4444544331 111111
Q ss_pred ----------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCCC
Q 040202 163 ----------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHFV 200 (297)
Q Consensus 163 ----------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~~ 200 (297)
+..++.+||++||..||++|||++|+|+||||++.++.
T Consensus 318 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred hCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 23467899999999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=314.65 Aligned_cols=188 Identities=36% Similarity=0.598 Sum_probs=151.9
Q ss_pred cccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
.+.++||||+++++++...+ ..|+||||++|++.+.+. ..+++..++.++.||+.||+|||++||+||||
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 153 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 153 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 34459999999999997655 789999999998887764 34999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||+++ +.+||+|||+++...........+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp CGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999985 79999999999887665555677899999999998754 4689999999999999999999999887765
Q ss_pred HHHHHH-----------------------------------------------------HHHHHHHHHHhhhcCCCCCCC
Q 040202 158 DQIYKI-----------------------------------------------------YGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 158 ~~~~~i-----------------------------------------------------~~~~~~li~~~l~~dP~~R~t 184 (297)
+...++ ...+++||++||..||++|||
T Consensus 233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 312 (371)
T 2xrw_A 233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312 (371)
T ss_dssp HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence 544333 346789999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 040202 185 AAEALEHPFFRSC 197 (297)
Q Consensus 185 ~~~ll~h~~f~~~ 197 (297)
++++|+||||+..
T Consensus 313 ~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 313 VDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHSHHHHTT
T ss_pred HHHHhCCcchhhh
Confidence 9999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=308.14 Aligned_cols=192 Identities=28% Similarity=0.424 Sum_probs=142.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++.+||||+++++++.+++..|+||||+.|+.+..+... .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 137 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence 44554699999999999999999999999988444444443 25699999999999999999999999999999999999
Q ss_pred EEeC-C---eEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC--
Q 040202 84 LVSK-G---VIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS-- 156 (297)
Q Consensus 84 ll~~-~---~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-- 156 (297)
|+++ + .+||+|||+++..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.
T Consensus 138 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 216 (325)
T 3kn6_A 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216 (325)
T ss_dssp EEEC----CEEEECCCTTCEECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC------
T ss_pred EEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCcccc
Confidence 9975 3 7999999999876443 333567789999999998654 458899999999999999999999986543
Q ss_pred -----HHHHHH---------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 157 -----ADQIYK---------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 157 -----~~~~~~---------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+...+ +..++++||.+||..||++|||++++++||||++.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 122222 34578999999999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=310.34 Aligned_cols=190 Identities=30% Similarity=0.469 Sum_probs=159.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++++.+++.+|+||||+.| ++.+.+... .+..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N 160 (351)
T 3c0i_A 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160 (351)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence 445999999999999999999999999997 555555543 23458999999999999999999999999999999999
Q ss_pred EEEeC-C---eEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 83 LLVSK-G---VIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 83 ill~~-~---~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||++. + .+||+|||+++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~- 238 (351)
T 3c0i_A 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE- 238 (351)
T ss_dssp EEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-
T ss_pred eEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH-
Confidence 99974 2 499999999988765432 3567899999999998654 458999999999999999999999987532
Q ss_pred HHHHH---------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 158 DQIYK---------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 158 ~~~~~---------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+.... +..++.+||.+||..||++|||+.++++||||+..
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 22222 23468899999999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=306.48 Aligned_cols=192 Identities=23% Similarity=0.492 Sum_probs=163.6
Q ss_pred cccccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+++++.+||||+++++++.+ ....++||||+.++.+..+... +++..++.++.||+.||+|||++||+||||||
T Consensus 83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 158 (330)
T 3nsz_A 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 158 (330)
T ss_dssp HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 34455459999999999998 6789999999998777666543 89999999999999999999999999999999
Q ss_pred CcEEEe-CC-eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH-
Q 040202 81 SNLLVS-KG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA- 157 (297)
Q Consensus 81 ~Nill~-~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~- 157 (297)
+|||++ ++ .+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||......
T Consensus 159 ~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 238 (330)
T 3nsz_A 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238 (330)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred HHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH
Confidence 999998 45 899999999998776666677889999999999876567799999999999999999999999544332
Q ss_pred HHHHH------------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 158 DQIYK------------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 158 ~~~~~------------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
+.... +..++.+||.+||..||++|||++|+|
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 22211 234678899999999999999999999
Q ss_pred cCCCCCCCC
Q 040202 190 EHPFFRSCH 198 (297)
Q Consensus 190 ~h~~f~~~~ 198 (297)
+||||++..
T Consensus 319 ~hp~f~~~~ 327 (330)
T 3nsz_A 319 EHPYFYTVV 327 (330)
T ss_dssp TSGGGTTCC
T ss_pred cCccHhhhc
Confidence 999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=302.53 Aligned_cols=188 Identities=24% Similarity=0.499 Sum_probs=164.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++..++..|+||||+.|+.+..+... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 97 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174 (321)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 345999999999999999999999999998777776654 459999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+ ++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8 4799999999998765432 3356689999999999765 45688999999999999999999999887766655444
Q ss_pred H--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 Y--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. ..+.+++.+||..||++|||+.++++||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 2 35789999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=305.18 Aligned_cols=194 Identities=28% Similarity=0.462 Sum_probs=153.9
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+.++.+||||+++++++.+++.+|+||||+.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 63 ~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 140 (316)
T 2ac3_A 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140 (316)
T ss_dssp HHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence 345556899999999999999999999999986 555555554 45999999999999999999999999999999999
Q ss_pred cEEEeC-C---eEEEEecCCceecCCC--------CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHH
Q 040202 82 NLLVSK-G---VIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 82 Nill~~-~---~~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell 145 (297)
|||++. + .+||+|||++...... ......+||+.|+|||++.. ...++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999975 3 3999999998765321 11234568999999999764 134688999999999999999
Q ss_pred hCCCCCCCCCCH---------------HHHHH---------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 146 SFRILFPGKNSA---------------DQIYK---------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 146 ~g~~pf~~~~~~---------------~~~~~---------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
+|+.||.+.... ..... +...+.+||++||..||++|||++++++||||+
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 999999876431 11111 233678999999999999999999999999998
Q ss_pred CCC
Q 040202 196 SCH 198 (297)
Q Consensus 196 ~~~ 198 (297)
+..
T Consensus 301 ~~~ 303 (316)
T 2ac3_A 301 GCA 303 (316)
T ss_dssp ---
T ss_pred CCC
Confidence 643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=328.27 Aligned_cols=193 Identities=27% Similarity=0.401 Sum_probs=165.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|||||++++++.+++.+|+||||+.|+.+..++.. ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318 (576)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence 345999999999999999999999999987555544443 2345999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---HHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS---ADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---~~~~ 160 (297)
+++ +.+||+|||+++...........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+
T Consensus 319 ld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i 397 (576)
T 2acx_A 319 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397 (576)
T ss_dssp ECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH
T ss_pred EeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH
Confidence 985 89999999999988766656677999999999998754 468999999999999999999999987643 2222
Q ss_pred H-HH-----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 161 Y-KI-----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 161 ~-~i-----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
. .+ ..++++||.+||..||.+|+ +++|+++||||++.+|
T Consensus 398 ~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 398 ERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 2 22 24689999999999999999 7899999999998765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=307.68 Aligned_cols=190 Identities=29% Similarity=0.450 Sum_probs=151.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+..|+||||+.|+.+..+... .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll 181 (349)
T 2w4o_A 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLY 181 (349)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEE
Confidence 334899999999999999999999999987444444433 2459999999999999999999999999999999999999
Q ss_pred e----CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH-
Q 040202 86 S----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI- 160 (297)
Q Consensus 86 ~----~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~- 160 (297)
+ ++.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 182 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 260 (349)
T 2w4o_A 182 ATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260 (349)
T ss_dssp SSSSTTCCEEECCCC----------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH
T ss_pred ecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH
Confidence 6 478999999999877665555677899999999997654 4689999999999999999999999877765532
Q ss_pred HHH---------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 YKI---------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~~i---------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.++ ..++.+||++||..||++|||+.++++||||++.
T Consensus 261 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 222 2368899999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=303.98 Aligned_cols=188 Identities=31% Similarity=0.475 Sum_probs=159.2
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+ ++.+|+||||++++.+..+.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 34599999999999986 678999999999865544433 24699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceeccccc--CCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEI--CGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|++. +.+||+|||+++...... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 9985 799999999998765432 2345689999999999865432 46789999999999999999999988766554
Q ss_pred HHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 160 IYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 160 ~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
..++. ..+.++|.+||..||++|||+.++++||||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 44432 3689999999999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=295.17 Aligned_cols=187 Identities=29% Similarity=0.526 Sum_probs=164.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil 138 (277)
T 3f3z_A 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138 (277)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence 334999999999999999999999999987 555555554 45999999999999999999999999999999999999
Q ss_pred E---e-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 V---S-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l---~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
+ + ++.+||+|||++.............||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.+.+..+..
T Consensus 139 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (277)
T 3f3z_A 139 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216 (277)
T ss_dssp ESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9 4 36899999999988877666677889999999998753 3689999999999999999999999987776655
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.++. ..+.+++.+||..||++|||+.++++||||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 217 LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 5443 36789999999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.91 Aligned_cols=191 Identities=32% Similarity=0.594 Sum_probs=156.2
Q ss_pred ccccccceeeeceeEEe-----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++||||+++++++.. ...+|+||||+.|++++.+... +..+++..++.++.||+.||+|||++||+||||||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 162 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP 162 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCCh
Confidence 34489999999999954 3478999999999988887754 34699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+|||+++ +.+||+|||+++............||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp GGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999984 899999999998766655556778999999999987656678999999999999999999999998876666
Q ss_pred HHHHH-------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 IYKIY-------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ~~~i~-------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..++. ..+.+||.+||..||++|||+.++++||||+.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 55442 24788999999999999999999999999987
Q ss_pred C
Q 040202 197 C 197 (297)
Q Consensus 197 ~ 197 (297)
.
T Consensus 323 ~ 323 (362)
T 3pg1_A 323 L 323 (362)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.58 Aligned_cols=190 Identities=34% Similarity=0.618 Sum_probs=161.3
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||++|+++..+.... ..+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~ 157 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV 157 (331)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE
Confidence 3458999999999999999999999999999888876543 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+. +.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+...++
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (331)
T 4aaa_A 158 SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237 (331)
T ss_dssp CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 85 79999999999765432 23355678999999999876656789999999999999999999999988776655443
Q ss_pred ------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 ------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...+.+|+.+||..||++|||+.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 235789999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=301.73 Aligned_cols=191 Identities=27% Similarity=0.443 Sum_probs=165.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~ 148 (321)
T 2a2a_A 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148 (321)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE
Confidence 345899999999999999999999999987555444444 3569999999999999999999999999999999999999
Q ss_pred eC-C----eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 86 SK-G----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~----~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++ + .+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 149 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 227 (321)
T 2a2a_A 149 LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227 (321)
T ss_dssp SCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred ecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 75 4 699999999998877665667789999999999764 44588999999999999999999999887766655
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
..+. ..+.++|.+||..||++|||+.++++||||+...
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 228 ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 4432 3578999999999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.07 Aligned_cols=190 Identities=33% Similarity=0.535 Sum_probs=164.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++++.+||||+++++++...+..|+||||+.| ++.+.+... ..+++..++.++.||+.||+|||+.||+||||||+|
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~N 230 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 33445899999999999999999999999998 455555443 459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc-----ccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-----EICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
||+++ +.+||+|||++............+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 310 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence 99985 79999999999988776666778899999999987632 2468899999999999999999999988776
Q ss_pred HHHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 157 ADQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 157 ~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
......+. ..+.++|.+||..||++|||+.++++||||+
T Consensus 311 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 65554443 2478999999999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=319.15 Aligned_cols=188 Identities=30% Similarity=0.548 Sum_probs=166.5
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+.+.+|+|||||.| ++++.+... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 167 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhE
Confidence 3455999999999999999999999999987 566666655 4599999999999999999999999999999999999
Q ss_pred EEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|++. +.+||+|||+++...........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus 168 l~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp EESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9963 459999999999887766667788999999999875 3468999999999999999999999998887776
Q ss_pred HHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 IYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..++. ..+++||++||+.||.+|||+.++|+||||+.
T Consensus 246 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 66553 36789999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=297.52 Aligned_cols=189 Identities=31% Similarity=0.501 Sum_probs=157.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++++.+.+..|+||||+.| ++.+.+... .+..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 75 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 154 (285)
T 3is5_A 75 KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154 (285)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred HhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHH
Confidence 345999999999999999999999999987 666665432 23569999999999999999999999999999999999
Q ss_pred EEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|++++ +.+||+|||+++............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~ 232 (285)
T 3is5_A 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232 (285)
T ss_dssp EEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH
Confidence 99943 579999999998776655556778999999999875 345889999999999999999999998877665
Q ss_pred HHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...++ ...+.+|+.+||+.||++|||+.|+++||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 54443 236789999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.58 Aligned_cols=190 Identities=22% Similarity=0.327 Sum_probs=162.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.++ .+..+... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 84 ~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 162 (335)
T 3dls_A 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV 162 (335)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEE
Confidence 3449999999999999999999999999653 44444443 246999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH----
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ---- 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~---- 159 (297)
+++ +.+||+|||+++...........+||+.|+|||++.+..+++.++|||||||++|+|++|+.||........
T Consensus 163 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 242 (335)
T 3dls_A 163 IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH 242 (335)
T ss_dssp ECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCC
T ss_pred EcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccC
Confidence 985 799999999999887776667788999999999988766668899999999999999999999975332110
Q ss_pred -HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 -IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 -~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...+..++.+||.+||..||++|||++++++||||++
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0113457899999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=305.98 Aligned_cols=187 Identities=26% Similarity=0.465 Sum_probs=164.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|++.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 187 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 344999999999999999999999999999888877655 3569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++ +.+||+|||+++..... ....||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+..+...+
T Consensus 188 ~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 264 (348)
T 1u5q_A 188 SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264 (348)
T ss_dssp ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 85 89999999999876543 45689999999999753 34568899999999999999999999988877666555
Q ss_pred HH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 163 IY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 163 i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+. ..+.+||.+||..||++|||++++++||||..
T Consensus 265 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 265 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 43 35789999999999999999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=298.91 Aligned_cols=192 Identities=26% Similarity=0.423 Sum_probs=152.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPS 81 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~ 81 (297)
.+.++||||+++++++.+++..|+||||++|++.+.+.. ..+..+++..++.++.|++.||+|||++ ||+||||||+
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~ 139 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 455699999999999999999999999999987666544 2345799999999999999999999998 9999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceec---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL---LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||++++ +.+||+|||+++............||+.|+|||++. ....++.++||||+||++|+|++|+.||......
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (290)
T 3fme_A 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219 (290)
T ss_dssp GCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH
T ss_pred HEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch
Confidence 999986 899999999998876665556668999999999962 3455688999999999999999999999874433
Q ss_pred H-HHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 D-QIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~-~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. ..... ..++.+++.+||..||++|||+.++++||||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 220 FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 2 22222 236899999999999999999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=305.83 Aligned_cols=189 Identities=40% Similarity=0.708 Sum_probs=163.6
Q ss_pred ccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++||||+++++++... ...|+||||++|++.+.+.. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 156 (364)
T 3qyz_A 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP 156 (364)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh
Confidence 334999999999999755 47999999999988776654 3599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
+|||++. +.+||+|||+++...... .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+
T Consensus 157 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 157 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp GGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999985 789999999998764332 23456899999999988766667999999999999999999999999887
Q ss_pred CHHHHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 156 SADQIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 156 ~~~~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
..+...++. .++.+||.+||+.||++|||+.++|+|||
T Consensus 237 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 237 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp GGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 766655542 35789999999999999999999999999
Q ss_pred CCCC
Q 040202 194 FRSC 197 (297)
Q Consensus 194 f~~~ 197 (297)
|+..
T Consensus 317 ~~~~ 320 (364)
T 3qyz_A 317 LEQY 320 (364)
T ss_dssp GTTT
T ss_pred hhhc
Confidence 9864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=318.23 Aligned_cols=189 Identities=33% Similarity=0.552 Sum_probs=164.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+.+.+|+||||+.| ++.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 76 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 153 (486)
T 3mwu_A 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153 (486)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence 344999999999999999999999999987 566666655 45999999999999999999999999999999999999
Q ss_pred EeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++. +.+||+|||+++...........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+..
T Consensus 154 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 231 (486)
T 3mwu_A 154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231 (486)
T ss_dssp ESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 952 4799999999987776666677889999999999764 3689999999999999999999999988877766
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.++. .++++||.+||..||.+|||+.++|+||||+...
T Consensus 232 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 5543 3689999999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=318.34 Aligned_cols=188 Identities=31% Similarity=0.532 Sum_probs=166.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++.+|+|||||.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 101 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178 (504)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence 344999999999999999999999999987 566666655 45999999999999999999999999999999999999
Q ss_pred EeC-C---eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK-G---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~---~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++. + .+||+|||+++...........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+..
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 975 3 69999999999887776667788999999999875 34689999999999999999999999988776665
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.++. .++++||++||..||.+|||++++|+||||+..
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 5543 468999999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=293.94 Aligned_cols=191 Identities=29% Similarity=0.469 Sum_probs=166.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 137 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 137 (284)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence 334999999999999999999999999987 555666655 45999999999999999999999999999999999999
Q ss_pred EeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++. +.+||+|||++.............||+.|+|||++.+. .++.++||||+|+++|+|++|+.||.+.+.....
T Consensus 138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 216 (284)
T 3kk8_A 138 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216 (284)
T ss_dssp ESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH
Confidence 963 34999999999888766655677899999999997654 4588999999999999999999999887766655
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
..+. .++.+++.+||+.||++|||+.++++||||++...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 217 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 5442 36899999999999999999999999999986443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=298.04 Aligned_cols=190 Identities=34% Similarity=0.617 Sum_probs=166.1
Q ss_pred cccceeeeceeEE-----eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 9 NHPNIVKLRNLVK-----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 9 ~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+||||+++++++. .....|+||||+.|++.+.+.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Ni 151 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHe
Confidence 8999999999997 56789999999999888877765555699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++. +.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...+
T Consensus 152 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 230 (326)
T 1blx_A 152 LVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230 (326)
T ss_dssp EECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 9975 79999999999876554444567889999999998654 468999999999999999999999998887766655
Q ss_pred HH--------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 163 IY--------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~--------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
+. ..+.+|+.+||..||.+|||+.++++||||++...
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 43 24579999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=303.69 Aligned_cols=184 Identities=22% Similarity=0.403 Sum_probs=153.3
Q ss_pred cceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeCCeE
Q 040202 11 PNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVI 90 (297)
Q Consensus 11 pnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~~~~ 90 (297)
+||+++++++.+++.+|+|||+.+|++.+.+... +.+++.+++.++.||+.||+|||++||+||||||+|||++++.+
T Consensus 69 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~ 146 (343)
T 3dbq_A 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML 146 (343)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEE
T ss_pred CceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcE
Confidence 9999999999999999999997777777777654 56999999999999999999999999999999999999999999
Q ss_pred EEEecCCceecCCCC---CCccccccCCCCCCceecc----------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 91 KIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLL----------SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 91 kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||+++...... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+....
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 999999998764432 2345689999999999754 245688999999999999999999999875543
Q ss_pred H-HHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 D-QIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~-~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. ....+. .++.+|+.+||..||.+|||+.++++||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 2 222222 36889999999999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=293.74 Aligned_cols=190 Identities=29% Similarity=0.472 Sum_probs=141.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+..|+||||+.++.+..+.......+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145 (278)
T ss_dssp TTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred HhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 44599999999999999999999999999866666665545679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++ +.+||+|||++...... .......||+.|+|||++.+. .++.++||||+|+++|+|++|+.||......+...+
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 224 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224 (278)
T ss_dssp CTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C
T ss_pred cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH
Confidence 85 79999999999876532 222456789999999987644 458899999999999999999999987655443332
Q ss_pred ----------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 163 ----------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 163 ----------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+..++.+++.+||..||++|||++++++||||.+
T Consensus 225 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 225 VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred hhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 2347899999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=306.90 Aligned_cols=187 Identities=40% Similarity=0.698 Sum_probs=158.0
Q ss_pred ccccccceeeeceeEEeCCeE------EEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDV------FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~------~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++||||+++++++...+.. |+||||+.+++.+.+ +..+++..++.++.||+.||+|||++||+|||||
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 171 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 171 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcC
Confidence 445899999999999877655 999999998776654 2459999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+|||+++ +.+||+|||+++...... ....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+
T Consensus 172 p~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 249 (371)
T 4exu_A 172 PGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 249 (371)
T ss_dssp GGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHHeEECCCCCEEEEecCcccccccCc--CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999985 789999999998765442 567889999999998765667899999999999999999999999887666
Q ss_pred HHHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...++ ...+.+||.+||+.||++|||+.++|+||||+.
T Consensus 250 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 250 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 55443 235789999999999999999999999999986
Q ss_pred CC
Q 040202 197 CH 198 (297)
Q Consensus 197 ~~ 198 (297)
..
T Consensus 330 ~~ 331 (371)
T 4exu_A 330 FR 331 (371)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=307.23 Aligned_cols=185 Identities=31% Similarity=0.468 Sum_probs=159.1
Q ss_pred cccceeeeceeEE----eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcE
Q 040202 9 NHPNIVKLRNLVK----EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNL 83 (297)
Q Consensus 9 ~HpnIv~~~~~~~----~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~Ni 83 (297)
+|+||+++++++. ++..+|+||||+++++++.+.......+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI 178 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence 4899999999998 55689999999999999998887556799999999999999999999998 999999999999
Q ss_pred EEeCC--------------------------------------------------eEEEEecCCceecCCCCCCcccccc
Q 040202 84 LVSKG--------------------------------------------------VIKIGDLGMVKEIDSSLPCTDYVTT 113 (297)
Q Consensus 84 ll~~~--------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~gt 113 (297)
|++.+ .+||+|||+++..... ....+||
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt 256 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQT 256 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSC
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCC
Confidence 99753 6999999999877554 3566899
Q ss_pred CCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH------HHHH--------------------------
Q 040202 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA------DQIY-------------------------- 161 (297)
Q Consensus 114 ~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~------~~~~-------------------------- 161 (297)
+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. +...
T Consensus 257 ~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 257 RQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp GGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 9999999987554 688999999999999999999999865531 1111
Q ss_pred ---------------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 ---------------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ---------------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.....+.+||.+||+.||++|||++|+|+||||++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 12235779999999999999999999999999963
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.40 Aligned_cols=188 Identities=38% Similarity=0.646 Sum_probs=149.2
Q ss_pred ccccccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++||||+++++++... ...|+|+||+++++.+.+. . ..+++..++.++.||+.||+|||++||+|||||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk 159 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-C--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHh-c--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 445899999999999754 5689999999766655543 3 459999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+|||+++ +.+||+|||+++..... .....||++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+
T Consensus 160 p~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 237 (367)
T 2fst_X 160 PSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237 (367)
T ss_dssp GGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999985 78999999999876543 3567899999999998765677999999999999999999999999888766
Q ss_pred HHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+...+. ..+.+||++||..||++|||+.++|+||||+.
T Consensus 238 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 655442 24689999999999999999999999999986
Q ss_pred CC
Q 040202 197 CH 198 (297)
Q Consensus 197 ~~ 198 (297)
..
T Consensus 318 ~~ 319 (367)
T 2fst_X 318 YH 319 (367)
T ss_dssp TC
T ss_pred cc
Confidence 54
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.42 Aligned_cols=185 Identities=30% Similarity=0.514 Sum_probs=161.5
Q ss_pred ccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEe-
Q 040202 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH--RQGYFHRDLKPSNLLVS- 86 (297)
Q Consensus 10 HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH--~~gi~Hrdikp~Nill~- 86 (297)
|++|+++++++...+..|+||||++|++.+.+.......+++..++.++.|++.||.||| +.||+||||||+|||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred ceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence 335999999999999999999999999888887765456999999999999999999999 57999999999999995
Q ss_pred --CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 040202 87 --KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY 164 (297)
Q Consensus 87 --~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~ 164 (297)
++.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...++.
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 367999999999887544 3567899999999998755 46899999999999999999999999887766655443
Q ss_pred ---------------------------------------------------------------------------HHHHH
Q 040202 165 ---------------------------------------------------------------------------GRWVA 169 (297)
Q Consensus 165 ---------------------------------------------------------------------------~~~~~ 169 (297)
..+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 25689
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 170 LISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 170 li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
||.+||+.||++|||++|+|+||||+..
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=319.19 Aligned_cols=193 Identities=25% Similarity=0.379 Sum_probs=163.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++++.+.+.+|+||||+.|+.+..++... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~N 319 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319 (543)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHH
Confidence 3459999999999999999999999999986555544432 2469999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC----
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS---- 156 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~---- 156 (297)
||++. |.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 320 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~ 398 (543)
T 3c4z_A 320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398 (543)
T ss_dssp EEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred EEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence 99985 8999999999988765433 345689999999999875 4568999999999999999999999987642
Q ss_pred HHHHHHH-----------HHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 157 ADQIYKI-----------YGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 157 ~~~~~~i-----------~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
.+...++ ...+.+||++||..||.+||+ ++++++||||++.+|
T Consensus 399 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 399 KELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 2233333 236899999999999999996 589999999998776
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=294.81 Aligned_cols=189 Identities=29% Similarity=0.476 Sum_probs=159.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++.+.+..|+||||+.++. .+.+... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni 140 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence 344589999999999999999999999999754 4555444 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
++++ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....
T Consensus 141 li~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 218 (279)
T 3fdn_A 141 LLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218 (279)
T ss_dssp EECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 9975 799999999986654432 245678999999998764 4558899999999999999999999998777666655
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+. ..+.+||.+||..||++|||+.++++||||+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 219 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 43 368899999999999999999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.75 Aligned_cols=188 Identities=32% Similarity=0.523 Sum_probs=165.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+.+..|+||||+.| ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 81 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 158 (484)
T 3nyv_A 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL 158 (484)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 445999999999999999999999999987 555555543 56999999999999999999999999999999999999
Q ss_pred Ee----CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~----~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
++ ++.+||+|||+++...........+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+..
T Consensus 159 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 236 (484)
T 3nyv_A 159 LESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236 (484)
T ss_dssp ESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 94 36899999999988776666667789999999999764 4689999999999999999999999998877766
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.++. ..+++||++||..||.+|||+.++|+||||+..
T Consensus 237 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 237 KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 6543 368999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=309.45 Aligned_cols=192 Identities=21% Similarity=0.406 Sum_probs=157.8
Q ss_pred cccccc-ccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNN-HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~-HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
|.++.. |+||+++++++.+++.+|+|||+..+++.+.+... ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N 185 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGG
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 344432 69999999999999999999996656777666554 469999999999999999999999999999999999
Q ss_pred EEEeCCeEEEEecCCceecCCCC---CCccccccCCCCCCceecc----------cccCCCccchhhHHHHHHHHHhCCC
Q 040202 83 LLVSKGVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLL----------SEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 83 ill~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
||++++.+||+|||+++...... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.
T Consensus 186 Ill~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~ 265 (390)
T 2zmd_A 186 FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265 (390)
T ss_dssp EEESSSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEECCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCC
Confidence 99999999999999998764432 2346689999999999864 1356889999999999999999999
Q ss_pred CCCCCCCH-HHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 150 LFPGKNSA-DQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 150 pf~~~~~~-~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
||.+.... .....+. .++.+||.+||..||++|||+.++++||||+..
T Consensus 266 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 266 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 99876543 2333322 368899999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=295.61 Aligned_cols=185 Identities=30% Similarity=0.492 Sum_probs=160.2
Q ss_pred ccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC--
Q 040202 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-- 87 (297)
Q Consensus 10 HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-- 87 (297)
|++|+++++++.+++..|+||||+++++.+.+.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp TTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred ceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 445999999999999999999999888888887765457999999999999999999999999999999999999964
Q ss_pred ------------------CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 88 ------------------GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 88 ------------------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
+.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH--STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSCC--CSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCccccccccccCCCceEeeCcccccCcccc--ccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCC
Confidence 369999999998765433 566889999999998754 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHH-------------------------------------------------------HHHHHHHHHHh
Q 040202 150 LFPGKNSADQIYKI-------------------------------------------------------YGRWVALISWL 174 (297)
Q Consensus 150 pf~~~~~~~~~~~i-------------------------------------------------------~~~~~~li~~~ 174 (297)
||.+.+..+....+ ...+.+||.+|
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 99887765543322 23567999999
Q ss_pred hhcCCCCCCCHHHHHcCCCCCCC
Q 040202 175 CSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 175 l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
|..||.+|||+.|+++||||+..
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hCcCcccccCHHHHhcCHHHHHH
Confidence 99999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=304.69 Aligned_cols=194 Identities=25% Similarity=0.432 Sum_probs=159.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
|.++.+||||+++++++.+++.+|+||||+.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 189 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 34444799999999999999999999999987 555555544 459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
||+++ +.+||+|||+++..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.......
T Consensus 190 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 269 (355)
T 1vzo_A 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269 (355)
T ss_dssp EEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred EEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc
Confidence 99985 79999999999865332 222456799999999998753 346789999999999999999999997543321
Q ss_pred ----HHHHH-----------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 159 ----QIYKI-----------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 159 ----~~~~i-----------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
....+ ...+.+||.+||..||++|| +++++++|+||+...+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 270 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred hHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 12222 23578999999999999999 9999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=293.66 Aligned_cols=193 Identities=32% Similarity=0.514 Sum_probs=166.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
++++.+||||+++++++.+++..|+||||+.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 44554699999999999999999999999987 555555444 459999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL-----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|++++ +.+||+|||++.............|++.|+|||++.. ...++.++||||||+++|+|++|+.||.+.+.
T Consensus 155 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 155 ILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 99985 7899999999988776666667789999999998752 34467899999999999999999999988776
Q ss_pred HHHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 157 ADQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 157 ~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
......+. ..+.+++.+||..||++|||+.++++||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 55544432 3688999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.13 Aligned_cols=184 Identities=28% Similarity=0.471 Sum_probs=160.7
Q ss_pred eeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-------
Q 040202 13 IVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV------- 85 (297)
Q Consensus 13 Iv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill------- 85 (297)
|+.+++++...+..|+||||+++++++.+.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 9999999999999999999999999998887755679999999999999999999999999999999999999
Q ss_pred ------------e-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 86 ------------S-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 86 ------------~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
+ ++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSCC--CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCcEEEeecCccccccccc--cCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCC
Confidence 3 3689999999998765433 566899999999998754 45899999999999999999999998
Q ss_pred CCCCHHHHHHH-------------------------------------------------------HHHHHHHHHHhhhc
Q 040202 153 GKNSADQIYKI-------------------------------------------------------YGRWVALISWLCSW 177 (297)
Q Consensus 153 ~~~~~~~~~~i-------------------------------------------------------~~~~~~li~~~l~~ 177 (297)
+.+..+....+ ...+.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 87765543322 12567999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCCCC
Q 040202 178 NPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 178 dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
||++|||+.++++||||++..+
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCCH
T ss_pred ChhhCcCHHHHhcChhhcCCCh
Confidence 9999999999999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.26 Aligned_cols=189 Identities=30% Similarity=0.498 Sum_probs=154.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+.+..|+||||+.| ++.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143 (276)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence 345899999999999999999999999987 555555444 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++. +.+||+|||++.............|++.|+|||++.+....+.++||||+|+++|+|++|+.||.+........++
T Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 223 (276)
T 2h6d_A 144 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223 (276)
T ss_dssp ECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 985 7999999999987766555556788999999999876555568899999999999999999999887766555544
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. ..+.+++.+||..||++|||+.++++||||++
T Consensus 224 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 224 RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred hcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 3 36889999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.68 Aligned_cols=192 Identities=28% Similarity=0.395 Sum_probs=160.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++||||+++++++.+++..|+||||+.|+.+..+... ...+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 137 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEE
Confidence 3445999999999999999999999999988444443333 245999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||++...... .......||+.|+|||++.+...++.++||||+|+++|+|++|+.||.+.......
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 217 (276)
T 2yex_A 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (276)
T ss_dssp ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH
T ss_pred EccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 985 89999999999765322 22345678999999999876665577899999999999999999999876653322
Q ss_pred H--------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 Y--------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~--------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
. .+...+.+++.+||..||++|||++++++||||++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 1 123468899999999999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=293.97 Aligned_cols=193 Identities=24% Similarity=0.476 Sum_probs=162.7
Q ss_pred ccccccceeeeceeE--EeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLV--KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~--~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++ .+.+..|+||||+.+++.+.+.......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NI 140 (305)
T 2wtk_C 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140 (305)
T ss_dssp TTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 344899999999998 455689999999999987777765556799999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++++ +.+||+|||++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 141 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 220 (305)
T 2wtk_C 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220 (305)
T ss_dssp EECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Confidence 9974 79999999999876432 223456789999999987643 234678999999999999999999999877666
Q ss_pred HHHHHH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 159 QIYKIY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 159 ~~~~i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
....+. ..+.+++.+||..||++|||+.++++||||+...
T Consensus 221 ~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 221 LFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 555543 3678999999999999999999999999998644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=293.47 Aligned_cols=190 Identities=26% Similarity=0.365 Sum_probs=156.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA--GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~--~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++.+||||+++++++.+++..|+||||++| ++.+.+.... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 64 ~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp 143 (289)
T 1x8b_A 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP 143 (289)
T ss_dssp HHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCH
Confidence 34445999999999999999999999999987 5555554431 25699999999999999999999999999999999
Q ss_pred CcEEEeC--------------------CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHH
Q 040202 81 SNLLVSK--------------------GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAI 140 (297)
Q Consensus 81 ~Nill~~--------------------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~ 140 (297)
+|||++. ..+||+|||++...... ....||+.|+|||++.+...++.++|||||||+
T Consensus 144 ~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 220 (289)
T 1x8b_A 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALT 220 (289)
T ss_dssp GGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHH
T ss_pred HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHH
Confidence 9999963 26899999999887654 345689999999998765556689999999999
Q ss_pred HHHHHhCCCCCCCCCCHHHHH---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 141 MFEMLSFRILFPGKNSADQIY---------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 141 l~ell~g~~pf~~~~~~~~~~---------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+|+|++|..++.......... .+...+.+++.+||..||++|||+.++++||||++
T Consensus 221 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 221 VVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHTTCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHHhcCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 999999998775443322221 12347899999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=302.73 Aligned_cols=193 Identities=33% Similarity=0.474 Sum_probs=158.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---------------------------------------cC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---------------------------------------AG 46 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---------------------------------------~~ 46 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... ..
T Consensus 83 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (345)
T 3hko_A 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD 162 (345)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred HhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344899999999999999999999999987555444421 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-C--eEEEEecCCceecCCC-----CCCccccccCCCCC
Q 040202 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G--VIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRA 118 (297)
Q Consensus 47 ~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~--~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~a 118 (297)
..+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+++..... .......||+.|+|
T Consensus 163 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 242 (345)
T 3hko_A 163 FVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence 12468889999999999999999999999999999999974 3 7999999999875331 12346678999999
Q ss_pred Cceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------HHHHHHHHHhhhcCCCCC
Q 040202 119 PEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY---------------GRWVALISWLCSWNPRMR 182 (297)
Q Consensus 119 PE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~---------------~~~~~li~~~l~~dP~~R 182 (297)
||++.+. ..++.++|||||||++|+|++|+.||.+.+..+...++. ..+.+||.+||..||.+|
T Consensus 243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9998642 556889999999999999999999999888777665543 368999999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q 040202 183 PTAAEALEHPFFRSCH 198 (297)
Q Consensus 183 ~t~~~ll~h~~f~~~~ 198 (297)
||+.++++||||++..
T Consensus 323 ps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 323 FDAMRALQHPWISQFS 338 (345)
T ss_dssp CCHHHHHHSHHHHTTS
T ss_pred CCHHHHhcChhhccCh
Confidence 9999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=289.64 Aligned_cols=187 Identities=28% Similarity=0.415 Sum_probs=157.0
Q ss_pred ccccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdik 79 (297)
+.++||||+++++++.+ ++.+|+||||+.|+.+..+.... +.+++..++.++.||+.||+|||++| |+|||||
T Consensus 80 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dik 158 (290)
T 1t4h_A 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158 (290)
T ss_dssp TTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred HhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCC
Confidence 34499999999999875 45799999999875554444432 45999999999999999999999999 9999999
Q ss_pred CCcEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 80 PSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 80 p~Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|+|||++ ++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....
T Consensus 159 p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 235 (290)
T 1t4h_A 159 CDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp GGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred HHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH
Confidence 9999997 479999999999755443 2345678999999998753 3689999999999999999999999886665
Q ss_pred HHHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 DQIYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 ~~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
....... .++.++|.+||..||++|||+.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 5544322 36899999999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.54 Aligned_cols=189 Identities=32% Similarity=0.518 Sum_probs=148.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.. +..|+||||+.|+ +.+.+... +.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 195 ~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 271 (419)
T 3i6u_A 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271 (419)
T ss_dssp HHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 33499999999999864 5689999999874 44444332 56999999999999999999999999999999999999
Q ss_pred EeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++. ..+||+|||+++...........+||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.....
T Consensus 272 l~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp ESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred EecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 963 3599999999998776666677889999999999753 3455789999999999999999999997654322
Q ss_pred HH----------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 159 QI----------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 159 ~~----------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.. ..+...+.+||.+||+.||++|||++++|+||||++.
T Consensus 352 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 11 1234578999999999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=298.33 Aligned_cols=191 Identities=29% Similarity=0.432 Sum_probs=163.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+++..|+||||+.|+.+..+.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 173 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE
Confidence 34459999999999999999999999999975544444432 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....
T Consensus 174 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 252 (335)
T 2owb_A 174 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252 (335)
T ss_dssp ECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 985 78999999999876532 333556789999999998654 458899999999999999999999988776665544
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+. ..+.++|.+||..||++|||++++++|+||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 43 367899999999999999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=289.82 Aligned_cols=190 Identities=29% Similarity=0.433 Sum_probs=162.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||++|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 148 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL 148 (294)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 4459999999999999999999999999975554444442 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+|+++|+|++|+.||.+....+....+
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 227 (294)
T 2rku_A 149 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227 (294)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 85 78999999999876532 333456789999999997644 4588999999999999999999999887766555444
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
. ..+.+++.+||..||++|||++++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 228 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred hhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 2 367899999999999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=292.34 Aligned_cols=192 Identities=25% Similarity=0.436 Sum_probs=154.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKES------AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~------~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
+.++||||+++++++.+++..|+||||+.|+ +.+.+... ....+++..++.++.||+.||+|||++||+||||
T Consensus 68 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 147 (303)
T 2vwi_A 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 147 (303)
T ss_dssp CCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3348999999999999999999999999874 44444321 2345999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCC------CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSS------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
||+||++++ +.+||+|||++...... .......||+.|+|||++.....++.++|||||||++|+|++|+.||
T Consensus 148 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 227 (303)
T 2vwi_A 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227 (303)
T ss_dssp SGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999985 79999999998765432 12235578999999999865455689999999999999999999999
Q ss_pred CCCCCHHHHHHH---------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 152 PGKNSADQIYKI---------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 152 ~~~~~~~~~~~i---------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+.......... ...+.+++.+||..||.+|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 228 HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 876655443322 2357899999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.83 Aligned_cols=194 Identities=26% Similarity=0.353 Sum_probs=155.4
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+|+++.+|||||++++++.+++..|+||||+.|++.+.+... ...+.+..++.++.||+.||+|||++||+||||||+|
T Consensus 70 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~N 148 (432)
T 3p23_A 70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN 148 (432)
T ss_dssp HHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTS
T ss_pred HHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHH
Confidence 344555899999999999999999999999999888777654 3346677788999999999999999999999999999
Q ss_pred EEEeC----C--eEEEEecCCceecCCC----CCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHh-CCC
Q 040202 83 LLVSK----G--VIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 83 ill~~----~--~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
||++. + .+||+|||+++..... ......+||+.|+|||++.. ...++.++||||+||++|||++ |..
T Consensus 149 Ill~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~ 228 (432)
T 3p23_A 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228 (432)
T ss_dssp EEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred EEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99952 2 5789999999876543 22345679999999999864 2345678999999999999999 999
Q ss_pred CCCCCCCHHHHH--------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 150 LFPGKNSADQIY--------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 150 pf~~~~~~~~~~--------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
||.......... .....+.+||.+||+.||++|||+.++++||||...
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred CcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 996654433221 123357899999999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=294.57 Aligned_cols=171 Identities=25% Similarity=0.401 Sum_probs=136.1
Q ss_pred eEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe-CCeEEEEecCCceec
Q 040202 25 DVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI 101 (297)
Q Consensus 25 ~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~-~~~~kl~Dfgla~~~ 101 (297)
.+|+||||+.|+.+..+..... ...++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 3899999999866655555422 2356677999999999999999999999999999999998 489999999999877
Q ss_pred CCC-------------CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC----------CHH
Q 040202 102 DSS-------------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN----------SAD 158 (297)
Q Consensus 102 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~----------~~~ 158 (297)
... ......+||+.|+|||++.+. .++.++||||+||++|+|++|..++.... ...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~ 293 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPL 293 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCH
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCc
Confidence 553 223456799999999998754 45899999999999999999876642211 011
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
........+.+++.+||+.||++|||+.++++||||++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11223346789999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.33 Aligned_cols=187 Identities=26% Similarity=0.459 Sum_probs=162.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.+ ++.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 69 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 445899999999999999999999999987 555555554 45999999999999999999999999999999999999
Q ss_pred Ee-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ ++.+||+|||++....... .....|++.|+|||++.+. .++.++||||+|+++|+|++|..||...+..+....+
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 224 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence 97 4899999999997665432 3456789999999997654 4588999999999999999999999887766655544
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. ..+.++|.+||..||.+|||++++++||||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 225 VNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred hccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 3 46889999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.22 Aligned_cols=185 Identities=18% Similarity=0.272 Sum_probs=150.9
Q ss_pred cccccceeeec-------eeEEeCC-----------------eEEEEEecCCCcHHHHHHHhcCCCCCH-------HHHH
Q 040202 7 MNNHPNIVKLR-------NLVKEHE-----------------DVFIVFDYMESDLLKLMKESAGQNFSE-------DEAR 55 (297)
Q Consensus 7 l~~HpnIv~~~-------~~~~~~~-----------------~~~lv~e~~~g~ll~~~~~~~~~~l~e-------~~~~ 55 (297)
.++|||||+++ +++++.+ ..|+||||++|++.+.+.... .+++ ..+.
T Consensus 132 ~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~ 209 (377)
T 3byv_A 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARL 209 (377)
T ss_dssp TCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHH
T ss_pred ccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHH
Confidence 34899999999 7766554 389999999888877776542 2444 8888
Q ss_pred HHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc---------
Q 040202 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS--------- 125 (297)
Q Consensus 56 ~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--------- 125 (297)
.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+++.... .....+| +.|+|||++.+.
T Consensus 210 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccc
Confidence 99999999999999999999999999999984 8999999999987544 2356677 999999998755
Q ss_pred -ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 126 -EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK-------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 126 -~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~-------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..++.++|||||||++|||++|+.||.+.+....... +..++.+||.+||+.||++|||+.++++||||++
T Consensus 287 ~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred cccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 2568999999999999999999999987654333322 2457899999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=296.25 Aligned_cols=191 Identities=35% Similarity=0.646 Sum_probs=159.9
Q ss_pred ccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++||||+++++++... ...|+||||+.|++.+.+.. +.+++..++.++.|++.||+|||++||+||||||
T Consensus 64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp 140 (353)
T 2b9h_A 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKP 140 (353)
T ss_dssp HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 344899999999988754 68999999999887766654 4599999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCC-----------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSL-----------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFR 148 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~ 148 (297)
+|||++. +.+||+|||+++...... .....+||+.|+|||++.....++.++|||||||++|+|++|+
T Consensus 141 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 220 (353)
T 2b9h_A 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220 (353)
T ss_dssp GGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCC
Confidence 9999985 789999999998764321 1234578999999998876666789999999999999999999
Q ss_pred CCCCCCCCHHHHHHH-------------------------------------------HHHHHHHHHHhhhcCCCCCCCH
Q 040202 149 ILFPGKNSADQIYKI-------------------------------------------YGRWVALISWLCSWNPRMRPTA 185 (297)
Q Consensus 149 ~pf~~~~~~~~~~~i-------------------------------------------~~~~~~li~~~l~~dP~~R~t~ 185 (297)
.||.+.+..+....+ ..++.+||.+||..||++|||+
T Consensus 221 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (353)
T 2b9h_A 221 PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300 (353)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence 999887654433222 2356799999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 040202 186 AEALEHPFFRSCHF 199 (297)
Q Consensus 186 ~~ll~h~~f~~~~~ 199 (297)
.++++||||+....
T Consensus 301 ~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 301 KEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHTSGGGTTTCC
T ss_pred HHHhcCccccccCC
Confidence 99999999987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=300.83 Aligned_cols=189 Identities=25% Similarity=0.397 Sum_probs=155.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... +.+++..++.++.|++.||+|||+. ||+||||||+|||
T Consensus 86 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 164 (360)
T 3eqc_A 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164 (360)
T ss_dssp GGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred HHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEE
Confidence 3449999999999999999999999999885544444432 4599999999999999999999996 9999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH-
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK- 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~- 162 (297)
++. +.+||+|||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....
T Consensus 165 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 165 VNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242 (360)
T ss_dssp ECTTCCEEECCCCCCHHHHHHC-----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred ECCCCCEEEEECCCCccccccc-ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 985 799999999987653322 2456789999999998654 458899999999999999999999987654332111
Q ss_pred ------------------------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 163 ------------------------------------------------------IYGRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 163 ------------------------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
+..++.+||.+||..||++|||++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 322 (360)
T 3eqc_A 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322 (360)
T ss_dssp C------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence 12357899999999999999999999
Q ss_pred HcCCCCCCC
Q 040202 189 LEHPFFRSC 197 (297)
Q Consensus 189 l~h~~f~~~ 197 (297)
++||||+..
T Consensus 323 l~hp~~~~~ 331 (360)
T 3eqc_A 323 MVHAFIKRS 331 (360)
T ss_dssp HTSHHHHHH
T ss_pred hhChHhhcc
Confidence 999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=294.32 Aligned_cols=191 Identities=36% Similarity=0.647 Sum_probs=159.5
Q ss_pred ccccccceeeeceeEE--------------eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 040202 6 KMNNHPNIVKLRNLVK--------------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~--------------~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~ 71 (297)
+.++||||+++++++. +.+..|+||||++|++.+.+. . +.+++..++.++.|++.||+|||++
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-~--~~~~~~~~~~~~~qi~~~l~~lH~~ 139 (320)
T 2i6l_A 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE-Q--GPLLEEHARLFMYQLLRGLKYIHSA 139 (320)
T ss_dssp HTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT-T--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh-c--CCccHHHHHHHHHHHHHHHHHHHhC
Confidence 3449999999999873 457899999999987666553 3 4699999999999999999999999
Q ss_pred CccccCCCCCcEEEe-C-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHH
Q 040202 72 GYFHRDLKPSNLLVS-K-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 72 gi~Hrdikp~Nill~-~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell 145 (297)
||+||||||+||+++ + +.+||+|||+++..... .......+|+.|+|||++.....++.++|||||||++|+|+
T Consensus 140 ~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 999999999999997 3 58999999999876432 22345567999999999876566789999999999999999
Q ss_pred hCCCCCCCCCCHHHHHHH-----------------------------------------HHHHHHHHHHhhhcCCCCCCC
Q 040202 146 SFRILFPGKNSADQIYKI-----------------------------------------YGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 146 ~g~~pf~~~~~~~~~~~i-----------------------------------------~~~~~~li~~~l~~dP~~R~t 184 (297)
+|+.||.+.+..+...++ ..++.+||.+||..||++|||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 999999987765544332 235789999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 040202 185 AAEALEHPFFRSCHF 199 (297)
Q Consensus 185 ~~~ll~h~~f~~~~~ 199 (297)
++++++||||+...+
T Consensus 300 ~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 300 AEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHTSHHHHTTCC
T ss_pred HHHHhCCcccccccC
Confidence 999999999986543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.06 Aligned_cols=192 Identities=24% Similarity=0.426 Sum_probs=164.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+....+..+++..++.++.|++.||.|||+.||+||||||+||++
T Consensus 79 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 33499999999999999999999999999866555554445679999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+ ++.+||+|||++...... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......+
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 237 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 7 489999999999876543 223456789999999997654 4588999999999999999999999887665544433
Q ss_pred --------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 164 --------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 164 --------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
...+.+++.+||..||.+|||+.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 23678999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=289.15 Aligned_cols=189 Identities=28% Similarity=0.518 Sum_probs=158.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+.+..|+||||+.| ++.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 140 (283)
T 3bhy_A 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM 140 (283)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEE
Confidence 344899999999999999999999999986 555555443 45999999999999999999999999999999999999
Q ss_pred EeC-C----eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 85 VSK-G----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~----~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+++ + .+||+|||++.............|++.|+|||++... .++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 141 ~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 219 (283)
T 3bhy_A 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQET 219 (283)
T ss_dssp ESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH
Confidence 975 3 7999999999887665555667899999999987644 458899999999999999999999988776655
Q ss_pred HHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...+. ..+.+++.+||..||++|||+.++++||||+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 44432 357899999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.34 Aligned_cols=188 Identities=29% Similarity=0.436 Sum_probs=161.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl 138 (304)
T 2jam_A 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138 (304)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCE
T ss_pred HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 334999999999999999999999999987 555666554 45999999999999999999999999999999999999
Q ss_pred E---e-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 V---S-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l---~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
+ + ++.+||+|||+++..... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+..
T Consensus 139 ~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 216 (304)
T 2jam_A 139 YLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216 (304)
T ss_dssp ESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9 4 368999999998765443 2345678999999999764 44588999999999999999999999887766555
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.++. ..+.++|.+||..||++|||+.++++||||++.
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 217 EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 4442 468899999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=291.42 Aligned_cols=193 Identities=25% Similarity=0.450 Sum_probs=159.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+....+..+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150 (302)
T ss_dssp HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence 34599999999999999999999999999877666655545679999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCC-CCCCccccccCCCCCCceec----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLL----LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||++..... ........||+.|+|||++. ....++.++|||||||++|+|++|+.||...+....
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 230 (302)
T 2j7t_A 151 TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230 (302)
T ss_dssp CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 8 58999999998754321 11123567899999999874 244568899999999999999999999988776655
Q ss_pred HHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 160 IYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 160 ~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
..++. ..+.+++.+||..||++|||+.++++||||++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 231 LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 54432 3578999999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=298.26 Aligned_cols=186 Identities=40% Similarity=0.690 Sum_probs=155.8
Q ss_pred ccccccceeeeceeEEeCCe------EEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHED------VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~------~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++||||+++++++.+.+. .|+||||+.|++.+.+ +..+++..++.++.||+.||+|||++||+|||||
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 153 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 153 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 34589999999999987654 5999999998766543 2359999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+||++++ +.+||+|||+++..... .....||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+
T Consensus 154 p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 231 (353)
T 3coi_A 154 PGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231 (353)
T ss_dssp GGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred HHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999985 78999999999876543 2456789999999998765667899999999999999999999999877655
Q ss_pred HHHHH------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKI------------------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
....+ ...+.+||.+||..||++|||++++++||||+.
T Consensus 232 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 54433 235789999999999999999999999999986
Q ss_pred C
Q 040202 197 C 197 (297)
Q Consensus 197 ~ 197 (297)
.
T Consensus 312 ~ 312 (353)
T 3coi_A 312 F 312 (353)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=305.98 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=151.8
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQ-----NFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~-----~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
.|.++.+|||||++++++.+++.+|+|||||+|++.+.+...... ..++..++.++.||+.||+|||++||+|||
T Consensus 61 ~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 140 (434)
T 2rio_A 61 LLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD 140 (434)
T ss_dssp HHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccC
Confidence 344566899999999999999999999999988777666543111 013345678999999999999999999999
Q ss_pred CCCCcEEEeC--------------CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecc------cccCCCcc
Q 040202 78 LKPSNLLVSK--------------GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLL------SEICGPEV 132 (297)
Q Consensus 78 ikp~Nill~~--------------~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~------~~~~~~~~ 132 (297)
|||+|||++. ..+||+|||+++...... ......||+.|+|||++.+ ...++.++
T Consensus 141 Lkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 220 (434)
T 2rio_A 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220 (434)
T ss_dssp CSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHH
T ss_pred CChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhh
Confidence 9999999964 279999999998875432 1235679999999999864 24568899
Q ss_pred chhhHHHHHHHHHh-CCCCCCCCCCHHHH----------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 133 DRWAMGAIMFEMLS-FRILFPGKNSADQI----------------YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 133 DiwSlGv~l~ell~-g~~pf~~~~~~~~~----------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
|||||||++|||++ |+.||.+....+.. ..+..++.++|.+||+.||++|||+.++++||||.
T Consensus 221 DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 221 DIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp HHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 99999999999999 99999765443321 12345789999999999999999999999999996
Q ss_pred C
Q 040202 196 S 196 (297)
Q Consensus 196 ~ 196 (297)
.
T Consensus 301 ~ 301 (434)
T 2rio_A 301 P 301 (434)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.62 Aligned_cols=194 Identities=22% Similarity=0.449 Sum_probs=155.8
Q ss_pred ccccccccceeeeceeEEe------CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 040202 4 LRKMNNHPNIVKLRNLVKE------HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHR 76 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~------~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hr 76 (297)
++++.+||||+++++++.. .+.+|+||||++| ++.+.+....+..+++..++.++.||+.||+|||++||+||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 153 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 4455589999999999987 5689999999998 44454444333569999999999999999999999999999
Q ss_pred CCCCCcEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCC
Q 040202 77 DLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRIL 150 (297)
Q Consensus 77 dikp~Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~p 150 (297)
||||+||++++ +.+||+|||++...... .......||+.|+|||++.. ...++.++|||||||++|+|++|+.|
T Consensus 154 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred CCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999985 78999999998776433 22345678999999999752 34568899999999999999999999
Q ss_pred CCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 151 FPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 151 f~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
|.+.+.......+. ..+.++|.+||..||.+|||+.++++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp TTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 98877666555443 368999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=293.63 Aligned_cols=191 Identities=23% Similarity=0.380 Sum_probs=152.5
Q ss_pred ccccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++||||+++++++.... ..|+||||++|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+
T Consensus 67 ~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 145 (311)
T 3ork_A 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145 (311)
T ss_dssp CCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 4459999999999997654 459999999875555544432 45999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|||++. +.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 146 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp GEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999985 78999999999866432 222345789999999998754 468899999999999999999999998876
Q ss_pred HHHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 157 ADQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 157 ~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
.+....+. .++.++|.+||..||++||++.+++.|+|++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 66544332 3688999999999999999999999999997533
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.07 Aligned_cols=188 Identities=20% Similarity=0.312 Sum_probs=155.5
Q ss_pred ccccccceeeeceeEEeCC--eEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~--~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++||||+++++++.+.+ ..|+||||+.|+.+..+..... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG 141 (319)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH
Confidence 3448999999999998765 8899999998755544444322 23999999999999999999999999999999999
Q ss_pred cEEE----eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc-------cccCCCccchhhHHHHHHHHHhCCC
Q 040202 82 NLLV----SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL-------SEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 82 Nill----~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|||+ +. +.+||+|||+++............||+.|+|||++.. ...++.++|||||||++|||++|+.
T Consensus 142 NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 221 (319)
T 4euu_A 142 NIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (319)
T ss_dssp GEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred HEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9998 43 5799999999998877766677889999999998753 3556889999999999999999999
Q ss_pred CCCCCCC----HHHHHH------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 150 LFPGKNS----ADQIYK------------------------------------IYGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 150 pf~~~~~----~~~~~~------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
||..... .+...+ +...+.+++++||+.||++|||++|+|
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell 301 (319)
T 4euu_A 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (319)
T ss_dssp SEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred CCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhh
Confidence 9975433 222222 233678899999999999999999999
Q ss_pred cCCC
Q 040202 190 EHPF 193 (297)
Q Consensus 190 ~h~~ 193 (297)
+||-
T Consensus 302 ~h~~ 305 (319)
T 4euu_A 302 AETS 305 (319)
T ss_dssp HHHH
T ss_pred hccH
Confidence 9874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.57 Aligned_cols=192 Identities=23% Similarity=0.385 Sum_probs=151.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~N 82 (297)
+.+.++||||+++++++.+++..|+||||+ ++++..+.......+++..++.++.|++.||+|||++ ||+||||||+|
T Consensus 77 ~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N 155 (318)
T 2dyl_A 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 155 (318)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred HHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence 345569999999999999999999999999 4455555554456799999999999999999999995 99999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceec----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL----LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
|++++ +.+||+|||+++............||+.|+|||++. ....++.++||||+||++|+|++|+.||......
T Consensus 156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp EEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 99985 799999999998776555555678999999999975 2345688999999999999999999999875433
Q ss_pred -HHHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 158 -DQIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 158 -~~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+...++ ..++.+++.+||..||.+|||++++++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 333332 246899999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=293.80 Aligned_cols=188 Identities=31% Similarity=0.518 Sum_probs=156.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++..++ .|+||||+.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl 146 (322)
T 2ycf_A 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146 (322)
T ss_dssp HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 3349999999999997665 8999999987 555544433 56999999999999999999999999999999999999
Q ss_pred EeC-C---eEEEEecCCceecCCCCCCccccccCCCCCCceec--ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK-G---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL--LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~---~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++. + .+||+|||+++............||+.|+|||++. ....++.++|||||||++|+|++|..||.+.....
T Consensus 147 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp ESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred EecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 974 3 49999999998876554344567899999999874 23456889999999999999999999997654321
Q ss_pred HH-H---------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QI-Y---------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~-~---------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.. . .+...+.+++.+||..||++|||++++++||||++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 227 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 11 1 12346789999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=295.24 Aligned_cols=186 Identities=31% Similarity=0.497 Sum_probs=154.8
Q ss_pred cccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcE
Q 040202 9 NHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLKPSNL 83 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdikp~Ni 83 (297)
.|+||+++++++...+ .+++||||+++++.+.+.......+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 5999999999998654 89999999977888777765556699999999999999999999998 999999999999
Q ss_pred EEeC-------CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 84 LVSK-------GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 84 ll~~-------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
|++. +.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EEeccCCCcCcceEEEcccccccccCCCC--CCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9952 279999999998776543 456889999999998754 458999999999999999999999986542
Q ss_pred H------HHH-----------------------------------------------------HHHHHHHHHHHHHhhhc
Q 040202 157 A------DQI-----------------------------------------------------YKIYGRWVALISWLCSW 177 (297)
Q Consensus 157 ~------~~~-----------------------------------------------------~~i~~~~~~li~~~l~~ 177 (297)
. +.. .....++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 1 111 12234678999999999
Q ss_pred CCCCCCCHHHHHcCCCCCCC
Q 040202 178 NPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 178 dP~~R~t~~~ll~h~~f~~~ 197 (297)
||++|||++++|+||||++.
T Consensus 321 dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 321 DPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp STTTCBCHHHHHTCGGGTTC
T ss_pred CccccCCHHHHhhChhhhcc
Confidence 99999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=284.43 Aligned_cols=193 Identities=25% Similarity=0.346 Sum_probs=158.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.+.++||||+++++++.+++..|+||||+.|+.+..+..... ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 152 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhh
Confidence 344599999999999999999999999998755555554432 246799999999999999999999999999999999
Q ss_pred EEEe--CCeEEEEecCCceecCCC-CCCccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVS--KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~--~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+++ ++.+||+|||+++..... .......||+.|+|||++... ..++.++||||||+++|+|++|+.||.......
T Consensus 153 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (295)
T 2clq_A 153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232 (295)
T ss_dssp EEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH
T ss_pred EEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh
Confidence 9997 478999999999876543 223456789999999998654 236789999999999999999999997655433
Q ss_pred HH-HH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 159 QI-YK-------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 159 ~~-~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.. .+ +...+.+++.+||..||++|||+.++++|+||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 22 11 12367899999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=295.94 Aligned_cols=191 Identities=26% Similarity=0.429 Sum_probs=138.4
Q ss_pred cccccccceeeeceeEEe----CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 5 RKMNNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
.+.++||||+++++++.. ++.+|+||||+.| ++.+.+....+..+++..++.++.||+.||+|||++||+|||||
T Consensus 76 ~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlk 155 (336)
T 3fhr_A 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK 155 (336)
T ss_dssp HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 456699999999999976 5569999999988 55555554434569999999999999999999999999999999
Q ss_pred CCcEEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 80 PSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 80 p~Nill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|+|||++. +.+||+|||+++...... .....||+.|+|||++... .++.++|||||||++|+|++|+.||.+..
T Consensus 156 p~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 156 PENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEEC-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred HHHEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999963 469999999998765432 3466789999999997544 45789999999999999999999997655
Q ss_pred CHHHHH-------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 156 SADQIY-------------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 156 ~~~~~~-------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...... .+..++.+||.+||..||++|||+.++++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 433211 123468999999999999999999999999999763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=285.69 Aligned_cols=188 Identities=22% Similarity=0.413 Sum_probs=162.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... +.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 152 (303)
T 3a7i_A 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152 (303)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE
Confidence 345999999999999999999999999998666666654 469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
++ +.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 231 (303)
T 3a7i_A 153 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231 (303)
T ss_dssp CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence 75 799999999998765432 33456789999999997654 4588999999999999999999999887766555444
Q ss_pred H------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 Y------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. ..+.+++.+||..||++|||+.++++||||..
T Consensus 232 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 2 35899999999999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.87 Aligned_cols=193 Identities=24% Similarity=0.418 Sum_probs=143.0
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKE---SAGQNFSEDEARNLCFQVFQGLHYMHRQ-GYFHRDLK 79 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~---~~~~~l~e~~~~~~~~qll~al~yLH~~-gi~Hrdik 79 (297)
+.+.++||||+++++++.+++..|+||||+.|++.+.+.. .....+++..+..++.|++.||.|||++ ||+|||||
T Consensus 74 ~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk 153 (327)
T 3aln_A 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153 (327)
T ss_dssp HHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred HHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence 4556699999999999999999999999999987766553 2245699999999999999999999999 99999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceec---ccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL---LSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|+||++++ +.+||+|||+++............||+.|+|||++. ....++.++|||||||++|+|++|+.||.+..
T Consensus 154 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp GGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred HHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999985 899999999998776655545568999999999974 23446889999999999999999999997644
Q ss_pred CH-HHHH----------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 156 SA-DQIY----------------KIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 156 ~~-~~~~----------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.. +... .+...+.+|+.+||..||++|||+.++++||||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 234 SVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 32 1111 13347899999999999999999999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=294.64 Aligned_cols=187 Identities=21% Similarity=0.404 Sum_probs=155.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG---------------QNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~---------------~~l~e~~~~~~~~qll~al~yL 68 (297)
++++.+||||+++++++.+++.+|+||||+.|+.+..++...+ ..+++.+++.++.||+.||+||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3444489999999999999999999999998754444443322 3489999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+|||+++ +.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 220 H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 220 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHH
T ss_pred HhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999985 899999999998765432 2234556789999999865 4468999999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |+.||.+....+....+. ..+.+++.+||..||++|||+.+++++
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99 999999877666555443 268899999999999999999998863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=283.75 Aligned_cols=186 Identities=33% Similarity=0.557 Sum_probs=162.2
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
.++||||+++++++.+.+..|+||||+.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 77 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv 154 (287)
T 2wei_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154 (287)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEE
Confidence 34999999999999999999999999987 566666555 459999999999999999999999999999999999999
Q ss_pred eC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 86 SK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
+. +.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+...
T Consensus 155 ~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (287)
T 2wei_A 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232 (287)
T ss_dssp SCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 64 3699999999987766655566678999999998754 36889999999999999999999998877665554
Q ss_pred HHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+. .++.+++.+||..||++|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 432 36789999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=286.07 Aligned_cols=191 Identities=22% Similarity=0.400 Sum_probs=154.6
Q ss_pred cccccc-ccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNN-HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~-HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++.. |+||+++++++.+++..|+|||+..+++.+.+... ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 157 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 157 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCccc
Confidence 344432 69999999999999999999997666777776654 469999999999999999999999999999999999
Q ss_pred EEEeCCeEEEEecCCceecCCCC---CCccccccCCCCCCceeccc----------ccCCCccchhhHHHHHHHHHhCCC
Q 040202 83 LLVSKGVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLS----------EICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 83 ill~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
||++++.+||+|||+++...... ......||+.|+|||++... ..++.++|||||||++|+|++|+.
T Consensus 158 Il~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (313)
T 3cek_A 158 FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237 (313)
T ss_dssp EEEETTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEECCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence 99999999999999998764432 22355789999999997641 356789999999999999999999
Q ss_pred CCCCCCCHHH-HHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 150 LFPGKNSADQ-IYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 150 pf~~~~~~~~-~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
||........ ...+ ...+.+++.+||..||++|||+.++++||||+.
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp TTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred chhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 9987654322 2222 236889999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.40 Aligned_cols=186 Identities=17% Similarity=0.240 Sum_probs=142.9
Q ss_pred cccceeeec-------eeEEeC-----------------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHH------HHHH
Q 040202 9 NHPNIVKLR-------NLVKEH-----------------EDVFIVFDYMESDLLKLMKESAGQNFSEDEA------RNLC 58 (297)
Q Consensus 9 ~HpnIv~~~-------~~~~~~-----------------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~------~~~~ 58 (297)
+||||++++ +++... ..+|+||||++|++.+.+... +..+++..+ ..++
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~ 200 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL-DFVYVFRGDEGILALHILT 200 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHH-HHSCCCCHHHHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHh-ccccchhhhhhhhhHHHHH
Confidence 699988755 555443 348999999998888777664 233555555 6777
Q ss_pred HHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc-ccCCCccchhh
Q 040202 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EICGPEVDRWA 136 (297)
Q Consensus 59 ~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwS 136 (297)
.||+.||+|||++||+||||||+|||+++ +.+||+|||+++...... ....+|+.|+|||++.+. ..++.++||||
T Consensus 201 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwS 278 (371)
T 3q60_A 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQ 278 (371)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHH
Confidence 99999999999999999999999999985 799999999998775432 255677999999998642 45689999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHH--------------------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 137 MGAIMFEMLSFRILFPGKNSADQ--------------------IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 137 lGv~l~ell~g~~pf~~~~~~~~--------------------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
|||++|+|++|+.||.+...... ...+...+.+||.+||..||++|||+.++++||||++
T Consensus 279 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999987632110 0123457899999999999999999999999999976
Q ss_pred C
Q 040202 197 C 197 (297)
Q Consensus 197 ~ 197 (297)
.
T Consensus 359 ~ 359 (371)
T 3q60_A 359 L 359 (371)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.35 Aligned_cols=192 Identities=21% Similarity=0.371 Sum_probs=161.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHH-------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKL-------MKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~-------~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrd 77 (297)
+.++||||+++++++.+++..|+||||+.|+.+.. +.......+++..++.++.|++.||+|||+ .||+|||
T Consensus 98 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp TTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred HhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 33489999999999999999999999999854443 332224679999999999999999999999 9999999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCC-ccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGP-EVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|||+||++++ +.+||+|||++...... ......||+.|+|||++.+...++. ++||||+||++|+|++|+.||.+..
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999975 79999999999876544 3356678999999999876534444 8999999999999999999998876
Q ss_pred C-HHHHHHH------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 156 S-ADQIYKI------------------------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 156 ~-~~~~~~i------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
. .+....+ ...+.+|+.+||..||.+|||+.++++||||++..
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 6 4433322 34678999999999999999999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.89 Aligned_cols=188 Identities=30% Similarity=0.432 Sum_probs=146.9
Q ss_pred ccccccceeeeceeEEe-------------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 040202 6 KMNNHPNIVKLRNLVKE-------------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG 72 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-------------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g 72 (297)
+.++||||+++++++.+ .+..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 136 (303)
T 1zy4_A 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG 136 (303)
T ss_dssp TTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC
Confidence 34499999999998865 45789999999875555555544556899999999999999999999999
Q ss_pred ccccCCCCCcEEEeC-CeEEEEecCCceecCCC---------------CCCccccccCCCCCCceecccccCCCccchhh
Q 040202 73 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---------------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWA 136 (297)
Q Consensus 73 i~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 136 (297)
|+||||||+||++++ +.+||+|||+++..... .......||+.|+|||++.+...++.++||||
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 216 (303)
T 1zy4_A 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216 (303)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH
T ss_pred eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH
Confidence 999999999999985 78999999999765422 22345678999999999876556789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCH-HHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 137 MGAIMFEMLSFRILFPGKNSA-DQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 137 lGv~l~ell~g~~pf~~~~~~-~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+||++|+|++ ||...... ....++. ..+.+++.+||..||++|||+.++++||||+.
T Consensus 217 lG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 217 LGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 9999999998 55432221 2222221 24789999999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.97 Aligned_cols=185 Identities=17% Similarity=0.240 Sum_probs=153.4
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++.+|+||+++++++.+++..|+||||+++++.+.+... ++.+++..++.++.|++.||+|||++||+||||||+||
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 136 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENF 136 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 34445999999999999999999999999955665555443 46799999999999999999999999999999999999
Q ss_pred EEeC-Ce-----EEEEecCCceecCCCCC--------CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 84 LVSK-GV-----IKIGDLGMVKEIDSSLP--------CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 84 ll~~-~~-----~kl~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|++. +. +||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 137 ll~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~ 215 (330)
T 2izr_A 137 LIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSL 215 (330)
T ss_dssp EECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCC
Confidence 9985 44 99999999987644321 2467899999999998754 45889999999999999999999
Q ss_pred CCCCCCCHH---HHHHH---------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSAD---QIYKI---------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~---~~~~i---------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||.+.+..+ ...++ ..++.+++.+||..||.+||+++++++
T Consensus 216 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 216 PWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp TTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 998854322 22222 127889999999999999999988764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=290.33 Aligned_cols=186 Identities=24% Similarity=0.488 Sum_probs=157.6
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCC--cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMES--DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g--~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.|+||+++++++.+++..++|||++.+ ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe
Confidence 479999999999999999999999974 566666554 4599999999999999999999999999999999999998
Q ss_pred -C-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH----
Q 040202 87 -K-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI---- 160 (297)
Q Consensus 87 -~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~---- 160 (297)
+ +.+||+|||+++...... .....||+.|+|||++.....++.++|||||||++|+|++|+.||.........
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 262 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCC
T ss_pred CCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccc
Confidence 4 799999999998776432 345679999999999876666678899999999999999999999753211000
Q ss_pred -HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 -YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 -~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+..++.++|.+||..||++|||++++++||||++.
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0123478999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=284.92 Aligned_cols=184 Identities=17% Similarity=0.332 Sum_probs=152.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+....+..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 62 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred HhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 34489999999999999999999999999866666666555679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC---------------ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC---------------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
++ +.+||+|||+++........ ...+||+.|+|||++.+ ..++.++||||+||++|+|++|..
T Consensus 142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCC
Confidence 85 78999999999876433211 25679999999999865 456899999999999999999999
Q ss_pred CCCCCCCHHH-----HHH---------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQ-----IYK---------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~-----~~~---------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||........ ... +...+.+++.+||..||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 221 ADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9876432111 111 1236789999999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=282.19 Aligned_cols=187 Identities=24% Similarity=0.330 Sum_probs=150.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||++|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 66 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 144 (294)
T 4eqm_A 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144 (294)
T ss_dssp TTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred hcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 3459999999999999999999999999985554444442 469999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+. +.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+......+
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~ 223 (294)
T 4eqm_A 145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223 (294)
T ss_dssp CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 75 789999999997664432 22446789999999998754 458899999999999999999999998776554333
Q ss_pred H----------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 163 I----------------YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 163 i----------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
. ...+.+++.+||..||++||+..+.+.+.|.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 2 2468899999999999999966666665554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=279.02 Aligned_cols=185 Identities=24% Similarity=0.438 Sum_probs=157.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||++|+.+..+.......+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 139 (269)
T 4hcu_A 60 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139 (269)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE
Confidence 34489999999999999999999999999866665555545669999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+++...... ......+|..|+|||++... .++.++||||+|+++|+|++ |+.||.+....+...
T Consensus 140 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~ 218 (269)
T 4hcu_A 140 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218 (269)
T ss_dssp CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 75 789999999997654321 22344567789999997654 45889999999999999999 999999887776666
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+. ..+.+++.+||..||++|||+.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 219 DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 554 367899999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.08 Aligned_cols=184 Identities=24% Similarity=0.365 Sum_probs=154.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.......+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 105 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 184 (325)
T 3kul_A 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184 (325)
T ss_dssp TTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE
Confidence 34499999999999999999999999998866666555545679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+.
T Consensus 185 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 85 7899999999987654321 1233457789999998654 45889999999999999999 9999988877766
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+||..||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 66543 36889999999999999999998875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=287.99 Aligned_cols=183 Identities=16% Similarity=0.176 Sum_probs=148.5
Q ss_pred ccccccceeeeceeEEeC----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++|+||+++++++.+. ...|+||||+ |+.+..+....++.+++..++.++.||+.||+|||++||+||||||+
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~ 181 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHH
Confidence 345899999999999764 5689999999 64554555544567999999999999999999999999999999999
Q ss_pred cEEEe--C-CeEEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCC
Q 040202 82 NLLVS--K-GVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL 150 (297)
Q Consensus 82 Nill~--~-~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~p 150 (297)
|||++ + +.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence 99997 4 789999999997754321 123456999999999986544 68999999999999999999999
Q ss_pred CCCCCCHHHHHH------------H----------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 151 FPGKNSADQIYK------------I----------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 151 f~~~~~~~~~~~------------i----------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|.+......... + ..++.+++..|+..||.+||++.++++
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 986433222110 0 235788999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=283.83 Aligned_cols=189 Identities=26% Similarity=0.437 Sum_probs=149.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdikp~ 81 (297)
+.++||||+++++++.+.+..|+||||+.|+.+..+....+ ..+++..++.++.|++.||+|||++| |+||||||+
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~ 168 (309)
T 3p86_A 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168 (309)
T ss_dssp HHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGG
T ss_pred HhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChh
Confidence 33489999999999999999999999999855555554322 13999999999999999999999999 999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|||+++ +.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 169 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~ 247 (309)
T 3p86_A 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247 (309)
T ss_dssp GEEECTTCCEEECCCC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred hEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999986 699999999997654432 23456789999999998754 458899999999999999999999998877666
Q ss_pred HHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHc--CCCCC
Q 040202 160 IYKI-------------YGRWVALISWLCSWNPRMRPTAAEALE--HPFFR 195 (297)
Q Consensus 160 ~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~--h~~f~ 195 (297)
...+ ...+.++|.+||..||.+|||+.++++ +++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 5544 236899999999999999999999987 45544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=281.61 Aligned_cols=183 Identities=14% Similarity=0.205 Sum_probs=150.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+....+..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 146 (289)
T 4fvq_A 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146 (289)
T ss_dssp HTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred HhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEE
Confidence 34589999999999999999999999999755555555544459999999999999999999999999999999999999
Q ss_pred eC-Ce--------EEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 86 SK-GV--------IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 86 ~~-~~--------~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
+. +. +||+|||++...... ....||+.|+|||++.+...++.++||||+||++|+|++|..|+.....
T Consensus 147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 147 IREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp EECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 74 44 999999998655432 3456799999999987656678999999999999999996555444443
Q ss_pred HHHHHHHH-----------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 157 ADQIYKIY-----------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 157 ~~~~~~i~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
........ .++.+++.+||+.||++|||+.++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 224 SQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33333322 257899999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=290.91 Aligned_cols=187 Identities=22% Similarity=0.427 Sum_probs=156.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESA--------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.++.+||||+++++++.+++..|+||||+.|+ +.+.+.... ...+++..++.++.||+.||+||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 344459999999999999999999999999874 444444432 13599999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+|||+++ +.+||+|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 208 H~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el 286 (382)
T 3tt0_A 208 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI 286 (382)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHH
T ss_pred HhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHH
Confidence 9999999999999999985 89999999999876543 22344567889999999875 4568899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |..||.+.+..+....+. .++.+++.+||..||++|||+.+++++
T Consensus 287 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 287 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99 999998877666555443 368999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=285.68 Aligned_cols=186 Identities=24% Similarity=0.433 Sum_probs=151.8
Q ss_pred cccceeeeceeEEeCCeEEEEEec-CCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDY-MES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~-~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
+|+||+++++++.+.+..|+|||| +.| ++.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe
Confidence 899999999999999999999999 666 555555544 4599999999999999999999999999999999999998
Q ss_pred --CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH----
Q 040202 87 --KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI---- 160 (297)
Q Consensus 87 --~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~---- 160 (297)
++.+||+|||+++...... .....||..|+|||++.+...++.++|||||||++|+|++|+.||.........
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 252 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCC
T ss_pred CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCC
Confidence 4789999999998776543 356678999999999876666566899999999999999999999753211100
Q ss_pred -HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 161 -YKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 161 -~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+...+.++|.+||..||++|||++++++||||+..
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 1123468899999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=283.44 Aligned_cols=193 Identities=21% Similarity=0.310 Sum_probs=145.4
Q ss_pred ccccccceeeeceeEEeCCeE------EEEEecCCC-cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDV------FIVFDYMES-DLLKLMKESAG----QNFSEDEARNLCFQVFQGLHYMHRQGYF 74 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~------~lv~e~~~g-~ll~~~~~~~~----~~l~e~~~~~~~~qll~al~yLH~~gi~ 74 (297)
+.++||||+++++++.+.+.. |+||||+.| ++.+.+..... ..+++..++.++.||+.||+|||++||+
T Consensus 80 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~iv 159 (323)
T 3qup_A 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159 (323)
T ss_dssp TTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence 334999999999999877655 999999998 45554443321 1599999999999999999999999999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRI 149 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~ 149 (297)
||||||+|||+++ +.+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.
T Consensus 160 H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCC
Confidence 9999999999985 7999999999987644321 1234567789999997654 46899999999999999999 999
Q ss_pred CCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCC-------HHHHHcCCCCCCCCC
Q 040202 150 LFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPT-------AAEALEHPFFRSCHF 199 (297)
Q Consensus 150 pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t-------~~~ll~h~~f~~~~~ 199 (297)
||.+.+..+....+. ..+.+++.+||..||++||| ++++++|+|+.....
T Consensus 239 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 239 PYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp TTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 999888777666543 36899999999999999999 678889999976433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.56 Aligned_cols=184 Identities=22% Similarity=0.405 Sum_probs=155.4
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++.+++..|+||||++|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~ 138 (268)
T 3sxs_A 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD 138 (268)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC
T ss_pred hCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC
Confidence 34899999999999999999999999987554444444345699999999999999999999999999999999999998
Q ss_pred C-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
+ +.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+|+++|+|++ |+.||...+..+...+
T Consensus 139 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (268)
T 3sxs_A 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217 (268)
T ss_dssp TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH
Confidence 5 7899999999987654421 1234456779999997654 45889999999999999999 9999988877666555
Q ss_pred HH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 163 IY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 163 i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+. ..+.+++.+||+.||++|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 218 VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43 368899999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.73 Aligned_cols=185 Identities=18% Similarity=0.235 Sum_probs=153.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+|+||+++++++.++...|+||||+++++.+.+.. .+..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 59 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 4555689999999999999999999999995566555544 355699999999999999999999999999999999999
Q ss_pred EEeC-Ce-----EEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 84 LVSK-GV-----IKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 84 ll~~-~~-----~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|++. +. +||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCC
Confidence 9974 33 9999999998765432 23556799999999997654 45899999999999999999999
Q ss_pred CCCCCCCH---HHHHHH----------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSA---DQIYKI----------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~---~~~~~i----------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||.+.+.. ....++ ...+.+++.+||..||++|||++++++
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 99885432 222222 236789999999999999999998865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.57 Aligned_cols=187 Identities=25% Similarity=0.403 Sum_probs=154.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA--------------GQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~--------------~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.++.+||||+++++++.+++..|+||||++| ++.+.+.... ...+++..++.++.||+.||+||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 44555999999999999999999999999987 5555444321 23699999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS- 146 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~- 146 (297)
|++||+||||||+|||+++ +.+||+|||+++............+++.|+|||++... .++.++|||||||++|+|++
T Consensus 159 H~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTT
T ss_pred HhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcC
Confidence 9999999999999999985 79999999999755443333455678899999997644 45889999999999999998
Q ss_pred CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|+.||.+.+..+....+. ..+.+++.+||..||++|||+++++++
T Consensus 238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 238 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999998887666555442 368999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=292.27 Aligned_cols=188 Identities=23% Similarity=0.385 Sum_probs=158.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAG-----QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~-----~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+..... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 208 (367)
T 3l9p_A 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208 (367)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 334999999999999999999999999987 55555544321 349999999999999999999999999999999
Q ss_pred CCcEEEeC----CeEEEEecCCceecC---CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCC
Q 040202 80 PSNLLVSK----GVIKIGDLGMVKEID---SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILF 151 (297)
Q Consensus 80 p~Nill~~----~~~kl~Dfgla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf 151 (297)
|+|||++. ..+||+|||+++... .........||+.|+|||++.+. .++.++|||||||++|||++ |..||
T Consensus 209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999973 359999999997542 22233456789999999998654 46899999999999999998 99999
Q ss_pred CCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 152 PGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 152 ~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.+.+..+....+. ..+.+++.+||+.||++|||+.+++++.++
T Consensus 288 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 288 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 9887776665543 258899999999999999999999998776
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=279.53 Aligned_cols=186 Identities=18% Similarity=0.283 Sum_probs=154.7
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||+++++++.+.+..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl 162 (319)
T 2y4i_B 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF 162 (319)
T ss_dssp GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEE
T ss_pred HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEE
Confidence 34459999999999999999999999999986666666554557999999999999999999999999999999999999
Q ss_pred EeCCeEEEEecCCceecCC------CCCCccccccCCCCCCceecc--------cccCCCccchhhHHHHHHHHHhCCCC
Q 040202 85 VSKGVIKIGDLGMVKEIDS------SLPCTDYVTTRWYRAPEVLLL--------SEICGPEVDRWAMGAIMFEMLSFRIL 150 (297)
Q Consensus 85 l~~~~~kl~Dfgla~~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlGv~l~ell~g~~p 150 (297)
++++.+||+|||+++.... ........||+.|+|||++.. ...++.++|||||||++|+|++|+.|
T Consensus 163 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 163 YDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp EC--CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999865431 122244568999999999764 23467889999999999999999999
Q ss_pred CCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 151 FPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 151 f~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|.+.........+. ..+.+++.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 243 FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 98877666555443 36789999999999999999999886
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=276.95 Aligned_cols=183 Identities=23% Similarity=0.385 Sum_probs=143.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++. ++..|+||||+.++.+..+....+..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 71 ~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 149 (281)
T 1mp8_A 71 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 149 (281)
T ss_dssp HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE
Confidence 3348999999999985 567899999999855555555545569999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
+ ++.+||+|||+++....... .....+++.|+|||++... .++.++|||||||++|+|++ |..||.+....+...
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~ 228 (281)
T 1mp8_A 150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228 (281)
T ss_dssp EETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CCCCCEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH
Confidence 8 58999999999987654322 2334567889999997644 45889999999999999996 999999887776665
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+. ..+.+++.+||..||++|||+.++++
T Consensus 229 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 229 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 553 36889999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=278.18 Aligned_cols=185 Identities=22% Similarity=0.398 Sum_probs=156.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|+||+++++++.+++..|+||||+.|+.+..+.......+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 74 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili 153 (283)
T 3gen_A 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153 (283)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred hcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE
Confidence 33489999999999999999999999998755545444434569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+++..... .......+|+.|+|||++... .++.++||||+|+++|+|++ |+.||...+..+...
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~ 232 (283)
T 3gen_A 154 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232 (283)
T ss_dssp CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH
Confidence 85 79999999999765432 112334567889999998754 45889999999999999998 999999888776666
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+. ..+.+++.+||..||++|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 233 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 554 367899999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.13 Aligned_cols=189 Identities=25% Similarity=0.469 Sum_probs=156.0
Q ss_pred cccccceeeeceeEE--eCCeEEEEEecCCC-cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccc
Q 040202 7 MNNHPNIVKLRNLVK--EHEDVFIVFDYMES-DLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQG-----YFHR 76 (297)
Q Consensus 7 l~~HpnIv~~~~~~~--~~~~~~lv~e~~~g-~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~g-----i~Hr 76 (297)
.++||||+++++++. +++..|+||||++| ++.+.+... .+..+++..++.++.|++.||+|||++| |+||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~ 140 (279)
T 2w5a_A 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140 (279)
T ss_dssp HCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCC
T ss_pred hcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEe
Confidence 349999999999885 46789999999987 555555432 2345999999999999999999999999 9999
Q ss_pred CCCCCcEEEeC-CeEEEEecCCceecCCCCC-CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 77 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 77 dikp~Nill~~-~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||||+||++++ +.+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 141 dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 141 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 99999999985 7899999999876654321 2345789999999998654 4588999999999999999999999987
Q ss_pred CCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 155 NSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 155 ~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+..+...++. .++.+++.+||..||++|||+.++++|+|+.+
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 220 SQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp SHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred CHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 7665554443 36889999999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=288.73 Aligned_cols=187 Identities=22% Similarity=0.376 Sum_probs=152.7
Q ss_pred ccccccccceeeeceeEEeCC-eEEEEEecCCCcHHHHHHHhcC------------------------------------
Q 040202 4 LRKMNNHPNIVKLRNLVKEHE-DVFIVFDYMESDLLKLMKESAG------------------------------------ 46 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~-~~~lv~e~~~g~ll~~~~~~~~------------------------------------ 46 (297)
+.++.+||||+++++++.+.+ ..|+||||+.|+.+..+.....
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 445558999999999998755 4999999999855544444322
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecC
Q 040202 47 -----------------------------QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLG 96 (297)
Q Consensus 47 -----------------------------~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfg 96 (297)
..+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg 238 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 238 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCG
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEecc
Confidence 12899999999999999999999999999999999999984 789999999
Q ss_pred CceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHHHH--------
Q 040202 97 MVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYKIY-------- 164 (297)
Q Consensus 97 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~i~-------- 164 (297)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+......
T Consensus 239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (359)
T 3vhe_A 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317 (359)
T ss_dssp GGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred ceeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC
Confidence 998664332 2244567889999999875 446899999999999999998 999998877555443322
Q ss_pred -----HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 165 -----GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 165 -----~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.++.+++.+||..||.+|||+.++++|
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 368999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=276.01 Aligned_cols=182 Identities=25% Similarity=0.478 Sum_probs=147.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG---YFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g---i~Hrdikp~N 82 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... +.+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N 138 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138 (271)
T ss_dssp HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence 445899999999999999999999999998777776654 56999999999999999999999999 9999999999
Q ss_pred EEEe---------CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 83 LLVS---------KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 83 ill~---------~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|+++ ++.+||+|||+++....... ....||+.|+|||++.+. .++.++||||+|+++|+|++|+.||.+
T Consensus 139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 139 ILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp EEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred EEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9996 35799999999987654432 356789999999987654 458899999999999999999999998
Q ss_pred CCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 154 KNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 154 ~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+.......+. ..+.+++.+||..||.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp SCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 77666554432 368999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=284.16 Aligned_cols=182 Identities=19% Similarity=0.290 Sum_probs=150.5
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
.++||||+++++++. ++..|+||||+.| ++.+.+.. .++.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 71 ~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~ 148 (325)
T 3kex_A 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148 (325)
T ss_dssp TCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE
T ss_pred cCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE
Confidence 349999999999986 4678999999986 55555543 34569999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++ +.+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+..
T Consensus 149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 227 (325)
T 3kex_A 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227 (325)
T ss_dssp SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence 75 899999999998764332 23455678899999998654 46899999999999999999 99999987766655
Q ss_pred HHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 161 YKIYG------------RWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 161 ~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..+.. ++.+++.+||..||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54432 56889999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=279.41 Aligned_cols=187 Identities=22% Similarity=0.413 Sum_probs=155.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAG----------------QNFSEDEARNLCFQVFQGLH 66 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~----------------~~l~e~~~~~~~~qll~al~ 66 (297)
+.++.+||||+++++++.+++..|+||||+.| ++.+.+..... ..+++..++.++.||+.||+
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 34444899999999999999999999999987 55555444321 14899999999999999999
Q ss_pred HHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHH
Q 040202 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMF 142 (297)
Q Consensus 67 yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ 142 (297)
|||++||+||||||+||++++ +.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|
T Consensus 160 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ 238 (313)
T 1t46_A 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLW 238 (313)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred HHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHH
Confidence 999999999999999999985 7999999999987654432 2344567889999987654 4689999999999999
Q ss_pred HHHh-CCCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 143 EMLS-FRILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 143 ell~-g~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+|++ |+.||.+........+.. ..+.+++.+||..||.+|||+.+++++
T Consensus 239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9998 999998877655444332 368899999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=284.87 Aligned_cols=188 Identities=23% Similarity=0.430 Sum_probs=154.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcC---------------------CCCCHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAG---------------------QNFSEDEARNLCFQV 61 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~---------------------~~l~e~~~~~~~~ql 61 (297)
+.++.+||||+++++++.+++..|+||||+.| ++.+.+..... ..+++..++.++.||
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 34444899999999999999999999999987 55554443321 237999999999999
Q ss_pred HHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhH
Q 040202 62 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAM 137 (297)
Q Consensus 62 l~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 137 (297)
+.||+|||++||+||||||+|||++. +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||
T Consensus 182 ~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~sl 260 (344)
T 1rjb_A 182 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSY 260 (344)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred HHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHH
Confidence 99999999999999999999999985 7999999999987644322 2345568889999987654 46899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 138 GAIMFEMLS-FRILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 138 Gv~l~ell~-g~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
||++|+|++ |..||.+........++. ..+.+++.+||..||.+|||+.++++|-
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999998 999998877655444332 3689999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=278.06 Aligned_cols=185 Identities=22% Similarity=0.385 Sum_probs=154.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcC----------------------CCCCHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAG----------------------QNFSEDEARNLCFQVF 62 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~----------------------~~l~e~~~~~~~~qll 62 (297)
+.++||||+++++++.+++..|+||||+.|+ +.+.+..... ..+++..++.++.||+
T Consensus 81 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 160 (314)
T 2ivs_A 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160 (314)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHH
T ss_pred hhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHH
Confidence 3349999999999999999999999999874 4444443211 2389999999999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHH
Q 040202 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMG 138 (297)
Q Consensus 63 ~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 138 (297)
.||+|||++||+||||||+||++++ +.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||||
T Consensus 161 ~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 239 (314)
T 2ivs_A 161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFG 239 (314)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHH
T ss_pred HHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHH
Confidence 9999999999999999999999985 789999999998764432 12344567889999998654 458899999999
Q ss_pred HHHHHHHh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 139 AIMFEMLS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 139 v~l~ell~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|++|+|++ |..||.+.........+. ..+.+++.+||..||++|||+.+++++
T Consensus 240 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 240 VLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999 999998877666554432 368999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=281.26 Aligned_cols=184 Identities=19% Similarity=0.273 Sum_probs=151.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++ .++|+||+.++.+..+....+..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 72 ~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll 150 (327)
T 3poz_A 72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150 (327)
T ss_dssp HHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE
Confidence 3459999999999998765 788899998744444444445679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++ +.+||+|||+++....... .....+|..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+..
T Consensus 151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 229 (327)
T 3poz_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence 74 8999999999987654322 2334567889999998754 45899999999999999999 99999887766554
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..+. .++.+++.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 4432 268899999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=282.94 Aligned_cols=184 Identities=26% Similarity=0.366 Sum_probs=152.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc-----------------------CCCCCHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA-----------------------GQNFSEDEARNLCFQVF 62 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~-----------------------~~~l~e~~~~~~~~qll 62 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... +..+++.+++.++.||+
T Consensus 105 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 184 (343)
T 1luf_A 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184 (343)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHH
Confidence 3349999999999999999999999999874444444332 14699999999999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHH
Q 040202 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMG 138 (297)
Q Consensus 63 ~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 138 (297)
.||+|||++||+||||||+|||+++ +.+||+|||+++..... .......+|+.|+|||++.+. .++.++||||||
T Consensus 185 ~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG 263 (343)
T 1luf_A 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYG 263 (343)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred HHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHH
Confidence 9999999999999999999999985 79999999999765332 222445678899999998754 468899999999
Q ss_pred HHHHHHHh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 139 AIMFEMLS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 139 v~l~ell~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|++|+|++ |..||.+.+..+....+. ..+.+++.+||..||++|||+.++++
T Consensus 264 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999 999998877766555443 36889999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=287.79 Aligned_cols=183 Identities=23% Similarity=0.417 Sum_probs=152.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+.. .+..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 167 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 245 (377)
T 3cbl_A 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245 (377)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEE
Confidence 445999999999999999999999999986 55555544 3456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+++ +.+||+|||+++....... .....++..|+|||++... .++.++|||||||++|||++ |..||.+.+..+.
T Consensus 246 ~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~ 324 (377)
T 3cbl_A 246 VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324 (377)
T ss_dssp ECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH
T ss_pred EcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 985 7999999999987544311 1223356789999998754 45889999999999999998 9999988776555
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+||..||++|||+.++++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 325 REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44432 36789999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=281.41 Aligned_cols=186 Identities=23% Similarity=0.352 Sum_probs=152.5
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG---QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~---~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+.++||||+++++++.+++..|+||||+.|+.+..+..... ..+++..++.++.|++.||+|||++||+||||||+
T Consensus 89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~ 168 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI 168 (321)
T ss_dssp GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCST
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHH
Confidence 344599999999999999999999999998755544443221 24899999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||++++ +.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 169 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 169 NILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247 (321)
T ss_dssp TEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred HEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence 999985 79999999999875432 223445689999999998654 4589999999999999999999999764321
Q ss_pred HH----------------------------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 158 DQ----------------------------IYKIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 158 ~~----------------------------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+. .......+.+++.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11 12234568899999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=273.72 Aligned_cols=185 Identities=23% Similarity=0.380 Sum_probs=143.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|+||++++++. ..+..++||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil 152 (289)
T 3og7_A 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF 152 (289)
T ss_dssp HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 3445999999999954 566789999999986555555444566999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC---CCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+++.... ........||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+....+
T Consensus 153 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 232 (289)
T 3og7_A 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232 (289)
T ss_dssp EETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH
T ss_pred ECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH
Confidence 985 7999999999976543 222345678999999998752 3445779999999999999999999999877766
Q ss_pred HHHHHH-----------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKIY-----------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i~-----------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...... ..+.+++.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 554432 35789999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.68 Aligned_cols=183 Identities=23% Similarity=0.285 Sum_probs=148.8
Q ss_pred ccccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------
Q 040202 6 KMNNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ---------- 71 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~---------- 71 (297)
+.++||||+++++++.+.. .+|+||||+.++.+..+... ..+++..++.++.|++.||+|||+.
T Consensus 73 ~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~ 150 (322)
T 3soc_A 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150 (322)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEEC
T ss_pred hcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCC
Confidence 3449999999999998744 47999999988555555555 3499999999999999999999999
Q ss_pred CccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceeccc----ccCCCccchhhHHHHHHH
Q 040202 72 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLS----EICGPEVDRWAMGAIMFE 143 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGv~l~e 143 (297)
||+||||||+|||+++ +.+||+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++||
T Consensus 151 ~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~e 230 (322)
T 3soc_A 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230 (322)
T ss_dssp EEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHH
Confidence 9999999999999985 7999999999987654322 3446789999999998753 234567899999999999
Q ss_pred HHhCCCCCCCCCCH---------------HHHHH-------------------HHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 144 MLSFRILFPGKNSA---------------DQIYK-------------------IYGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 144 ll~g~~pf~~~~~~---------------~~~~~-------------------i~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
|++|+.||.+.... ..... ....+.+|+.+||+.||++|||+.+++
T Consensus 231 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp HHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999764321 11111 123488999999999999999999987
Q ss_pred c
Q 040202 190 E 190 (297)
Q Consensus 190 ~ 190 (297)
+
T Consensus 311 ~ 311 (322)
T 3soc_A 311 E 311 (322)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=284.98 Aligned_cols=184 Identities=22% Similarity=0.362 Sum_probs=144.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+....+..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 101 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 180 (373)
T 2qol_A 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180 (373)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE
Confidence 34499999999999999999999999998766666555555679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||+++....... .....++..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~ 259 (373)
T 2qol_A 181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259 (373)
T ss_dssp CTTCCEEECCC----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 85 7899999999987654321 1223346789999998654 45889999999999999998 9999988776665
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+||+.||++||++.++++
T Consensus 260 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 55543 36889999999999999999998875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=280.82 Aligned_cols=182 Identities=15% Similarity=0.143 Sum_probs=147.9
Q ss_pred ccccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++||||+++++++.+ ++..|+||||+ |+.+..+.... +.+++..++.++.||+.||+|||++||+||||||+
T Consensus 103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 180 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAA 180 (345)
T ss_dssp HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHH
Confidence 34599999999999988 78999999999 54444444432 26999999999999999999999999999999999
Q ss_pred cEEEeC-C--eEEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCC
Q 040202 82 NLLVSK-G--VIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL 150 (297)
Q Consensus 82 Nill~~-~--~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~p 150 (297)
|||++. + .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 999984 4 89999999998763221 11455789999999997754 468999999999999999999999
Q ss_pred CCCCCC-HHHHH---------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 151 FPGKNS-ADQIY---------------------KIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 151 f~~~~~-~~~~~---------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|.+... ..... .+..++.+++.+||..||++|||++++++
T Consensus 260 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 260 WEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp TGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 965322 21111 11126789999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.99 Aligned_cols=184 Identities=24% Similarity=0.427 Sum_probs=155.4
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++.+++..|+||||+.|+.+..+.......+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~ 138 (267)
T 3t9t_A 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 138 (267)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred hCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC
Confidence 34899999999999999999999999987555555555455699999999999999999999999999999999999997
Q ss_pred C-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 87 K-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 87 ~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
+ +.+||+|||+++..... .......++..|+|||++... .++.++||||+|+++|+|++ |+.||.+.+..+....
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (267)
T 3t9t_A 139 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217 (267)
T ss_dssp GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCCEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH
Confidence 5 78999999998765432 112344567889999997644 45889999999999999999 9999988777666555
Q ss_pred HH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 163 IY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 163 i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+. ..+.+++.+||..||++|||+.+++++
T Consensus 218 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43 368899999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=271.76 Aligned_cols=184 Identities=21% Similarity=0.296 Sum_probs=155.4
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++ +.+..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 66 ~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 144 (287)
T 1u59_A 66 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 144 (287)
T ss_dssp HCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred hCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc
Confidence 34999999999999 55679999999998666665554456699999999999999999999999999999999999997
Q ss_pred -CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 87 -KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 87 -~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
++.+||+|||+++....... .....+|+.|+|||++... .++.++|||||||++|+|++ |+.||.+.+..+..
T Consensus 145 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 223 (287)
T 1u59_A 145 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223 (287)
T ss_dssp ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 58999999999987654321 2334568889999997644 45889999999999999998 99999988776665
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCC
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALEHP 192 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~ 192 (297)
..+. ..+.+++.+||..||++||++.+++++.
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 5443 3689999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=277.64 Aligned_cols=185 Identities=21% Similarity=0.338 Sum_probs=150.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+.+..|+||||+.|+.+..+....+..+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 101 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 180 (333)
T 1mqb_A 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180 (333)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE
Confidence 34499999999999999999999999999866655555545679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||+++...... ......+|..|+|||++... .++.++|||||||++|+|++ |+.||.+.+..+.
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 259 (333)
T 1mqb_A 181 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259 (333)
T ss_dssp CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 85 799999999998764432 11233457789999997644 45889999999999999998 9999988776665
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
...+. ..+.+++.+||..||++||++.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55443 368899999999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=277.03 Aligned_cols=182 Identities=25% Similarity=0.316 Sum_probs=146.7
Q ss_pred ccccceeeeceeEEeC----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------Cccc
Q 040202 8 NNHPNIVKLRNLVKEH----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ--------GYFH 75 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~--------gi~H 75 (297)
++||||+++++++.+. +..|+||||+.|+.+..+... ..+++..++.++.|++.||+|||++ ||+|
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 165 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence 5999999999999887 789999999988555555554 3599999999999999999999999 9999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCCC-----CccccccCCCCCCceecccccCCC-----ccchhhHHHHHHHH
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-----CTDYVTTRWYRAPEVLLLSEICGP-----EVDRWAMGAIMFEM 144 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwSlGv~l~el 144 (297)
|||||+|||+++ +.+||+|||+++....... .....||+.|+|||++.+...... ++|||||||++|||
T Consensus 166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 999999999975 7999999999977644322 235689999999999865443222 38999999999999
Q ss_pred HhC----------CCCCCCCCC----HHHHH-------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LSF----------RILFPGKNS----ADQIY-------------------KIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~g----------~~pf~~~~~----~~~~~-------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++| +.||..... ..... .+...+.+++.+||..||++|||+.++++|
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 999 777755322 11111 334568899999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=280.55 Aligned_cols=190 Identities=27% Similarity=0.423 Sum_probs=137.0
Q ss_pred ccccccccceeeeceeEE--------eCCeEEEEEecCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 040202 4 LRKMNNHPNIVKLRNLVK--------EHEDVFIVFDYMESDLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQG-- 72 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~--------~~~~~~lv~e~~~g~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~g-- 72 (297)
++++.+||||+++++++. ....+|+||||+.|++.+.+... ..+.+++..++.++.||+.||+|||+.|
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ 158 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPP 158 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 455546999999999994 34568999999999888877653 2356999999999999999999999999
Q ss_pred ccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCC-------------ccccccCCCCCCceec--ccccCCCccchhh
Q 040202 73 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-------------TDYVTTRWYRAPEVLL--LSEICGPEVDRWA 136 (297)
Q Consensus 73 i~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwS 136 (297)
|+||||||+|||+++ +.+||+|||+++........ ....||+.|+|||++. ....++.++||||
T Consensus 159 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~s 238 (337)
T 3ll6_A 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238 (337)
T ss_dssp CBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHH
T ss_pred EEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHH
Confidence 999999999999985 79999999999876543211 2456899999999974 2345678999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 137 MGAIMFEMLSFRILFPGKNSADQIYKI---------YGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 137 lGv~l~ell~g~~pf~~~~~~~~~~~i---------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
|||++|+|++|+.||.+.......... ...+.+++.+||+.||.+|||+.++++|-+
T Consensus 239 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 239 LGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHHHHHHHSSCCC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999999999999875544333221 135789999999999999999999998643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.00 Aligned_cols=188 Identities=20% Similarity=0.288 Sum_probs=153.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG---QNFSEDEARNLCFQVFQGLHYMHRQ---GYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~---~~l~e~~~~~~~~qll~al~yLH~~---gi~Hrdi 78 (297)
.+.++||||+++++++.+.+..|+||||+.|+.+..+..... ..+++..++.++.|++.||+|||++ ||+||||
T Consensus 81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl 160 (326)
T 3uim_A 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDV 160 (326)
T ss_dssp GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCC
T ss_pred HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Confidence 344589999999999999999999999999855555544322 3499999999999999999999999 9999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC-
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK- 154 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~- 154 (297)
||+|||+++ +.+||+|||+++...... ......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...
T Consensus 161 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (326)
T 3uim_A 161 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLAR 239 (326)
T ss_dssp SGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred chhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccc
Confidence 999999986 699999999998764332 234456899999999986544 588999999999999999999999510
Q ss_pred ----CC-------------------------HHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCC
Q 040202 155 ----NS-------------------------ADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPF 193 (297)
Q Consensus 155 ----~~-------------------------~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~ 193 (297)
.. ..........+.+++.+||..||.+|||+.++++|-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred cccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00 0011233457889999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=270.77 Aligned_cols=183 Identities=21% Similarity=0.312 Sum_probs=149.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.++||||+++++++.++ ..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 69 ~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 147 (281)
T 3cc6_A 69 NLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA 147 (281)
T ss_dssp HHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE
T ss_pred hCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC
Confidence 34899999999998754 56899999997555555544455699999999999999999999999999999999999997
Q ss_pred -CCeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 040202 87 -KGVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIYK 162 (297)
Q Consensus 87 -~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~~ 162 (297)
++.+||+|||+++...... ......+++.|+|||++... .++.++|||||||++|+|++ |+.||......+....
T Consensus 148 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 148 SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 5899999999998664432 12344567889999987644 45889999999999999998 9999987766655544
Q ss_pred HH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 163 IY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 163 i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+. ..+.+++.+||..||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 33 358899999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=266.30 Aligned_cols=181 Identities=14% Similarity=0.260 Sum_probs=150.8
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdikp 80 (297)
+.++||||+++++++.+. +..|+||||+.| ++.+.+....+..+++..++.++.|++.||+|||++| |+||||||
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp 141 (271)
T 3kmu_A 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS 141 (271)
T ss_dssp CCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSG
T ss_pred HhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCcc
Confidence 344999999999999877 789999999997 5555554433335999999999999999999999999 99999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccC--CCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIC--GPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
+||++++ +.++|+|||++..... ....||+.|+|||++.+.... +.++||||+||++|+|++|+.||.+.+..
T Consensus 142 ~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 142 RSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp GGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred ceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 9999985 6899999988755333 355789999999998754332 23799999999999999999999988776
Q ss_pred HHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 DQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 ~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+....+. ..+.+++.+||..||++|||++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6655443 36889999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=278.09 Aligned_cols=187 Identities=21% Similarity=0.399 Sum_probs=154.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG---------------QNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~---------------~~l~e~~~~~~~~qll~al~yL 68 (297)
+.++.+||||+++++++.+++..|+||||+.|+.+..+..... ..+++..++.++.||+.||+||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3444489999999999999999999999998755544444322 2489999999999999999999
Q ss_pred HHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHH
Q 040202 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~el 144 (297)
|++||+||||||+||++++ +.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|
T Consensus 174 H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el 252 (334)
T 2pvf_A 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEI 252 (334)
T ss_dssp HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHH
T ss_pred HhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHH
Confidence 9999999999999999985 7899999999987654321 2334567889999997654 458899999999999999
Q ss_pred Hh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++ |..||.+....+....+. ..+.+++.+||..||.+|||+.+++++
T Consensus 253 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 253 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99 999998877665554443 368899999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.83 Aligned_cols=186 Identities=23% Similarity=0.414 Sum_probs=154.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA------------GQNFSEDEARNLCFQVFQGLHYMHR 70 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~------------~~~l~e~~~~~~~~qll~al~yLH~ 70 (297)
+.++.+||||+++++++.+++..|+||||+.| ++.+.+.... ...+++..++.++.||+.||+|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 33444899999999999999999999999987 5555554331 2458999999999999999999999
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
+||+||||||+|||+++ +.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 183 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTT
T ss_pred CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHc
Confidence 99999999999999985 7999999999986543321 2345567889999987654 45899999999999999998
Q ss_pred -CCCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 147 -FRILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 147 -g~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|..||.+........++. ..+.+++.+||..||.+|||+.++++
T Consensus 262 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 262 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp TSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999998877655544432 36789999999999999999999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=276.69 Aligned_cols=186 Identities=21% Similarity=0.374 Sum_probs=154.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESA--------GQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~--------~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
.+.++||||+++++++.+++..|+||||+.| ++.+.+.... ...+++..++.++.||+.||+|||++||+|
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 3445999999999999999999999999987 5555444321 135799999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRIL 150 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~p 150 (297)
|||||+||++++ +.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||+||++|+|++ |..|
T Consensus 162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCc
Confidence 999999999985 799999999997654322 12344568899999997654 45889999999999999999 8999
Q ss_pred CCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 151 FPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 151 f~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|.+.+..+....+. ..+.+++.+||..||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 241 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 98877666555443 368899999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=274.84 Aligned_cols=182 Identities=20% Similarity=0.309 Sum_probs=145.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++ .++|+||+.+ ++.+.+.. .+..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 72 ~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 149 (327)
T 3lzb_A 72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp TTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEE
Confidence 4459999999999998765 7888899887 55555544 3556999999999999999999999999999999999999
Q ss_pred Ee-CCeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 85 VS-KGVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 85 l~-~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
++ ++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+.
T Consensus 150 ~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp EEETTEEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 97 48999999999987643321 2334567789999998754 46889999999999999999 9999998776665
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. .++.+++.+||..||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54443 36889999999999999999999886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=274.55 Aligned_cols=173 Identities=25% Similarity=0.451 Sum_probs=143.3
Q ss_pred ccccccccceeeeceeEEe----CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 4 LRKMNNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
+.+..+||||+++++++.+ ++..|+||||+.| ++.+.+....+..+++..++.++.|++.||+|||++||+||||
T Consensus 64 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 143 (299)
T 3m2w_A 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143 (299)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 4466799999999999987 7789999999987 5555555544456999999999999999999999999999999
Q ss_pred CCCcEEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 79 KPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 79 kp~Nill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
||+||+++. +.+||+|||+++.... ..++.++||||+||++|+|++|+.||.+.
T Consensus 144 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 144 KPENLLYTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred CHHHEEEecCCCCCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999999974 6799999999865321 23577999999999999999999999765
Q ss_pred CCHHH-------------------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 155 NSADQ-------------------IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 155 ~~~~~-------------------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
..... ...+..++.+++.+||..||++|||+.++++||||++..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 43221 123455789999999999999999999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=272.57 Aligned_cols=186 Identities=26% Similarity=0.364 Sum_probs=155.1
Q ss_pred ccccccceeeeceeEEe----------------CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKE----------------HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~----------------~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yL 68 (297)
+.++||||+++++++.. ...+|+||||+++ ++.+.+....+..+++..++.++.||+.||.||
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 138 (284)
T 2a19_B 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI 138 (284)
T ss_dssp HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33499999999999865 4568999999998 555555554446799999999999999999999
Q ss_pred HHCCccccCCCCCcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC
Q 040202 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF 147 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g 147 (297)
|++||+||||||+||+++ ++.+||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 139 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~ 217 (284)
T 2a19_B 139 HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHV 217 (284)
T ss_dssp HHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSC
T ss_pred HhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhc
Confidence 999999999999999997 579999999999887766555677899999999997654 458899999999999999999
Q ss_pred CCCCCCCCCHHHHHH---------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 148 RILFPGKNSADQIYK---------IYGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 148 ~~pf~~~~~~~~~~~---------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..||.... ..... +...+.+++.+||..||.+|||+.++++|.+.
T Consensus 218 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 218 CDTAFETS--KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp CSSHHHHH--HHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcchhHH--HHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 98874321 11111 12367899999999999999999999998775
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=282.83 Aligned_cols=186 Identities=19% Similarity=0.322 Sum_probs=144.3
Q ss_pred cccccccceeeeceeEE-eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVK-EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~-~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++. .++..|+||||+.|+.+..+....+..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 223 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 223 (373)
T ss_dssp STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheE
Confidence 34449999999999864 45688999999998555555555456699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNS 156 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~ 156 (297)
|+++ +.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+.
T Consensus 224 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp EECTTCCEEECCC---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred EECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 9985 789999999998654321 12334567889999997654 45889999999999999999 7888887766
Q ss_pred HHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 157 ADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 157 ~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+....+. ..+.+++.+||..||++|||+.+++++
T Consensus 303 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 303 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp SCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55444332 368899999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=268.27 Aligned_cols=180 Identities=23% Similarity=0.360 Sum_probs=148.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdikp~N 82 (297)
+.++||||+++++++.+.. ++||||+.| ++.+.+... ...+++..++.++.|++.||+|||++| |+||||||+|
T Consensus 78 ~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 78 SNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp TTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred HhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 3348999999999997665 699999986 555555544 456999999999999999999999999 9999999999
Q ss_pred EEEeC-Ce-----EEEEecCCceecCCCCCCccccccCCCCCCceecc-cccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 83 LLVSK-GV-----IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL-SEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 83 ill~~-~~-----~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
||++. +. +||+|||+++..... .....||+.|+|||++.. ...++.++||||+||++|+|++|+.||....
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99974 33 999999999865443 356789999999999742 3445789999999999999999999998766
Q ss_pred CHHH--HHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 156 SADQ--IYKI-------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 156 ~~~~--~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.... ...+ ...+.+++.+||..||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5443 2221 236899999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.56 Aligned_cols=182 Identities=24% Similarity=0.414 Sum_probs=151.5
Q ss_pred ccccccceeeeceeEEeCC-eEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEHE-DVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~-~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+.+ .+|+||||+.| ++.+++.......+++..+..++.|++.||+|||++||+||||||+||
T Consensus 241 ~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 320 (450)
T 1k9a_A 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320 (450)
T ss_dssp HTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 3459999999999987665 79999999987 556666555334479999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++...... ....++..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+...
T Consensus 321 ll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 321 LVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp EECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred EECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9985 799999999998654432 334678899999998754 45899999999999999998 999999877666655
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+. ..+.++|.+||..||++|||+.++++
T Consensus 398 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 543 36889999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=275.68 Aligned_cols=187 Identities=22% Similarity=0.372 Sum_probs=152.8
Q ss_pred ccccccccceeeeceeEEeCC-eEEEEEecCCCcHHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHE-DVFIVFDYMESDLLKLMKESAGQ---------------NFSEDEARNLCFQVFQGLHY 67 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~-~~~lv~e~~~g~ll~~~~~~~~~---------------~l~e~~~~~~~~qll~al~y 67 (297)
+.++.+||||+++++++.+.+ .+|+||||+.|+.+..+...... .+++..++.++.||+.||+|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 445558999999999987654 59999999998555555544222 28999999999999999999
Q ss_pred HHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHH
Q 040202 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFE 143 (297)
Q Consensus 68 LH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~e 143 (297)
||++||+||||||+||++++ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+
T Consensus 164 lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~ 242 (316)
T 2xir_A 164 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWE 242 (316)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHH
T ss_pred HHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHH
Confidence 99999999999999999974 7899999999987644322 2345678899999998654 45889999999999999
Q ss_pred HHh-CCCCCCCCCCHHHHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 144 MLS-FRILFPGKNSADQIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 144 ll~-g~~pf~~~~~~~~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|++ |..||.+....+..... ...+.+++.+||..||.+|||+.++++|
T Consensus 243 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 243 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998 99999887654443322 2368999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=286.22 Aligned_cols=185 Identities=20% Similarity=0.323 Sum_probs=151.1
Q ss_pred ccccccceeeeceeEEeCC--eEEEEEecCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESA--GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~--~~~lv~e~~~g~ll~~~~~~~--~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+.++||||+++++++.+.+ ..|+||||+.|+.+..+.... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 62 ~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 141 (396)
T 4eut_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG 141 (396)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHH
Confidence 3448999999999998765 789999999875555544432 223999999999999999999999999999999999
Q ss_pred cEEE----eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceeccc-------ccCCCccchhhHHHHHHHHHhCCC
Q 040202 82 NLLV----SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-------EICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 82 Nill----~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|||+ +. +.+||+|||+++............||+.|+|||++... ..++.++|||||||++|||++|+.
T Consensus 142 NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~ 221 (396)
T 4eut_A 142 NIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (396)
T ss_dssp GEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9998 43 46999999999987766555677899999999987641 345788999999999999999999
Q ss_pred CCCCCC----CHHHHHH------------------------------------HHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 150 LFPGKN----SADQIYK------------------------------------IYGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 150 pf~~~~----~~~~~~~------------------------------------i~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
||.+.. ..+...+ +...+.+++++||+.||++|+|+.+++
T Consensus 222 Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (396)
T ss_dssp SEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred CCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence 996532 2222322 234678899999999999999999875
Q ss_pred c
Q 040202 190 E 190 (297)
Q Consensus 190 ~ 190 (297)
+
T Consensus 302 ~ 302 (396)
T 4eut_A 302 A 302 (396)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=270.86 Aligned_cols=184 Identities=20% Similarity=0.342 Sum_probs=150.4
Q ss_pred ccccccceeeeceeE-EeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLV-KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~-~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++ .+++..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil 160 (298)
T 3f66_A 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 160 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEE
Confidence 345899999999985 5567889999999985555555554566999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSA 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 157 (297)
+++ +.+||+|||+++..... .......+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp ECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred ECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 985 68999999999765432 122345678889999998654 45889999999999999999 67777776665
Q ss_pred HHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 DQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 ~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+....+. ..+.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 240 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5544432 36899999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=269.72 Aligned_cols=184 Identities=24% Similarity=0.422 Sum_probs=155.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+.......+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 143 (288)
T 3kfa_A 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143 (288)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEE
T ss_pred HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEE
Confidence 345899999999999999999999999997 5555555444456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||++........ .....+|+.|+|||++.+. .++.++||||+|+++|+|++ |..||.+.+.....
T Consensus 144 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp ECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 975 7899999999987654321 2334567889999998654 45889999999999999999 99999887766555
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+. ..+.+++.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 4443 36889999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=269.74 Aligned_cols=183 Identities=21% Similarity=0.247 Sum_probs=142.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+.... +.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~ 167 (309)
T 2h34_A 89 GRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167 (309)
T ss_dssp TTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE
Confidence 3459999999999999999999999999984444444432 459999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+. +.+||+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246 (309)
T ss_dssp CTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH
T ss_pred cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH
Confidence 84 799999999987664432 2245678999999998764 4558899999999999999999999987655433222
Q ss_pred H--------------HHHHHHHHHHhhhcCCCCCC-CHHHHHc
Q 040202 163 I--------------YGRWVALISWLCSWNPRMRP-TAAEALE 190 (297)
Q Consensus 163 i--------------~~~~~~li~~~l~~dP~~R~-t~~~ll~ 190 (297)
+ ...+.++|.+||..||++|| +++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 247 INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 2 23578999999999999999 7887764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=267.27 Aligned_cols=182 Identities=21% Similarity=0.344 Sum_probs=150.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++ +.+..|+||||+.|+.+..+.... ..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 73 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~ 150 (291)
T 1xbb_A 73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 150 (291)
T ss_dssp HTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE
Confidence 344999999999999 667889999999975555555442 459999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||+++....... .....++..|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+..+.
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 229 (291)
T 1xbb_A 151 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229 (291)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 7 58999999999987654322 12234578899999986544 5789999999999999999 9999998776655
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+||..||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 54432 36899999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.65 Aligned_cols=182 Identities=13% Similarity=0.136 Sum_probs=148.7
Q ss_pred ccccceee---------------eceeEEe-CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 040202 8 NNHPNIVK---------------LRNLVKE-HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ 71 (297)
Q Consensus 8 ~~HpnIv~---------------~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~ 71 (297)
++||||++ +++++.. ++..|+||||+.++|.+.+....+..+++..++.++.||+.||+|||++
T Consensus 99 l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 178 (352)
T 2jii_A 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN 178 (352)
T ss_dssp HCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 48888887 6777776 7899999999954666665543345699999999999999999999999
Q ss_pred CccccCCCCCcEEEeCC---eEEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHH
Q 040202 72 GYFHRDLKPSNLLVSKG---VIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAI 140 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~---~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~ 140 (297)
||+||||||+|||++++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 179 ~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~i 257 (352)
T 2jii_A 179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYC 257 (352)
T ss_dssp TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHH
Confidence 99999999999999864 79999999997654321 12345789999999987654 46889999999999
Q ss_pred HHHHHhCCCCCCCCC-CHHHHHHH---------------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 141 MFEMLSFRILFPGKN-SADQIYKI---------------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 141 l~ell~g~~pf~~~~-~~~~~~~i---------------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+|+|++|+.||.+.. ........ ...+.+++.+||..||++|||++++++
T Consensus 258 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 258 MLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 999999999998764 33322221 346899999999999999999998865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=265.13 Aligned_cols=181 Identities=18% Similarity=0.238 Sum_probs=145.7
Q ss_pred ccccceeeeceeE-EeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 8 NNHPNIVKLRNLV-KEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 8 ~~HpnIv~~~~~~-~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
++|++++..++.+ .+++..|+||||+++++.+.+.. ....+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred hhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 4666655555544 67889999999995566665543 345699999999999999999999999999999999999993
Q ss_pred ----CCeEEEEecCCceecCCCCC--------CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 87 ----KGVIKIGDLGMVKEIDSSLP--------CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 87 ----~~~~kl~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 47899999999987654322 34567999999999977544 688999999999999999999999874
Q ss_pred CCH---HHHHHH----------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 155 NSA---DQIYKI----------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 155 ~~~---~~~~~i----------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... +...++ ..++.+++.+||+.||++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 321 122211 236789999999999999999998865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=290.22 Aligned_cols=184 Identities=23% Similarity=0.424 Sum_probs=155.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+++.+|+||||+.| ++.+++.......+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 271 ~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 350 (495)
T 1opk_A 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350 (495)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 445999999999999999999999999986 5555555444456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|||++ |..||.+.+..+..
T Consensus 351 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 351 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp ECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 975 789999999998765432 12334457789999998754 45889999999999999999 99999987766655
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+. ..+.+||.+||..||++|||+.++++
T Consensus 430 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 4443 36889999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=267.76 Aligned_cols=184 Identities=21% Similarity=0.314 Sum_probs=149.0
Q ss_pred ccccccceeeeceeEEeCCeE-EEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDV-FIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~-~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+.+.. |+||||+.++.+..+....+..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 77 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil 156 (298)
T 3pls_A 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCM 156 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 344999999999999876655 9999999875555555444567999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC-CCCCCCCCCH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSA 157 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~pf~~~~~~ 157 (297)
+++ +.+||+|||+++..... .......+++.|+|||++.+. .++.++||||+||++|+|++| ..||...+..
T Consensus 157 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp ECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred EcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 986 69999999999755332 223455678899999997644 458899999999999999995 5555555554
Q ss_pred HHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 158 DQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 158 ~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+....+. ..+.+++.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 4444332 36899999999999999999998875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=271.45 Aligned_cols=184 Identities=20% Similarity=0.295 Sum_probs=151.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKES-AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~-~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+++..|+||||+.| ++.+.+... ....+++..++.++.|++.||+|||++||+||||||+||
T Consensus 85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164 (307)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHE
Confidence 344999999999999999999999999987 555554432 234599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
++++ +.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9985 789999999998765432 1234578999999998753 358899999999999999999999987543221
Q ss_pred H--------------------------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 I--------------------------YKIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~--------------------------~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
. ......+.+++.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 1123457889999999999999999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=293.81 Aligned_cols=182 Identities=21% Similarity=0.297 Sum_probs=150.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||++++++.+ +.+|+||||+.|+.+..++...+..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 391 ~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 469 (613)
T 2ozo_A 391 HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469 (613)
T ss_dssp TTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE
Confidence 44599999999999976 56999999999866655555445669999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||+++....... .....+++.|+|||++... .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 470 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 548 (613)
T 2ozo_A 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548 (613)
T ss_dssp EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH
T ss_pred cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 7 58999999999987643221 1223456889999998654 46899999999999999998 9999999888777
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
...+. .++.++|.+||..||++||++.+++
T Consensus 549 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 66553 3789999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=276.59 Aligned_cols=187 Identities=22% Similarity=0.365 Sum_probs=155.4
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG------QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~------~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.++||||+++++++.+.+..|+||||+.|+.+..+....+ ..+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp 168 (327)
T 2yfx_A 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 168 (327)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred hCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCH
Confidence 3499999999999999999999999998744444444322 3489999999999999999999999999999999
Q ss_pred CcEEEeC----CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCC
Q 040202 81 SNLLVSK----GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFP 152 (297)
Q Consensus 81 ~Nill~~----~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~ 152 (297)
+|||++. ..+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 169 ~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp GGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999973 36999999998755332 122345678899999997654 45889999999999999998 999998
Q ss_pred CCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 153 GKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 153 ~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+....+....+. ..+.+++.+||..||.+|||+.++++|.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 248 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp TCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 877665555443 368899999999999999999999999886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=267.39 Aligned_cols=181 Identities=17% Similarity=0.208 Sum_probs=145.9
Q ss_pred ccccceeeece-eEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-
Q 040202 8 NNHPNIVKLRN-LVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV- 85 (297)
Q Consensus 8 ~~HpnIv~~~~-~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill- 85 (297)
++|+|++..++ ++.+++..|+||||+++++.+.+... +..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred hcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 36666555555 44778899999999955666655533 4569999999999999999999999999999999999999
Q ss_pred --e-CCeEEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 040202 86 --S-KGVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK 154 (297)
Q Consensus 86 --~-~~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~ 154 (297)
+ ++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.
T Consensus 140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 4 4789999999998765432 22456789999999997754 4688999999999999999999999875
Q ss_pred CCH---HHHHH----------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 155 NSA---DQIYK----------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 155 ~~~---~~~~~----------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
+.. ....+ +..++.+++.+||+.||++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 432 11111 1346889999999999999999998875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=267.73 Aligned_cols=181 Identities=25% Similarity=0.300 Sum_probs=147.0
Q ss_pred ccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccc
Q 040202 8 NNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH--------RQGYFH 75 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH--------~~gi~H 75 (297)
++||||+++++++.+ ....|+||||+.++.+..+... ..+++..+..++.|++.||+||| +.||+|
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 136 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence 699999999998754 3568999999998555555544 46999999999999999999999 999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCCC-----CccccccCCCCCCceeccccc-----CCCccchhhHHHHHHHH
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-----CTDYVTTRWYRAPEVLLLSEI-----CGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGv~l~el 144 (297)
|||||+|||+++ +.+||+|||+++....... .....||+.|+|||++.+... ++.++||||+||++|||
T Consensus 137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el 216 (301)
T 3q4u_A 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216 (301)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence 999999999985 7999999999977644322 234579999999999875432 23689999999999999
Q ss_pred HhC----------CCCCCCCCC----HHHHHH-------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 145 LSF----------RILFPGKNS----ADQIYK-------------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 145 l~g----------~~pf~~~~~----~~~~~~-------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
++| +.||..... .....+ ....+.+++.+||+.||++|||+.++++
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 999 888865322 222222 3346889999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=270.83 Aligned_cols=184 Identities=21% Similarity=0.320 Sum_probs=143.8
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+ ...+|+||||+.|+.+..+....+..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 66 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 145 (295)
T 3ugc_A 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 145 (295)
T ss_dssp HTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhE
Confidence 34489999999999854 4569999999987555555544445699999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|++ ++.+||+|||+++...... ......++..|+|||++.+. .++.++||||+||++|+|++|..||.......
T Consensus 146 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~ 224 (295)
T 3ugc_A 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224 (295)
T ss_dssp EEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH
T ss_pred EEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHH
Confidence 997 5899999999998764432 12334567789999998754 45899999999999999999999986432110
Q ss_pred ----------------HHHH------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 ----------------QIYK------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ----------------~~~~------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.... ...++.+++.+||..||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011 1236889999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.07 Aligned_cols=181 Identities=13% Similarity=0.156 Sum_probs=146.4
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.|+||+++++++.+++..|+||||+.|+ +.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFI 204 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 5999999999999999999999999874 44444432 2356999999999999999999999999999999999999
Q ss_pred EeC------------CeEEEEecCCceecC---CCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 85 VSK------------GVIKIGDLGMVKEID---SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 85 l~~------------~~~kl~Dfgla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
++. +.+||+|||+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSC
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCC
Confidence 965 689999999997653 233345678999999999987654 6899999999999999999999
Q ss_pred CCCCCCCHHH-------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 150 LFPGKNSADQ-------IYKIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 150 pf~~~~~~~~-------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||........ .......|.+++.+||+.+|.+|++..+.+.
T Consensus 284 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 284 MKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CCEEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ccccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 9854322100 0012446789999999999999976544443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=286.81 Aligned_cols=184 Identities=25% Similarity=0.448 Sum_probs=153.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++||||+++++++. .+.+|+||||+.+ ++.+.+....+..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 34459999999999987 5678999999987 555555544334689999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
|+++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~ 394 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9985 799999999998764321 11334467789999998654 46899999999999999999 9999998877666
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+||..||++|||++++++
T Consensus 395 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 55543 36789999999999999999998865
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=268.09 Aligned_cols=181 Identities=23% Similarity=0.371 Sum_probs=150.6
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
.++||||+++++++.+++ .++||||+.+ ++.+.+... ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 77 ~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili 154 (291)
T 1u46_A 77 SLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154 (291)
T ss_dssp HCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred hCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence 348999999999998765 8999999986 555555544 3459999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||+++....... .....+|..|+|||++... .++.++||||||+++|+|++ |+.||.+.+..+.
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 233 (291)
T 1u46_A 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233 (291)
T ss_dssp EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH
Confidence 7 58999999999987654321 2344567889999997654 45789999999999999999 9999998877666
Q ss_pred HHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+++.+||..||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55543 36899999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=269.62 Aligned_cols=185 Identities=19% Similarity=0.295 Sum_probs=145.6
Q ss_pred ccccccceeeeceeEEeCC-----eEEEEEecCCCcHH-HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 6 KMNNHPNIVKLRNLVKEHE-----DVFIVFDYMESDLL-KLMKES----AGQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll-~~~~~~----~~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
+.++||||+++++++.+.+ ..|+||||+.++.+ +.+... ....+++..++.++.||+.||.|||++||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (313)
T 3brb_A 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170 (313)
T ss_dssp HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3348999999999998655 45999999997544 444321 2356999999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRIL 150 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~p 150 (297)
|||||+||++++ +.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp CCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999985 799999999997764332 1233456888999999765 446889999999999999999 9999
Q ss_pred CCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 151 FPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 151 f~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|.+....+....+. ..+.+++.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 250 YPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp STTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98877766555443 368999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=267.35 Aligned_cols=184 Identities=23% Similarity=0.395 Sum_probs=148.0
Q ss_pred ccccccceeeeceeEEeC--CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEH--EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~--~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+. +.+|+||||+.|+.+..+.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 78 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 157 (302)
T 4e5w_A 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 157 (302)
T ss_dssp HTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheE
Confidence 344899999999999876 679999999988555555544445699999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC---
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN--- 155 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~--- 155 (297)
+++ ++.+||+|||+++...... ......||..|+|||++.+.. ++.++||||+||++|+|++|..|+....
T Consensus 158 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 236 (302)
T 4e5w_A 158 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALF 236 (302)
T ss_dssp EEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHH
Confidence 997 5899999999998775542 224556788899999986544 4789999999999999999998764221
Q ss_pred -----------CHHHHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 156 -----------SADQIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 156 -----------~~~~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
....... +...+.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 237 LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1111111 1136789999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=274.54 Aligned_cols=185 Identities=20% Similarity=0.309 Sum_probs=148.8
Q ss_pred ccccccceeeeceeEE--eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVK--EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~--~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++|+||+++++++. +.+..|+||||++|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 79 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NI 158 (327)
T 3lxl_A 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158 (327)
T ss_dssp HTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhE
Confidence 3349999999999986 56679999999987555544444344699999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|++ ++.+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 159 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 237 (327)
T 3lxl_A 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237 (327)
T ss_dssp EEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchh
Confidence 997 5899999999998765432 22345678889999997654 45889999999999999999999986533211
Q ss_pred --------------HHHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 159 --------------QIYK-------------IYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 159 --------------~~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.... +...+.+++.+||..||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 12368899999999999999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.80 Aligned_cols=191 Identities=28% Similarity=0.424 Sum_probs=156.5
Q ss_pred ccccccceeeeceeEEe------CCeEEEEEecCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 6 KMNNHPNIVKLRNLVKE------HEDVFIVFDYMESDLLKLMKESAG--QNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~------~~~~~lv~e~~~g~ll~~~~~~~~--~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.++||||+++++++.. ++..|+||||+.|+.+..+....+ ..+++..++.++.|++.||+|||+.||+|||
T Consensus 67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrD 146 (676)
T 3qa8_A 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRD 146 (676)
T ss_dssp HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCC
T ss_pred HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 34499999999999865 778899999998755555554422 2599999999999999999999999999999
Q ss_pred CCCCcEEEeC-C---eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 78 LKPSNLLVSK-G---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 78 ikp~Nill~~-~---~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|||+||+++. + .+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus 147 LKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 147 LKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9999999984 2 4899999999988776666778899999999998654 458899999999999999999999965
Q ss_pred CCCHHH-----------------------------------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 154 KNSADQ-----------------------------------IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 154 ~~~~~~-----------------------------------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
...... ...+...+.++|.+||..||++|||+.++++||||+..
T Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 226 NWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 422111 01134578999999999999999999999999999654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=293.27 Aligned_cols=182 Identities=21% Similarity=0.338 Sum_probs=149.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||++++++++ +..|+||||+.|+.+..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 425 ~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl 502 (635)
T 4fl3_A 425 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 502 (635)
T ss_dssp HHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE
Confidence 34489999999999964 568999999998555555544 3569999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||+++...... ......+|..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 503 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 581 (635)
T 4fl3_A 503 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581 (635)
T ss_dssp EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 7 5899999999998764332 12334567889999998654 45899999999999999998 9999998887766
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. .++.++|.+||..||++|||++++++
T Consensus 582 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 582 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 55543 36899999999999999999999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.15 Aligned_cols=182 Identities=24% Similarity=0.417 Sum_probs=144.3
Q ss_pred ccccccceeeeceeEEe-CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE-HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+ ++..|+||||+.| ++.+.+.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (278)
T 1byg_A 69 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 148 (278)
T ss_dssp TTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceE
Confidence 34599999999998754 4579999999988 555555544223489999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++++ +.+||+|||+++...... ....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||...+..+...
T Consensus 149 l~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 225 (278)
T 1byg_A 149 LVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225 (278)
T ss_dssp EECTTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred EEeCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9984 799999999987665432 344678899999997654 45889999999999999998 999998877666555
Q ss_pred HH------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KI------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+ ...+.+++.+||..||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 44 236899999999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=277.70 Aligned_cols=189 Identities=24% Similarity=0.269 Sum_probs=146.9
Q ss_pred ccccccceeeeceeEEe-----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------
Q 040202 6 KMNNHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ--------- 71 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~--------- 71 (297)
+.++|+||+++++.+.. ...+|+||||++|+.+..+... ..+++..+..++.||+.||+|||+.
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~ 139 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBC
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhcccccccc
Confidence 34699999999986642 3368999999987555555554 3469999999999999999999999
Q ss_pred CccccCCCCCcEEEeC-CeEEEEecCCceecCCC---------CCCccccccCCCCCCceeccc------ccCCCccchh
Q 040202 72 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---------LPCTDYVTTRWYRAPEVLLLS------EICGPEVDRW 135 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---------~~~~~~~gt~~y~aPE~~~~~------~~~~~~~Diw 135 (297)
||+||||||+|||+++ +.+||+|||+++..... .......||+.|+|||++.+. ..++.++|||
T Consensus 140 ~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp CEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred ceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 9999999999999985 79999999999876432 122355799999999998652 3346789999
Q ss_pred hHHHHHHHHHhCCCCCCCCCC-----------------HHHHH--------------------HHHHHHHHHHHHhhhcC
Q 040202 136 AMGAIMFEMLSFRILFPGKNS-----------------ADQIY--------------------KIYGRWVALISWLCSWN 178 (297)
Q Consensus 136 SlGv~l~ell~g~~pf~~~~~-----------------~~~~~--------------------~i~~~~~~li~~~l~~d 178 (297)
||||++|||++|..||..... .+... .....+.++|.+||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 999999999999776533221 01111 12336899999999999
Q ss_pred CCCCCCHHHH------HcCCCCCC
Q 040202 179 PRMRPTAAEA------LEHPFFRS 196 (297)
Q Consensus 179 P~~R~t~~~l------l~h~~f~~ 196 (297)
|++|||+.++ +-++|-++
T Consensus 300 P~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhCcchHHHHHHHHHHHHHHHhc
Confidence 9999999998 45788765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=279.50 Aligned_cols=194 Identities=18% Similarity=0.245 Sum_probs=155.5
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++..|++|..+..++.+++..||||||+.+++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 134 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceE
Confidence 4455455777777777788999999999996666665554 345699999999999999999999999999999999999
Q ss_pred EEe----CCeEEEEecCCceecCCCCC--------CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 84 LVS----KGVIKIGDLGMVKEIDSSLP--------CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 84 ll~----~~~~kl~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
|++ ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf 213 (483)
T 3sv0_A 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPW 213 (483)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCC
Confidence 993 47899999999987654322 2367899999999997754 4588999999999999999999999
Q ss_pred CCCCCHH---HHHHH----------------HHHHHHHHHHhhhcCCCCCCCHHHHH----------cCCCCCCCCC
Q 040202 152 PGKNSAD---QIYKI----------------YGRWVALISWLCSWNPRMRPTAAEAL----------EHPFFRSCHF 199 (297)
Q Consensus 152 ~~~~~~~---~~~~i----------------~~~~~~li~~~l~~dP~~R~t~~~ll----------~h~~f~~~~~ 199 (297)
.+..... .+.++ ..++.+++.+||..||++||++.+++ .++|+...+|
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW 290 (483)
T 3sv0_A 214 QGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW 290 (483)
T ss_dssp SSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred ccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence 8765422 22221 13678999999999999999998765 3677755544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=283.77 Aligned_cols=188 Identities=26% Similarity=0.449 Sum_probs=150.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+ +..|+||||+.| ++.+.+....+..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 234 ~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 312 (452)
T 1fmk_A 234 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312 (452)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence 34599999999999876 678999999987 5555555443456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|||++ |+.||.+....+..
T Consensus 313 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 391 (452)
T 1fmk_A 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391 (452)
T ss_dssp ECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 985 789999999998764332 12334567889999998754 45889999999999999999 99999988776666
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc--CCCCC
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE--HPFFR 195 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~--h~~f~ 195 (297)
..+. ..+.+++.+||..||++|||++++++ ..++.
T Consensus 392 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 392 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 5543 35789999999999999999999876 24543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=263.38 Aligned_cols=183 Identities=25% Similarity=0.458 Sum_probs=150.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++||||+++++++.+ +..|+||||+.| ++.+.+....+..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 63 ~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 34499999999999874 568999999987 4444443332235999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|+|++ |+.||.+.+..+..
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 220 (279)
T 1qpc_A 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (279)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 985 789999999998765432 12344567889999997644 45889999999999999999 99999887766655
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
..+. ..+.+++.+||..||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 5443 36889999999999999999998875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=264.07 Aligned_cols=184 Identities=26% Similarity=0.435 Sum_probs=140.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+.++||||+++++++.+++..|+||||+.++.+..+... .+..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 87 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 166 (310)
T 2wqm_A 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166 (310)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHH
Confidence 334999999999999999999999999998544444332 34569999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH--H
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA--D 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~--~ 158 (297)
|+++. +.+||+|||+++...... ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.... .
T Consensus 167 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 245 (310)
T 2wqm_A 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245 (310)
T ss_dssp EEECTTSCEEECCC------------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred EEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence 99984 799999999987664432 22455789999999987654 4588999999999999999999999765422 2
Q ss_pred HHHHH-------------HHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKI-------------YGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i-------------~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...++ ..++.+++.+||..||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22222 236899999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.26 Aligned_cols=179 Identities=31% Similarity=0.478 Sum_probs=139.4
Q ss_pred cccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCC
Q 040202 7 MNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQ--NFSEDEARNLCFQVFQGLHYMHR---QGYFHRDLKPS 81 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~--~l~e~~~~~~~~qll~al~yLH~---~gi~Hrdikp~ 81 (297)
.++||||+++++++.+ ..|+||||+.|+.+..+....+. .+++..+..++.|++.||+|||+ +||+||||||+
T Consensus 57 ~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~ 134 (307)
T 2eva_A 57 RVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134 (307)
T ss_dssp HCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGG
T ss_pred cCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChh
Confidence 3499999999998874 47999999987555555543222 47899999999999999999999 89999999999
Q ss_pred cEEEeC-C-eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSK-G-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
||++++ + .+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 135 NIll~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 135 NLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp GEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred HEEEeCCCCEEEEccccccccccccc--ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 999975 4 48999999997665432 345789999999997654 468999999999999999999999986543221
Q ss_pred --HHH------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 --IYK------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 --~~~------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... +...+.+++.+||..||++|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 212 RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111 1246789999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=268.12 Aligned_cols=186 Identities=24% Similarity=0.432 Sum_probs=147.1
Q ss_pred ccccccceeeeceeEEe----CCeEEEEEecCCC-cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 6 KMNNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKES--AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g-~ll~~~~~~--~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
+.++||||+++++++.. .+..|+||||+.+ ++.+.+... .+..+++..++.++.||+.||+|||++||+||||
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dl 160 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 44599999999999972 3488999999998 554544432 3456999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCC----------CccccccCCCCCCceecccc--cCCCccchhhHHHHHHHHH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLP----------CTDYVTTRWYRAPEVLLLSE--ICGPEVDRWAMGAIMFEML 145 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv~l~ell 145 (297)
||+||++++ +.+||+|||+++....... .....||+.|+|||++.... .++.++|||||||++|+|+
T Consensus 161 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp CGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 999999975 7999999999876532111 12345699999999876433 2578999999999999999
Q ss_pred hCCCCCCCC----CCHHHH-H---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 146 SFRILFPGK----NSADQI-Y---------KIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 146 ~g~~pf~~~----~~~~~~-~---------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+|+.||... ...... . .+...+.++|.+||+.||++|||+.+++++
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 999999531 111111 0 123468999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=287.90 Aligned_cols=189 Identities=26% Similarity=0.443 Sum_probs=155.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++.++|+||+++++++.+ +.+||||||+.+ +|.+++....+..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 344599999999999876 678999999987 555555544345699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
|+++ +.+||+|||+++...... ......++..|+|||++... .++.++|||||||++|||++ |+.||.+....+.
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~ 473 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9985 789999999997654321 11234567889999998754 45889999999999999999 9999998877666
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC--CCCC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH--PFFR 195 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h--~~f~ 195 (297)
...+. ..+.+||.+||..||++|||++++++. .+|.
T Consensus 474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 65543 358899999999999999999998763 4443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=289.04 Aligned_cols=183 Identities=23% Similarity=0.384 Sum_probs=151.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++. ++..|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 446 ~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl 524 (656)
T 2j0j_A 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524 (656)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE
Confidence 3349999999999985 456899999999755555555545569999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
+ ++.+||+|||+++....... .....+|+.|+|||++... .++.++||||+||++|||++ |..||.+.+..+...
T Consensus 525 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~ 603 (656)
T 2j0j_A 525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603 (656)
T ss_dssp EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 8 58999999999987654322 2234567889999998654 56889999999999999997 999999887776665
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.+. ..+.+++.+||..||++|||+.++++
T Consensus 604 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 604 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 553 36889999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=268.59 Aligned_cols=182 Identities=21% Similarity=0.331 Sum_probs=148.2
Q ss_pred ccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++.+ ...+|+||||+.++.+..+... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni 165 (318)
T 3lxp_A 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV 165 (318)
T ss_dssp HHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence 34489999999999987 4689999999998666666555 3499999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++++ +.+||+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 244 (318)
T 3lxp_A 166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244 (318)
T ss_dssp EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence 9985 789999999998875542 123456788899999987544 4789999999999999999999987542210
Q ss_pred H--------------HHH-------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 Q--------------IYK-------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~--------------~~~-------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
. ... +...+.++|.+||..||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 001 1236889999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=264.42 Aligned_cols=182 Identities=25% Similarity=0.287 Sum_probs=149.1
Q ss_pred ccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccc
Q 040202 8 NNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH--------RQGYFH 75 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH--------~~gi~H 75 (297)
++||||+++++++.+.+ ..|+||||+.++.+..+..+ ..+++..++.++.|++.||+||| +.||+|
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 170 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeee
Confidence 69999999999998776 89999999998555555544 35999999999999999999999 899999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceeccccc-----CCCccchhhHHHHHHHH
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEI-----CGPEVDRWAMGAIMFEM 144 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGv~l~el 144 (297)
|||||+|||+++ +.+||+|||+++...... ......||+.|+|||++.+... ++.++|||||||++|+|
T Consensus 171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 999999999985 799999999998765543 2345679999999999765422 12679999999999999
Q ss_pred HhC----------CCCCCCCCC----HHHHH-------------------HHHHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 145 LSF----------RILFPGKNS----ADQIY-------------------KIYGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 145 l~g----------~~pf~~~~~----~~~~~-------------------~i~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++| +.||..... .+... .....+.+++.+||..||++|||+.++++|
T Consensus 251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 999 788866432 12221 122367899999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.46 Aligned_cols=172 Identities=16% Similarity=0.178 Sum_probs=140.7
Q ss_pred ccceeeeceeEEe-------------CCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcc
Q 040202 10 HPNIVKLRNLVKE-------------HEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH-RQGYF 74 (297)
Q Consensus 10 HpnIv~~~~~~~~-------------~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH-~~gi~ 74 (297)
||||+++++++.+ ++.+|+||||+.++ +++.+.. +.+++..++.++.||+.||+||| ++||+
T Consensus 108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~iv 184 (336)
T 2vuw_A 108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFE 184 (336)
T ss_dssp CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCB
T ss_pred cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 5666666666654 78999999999864 6766643 45899999999999999999999 99999
Q ss_pred ccCCCCCcEEEeC-C--------------------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccc
Q 040202 75 HRDLKPSNLLVSK-G--------------------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVD 133 (297)
Q Consensus 75 Hrdikp~Nill~~-~--------------------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 133 (297)
||||||+|||++. + .+||+|||+|+..... ..+||+.|+|||++.+.. +.++|
T Consensus 185 HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~D 258 (336)
T 2vuw_A 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFD 258 (336)
T ss_dssp CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHH
T ss_pred ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--cccee
Confidence 9999999999975 4 8999999999887653 458999999999987443 77999
Q ss_pred hhhHHHH-HHHHHhCCCCCCCC-------------------CCHHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHH-cCC
Q 040202 134 RWAMGAI-MFEMLSFRILFPGK-------------------NSADQIYKIYGRWVALISWLCSWNPRMRPTAAEAL-EHP 192 (297)
Q Consensus 134 iwSlGv~-l~ell~g~~pf~~~-------------------~~~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll-~h~ 192 (297)
|||+|++ .+++++|..||.+. ........+..++++||++||+.| |++|+| +||
T Consensus 259 iwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 259 IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred hhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 9998766 77788898888541 111223456678999999999987 999999 999
Q ss_pred CCC
Q 040202 193 FFR 195 (297)
Q Consensus 193 ~f~ 195 (297)
||+
T Consensus 334 ~f~ 336 (336)
T 2vuw_A 334 LFK 336 (336)
T ss_dssp GGC
T ss_pred CcC
Confidence 995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=293.41 Aligned_cols=182 Identities=26% Similarity=0.384 Sum_probs=153.2
Q ss_pred ccccccceeeeceeEEeCCe-----EEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 6 KMNNHPNIVKLRNLVKEHED-----VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~-----~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+.++||||+++++++.+.+. .||||||++|+.+..... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 134 ~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp 210 (681)
T 2pzi_A 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKP 210 (681)
T ss_dssp GGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCh
Confidence 34599999999999987665 799999999866655443 2599999999999999999999999999999999
Q ss_pred CcEEEeCCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC-----
Q 040202 81 SNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN----- 155 (297)
Q Consensus 81 ~Nill~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~----- 155 (297)
+|||++++.+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+..
T Consensus 211 ~NIll~~~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~ 285 (681)
T 2pzi_A 211 ENIMLTEEQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285 (681)
T ss_dssp GGEEECSSCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC
T ss_pred HHeEEeCCcEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccccc
Confidence 999999999999999999887654 566799999999987643 3789999999999999999998876532
Q ss_pred CHHHHHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 156 SADQIYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 156 ~~~~~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
.......+...+.++|.+||..||++||+..+.+.|+|+.
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 1222334556789999999999999999999999998874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=261.11 Aligned_cols=184 Identities=21% Similarity=0.326 Sum_probs=146.5
Q ss_pred ccccccceeeeceeEEeCC--eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 6 KMNNHPNIVKLRNLVKEHE--DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~--~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++||||+++++++...+ .+|+||||+.|+.+..+....+..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 97 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NI 176 (326)
T 2w1i_A 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176 (326)
T ss_dssp HTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence 3348999999999986543 78999999988555555555455699999999999999999999999999999999999
Q ss_pred EEe-CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC--
Q 040202 84 LVS-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS-- 156 (297)
Q Consensus 84 ll~-~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~-- 156 (297)
+++ ++.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 177 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 255 (326)
T 2w1i_A 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255 (326)
T ss_dssp EEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH
T ss_pred EEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHH
Confidence 997 58999999999987654422 23345677899999976544 57899999999999999999998864210
Q ss_pred ----------HHH----HHH------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 157 ----------ADQ----IYK------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 157 ----------~~~----~~~------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
... ... +...+.++|.+||..||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 256 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011 1236789999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=278.41 Aligned_cols=171 Identities=17% Similarity=0.246 Sum_probs=142.0
Q ss_pred CeEEEEEecCCCcHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCC
Q 040202 24 EDVFIVFDYMESDLLKLMKE-----SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM 97 (297)
Q Consensus 24 ~~~~lv~e~~~g~ll~~~~~-----~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgl 97 (297)
..++++|+++.+++.+.+.. ..+..+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+
T Consensus 178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 35789999988887766642 22345888899999999999999999999999999999999985 7899999999
Q ss_pred ceecCCCCCCccccccCCCCCCceec---------ccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH------
Q 040202 98 VKEIDSSLPCTDYVTTRWYRAPEVLL---------LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK------ 162 (297)
Q Consensus 98 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~------ 162 (297)
++..... ....+| +.|+|||++. ....++.++|||||||++|||++|+.||.+.+..+....
T Consensus 258 a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 334 (413)
T 3dzo_A 258 LVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK 334 (413)
T ss_dssp CEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCC
T ss_pred eeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhcc
Confidence 9876554 356678 9999999983 334467899999999999999999999987654333222
Q ss_pred -HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 163 -IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 163 -i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
+...+.+||.+||..||++|||+.++++||||+..
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 34578999999999999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=240.68 Aligned_cols=154 Identities=17% Similarity=0.177 Sum_probs=128.7
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++++++.+++..|+||||+.|+.+..+... + ..+.++..++.|++.||+|||++||+||||||+|||+
T Consensus 86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll 162 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV 162 (286)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE
Confidence 345999999999999999999999999998666666543 2 4666789999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH-----
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ----- 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~----- 159 (297)
++ |.+||+++| |++| ++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 163 ~~~g~~kl~~~~-------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~ 215 (286)
T 3uqc_A 163 SIDGDVVLAYPA-------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215 (286)
T ss_dssp ETTSCEEECSCC-------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC
T ss_pred cCCCCEEEEecc-------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH
Confidence 85 788988543 3332 47899999999999999999999987654221
Q ss_pred -------------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 -------------IYKIYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 -------------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+...+.++|.+||+.||++| |+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 12244578999999999999999 9999876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-33 Score=267.43 Aligned_cols=182 Identities=13% Similarity=0.147 Sum_probs=121.4
Q ss_pred ccccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 2 ~~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
.+|+++..|+||+++++++++++..||||||++|+.|..++.. ++.+++. .|+.||+.||+|||++||+||||||+
T Consensus 293 ~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPe 368 (569)
T 4azs_A 293 KFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPW 368 (569)
T ss_dssp HHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGG
T ss_pred HHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchH
Confidence 3577888999999999999999999999999999666666655 3457764 58899999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|||+++ |.+||+|||+|+..... ....+.+||+.|||||++.+. +..++|+||+|++++++.++..++. ..
T Consensus 369 NILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~~-----~~ 441 (569)
T 4azs_A 369 NVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNWL-----YA 441 (569)
T ss_dssp GEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH-----HH
T ss_pred hEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchhH-----HH
Confidence 999984 89999999999876543 344678899999999998643 4678999999998877655432210 00
Q ss_pred HHHH---HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 160 IYKI---YGRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 160 ~~~i---~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
.... ...+..+...+...+|..|+.......++|.
T Consensus 442 l~~~~~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 442 VWQEPVERWNFVLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHTSCGGGCSHHHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred hhcCCCCCCcHHHHHHHHhCCCCCCCCChhhhccchhH
Confidence 0000 0012345556666677777665544444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-24 Score=204.69 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=110.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++||||+++..++.+.+..||||||++|+.+..+... +..++.|++.||+|||++||+||||||+|||+
T Consensus 394 ~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl 464 (540)
T 3en9_A 394 ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF 464 (540)
T ss_dssp HHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE
T ss_pred HhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE
Confidence 334999999766666677888999999997555544432 56899999999999999999999999999999
Q ss_pred eCCeEEEEecCCceecCCCCC--------CccccccCCCCCCceeccc-ccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 86 SKGVIKIGDLGMVKEIDSSLP--------CTDYVTTRWYRAPEVLLLS-EICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 86 ~~~~~kl~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
++ .+||+|||+++....... ....+||+.|||||++... ..|+..+|+|+.++-..+.+.++-+|
T Consensus 465 ~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 465 DK-DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp SS-SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CC-eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99 999999999998765321 1367899999999998641 33577789999988888877766655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=8.7e-18 Score=148.00 Aligned_cols=90 Identities=18% Similarity=0.173 Sum_probs=72.6
Q ss_pred ceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeCCeEE
Q 040202 12 NIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIK 91 (297)
Q Consensus 12 nIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~~~~k 91 (297)
| +++.+++.. +..|+||||++|+.+..+ ....+..++.|++.||+|||+.||+||||||+|||++++.+|
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vk 232 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW 232 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHHc--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEE
Confidence 5 677776654 456999999998555332 123456799999999999999999999999999999988999
Q ss_pred EEecCCceecCCCCCCccccccCCCCCCceec
Q 040202 92 IGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123 (297)
Q Consensus 92 l~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~ 123 (297)
|+|||+++. +..++|||.+.
T Consensus 233 l~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEECCCCeE------------CCCCCHHHHHH
Confidence 999999863 45578899864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-14 Score=125.49 Aligned_cols=72 Identities=13% Similarity=0.269 Sum_probs=59.2
Q ss_pred eEEEEEecCCC-c----HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEeCCeEEEEecCCc
Q 040202 25 DVFIVFDYMES-D----LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMH-RQGYFHRDLKPSNLLVSKGVIKIGDLGMV 98 (297)
Q Consensus 25 ~~~lv~e~~~g-~----ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH-~~gi~Hrdikp~Nill~~~~~kl~Dfgla 98 (297)
..+|||||+++ + .+..+... .++..+..++.|++.||.||| +.||+||||||+|||+++ .++|+|||+|
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-~~~liDFG~a 216 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-KVYFIDMGQA 216 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-SEEECCCTTC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-cEEEEECccc
Confidence 56899999952 2 34333221 345678899999999999999 999999999999999999 9999999999
Q ss_pred eec
Q 040202 99 KEI 101 (297)
Q Consensus 99 ~~~ 101 (297)
...
T Consensus 217 ~~~ 219 (258)
T 1zth_A 217 VTL 219 (258)
T ss_dssp EET
T ss_pred ccC
Confidence 754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-12 Score=117.90 Aligned_cols=87 Identities=14% Similarity=0.146 Sum_probs=64.0
Q ss_pred cccceeeeceeEEeC------CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 9 NHPNIVKLRNLVKEH------EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~------~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.|+|++++++....- ...+|||||++|..+..+ .....+..++.||+.+|.|||+.||+||||||.|
T Consensus 163 E~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~N 235 (397)
T 4gyi_A 163 EFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFN 235 (397)
T ss_dssp HHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred HHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 477777776543211 122699999998655322 1223457789999999999999999999999999
Q ss_pred EEEeCC-----------eEEEEecCCceecC
Q 040202 83 LLVSKG-----------VIKIGDLGMVKEID 102 (297)
Q Consensus 83 ill~~~-----------~~kl~Dfgla~~~~ 102 (297)
||++++ .+.|+||+-+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999753 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=4.9e-09 Score=90.27 Aligned_cols=87 Identities=16% Similarity=0.145 Sum_probs=69.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---------------
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR--------------- 70 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~--------------- 70 (297)
.+.+|..+.++++++.+.+..|+||||++|..+.... .+......++.++..++..||+
T Consensus 65 ~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 138 (263)
T 3tm0_A 65 WLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSR 138 (263)
T ss_dssp HHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHH
T ss_pred HHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHH
Confidence 3434678889999999999999999999996655431 1222345788899999999998
Q ss_pred --------------------------------------------CCccccCCCCCcEEEeCCe-EEEEecCCc
Q 040202 71 --------------------------------------------QGYFHRDLKPSNLLVSKGV-IKIGDLGMV 98 (297)
Q Consensus 71 --------------------------------------------~gi~Hrdikp~Nill~~~~-~kl~Dfgla 98 (297)
.+++|+|+++.||+++++. +.|+||+.+
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 139 LAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 4589999999999998765 569999965
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.57 E-value=4.2e-08 Score=83.74 Aligned_cols=78 Identities=14% Similarity=0.179 Sum_probs=58.7
Q ss_pred eeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------
Q 040202 13 IVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG-------------------- 72 (297)
Q Consensus 13 Iv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g-------------------- 72 (297)
+.+++++..+++..|+||||++|..+. .. ... ...++.++...+..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~ 147 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR 147 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence 667888888888899999999996553 11 122 2255667777777777643
Q ss_pred --------------------------------------ccccCCCCCcEEEeCCe-EEEEecCCce
Q 040202 73 --------------------------------------YFHRDLKPSNLLVSKGV-IKIGDLGMVK 99 (297)
Q Consensus 73 --------------------------------------i~Hrdikp~Nill~~~~-~kl~Dfgla~ 99 (297)
++|+|++|.||+++++. +.|+|||.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 99999999999999865 4699999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.44 E-value=2e-07 Score=84.02 Aligned_cols=88 Identities=16% Similarity=0.252 Sum_probs=69.9
Q ss_pred ccceeeeceeEEeC---CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------
Q 040202 10 HPNIVKLRNLVKEH---EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR---------------- 70 (297)
Q Consensus 10 HpnIv~~~~~~~~~---~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~---------------- 70 (297)
+..+.+++.++.+. +..|+||||++|..+.. ..-..+++.+...++.++..+|..||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~---~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~ 173 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWD---QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN 173 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCC---TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCC---CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence 45688888888776 45899999999954421 111237888899999999999999997
Q ss_pred ------------------------------------------CCccccCCCCCcEEEeC-C--eEEEEecCCcee
Q 040202 71 ------------------------------------------QGYFHRDLKPSNLLVSK-G--VIKIGDLGMVKE 100 (297)
Q Consensus 71 ------------------------------------------~gi~Hrdikp~Nill~~-~--~~kl~Dfgla~~ 100 (297)
.+++|+|+++.||++++ + .+.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999975 2 369999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.37 E-value=1.9e-07 Score=82.22 Aligned_cols=136 Identities=13% Similarity=0.097 Sum_probs=83.2
Q ss_pred eeeeceeEEeCC---eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------
Q 040202 13 IVKLRNLVKEHE---DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR------------------- 70 (297)
Q Consensus 13 Iv~~~~~~~~~~---~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~------------------- 70 (297)
+.+.+......+ ..|+|||+++|..+..... ..++.++...++.|+...+..||+
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~ 151 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKIN 151 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHH
Confidence 344444433333 4589999999954432221 237888888889999999988886
Q ss_pred ---------------------------------------CCccccCCCCCcEEEeC--C-eEEEEecCCceecCCCCCCc
Q 040202 71 ---------------------------------------QGYFHRDLKPSNLLVSK--G-VIKIGDLGMVKEIDSSLPCT 108 (297)
Q Consensus 71 ---------------------------------------~gi~Hrdikp~Nill~~--~-~~kl~Dfgla~~~~~~~~~~ 108 (297)
..++|+|+++.||++++ + .+.|+||+.+..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~ 231 (304)
T 3sg8_A 152 EDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI 231 (304)
T ss_dssp HHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH
T ss_pred HHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH
Confidence 13699999999999986 4 57899999886543211000
Q ss_pred cccccCCCCCCceecc-cccCC------------CccchhhHHHHHHHHHhCCCCC
Q 040202 109 DYVTTRWYRAPEVLLL-SEICG------------PEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 109 ~~~gt~~y~aPE~~~~-~~~~~------------~~~DiwSlGv~l~ell~g~~pf 151 (297)
.......-..++.... -..|+ ...+.|++|.+++.+.+|..+|
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 232 SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000000012221110 00011 1258999999999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00012 Score=62.68 Aligned_cols=85 Identities=18% Similarity=0.237 Sum_probs=58.6
Q ss_pred ccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC------------------
Q 040202 10 HPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ------------------ 71 (297)
Q Consensus 10 HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~------------------ 71 (297)
+--+.+.++++++++..|+|||+++|..+....... ......+..++...|.-||+.
T Consensus 79 ~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 79 FMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred CCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 334778888899999999999999996554433321 112233445555555555531
Q ss_pred ----------------------------------------CccccCCCCCcEEEeCCe-EEEEecCCce
Q 040202 72 ----------------------------------------GYFHRDLKPSNLLVSKGV-IKIGDLGMVK 99 (297)
Q Consensus 72 ----------------------------------------gi~Hrdikp~Nill~~~~-~kl~Dfgla~ 99 (297)
.++|+|+.+.||+++++. +-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 278999999999999865 4699999763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00017 Score=63.40 Aligned_cols=85 Identities=18% Similarity=0.226 Sum_probs=57.3
Q ss_pred eeeeceeEE-eCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------
Q 040202 13 IVKLRNLVK-EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQ-------------------- 71 (297)
Q Consensus 13 Iv~~~~~~~-~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~-------------------- 71 (297)
+.+.+.+.. ..+..|+|||+++|..+....- ..++..+...+..++...|..||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 556666554 4556789999999955443211 1245555556666666666666542
Q ss_pred ----------------------------------------CccccCCCCCcEEEeC----Ce-EEEEecCCcee
Q 040202 72 ----------------------------------------GYFHRDLKPSNLLVSK----GV-IKIGDLGMVKE 100 (297)
Q Consensus 72 ----------------------------------------gi~Hrdikp~Nill~~----~~-~kl~Dfgla~~ 100 (297)
.++|+|+++.||++++ +. +.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999976 55 48999997754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00065 Score=56.50 Aligned_cols=121 Identities=16% Similarity=0.155 Sum_probs=75.3
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEe-CCeEEEEecCCceecCCCCCCccccccC
Q 040202 37 LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTR 114 (297)
Q Consensus 37 ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 114 (297)
+|..+++..+.+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++. +|.|-+.+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 4667777778899999999999999999877622 2222344456888886 47776664 2110 1233
Q ss_pred CCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 040202 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCSW 177 (297)
Q Consensus 115 ~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i~~~~~~li~~~l~~ 177 (297)
.+.+||... .....+.=|||||+++|.-+-...+-.. ...++..+-.||..|...
T Consensus 102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~e------E~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENE------ERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTE------EECCCHHHHHHHHHHTTC
T ss_pred CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCccc------chhhCHHHHHHHHHHHhc
Confidence 467888753 2335678899999999999976555221 222345567788888755
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00048 Score=61.52 Aligned_cols=29 Identities=21% Similarity=0.177 Sum_probs=25.0
Q ss_pred CCccccCCCCCcEEEeCC-eEEEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKG-VIKIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~-~~kl~Dfgla~ 99 (297)
..++|+|+.+.||+++++ .+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 468999999999999976 47899999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.01 Score=51.97 Aligned_cols=29 Identities=28% Similarity=0.335 Sum_probs=25.5
Q ss_pred CCccccCCCCCcEEEe-CCeEEEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVS-KGVIKIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~-~~~~kl~Dfgla~ 99 (297)
.+++|+|+++.||+++ ++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5799999999999996 5789999999763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.77 E-value=0.015 Score=50.53 Aligned_cols=29 Identities=21% Similarity=0.023 Sum_probs=25.3
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
.++|+|+.+.||+.+++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEECCCCEEEEecccccC
Confidence 48999999999997778889999997754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.01 Score=54.31 Aligned_cols=32 Identities=19% Similarity=0.269 Sum_probs=27.5
Q ss_pred HHCCccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 69 HRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 69 H~~gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
+...++|+|+++.|||++++.++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCccccc
Confidence 35679999999999999876699999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.28 E-value=0.047 Score=47.53 Aligned_cols=39 Identities=18% Similarity=0.284 Sum_probs=29.7
Q ss_pred HHHHHHHHHH-------CCccccCCCCCcEEEeCCeE-EEEecCCce
Q 040202 61 VFQGLHYMHR-------QGYFHRDLKPSNLLVSKGVI-KIGDLGMVK 99 (297)
Q Consensus 61 ll~al~yLH~-------~gi~Hrdikp~Nill~~~~~-kl~Dfgla~ 99 (297)
+...++.+.+ .+++|+|+++.||+++++.+ .|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3344555553 36999999999999998665 799999764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.89 E-value=0.079 Score=47.25 Aligned_cols=29 Identities=17% Similarity=0.344 Sum_probs=24.9
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
+++|+|+++.|||++++.+.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKCLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCcEEEEEecCCCC
Confidence 58999999999999887799999997743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.88 E-value=0.067 Score=46.67 Aligned_cols=29 Identities=21% Similarity=0.140 Sum_probs=24.8
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
..++|+|+++.||++++ .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWRD-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEESS-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEcC-CCEEEECCCCCc
Confidence 45899999999999985 889999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.36 E-value=0.049 Score=47.81 Aligned_cols=30 Identities=27% Similarity=0.315 Sum_probs=26.0
Q ss_pred CCccccCCCCCcEEEeC-----CeEEEEecCCcee
Q 040202 71 QGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKE 100 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-----~~~kl~Dfgla~~ 100 (297)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 47999999999999975 5789999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.02 E-value=0.093 Score=47.25 Aligned_cols=30 Identities=20% Similarity=0.256 Sum_probs=26.2
Q ss_pred HCCccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 70 RQGYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 70 ~~gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
...++|+|+.+.||+++++.++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSCEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCCeEEEeCcccc
Confidence 357999999999999988779999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=91.04 E-value=0.35 Score=42.29 Aligned_cols=26 Identities=15% Similarity=0.137 Sum_probs=22.4
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecC
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLG 96 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfg 96 (297)
-.++|+|+.+.|++++.+...|+|++
T Consensus 207 ~~l~HgD~~~~N~l~~~~~~~~iD~~ 232 (312)
T 3jr1_A 207 PSILHGNLWIENCIQVDDKIFVCNPA 232 (312)
T ss_dssp CEEECSSCSGGGEEEETTEEEECSCC
T ss_pred ceeEeCCCCcCcEeecCCCeEEEcCc
Confidence 35899999999999987558899984
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=87.85 E-value=0.28 Score=43.22 Aligned_cols=30 Identities=27% Similarity=0.210 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEeC-CeEEEEecCCcee
Q 040202 71 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 100 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~ 100 (297)
.+++|+|+.+.||++++ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46999999999999985 6899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=86.45 E-value=0.31 Score=45.03 Aligned_cols=15 Identities=33% Similarity=0.392 Sum_probs=14.1
Q ss_pred CccccCCCCCcEEEe
Q 040202 72 GYFHRDLKPSNLLVS 86 (297)
Q Consensus 72 gi~Hrdikp~Nill~ 86 (297)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999997
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.22 E-value=0.24 Score=45.29 Aligned_cols=29 Identities=24% Similarity=0.399 Sum_probs=24.2
Q ss_pred CccccCCCCCcEEEeC-----------------------------CeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSK-----------------------------GVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-----------------------------~~~kl~Dfgla~~ 100 (297)
.++|+|+.+.|||+++ +.+.|+||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 5899999999999975 4689999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=84.41 E-value=0.42 Score=43.00 Aligned_cols=29 Identities=17% Similarity=0.331 Sum_probs=25.2
Q ss_pred CccccCCCCCcEEEeC-----CeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSK-----GVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~-----~~~kl~Dfgla~~ 100 (297)
.++|+|+.+.||++++ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 5899999999999975 4899999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 297 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-47 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-12 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-50
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HPNIVKL + +++I+ ++ + + + +E + + +C Q L+Y+
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSE 126
H HRDLK N+L G IK+ D G+ + ++ D ++ T ++ APEV++
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 127 IC----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG--------------RWV 168
+ D W++G + EM N + KI +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 169 ALISWLCSWNPRMRPTAAEALEHPFFR 195
+ N R T ++ L+HPF
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 9e-50
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
LRK++ HPNI++L++ + + F+VFD M+ +L + E SE E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 120
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 121
+ + +H+ HRDLKP N+L+ IK+ D G ++D + T Y APE+
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 122 LLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-------- 168
+ S G EVD W+ G IM+ +L+ F + + I
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 169 -------ALISWLCSWNPRMRPTAAEALEHPFFR 195
L+S P+ R TA EAL HPFF+
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 1e-49
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 20/222 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPN ++ R ++V +Y L++ + E E + QGL Y+
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYL 131
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-- 125
H HRD+K N+L+S+ G++K+GD G + P +V T ++ APEV+L
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDE 188
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------------WVALIS 172
+VD W++G E+ + N+ +Y I + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 173 WLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLLCNNFEAV 214
P+ RPT+ L+H F + L+ +AV
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 8e-49
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 19/216 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HP +V L + ++ ++ +++++M L SEDEA QV +GL +M
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 69 HRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
H Y H DLKP N++ + +K+ D G+ +D T + APEV
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEG 199
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY-GRW--------------VAL 170
+ G D W++G + + +LS F G+N + + + W
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 171 ISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
I L +P R T +ALEHP+ + R +
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 15/207 (7%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+ ++ HPNI++L + V+++ +Y + + F E ++
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITEL 115
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
L Y H + HRD+KP NLL+ S G +KI D G SS T T Y PE
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPE 174
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-----------RWVA 169
+ + + +VD W++G + +E L + F + +I
Sbjct: 175 M-IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233
Query: 170 LISWLCSWNPRMRPTAAEALEHPFFRS 196
LIS L NP RP E LEHP+ +
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 29/227 (12%)
Query: 4 LRKMNNHPNIVKL----RNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLC 58
+ + P+IV++ NL + + IV + ++ +L +++ Q F+E EA +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 59 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTR 114
+ + + Y+H HRD+KP NLL + ++K+ D G KE S T T
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW------- 167
+Y APEV L E D W++G IM+ +L F + + R
Sbjct: 178 YYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 168 ------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPR 202
LI L P R T E + HP+ VP+
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 3e-48
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP ++ L + ++ ++ ++ +++ L + SE E N Q +GL +M
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 69 HRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
H H D+KP N++ +KI D G+ +++ T + APE+ +
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDR 202
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR---------------WVAL 170
E G D WA+G + + +LS F G++ + + +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 171 ISWLCSWNPRMRPTAAEALEHPFFRSCH 198
I L PR R T +ALEHP+ + H
Sbjct: 263 IKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-48
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 19/222 (8%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + + N +PNIV + +++++V +Y+ L E + +C +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL--TDVVTETCMDEGQIAAVCREC 125
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAP 119
Q L ++H HRD+K N+L+ G +K+ D G +I + V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV----------- 168
EV+ GP+VD W++G + EM+ + +N +Y I
Sbjct: 186 EVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 169 ---ALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPLL 207
++ + R +A E L+H F + + PL+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-47
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + KM NH N+VK +E ++ +Y L E E +A+ Q+
Sbjct: 54 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQL 112
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYR 117
G+ Y+H G HRD+KP NLL+ + +KI D G+ + T Y
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR----------- 166
APE+L E VD W+ G ++ ML+ + + + + Q Y +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 167 ---WVALISWLCSWNPRMRPTAAEALEHPFFR 195
+AL+ + NP R T + + ++
Sbjct: 233 DSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-45
Identities = 45/201 (22%), Positives = 88/201 (43%), Gaps = 9/201 (4%)
Query: 4 LRKMN-NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
L+K++ +++L + + + ++ + E + E+ AR+ +QV
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 63 QGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
+ + + H G HRD+K N+L+ ++G +K+ D G + + TD+ TR Y PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPE 179
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-----ALISWLC 175
+ G W++G ++++M+ I F + + + V LI W
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239
Query: 176 SWNPRMRPTAAEALEHPFFRS 196
+ P RPT E HP+ +
Sbjct: 240 ALRPSDRPTFEEIQNHPWMQD 260
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-44
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 6 KMNNHPNIVKL----RNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
K HPNIV+ + VK + + +V + M S LK + R+ C Q+
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQI 121
Query: 62 FQGLHYMHRQGY--FHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
+GL ++H + HRDLK N+ ++ G +KIGDLG+ +S + T +
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFM 180
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV--------- 168
APE+ E VD +A G M EM + + +A QIY+ V
Sbjct: 181 APEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 169 -----ALISWLCSWNPRMRPTAAEALEHPFFR 195
+I N R + + L H FF+
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-43
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQ 60
I + + H NI+ L + E++ ++F+++ D+ + + S +E E + Q
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQ 110
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
V + L ++H H D++P N++ IKI + G +++ T Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR----------- 166
APEV ++ D W++G +++ +LS F + + I I
Sbjct: 171 APEV-HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 167 ----WVALISWLCSWNPRMRPTAAEALEHPFFR 195
+ + L + R TA+EAL+HP+ +
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-43
Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 42/234 (17%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
+ +HPNI+ L + ++ +VFD+ME+DL ++K++ + + QGL
Sbjct: 55 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGL 113
Query: 66 HYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLL 123
Y+H+ HRDLKP+NLL+ GV+K+ D G+ K S T V TRWYRAPE+L
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW---------------- 167
+ + G VD WA+G I+ E+L PG + DQ+ +I+
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 168 -----------------------VALISWLCSWNPRMRPTAAEALEHPFFRSCH 198
+ LI L +NP R TA +AL+ +F +
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (373), Expect = 4e-43
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 23/217 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
HPNIV L ++ + ++++ + +L + E ++E +A L FQV + Y
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKY 122
Query: 68 MHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
+H G HRDLKP NLL I I D G+ K D + T Y APEVL
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV--------------- 168
+ VD W++G I + +L F +N A +I
Sbjct: 183 -QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 169 ALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVP 205
I L +P R T +AL+HP+ + +++
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-42
Identities = 78/241 (32%), Positives = 117/241 (48%), Gaps = 45/241 (18%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
NHPNIVKL +++ +++VF+++ DL K M SA ++ FQ+ QGL +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 69 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSE 126
H HRDLKP NLL++ G IK+ D G+ + + T V T WYRAPE+LL +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 127 ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI----------------------- 163
VD W++G I EM++ R LFPG + DQ+++I
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 164 -YGRW----------------VALISWLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
+ +W +L+S + ++P R +A AL HPFF+ V + VP
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD---VTKPVPH 295
Query: 207 L 207
L
Sbjct: 296 L 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-42
Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 9 NHPNIVKLRNLVKEHED--VFIVFDYME-SDLLKLMKES--AGQNFSEDEARNLCFQVFQ 63
HPNIV+ + + + + ++IV +Y E DL ++ + Q E+ + Q+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 64 GLHYMHRQGY-----FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWY 116
L HR+ HRDLKP+N+ + K +K+GD G+ + ++ +V T +Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 117 RAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY------------ 164
+PE + + D W++G +++E+ + F + + KI
Sbjct: 181 MSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 165 GRWVALISWLCSWNPRMRPTAAEALEHPF 193
+I+ + + RP+ E LE+P
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-42
Identities = 53/212 (25%), Positives = 82/212 (38%), Gaps = 23/212 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP VKL ++ E ++ Y ++ L G F E R ++ L Y+
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYL 124
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLL 124
H +G HRDLKP N+L+ I+I D G K + +V T Y +PE+L
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-----------RWVALISW 173
D WA+G I++++++ F N KI + L+
Sbjct: 185 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 174 LCSWNPRMRPTAAEA------LEHPFFRSCHF 199
L + R E HPFF S +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 9e-42
Identities = 53/216 (24%), Positives = 85/216 (39%), Gaps = 22/216 (10%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
M+ L + P IV + + + + D M L G E + R +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAE 115
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
+ GL +MH + +RDLKP+N+L+ + G ++I DLG+ + P V T Y AP
Sbjct: 116 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAP 174
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW------------ 167
EVL D +++G ++F++L F + D+
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 168 --VALISWLCSWNPRMRPT-----AAEALEHPFFRS 196
+L+ L + R A E E PFFRS
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-41
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 51/252 (20%)
Query: 4 LRKMNNHPNIVKLRNLVKEHED------VFIVFDYMESDLLKLMKE--SAGQNFSEDEAR 55
+RK++ H NIV+LR + + +V DY+ + ++ + A Q +
Sbjct: 67 MRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTT 113
+Q+F+ L Y+H G HRD+KP NLL+ V+K+ D G K++ P Y+ +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 114 RWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW------ 167
R+YRAPE++ + +D W+ G ++ E+L + +FPG + DQ+ +I
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 168 ----------------------------------VALISWLCSWNPRMRPTAAEALEHPF 193
+AL S L + P R T EA H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 194 FRSCHFVPRSVP 205
F +P
Sbjct: 306 FDELRDPNVKLP 317
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
HPN++ L + + DV ++ + + L ++ +E+EA Q+ G++Y+
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYL 129
Query: 69 HRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
H H DLKP N+++ K IKI D G+ +ID + T + APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV--------------- 168
E G E D W++G I + +LS F G + + +
Sbjct: 190 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 169 ALISWLCSWNPRMRPTAAEALEHPFFRS 196
I L +P+ R T ++L+HP+ +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 5e-40
Identities = 43/206 (20%), Positives = 78/206 (37%), Gaps = 24/206 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
H NI+ + IV + E L F + ++ Q QG+ Y+
Sbjct: 62 RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK---EIDSSLPCTDYVTTRWYRAPEVLLL 124
H + HRDLK +N+ + +KIGD G+ S + + APEV+ +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 125 SE--ICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR---------------- 166
+ + D +A G +++E+++ ++ + N+ DQI + GR
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 167 -WVALISWLCSWNPRMRPTAAEALEH 191
L++ RP + L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-40
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 31/237 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVF 62
L HP + + + E++F V +Y+ DL+ ++ F A ++
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEII 113
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPE 120
GL ++H +G +RDLK N+L+ K G IKI D GM KE + T Y APE
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI------YGRWV-----A 169
+LL + VD W+ G +++EML + F G++ + + I Y RW+
Sbjct: 174 ILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 170 LISWLCSWNPRMRPTAA-EALEHPFFRSCH------------FVPR-SVPLLCNNFE 212
L+ L P R + +HP FR + F P+ P C+NF+
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 76/256 (29%), Positives = 119/256 (46%), Gaps = 56/256 (21%)
Query: 9 NHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
H NI+ + ++++ +DV++V M +DL KL+K Q+ S D +Q+ +
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILR 120
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRA 118
GL Y+H HRDLKPSNLL++ +KI D G+ + D T+YV TRWYRA
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW----------- 167
PE++L S+ +D W++G I+ EMLS R +FPGK+ DQ+ I G
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 168 -------------------------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
+ L+ + ++NP R +AL HP+
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 197 CHFVPRSVPLLCNNFE 212
++ P P+ F+
Sbjct: 301 -YYDPSDEPIAEAPFK 315
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-39
Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 45/235 (19%)
Query: 6 KMNNHPNIVKLRNLVKEHED-----VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQ 60
+ HPN+V+L ++ + +VF++++ DL + + + +++ FQ
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 61 VFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
+ +GL ++H HRDLKP N+LV S G IK+ D G+ + + T V T WYRAP
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW------------ 167
EV LL VD W++G I EM + LF G + DQ+ KI
Sbjct: 185 EV-LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 168 --------------------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
L+ ++NP R +A AL HP+F+
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-39
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 8/225 (3%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
N P IV ++ I ++M+ L + + AG+ E + V +GL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 66 HYMH-RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL 123
Y+ + HRD+KPSN+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPER-L 175
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWLCSWNPRMRP 183
+ D W+MG + EM R P ++ ++ ++G V PR R
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-KELELMFGCQV--EGDAAETPPRPRT 232
Query: 184 TAAEALEHPFFRSCHFVPRSVPLLCNNFEAVAFPTATVTMQGRSL 228
+ + N P+ +++ +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-38
Identities = 80/258 (31%), Positives = 117/258 (45%), Gaps = 56/258 (21%)
Query: 6 KMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59
K H N++ L ++ E D ++V +M +DL KLMK + ED + L +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVY 128
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
Q+ +GL Y+H G HRDLKP NL V++ +KI D G+ ++ DS + T YV TRWYRA
Sbjct: 129 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRA 186
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW----------- 167
PEV+L VD W++G IM EM++ + LF G + DQ+ +I
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 168 -------------------------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
V L+ + + R TA EAL HP+F S
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
Query: 197 CHFV--PRSVPLLCNNFE 212
H V ++F+
Sbjct: 307 LHDTEDEPQVQKYDDSFD 324
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-37
Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 19/199 (9%)
Query: 9 NHPNIVKLRNLVKEHED-VFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQGLH 66
H N+V+L ++ E + ++IV +YM L+ ++ D V + +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 125
Y+ + HRDL N+LVS+ V K+ D G+ KE S+ + APE L
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEA-LRE 174
Query: 126 EICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY------------GRWVALIS 172
+ + D W+ G +++E+ SF R+ +P D + ++ ++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 173 WLCSWNPRMRPTAAEALEH 191
+ MRP+ + E
Sbjct: 235 NCWHLDAAMRPSFLQLREQ 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-37
Identities = 63/252 (25%), Positives = 101/252 (40%), Gaps = 58/252 (23%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHE--------DVFIVFDYMESDLLKLMKESAGQNFSEDE 53
I + ++ H N+V L + + +++VFD+ E DL L+ F+ E
Sbjct: 60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSE 118
Query: 54 ARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-----LPC 107
+ + + GL+Y+HR HRD+K +N+L+++ GV+K+ D G+ + +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIY--- 164
T+ V T WYR PE+LL GP +D W G IM EM + + G Q+ I
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 165 ----------------------------------------GRWVALISWLCSWNPRMRPT 184
+ LI L +P R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 185 AAEALEHPFFRS 196
+ +AL H FF S
Sbjct: 299 SDDALNHDFFWS 310
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 6e-37
Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 43/236 (18%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
I + K H NIVKL +++ + + +VF++++ DL KL+ G A++ Q+
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQL 109
Query: 62 FQGLHYMHRQGYFHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 119
G+ Y H + HRDLKP + L+ +G +KI D G+ + + T + T WYRAP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW------------ 167
+VL+ S+ +D W++G I EM++ LFPG + ADQ+ +I+
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 168 ----------------------------VALISWLCSWNPRMRPTAAEALEHPFFR 195
+ L+S + +P R TA +ALEH +F+
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (329), Expect = 1e-36
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 2 IFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQV 61
+ + HP I+++ ++ + +F++ DY+E L + Q F A+ +V
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEV 113
Query: 62 FQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 120
L Y+H + +RDLKP N+L+ G IKI D G K + T Y APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPE 171
Query: 121 VLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-----------A 169
V + ++ +D W+ G +++EML+ F N+ KI +
Sbjct: 172 V-VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 170 LISWLCSWNPRMR-----PTAAEALEHPFFRS 196
L+S L + + R + HP+F+
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-36
Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 17/199 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP +V+L + E + +VF++ME L + F+ + +C V +G+ Y+
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLS 125
HRDL N LV VIK+ D GM + + D T + +PEV S
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 126 EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------------WVALIS 172
+ D W+ G +M+E+ S + S ++ + +++
Sbjct: 178 RY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 173 WLCSWNPRMRPTAAEALEH 191
P RP + L
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 5e-36
Identities = 51/249 (20%), Positives = 105/249 (42%), Gaps = 59/249 (23%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHED--VFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCF 59
L + PNI+ L ++VK+ +VF+++ +D +L Q ++ + R +
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMY 136
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 117
++ + L Y H G HRD+KP N+++ +++ D G+ + V +R+++
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 196
Query: 118 APEVLLLSEICGPEVDRWAMGAIMFEMLSFRI-LFPGKNSADQIYKI------------- 163
PE+L+ ++ +D W++G ++ M+ + F G ++ DQ+ +I
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 164 -------------------YGRW----------------VALISWLCSWNPRMRPTAAEA 188
RW + + L ++ + R TA EA
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
Query: 189 LEHPFFRSC 197
+EHP+F +
Sbjct: 317 MEHPYFYTV 325
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-35
Identities = 44/228 (19%), Positives = 87/228 (38%), Gaps = 41/228 (17%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMK-------------------- 42
+ ++ +H NIV L ++++F+Y DLL ++
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 43 -ESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE 100
E + ++ +QV +G+ ++ + HRDL N+LV V+KI D G+ ++
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 101 I---DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNS 156
I + + + + APE L I + D W+ G +++E+ S +PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPES-LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 157 ADQIYKIYGR-------------WVALISWLCSWNPRMRPTAAEALEH 191
YK+ ++ +++ R RP+
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-35
Identities = 46/207 (22%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHY 67
H +V+L V E ++I+ +YME+ L +K +G + ++ ++ Q+ +G+ +
Sbjct: 66 QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 68 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLL 124
+ + Y HRDL+ +N+LV KI D G+ + I+ + + APE +
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA-IN 183
Query: 125 SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIYGRW------------VALI 171
+ D W+ G ++ E+++ RI +PG + + I + + L+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 172 SWLCSWNPRMRPTAAEALE--HPFFRS 196
P RPT FF +
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-34
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 18/208 (8%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
+ HP + L+ + H+ + V +Y L + F+E+ AR ++ L
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSAL 118
Query: 66 HYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
Y+H + +RD+K NL++ K G IKI D G+ KE S +L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-----------WVALISW 173
G VD W +G +M+EM+ R+ F ++ I +L++
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 174 LCSWNPRMRP-----TAAEALEHPFFRS 196
L +P+ R A E +EH FF S
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-34
Identities = 42/207 (20%), Positives = 79/207 (38%), Gaps = 24/207 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
++P IV++ + E E +V + E L + + L QV G+ Y+
Sbjct: 66 DNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL 123
Query: 69 HRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLL 123
+ HRDL N LLV++ KI D G+ K + + T + APE +
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-I 182
Query: 124 LSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY------------GRWVAL 170
+ D W+ G +M+E S+ + + G ++ + L
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242
Query: 171 ISWLCSWNPRMRPTAAE---ALEHPFF 194
++ +++ RP A L + ++
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (307), Expect = 7e-34
Identities = 40/211 (18%), Positives = 80/211 (37%), Gaps = 26/211 (12%)
Query: 9 NHPNIVKLRNLVKEHED----VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
NHP IV + + + +IV +Y++ L+ + + G + A + Q
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQA 123
Query: 65 LHYMHRQGYFHRDLKPSNLLVSKG-----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 119
L++ H+ G HRD+KP+N+++S + + +S + T Y +P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR------------- 166
E + D +++G +++E+L+ F G + Y+
Sbjct: 184 EQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 167 --WVALISWLCSWNPRMRPTAAEALEHPFFR 195
A++ + NP R A + R
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 40/207 (19%), Positives = 74/207 (35%), Gaps = 23/207 (11%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
++P IV+L V + E + +V + L + L QV G+ Y+
Sbjct: 67 DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLL 123
+ + HRDL N+L+ ++ KI D G+ K + + + + APE +
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC-I 184
Query: 124 LSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY------------GRWVAL 170
D W+ G M+E LS+ + + + + I AL
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 171 ISWLCSWNPRMRPTAAE---ALEHPFF 194
+S + RP + ++
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-33
Identities = 41/199 (20%), Positives = 79/199 (39%), Gaps = 17/199 (8%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+H +V+L + + +FI+ +YM + L F + +C V + + Y+
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLS 125
+ + HRDL N LV +GV+K+ D G+ + + D + PEV L+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV-LMY 175
Query: 126 EICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY------------GRWVALIS 172
+ D WA G +M+E+ S ++ + +++ I + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 173 WLCSWNPRMRPTAAEALEH 191
RPT L +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-33
Identities = 43/217 (19%), Positives = 82/217 (37%), Gaps = 30/217 (13%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYM---------------ESDLLKLMKESAGQN 48
L K+ +HPNI+ L + +++ +Y E+D + S
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 49 FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC 107
S + + V +G+ Y+ ++ + HRDL N+LV V KI D G+ + + +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 108 TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW 167
T + A E L + D W+ G +++E++S + ++Y+ +
Sbjct: 184 TMGRLPVRWMAIES-LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 168 -------------VALISWLCSWNPRMRPTAAEALEH 191
L+ P RP+ A+ L
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 2e-33
Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 21/203 (10%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HPN++ L +V + V I+ ++ME+ L F+ + + + G+ Y+
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT------TRWYRAPEV 121
Y HRDL N+LV S V K+ D G+ + ++ Y + + APE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIYGRW------------V 168
+ + D W+ G +M+E++S+ + + D I I +
Sbjct: 205 IQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 169 ALISWLCSWNPRMRPTAAEALEH 191
L+ + RP + +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-33
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 44/236 (18%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
K H NIV+L +++ + + +VF++ + DL K G + ++ FQ+ +GL
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-PEIVKSFLFQLLKGL 114
Query: 66 HYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLL 123
+ H + HRDLKP NLL+ G +K+ + G+ + + C + V T WYR P+VL
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRI-LFPGKNSADQIYKIYGRWVA------------- 169
+++ +D W+ G I E+ + LFPG + DQ+ +I+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 170 ---------------------------LISWLCSWNPRMRPTAAEALEHPFFRSCH 198
L+ L NP R +A EAL+HP+F
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-33
Identities = 38/201 (18%), Positives = 77/201 (38%), Gaps = 19/201 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+H N+++L V + +V + L +F QV +G+ Y+
Sbjct: 69 DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 69 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLL 124
+ + HRDL NLL++ + ++KIGD G+++ + D ++ + L
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 125 SEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY-------------GRWVAL 170
+ D W G ++EM ++ + + G N + ++KI +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 171 ISWLCSWNPRMRPTAAEALEH 191
+ + P RPT +
Sbjct: 248 MVQCWAHKPEDRPTFVALRDF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-33
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K H +V+L V E ++IV +YM LL +K G+ + ++ Q+ G
Sbjct: 67 KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEV 121
+ Y+ R Y HRDL+ +N+LV V K+ D G+ + I+ + + APE
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIYGRW------------V 168
L + D W+ G ++ E+ + R+ +PG + + + ++ +
Sbjct: 186 ALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 244
Query: 169 ALISWLCSWNPRMRPTAAEALE--HPFFRS 196
L+ P RPT +F S
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-32
Identities = 44/220 (20%), Positives = 83/220 (37%), Gaps = 25/220 (11%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
L + P +V L + + ++ DY+ L + F+E E + ++
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVL 140
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM---VKEIDSSLPCTDYVTTRWYRAP 119
L ++H+ G +RD+K N+L+ G + + D G+ ++ T +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 120 EVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV----------- 168
V VD W++G +M+E+L+ F + +I R +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 169 ----ALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199
LI L +P+ R A E EH FF+ ++
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-32
Identities = 38/200 (19%), Positives = 73/200 (36%), Gaps = 19/200 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
++P++ +L + V ++ M L N N C Q+ +G++Y+
Sbjct: 69 DNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLL 124
+ HRDL N+LV + +KI D G+ K + + + A E +L
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-IL 186
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------------WVALI 171
I + D W+ G ++E+++F A +I I + ++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 246
Query: 172 SWLCSWNPRMRPTAAEALEH 191
+ RP E +
Sbjct: 247 VKCWMIDADSRPKFRELIIE 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 5e-32
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGL 65
+ N P +VKL K++ ++++V +Y+ + G+ FSE AR Q+
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTF 154
Query: 66 HYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 124
Y+H +RDLKP NLL+ +G I++ D G K + T APE+ +L
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEI-IL 211
Query: 125 SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWV-----------ALISW 173
S+ VD WA+G +++EM + F KI V L+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 174 LCSWNP-----RMRPTAAEALEHPFFRSCHF 199
L + ++ + H +F + +
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-32
Identities = 43/222 (19%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMK----------------ESAG 46
L + NH NIV L ++ +Y DLL ++ E
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 QNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---D 102
++ + +QV +G+ ++ + HRDL N+L+ + KI D G+ ++I
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 103 SSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIY 161
+ + + + APE + + + E D W+ G ++E+ S +PG + Y
Sbjct: 200 NYVVKGNARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 162 KIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190
K+ ++ +P RPT + ++
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-31
Identities = 74/242 (30%), Positives = 108/242 (44%), Gaps = 54/242 (22%)
Query: 6 KMNNHPNIVKLRNLVK------EHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCF 59
K H N++ L ++ E DV++V M +DL ++K Q ++D + L +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIY 128
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
Q+ +GL Y+H HRDLKPSNL V++ +KI D G+ + D T YV TRWYRA
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRA 186
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW----------- 167
PE++L VD W++G IM E+L+ R LFPG + DQ+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 168 -------------------------------VALISWLCSWNPRMRPTAAEALEHPFFRS 196
V L+ + + R TAA+AL H +F
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 197 CH 198
H
Sbjct: 307 YH 308
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 3e-31
Identities = 45/202 (22%), Positives = 85/202 (42%), Gaps = 18/202 (8%)
Query: 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
K HPN+V+L + +I+ ++M +LL ++E Q S + Q+
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 65 LHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEV 121
+ Y+ ++ + HRDL N LV ++K+ D G+ + + D+ + APE
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGR-------------WV 168
L + D WA G +++E+ ++ + Q+Y++ +
Sbjct: 188 -LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 169 ALISWLCSWNPRMRPTAAEALE 190
L+ WNP RP+ AE +
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-31
Identities = 40/200 (20%), Positives = 81/200 (40%), Gaps = 19/200 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+H NI++L ++ +++ + I+ +YME+ L FS + + + G+ Y+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI----DSSLPCTDYVTTRWYRAPEVLL 123
Y HRDL N+LV S V K+ D G+ + + +++ + + APE +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-I 185
Query: 124 LSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYG-------------RWVAL 170
D W+ G +M+E++++ + S ++ K L
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 171 ISWLCSWNPRMRPTAAEALE 190
+ RP A+ +
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-31
Identities = 39/203 (19%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 9 NHPNIVKLRNLVKEHED-VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHY 67
+HPN++ L + E +V YM+ L+ + N + + QV +G+ +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 68 MHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVK-----EIDSSLPCTDYVTTRWYRAPEV 121
+ + + HRDL N ++ + +K+ D G+ + E DS T + A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 122 LLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY------------GRWV 168
L ++ + D W+ G +++E+++ +P N+ D +
Sbjct: 206 -LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 169 ALISWLCSWNPRMRPTAAEALEH 191
++ MRP+ +E +
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 2e-30
Identities = 36/228 (15%), Positives = 72/228 (31%), Gaps = 36/228 (15%)
Query: 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVF 62
+ M I +R E + +V + + L L + FS L Q+
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMI 113
Query: 63 QGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSS--------LPCTDY 110
+ Y+H + + HRD+KP N L+ ++ I D G+ K+ + +
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 111 VTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRW--- 167
T Y + L D ++G ++ + + G +A + K
Sbjct: 174 TGTARYASINT-HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 168 ----------------VALISWLCSWNPRMRPTAA---EALEHPFFRS 196
+++ S +P + + + F R
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-30
Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 18/199 (9%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYM 68
+HP+IVKL ++ E+ V+I+ + L+ + + +Q+ L Y+
Sbjct: 66 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 69 HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLS 125
+ + HRD+ N+LV S +K+GD G+ + ++ S + + APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 126 EICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY------------GRWVALIS 172
D W G M+E+L F G + D I +I +L++
Sbjct: 185 RFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 173 WLCSWNPRMRPTAAEALEH 191
+++P RP E
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 2e-29
Identities = 34/174 (19%), Positives = 60/174 (34%), Gaps = 16/174 (9%)
Query: 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQ 63
+ + I + +E +V D + L L+ G+ FS Q+
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLA 112
Query: 64 GLHYMHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVKEIDSSL--------PCTD 109
+ +H + +RD+KP N L+ + +I + D GMVK + +
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 110 YVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163
T Y + L E D A+G + L + + G +A K
Sbjct: 173 LSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 40/223 (17%), Positives = 87/223 (39%), Gaps = 33/223 (14%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMK--------------ESA 45
M ++ + H NI+ L + ++++ +Y +L + ++ +
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 46 GQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS 104
+ S + + +QV +G+ Y+ + HRDL N+LV+ V+KI D G+ ++I
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 105 LPCT---DYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161
+ + APE L I + D W+ G +++E+ + ++++
Sbjct: 189 DYYKKTTNGRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 162 KIYGR-------------WVALISWLCSWNPRMRPTAAEALEH 191
K+ ++ P RPT + +E
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (264), Expect = 2e-27
Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 41/222 (18%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYME-SDLLKLMKESAGQN------------------- 48
++PNIVKL + + + ++F+YM DL + ++ +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 49 ---FSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 104
S E + QV G+ Y+ + + HRDL N LV + V+KI D G+ + I S+
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 105 ---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPGKNSADQI 160
+ + PE + E D WA G +++E+ S+ + + G + I
Sbjct: 194 DYYKADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252
Query: 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190
Y + L+ S P RP+
Sbjct: 253 YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-27
Identities = 42/223 (18%), Positives = 86/223 (38%), Gaps = 33/223 (14%)
Query: 9 NHPNIVKLRNLVKEHEDVFIVFDYMESDLL---------KLMKESAGQNFSEDEARNLCF 59
N ++V+L +V + + ++ + M L + S + +
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSSLPCTDYVTTRW 115
++ G+ Y++ + HRDL N +V++ +KIGD GM ++I D +
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 116 YRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RILFPGKNSADQIYKIY---------- 164
+ +PE L + D W+ G +++E+ + + G ++ + +
Sbjct: 201 WMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 259
Query: 165 --GRWVALISWLCSWNPRMRPTAAEALE------HPFFRSCHF 199
L+ +NP+MRP+ E + P FR F
Sbjct: 260 CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 5e-26
Identities = 41/225 (18%), Positives = 85/225 (37%), Gaps = 35/225 (15%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHED-VFIVFDYMESDLLK---------------LMKES 44
+ L + +H N+V L + + ++ ++ + L ++
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 45 AGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-- 101
+ + FQV +G+ ++ + HRDL N+L+S+ V+KI D G+ ++I
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 102 -DSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPGKNSADQ 159
+ D + APE + + + D W+ G +++E+ S +PG ++
Sbjct: 187 DPDYVRKGDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 160 IYKIYGR-------------WVALISWLCSWNPRMRPTAAEALEH 191
+ + P RPT +E +EH
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-25
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 2 IFLRKMNNHPNIVKL------RNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEAR 55
+ L K NH NI+ L + ++E +DV++V + M+++L ++++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMS 122
Query: 56 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR 114
L +Q+ G+ ++H G HRDLKPSN++V S +KI D G+ + +S T YV TR
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKIYGRWVALISWL 174
+YRAPEV +L VD W++G IM EM+ +ILFPG++ DQ K+ I L
Sbjct: 183 YYRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-------IEQL 234
Query: 175 CSWNPRMRPTAAEALEHPFFRSCHFVPRSVP 205
+ P + + + + P
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 4e-24
Identities = 51/246 (20%), Positives = 75/246 (30%), Gaps = 60/246 (24%)
Query: 2 IFLRKMNNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARN 56
I+ M H NI+ + +++V DY E L + + +
Sbjct: 48 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 104
Query: 57 LCFQVFQGLHYMH--------RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDS---- 103
L GL ++H + HRDLK N+LV G I DLG+ DS
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 104 -SLPCTDYVTTRWYRAPEVLLLSEIC-----GPEVDRWAMGAIMFEMLSFRILFPGKNSA 157
+ V T+ Y APEVL S D +AMG + +E+ +
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 158 DQIY------------------------KIYGRW---------VALISWLCSWNPRMRPT 184
Y I RW ++ N R T
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 185 AAEALE 190
A +
Sbjct: 285 ALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.4 bits (189), Expect = 8e-17
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 17/214 (7%)
Query: 9 NHPNIVKLRNLVKEHED----VFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQG 64
+I+KL + V +VF+ + +LL L+K+ + + + Q+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 65 LHYMH-RQGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 118
L YMH R G H D+KP N+L+ +I+I + T+ + TR YR+
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 119 PEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS------ADQIYKIYGRWVALIS 172
PEVLL + G D W+ ++FE+++ LF D I +I L S
Sbjct: 198 PEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 173 WLCSWNPRMRPTAAEALEHPFFRSCHFVPRSVPL 206
+L R F P L
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.0 bits (147), Expect = 6e-12
Identities = 22/149 (14%), Positives = 46/149 (30%), Gaps = 19/149 (12%)
Query: 1 MIFLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCF 59
+ N + KL+ V V+ + + +L +L+ + +
Sbjct: 56 LAIRSARNEFRALQKLQ-----GLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLD 110
Query: 60 QVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSS-----LPCTDYVTTR 114
+ + + + +G H DL N+LVS+ I I D E+ L
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 115 WYRAPEVLLLSEICGPEVDRWAMGAIMFE 143
++ E D + + +
Sbjct: 171 YFSRT--------YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.27 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=364.06 Aligned_cols=191 Identities=27% Similarity=0.397 Sum_probs=163.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|||||||.|+.+..++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NIL 135 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 135 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEE
Confidence 4445999999999999999999999999997444433333 346999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+|+..... ....+.+||+.|||||++.+..+++.++||||+||++|||++|+.||.+.+.....
T Consensus 136 l~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 136 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred ECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 985 79999999999876432 33456789999999999887777778899999999999999999999876654433
Q ss_pred HH--------------HHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 161 YK--------------IYGRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 161 ~~--------------i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.. +..++++||.+||+.||++|||++|+|+||||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 22 2347889999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=365.63 Aligned_cols=190 Identities=25% Similarity=0.478 Sum_probs=167.9
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||++++++.+++.+|+|||||.|+.+..+..+ +.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 147 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence 34456999999999999999999999999998777666665 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ |.+||+|||+|+..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 148 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 226 (293)
T d1yhwa1 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (293)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9974 79999999999887543 345677899999999998754 46899999999999999999999999888777665
Q ss_pred HHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++. .++++||.+||+.||++|||++|+|+||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 543 36899999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=357.36 Aligned_cols=189 Identities=28% Similarity=0.454 Sum_probs=165.4
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||++++++.+++.+|+|||||+|+.+..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nil 138 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 138 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccce
Confidence 44559999999999999999999999999975554444432 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYKI 163 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~i 163 (297)
+++ +.+||+|||+|+...... ....+||+.|||||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++
T Consensus 139 l~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 216 (263)
T d2j4za1 139 LGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216 (263)
T ss_dssp ECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 985 799999999998765543 3567899999999998754 5689999999999999999999999988877776665
Q ss_pred H-----------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 164 Y-----------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 164 ~-----------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
. .++++||.+||+.||++|||++|+|+||||+.
T Consensus 217 ~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 3 37899999999999999999999999999963
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=359.66 Aligned_cols=192 Identities=24% Similarity=0.421 Sum_probs=166.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|+|||||.|+.+..+..+.++.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIl 142 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 142 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhee
Confidence 34459999999999999999999999999987766665544567999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLL----SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
++. +.+||+|||+|+..... ....+.+||+.|||||++.. ...|+.++||||+||++|||++|+.||.+.+..+
T Consensus 143 l~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 143 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp ECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred ECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 984 79999999999765432 22346789999999999752 3456889999999999999999999999988777
Q ss_pred HHHHHH--------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIY--------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~--------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
...++. .++++||.+||+.||++|||++|+|+||||+.
T Consensus 223 ~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 223 VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 766554 36899999999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=358.36 Aligned_cols=193 Identities=30% Similarity=0.473 Sum_probs=168.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++++++.+|+|||||.|+.+..+..+. +.++|..++.+++||+.||+|||++||+||||||+|||
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 34459999999999999999999999999985554444442 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ |.+||+|||+|+.... .....+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+..+...+
T Consensus 138 l~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 216 (337)
T d1o6la_ 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH
Confidence 985 8999999999987644 44556789999999999987554 59999999999999999999999999887776665
Q ss_pred HH-----------HHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 163 IY-----------GRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~-----------~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
+. .++++||++||+.||.+|++ ++++++||||++.+|
T Consensus 217 i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 217 ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 54 37899999999999999994 899999999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=357.83 Aligned_cols=193 Identities=28% Similarity=0.447 Sum_probs=165.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|||||++++++++++.+|+|||||+|+ +.+.+... +.+++..++.++.|++.||+|||++||+||||||+||
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI 139 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence 34459999999999999999999999999975 44555544 4699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|+++ +.+||+|||+|+..... ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+.
T Consensus 140 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp EECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccCCCceEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 9985 79999999999887532 233567899999999998754 468999999999999999999999999887777
Q ss_pred HHHHH-----------HHHHHHHHHhhhcCCCCCCCHHH------HHcCCCCCCCCCC
Q 040202 160 IYKIY-----------GRWVALISWLCSWNPRMRPTAAE------ALEHPFFRSCHFV 200 (297)
Q Consensus 160 ~~~i~-----------~~~~~li~~~l~~dP~~R~t~~~------ll~h~~f~~~~~~ 200 (297)
..++. .++++||++||+.||++|||++| +++||||++++|.
T Consensus 219 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 219 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 76654 37899999999999999999987 6899999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-50 Score=357.41 Aligned_cols=189 Identities=31% Similarity=0.475 Sum_probs=152.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++.++|||||++++++.+++.+|||||||+| +|.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni 138 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence 3445999999999999999999999999997 45555543 35699999999999999999999999999999999999
Q ss_pred EEe----CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 84 LVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 84 ll~----~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
|+. ++.+||+|||+|+.........+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+.
T Consensus 139 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp EESSSSTTCCEEECCC------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 994 368999999999988776666778999999999998754 468999999999999999999999998877766
Q ss_pred HHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 160 IYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 160 ~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..++. .++.+||.+||+.||++|||++|+++||||++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 65553 36899999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=356.69 Aligned_cols=193 Identities=36% Similarity=0.648 Sum_probs=171.0
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|+||||+.|+++..+... +..+++..++.+++||+.||+|||++||+||||||+|||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIl 132 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 132 (299)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEE
Confidence 4445999999999999999999999999999888776654 456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||+|+..... ....+.+||+.|+|||++.....|+.++||||+||++|||++|..||.+.+..++..+
T Consensus 133 i~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 133 LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp ECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH
Confidence 985 89999999999876543 3345678999999999988777789999999999999999999999999888777665
Q ss_pred HH---------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 163 IY---------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 163 i~---------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
|. .++++||.+||+.||++|||++|+|+||||++..
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 53 3678999999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.7e-50 Score=361.93 Aligned_cols=193 Identities=27% Similarity=0.425 Sum_probs=169.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|||||||+|+.+..++....+.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIl 156 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 156 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHee
Confidence 34459999999999999999999999999975554444333456999999999999999999999999999999999999
Q ss_pred EeC---CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++. +.+||+|||+|+.........+..||+.|||||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 157 l~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 235 (350)
T d1koaa2 157 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235 (350)
T ss_dssp ESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 952 68999999999998877777788999999999998754 45899999999999999999999999888777766
Q ss_pred HHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 162 KIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 162 ~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
++. .++++||++||+.||++|||++|+|+||||+...
T Consensus 236 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 654 3689999999999999999999999999998654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=349.32 Aligned_cols=187 Identities=28% Similarity=0.411 Sum_probs=158.7
Q ss_pred cccccccceeeeceeEEe----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKE----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQG--YFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~g--i~Hrdi 78 (297)
++.++|||||++++++++ ++.+|+|||||+|+.+..+..+. ..+++..++.++.||+.||+|||++| |+||||
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDi 140 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 140 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCc
Confidence 445599999999999975 45789999999985555544442 45999999999999999999999999 999999
Q ss_pred CCCcEEEe--CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 040202 79 KPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNS 156 (297)
Q Consensus 79 kp~Nill~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~ 156 (297)
||+|||++ ++.+||+|||+|+..... ...+.+||+.|||||++.+ .++.++||||+||++|||++|+.||.+...
T Consensus 141 Kp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~ 217 (270)
T d1t4ha_ 141 KCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN 217 (270)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred ChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence 99999995 368999999999865443 3357789999999998763 368999999999999999999999988766
Q ss_pred HHHHHHH--------------HHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 157 ADQIYKI--------------YGRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 157 ~~~~~~i--------------~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
.....+. ..++.+||.+||+.||++|||++|+|+||||+
T Consensus 218 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 218 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 6554432 23689999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-50 Score=356.37 Aligned_cols=188 Identities=26% Similarity=0.459 Sum_probs=167.1
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|+|||||.|+++..+... ++.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NIL 147 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEE
Confidence 3445999999999999999999999999999888766655 356999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
+++ +.+||+|||+|+..... ...+||+.|||||++.+ ...|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 148 LSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp EETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 985 79999999999876543 46789999999999864 2457889999999999999999999999888777776
Q ss_pred HHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIY-------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++. ..+++||.+||+.||++|||++|+|+||||..
T Consensus 225 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 654 36899999999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=361.84 Aligned_cols=191 Identities=25% Similarity=0.395 Sum_probs=159.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~N 82 (297)
+++.++|||||+++++|.+++.+|+|||||.|+.+..++.+. +.+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N 135 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence 445559999999999999999999999999986555555443 459999999999999999999997 599999999999
Q ss_pred EEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
||++ ++.+||+|||+|+...... ..+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+...
T Consensus 136 ILl~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 136 ILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp EEECTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred eeECCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9997 4899999999998765432 2567999999999998764 56999999999999999999999998765322100
Q ss_pred ------------------------------------------H-------------HHHHHHHHHHHhhhcCCCCCCCHH
Q 040202 162 ------------------------------------------K-------------IYGRWVALISWLCSWNPRMRPTAA 186 (297)
Q Consensus 162 ------------------------------------------~-------------i~~~~~~li~~~l~~dP~~R~t~~ 186 (297)
. ++.++++||.+||+.||++|||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 0 113578999999999999999999
Q ss_pred HHHcCCCCCCC
Q 040202 187 EALEHPFFRSC 197 (297)
Q Consensus 187 ~ll~h~~f~~~ 197 (297)
|+|+||||+..
T Consensus 294 e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 294 QLMVHAFIKRS 304 (322)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhCHhhCcC
Confidence 99999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-49 Score=355.24 Aligned_cols=192 Identities=28% Similarity=0.469 Sum_probs=170.8
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||++++++.+++.+|+|||||.|+.+..+.... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence 345569999999999999999999999999987776666653 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
|+++ |.+||+|||+|+...... .+.+||+.|||||++.+. .|+.++||||+||++|+|++|+.||.+.+..+...+
T Consensus 136 Ll~~~g~vkL~DFG~a~~~~~~~--~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 212 (316)
T d1fota_ 136 LLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212 (316)
T ss_dssp EECTTSCEEECCCSSCEECSSCB--CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred eEcCCCCEEEecCccceEecccc--ccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH
Confidence 9985 899999999999876543 567899999999998654 468999999999999999999999999888777776
Q ss_pred HHH-----------HHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 163 IYG-----------RWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 163 i~~-----------~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
+.. ++.+++.+||+.||.+|+ |++++++||||++..|
T Consensus 213 i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 213 ILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 643 789999999999999996 8999999999998765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-50 Score=361.98 Aligned_cols=192 Identities=24% Similarity=0.403 Sum_probs=169.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||+++++|++++.+|||||||+|+.|.......+..+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NIL 159 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 159 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccc
Confidence 34459999999999999999999999999975554443333456999999999999999999999999999999999999
Q ss_pred Ee---CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 85 VS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 85 l~---~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
++ ++.+||+|||+|+.........+..||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 160 l~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 238 (352)
T d1koba_ 160 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238 (352)
T ss_dssp ESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred ccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 96 37899999999999887777778899999999999865 456999999999999999999999999988877766
Q ss_pred HHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 162 KIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 162 ~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
++. .++++||++||+.||.+|||++|+|+||||++.
T Consensus 239 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 654 368999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=350.39 Aligned_cols=193 Identities=26% Similarity=0.439 Sum_probs=166.8
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
++.++|||||++++++.+++.+|||||||.|+.+..++... +.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nil 145 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 145 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEE
Confidence 34459999999999999999999999999975554444432 46999999999999999999999999999999999999
Q ss_pred EeC-C----eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 85 VSK-G----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~----~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
++. + .+||+|||+|+.........+..||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+.
T Consensus 146 l~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 224 (293)
T d1jksa_ 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224 (293)
T ss_dssp ESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence 974 3 599999999998877666677889999999999875 4568999999999999999999999998887776
Q ss_pred HHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCCC
Q 040202 160 IYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCHF 199 (297)
Q Consensus 160 ~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~~ 199 (297)
..++. ..+++||++||+.||++|||++|+|+||||+..++
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 65543 36789999999999999999999999999986543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-49 Score=359.81 Aligned_cols=193 Identities=26% Similarity=0.380 Sum_probs=166.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||++++++.+++.+|+|||||.|+.+..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NIL 139 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 139 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeE
Confidence 44558999999999999999999999999975554444432 45999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH--
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY-- 161 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~-- 161 (297)
+++ |.+||+|||+|+...... ....+||+.|+|||++..+..|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 140 l~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 140 LDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp ECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred EcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 985 899999999999876543 3567899999999998766677999999999999999999999998765433221
Q ss_pred H------------HHHHHHHHHHHhhhcCCCCCCC-----HHHHHcCCCCCCCCC
Q 040202 162 K------------IYGRWVALISWLCSWNPRMRPT-----AAEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~------------i~~~~~~li~~~l~~dP~~R~t-----~~~ll~h~~f~~~~~ 199 (297)
+ +..++++||.+||+.||++||| ++++++||||++++|
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 1 2347899999999999999999 799999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=353.59 Aligned_cols=191 Identities=26% Similarity=0.406 Sum_probs=168.3
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+++.++|||||++++++.+.+.+|+||||+.|+. ...+... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~N 171 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHH
Confidence 3455599999999999999999999999999755 4555444 459999999999999999999999999999999999
Q ss_pred EEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
||++ +|.+||+|||+|+...... .+.+||+.|||||++.+. .++.++|||||||++|||++|+.||.+.+......
T Consensus 172 ILl~~~g~ikL~DFG~a~~~~~~~--~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 172 LLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp EEECTTSCEEECCCTTCEECSSCB--CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccCCCCCEEeeeceeeeeccccc--ccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 9998 4899999999999876543 567899999999998754 46899999999999999999999999988777777
Q ss_pred HHHH-----------HHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 162 KIYG-----------RWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~~-----------~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
++.. ++.+||++||+.||.+|+ |++++++||||++.+|
T Consensus 249 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 6643 789999999999999995 8999999999998776
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=347.43 Aligned_cols=195 Identities=38% Similarity=0.701 Sum_probs=173.7
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||++++++.+++.+|+||||+.|+++..+.....+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNI 133 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhe
Confidence 34456999999999999999999999999999988888776667799999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|++. +.+||+|||+|+.... ........||+.|+|||++....+++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 134 l~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~ 213 (298)
T d1gz8a_ 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213 (298)
T ss_dssp EECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred eecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH
Confidence 9985 7899999999987654 3344567899999999998877777899999999999999999999999888777666
Q ss_pred HHH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 162 KIY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 162 ~i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
++. .++++|+++||+.||++|||++|+|+||||++..
T Consensus 214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 543 2568999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=344.77 Aligned_cols=189 Identities=24% Similarity=0.440 Sum_probs=149.9
Q ss_pred cccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cc
Q 040202 5 RKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKES---AGQNFSEDEARNLCFQVFQGLHYMHRQG-----YF 74 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~---~~~~l~e~~~~~~~~qll~al~yLH~~g-----i~ 74 (297)
.+.++|||||++++++.+ ++.+|+|||||+|+.+..+..+ .+..+++..++.++.||+.||+|||+.| |+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 444599999999999864 5679999999998555444332 2456999999999999999999999976 99
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCC
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFP 152 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~ 152 (297)
||||||+|||+++ +.+||+|||+|+..... ....+.+||+.|||||++.+. .++.++|||||||++|||++|+.||.
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCC
Confidence 9999999999985 89999999999876543 233567899999999998654 46899999999999999999999999
Q ss_pred CCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 153 GKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 153 ~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
+.+..+...++. .++.+||++||+.||++|||++|+++|||+
T Consensus 216 ~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 216 AFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 888777666654 368999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-48 Score=342.35 Aligned_cols=192 Identities=32% Similarity=0.522 Sum_probs=168.6
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+|.++..|||||++++++.+++..|||||||+| ++.+.+..+ +.+++..++.++.||+.||+|||++||+||||||+
T Consensus 62 ~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 139 (277)
T d1phka_ 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 139 (277)
T ss_dssp HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 344554699999999999999999999999987 555555444 46999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL-----SEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|||+++ +.+||+|||+++............||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+
T Consensus 140 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 140 NILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999985 7999999999998877766677889999999999863 2345789999999999999999999999988
Q ss_pred CHHHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 156 SADQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 156 ~~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
..+....+. .++++|+.+||+.||++|||++|+|+||||+.
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 777666554 36899999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=353.99 Aligned_cols=194 Identities=26% Similarity=0.436 Sum_probs=165.5
Q ss_pred cccccccccceeeeceeEEe----CCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 3 FLRKMNNHPNIVKLRNLVKE----HEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~----~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
++.++.+|||||+++++|++ ++.+|+|||||+| +|.+.+..+....++|.+++.++.||+.||+|||++||+|||
T Consensus 57 ~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRD 136 (335)
T d2ozaa1 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136 (335)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccc
Confidence 34667799999999999976 4679999999997 555555544345699999999999999999999999999999
Q ss_pred CCCCcEEEeC----CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 78 LKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 78 ikp~Nill~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
|||+|||+++ +.+||+|||+|+...........+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+
T Consensus 137 iKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 9999999974 47999999999988777777788999999999998654 468999999999999999999999977
Q ss_pred CCCHHH-------------------HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 154 KNSADQ-------------------IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 154 ~~~~~~-------------------~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.+.... ...++.++++||++||+.||++|||+.|+++||||+..
T Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 654322 12345678999999999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=349.94 Aligned_cols=194 Identities=29% Similarity=0.471 Sum_probs=169.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.+.++|||||++++++.+++.+|+|||||.|+.+..++... ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 56 l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~Ni 134 (320)
T d1xjda_ 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 134 (320)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccce
Confidence 455679999999999999999999999999985555444442 4599999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCC-CCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
|+++ +.+||+|||+++.... .......+||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 135 L~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9986 8999999999987654 33345578999999999987654 5899999999999999999999999988877776
Q ss_pred HHH-----------HHHHHHHHHhhhcCCCCCCCHH-HHHcCCCCCCCCC
Q 040202 162 KIY-----------GRWVALISWLCSWNPRMRPTAA-EALEHPFFRSCHF 199 (297)
Q Consensus 162 ~i~-----------~~~~~li~~~l~~dP~~R~t~~-~ll~h~~f~~~~~ 199 (297)
++. .++.+||++||+.||++|||+. ++++||||++..+
T Consensus 214 ~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 214 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 664 4789999999999999999995 8999999988654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=342.09 Aligned_cols=190 Identities=34% Similarity=0.613 Sum_probs=168.9
Q ss_pred ccccceeeeceeEEe-----CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 8 NNHPNIVKLRNLVKE-----HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
.+||||++++++|.. ...+|++|||+.|+++..........+++..++.++.|++.||+|||++||+||||||+|
T Consensus 67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 379999999999953 347899999999998877776666779999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIY 161 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~ 161 (297)
||+++ +.+||+|||+++...........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+...
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99985 89999999999877666666788999999999998754 46899999999999999999999999988777766
Q ss_pred HHH--------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCCC
Q 040202 162 KIY--------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRSCH 198 (297)
Q Consensus 162 ~i~--------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~~ 198 (297)
++. ..+++||++||+.||++|||++|+|+||||++++
T Consensus 226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 653 2568899999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=349.01 Aligned_cols=192 Identities=22% Similarity=0.388 Sum_probs=168.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+++.++|||||+++++|++++.+|+|||||+|+.+..++...+..++|.+++.++.||+.||+|||++||+||||||+||
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NI 133 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccce
Confidence 34556999999999999999999999999998544444444445699999999999999999999999999999999999
Q ss_pred EEeC---CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 84 LVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 84 ll~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|++. ..+||+|||+++............||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..+..
T Consensus 134 ll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~ 212 (321)
T d1tkia_ 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred eecCCCceEEEEcccchhhccccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9974 4799999999998877666677889999999998764 45689999999999999999999999998877766
Q ss_pred HHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 161 YKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 161 ~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
.+|. .++++||.+||..||++|||++|+++||||+.
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 6553 36789999999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=344.03 Aligned_cols=193 Identities=32% Similarity=0.559 Sum_probs=168.8
Q ss_pred ccccccceeeeceeEEe------CCeEEEEEecCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 6 KMNNHPNIVKLRNLVKE------HEDVFIVFDYMESDLLKLMKE--SAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~------~~~~~lv~e~~~g~ll~~~~~--~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.++|+|||+++++|.. ..++|||||||+++++..+.. .....+++.+++.+++||+.||+|||++||+|||
T Consensus 68 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrD 147 (350)
T d1q5ka_ 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147 (350)
T ss_dssp HHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 44599999999999953 336899999999987766543 2345699999999999999999999999999999
Q ss_pred CCCCcEEEeC-C-eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 78 LKPSNLLVSK-G-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 78 ikp~Nill~~-~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
|||+|||++. + .+||+|||+++.........+.+||+.|+|||++.+...++.++||||+||++|||++|+.||.+.+
T Consensus 148 iKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred CCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 9999999984 3 7999999999988777777788999999999998777778999999999999999999999999888
Q ss_pred CHHHHHHHH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 156 SADQIYKIY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 156 ~~~~~~~i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
..+++.++. .++.+||.+||+.||++|||+.|+|+||||+
T Consensus 228 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 777666553 2578899999999999999999999999998
Q ss_pred CCC
Q 040202 196 SCH 198 (297)
Q Consensus 196 ~~~ 198 (297)
+..
T Consensus 308 ~~~ 310 (350)
T d1q5ka_ 308 ELR 310 (350)
T ss_dssp GGG
T ss_pred ccc
Confidence 653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=338.58 Aligned_cols=186 Identities=23% Similarity=0.464 Sum_probs=158.9
Q ss_pred cccceeeeceeEEeCCeEEEEEecCCC-cH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEe
Q 040202 9 NHPNIVKLRNLVKEHEDVFIVFDYMES-DL-LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 86 (297)
Q Consensus 9 ~HpnIv~~~~~~~~~~~~~lv~e~~~g-~l-l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~ 86 (297)
.|||||++++++.+++..|+||||+.| ++ .+.+... ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 144 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe
Confidence 399999999999999999999999975 44 4444444 4699999999999999999999999999999999999998
Q ss_pred -C-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH-----
Q 040202 87 -K-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ----- 159 (297)
Q Consensus 87 -~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~----- 159 (297)
+ +.+||+|||+|+..... ...+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~ 223 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCC
T ss_pred cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCC
Confidence 3 68999999999876544 346788999999999988777777889999999999999999999976321110
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCCC
Q 040202 160 IYKIYGRWVALISWLCSWNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 160 ~~~i~~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~~ 197 (297)
..+++.++++||++||+.||++|||++|+|+||||++.
T Consensus 224 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01234588999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-46 Score=330.77 Aligned_cols=191 Identities=35% Similarity=0.644 Sum_probs=165.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||++++++.+++..|++|||+.++++..+.... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIl 132 (286)
T d1ob3a_ 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132 (286)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceee
Confidence 34459999999999999999999999999999988887653 56999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCC-CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQIYK 162 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~~~ 162 (297)
+++ +.+||+|||.+...... .......|++.|+|||++.....++.++||||+||++|||++|+.||.+.+..++..+
T Consensus 133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~ 212 (286)
T d1ob3a_ 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (286)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH
Confidence 985 79999999999876543 2235567899999999988777889999999999999999999999998887777666
Q ss_pred HHH----------------------------------------HHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 163 IYG----------------------------------------RWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 163 i~~----------------------------------------~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
+.. ++++||++||+.||++|||++|+|+||||++
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 532 5679999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=326.24 Aligned_cols=185 Identities=22% Similarity=0.319 Sum_probs=152.0
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||++++++.+ +.+|+|||||+|+.+..++...+..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 59 ~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl 137 (276)
T d1uwha_ 59 RKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137 (276)
T ss_dssp TTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE
Confidence 34499999999998754 56899999999755555554445679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceeccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLS--EICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~ 159 (297)
++ +.+||+|||+|+..... ....+..||+.|||||++... ..++.++|||||||++|||++|+.||.+.+....
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~ 217 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence 85 79999999999876432 233567899999999998643 3468899999999999999999999998877665
Q ss_pred HHHHH-----------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 IYKIY-----------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~~~i~-----------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
..... .++.+|+.+||..||++|||+.+++++
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 54332 267899999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=332.98 Aligned_cols=189 Identities=39% Similarity=0.669 Sum_probs=163.0
Q ss_pred cccccccceeeeceeEEeCC------eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHE------DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~------~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
++.++|||||+++++|...+ .+|+||||+++.+ ..+..+ ..+++..++.++.||+.||+|||++||+||||
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l-~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDi 147 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL-GKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 147 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEH-HHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecccccH-HHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCccccc
Confidence 34459999999999997654 5799999995554 445554 45999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||++. +.+|++|||+|+...... ....||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..
T Consensus 148 Kp~NIL~~~~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 148 KPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSSC--CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcchhhcccccccccccccceeccCCcc--ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence 999999985 799999999998876543 56789999999999887777799999999999999999999999988766
Q ss_pred HHHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCC
Q 040202 158 DQIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFR 195 (297)
Q Consensus 158 ~~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~ 195 (297)
+...++. ..+++||++||..||++|||+.|+|+||||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 5544322 2567899999999999999999999999998
Q ss_pred CCC
Q 040202 196 SCH 198 (297)
Q Consensus 196 ~~~ 198 (297)
+..
T Consensus 306 ~~~ 308 (346)
T d1cm8a_ 306 SLH 308 (346)
T ss_dssp TTC
T ss_pred cCC
Confidence 754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=335.41 Aligned_cols=188 Identities=23% Similarity=0.394 Sum_probs=158.3
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC----------------------CCCCHHHHHHHHHH
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG----------------------QNFSEDEARNLCFQ 60 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~----------------------~~l~e~~~~~~~~q 60 (297)
.|.++.+|||||++++++.+.+.+|+|||||+|+.+..++.... ..+++..++.++.|
T Consensus 93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 172 (325)
T d1rjba_ 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172 (325)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred HHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHH
Confidence 35566699999999999999999999999998754444443221 24899999999999
Q ss_pred HHHHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhh
Q 040202 61 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWA 136 (297)
Q Consensus 61 ll~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 136 (297)
++.||+|||++||+||||||+|||++. +.+||+|||+|+....... ..+..||+.|||||++.+. .++.++||||
T Consensus 173 i~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS 251 (325)
T d1rjba_ 173 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWS 251 (325)
T ss_dssp HHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHH
T ss_pred HHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccc
Confidence 999999999999999999999999985 7999999999987654432 2456789999999998754 4689999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 137 MGAIMFEMLS-FRILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 137 lGv~l~ell~-g~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|||++|||++ |+.||.+.+..+.+.++. .++++||.+||+.||++|||++|+++|
T Consensus 252 ~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999997 899999877766665543 368999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-45 Score=326.57 Aligned_cols=185 Identities=22% Similarity=0.341 Sum_probs=150.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||+++|++.+++.+|+|||||+|+.+..+.....+.+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 161 (299)
T ss_dssp TTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE
Confidence 44599999999999999999999999999977777666655679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCCC------ccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLPC------TDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSA 157 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~ 157 (297)
++ +.+||+|||+++........ ....||+.|||||++... .++.++|||||||++|||++ |+.||.+.+..
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 85 78999999999876543221 224578899999998754 56889999999999999998 89999988877
Q ss_pred HHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 158 DQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 158 ~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
+....+. ..+.+|+.+||+.||++|||+.+++++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 7666654 368999999999999999999988764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=329.78 Aligned_cols=193 Identities=24% Similarity=0.472 Sum_probs=164.8
Q ss_pred cccccccccceeeeceeEEe--CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 3 FLRKMNNHPNIVKLRNLVKE--HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~--~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
+|+++..||||++++++|.. .+.+|+|||||.++.+..+. +.+++.+++.+++||+.||+|||++||+||||||
T Consensus 82 il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp 157 (328)
T d3bqca1 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 157 (328)
T ss_dssp HHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccc
Confidence 45566569999999999984 45799999999987664432 4599999999999999999999999999999999
Q ss_pred CcEEEeC--CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 81 SNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 81 ~Nill~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+|||++. +.+||+|||+|+...........+||+.|+|||++.+...++.++||||+||++|+|++|+.||.......
T Consensus 158 ~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp GGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred cceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 9999974 47999999999988777677788999999999998877778999999999999999999999997665432
Q ss_pred -HHHHH------------------------------------------------HHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 159 -QIYKI------------------------------------------------YGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 159 -~~~~i------------------------------------------------~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
+...+ ..++++||++||..||++|+|++|+|
T Consensus 238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 21111 12468899999999999999999999
Q ss_pred cCCCCCCCCC
Q 040202 190 EHPFFRSCHF 199 (297)
Q Consensus 190 ~h~~f~~~~~ 199 (297)
+||||+++.+
T Consensus 318 ~Hp~F~~v~~ 327 (328)
T d3bqca1 318 EHPYFYTVVK 327 (328)
T ss_dssp TSGGGTTSCC
T ss_pred cCcccCCCCC
Confidence 9999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=324.11 Aligned_cols=190 Identities=33% Similarity=0.596 Sum_probs=161.7
Q ss_pred ccccccceeeeceeEEe--------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 040202 6 KMNNHPNIVKLRNLVKE--------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRD 77 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~--------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrd 77 (297)
+.++|+||+++++++.. ++.+|+||||+.++++..+... ...+++..++.+++||+.||+|||++||+|||
T Consensus 64 ~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrD 142 (318)
T d3blha1 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 142 (318)
T ss_dssp HHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecC
Confidence 44599999999999854 4568999999999888766554 45699999999999999999999999999999
Q ss_pred CCCCcEEEeC-CeEEEEecCCceecCCC-----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 78 LKPSNLLVSK-GVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 78 ikp~Nill~~-~~~kl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
|||+|||+++ +.+||+|||+++..... ....+.+||+.|+|||++.....++.++||||+||++|||++|+.||
T Consensus 143 lKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 143 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 9999999985 79999999999765432 22345689999999999887777899999999999999999999999
Q ss_pred CCCCCHHHHHHHH-------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHH
Q 040202 152 PGKNSADQIYKIY-------------------------------------------GRWVALISWLCSWNPRMRPTAAEA 188 (297)
Q Consensus 152 ~~~~~~~~~~~i~-------------------------------------------~~~~~li~~~l~~dP~~R~t~~~l 188 (297)
.+.+..+....+. ..+++||.+||+.||++|+|++|+
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 8877666544432 145789999999999999999999
Q ss_pred HcCCCCCC
Q 040202 189 LEHPFFRS 196 (297)
Q Consensus 189 l~h~~f~~ 196 (297)
|+||||+.
T Consensus 303 L~Hpff~~ 310 (318)
T d3blha1 303 LNHDFFWS 310 (318)
T ss_dssp HHSGGGSS
T ss_pred HcChhhcc
Confidence 99999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=318.03 Aligned_cols=185 Identities=24% Similarity=0.437 Sum_probs=147.5
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||+++|++.+++.+|+||||+.++.+..+.......+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134 (263)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred HhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence 34599999999999999999999999999866655555545679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++ |..||...+..+...
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~ 213 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213 (263)
T ss_dssp CGGGCEEECSCC------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH
T ss_pred cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 85 7899999999987654322 23467899999999987554 6899999999999999999 566666666555555
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+. .++.+++.+||+.||++|||++++++|
T Consensus 214 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 214 DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 553 268899999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=321.07 Aligned_cols=188 Identities=21% Similarity=0.313 Sum_probs=159.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||+++|++.+ +.+|+|||||+|+.+..+....+..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 64 ~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill 142 (285)
T d1u59a_ 64 HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 142 (285)
T ss_dssp HHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee
Confidence 34599999999999975 56899999999876666655545679999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||+++...... ......||+.|+|||++... .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 143 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~ 221 (285)
T d1u59a_ 143 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 221 (285)
T ss_dssp EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 7 5899999999998875432 22345688999999998755 45899999999999999998 9999999887776
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHH---HcCCCCC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEA---LEHPFFR 195 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~l---l~h~~f~ 195 (297)
...+. .++.+|+.+||..||++|||+.++ |+|.|+.
T Consensus 222 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 66553 368999999999999999999877 6777763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=319.56 Aligned_cols=186 Identities=21% Similarity=0.360 Sum_probs=154.8
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||+++|++++ +..|||||||+|+.+..+..+. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 63 ~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill 140 (277)
T d1xbba_ 63 QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140 (277)
T ss_dssp HTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc
Confidence 34499999999999965 4678999999986666555543 569999999999999999999999999999999999999
Q ss_pred e-CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 86 S-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 86 ~-~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+ ++.+||+|||+++....... .....||+.|||||++.+. .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 141 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~ 219 (277)
T d1xbba_ 141 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219 (277)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH
Confidence 7 58999999999987654322 2345689999999998754 45889999999999999998 8999998877666
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHH---HcCCCC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEA---LEHPFF 194 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~l---l~h~~f 194 (297)
...+. .++.+|+.+||+.||++|||++++ |+|+|+
T Consensus 220 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 220 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 55543 368999999999999999999987 466654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=313.12 Aligned_cols=186 Identities=22% Similarity=0.396 Sum_probs=161.3
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||+++|++.+++.+|+||||+.++.+..+.......+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nil 132 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 132 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEE
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEE
Confidence 34459999999999999999999999999976665555444556999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+..
T Consensus 133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~ 211 (258)
T d1k2pa_ 133 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211 (258)
T ss_dssp ECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH
T ss_pred EcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHH
Confidence 986 799999999998764432 223467899999999987654 5889999999999999998 89999998887777
Q ss_pred HHHHH------------HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 161 YKIYG------------RWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 161 ~~i~~------------~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.++.. ++.+|+++||+.||++|||++++++|
T Consensus 212 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 76653 68999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-44 Score=317.15 Aligned_cols=185 Identities=24% Similarity=0.431 Sum_probs=154.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++.++|||||++++++.+++.+|+|||||.+ ++.+.+.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI 146 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence 3445999999999999999999999999986 555555555456799999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCCC--CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSADQI 160 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~~~ 160 (297)
|+++ +.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++|..||.........
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~ 225 (287)
T d1opja_ 147 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225 (287)
T ss_dssp EECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH
Confidence 9985 7999999999987654432 2334578899999998765 4589999999999999999977776555555554
Q ss_pred HHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 161 YKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 161 ~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
.++. .++.+|+.+||+.||++|||++++++
T Consensus 226 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 4332 36899999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=321.52 Aligned_cols=191 Identities=38% Similarity=0.680 Sum_probs=158.9
Q ss_pred ccccccccceeeeceeEEeCC-----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 4 LRKMNNHPNIVKLRNLVKEHE-----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
+++.++||||+++++++.... .+|+++++++|+|.+.+. . ..+++..++.++.||+.||+|||++||+||||
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~-~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDI 135 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-T--QHLSNDHICYFLYQILRGLKYIHSANVLHRDL 135 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHH-H--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhh-c--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 344569999999999997543 466776665556665554 3 35999999999999999999999999999999
Q ss_pred CCCcEEEeC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 040202 79 KPSNLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPG 153 (297)
Q Consensus 79 kp~Nill~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~ 153 (297)
||+|||+++ +.+||+|||+++..... ......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+
T Consensus 136 Kp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 136 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 999999985 89999999999865332 2235677999999999987777789999999999999999999999988
Q ss_pred CCCHHHHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 154 KNSADQIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 154 ~~~~~~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
.+..+...... .++++|+.+||+.||++|||++|+|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 77655443321 247899999999999999999999999
Q ss_pred CCCCCC
Q 040202 192 PFFRSC 197 (297)
Q Consensus 192 ~~f~~~ 197 (297)
|||+..
T Consensus 296 pf~~~~ 301 (345)
T d1pmea_ 296 PYLEQY 301 (345)
T ss_dssp GGGTTT
T ss_pred HhhccC
Confidence 999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=322.84 Aligned_cols=187 Identities=36% Similarity=0.629 Sum_probs=152.1
Q ss_pred cccccccceeeeceeEEe------CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 040202 5 RKMNNHPNIVKLRNLVKE------HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDL 78 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~------~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdi 78 (297)
++.++|||||+++++|.. .+.+|+|||||.|++++.+. ..+++..++.+++||+.||+|||++||+||||
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDl 145 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccC
Confidence 345599999999999963 46899999999999887663 45999999999999999999999999999999
Q ss_pred CCCcEEEe-CCeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCH
Q 040202 79 KPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSA 157 (297)
Q Consensus 79 kp~Nill~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~ 157 (297)
||+|||++ ++.+|++|||+++...........+||+.|+|||++.+. .++.++||||+||++++|++|+.||.+.+..
T Consensus 146 KP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~ 224 (355)
T d2b1pa1 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_dssp CGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CccccccccccceeeechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHH
Confidence 99999998 578999999999888777666788899999999998764 5689999999999999999999999877655
Q ss_pred HHHHHH-----------------------------------------------------HHHHHHHHHHhhhcCCCCCCC
Q 040202 158 DQIYKI-----------------------------------------------------YGRWVALISWLCSWNPRMRPT 184 (297)
Q Consensus 158 ~~~~~i-----------------------------------------------------~~~~~~li~~~l~~dP~~R~t 184 (297)
....++ ..++.+||++||..||++|||
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 443332 335788999999999999999
Q ss_pred HHHHHcCCCCCC
Q 040202 185 AAEALEHPFFRS 196 (297)
Q Consensus 185 ~~~ll~h~~f~~ 196 (297)
|+|+|+||||+.
T Consensus 305 a~elL~Hpw~~~ 316 (355)
T d2b1pa1 305 VDDALQHPYINV 316 (355)
T ss_dssp HHHHHTSTTTGG
T ss_pred HHHHhcCcccCC
Confidence 999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=313.74 Aligned_cols=184 Identities=23% Similarity=0.389 Sum_probs=146.9
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||+++|++. ++.+|+||||+.++.+..+.......+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 63 ~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll 141 (273)
T d1mp8a_ 63 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 141 (273)
T ss_dssp HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee
Confidence 3459999999999996 467899999999866655554445679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQIY 161 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~~~ 161 (297)
++ +.+||+|||+|+...... ......||+.|+|||++... .++.++|||||||++|||++ |..||.+.+..+...
T Consensus 142 ~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 142 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp EETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 75 899999999998765432 22455679999999998754 46889999999999999998 899999888877766
Q ss_pred HHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 162 KIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 162 ~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
++. .++.+||.+||..||++|||+.++++|
T Consensus 221 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 654 368999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=310.79 Aligned_cols=191 Identities=29% Similarity=0.578 Sum_probs=163.9
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
.+.++|||||++++++.+.+..++|+|++.|+.+..+... .+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIl 133 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL 133 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhcCcCCEEeeccccccccceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccc
Confidence 3446999999999999999999999999999888777765 456999999999999999999999999999999999999
Q ss_pred Ee-CCeEEEEecCCceecCCCC-CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC-CCHHHHH
Q 040202 85 VS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK-NSADQIY 161 (297)
Q Consensus 85 l~-~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~~~ 161 (297)
++ ++.+||+|||.++...... ......+++.|+|||++.....++.++||||+||++|||++|+.||... +..+...
T Consensus 134 i~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp ECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred cccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 98 4799999999998876543 3344567888999999887777799999999999999999999986444 4344444
Q ss_pred HHH----------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 162 KIY----------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 162 ~i~----------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
++. ..+.+|+++||+.||++|||++|+|+||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 332 25678999999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=318.63 Aligned_cols=196 Identities=24% Similarity=0.401 Sum_probs=161.8
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSN 82 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~N 82 (297)
+|+++..||||+++++++.+.+.+|++|||+.|+.+..+.... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 81 il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~N 159 (322)
T d1vzoa_ 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 159 (322)
T ss_dssp HHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccc
Confidence 3455534489999999999999999999999975544444432 458999999999999999999999999999999999
Q ss_pred EEEeC-CeEEEEecCCceecCCC--CCCccccccCCCCCCceecccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 83 LLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSE-ICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 83 ill~~-~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
||++. +.+||+|||+++..... ....+..|++.|+|||++.... .++.++||||+||++|+|++|+.||.+.+..+
T Consensus 160 ill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 160 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred eeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99985 79999999999876432 2335678999999999987543 46789999999999999999999998876544
Q ss_pred HHHHH---------------HHHHHHHHHHhhhcCCCCCC-----CHHHHHcCCCCCCCCC
Q 040202 159 QIYKI---------------YGRWVALISWLCSWNPRMRP-----TAAEALEHPFFRSCHF 199 (297)
Q Consensus 159 ~~~~i---------------~~~~~~li~~~l~~dP~~R~-----t~~~ll~h~~f~~~~~ 199 (297)
....+ ..++++||.+||+.||++|+ |++|+++||||++.++
T Consensus 240 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 33332 23689999999999999999 5899999999988664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=314.07 Aligned_cols=188 Identities=24% Similarity=0.450 Sum_probs=153.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|||||+++|++.+ +.+|+||||+.++.+ +.+....+..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 63 ~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 34499999999998865 567999999997555 4443333345999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC-CCCCCCCHHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI-LFPGKNSADQI 160 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~-pf~~~~~~~~~ 160 (297)
+++ +.+||+|||+|+...... ......||+.|||||++... .++.++|||||||++|||++|.. ||...+..+..
T Consensus 142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~ 220 (272)
T d1qpca_ 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (272)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred eecccceeeccccceEEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 986 799999999999875432 23456789999999998754 45899999999999999999654 55555554444
Q ss_pred HHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc--CCCCC
Q 040202 161 YKIY------------GRWVALISWLCSWNPRMRPTAAEALE--HPFFR 195 (297)
Q Consensus 161 ~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~--h~~f~ 195 (297)
..+. .++.+|+.+||+.||++|||++++++ |+||.
T Consensus 221 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 4443 36899999999999999999999988 77774
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.2e-44 Score=312.80 Aligned_cols=188 Identities=22% Similarity=0.378 Sum_probs=147.8
Q ss_pred cccccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKP 80 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp 80 (297)
.+.++|||||++++++.+.+ .+|+||||++|+.+..+.... +.+++.+++.++.||+.||+|||++||+||||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP 139 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence 34469999999999997654 489999999986555444443 4699999999999999999999999999999999
Q ss_pred CcEEEeC-CeEEEEecCCceecCCC----CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 81 SNLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 81 ~Nill~~-~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
+|||++. +..+++|||.++..... ......+||+.|||||++.+. .++.++||||+||++|+|++|+.||.+.+
T Consensus 140 ~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 140 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp GGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 9999985 78999999998765332 234567899999999998654 56889999999999999999999999888
Q ss_pred CHHHHHHHH---------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCC
Q 040202 156 SADQIYKIY---------------GRWVALISWLCSWNPRMRPTAAEALEHPFF 194 (297)
Q Consensus 156 ~~~~~~~i~---------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f 194 (297)
..+...++. .++.++|++||+.||++||+..+.+.|+|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 777665543 368999999999999999954444445554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=309.62 Aligned_cols=184 Identities=21% Similarity=0.347 Sum_probs=147.1
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV 85 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill 85 (297)
+.++|||||+++|++.+.+..|+||||+.++++..+.......+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 64 ~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl 143 (283)
T d1mqba_ 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 143 (283)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE
Confidence 34599999999999999999999999999876666655555679999999999999999999999999999999999999
Q ss_pred eC-CeEEEEecCCceecCCCC----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCC-CCHHH
Q 040202 86 SK-GVIKIGDLGMVKEIDSSL----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGK-NSADQ 159 (297)
Q Consensus 86 ~~-~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~-~~~~~ 159 (297)
++ +.+||+|||+++...... ......||+.|||||++.+. .++.++|||||||++|||++|..||... +..+.
T Consensus 144 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~ 222 (283)
T d1mqba_ 144 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222 (283)
T ss_dssp CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHH
Confidence 85 799999999998764432 22345689999999998754 5688999999999999999965555444 44333
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...+. ..+.+|+.+||..||++|||+.++++
T Consensus 223 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 33332 36899999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=319.03 Aligned_cols=189 Identities=35% Similarity=0.563 Sum_probs=154.4
Q ss_pred cccccccceeeeceeEEeC-----CeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 040202 5 RKMNNHPNIVKLRNLVKEH-----EDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLK 79 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdik 79 (297)
++.++|||||++++++... ...+++++|+.|+.|..+... +.+++.+++.++.||+.||+|||++||+|||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiK 148 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence 3445999999999999632 334555566666555555544 469999999999999999999999999999999
Q ss_pred CCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 80 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 80 p~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
|+|||++. +.+|++|||++...... ..+..||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+...
T Consensus 149 p~NILi~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 149 PSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226 (348)
T ss_dssp GGGEEECTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CccccccccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 99999985 79999999998765443 3567889999999998877777899999999999999999999999887666
Q ss_pred HHHHHH------------------------------------------HHHHHHHHHhhhcCCCCCCCHHHHHcCCCCCC
Q 040202 159 QIYKIY------------------------------------------GRWVALISWLCSWNPRMRPTAAEALEHPFFRS 196 (297)
Q Consensus 159 ~~~~i~------------------------------------------~~~~~li~~~l~~dP~~R~t~~~ll~h~~f~~ 196 (297)
....+. .++++||++||..||++|+|++|+|+||||+.
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 554442 24688999999999999999999999999986
Q ss_pred C
Q 040202 197 C 197 (297)
Q Consensus 197 ~ 197 (297)
.
T Consensus 307 ~ 307 (348)
T d2gfsa1 307 Y 307 (348)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=310.00 Aligned_cols=188 Identities=22% Similarity=0.394 Sum_probs=148.6
Q ss_pred cccccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHH
Q 040202 3 FLRKMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLH 66 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~ 66 (297)
.+.++.+|+|||++++++.+ ++.+|+|||||+|+.+..++... +..+++..++.++.||+.||+
T Consensus 69 ~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 148 (299)
T d1ywna1 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 148 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHH
Confidence 35566789999999999865 45789999999975554444321 234899999999999999999
Q ss_pred HHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHHHHHH
Q 040202 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMF 142 (297)
Q Consensus 67 yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ 142 (297)
|||++||+||||||+|||+++ +.+||+|||+|+..... .......||+.|||||++.+. .++.++||||+||++|
T Consensus 149 ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ 227 (299)
T d1ywna1 149 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLW 227 (299)
T ss_dssp HHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred HHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHH
Confidence 999999999999999999985 79999999999865433 233456899999999998754 4689999999999999
Q ss_pred HHHhC-CCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 143 EMLSF-RILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 143 ell~g-~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
||++| ..||.+.+..+...++. .++.+++.+||+.||++|||++|+++|
T Consensus 228 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 228 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99986 56788776655544332 368999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=307.09 Aligned_cols=190 Identities=25% Similarity=0.430 Sum_probs=150.2
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDL-LKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~l-l~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
.+.++|+|||+++|++.+ +..|+||||+.++. ...+.......+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 344599999999999965 56799999999754 4444444445699999999999999999999999999999999999
Q ss_pred EEeC-CeEEEEecCCceecCCCC--CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCC-CCCCCCHHH
Q 040202 84 LVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRIL-FPGKNSADQ 159 (297)
Q Consensus 84 ll~~-~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~p-f~~~~~~~~ 159 (297)
|+++ +.+||+|||+++...... ......||+.|+|||++..+. ++.++||||+||++|||++|..| +.+....+.
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~ 223 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223 (285)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 9985 789999999998764432 224467899999999987554 58899999999999999996555 555555445
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc--CCCCCC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALE--HPFFRS 196 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~--h~~f~~ 196 (297)
...+. .++.+++.+||+.||++|||++++++ ++||..
T Consensus 224 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 55443 36899999999999999999999988 889865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=309.68 Aligned_cols=188 Identities=23% Similarity=0.360 Sum_probs=157.6
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHH
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKES---------------AGQNFSEDEARNLCFQVFQGLHY 67 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~---------------~~~~l~e~~~~~~~~qll~al~y 67 (297)
+|.++.+|||||+++|++.+++.+|+||||++|+.+..++.. .+..+++..+..++.||+.||.|
T Consensus 63 ~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~ 142 (309)
T d1fvra_ 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142 (309)
T ss_dssp HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence 455555899999999999999999999999997555555432 23569999999999999999999
Q ss_pred HHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh
Q 040202 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS 146 (297)
Q Consensus 68 LH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~ 146 (297)
||++||+||||||+|||+++ +.+||+|||+++............||..|+|||.+.... ++.++|||||||++|||++
T Consensus 143 lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~ 221 (309)
T d1fvra_ 143 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVS 221 (309)
T ss_dssp HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred hhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHh
Confidence 99999999999999999985 789999999998766555555677899999999987654 5889999999999999999
Q ss_pred CC-CCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 147 FR-ILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 147 g~-~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
|. .||.+.+..+...++. .++.+||.+||+.||++|||+.++++|
T Consensus 222 ~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 222 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65 5787777666655543 378999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=307.78 Aligned_cols=183 Identities=20% Similarity=0.309 Sum_probs=151.2
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|||||+++|++.+++ .++++||+.+ ++++.+... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 66 ~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIl 143 (317)
T d1xkka_ 66 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143 (317)
T ss_dssp HHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCEeeEEEEEecCC-eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcce
Confidence 3459999999999998765 5666777765 666666554 456999999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
+++ +.+||+|||+|+....... .....||+.|+|||++.++ .++.++|||||||++|||++ |+.||.+.+..+.
T Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~ 222 (317)
T d1xkka_ 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222 (317)
T ss_dssp EEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH
T ss_pred eCCCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 984 7999999999987654322 2345689999999998765 46899999999999999998 8999988776665
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
...+. .++.+|+.+||..||++|||+.++++|
T Consensus 223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 54443 268999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=305.56 Aligned_cols=187 Identities=22% Similarity=0.414 Sum_probs=157.7
Q ss_pred cccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHH
Q 040202 3 FLRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA---------------GQNFSEDEARNLCFQVFQGLHY 67 (297)
Q Consensus 3 ~l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~---------------~~~l~e~~~~~~~~qll~al~y 67 (297)
.+.++.+|||||++++++.+++..|+|||||.++.+..++... ...+++..+..++.||+.||+|
T Consensus 71 ~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 3456668999999999999999999999999975555544332 2358999999999999999999
Q ss_pred HHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHHH
Q 040202 68 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFE 143 (297)
Q Consensus 68 LH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~e 143 (297)
||++||+||||||+|||++. +.+||+|||+++...... ......||+.|+|||++.+. .|+.++|||||||++||
T Consensus 151 lH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~e 229 (299)
T d1fgka_ 151 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWE 229 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHH
T ss_pred hhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHH
Confidence 99999999999999999985 799999999998764432 23456789999999998754 56999999999999999
Q ss_pred HHh-CCCCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 144 MLS-FRILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 144 ll~-g~~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|++ |..||.+.+..+....+. .++.+||.+||+.||++|||+.|+++
T Consensus 230 ll~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 230 IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 998 788998777665554443 36899999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=302.53 Aligned_cols=182 Identities=23% Similarity=0.372 Sum_probs=152.4
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCC-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMES-DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g-~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|||||+++|++.+ +..|+||||+.+ ++.+.+..+ .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 66 ~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIl 143 (273)
T d1u46a_ 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143 (273)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhc
Confidence 34499999999999976 467899999986 555555554 346999999999999999999999999999999999999
Q ss_pred Ee-CCeEEEEecCCceecCCCCC----CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHH
Q 040202 85 VS-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSAD 158 (297)
Q Consensus 85 l~-~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~ 158 (297)
++ ++.+||+|||+++....... .....|+..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+
T Consensus 144 l~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~ 222 (273)
T d1u46a_ 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222 (273)
T ss_dssp EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence 97 58999999999998754422 234457889999999875 456889999999999999998 899999988887
Q ss_pred HHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 159 QIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 159 ~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
...++. .++.+|+.+||..||++|||++++++
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 777664 37899999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=299.01 Aligned_cols=184 Identities=24% Similarity=0.424 Sum_probs=147.0
Q ss_pred ccccccccceeeeceeEEe-CCeEEEEEecCCCc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 040202 4 LRKMNNHPNIVKLRNLVKE-HEDVFIVFDYMESD-LLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPS 81 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~-ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~ 81 (297)
+++ ++|||||+++|++.+ .+.+|+||||+.++ +.+++..+....+++..++.++.||+.||.|||+++|+||||||+
T Consensus 54 l~~-l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~ 132 (262)
T d1byga_ 54 MTQ-LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 132 (262)
T ss_dssp HTT-CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHh-CCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence 444 499999999999854 56789999999875 555554443345999999999999999999999999999999999
Q ss_pred cEEEeC-CeEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCHHH
Q 040202 82 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLS-FRILFPGKNSADQ 159 (297)
Q Consensus 82 Nill~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~-g~~pf~~~~~~~~ 159 (297)
|||+++ +.+||+|||+++...... ....+|..|+|||++.+. .++.++|||||||++|||++ |+.||...+..+.
T Consensus 133 Nil~~~~~~~kl~dfg~s~~~~~~~--~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~ 209 (262)
T d1byga_ 133 NVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209 (262)
T ss_dssp GEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred hheecCCCCEeecccccceecCCCC--ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 999985 889999999998765543 456789999999998765 45899999999999999998 7989988777766
Q ss_pred HHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 160 IYKIY------------GRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 160 ~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
...+. .++.+||++||..||++|||+.+++++
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 66653 378999999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=301.07 Aligned_cols=186 Identities=22% Similarity=0.362 Sum_probs=156.1
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHH
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAG-----------------QNFSEDEARNLCFQVFQGLH 66 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~-----------------~~l~e~~~~~~~~qll~al~ 66 (297)
+.++.+|||||++++++.+++.+|+|||||+|+.+..++.... ..+++..++.++.||+.||+
T Consensus 80 ~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 4455589999999999999999999999999855555443321 25899999999999999999
Q ss_pred HHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCCC---CCccccccCCCCCCceecccccCCCccchhhHHHHHH
Q 040202 67 YMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMF 142 (297)
Q Consensus 67 yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ 142 (297)
|||++||+||||||+||+++. +.+|++|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLW 238 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred HHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHH
Confidence 999999999999999999985 899999999998765432 2244678999999999875 45689999999999999
Q ss_pred HHHh-CCCCCCCCCCHHHHHHHH-------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 143 EMLS-FRILFPGKNSADQIYKIY-------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 143 ell~-g~~pf~~~~~~~~~~~i~-------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
||++ |..+|.+.+..+.+.++. .++.+||.+||+.||++|||++++++
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9998 677777777766655543 36899999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=295.88 Aligned_cols=185 Identities=18% Similarity=0.270 Sum_probs=151.9
Q ss_pred ccccccceeeeceeEEe-CCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 040202 6 KMNNHPNIVKLRNLVKE-HEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLL 84 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~-~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nil 84 (297)
+.++|||||+++|++.+ ++.+|+|||||+++++..+.......+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 83 ~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NIL 162 (311)
T d1r0pa_ 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 162 (311)
T ss_dssp HTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEe
Confidence 34599999999999875 56899999999987777666665667889999999999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCCCHH
Q 040202 85 VSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKNSAD 158 (297)
Q Consensus 85 l~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~~~~ 158 (297)
+++ +.+||+|||+++...... ......||+.|+|||++... .++.++||||||+++|||++|..||.......
T Consensus 163 l~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~ 241 (311)
T d1r0pa_ 163 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241 (311)
T ss_dssp ECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred ECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 986 789999999998765432 22335689999999997754 45899999999999999999888776543322
Q ss_pred -HHHHH------------HHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 040202 159 -QIYKI------------YGRWVALISWLCSWNPRMRPTAAEALEH 191 (297)
Q Consensus 159 -~~~~i------------~~~~~~li~~~l~~dP~~R~t~~~ll~h 191 (297)
....+ ..++.+|+.+||..||++|||+.|+++|
T Consensus 242 ~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 242 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 22222 2478999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-41 Score=296.02 Aligned_cols=184 Identities=26% Similarity=0.387 Sum_probs=152.6
Q ss_pred ccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhc-----------------------CCCCCHHHHHHHHHHHH
Q 040202 6 KMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESA-----------------------GQNFSEDEARNLCFQVF 62 (297)
Q Consensus 6 kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~-----------------------~~~l~e~~~~~~~~qll 62 (297)
+.++||||+++++++.+.+..++||||+.++.+..++... ...+++..+..++.|++
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 150 (301)
T d1lufa_ 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150 (301)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred HhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHH
Confidence 3459999999999999999999999999875544444321 12489999999999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEeC-CeEEEEecCCceecCCC---CCCccccccCCCCCCceecccccCCCccchhhHH
Q 040202 63 QGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMG 138 (297)
Q Consensus 63 ~al~yLH~~gi~Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 138 (297)
.||+|||++||+||||||+|||+++ +.+||+|||+|+..... ....+..||+.|+|||++.+. .++.++||||||
T Consensus 151 ~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~G 229 (301)
T d1lufa_ 151 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYG 229 (301)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred HHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccch
Confidence 9999999999999999999999985 78999999999865332 333466789999999998754 468999999999
Q ss_pred HHHHHHHhCC-CCCCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 139 AIMFEMLSFR-ILFPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 139 v~l~ell~g~-~pf~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|++|||++|. .||.+.+..+...++. .++.+|+.+||+.||++|||+.|+++
T Consensus 230 vvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999985 5788877777666554 36899999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=293.95 Aligned_cols=191 Identities=21% Similarity=0.382 Sum_probs=157.6
Q ss_pred cccccccceeeeceeEEeCCeEEEEEecCCCcHH-HHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 040202 5 RKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLL-KLMKESA--------GQNFSEDEARNLCFQVFQGLHYMHRQGYFH 75 (297)
Q Consensus 5 ~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll-~~~~~~~--------~~~l~e~~~~~~~~qll~al~yLH~~gi~H 75 (297)
.+.++|||||++++++..++..++||||+.++.+ +.+.... -..+++..+..++.|++.||.|||+++|+|
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 3445999999999999999999999999987544 4443321 123789999999999999999999999999
Q ss_pred cCCCCCcEEEeC-CeEEEEecCCceecCCCCC---CccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhC-CCC
Q 040202 76 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSF-RIL 150 (297)
Q Consensus 76 rdikp~Nill~~-~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g-~~p 150 (297)
|||||+|||+++ +.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.|
T Consensus 157 rDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCC
Confidence 999999999986 6899999999987644322 2344689999999998754 458899999999999999998 578
Q ss_pred CCCCCCHHHHHHHH------------HHHHHHHHHhhhcCCCCCCCHHHHHc------CCCCCC
Q 040202 151 FPGKNSADQIYKIY------------GRWVALISWLCSWNPRMRPTAAEALE------HPFFRS 196 (297)
Q Consensus 151 f~~~~~~~~~~~i~------------~~~~~li~~~l~~dP~~R~t~~~ll~------h~~f~~ 196 (297)
|.+.+..+....+. ..+.+++.+||+.||++|||+.++++ +|+|+.
T Consensus 236 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 88877766666553 36899999999999999999999987 666653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-39 Score=283.68 Aligned_cols=190 Identities=19% Similarity=0.265 Sum_probs=150.6
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
++++..|++|+.+.+++.+++..++||||++|++...+... ++.+++..+..++.|++.||+|||++||+||||||+||
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NI 134 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhc
Confidence 33443444566666777888999999999999888776654 45699999999999999999999999999999999999
Q ss_pred EEeC----CeEEEEecCCceecCCCC--------CCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCC
Q 040202 84 LVSK----GVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILF 151 (297)
Q Consensus 84 ll~~----~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf 151 (297)
|++. ..+||+|||+|+...... ...+.+||+.|||||++.+. .++.++|||||||++|||++|+.||
T Consensus 135 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp EECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcc
Confidence 9853 469999999998865432 23456899999999997754 4689999999999999999999999
Q ss_pred CCCCCHHHHHH-------------------HHHHHHHHHHHhhhcCCCCCCCHH---HHHcCCCCC
Q 040202 152 PGKNSADQIYK-------------------IYGRWVALISWLCSWNPRMRPTAA---EALEHPFFR 195 (297)
Q Consensus 152 ~~~~~~~~~~~-------------------i~~~~~~li~~~l~~dP~~R~t~~---~ll~h~~f~ 195 (297)
.+......... +..++.+++.+|+..||++||+++ ++|+|.|.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 214 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 87654332211 113578999999999999999987 457777654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=290.99 Aligned_cols=182 Identities=27% Similarity=0.275 Sum_probs=144.5
Q ss_pred cccccceeeeceeEEeCC----eEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcc
Q 040202 7 MNNHPNIVKLRNLVKEHE----DVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR--------QGYF 74 (297)
Q Consensus 7 l~~HpnIv~~~~~~~~~~----~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~--------~gi~ 74 (297)
.++|||||++++++.+.+ .+|+|||||.++.+..++.+ ..+++..+..++.|++.||+|||+ +||+
T Consensus 53 ~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~Iv 130 (303)
T d1vjya_ 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130 (303)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred hCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCee
Confidence 358999999999997654 68999999998666666655 359999999999999999999996 5999
Q ss_pred ccCCCCCcEEEeC-CeEEEEecCCceecCCCC-----CCccccccCCCCCCceecccc-----cCCCccchhhHHHHHHH
Q 040202 75 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSE-----ICGPEVDRWAMGAIMFE 143 (297)
Q Consensus 75 Hrdikp~Nill~~-~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGv~l~e 143 (297)
||||||+|||+++ +.+||+|||+++...... .....+||+.|+|||++.... .++.++|||||||++||
T Consensus 131 HrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred ccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHH
Confidence 9999999999975 799999999998765432 234578999999999876432 14568999999999999
Q ss_pred HHhCCCCCCCCC--------------CHHHHHH-------------------HHHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 040202 144 MLSFRILFPGKN--------------SADQIYK-------------------IYGRWVALISWLCSWNPRMRPTAAEALE 190 (297)
Q Consensus 144 ll~g~~pf~~~~--------------~~~~~~~-------------------i~~~~~~li~~~l~~dP~~R~t~~~ll~ 190 (297)
|++|..||.... ..+...+ ....+.+|+.+||+.||++|||+.|+++
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 999988763211 1111111 2235789999999999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-38 Score=279.03 Aligned_cols=184 Identities=18% Similarity=0.227 Sum_probs=152.2
Q ss_pred ccccccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 040202 4 LRKMNNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNL 83 (297)
Q Consensus 4 l~kl~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Ni 83 (297)
+.++.+|+||+++++++.++...|+||||+++++.+.+.. .+..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Ni 132 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Confidence 4455566999999999999999999999998887776654 455799999999999999999999999999999999999
Q ss_pred EEe------CCeEEEEecCCceecCCC--------CCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCC
Q 040202 84 LVS------KGVIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRI 149 (297)
Q Consensus 84 ll~------~~~~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~ 149 (297)
|++ .+.+||+|||+|+..... ....+.+||+.|||||++.+. .++.++|||||||++|||++|+.
T Consensus 133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~ 211 (293)
T d1csna_ 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSL 211 (293)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCC
Confidence 996 257999999999875432 223456899999999998754 46899999999999999999999
Q ss_pred CCCCCCCHHH---HHHH----------------HHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040202 150 LFPGKNSADQ---IYKI----------------YGRWVALISWLCSWNPRMRPTAAEAL 189 (297)
Q Consensus 150 pf~~~~~~~~---~~~i----------------~~~~~~li~~~l~~dP~~R~t~~~ll 189 (297)
||.+...... ..++ ..++.+++..|+..+|++||+.+.+.
T Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 212 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 9986544221 1111 13678899999999999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-37 Score=279.51 Aligned_cols=187 Identities=29% Similarity=0.465 Sum_probs=148.4
Q ss_pred ccccceeeeceeEEe--CCeEEEEEecCCC--cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCc
Q 040202 8 NNHPNIVKLRNLVKE--HEDVFIVFDYMES--DLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHR-QGYFHRDLKPSN 82 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~--~~~~~lv~e~~~g--~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~-~gi~Hrdikp~N 82 (297)
..|+||+++++++.. ....+++++++.+ +............+++..++.++.|++.||+|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 368999999999864 4566777776653 44444455545679999999999999999999998 899999999999
Q ss_pred EEEeC-C------eEEEEecCCceecCCCCCCccccccCCCCCCceecccccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 040202 83 LLVSK-G------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEICGPEVDRWAMGAIMFEMLSFRILFPGKN 155 (297)
Q Consensus 83 ill~~-~------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv~l~ell~g~~pf~~~~ 155 (297)
||++. + .+|++|||.+....... ...+||+.|+|||++.... ++.++||||+||++++|++|+.||....
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeeccCcccccceeeEeeccccccccccc--ccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCc
Confidence 99963 2 49999999998765433 5678999999999987654 5889999999999999999999997543
Q ss_pred CHH------HH-----------------------------------------------------HHHHHHHHHHHHHhhh
Q 040202 156 SAD------QI-----------------------------------------------------YKIYGRWVALISWLCS 176 (297)
Q Consensus 156 ~~~------~~-----------------------------------------------------~~i~~~~~~li~~~l~ 176 (297)
... .. .....++++||.+||.
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 210 00 0123357889999999
Q ss_pred cCCCCCCCHHHHHcCCCCCCC
Q 040202 177 WNPRMRPTAAEALEHPFFRSC 197 (297)
Q Consensus 177 ~dP~~R~t~~~ll~h~~f~~~ 197 (297)
.||.+|||++|+|+||||++.
T Consensus 314 ~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 314 LDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp SSTTTCBCHHHHHTCGGGTTC
T ss_pred CChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.71 E-value=8.7e-19 Score=143.50 Aligned_cols=116 Identities=15% Similarity=0.090 Sum_probs=82.6
Q ss_pred ccccceeeeceeEEeCCeEEEEEecCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEeC
Q 040202 8 NNHPNIVKLRNLVKEHEDVFIVFDYMESDLLKLMKESAGQNFSEDEARNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 87 (297)
Q Consensus 8 ~~HpnIv~~~~~~~~~~~~~lv~e~~~g~ll~~~~~~~~~~l~e~~~~~~~~qll~al~yLH~~gi~Hrdikp~Nill~~ 87 (297)
+.|.++++.+++.. .+++|||++++... .+++..+..++.|++.+|+|||++||+||||||+|||+++
T Consensus 71 l~~~~v~~~~~~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 71 LQGLAVPKVYAWEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp TTTSSSCCEEEEET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred ccCCCcceEEEecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence 37888888776532 27999999985432 2566777899999999999999999999999999999999
Q ss_pred CeEEEEecCCceecCCCCCCccccc-cCCCCCCceecccccCCCccchhhHHH
Q 040202 88 GVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEVLLLSEICGPEVDRWAMGA 139 (297)
Q Consensus 88 ~~~kl~Dfgla~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlGv 139 (297)
+.++|+|||.|........ ..... .... -.+.+ .+.|+.++|+||+.-
T Consensus 139 ~~~~liDFG~a~~~~~~~~-~~~l~rd~~~-~~~~f--~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGW-REILERDVRN-IITYF--SRTYRTEKDINSAID 187 (191)
T ss_dssp TEEEECCCTTCEETTSTTH-HHHHHHHHHH-HHHHH--HHHHCCCCCHHHHHH
T ss_pred CCEEEEECCCcccCCCCCc-HHHHHHHHHH-HHHHH--cCCCCCcccHHHHHH
Confidence 8999999999977653321 00000 0000 00111 244688999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.45 E-value=0.00015 Score=59.70 Aligned_cols=27 Identities=37% Similarity=0.543 Sum_probs=23.5
Q ss_pred ccccCCCCCcEEEeCCeE-EEEecCCce
Q 040202 73 YFHRDLKPSNLLVSKGVI-KIGDLGMVK 99 (297)
Q Consensus 73 i~Hrdikp~Nill~~~~~-kl~Dfgla~ 99 (297)
++|+|+.+.||+++++.+ -|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 799999999999998765 599999653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.32 E-value=0.0019 Score=52.36 Aligned_cols=26 Identities=27% Similarity=0.289 Sum_probs=23.0
Q ss_pred ccccCCCCCcEEEeCCe-EEEEecCCc
Q 040202 73 YFHRDLKPSNLLVSKGV-IKIGDLGMV 98 (297)
Q Consensus 73 i~Hrdikp~Nill~~~~-~kl~Dfgla 98 (297)
++|+|+.|.|||++++. +-|+||+.+
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhc
Confidence 79999999999999876 579999965
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.20 E-value=0.0022 Score=56.12 Aligned_cols=29 Identities=21% Similarity=0.221 Sum_probs=26.1
Q ss_pred CccccCCCCCcEEEeCCeEEEEecCCcee
Q 040202 72 GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 100 (297)
Q Consensus 72 gi~Hrdikp~Nill~~~~~kl~Dfgla~~ 100 (297)
.++|+|+.+.|||++++.++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCceEEechhhccc
Confidence 58999999999999998899999997753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.81 E-value=0.012 Score=49.37 Aligned_cols=29 Identities=21% Similarity=0.251 Sum_probs=25.1
Q ss_pred CCccccCCCCCcEEEeCCeE-EEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKGVI-KIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~-kl~Dfgla~ 99 (297)
.|+||+|+.++||+++++.+ -|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 47999999999999998765 799999763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.27 E-value=0.046 Score=45.94 Aligned_cols=28 Identities=25% Similarity=0.261 Sum_probs=23.5
Q ss_pred CCccccCCCCCcEEEeCCeEEEEecCCce
Q 040202 71 QGYFHRDLKPSNLLVSKGVIKIGDLGMVK 99 (297)
Q Consensus 71 ~gi~Hrdikp~Nill~~~~~kl~Dfgla~ 99 (297)
.+++|+|+.+.|||++++. .++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~~-~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDGP-MFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSSE-EECCCTTCC
T ss_pred ceeecCCCCcccEEEeCCc-eEEechhcc
Confidence 3689999999999998765 489999664
|